Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AADACL2	MGC72001	ENSG00000197953	"Arylacetamide deacetylase like 2"	Q6P093	3	151733916-151761339	"Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 35.6"	"Cell type enriched"	"Detected in some"	7	"Suprabasal keratinocytes: 30.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 28: Keratinocytes - Keratinization"					"unprognostic (2.20e-2)"				"unprognostic (3.10e-3)"		"unprognostic (2.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"				"unprognostic (3.00e-1)"			"unprognostic (2.91e-4)"	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	35.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	30.7	0.1	0.1	0.0	0.0	0.0
AAMDC	"C11orf67, CK067, FLJ21035, PTD015"	ENSG00000087884	"Adipogenesis associated Mth938 domain containing"	Q9H7C9	11	77821109-77918432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 656.7"	"Cell type enhanced"	"Detected in all"		"Theca cells: 385.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 143.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 280.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA037918, HPA037919"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA037918: AB_2675737, HPA037919: AB_2675738"	"unprognostic (3.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (6.02e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.84e-2)"	75.8	180.9	30.1	13.0	35.8	21.0	62.5	35.2	42.6	51.0	31.4	66.6	37.4	41.4	27.9	24.6	47.5	23.4	178.9	30.5	31.7	56.0	57.9	46.9	13.8	37.2	34.4	56.7	34.4	27.4	28.6	21.7	35.9	46.0	29.2	20.1	36.6	34.6	656.7	55.4	47.5	40.2	31.9	31.7	62.4	42.2	34.3	23.7	42.2	173.0	13.6	48.1	42.7	42.7	30.3	24.3	37.2	26.5	106.0	73.3	10.0	49.2	33.4	43.8	54.1	280.1	44.6	20.3	46.5	83.0	43.2	16.9	56.4	32.9	51.9	47.1	45.3	19.5	43.5	52.4	52.2	11.2	17.1	98.3	22.2	46.0	24.2	40.2	131.3	27.0	23.1	32.0	93.2	35.6	23.8	44.3	17.3	84.5	41.4	22.3	63.6	19.6	58.2	18.1	13.1	49.2	62.4	26.7	36.0	55.1	41.2	21.1	138.2	45.5	24.7	87.5	16.5	34.2	58.4	37.8	17.7	18.0	26.2	143.1	28.9	33.3	14.6	17.7	18.8	18.3	28.4	24.2	32.6	25.2	24.8	18.4	16.9	35.9	17.5	33.8	47.3	16.3	30.1	35.8	35.2	42.6	30.5	31.7	37.2	34.4	35.9	31.9	34.3	42.7	68.4	83.3	25.4	19.6	10.0	64.2	82.7	51.0	24.5	10.0	58.7	67.2	114.1	62.9	42.5	79.1	4.2	29.1	11.8	70.2	144.8	60.0	100.1	37.7	27.8	55.7	22.7	19.1	6.9	73.1	43.1	64.5	39.3	35.8	41.2	53.4	93.9	122.2	46.9	11.8	8.9	48.7	44.7	29.9	35.9	36.3	68.3	22.5	83.6	8.4	56.2	101.3	16.5	18.1	24.8	70.2	132.2	64.3	10.2	46.6	160.3	200.8	50.1	13.9	46.0	53.5	65.8	154.0	85.4	29.2	100.7	15.7	14.8	385.5	61.0	71.2
ACAD9	"MGC14452, NPD002"	ENSG00000177646	"Acyl-CoA dehydrogenase family member 9"	Q9H845	3	128879596-128924003	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037716, HPA046720"	Supported		Enhanced	Mitochondria		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA037716: AB_10673638, HPA046720: AB_2679773"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.67e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-3)"	"prognostic favorable (4.32e-8)"	"unprognostic (1.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.96e-2)"	16.7	20.5	9.0	6.1	8.5	4.7	14.5	9.6	10.2	14.4	9.1	13.6	9.0	14.6	7.7	23.2	12.9	7.3	21.9	8.3	8.7	15.6	20.6	11.0	6.6	8.2	8.7	12.9	14.4	27.7	14.6	8.4	8.4	12.1	9.4	4.1	14.2	12.0	30.4	48.0	11.2	11.1	7.4	12.2	15.9	12.5	8.7	12.1	13.6	28.7	11.2	12.9	14.5	9.0	46.2	22.6	18.0	12.6	28.7	20.7	17.5	22.4	26.2	43.6	36.8	33.3	27.1	33.3	21.1	29.5	29.0	35.5	33.8	45.9	32.8	21.2	23.1	29.3	46.8	24.4	21.6	23.9	10.6	22.5	16.8	23.6	26.7	25.1	35.8	25.2	14.4	11.4	29.5	46.5	36.7	19.0	9.9	49.3	33.8	25.5	17.4	35.1	30.9	25.1	19.0	11.6	37.0	32.9	23.2	17.4	44.5	54.8	18.2	13.2	13.4	14.2	20.3	14.5	5.8	28.3	28.3	21.4	22.7	2.4	15.1	4.9	8.3	18.3	7.8	8.1	7.6	7.3	17.5	5.4	6.2	8.0	0.7	6.8	25.2	9.9	8.3	12.1	9.0	8.5	9.6	10.2	8.3	8.7	8.2	8.7	8.4	7.4	8.7	9.0	10.4	16.0	21.7	13.1	9.3	6.2	11.4	16.7	8.6	14.1	11.9	9.5	30.5	15.7	14.8	14.7	10.4	26.2	10.5	11.7	21.5	20.6	20.2	10.4	11.5	11.2	5.4	14.3	14.3	17.8	18.8	12.9	16.8	12.9	16.5	12.0	15.7	26.7	31.5	10.1	17.7	7.4	16.2	9.5	4.0	17.3	10.2	10.8	16.0	7.5	13.4	15.0	12.3	6.0	12.2	14.1	8.7	14.7	9.5	8.1	9.4	26.3	12.0	11.9	13.1	12.7	14.9	22.6	9.6	13.5	14.2	30.6	8.2	18.1	14.3	8.4
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857405	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 104.2;Late spermatids: 90.3;Proximal enterocytes: 105.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	8.3	31.7	27.8	8.6	29.8	18.1	7.6	28.2	35.2	9.3	24.3	18.5	21.1	8.5	11.0	17.5	10.7	9.2	28.1	29.8	28.6	21.3	26.0	11.0	12.6	27.0	28.5	8.0	15.6	15.1	15.4	7.1	28.7	12.7	12.8	9.2	12.8	5.9	28.7	17.0	20.5	6.4	26.0	12.3	21.3	20.2	28.7	13.1	11.4	17.8	9.7	11.0	10.4	28.1	16.8	20.2	6.8	13.4	18.3	11.0	11.7	11.1	9.5	15.1	13.7	29.2	22.7	20.8	48.2	16.3	35.4	32.3	13.0	27.8	6.6	15.5	22.3	21.2	25.1	28.5	16.9	19.9	19.3	12.9	21.3	15.1	10.9	22.6	9.4	23.6	18.8	24.2	11.0	47.4	28.7	27.0	11.8	32.4	52.2	14.0	12.2	37.6	16.5	19.1	23.1	10.8	24.9	61.7	39.5	10.6	34.4	48.8	11.6	37.9	8.5	19.5	18.9	20.7	33.8	14.0	46.3	21.2	20.8	34.3	34.3	43.6	24.8	34.6	21.8	27.5	23.2	21.9	36.7	27.9	20.0	21.6	25.0	16.3	34.2	23.3	31.9	26.7	27.8	29.8	28.2	35.2	29.8	28.6	27.0	28.5	28.7	26.0	28.7	28.1	8.2	35.3	14.1	5.9	17.9	6.1	12.3	21.9	8.6	19.2	9.8	10.9	9.3	11.5	17.7	12.9	16.7	34.2	11.8	104.2	64.6	21.6	38.5	14.2	10.4	10.9	19.2	17.0	12.3	21.0	20.9	11.4	19.9	14.0	14.0	27.6	11.4	25.5	27.8	8.4	12.0	37.3	10.2	18.6	7.1	90.3	9.9	17.5	10.6	3.7	27.5	17.8	34.0	5.0	9.6	21.6	68.4	8.6	21.3	11.3	105.4	81.5	27.1	22.8	13.1	5.8	12.8	27.0	10.2	16.1	8.0	19.4	13.9	37.6	30.3	16.0
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 71.9;placenta: 47.4"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		110000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.8	2.8	2.6	4.1	2.3	0.4	5.2	1.6	1.9	3.0	1.9	6.2	17.5	1.1	1.3	11.6	5.2	8.3	4.0	1.8	1.7	7.2	71.9	15.2	1.7	2.4	2.9	1.4	3.2	1.3	0.3	47.4	2.2	3.2	6.4	0.1	9.0	6.5	0.5	14.5	10.2	2.2	2.5	7.5	12.3	2.1	4.6	4.6	1.6	1.2	4.0	15.1	5.6	1.9	17.0	88.6	1.9	9.4	0.5	0.0	0.2	23.1	4.3	17.2	10.7	71.3	51.0	0.0	20.3	13.4	4.9	41.3	2.6	22.1	28.3	0.0	6.8	3.6	14.5	84.8	16.7	14.6	0.0	0.1	34.9	0.4	81.5	10.0	161.4	0.4	0.6	0.1	6.9	155.6	0.3	0.0	0.7	6.2	20.0	0.0	7.7	17.7	9.0	37.9	0.1	0.1	6.8	30.8	14.5	14.1	16.7	0.3	5.6	0.1	7.6	7.7	11.5	0.0	0.1	0.0	0.1	0.1	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.3	1.6	1.9	1.8	1.7	2.4	2.9	2.2	2.5	4.6	1.9	5.1	6.4	5.9	0.0	0.3	0.0	21.9	0.0	18.8	0.0	5.3	2.7	1.9	24.3	8.1	9.2	0.0	5.3	0.0	0.6	0.0	13.2	0.1	0.1	0.5	41.7	0.0	17.0	1.6	5.4	33.5	14.5	32.1	0.5	0.0	0.0	27.1	143.8	2.2	0.0	12.7	3.5	0.0	40.5	0.0	0.6	0.6	8.1	0.0	15.0	0.9	0.0	0.0	0.5	0.3	37.9	8.8	0.4	0.1	18.7	9.5	11.8	2.9	0.0	6.6	0.4	1.3	2.6	5.3	30.2	0.0	13.5	1.6	0.0	1.7	25.0
ADIPOR1	"ACDCR1, PAQR1"	ENSG00000159346	"Adiponectin receptor 1"	Q96A54	1	202940826-202958572	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 329.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.63e-2)"	59.8	58.5	56.1	49.1	60.1	215.2	63.6	58.7	64.2	55.4	82.9	55.6	46.5	40.9	91.4	110.9	68.6	48.2	92.6	56.8	57.7	70.4	106.2	80.5	48.0	61.2	58.6	47.7	91.7	107.1	45.5	100.0	60.2	53.7	59.8	135.6	106.6	47.4	136.5	110.8	47.4	50.9	60.1	65.8	63.3	48.7	58.7	50.2	56.6	140.2	77.9	70.9	69.2	65.2	97.0	87.2	53.4	59.9	111.4	85.4	276.8	103.4	123.9	108.8	99.4	88.7	114.7	63.5	75.3	120.6	86.3	118.0	81.3	145.5	96.5	118.5	93.5	48.6	104.3	72.6	109.7	101.6	71.6	101.7	235.0	115.9	118.3	108.4	108.8	111.7	128.1	133.5	111.2	105.6	85.3	77.4	119.7	87.1	103.1	66.7	128.7	125.7	106.5	111.0	89.2	90.8	109.6	166.5	135.5	143.6	121.1	99.4	95.7	78.9	62.2	39.4	117.3	137.8	197.4	71.4	113.5	58.9	94.5	362.2	361.8	455.4	136.0	253.6	143.8	157.9	143.4	134.1	209.8	165.2	141.5	124.3	825.9	126.0	259.6	146.1	179.5	557.4	56.1	60.1	58.7	64.2	56.8	57.7	61.2	58.6	60.2	60.1	58.7	65.2	40.7	35.3	52.5	6.8	46.8	235.0	95.2	109.8	75.7	24.8	81.9	54.2	59.7	32.9	79.3	53.3	29.2	112.7	42.8	49.3	68.4	73.8	68.2	58.8	24.5	53.4	49.1	329.0	13.7	86.3	172.4	40.9	37.2	54.3	37.3	18.8	58.5	60.8	104.2	11.8	15.1	49.1	85.5	148.5	89.7	62.5	28.6	107.6	85.4	15.9	85.0	38.0	42.2	9.5	20.0	120.0	43.5	24.5	116.0	133.1	67.3	65.9	82.5	54.9	39.5	29.2	61.7	26.4	27.2	79.3	228.9	202.8	47.1	29.2	41.7	206.6
AEBP2	MGC17922	ENSG00000139154	"AE binding protein 2"	Q6ZN18	12	19404045-19720801	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020893, HPA022282"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA020893: AB_2670528, HPA022282: AB_2670931"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	19.0	27.2	9.9	20.0	11.6	20.5	23.5	13.0	16.5	25.8	12.5	18.8	16.3	34.0	20.2	35.1	28.0	21.8	17.8	17.7	7.2	27.8	20.3	20.7	27.7	1.9	6.7	35.1	17.5	29.9	8.9	44.1	2.0	24.8	20.6	27.7	19.3	30.7	13.6	29.4	16.7	31.1	0.3	23.1	16.1	20.8	11.8	29.2	30.8	19.8	32.3	25.0	18.2	14.7	32.4	42.4	42.6	20.1	31.1	38.6	95.2	29.9	34.1	43.5	45.7	48.0	54.5	51.0	24.3	41.4	27.6	38.0	93.7	34.6	69.1	149.4	30.6	46.7	60.8	30.0	36.4	60.1	30.8	36.2	36.3	35.6	52.8	52.0	35.6	34.8	25.2	1.4	41.2	38.5	63.0	71.7	82.6	26.6	18.9	50.3	82.3	35.9	32.2	68.2	10.0	23.4	60.6	25.7	29.8	91.3	32.8	35.0	40.5	40.7	30.9	12.8	44.9	14.0	24.9	106.0	30.3	25.1	29.2	4.3	2.5	2.5	4.2	2.7	4.4	2.2	4.4	3.6	2.0	2.8	3.7	5.8	2.7	6.0	2.2	2.6	4.5	1.2	9.9	11.6	13.0	16.5	17.7	7.2	1.9	6.7	2.0	0.3	11.8	14.7	23.9	25.6	14.3	31.6	20.5	75.2	25.1	15.5	53.5	29.8	22.0	13.3	22.1	12.8	24.2	12.9	43.8	60.3	24.3	9.5	17.6	12.3	1.3	31.1	31.5	22.2	22.7	11.6	57.2	12.2	24.8	28.3	14.3	28.8	27.8	17.7	14.3	12.9	15.4	52.2	59.4	11.2	4.1	17.0	47.9	2.3	24.5	17.8	28.4	30.0	17.7	21.5	14.4	42.3	51.6	11.5	10.3	29.0	18.3	24.5	9.0	18.3	26.1	16.1	19.7	46.7	40.1	16.2	26.3	51.0	76.0	83.0	28.1	34.2	10.7	28.2
AGO4	"EIF2C4, FLJ20033, hAGO4, KIAA1567"	ENSG00000134698	"Argonaute RISC component 4"	Q9HCK5	1	35808016-35857890	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 60.6;Inhibitory neurons: 72.0;Microglial cells: 63.7;Oligodendrocyte precursor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 7.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012179, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Cytoplasmic bodies"	Cytosol	"CAB012179: , HPA067849: "	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.70e-5)"	"unprognostic (3.92e-3)"	"unprognostic (3.99e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-3)"	"unprognostic (4.91e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.58e-2)"	8.8	4.9	7.2	8.8	7.1	20.4	7.7	8.6	7.9	8.4	8.6	9.6	4.7	8.9	6.6	7.3	7.2	6.2	9.9	6.8	6.8	5.0	7.5	11.4	7.0	7.4	7.1	7.0	8.6	6.5	5.8	8.9	7.4	8.1	6.4	18.1	8.4	6.1	13.3	20.1	7.8	9.8	6.8	14.2	9.7	7.3	7.3	7.3	5.5	11.8	6.8	8.2	8.5	7.6	6.0	1.5	11.3	6.5	5.8	6.6	5.7	4.5	4.4	4.6	5.3	0.8	9.0	9.6	6.0	6.6	4.7	2.4	4.9	3.6	4.3	10.7	4.5	4.9	4.2	2.8	5.5	5.6	7.2	4.3	7.6	2.5	3.8	8.8	7.9	11.5	3.7	3.7	6.2	0.9	9.1	6.2	3.7	3.8	2.7	9.0	10.1	1.2	4.5	7.4	5.0	7.3	4.1	3.7	12.7	9.6	3.0	24.6	9.5	3.5	1.7	3.6	3.4	5.4	1.8	1.4	4.3	7.0	3.2	1.3	2.7	3.0	0.8	1.5	1.4	0.6	0.7	1.1	2.0	0.4	0.3	0.4	7.5	0.6	1.4	0.4	0.2	0.8	7.2	7.1	8.6	7.9	6.8	6.8	7.4	7.1	7.4	6.8	7.3	7.6	16.4	19.2	21.7	54.9	6.7	9.8	4.7	5.4	9.6	28.2	8.5	7.1	21.8	12.8	9.2	11.0	22.9	4.2	17.9	5.5	1.9	5.6	2.0	12.7	9.4	11.6	12.6	5.0	60.6	5.6	4.7	7.2	10.7	10.9	2.5	11.4	22.1	11.5	13.5	6.7	72.0	8.4	2.0	42.3	10.0	1.6	5.0	28.9	3.6	63.7	33.6	6.5	6.2	87.4	54.8	14.4	11.7	5.7	4.3	9.0	10.0	1.5	10.3	32.2	19.7	6.8	8.5	11.3	1.6	5.9	12.8	4.1	10.3	3.6	5.7	6.7
AJUBA	"JUB, MGC15563"	ENSG00000129474	"Ajuba LIM protein"	Q96IF1	14	22971177-22982551	"Cancer-related genes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 61.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 47.5;Basal squamous epithelial cells: 35.3;Pancreatic endocrine cells: 33.8;Prostatic glandular cells: 34.2;Sertoli cells: 32.9;Suprabasal keratinocytes: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 217.0;hTCEpi: 222.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006171	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Golgi apparatus"		"HPA006171: AB_1852044"	"unprognostic (1.15e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.07e-1)"	4.8	3.0	2.3	1.4	1.8	0.5	6.7	2.0	2.2	14.4	9.2	3.2	1.5	12.1	8.5	18.3	7.5	4.9	6.3	2.2	1.5	17.7	43.4	15.2	2.6	2.5	2.1	12.2	11.6	7.2	2.0	19.3	1.6	10.6	2.5	3.7	8.2	15.9	1.9	61.7	1.9	8.4	2.2	3.8	4.2	5.5	1.9	8.2	10.9	2.3	5.5	7.6	15.5	2.7	46.9	54.1	71.0	27.6	6.8	12.2	57.4	44.9	58.5	102.6	91.4	116.0	47.3	1.2	45.5	92.9	70.8	146.2	54.9	217.0	124.6	4.5	5.0	3.5	90.8	131.4	78.9	4.9	3.1	38.9	222.3	42.9	164.3	72.7	40.0	8.3	1.9	2.8	96.2	37.3	4.5	5.7	4.5	86.6	73.9	12.7	59.0	1.2	103.9	71.3	0.2	6.2	135.5	39.4	8.8	57.4	55.3	4.5	36.1	44.2	88.4	7.3	43.6	0.4	1.3	0.5	7.0	4.2	20.6	0.7	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.5	0.1	0.2	0.3	0.2	0.5	0.5	0.2	0.2	0.0	0.1	2.3	1.8	2.0	2.2	2.2	1.5	2.5	2.1	1.6	2.2	1.9	2.7	2.1	19.2	6.4	0.7	0.0	47.5	13.0	27.6	35.3	0.1	3.7	9.7	4.5	20.0	10.2	7.3	0.0	10.0	0.1	0.3	5.9	14.3	5.8	13.0	2.5	4.0	0.0	0.0	0.0	14.9	9.8	3.4	0.0	4.4	0.0	12.8	2.5	17.1	1.7	0.0	0.0	0.4	2.0	0.0	2.2	5.0	3.7	0.6	3.6	0.0	0.0	8.1	0.0	0.5	0.0	33.8	0.1	0.7	1.2	34.2	0.3	21.0	8.3	0.2	32.9	2.7	14.0	7.0	2.7	14.2	49.6	4.0	0.5	1.6	0.8	18.0
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 496.1;salivary gland: 128.0;stomach 1: 224.8"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 389.5;Basal squamous epithelial cells: 274.3;Club cells: 150.1;Gastric mucus-secreting cells: 437.9;Respiratory ciliated cells: 412.7;Squamous epithelial cells: 342.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.4;lung cancer: 60.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"A549: 5094.7;OE19: 6071.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		52000	"Cluster 22: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	1.7	1.0	0.4	1.3	0.7	0.1	3.2	0.3	0.4	6.7	17.5	4.5	6.2	0.3	0.2	496.1	5.5	10.3	0.3	1.0	0.4	1.3	1.9	10.9	0.5	0.6	2.1	0.4	0.5	0.0	0.9	0.0	0.5	1.9	3.3	0.1	128.0	1.5	1.3	72.6	3.5	0.4	0.9	0.9	224.8	1.6	1.3	0.6	0.5	0.3	33.7	6.2	22.3	0.9	0.1	5094.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	10.7	246.5	0.0	2.7	0.5	2.0	29.3	0.7	12.8	0.0	0.0	0.8	0.1	116.6	1.0	0.3	0.1	0.5	0.0	14.9	0.5	0.4	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.1	0.3	0.4	6071.6	19.8	0.0	0.0	0.0	0.0	87.0	0.2	0.6	24.8	0.0	0.0	0.2	0.2	0.9	0.6	0.3	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.4	1.0	0.4	0.6	2.1	0.5	0.9	1.3	0.9	0.7	3.2	5.5	0.0	0.7	44.1	46.8	389.5	274.3	0.0	0.1	1.5	0.4	2.8	150.1	0.0	0.0	0.0	0.0	5.1	0.0	1.4	1.5	12.4	0.2	1.3	1.8	0.0	0.1	0.5	0.0	1.6	437.9	0.8	2.5	0.3	1.4	3.2	0.2	0.0	0.0	4.8	83.4	0.3	1.8	5.2	0.9	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	9.5	4.7	1.9	3.2	5.8	3.4	5.0	412.7	0.2	0.0	1.7	20.1	1.7	8.6	342.2	32.0	0.0	0.5	0.2	8.4	64.3
AMBRA1	"DCAF3, FLJ20294, KIAA1736, WDR94"	ENSG00000110497	"Autophagy and beclin 1 regulator 1"	Q9C0C7	11	46396414-46594125	"Predicted intracellular proteins"	"Autophagy, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 65.6;Excitatory neurons: 101.4;Inhibitory neurons: 101.9;Microglial cells: 84.3;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 11.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017825, HPA038535"	Approved		Approved	Vesicles,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Mitochondria	"CAB017825: , HPA038535: AB_2676068"	"unprognostic (1.76e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.98e-2)"	10.2	16.4	7.5	6.7	9.1	11.6	10.5	7.8	9.1	10.4	7.4	10.1	10.0	11.7	5.8	10.6	10.1	6.4	8.4	7.9	6.4	8.2	9.1	8.6	8.2	6.6	6.1	11.6	8.3	12.3	9.2	7.6	7.3	9.8	7.0	7.8	10.6	7.6	13.0	17.4	9.8	8.8	5.4	10.3	9.7	12.6	8.4	13.5	9.4	8.3	8.1	9.4	10.0	10.8	8.7	23.0	15.5	16.8	16.1	12.0	9.6	8.5	16.1	13.6	14.1	17.4	14.8	17.5	8.5	15.1	16.1	15.4	7.9	15.0	10.0	15.3	25.5	11.9	14.6	22.5	10.5	17.3	14.6	16.7	11.6	8.6	16.3	14.8	14.3	14.9	20.8	11.7	10.2	21.4	22.2	12.2	26.1	19.6	12.4	21.5	21.3	9.7	13.1	15.4	12.5	13.9	14.7	16.6	15.6	10.1	17.2	11.6	15.2	12.5	11.1	14.6	12.8	13.2	11.3	18.1	11.1	9.6	11.3	11.8	2.2	1.7	2.6	1.1	2.2	2.4	1.9	2.0	2.0	2.1	1.9	1.7	2.5	1.4	1.9	2.1	3.2	1.9	7.5	9.1	7.8	9.1	7.9	6.4	6.6	6.1	7.3	5.4	8.4	10.8	5.1	3.2	5.6	65.6	7.2	4.1	2.5	3.4	4.0	6.6	5.1	5.2	8.2	4.3	4.3	0.0	2.1	4.0	5.9	16.0	0.0	6.9	13.8	5.2	5.3	4.7	9.6	10.3	101.4	9.3	2.1	6.7	13.7	8.3	4.5	8.8	3.6	4.1	5.2	5.0	101.9	9.7	2.0	3.5	2.3	6.7	5.3	4.8	5.4	84.3	3.1	3.2	6.2	84.9	136.4	8.4	7.5	7.9	6.6	3.5	8.2	3.2	4.4	5.7	13.1	4.2	5.8	2.1	2.1	7.4	4.5	6.8	6.4	7.9	6.4	4.2
AMMECR1		ENSG00000101935	"AMMECR nuclear protein 1"	Q9Y4X0	X	110194186-110440318	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 83.1;Excitatory neurons: 92.8;Inhibitory neurons: 108.7;Rod photoreceptor cells: 87.3;Syncytiotrophoblasts: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000590, HPA051762"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Mitochondria	"HPA000590: AB_2666037, HPA051762: AB_2681596"	"unprognostic (7.77e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.55e-2)"	"unprognostic (5.98e-2)"	"prognostic favorable (6.62e-5)"	"unprognostic (3.61e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (7.82e-2)"	3.6	2.9	1.7	3.7	1.7	13.4	3.4	1.8	2.0	2.9	8.5	3.7	3.1	2.3	2.1	7.9	3.3	2.3	1.1	1.5	1.7	3.4	3.3	2.8	4.2	1.3	1.3	5.5	2.0	2.2	2.0	7.0	1.2	2.2	3.9	14.5	2.8	1.9	1.3	7.4	3.3	2.9	1.0	3.7	3.7	1.6	1.7	4.5	2.4	1.7	5.7	4.8	4.5	1.5	20.3	9.8	7.1	3.4	7.9	11.8	7.8	13.8	12.3	11.1	16.2	15.9	14.4	12.0	6.4	18.4	9.0	9.5	22.7	15.7	11.3	8.4	10.1	16.7	21.7	3.3	19.9	13.5	6.7	6.6	27.3	12.7	22.6	6.0	8.9	5.9	47.1	34.8	8.5	17.2	6.5	4.8	32.6	17.4	19.1	13.7	7.6	21.2	18.8	16.8	11.3	5.3	23.2	22.7	19.9	8.5	5.6	13.3	4.1	7.6	4.6	22.8	12.6	7.1	8.6	18.9	11.6	27.5	25.9	0.6	0.9	0.8	1.6	0.6	2.1	1.6	3.2	2.6	1.5	2.2	2.1	1.9	0.4	0.6	2.7	0.6	2.3	1.0	1.7	1.7	1.8	2.0	1.5	1.7	1.3	1.3	1.2	1.0	1.7	1.5	4.4	0.0	9.8	17.9	11.5	9.6	3.9	10.5	5.7	35.3	7.5	4.4	4.2	8.6	8.9	3.7	52.1	27.2	9.5	8.9	23.5	9.2	0.5	10.5	7.7	9.6	15.0	83.1	92.8	12.0	9.9	12.8	13.7	13.4	2.5	14.4	19.6	8.4	7.1	1.7	108.7	11.2	12.2	7.6	3.1	2.1	12.8	7.3	3.6	21.5	9.4	7.1	14.4	35.7	19.2	11.5	3.7	17.3	8.0	9.1	10.3	10.2	10.4	87.3	13.1	6.7	8.4	2.2	6.9	17.4	26.7	86.5	13.0	34.7	10.5	15.7
ANKRD16	DKFZP434N1511	ENSG00000134461	"Ankyrin repeat domain 16"	Q6P6B7	10	5861616-5889906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 26.9;Inhibitory neurons: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037920, HPA037921"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA037920: AB_10671381, HPA037921: AB_2675740"	"unprognostic (1.90e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.06e-2)"	"unprognostic (7.64e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.93e-2)"	3.8	4.0	5.5	2.3	5.5	1.9	4.1	5.6	7.9	6.3	3.1	3.7	3.2	5.1	4.9	3.7	5.8	2.5	3.3	5.2	4.2	3.5	4.1	3.0	3.1	5.0	4.5	6.2	4.1	5.7	3.9	1.7	5.2	4.1	2.5	4.4	4.0	3.1	3.9	6.7	3.2	3.2	4.0	3.2	6.6	8.7	4.8	3.8	3.7	2.6	3.3	4.3	4.4	5.6	8.3	9.8	4.5	9.2	4.6	3.4	6.6	2.5	1.9	4.4	3.8	12.1	4.3	8.8	3.5	4.2	1.6	8.5	5.5	6.4	2.0	3.1	8.6	5.5	4.8	11.1	5.9	3.4	3.8	5.3	4.8	4.0	3.1	3.5	4.9	9.0	7.5	2.6	3.1	11.5	12.7	5.8	3.7	11.2	6.9	9.6	2.9	18.1	5.0	5.3	2.7	6.0	5.2	6.4	6.0	3.6	8.9	6.9	3.2	2.6	3.4	5.8	3.5	14.7	7.1	5.8	5.4	3.3	2.9	0.3	0.2	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.4	0.4	0.1	0.1	0.4	0.1	0.5	0.2	0.1	5.5	5.5	5.6	7.9	5.2	4.2	5.0	4.5	5.2	4.0	4.8	5.6	5.3	3.2	1.3	14.7	5.9	4.7	7.8	1.4	4.6	14.1	7.0	6.0	2.8	10.0	1.8	3.7	6.2	4.7	3.0	2.4	13.7	2.1	8.4	7.8	9.8	4.2	4.2	5.5	25.1	2.2	3.6	10.2	4.1	4.4	0.0	13.0	3.3	3.8	3.3	26.9	28.4	3.1	0.0	1.0	3.3	14.6	5.6	3.2	3.6	5.6	3.6	8.8	1.0	12.5	16.2	1.0	1.3	3.8	11.3	7.3	5.2	8.3	1.0	14.4	0.0	8.5	4.5	13.0	7.8	6.5	5.7	1.5	3.5	10.5	5.2	3.7
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 181.7;salivary gland: 180.5;seminal vesicle: 209.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 6.6"	"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	16.3	2.2	0.3	3.6	1.6	0.1	86.8	0.8	1.3	46.7	0.1	14.3	3.6	40.0	181.7	12.7	59.1	54.4	21.9	0.5	0.1	6.4	108.5	16.1	3.4	1.0	0.2	2.9	9.1	48.0	4.4	5.2	1.1	17.1	11.0	0.9	180.5	209.2	12.7	97.4	4.6	30.1	0.2	1.2	48.3	10.4	0.1	1.5	35.4	33.0	4.0	6.7	12.8	0.5	140.2	5.3	0.3	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	207.9	0.0	2.5	0.0	0.3	254.0	0.0	0.7	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.0	1.0	0.5	0.3	1.1	182.2	19.6	0.3	0.0	0.7	0.0	0.2	7.3	0.2	0.1	43.1	0.8	1.4	16.2	0.5	0.5	0.3	1.1	0.0	3.5	0.1	0.3	0.2	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.8	1.3	0.5	0.1	1.0	0.2	1.1	0.2	0.1	0.5	7.2	0.0	0.0	0.7	0.4	17.7	21.5	4.2	0.0	0.0	30.5	70.2	3.5	17.2	2.0	0.0	0.0	1.3	0.2	0.4	0.0	4.1	54.9	10.0	27.5	5.6	0.0	2.7	0.7	0.0	0.6	4.2	36.7	18.5	4.5	0.0	3.3	141.3	0.2	0.0	20.4	13.3	0.0	1.6	3.0	75.1	1.8	0.7	5.4	2.8	0.0	0.8	0.0	1.5	0.7	1.0	0.5	1.5	0.3	22.6	0.0	0.7	0.3	0.4	46.0	1.1	52.5	1.4	2.3	1.4	46.7	4.1	0.7	0.1	0.4	20.9
AP1M2	"AP1-mu2, HSMU1B, mu2"	ENSG00000129354	"Adaptor related protein complex 1 subunit mu 2"	Q9Y6Q5	19	10572671-10587315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 162.0;Proximal tubular cells: 373.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.3;neutrophil: 7.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 172.8;Hep G2: 313.8;MCF7: 268.3;OE19: 156.7;RT4: 164.9;U-2 OS: 166.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA054999			Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA054999: AB_2682666"	"unprognostic (8.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (3.73e-6)"	"unprognostic (1.80e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.06e-1)"	3.4	0.1	0.8	6.4	0.3	0.9	32.9	0.6	0.8	27.1	0.3	67.1	64.0	6.6	61.8	51.9	46.6	22.7	0.4	0.5	0.4	76.3	1.5	19.2	0.4	0.7	0.6	0.3	55.9	62.4	34.8	16.2	0.4	30.8	63.4	0.1	41.5	24.0	0.3	42.1	54.8	3.0	0.3	0.6	59.1	9.6	0.7	4.2	58.8	0.3	9.5	23.4	19.1	0.6	144.2	71.1	0.4	10.4	0.0	0.0	65.0	0.2	0.0	2.3	1.6	172.8	82.1	0.4	64.7	1.2	43.4	97.6	0.1	109.0	3.2	0.6	1.0	6.7	48.5	313.8	1.3	0.3	0.8	0.2	81.6	3.9	0.1	5.0	0.0	0.4	0.3	0.6	1.2	268.3	0.6	1.8	31.4	156.7	0.0	2.4	9.3	0.7	2.7	164.9	67.3	0.2	0.0	120.0	0.6	34.6	123.3	0.4	0.0	0.4	166.7	0.9	2.2	0.4	0.9	1.4	0.2	0.4	0.2	4.3	0.4	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.6	0.0	1.4	0.2	0.0	2.7	0.8	0.3	0.6	0.8	0.5	0.4	0.7	0.6	0.4	0.3	0.7	0.6	0.4	28.9	34.8	0.0	1.9	6.9	19.2	68.9	13.1	0.0	49.3	30.0	0.5	47.1	64.2	86.5	0.0	123.0	0.5	112.2	137.0	141.3	43.4	52.4	5.4	1.7	74.4	0.0	0.3	115.8	101.0	1.5	73.4	57.7	2.5	0.0	0.7	0.0	9.8	0.0	0.2	95.5	97.6	0.8	0.0	19.9	1.5	2.6	3.6	0.0	1.7	0.0	0.0	0.0	0.2	130.2	125.6	0.7	0.0	37.6	162.0	373.6	61.5	0.0	0.0	0.0	6.2	16.9	4.1	39.1	13.1	66.1	2.8	0.0	131.4	48.3
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 subunit sigma 1"	P61966	7	101154456-101161596	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	14.4	24.6	72.2	13.9	75.7	5.8	17.2	43.7	82.6	18.3	34.6	28.6	39.0	16.9	17.0	34.2	13.8	12.8	11.8	85.2	59.6	41.2	36.2	14.7	11.9	53.6	51.9	13.5	21.9	22.8	31.0	15.9	53.4	22.2	22.4	14.6	20.3	9.3	6.4	39.2	30.3	12.7	46.1	20.2	22.0	16.4	62.5	19.1	15.2	8.5	13.6	20.1	19.5	62.7	121.0	87.3	63.3	118.4	42.8	70.4	138.2	76.8	51.1	50.8	52.8	47.3	147.5	24.9	127.5	84.6	97.1	59.0	35.3	116.0	45.6	57.0	56.6	16.8	52.0	61.4	54.2	46.8	87.7	79.1	91.0	49.4	20.6	76.7	76.8	54.1	56.7	103.2	129.9	292.1	40.4	107.8	97.8	177.0	188.2	24.9	27.2	54.6	127.8	88.8	47.5	157.7	40.4	121.1	151.4	101.6	50.7	46.8	79.0	74.1	132.3	27.6	55.2	21.4	51.4	48.4	195.2	50.1	152.9	0.5	3.3	0.3	2.3	3.1	2.2	2.6	3.2	2.5	4.6	2.0	1.9	1.8	1.2	1.3	1.8	5.0	3.3	2.4	72.2	75.7	43.7	82.6	85.2	59.6	53.6	51.9	53.4	46.1	62.5	62.7	34.4	6.4	0.0	2.3	17.9	38.7	29.7	173.0	46.7	30.7	54.8	49.0	1.1	45.8	72.9	55.2	8.4	170.7	19.8	88.4	344.4	128.2	2.5	28.8	34.2	36.7	90.3	16.2	21.2	111.7	101.3	27.7	42.8	31.9	5.7	85.3	28.9	43.0	95.2	30.3	10.3	96.5	116.0	24.8	21.6	3.4	35.1	27.3	53.4	7.5	58.0	34.1	17.5	2.5	9.8	183.3	86.1	21.8	17.4	34.9	241.3	304.8	34.9	22.3	19.7	11.4	38.4	13.1	70.9	51.4	45.5	60.5	19.5	157.4	119.9	38.2
AP5Z1	"KIAA0415, SPG48, zeta"	ENSG00000242802	"Adaptor related protein complex 5 subunit zeta 1"	O43299	7	4775615-4794397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035693	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"	Nucleoplasm	"HPA035693: AB_10960687"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.01e-3)"	"unprognostic (4.24e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.19e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.32e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.22e-1)"	14.8	18.5	7.0	0.7	7.1	1.5	11.8	7.3	10.0	12.4	5.8	13.2	1.1	13.4	1.0	11.0	11.0	0.8	7.7	6.9	5.7	9.2	9.2	12.9	1.8	8.3	6.5	11.8	9.9	0.7	9.8	1.1	7.4	11.7	0.4	0.6	12.4	0.7	8.5	21.8	15.5	0.4	5.9	22.9	12.0	8.6	7.4	0.9	11.2	0.2	0.6	13.4	10.9	7.3	2.8	4.2	0.7	2.4	1.0	0.9	4.3	1.3	1.9	2.0	1.7	5.2	3.5	1.6	1.8	0.9	5.1	5.4	0.7	0.5	0.6	1.8	3.5	2.4	4.5	4.6	3.0	2.5	5.1	2.2	1.6	1.8	1.3	0.7	0.5	2.2	3.4	1.1	1.2	7.7	0.3	15.0	5.9	0.3	4.3	2.9	2.6	4.8	1.0	4.4	1.7	3.0	1.8	8.7	6.4	0.5	6.4	8.9	3.8	2.3	4.4	6.5	1.7	8.5	7.4	2.3	1.7	5.6	3.6	1.9	2.3	2.9	2.4	2.8	1.4	1.9	1.8	2.4	1.2	1.8	2.5	2.2	2.2	2.4	2.5	2.4	1.8	1.3	7.0	7.1	7.3	10.0	6.9	5.7	8.3	6.5	7.4	5.9	7.4	7.3	12.4	9.6	15.0	7.5	18.2	6.9	2.9	8.8	8.0	10.5	5.7	5.8	4.3	15.7	6.6	11.0	4.2	11.5	20.3	20.1	0.0	14.1	2.2	9.9	10.1	11.6	12.0	5.0	12.4	13.6	7.7	9.9	21.4	16.4	17.1	14.3	12.5	8.1	28.7	18.5	10.7	15.1	10.2	12.3	10.7	1.5	13.4	16.3	14.2	13.1	23.4	8.2	21.6	10.6	12.6	20.6	15.9	10.9	19.8	4.9	14.7	6.8	8.3	9.4	0.0	5.8	9.5	8.1	10.8	7.6	11.1	16.6	15.6	12.6	14.1	3.8
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000363-55009057	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	7.2	8.9	6.1	8.8	6.3	10.0	7.2	6.0	6.6	7.6	6.5	8.9	8.9	7.4	8.5	15.5	7.3	6.3	9.0	5.9	6.4	10.8	11.0	7.2	11.3	6.4	6.3	9.6	7.4	7.1	7.0	9.0	6.3	7.8	10.5	2.3	7.0	6.6	7.5	12.2	9.1	7.0	6.3	11.2	7.9	4.1	6.6	10.9	6.3	7.3	13.5	10.2	9.4	6.7	36.9	32.4	12.5	18.3	17.9	11.9	21.3	14.8	19.8	28.0	27.2	17.8	30.0	24.1	22.7	14.0	33.0	26.9	29.1	28.2	21.0	19.7	22.1	29.4	31.6	18.3	11.5	18.3	26.6	11.8	22.6	39.6	14.2	13.2	22.6	25.3	15.4	15.9	21.2	35.7	24.9	23.8	25.0	17.4	38.6	21.8	20.8	26.4	15.2	18.1	11.6	12.7	28.0	33.4	14.7	28.5	26.4	14.1	13.1	16.6	23.9	33.7	19.6	16.4	22.9	19.9	17.7	30.9	20.1	16.2	11.5	13.1	10.2	14.4	8.6	8.2	9.6	10.2	13.7	8.5	8.5	8.4	4.1	42.0	13.4	7.4	11.6	10.1	6.1	6.3	6.0	6.6	5.9	6.4	6.4	6.3	6.3	6.3	6.6	6.7	6.1	3.2	11.8	1.6	12.7	12.9	12.5	20.1	6.8	3.6	7.2	7.1	5.9	15.7	14.9	11.0	0.0	52.7	7.1	17.9	15.6	31.5	0.3	6.0	5.7	11.5	6.1	31.5	0.8	15.1	35.3	7.6	10.2	9.7	8.8	13.1	10.4	11.4	24.2	6.7	0.7	10.1	10.2	10.9	11.1	1.1	5.9	12.0	0.0	1.9	21.7	5.2	16.5	1.0	1.9	20.5	19.1	8.6	9.8	10.5	16.6	21.6	11.8	2.1	19.7	4.4	6.9	1.4	10.6	13.8	12.6	47.6	11.6	12.4	13.7	13.2
ARAP2	"CENTD1, PARX"	ENSG00000047365	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2"	Q8WZ64	4	35948221-36244514	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.9;brain: 92.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 285.4;Late spermatids: 167.5;Oligodendrocytes: 781.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.7;hTCEpi: 12.7;MOLT-4: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035925	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites"	"Actin filaments"	"HPA035925: AB_10672075"	"unprognostic (2.97e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	4.5	2.2	28.9	10.0	70.4	39.9	5.1	19.9	39.5	3.5	0.0	5.3	8.9	3.3	3.8	13.1	3.3	9.3	1.5	24.5	21.5	3.7	9.4	13.4	15.7	34.1	38.8	1.5	7.0	5.4	2.9	3.5	32.6	2.2	5.6	1.4	4.6	2.9	0.7	16.1	8.9	4.3	18.3	11.5	6.1	6.2	32.1	24.6	23.2	0.8	11.0	9.9	6.3	92.8	8.6	0.7	0.8	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	4.2	13.7	4.1	3.2	0.4	0.0	3.2	1.3	6.7	0.0	0.0	7.6	0.1	2.9	0.2	1.6	5.5	0.0	0.4	12.7	0.0	2.7	4.9	0.0	11.1	0.2	0.7	0.0	3.6	12.8	4.5	1.0	6.0	2.6	6.5	0.0	4.7	9.3	8.7	7.3	0.0	0.4	2.1	2.7	0.4	5.6	1.6	0.0	2.3	7.5	0.0	1.1	0.0	0.0	8.0	0.9	6.1	1.9	0.0	0.5	0.0	3.8	1.8	3.5	1.8	2.1	2.7	0.3	0.9	0.7	1.9	0.4	6.7	4.7	1.2	1.1	0.6	28.9	70.4	19.9	39.5	24.5	21.5	34.1	38.8	32.6	18.3	32.1	92.8	18.6	153.8	23.3	285.4	46.1	39.1	32.9	13.5	21.6	0.8	11.2	7.0	2.1	17.2	33.2	7.3	0.0	0.2	100.4	15.5	7.9	7.9	123.6	31.4	3.0	15.8	3.0	8.6	140.8	10.0	0.4	9.4	20.4	50.0	9.5	5.9	3.3	4.2	8.7	0.0	29.9	11.3	6.1	33.2	24.9	167.5	2.8	35.1	5.4	40.3	26.7	5.4	95.8	161.4	781.2	21.5	23.3	0.7	43.0	30.0	17.4	5.8	18.0	1.2	0.0	8.1	3.6	4.2	3.0	37.0	67.5	0.8	90.7	0.1	6.9	44.1
ARF5		ENSG00000004059	"ADP ribosylation factor 5"	P84085	7	127588386-127591700	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		3900000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (6.72e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.81e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.46e-2)"	100.2	93.7	139.3	72.6	147.7	143.0	99.8	128.4	200.6	100.7	124.4	108.3	92.3	104.8	114.1	227.5	97.5	81.7	118.6	152.0	137.2	125.8	139.0	90.8	102.7	133.8	132.0	72.1	168.1	104.0	100.2	69.3	135.1	98.7	61.3	22.9	103.1	71.1	131.9	199.8	98.5	66.3	131.9	105.8	117.8	82.9	135.2	95.8	80.5	101.4	74.6	92.5	122.1	133.4	157.4	148.9	120.1	386.5	101.6	159.1	163.3	43.9	129.6	118.7	135.8	232.0	211.4	114.7	64.4	132.6	135.9	117.5	92.4	198.0	38.4	104.9	222.8	44.9	137.5	160.2	150.1	69.7	100.1	163.1	196.2	77.7	75.8	94.5	173.2	164.1	105.1	124.1	116.9	531.2	249.0	303.7	179.9	157.1	191.7	148.3	73.9	245.6	198.2	158.7	349.1	226.2	142.8	461.8	116.1	77.6	123.9	108.0	103.7	177.3	75.3	128.0	101.9	115.2	77.5	153.9	181.1	142.0	154.6	289.0	321.4	279.7	144.3	270.3	146.7	129.5	151.1	148.4	409.6	117.2	112.0	122.2	447.5	156.5	216.2	259.6	181.8	381.8	139.3	147.7	128.4	200.6	152.0	137.2	133.8	132.0	135.1	131.9	135.2	133.4	110.3	3.2	12.1	28.4	81.3	105.7	72.9	217.1	130.9	14.8	111.8	180.7	2.0	91.5	83.0	112.2	0.0	151.6	89.7	89.4	201.5	107.8	39.3	90.3	95.7	73.9	119.9	102.2	46.5	90.7	125.0	82.2	135.5	88.2	21.0	91.1	75.7	51.6	102.7	20.2	42.5	108.8	140.4	129.6	221.9	40.7	93.2	123.9	149.4	28.1	118.6	27.6	82.4	27.2	36.2	86.4	134.0	94.8	75.1	57.2	147.5	160.0	58.4	11.9	72.3	58.7	85.4	99.2	116.7	248.3	153.4	146.3	100.2	69.1	125.4	93.4
ARHGAP23	KIAA1501	ENSG00000275832	"Rho GTPase activating protein 23"	Q9P227	17	38419280-38512385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 97.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.4;Hepatic stellate cells: 46.1;Oligodendrocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 296.7;RT4: 115.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019818, HPA047291"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA019818: AB_1844993, HPA047291: AB_2680012"	"unprognostic (3.35e-1)"	"unprognostic (5.11e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.50e-3)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.38e-5)"	"unprognostic (8.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.25e-1)"	25.6	13.8	36.2	8.3	66.2	10.7	18.8	47.2	54.6	25.9	5.5	22.8	3.0	28.4	3.7	60.8	18.4	7.8	27.3	34.4	37.5	11.8	2.9	28.0	4.1	63.7	59.6	18.1	3.5	3.1	6.2	19.4	54.1	19.9	2.8	8.5	12.8	12.5	10.6	61.1	10.4	11.6	43.0	30.7	13.4	16.1	66.1	5.4	9.5	5.8	11.0	36.3	29.5	97.8	32.5	17.2	15.2	5.1	9.5	31.1	19.6	44.8	49.5	37.7	21.8	56.8	55.1	0.7	35.2	102.5	18.7	296.7	1.7	62.3	26.6	3.5	3.3	0.0	55.1	0.4	47.2	3.0	0.3	18.8	11.8	27.7	17.3	31.0	39.4	6.0	0.6	8.3	21.6	0.0	10.2	6.3	9.0	1.2	6.3	17.0	33.0	10.4	16.0	115.7	3.7	8.8	26.9	0.1	0.3	21.2	6.7	7.9	57.7	62.6	22.9	12.9	12.1	6.5	7.3	1.9	16.3	8.1	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	66.2	47.2	54.6	34.4	37.5	63.7	59.6	54.1	43.0	66.1	97.8	27.2	12.8	1.5	23.8	0.7	9.9	17.5	10.6	9.1	59.4	1.7	3.9	20.4	1.5	13.2	3.7	0.0	27.0	0.2	0.1	0.0	2.9	7.6	8.5	10.0	34.9	0.0	4.0	9.3	1.4	3.1	11.6	3.1	5.7	0.0	4.9	46.1	0.5	5.1	26.9	16.2	0.4	2.0	2.5	4.2	21.0	9.0	1.2	1.8	9.4	0.2	9.6	0.0	20.1	129.2	7.0	0.1	7.2	1.7	15.4	0.0	0.2	8.3	3.4	0.0	10.9	7.6	13.5	2.7	27.5	25.9	16.6	1.8	1.3	0.3	42.2
ARID1B	"6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R"	ENSG00000049618	"AT-rich interaction domain 1B"	Q8NFD5	6	156776020-157210779	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 404.3;Inhibitory neurons: 475.4;Microglial cells: 327.0;Oligodendrocyte precursor cells: 417.7;Oligodendrocytes: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016511, HPA075291"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016511: AB_1845008, HPA075291: AB_2686743"	"prognostic unfavorable (1.04e-4)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-1)"	15.2	12.0	14.6	14.5	13.4	28.7	15.6	29.0	16.0	19.0	2.2	15.9	14.2	17.0	11.3	15.7	18.6	14.4	14.4	20.4	10.1	13.2	9.7	14.6	18.2	13.4	10.9	27.5	17.1	28.2	12.2	11.7	11.1	14.6	12.1	11.7	20.4	12.7	33.6	23.2	15.3	15.8	7.3	18.4	12.5	9.8	12.5	25.4	22.0	25.4	18.8	17.4	17.4	17.2	13.0	19.4	29.6	41.2	24.7	21.5	20.4	14.6	18.6	18.1	18.0	17.7	20.0	43.0	8.1	23.9	22.4	16.5	25.2	23.3	18.1	40.4	18.1	30.6	19.6	22.1	17.1	25.3	21.8	25.5	18.4	27.1	24.6	20.4	25.6	26.8	35.8	32.3	13.2	15.9	29.1	30.5	15.3	18.3	10.5	66.3	12.7	22.9	12.7	24.3	28.0	34.7	28.3	29.4	15.8	15.7	19.6	40.2	26.4	23.4	23.6	22.0	27.5	21.8	18.2	52.7	19.7	30.3	32.0	5.0	2.3	2.3	4.1	1.9	3.7	5.3	3.5	2.8	1.8	6.9	2.9	4.1	4.2	2.4	2.1	9.4	3.7	1.2	14.6	13.4	29.0	16.0	20.4	10.1	13.4	10.9	11.1	7.3	12.5	17.2	85.7	48.1	51.8	282.7	83.3	47.5	22.3	22.3	41.5	36.0	70.9	44.4	36.9	27.1	32.6	126.9	29.2	14.7	103.7	21.8	7.9	40.8	15.0	70.8	124.5	43.9	40.8	37.8	404.3	34.5	7.5	49.9	31.1	78.0	38.7	137.1	33.9	27.3	14.1	47.1	475.4	33.7	20.3	32.6	36.1	19.4	56.8	49.1	30.2	327.0	59.4	21.9	24.7	417.7	503.7	46.6	26.9	62.8	70.2	28.1	26.8	18.4	29.5	29.6	46.0	43.1	56.7	8.0	12.2	39.7	55.7	17.5	51.9	72.9	36.3	27.1
ARL4A	ARL4	ENSG00000122644	"ADP ribosylation factor like GTPase 4A"	P40617	7	12686856-12690958	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 191.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1523.0;Late spermatids: 3892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 261.3;K-562: 328.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064513			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064513: AB_2685276"	"unprognostic (8.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.94e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.42e-3)"	"unprognostic (9.49e-3)"	31.6	7.9	17.1	16.8	20.1	98.4	55.3	14.3	25.8	38.0	22.5	40.7	29.9	16.8	13.8	60.0	27.7	19.2	15.5	23.0	15.4	8.9	15.6	19.4	18.6	14.4	14.3	8.0	7.2	5.3	9.2	23.6	14.5	21.0	34.7	6.7	86.6	16.5	9.1	88.5	62.7	25.1	14.7	21.0	24.5	191.1	15.4	22.7	19.2	8.7	15.9	21.4	63.8	18.6	45.0	46.7	121.5	261.3	19.3	31.8	0.3	17.9	16.2	28.7	17.2	41.6	32.9	0.3	7.5	25.4	73.4	12.6	27.3	22.6	28.9	9.8	20.4	9.2	61.7	39.3	39.8	39.6	16.0	14.3	88.3	16.7	74.2	18.1	69.0	17.7	328.1	42.5	29.4	19.3	2.2	55.6	44.2	129.2	53.1	0.0	42.4	20.8	37.8	21.3	22.3	20.8	29.5	31.1	6.3	31.3	15.3	32.0	24.3	11.5	40.6	43.5	73.1	19.4	27.2	10.3	29.7	16.5	46.4	8.1	14.8	0.7	11.3	25.7	31.7	41.0	26.8	17.7	14.4	44.7	12.9	10.8	2.2	13.0	32.1	12.8	17.8	13.6	17.1	20.1	14.3	25.8	23.0	15.4	14.4	14.3	14.5	14.7	15.4	18.6	134.0	22.4	20.3	1.0	96.9	339.7	179.1	144.5	70.0	20.9	217.9	230.0	15.8	64.3	86.6	20.2	85.5	152.9	61.0	236.6	27.4	47.8	1523.0	179.1	41.5	162.5	62.6	249.9	11.6	29.6	18.7	46.1	63.2	86.5	80.5	27.7	157.1	21.7	59.5	3.3	3.4	107.1	337.7	168.2	171.1	3892.8	69.0	170.9	120.9	17.8	38.7	11.0	3.1	36.7	8.7	55.3	118.0	26.7	24.4	53.4	641.5	14.6	102.5	125.9	13.1	59.5	55.3	564.1	57.5	134.9	234.7	444.0	98.0	32.4	124.2	89.1
ARMH3	"C10orf76, FLJ13114"	ENSG00000120029	"Armadillo like helical domain containing 3"	Q5T2E6	10	101845599-102056193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.2;dendritic cells: 10.5;Extravillous trophoblasts: 14.8;Granulosa cells: 11.5;Hofbauer cells: 12.6;Syncytiotrophoblasts: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050913, HPA053580"	Approved		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA050913: AB_2681270, HPA053580: AB_2682198"	"unprognostic (5.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.55e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.40e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.87e-2)"	10.4	9.1	5.9	12.0	7.6	21.8	9.9	10.2	7.3	11.2	8.0	12.5	12.8	10.5	9.4	14.3	10.5	9.2	16.6	5.7	7.3	10.0	12.0	11.8	12.7	7.1	8.2	11.2	10.1	16.4	7.9	11.0	6.1	10.8	13.2	16.3	9.5	10.5	19.7	12.2	12.2	12.9	6.0	13.6	10.3	8.9	6.7	13.1	10.0	19.8	13.3	10.8	10.1	7.9	23.2	17.7	15.5	19.1	12.9	17.3	13.9	20.3	24.0	20.0	16.9	12.2	18.6	17.0	13.5	22.9	14.5	17.7	20.4	22.4	18.3	17.9	18.9	30.3	15.9	14.6	15.2	21.3	26.4	16.0	17.7	22.6	19.9	23.4	15.3	15.3	0.9	15.9	16.6	14.4	16.5	13.8	8.5	18.8	11.6	16.0	28.1	11.0	16.4	18.6	7.3	12.1	15.8	10.9	21.0	15.8	28.8	12.4	15.1	10.5	17.1	9.8	14.7	15.4	17.0	17.1	16.9	23.7	7.9	19.4	7.3	7.4	5.9	8.7	5.5	6.1	6.2	4.5	7.7	7.0	4.8	4.9	1.9	5.2	10.7	7.4	6.0	4.7	5.9	7.6	10.2	7.3	5.7	7.3	7.1	8.2	6.1	6.0	6.7	7.9	8.8	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	7.4	6.0	0.0	0.0	0.0	0.0	0.0	11.2	10.5	0.0	1.9	7.8	0.0	6.9	6.8	1.9	0.0	0.0	0.0	9.7	14.8	2.7	0.0	7.7	0.0	11.5	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	9.9	0.0	0.0	2.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	16.3	3.9	5.7	0.0	0.0
ARPC2	"ARC34, p34-Arc"	ENSG00000163466	"Actin related protein 2/3 complex subunit 2"	O15144	2	218217141-218254356	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001994, HPA008352, HPA052703"	Approved		Supported	Nucleoplasm		NA	NA		6600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"CAB001994: , HPA008352: AB_1854887, HPA052703: "	"unprognostic (7.42e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.41e-2)"	205.4	121.8	114.0	361.4	125.6	544.1	163.5	109.4	130.8	163.1	117.4	252.8	200.3	153.3	161.8	460.5	146.3	211.3	167.3	135.2	123.1	155.0	152.8	259.7	505.2	115.1	114.7	121.3	122.1	115.4	94.7	295.0	116.4	132.1	274.8	77.4	163.6	176.0	385.3	293.4	226.5	291.2	117.8	294.6	251.5	149.7	118.2	298.3	115.3	250.8	626.0	402.0	231.7	125.4	438.3	188.3	264.1	198.0	346.6	463.6	489.4	680.5	640.7	551.2	549.5	588.6	452.0	358.6	347.6	764.7	396.8	492.3	362.6	985.4	645.4	284.2	296.5	362.1	279.0	325.8	386.8	764.2	968.9	310.2	784.1	552.0	454.6	515.1	731.3	294.1	179.5	681.4	858.6	304.3	416.8	888.6	310.8	500.8	201.1	307.2	235.0	488.7	556.8	787.8	156.3	278.8	246.7	265.8	590.0	544.4	192.7	689.2	642.1	709.5	268.1	321.9	507.8	359.8	418.8	624.7	515.1	472.9	548.2	1728.0	1318.5	1975.5	930.7	1773.7	626.1	785.9	720.7	913.6	1330.1	658.5	505.7	750.0	2200.3	698.9	2060.4	734.3	1039.0	2503.2	114.0	125.6	109.4	130.8	135.2	123.1	115.1	114.7	116.4	117.8	118.2	125.4	334.8	285.2	326.6	21.2	506.7	928.5	691.0	1140.2	425.2	89.8	150.3	189.7	145.3	200.1	465.4	172.9	56.3	944.5	902.3	595.0	342.4	585.8	604.0	220.6	288.5	363.5	319.7	144.9	48.5	658.7	1509.4	301.7	242.6	222.4	414.5	600.6	281.3	98.4	1094.0	58.9	33.1	329.4	364.2	779.9	1321.0	759.3	214.0	896.1	414.4	53.4	1721.9	175.3	1336.7	30.7	33.7	919.8	604.5	326.5	529.9	762.7	510.9	342.8	249.6	95.3	302.4	131.6	571.2	324.4	227.9	645.2	970.6	1045.8	694.1	285.6	337.6	1126.5
ATF6	ATF6A	ENSG00000118217	"Activating transcription factor 6"	P18850	1	161766298-161977574	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005935	Approved					NA	NA		46000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA005935: AB_2667472"	"unprognostic (1.31e-1)"	"unprognostic (5.15e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.57e-3)"	13.6	10.1	7.2	13.9	8.4	12.6	11.5	8.3	7.5	8.4	13.6	9.9	9.9	10.6	18.9	11.0	8.9	11.3	9.4	7.2	9.9	14.6	22.0	11.4	10.6	10.2	9.4	9.0	34.4	18.9	7.1	18.0	10.5	10.7	11.2	16.7	13.3	10.3	8.9	11.2	9.4	12.8	10.0	11.3	11.2	10.1	8.0	8.4	15.1	9.5	11.1	13.7	7.9	11.9	23.3	17.9	15.1	22.4	18.6	17.7	26.7	27.8	25.3	17.7	19.2	11.6	38.2	16.9	39.6	34.6	19.9	34.0	15.1	18.6	17.6	23.2	12.9	15.9	22.6	12.7	40.3	29.7	40.6	18.3	29.0	18.2	53.3	23.8	40.3	22.7	37.9	19.2	19.3	23.0	15.9	17.3	12.2	24.5	23.1	13.7	21.4	39.2	19.3	11.1	9.1	13.8	33.3	19.8	41.0	32.9	24.5	39.2	54.4	23.2	21.9	8.7	31.5	28.0	29.2	20.4	28.2	5.1	29.0	9.7	17.8	12.0	9.2	18.3	9.0	8.7	8.3	7.7	12.8	9.5	9.5	9.7	33.2	7.4	24.4	5.7	9.6	10.6	7.2	8.4	8.3	7.5	7.2	9.9	10.2	9.4	10.5	10.0	8.0	11.9	40.5	102.5	85.1	41.8	31.4	34.8	45.4	28.4	18.2	38.6	38.0	25.4	21.6	25.8	67.0	51.5	50.1	49.2	23.2	30.5	7.9	45.9	13.0	27.1	25.3	49.8	37.1	17.9	79.9	37.6	43.1	46.2	23.9	40.2	54.3	24.0	37.5	53.5	50.3	26.9	69.7	28.2	30.5	59.5	59.4	10.8	23.0	66.6	26.6	103.0	62.0	34.1	21.6	60.3	105.8	35.9	15.6	24.5	53.9	43.3	22.3	18.8	61.7	29.9	6.6	61.3	31.8	43.1	30.5	22.7	47.7	103.0	29.0	22.1	22.9	44.1
ATP10B	"ATPVB, FLJ21477, KIAA0715"	ENSG00000118322	"ATPase phospholipid transporting 10B (putative)"	O94823	5	160563120-160852214	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.1;gallbladder: 16.6;intestine: 45.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 136.4;Oligodendrocyte precursor cells: 293.0;Oligodendrocytes: 419.4;Undifferentiated cells: 90.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034574	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA034574: AB_10669992"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.47e-4)"	"unprognostic (3.99e-2)"	"unprognostic (6.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.38e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.14e-1)"	0.1	0.0	4.1	5.0	9.0	0.0	0.4	8.8	6.4	1.0	0.1	44.5	24.7	0.0	12.3	6.2	0.4	16.6	0.0	4.3	5.0	0.1	0.0	0.0	0.0	10.6	7.8	0.0	2.9	0.0	0.0	0.0	9.9	0.0	45.7	0.0	1.8	0.7	0.0	7.1	21.0	1.5	5.8	0.0	4.8	0.3	8.0	5.0	0.0	0.0	2.9	1.5	2.5	17.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	9.0	8.8	6.4	4.3	5.0	10.6	7.8	9.9	5.8	8.0	17.1	0.1	0.0	0.0	42.7	0.6	0.4	0.1	12.9	0.0	0.0	0.1	0.0	1.2	21.5	15.1	1.8	0.0	0.0	0.0	136.4	0.0	23.6	0.2	0.2	0.0	0.3	13.2	0.0	4.0	20.3	0.1	0.0	10.7	0.3	0.0	0.0	0.0	0.3	0.1	0.0	3.9	55.4	4.1	0.0	1.2	0.6	0.0	0.1	1.8	1.9	1.6	0.0	0.0	293.0	419.4	16.4	64.7	0.0	0.4	0.1	24.1	0.0	16.0	0.0	0.0	0.0	0.6	0.0	0.1	2.9	0.9	0.5	0.3	0.0	90.7	6.5
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485275-47593486	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	12	"basophil: 84.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 84.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 41.6"					"Low region specificity"	"Detected in all"			HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	4.9	6.0	2.6	5.0	2.9	1.3	4.2	1.9	2.7	7.0	15.9	3.7	3.9	7.4	7.2	10.2	4.7	7.4	4.2	1.8	4.1	10.2	2.4	6.1	6.2	3.1	3.7	8.1	4.5	10.4	3.1	14.9	2.9	4.6	3.8	4.1	3.4	6.4	1.0	9.9	4.5	9.7	2.4	10.0	5.1	2.0	5.0	4.5	9.1	2.7	7.9	7.3	6.5	2.9	2.6	1.8	4.0	2.8	11.1	12.0	0.7	17.9	21.5	8.4	15.1	9.4	15.4	8.1	6.5	29.1	14.3	4.6	41.6	15.0	12.9	3.2	3.2	6.5	2.8	0.5	9.8	2.1	3.9	10.3	11.2	16.4	10.9	27.5	14.4	4.0	0.1	4.3	23.2	1.0	4.4	1.2	1.4	0.0	2.2	4.9	9.0	0.1	15.0	3.1	2.6	4.9	8.4	2.1	5.2	8.7	3.8	2.1	21.9	20.7	4.1	1.9	7.8	1.9	1.5	0.0	10.2	11.9	6.8	84.3	3.1	0.4	1.1	5.0	1.9	2.7	0.5	0.8	4.0	6.7	0.1	0.9	1.5	2.3	6.9	2.4	0.8	1.6	2.6	2.9	1.9	2.7	1.8	4.1	3.1	3.7	2.9	2.4	5.0	2.9	22.9	9.6	7.5	39.2	27.8	19.2	9.2	21.9	23.9	12.2	6.7	8.4	4.9	4.3	8.5	16.5	31.3	48.5	17.1	1.6	1.9	5.5	4.4	4.8	29.5	16.1	9.6	4.0	25.7	4.6	11.0	22.4	14.3	7.0	2.5	21.3	18.2	6.6	13.0	13.5	42.8	4.6	18.3	21.7	7.9	1.5	62.1	17.7	7.2	47.8	15.7	21.9	15.5	52.3	24.1	2.7	3.4	25.2	23.0	5.7	1.9	9.2	6.2	9.2	26.3	12.8	23.6	0.6	2.8	35.4	27.0	176.8	15.5	51.7	4.1	8.1
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793503-182921629	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	20.6	10.7	4.7	24.9	6.9	70.6	17.4	15.9	7.6	19.1	13.8	26.3	24.3	18.7	14.6	45.4	13.7	21.1	14.1	6.0	6.3	18.0	18.3	16.5	27.9	7.5	6.1	20.5	21.0	29.4	10.3	14.5	7.3	28.3	29.0	30.8	19.4	13.4	11.4	28.2	24.0	19.5	5.6	21.8	51.1	31.6	6.6	44.6	16.8	16.8	28.4	25.7	22.5	15.8	69.7	9.7	20.5	28.7	42.6	46.1	19.3	32.8	41.6	23.2	27.1	23.7	34.0	31.3	53.5	44.0	48.2	40.4	24.6	31.3	40.2	73.9	20.9	76.7	13.1	5.2	24.8	62.3	47.3	31.5	34.7	26.1	37.4	34.1	37.0	48.7	27.7	94.3	37.8	22.9	50.3	19.1	14.5	38.1	19.2	21.2	59.8	37.8	28.1	55.8	12.5	22.0	86.2	10.7	36.9	18.3	11.9	43.7	36.6	35.0	38.7	30.5	56.2	131.0	125.5	58.1	24.1	25.3	20.9	5.5	1.0	4.3	1.7	1.0	1.7	2.1	1.4	1.7	1.1	1.3	1.2	1.8	3.8	1.8	1.0	2.4	1.2	0.8	4.7	6.9	15.9	7.6	6.0	6.3	7.5	6.1	7.3	5.6	6.6	15.8	26.8	16.0	13.2	34.6	27.8	34.3	25.7	15.9	26.2	12.2	13.8	9.7	15.6	18.6	16.5	20.2	14.6	12.8	43.0	44.6	0.0	12.5	34.1	19.0	22.9	15.7	6.7	26.1	81.6	16.5	3.8	19.5	46.4	22.1	11.4	14.0	16.1	16.4	10.4	38.7	64.3	30.5	16.2	19.4	26.4	23.8	19.3	29.3	14.2	45.9	19.9	8.4	27.8	67.8	132.6	25.2	27.0	21.1	55.5	35.8	24.3	7.8	19.8	31.4	19.7	24.1	17.7	18.7	11.4	43.8	44.6	9.6	40.9	7.0	27.3	45.4
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 61.1;Microglial cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA012887: AB_1845205, HPA048107: AB_2680266"	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	3.0	4.3	1.2	3.6	1.7	5.9	6.3	2.3	2.1	3.9	1.6	3.4	3.9	3.6	5.0	4.9	3.5	3.6	2.5	1.3	2.1	4.4	2.3	4.5	4.1	2.1	2.1	3.6	2.4	7.3	2.5	4.0	3.8	5.3	3.4	3.0	5.1	3.4	1.8	11.1	3.4	3.2	1.1	4.7	5.5	1.6	1.6	4.7	4.6	2.9	4.6	3.9	2.8	2.9	3.2	8.3	5.4	5.5	5.0	5.3	0.9	4.8	6.6	2.8	5.7	1.0	3.6	4.7	6.9	4.8	3.3	3.8	7.1	3.9	5.2	7.0	4.8	2.4	7.8	0.8	6.3	4.1	4.1	5.6	1.6	5.9	1.8	6.5	7.3	4.7	19.6	17.4	5.2	2.8	4.6	1.4	1.5	11.2	1.7	3.7	9.0	15.8	4.6	8.8	1.6	20.4	11.9	2.8	6.0	3.3	2.2	1.3	9.4	3.7	3.6	5.2	1.9	5.6	10.7	5.2	6.0	2.5	5.7	7.1	1.5	4.5	1.8	1.5	0.9	1.8	1.2	1.2	1.0	1.4	1.4	2.1	8.1	1.2	1.9	1.0	0.4	1.0	1.2	1.7	2.3	2.1	1.3	2.1	2.1	2.1	3.8	1.1	1.6	2.9	14.3	0.0	8.4	15.7	12.6	7.4	5.1	5.8	13.1	6.4	17.3	10.0	5.1	1.5	8.2	9.2	4.2	2.0	15.0	4.5	1.9	5.6	0.5	5.3	9.2	9.7	4.8	22.5	11.1	13.6	2.2	9.4	20.4	8.8	9.5	6.4	14.6	3.6	14.3	1.7	12.5	4.8	61.1	11.7	6.7	1.1	7.2	12.6	19.6	44.0	5.5	4.4	11.3	37.7	35.0	6.2	4.1	9.8	10.5	4.8	4.1	5.5	10.2	4.1	32.9	10.3	8.7	1.8	5.4	20.5	16.6	2.2	13.8	6.7	5.2	6.6
ATXN7	"ADCAII, OPCA3, SCA7, SGF73"	ENSG00000163635	"Ataxin 7"	O15265	3	63863155-64003462	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA034989: AB_10602596"	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	7.5	6.3	4.5	11.4	4.1	24.4	7.1	4.9	4.4	7.4	0.2	6.9	8.0	8.6	4.7	8.7	6.3	9.6	5.8	3.1	3.7	7.1	8.4	9.0	12.7	3.4	3.3	8.0	21.0	10.9	2.3	8.3	2.7	6.7	8.8	16.3	7.8	5.2	7.1	9.3	9.2	7.9	0.7	10.6	8.4	15.0	3.1	16.5	7.5	8.7	11.7	7.4	4.4	3.2	8.4	5.7	8.1	7.2	8.5	11.3	9.5	6.5	9.0	11.1	10.5	8.9	8.7	12.5	3.1	9.0	12.5	6.5	9.6	9.1	11.9	22.8	4.9	16.1	10.7	4.2	6.4	8.5	17.7	7.9	9.0	15.7	17.7	9.0	8.4	13.3	6.3	26.2	7.7	25.8	12.7	6.8	5.5	5.7	3.0	9.1	7.1	10.1	6.1	11.0	3.1	5.6	13.2	9.4	10.8	6.4	5.1	12.2	11.9	11.4	12.0	12.7	12.9	12.9	13.2	10.3	10.3	11.6	9.4	15.8	1.1	2.1	3.7	1.0	3.3	1.0	6.2	4.0	0.8	2.4	6.2	4.1	4.5	3.5	0.7	1.5	6.2	1.3	4.5	4.1	4.9	4.4	3.1	3.7	3.4	3.3	2.7	0.7	3.1	3.2	2.4	9.6	9.1	34.6	17.0	43.6	24.9	17.6	29.6	73.2	3.4	1.7	10.5	35.8	17.9	5.5	102.2	14.1	21.5	38.3	0.0	2.8	17.1	3.3	1.5	16.1	26.4	29.5	81.2	4.2	13.6	16.6	18.8	3.5	14.7	1.2	26.7	22.8	14.2	25.2	67.0	19.7	24.4	34.6	30.3	9.5	12.8	20.1	12.4	64.6	33.5	24.5	54.6	60.3	46.7	2.5	28.5	13.2	14.8	26.1	28.1	0.7	27.4	70.8	0.0	39.2	15.6	14.8	15.6	25.6	46.2	61.2	41.5	1.6	20.1	38.6
AVEN	PDCD12	ENSG00000169857	"Apoptosis and caspase activation inhibitor"	Q9NQS1	15	33858782-34075155	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 44.0;Oligodendrocytes: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020863	Approved		Approved	"Plasma membrane,Actin filaments,Centrosome"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Actin filaments"	Centrosome	"HPA020863: AB_1845219"	"unprognostic (1.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.77e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (5.29e-10)"	"unprognostic (7.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-3)"	13.7	11.4	8.5	7.2	8.6	4.4	10.8	8.9	10.1	11.4	10.5	15.2	7.4	12.5	5.2	12.3	11.3	6.4	28.5	8.2	9.2	5.5	16.9	7.2	4.8	9.2	9.0	10.5	20.8	3.0	5.8	12.4	9.4	9.4	9.4	2.5	7.9	9.1	31.1	11.2	7.5	12.5	8.8	6.5	12.3	10.7	9.0	6.9	5.6	13.6	7.9	16.2	10.8	9.1	16.4	26.3	26.0	8.6	21.4	24.1	14.7	41.1	36.2	31.9	19.9	7.2	11.3	15.2	24.8	34.8	24.2	10.4	12.2	26.9	25.7	14.6	7.7	26.1	15.9	20.5	31.5	26.6	18.2	19.8	50.9	18.4	45.8	38.6	35.2	7.6	26.6	21.1	45.6	17.3	10.5	46.1	11.9	22.2	8.5	15.7	14.6	32.2	26.4	21.0	13.4	16.8	22.6	11.6	11.4	10.7	12.6	29.4	24.5	27.7	9.5	12.0	34.6	21.2	17.7	31.1	13.3	31.0	15.2	0.0	0.2	0.0	0.5	0.6	0.6	0.4	0.5	0.2	0.2	0.1	0.2	0.3	0.0	0.5	0.2	2.3	0.9	0.1	8.5	8.6	8.9	10.1	8.2	9.2	9.2	9.0	9.4	8.8	9.0	9.1	9.0	3.2	5.3	16.6	5.6	5.7	8.7	1.8	3.4	5.6	7.5	9.0	32.7	2.8	0.8	0.0	6.2	11.0	10.5	7.4	0.0	2.9	13.8	4.4	14.3	10.2	4.8	9.5	21.8	8.6	44.0	8.5	5.6	5.6	0.0	14.7	8.6	19.1	7.4	8.4	24.1	7.7	0.0	4.1	4.4	6.5	7.5	5.0	3.6	22.5	3.5	10.9	7.2	26.7	86.6	7.0	5.2	10.5	15.6	21.5	9.4	4.6	1.5	5.3	6.6	4.9	9.7	6.2	7.4	12.9	9.7	9.4	6.5	23.1	6.0	14.7
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 467.9;liver: 131.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 1623.0"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTCEpi: 13.7;RPTEC TERT1: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		NA	NA		35000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Actin filaments"	"HPA007600: AB_1845284, HPA027823: AB_10602394"	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	1.4	0.0	24.3	0.0	23.4	0.0	25.1	28.8	34.0	5.1	17.3	0.2	0.0	0.1	8.1	17.5	9.0	9.6	0.0	22.8	25.6	467.9	131.9	0.3	0.1	27.2	33.1	0.0	0.8	0.0	6.9	0.3	35.0	0.5	0.0	0.4	6.1	4.1	0.9	51.8	0.0	0.0	28.8	0.0	0.2	0.1	25.2	1.1	9.6	0.0	0.6	0.1	11.3	27.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	13.7	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.2	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	23.4	28.8	34.0	22.8	25.6	27.2	33.1	35.0	28.8	25.2	27.0	0.1	0.0	0.6	66.3	5.3	8.2	9.0	80.9	0.6	0.0	16.3	11.0	0.0	15.7	18.1	46.0	0.0	0.3	0.2	0.0	223.0	0.7	1.1	10.3	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.4	27.9	0.0	0.0	0.8	0.0	12.2	0.6	1.1	1.1	0.0	7.1	1.8	4.7	0.0	13.8	0.0	2.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	1623.0	9.4	0.4	0.0	0.0	1.4	0.0	0.6	16.9	35.8	0.3	5.0	0.0	0.0	2.6
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"BAF chromatin remodeling complex subunit BCL11B"	Q9C0K0	14	99169287-99272197	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9"	"Group enriched"	"Detected in many"	8	"gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"JURKAT: 38.3;MOLT-4: 47.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 64.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 30.0"	HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.4	0.3	8.0	5.1	21.2	4.9	1.1	0.0	17.2	0.9	0.0	1.2	2.0	0.2	0.5	4.3	0.3	0.9	0.1	18.9	1.1	0.3	0.4	1.1	10.2	0.3	0.8	0.2	0.1	0.0	0.2	0.1	0.0	0.5	1.4	0.0	1.7	0.3	0.2	15.0	3.5	0.2	1.5	4.4	1.9	0.5	2.0	36.6	0.8	0.0	7.5	1.3	2.9	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.0	0.0	38.3	0.0	4.1	0.0	2.8	47.3	0.8	0.5	3.6	0.0	7.0	0.0	0.0	0.0	2.6	3.7	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.2	0.0	2.6	0.1	0.0	2.0	0.7	0.0	0.0	0.0	0.1	2.0	0.0	1.8	0.0	2.8	2.4	0.0	0.0	4.6	3.1	0.0	0.3	0.0	0.0	2.0	0.8	8.0	21.2	0.0	17.2	18.9	1.1	0.3	0.8	0.0	1.5	2.0	3.9	1.3	3.2	0.0	1.3	6.4	62.8	1.6	6.3	73.4	0.4	4.3	4.4	3.8	4.3	1.3	0.0	0.0	0.1	44.2	3.8	1.9	0.2	0.2	0.2	0.2	1.2	1.2	5.3	57.5	0.5	0.0	3.3	2.0	0.3	5.1	0.2	3.3	0.3	0.3	0.0	105.7	4.9	2.0	1.0	11.4	0.4	0.6	4.0	5.4	1.0	4.9	0.0	51.5	32.2	2.0	1.1	5.4	0.0	24.4	0.6	10.1	0.5	0.3	0.1	0.0	0.5	1.9	1.6	5.8	42.7	71.3	0.0	133.4	0.1	9.7	0.6
BNIPL	"BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753"	ENSG00000163141	"BCL2 interacting protein like"	Q7Z465	1	151036321-151047720	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 128.5;skin 1: 181.4;vagina: 69.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 17.2;Squamous epithelial cells: 42.7;Suprabasal keratinocytes: 57.1;Urothelial cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"T-47d: 46.1"	"Group enriched"	"Detected in some"	9	"basal ganglia: 1.6;cerebellum: 2.4"	"Not detected"	"Not detected"			HPA019946			Uncertain	Cytosol		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA019946: AB_2732424"	"unprognostic (2.62e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.50e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.88e-4)"	"unprognostic (1.91e-1)"	"unprognostic (8.43e-11)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (6.81e-2)"	0.4	0.3	0.9	0.4	1.0	0.6	15.6	3.0	1.3	25.1	0.7	0.4	0.3	0.3	0.2	128.5	2.7	0.3	0.7	0.9	1.0	2.9	1.2	9.4	0.6	1.5	1.0	0.6	0.4	1.1	0.6	0.5	1.1	12.5	0.2	0.8	22.9	4.7	1.6	181.4	0.5	0.1	0.7	1.1	1.4	4.3	1.0	0.7	7.4	0.1	10.1	9.7	69.7	1.1	0.4	0.4	0.6	0.6	0.4	0.4	0.7	0.3	0.0	0.3	0.2	1.5	0.4	0.7	0.7	0.0	0.1	1.5	0.9	0.2	0.6	1.1	1.0	1.2	0.8	0.2	0.1	0.6	0.6	0.0	3.1	0.2	0.3	1.0	0.0	1.1	0.6	0.5	0.3	2.0	0.7	1.2	0.5	1.0	0.4	0.3	0.3	0.4	0.6	0.4	1.3	0.6	0.5	0.9	0.3	2.2	46.1	0.4	1.1	0.7	0.5	0.2	0.1	1.7	1.3	3.9	0.1	0.3	0.8	0.5	0.1	0.1	0.3	0.1	0.2	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.9	1.0	3.0	1.3	0.9	1.0	1.5	1.0	1.1	0.7	1.0	1.1	0.4	16.0	17.2	0.0	0.3	15.3	6.1	3.9	12.5	0.4	14.2	6.1	0.3	0.0	11.0	11.0	0.0	1.6	1.2	0.3	0.0	0.0	7.6	1.1	1.3	0.8	0.0	0.0	1.1	0.0	0.4	0.9	0.0	1.1	0.0	0.4	2.5	0.1	0.3	0.0	1.2	0.3	2.0	0.6	5.5	1.3	0.9	1.9	3.6	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.6	5.5	0.8	0.3	12.8	1.5	0.0	0.9	1.2	0.9	0.3	42.7	57.1	2.6	1.3	0.2	0.4	24.4
BOLA1	CGI-143	ENSG00000178096	"BolA family member 1"	Q9Y3E2	1	149887890-149900798	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 49.3;MCF7: 52.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007005	Approved				"Intracellular and membrane"	NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA007005: AB_1078294"	"unprognostic (5.73e-2)"	"unprognostic (9.86e-3)"	"unprognostic (8.84e-2)"	"unprognostic (8.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.41e-4)"	"unprognostic (3.14e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.93e-3)"	14.9	21.2	8.6	5.8	9.3	3.9	16.1	9.7	17.9	16.1	7.3	24.0	15.3	17.2	0.9	15.7	15.6	3.7	20.5	8.4	8.2	23.0	26.4	10.0	7.0	9.3	8.0	14.5	19.7	5.5	14.4	2.6	8.4	16.8	1.7	1.1	19.3	7.2	23.2	22.5	15.9	2.0	9.2	16.2	20.3	9.9	9.3	5.3	15.8	5.0	1.4	19.0	13.8	10.8	16.4	21.3	2.0	4.2	1.2	4.1	4.0	6.7	1.7	5.0	4.1	15.2	22.0	2.1	16.6	2.8	2.3	17.9	0.0	3.5	0.2	22.8	8.2	1.1	6.1	2.4	7.7	0.0	16.8	3.8	7.3	1.5	0.5	2.0	6.0	49.3	9.1	5.4	2.7	52.9	21.1	5.3	1.3	14.7	6.1	16.4	1.2	4.4	2.3	2.1	13.5	14.8	8.8	14.5	15.9	1.7	26.9	4.5	2.5	6.4	10.5	14.6	0.2	29.5	23.3	0.2	9.0	5.1	6.8	8.6	9.4	12.4	14.8	8.1	15.3	16.2	13.5	11.5	9.9	14.6	18.8	18.1	4.6	9.1	5.2	19.2	18.8	9.3	8.6	9.3	9.7	17.9	8.4	8.2	9.3	8.0	8.4	9.2	9.3	10.8	11.9	3.2	9.5	5.5	10.0	4.5	16.3	19.0	10.8	7.3	23.9	30.5	21.1	34.3	11.2	23.9	4.2	20.2	6.3	12.8	68.4	24.6	8.8	12.1	13.6	13.7	12.6	27.1	2.4	19.8	25.3	16.4	19.4	10.4	5.1	13.9	20.7	40.9	17.0	10.1	3.3	22.8	18.3	12.5	3.5	3.5	15.8	6.6	5.4	1.0	10.3	23.5	19.6	2.5	7.5	15.7	17.6	20.7	18.0	23.1	41.5	57.4	14.2	12.3	39.5	10.9	15.7	22.6	16.2	18.4	6.7	14.0	10.1	22.8	21.2	10.0
BRD1	"BRL, BRPF2"	ENSG00000100425	"Bromodomain containing 1"	O95696	22	49773283-49827512	"Predicted intracellular proteins"	"Erythrocyte maturation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000807, HPA001063"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA000807: AB_1078298, HPA001063: AB_1078297"	"unprognostic (1.96e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.95e-3)"	11.4	7.3	3.1	8.1	3.0	15.0	10.8	12.0	5.0	12.5	3.6	14.7	11.7	15.8	2.8	12.8	13.7	7.7	7.5	3.4	3.2	5.4	6.9	10.0	9.4	3.2	2.8	16.0	13.2	8.5	11.2	8.3	2.9	8.7	5.8	6.1	12.1	8.0	16.7	23.2	12.0	6.7	1.5	12.0	11.5	30.7	3.2	14.0	10.2	8.9	7.6	11.8	12.3	4.5	12.7	12.7	22.8	12.8	9.2	8.2	19.3	13.7	9.3	14.2	11.1	19.3	8.3	13.3	7.9	11.4	5.2	17.9	14.7	9.8	6.1	13.4	26.6	13.2	20.3	11.8	17.8	30.5	18.2	12.2	15.1	8.3	10.5	10.3	10.4	15.9	15.3	14.3	7.3	20.8	23.0	15.9	15.7	9.4	10.1	33.6	19.9	13.9	5.5	18.2	14.6	25.8	17.6	22.7	18.4	10.5	10.6	24.9	12.9	13.1	14.1	9.9	12.7	16.8	4.3	18.9	9.3	10.7	11.8	0.3	0.6	0.7	0.5	0.2	1.0	0.4	0.8	1.0	0.4	0.7	0.8	1.0	0.6	0.8	2.9	0.9	0.3	0.5	3.1	3.0	12.0	5.0	3.4	3.2	3.2	2.8	2.9	1.5	3.2	4.5	25.9	22.4	27.6	16.3	13.8	15.8	5.7	7.1	8.6	26.6	14.0	14.7	8.4	5.7	12.7	3.7	29.2	6.7	76.8	13.3	0.0	6.7	7.5	32.4	37.1	13.9	16.2	8.2	25.3	9.3	6.6	17.2	14.8	47.7	10.1	28.3	14.3	12.3	6.7	33.7	22.2	13.9	4.1	13.3	14.0	6.7	11.8	15.4	12.4	16.9	11.2	13.8	7.2	19.1	21.9	9.5	8.7	13.9	43.1	9.1	10.6	3.2	11.3	36.1	0.0	25.4	20.1	42.6	19.7	10.7	18.5	10.1	40.6	26.4	11.3	9.0
BTG1	APRO2	ENSG00000133639	"BTG anti-proliferation factor 1"	P62324	12	92140278-92145846	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2751.6;Langerhans cells: 2893.3;Suprabasal keratinocytes: 3004.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 33.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA005972			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA005972: AB_1078303"	"prognostic favorable (4.36e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (9.81e-2)"	91.5	36.9	1.9	19.8	2.0	93.9	80.1	33.5	4.1	62.3	1.4	38.9	8.5	45.6	1.5	29.5	55.9	7.1	45.2	2.5	4.6	52.4	69.7	55.5	23.8	3.6	2.6	45.6	63.7	8.3	26.2	6.2	3.7	40.5	4.8	5.2	30.5	4.5	20.5	120.6	58.4	8.2	3.5	92.2	39.3	12.4	3.1	20.1	21.9	3.7	18.2	38.5	60.1	3.0	5.7	5.4	3.5	0.9	13.4	16.9	3.2	8.0	6.3	2.3	2.3	2.4	1.6	5.7	1.5	3.3	3.5	3.9	1.6	3.0	2.2	9.8	8.8	0.8	2.9	1.3	15.0	3.7	1.9	14.1	11.9	4.5	11.7	8.5	5.0	2.4	4.6	7.1	3.4	3.7	5.5	9.4	2.2	3.0	11.0	15.2	2.4	1.5	5.5	6.5	3.4	7.8	6.1	4.4	17.3	2.1	21.5	7.7	2.6	3.9	1.3	3.6	3.7	14.0	6.3	8.9	3.1	2.4	4.6	36.2	21.8	151.8	22.8	16.2	27.8	92.4	47.3	40.7	9.2	105.5	133.1	53.6	75.9	68.8	22.8	8.0	66.8	51.3	1.9	2.0	33.5	4.1	2.5	4.6	3.6	2.6	3.7	3.5	3.1	3.0	1186.6	96.1	185.4	12.1	2512.8	2751.6	1030.9	206.6	912.9	592.7	607.5	573.8	119.5	1009.4	140.4	174.7	196.0	412.8	1907.2	672.9	320.8	388.1	411.8	216.7	258.8	709.0	452.4	230.7	7.9	255.8	416.3	529.1	406.7	264.7	286.6	197.4	339.1	274.9	361.4	424.0	20.6	373.8	193.3	564.3	2893.3	213.7	287.1	1251.4	983.6	31.9	1241.2	877.6	1354.3	22.1	8.4	364.4	668.7	241.9	758.5	791.3	667.9	162.6	53.0	377.2	539.0	870.7	723.5	130.1	101.5	508.7	3004.2	1342.7	2354.0	786.4	410.9	1513.3
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101119-42142620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 157.0;skin 1: 73.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 163.8;Pancreatic endocrine cells: 219.9;Prostatic glandular cells: 144.6;Urothelial cells: 226.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 57.8;CACO-2: 52.0;CAPAN-2: 44.0;OE19: 181.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	3.7	1.0	0.4	2.2	0.4	1.0	8.7	0.6	0.7	31.7	0.3	14.1	33.4	1.0	0.1	157.0	5.8	6.6	1.8	0.4	0.1	14.9	0.5	5.8	0.3	0.4	0.1	0.2	18.0	2.5	1.7	1.5	0.4	12.1	11.7	0.9	47.1	2.3	0.9	73.6	20.7	0.5	0.0	0.1	36.2	0.7	0.3	0.7	10.7	0.3	13.9	9.9	54.9	0.6	57.8	0.5	0.0	0.1	0.3	6.1	29.0	2.9	4.4	7.6	7.6	52.0	44.0	0.0	5.4	5.4	0.1	37.5	0.1	17.3	5.2	5.1	7.2	2.8	5.0	12.1	2.0	0.0	0.2	4.0	30.4	5.9	8.8	3.1	0.0	0.3	1.7	0.5	1.7	20.4	0.4	0.3	3.6	181.7	1.5	0.1	0.0	0.3	6.2	25.5	3.0	0.1	4.7	35.2	0.1	4.1	25.2	0.3	0.8	0.4	3.5	13.5	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.4	0.4	0.6	0.7	0.4	0.1	0.4	0.1	0.4	0.0	0.3	0.6	0.8	44.8	16.6	0.3	0.2	52.5	88.6	31.8	19.4	0.8	41.7	19.8	5.1	45.8	63.1	51.5	20.9	12.4	1.2	89.9	0.0	57.9	22.2	91.9	9.4	2.8	7.3	0.0	0.5	134.7	1.0	9.2	57.1	135.8	1.3	18.3	1.4	0.0	0.8	5.0	0.5	41.3	38.7	1.2	6.8	163.8	0.6	1.5	12.4	0.0	3.8	0.5	4.1	0.5	0.2	219.9	66.8	1.5	0.3	144.6	102.7	7.7	92.1	7.9	0.0	7.9	4.9	4.9	9.1	81.4	82.0	4.1	1.5	45.4	43.7	226.0
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049480-15058293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skin 1: 486.0"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 96.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		3600000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.6	0.0	0.1	0.0	0.4	0.4	7.8	0.4	0.2	3.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.8	0.0	0.1	1.1	4.2	1.4	486.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.0	0.0	0.0	19.9	1.0	1.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.3	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	19.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	96.0	0.7	0.1	0.0	0.0	0.8
CBARP	"BARP, C19orf26, DOS, MGC40084"	ENSG00000099625	"CACN subunit beta associated regulatory protein"	Q8N350	19	1228287-1238027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.3;pituitary gland: 22.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 21.8;Early spermatids: 55.9;Late spermatids: 97.4;Spermatocytes: 54.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012777			Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA012777: AB_2067005"	"unprognostic (1.31e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-3)"	"unprognostic (3.03e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.42e-5)"	1.4	2.6	6.0	0.1	9.8	0.0	0.4	2.0	15.3	0.7	0.0	0.6	0.1	0.5	0.0	1.4	0.5	0.1	1.7	12.3	3.1	2.3	0.3	1.0	0.0	5.6	1.3	4.9	0.4	0.0	22.3	0.1	1.3	0.8	0.0	0.3	0.4	0.1	0.4	3.1	0.2	0.0	0.0	0.1	0.4	1.7	1.8	0.0	0.6	0.0	0.0	0.3	0.9	0.0	0.3	0.4	1.1	3.1	0.1	0.5	0.4	2.7	0.8	0.5	0.5	1.1	0.1	0.0	2.7	0.5	0.3	0.9	0.4	0.6	0.1	0.5	0.7	0.1	1.1	0.9	1.4	0.0	1.0	0.6	0.2	0.6	0.1	0.5	0.4	0.5	1.7	0.0	0.3	2.3	0.0	0.6	1.6	0.1	1.2	2.0	0.4	0.2	0.1	0.2	1.4	4.2	0.0	0.0	3.1	0.1	0.4	0.5	1.2	0.7	2.6	2.3	0.7	0.1	0.2	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	9.8	2.0	15.3	12.3	3.1	5.6	1.3	1.3	0.0	1.8	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	1.2	21.8	1.7	1.8	0.0	1.5	0.0	0.0	2.1	0.0	0.6	0.0	1.9	0.1	55.9	0.9	2.2	0.7	0.0	0.0	0.0	0.2	0.1	1.2	1.1	1.6	0.0	0.9	1.4	0.1	0.3	3.3	0.0	0.0	0.0	0.8	0.0	97.4	1.8	1.2	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	0.2	0.0	1.7	0.0	0.7	1.4	54.8	7.0	1.1	0.0	0.0	0.3	0.1	0.0	0.3
CCDC6	"D10S170, H4, PTC, TPC, TST1"	ENSG00000108091	"Coiled-coil domain containing 6"	Q16204	10	59788747-59906556	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019049, HPA019051"	Enhanced		Supported	Cytosol		No	No		12000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA019049: AB_1846163, HPA019051: AB_1846164"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.98e-3)"	"prognostic favorable (5.48e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (4.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.19e-2)"	11.9	12.2	21.1	13.9	23.4	16.8	22.4	10.2	20.0	23.4	8.5	23.5	22.8	24.9	16.7	34.1	25.3	16.7	10.0	24.9	21.4	21.2	12.1	17.3	21.4	12.4	15.8	15.7	25.2	17.9	11.5	13.2	17.4	19.4	19.8	18.3	29.0	14.3	17.3	28.6	16.2	30.8	11.9	14.7	18.6	11.4	20.8	12.1	18.3	12.2	21.6	17.3	23.1	12.6	42.9	38.0	18.7	41.9	27.8	41.6	37.9	20.6	27.2	20.2	23.7	74.4	81.8	36.5	30.2	34.6	11.7	61.7	37.7	37.5	30.0	55.1	18.7	29.8	29.1	45.5	33.5	34.5	26.9	30.3	48.7	33.7	81.8	28.3	30.2	20.4	22.6	22.7	26.6	57.6	14.5	19.8	29.9	40.1	25.6	19.2	30.5	23.0	33.9	36.2	19.0	16.6	26.1	107.8	23.1	24.1	68.7	18.4	31.1	18.8	33.9	29.3	34.9	12.0	14.9	16.3	29.6	64.6	11.9	0.0	2.0	0.0	1.0	2.3	1.1	4.3	1.5	1.3	5.0	4.9	1.3	1.0	0.1	0.8	1.3	1.3	1.4	1.0	21.1	23.4	10.2	20.0	24.9	21.4	12.4	15.8	17.4	11.9	20.8	12.6	24.0	99.3	25.9	45.1	41.6	95.0	51.7	25.3	70.0	15.1	51.2	38.7	16.5	28.6	46.3	25.8	41.7	37.8	31.4	42.6	29.4	50.2	27.6	105.2	54.6	22.4	27.0	25.7	83.2	65.3	18.8	27.8	39.8	134.5	29.1	45.2	17.2	20.1	23.1	16.8	58.4	38.9	30.5	40.7	35.3	80.6	24.5	36.4	16.0	32.8	23.0	11.5	13.4	55.3	34.2	50.2	25.0	19.5	26.4	52.2	47.1	48.4	28.1	49.8	19.7	31.4	27.0	2.3	22.4	92.3	80.1	27.0	24.3	32.5	46.3	46.1
CCDC96	FLJ90575	ENSG00000173013	"Coiled-coil domain containing 96"	Q2M329	4	7040849-7043001	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 65.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.7;Endometrial ciliated cells: 59.7;Late spermatids: 93.4;Respiratory ciliated cells: 53.4;Spermatocytes: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 5.3"									HPA047546	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA047546: AB_2680082"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.95e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.77e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.92e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.80e-5)"	"unprognostic (4.37e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	0.8	2.0	2.0	0.5	2.4	1.3	1.2	2.4	2.1	1.1	6.0	0.8	0.9	0.8	0.7	1.3	10.7	0.8	0.6	2.5	2.1	1.4	0.5	1.7	0.8	3.4	3.7	0.7	1.3	1.0	3.3	0.5	3.0	1.0	0.6	1.8	1.0	1.1	1.1	1.7	0.8	0.6	2.7	0.8	1.1	65.4	2.6	0.7	1.5	0.7	0.6	0.7	0.9	1.9	1.0	2.7	1.4	1.1	1.8	1.2	0.3	2.7	1.6	3.0	1.8	0.9	2.4	0.6	0.7	1.5	3.9	1.2	0.5	1.2	0.9	0.1	0.4	0.6	1.1	0.7	0.9	0.8	1.5	1.1	1.3	1.8	0.2	0.3	1.2	1.9	0.4	0.2	1.9	2.4	1.6	1.0	0.5	0.9	1.6	0.6	0.9	0.1	5.3	1.0	3.8	0.8	2.2	1.0	0.5	1.3	1.0	1.5	1.3	2.5	0.7	1.5	2.1	0.0	0.1	0.5	1.9	0.0	0.8	0.0	0.4	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.5	0.1	0.1	1.0	0.0	0.0	0.1	2.0	2.4	2.4	2.1	2.5	2.1	3.4	3.7	3.0	2.7	2.6	1.9	3.1	0.0	4.8	0.0	1.0	0.6	0.8	2.8	0.6	4.0	3.7	3.2	0.9	0.0	6.9	3.7	12.5	0.6	0.7	2.5	1.9	2.2	76.7	59.7	4.0	2.3	5.4	0.0	0.0	1.1	0.6	1.5	0.5	2.4	0.0	0.6	2.9	0.9	1.2	0.0	0.0	1.9	4.1	2.2	0.9	93.4	3.1	1.7	1.8	0.0	1.1	6.9	0.0	0.0	0.0	1.7	2.7	4.1	0.1	1.2	0.2	4.5	53.4	19.6	0.0	4.6	2.3	30.6	3.6	1.2	1.0	0.5	0.8	2.7	0.8	0.9
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 504.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1650.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		1200000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	143.7	42.4	29.2	218.0	33.9	308.1	164.7	63.0	25.1	146.0	16.8	91.1	53.0	200.4	20.1	227.8	69.0	129.7	30.4	33.0	116.5	31.3	31.0	214.1	108.8	114.9	102.3	11.7	263.2	6.0	8.1	74.1	118.3	87.3	111.5	38.0	504.2	57.0	17.1	433.3	60.8	175.8	114.3	83.8	61.5	6.6	62.8	64.2	76.2	27.7	188.7	235.2	193.4	114.9	493.0	448.6	4.3	1.2	252.6	691.5	1.6	962.2	740.3	521.3	288.2	30.4	150.4	0.7	126.5	1350.2	1065.4	820.1	9.9	1013.9	716.4	110.3	6.2	18.9	198.3	0.3	262.3	254.6	1124.3	315.4	778.3	693.2	552.7	1650.0	184.3	0.1	4.0	157.9	518.9	3.0	25.6	166.9	9.8	8.7	136.4	1.4	89.3	7.5	777.4	138.1	2.0	1.4	185.2	5.5	462.8	38.6	25.7	15.1	547.3	646.6	120.0	815.8	1006.0	281.6	327.7	3.7	980.4	145.1	969.8	127.4	403.0	35.4	140.6	257.8	196.5	122.5	210.1	186.5	229.0	90.0	179.7	153.6	92.6	322.3	356.1	79.9	309.7	437.3	29.2	33.9	63.0	25.1	33.0	116.5	114.9	102.3	118.3	114.3	62.8	114.9	41.0	96.1	361.8	54.5	250.1	999.7	297.7	335.3	228.2	0.6	139.6	71.2	8.6	27.1	125.6	20.2	2.1	4.5	257.0	14.0	1.9	992.1	41.3	43.6	395.4	50.9	100.1	94.4	0.4	869.6	3.6	282.2	39.8	196.9	763.2	25.2	13.2	3.6	226.6	0.0	0.4	93.3	30.5	474.3	1934.2	24.3	22.4	523.9	604.7	8.4	594.2	29.6	62.8	0.5	11.2	813.1	10.9	0.4	216.3	386.7	6.0	1.6	18.8	2.0	157.8	197.2	227.9	0.4	0.4	279.3	1024.9	17.9	430.8	1.0	79.1	330.7
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 64.2;Cytotrophoblasts: 84.5;Extravillous trophoblasts: 154.5;Spermatogonia: 69.9;Suprabasal keratinocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064971			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA064971: AB_2685395"	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (4.19e-4)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	3.9	2.6	1.9	7.4	2.0	55.8	4.2	3.0	2.1	8.7	2.1	4.6	4.7	5.4	1.8	18.6	4.1	2.6	2.7	1.7	1.8	3.4	2.7	3.6	11.6	2.1	1.9	4.1	3.2	1.8	1.7	9.2	2.1	3.8	2.9	1.3	5.5	2.2	1.4	24.7	4.9	3.5	1.9	6.6	3.8	11.6	2.0	14.6	3.3	1.5	8.5	4.2	10.2	2.0	40.6	41.3	46.7	35.6	7.9	13.2	61.1	59.0	18.0	45.2	39.7	50.9	50.2	52.9	31.5	20.9	34.5	63.5	32.9	68.0	27.1	58.2	26.1	33.4	33.9	43.2	9.7	59.8	27.0	9.4	20.8	35.2	32.7	15.1	31.4	45.0	37.5	53.0	32.1	98.8	56.2	40.1	34.8	35.1	94.0	53.6	68.1	19.7	15.9	46.2	27.2	33.5	56.6	22.3	46.8	20.5	44.0	39.8	48.8	39.9	50.5	55.3	79.5	19.5	25.9	54.4	33.5	30.2	67.5	1.1	4.3	10.6	11.9	4.9	14.8	8.4	12.7	16.7	4.7	5.4	7.4	8.9	1.6	12.9	5.6	5.1	11.1	7.0	1.9	2.0	3.0	2.1	1.7	1.8	2.1	1.9	2.1	1.9	2.0	2.0	5.4	0.0	2.2	0.7	7.4	64.2	26.5	36.6	13.1	3.4	8.7	8.3	0.6	0.0	9.0	1.8	0.0	84.5	11.5	4.3	3.9	12.7	8.1	9.0	9.0	10.9	3.0	53.0	1.8	7.0	154.5	10.2	3.1	12.5	28.6	15.1	7.9	2.2	24.3	13.5	1.3	6.6	6.1	5.9	22.6	6.8	8.4	8.4	17.8	2.8	9.3	4.6	9.2	1.0	1.8	12.3	3.3	6.0	11.8	16.1	1.9	1.8	7.7	2.6	6.6	4.6	12.5	43.0	69.9	21.3	67.1	25.9	17.7	3.6	9.5	43.2
CDON	"CDO, CDON1, ORCAM"	ENSG00000064309	"Cell adhesion associated, oncogene regulated"	Q4KMG0	11	125955796-126063335	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 58.3;Fibroblasts: 23.5;Inhibitory neurons: 49.5;Muller glia cells: 39.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 23.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 28.4;ASC diff: 32.7;RH-30: 48.9;SuSa: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB012422, HPA017377"	Uncertain					NA	NA		15000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB012422: AB_2260246, HPA017377: AB_1846453"	"prognostic favorable (1.35e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.25e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"	"unprognostic (5.77e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (5.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.86e-4)"	12.6	0.7	1.9	1.6	2.0	0.0	5.1	23.0	4.0	7.9	1.2	12.4	1.0	14.0	2.1	1.7	14.2	4.8	4.0	1.6	1.8	0.8	1.2	2.7	1.1	2.2	1.9	20.6	1.2	2.5	3.0	2.7	2.7	1.3	1.6	10.1	1.7	2.8	1.2	9.9	2.9	17.0	0.5	0.7	4.6	3.6	2.3	2.8	18.5	1.6	1.5	2.5	3.0	2.1	1.6	3.2	28.4	2.8	32.7	14.5	0.4	0.5	2.9	0.9	0.3	1.1	9.4	1.4	6.8	0.6	3.3	0.4	7.1	1.0	0.8	5.5	6.3	0.5	6.5	2.9	6.4	0.4	1.8	4.5	1.2	0.6	0.0	12.2	0.3	4.8	0.1	1.9	2.7	0.4	3.6	1.0	2.6	0.8	3.7	1.1	48.9	0.9	1.7	0.5	2.4	9.6	3.7	0.3	4.7	23.8	2.4	1.0	0.5	3.2	2.2	6.3	3.3	2.5	5.5	0.2	2.0	1.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.0	23.0	4.0	1.6	1.8	2.2	1.9	2.7	0.5	2.3	2.1	3.0	6.4	9.9	11.1	0.1	15.2	1.4	0.8	2.2	5.1	5.4	1.9	5.2	2.8	5.6	0.0	16.7	0.6	0.1	0.2	0.0	1.3	3.1	1.7	0.5	3.0	7.7	0.4	58.3	0.6	0.4	23.5	1.5	1.1	0.0	1.8	1.1	2.1	0.3	0.0	49.5	0.3	0.0	0.0	7.6	2.7	14.9	0.2	3.6	2.8	0.1	39.3	0.0	14.1	5.8	2.4	0.4	11.3	0.8	1.1	0.6	0.5	4.2	4.6	0.0	2.9	2.7	1.8	3.8	0.5	10.7	0.7	0.6	13.2	0.4	1.6
CDYL	"CDYL1, DKFZP586C1622"	ENSG00000153046	"Chromodomain Y like"	Q9Y232	6	4706159-4955551	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Lyase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035578	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA035578: AB_2674685"	"unprognostic (1.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.38e-3)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.94e-1)"	14.0	6.0	6.9	10.2	6.8	20.0	11.5	5.0	6.7	15.0	4.9	13.0	7.0	15.2	10.5	16.8	10.6	8.4	10.4	6.0	6.4	7.2	5.6	8.9	12.1	6.6	6.2	9.9	7.5	12.4	5.1	18.2	6.0	7.6	13.2	6.7	9.0	11.9	19.5	17.8	9.0	14.5	5.6	9.6	9.2	9.0	6.7	9.3	9.7	12.7	12.9	15.6	13.0	6.9	23.7	22.1	30.1	25.5	23.3	15.9	34.4	23.1	17.9	21.3	22.9	18.0	17.2	5.3	22.1	17.6	33.3	19.8	24.2	28.2	24.9	16.4	20.2	20.9	21.0	16.4	28.5	27.9	21.7	12.5	49.8	25.0	37.5	12.9	20.6	19.2	37.9	16.2	10.8	22.9	14.8	25.9	32.6	17.9	21.3	19.0	26.2	43.7	14.7	20.5	25.5	15.4	28.5	24.9	36.9	86.5	15.0	26.3	28.1	25.2	21.6	18.5	26.8	33.7	57.8	18.4	8.3	17.7	28.1	5.3	1.3	0.6	1.5	0.6	1.1	1.0	1.1	1.2	1.6	1.1	0.7	1.1	0.4	1.6	0.8	6.8	0.1	1.3	6.9	6.8	5.0	6.7	6.0	6.4	6.6	6.2	6.0	5.6	6.7	6.9	32.7	19.2	9.4	28.7	18.4	37.3	23.9	11.9	10.8	16.7	31.2	35.8	18.8	14.3	12.0	14.7	22.9	12.9	64.5	44.7	15.6	10.8	62.8	26.9	43.2	22.9	32.3	41.5	52.3	10.4	22.0	18.7	6.1	60.3	5.7	24.3	18.9	11.7	10.5	45.4	41.5	26.6	6.1	17.3	57.9	74.9	5.9	28.1	8.8	101.2	22.7	25.4	19.6	54.3	64.1	16.8	41.8	8.2	22.3	30.1	4.6	10.7	12.1	25.7	6.6	29.7	20.9	10.4	25.3	9.8	41.9	63.8	17.5	10.9	22.6	56.9
CEACAM19	CEAL1	ENSG00000186567	"CEA cell adhesion molecule 19"	Q7Z692	19	44662278-44684359	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 7.9;Skeletal myocytes: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.2;RPTEC TERT1: 15.8;TIME: 20.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"HPA014462, HPA052865"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA014462: AB_2669006, HPA052865: AB_2681976"	"unprognostic (2.91e-1)"	"unprognostic (5.29e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.26e-9)"	"unprognostic (8.01e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-1)"	3.9	5.6	3.7	1.3	3.7	1.5	3.8	4.9	5.1	7.0	3.5	4.7	3.0	5.2	1.7	5.1	6.8	2.4	11.7	4.0	3.8	9.4	8.2	8.2	1.1	2.8	3.0	6.6	8.9	1.5	7.0	2.2	2.7	7.8	3.4	2.4	5.7	3.1	13.8	12.4	3.8	3.1	1.9	3.5	4.6	5.7	3.7	0.9	6.5	3.4	2.2	4.2	8.7	4.7	5.1	10.3	1.5	1.0	3.5	4.0	3.8	2.8	4.2	0.9	1.8	0.4	1.1	0.1	1.0	3.8	1.0	6.2	2.6	1.1	0.8	1.5	5.8	0.1	6.7	1.7	3.6	0.2	1.0	1.3	10.0	2.6	6.1	12.2	2.4	0.7	0.3	0.3	1.4	1.2	0.0	0.6	0.9	1.4	1.1	0.0	1.8	0.2	15.8	1.2	1.9	0.5	1.1	1.1	0.9	1.4	1.4	0.3	20.9	0.4	6.8	1.5	0.9	0.1	0.3	0.0	0.5	2.0	1.7	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.7	3.7	4.9	5.1	4.0	3.8	2.8	3.0	2.7	1.9	3.7	4.7	3.6	3.2	2.2	2.0	0.0	2.0	0.9	2.1	1.2	2.9	1.9	1.5	4.5	1.5	2.4	0.0	0.0	0.2	0.1	2.1	0.0	1.6	3.8	0.9	0.9	4.1	1.8	0.0	7.9	3.3	0.2	1.0	3.6	2.4	0.0	0.8	4.6	2.6	0.3	0.0	6.1	2.3	4.1	0.6	0.8	1.9	3.1	0.5	0.0	1.9	0.4	0.3	1.0	2.0	2.4	4.5	2.6	2.6	0.0	1.8	1.2	0.4	1.8	0.6	0.0	8.8	1.7	3.1	0.9	1.2	6.0	0.0	0.2	1.6	2.5	0.9
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	12.5	11.9	11.2	13.5	12.5	35.3	14.8	16.3	13.2	12.4	10.5	14.0	9.4	14.8	11.1	14.9	12.9	10.1	12.0	11.1	12.2	11.7	9.6	13.7	18.0	11.4	11.6	17.1	13.6	22.3	13.1	11.7	11.1	13.2	12.3	14.8	13.6	12.1	15.7	22.3	14.7	14.8	11.5	15.8	14.2	12.9	12.5	25.4	14.8	12.7	17.5	12.8	12.9	13.6	31.2	39.6	43.6	20.7	27.7	23.6	24.9	24.4	28.4	36.5	35.4	35.0	26.3	51.4	14.8	33.1	28.4	37.2	54.9	35.1	46.0	39.3	24.2	46.3	27.6	43.5	25.7	64.6	40.4	32.8	27.2	40.9	29.7	28.6	33.4	40.2	32.4	26.7	28.0	33.9	46.1	26.0	33.4	30.9	34.3	42.0	32.9	17.4	27.3	57.9	30.9	30.7	37.5	29.8	21.8	39.7	20.7	30.5	36.4	29.2	23.0	17.8	29.1	30.3	38.4	50.3	12.1	23.2	29.6	9.1	3.8	9.8	5.5	3.8	6.4	4.2	4.9	5.6	2.7	11.2	5.0	4.4	7.9	7.8	6.7	6.1	4.7	2.7	11.2	12.5	16.3	13.2	11.1	12.2	11.4	11.6	11.1	11.5	12.5	13.6	27.6	38.5	56.3	27.4	32.2	12.6	11.3	15.9	23.3	33.3	21.9	22.6	19.6	24.3	32.6	33.1	27.1	14.7	40.0	16.8	1.9	21.8	3.4	32.5	37.9	25.5	27.1	27.8	41.0	23.6	12.3	24.0	27.5	39.5	28.4	41.7	13.9	14.9	17.5	23.5	40.2	16.0	8.2	20.1	9.3	4.1	16.1	25.3	10.6	20.6	27.1	18.9	32.0	29.7	33.1	26.5	13.9	17.7	32.4	16.1	12.0	7.4	28.8	24.3	0.0	32.1	26.2	29.2	25.1	24.6	16.6	12.3	31.4	34.1	16.8	12.7
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305707-190322446	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 309.8;skin 1: 288.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 440.1;Basal prostatic cells: 291.1;Prostatic glandular cells: 501.6;Squamous epithelial cells: 298.2;Suprabasal keratinocytes: 836.1;Urothelial cells: 562.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"EFO-21: 658.6;HaCaT: 236.5;hTCEpi: 288.6;RPTEC TERT1: 414.9;RT4: 267.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	12	"spinal cord: 25.4"	"CAB002602, HPA048319"	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	40.8	47.9	1.5	1.2	1.1	0.2	22.7	0.8	1.3	17.7	20.7	1.7	1.1	64.2	31.9	40.9	56.6	15.5	2.5	1.5	1.2	10.5	309.8	9.1	0.5	1.2	2.8	6.3	34.3	0.4	2.4	5.3	1.7	13.6	1.6	0.9	34.0	46.0	1.1	288.2	0.7	126.6	0.7	1.5	1.0	4.3	1.1	9.4	36.2	4.9	44.2	40.4	35.9	1.0	34.0	29.7	0.2	0.1	0.0	0.1	0.0	2.5	52.7	1.1	2.1	17.7	69.1	0.0	658.6	0.3	58.5	236.5	1.5	77.7	6.2	0.9	1.4	0.1	9.3	41.5	49.6	0.4	0.2	0.5	288.6	6.0	87.0	2.4	0.6	0.0	0.1	0.1	0.1	6.5	0.1	0.1	1.5	2.3	5.5	0.0	0.6	0.2	414.9	267.0	0.2	0.0	31.0	5.7	18.4	3.5	53.5	0.5	12.9	0.6	9.9	0.2	1.4	0.7	0.6	1.2	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.8	1.3	1.5	1.2	1.2	2.8	1.7	0.7	1.1	1.0	0.4	12.8	34.7	0.0	0.5	440.1	291.1	217.3	84.2	0.0	35.6	2.0	1.0	170.1	143.2	31.3	0.0	2.4	0.6	0.6	0.0	203.3	0.1	44.4	10.0	7.0	1.8	0.0	0.7	56.3	0.3	29.2	2.0	100.0	1.3	0.4	1.4	188.2	1.0	0.0	1.6	0.3	54.9	3.8	66.5	1.7	15.5	8.5	32.0	0.0	5.7	0.0	0.0	24.6	0.0	139.9	0.0	35.3	0.0	501.6	0.1	4.1	144.6	0.0	0.0	0.3	11.2	0.3	0.8	298.2	836.1	33.8	2.6	5.0	1.0	562.9
CNNM1	ACDP1	ENSG00000119946	"Cyclin and CBS domain divalent metal cation transport mediator 1"	Q9NRU3	10	99329356-99394330	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;testis: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.1;Excitatory neurons: 69.9;Horizontal cells: 50.5;Inhibitory neurons: 89.5;Late spermatids: 88.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.6;BJ hTERT+: 7.4;BJ hTERT+ SV40 Large T+ RasG12V: 11.3;HAP1: 8.7;OE19: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040408	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA040408: AB_10793963"	"unprognostic (9.04e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.60e-4)"	"unprognostic (4.08e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.03e-1)"	0.2	1.1	9.9	0.2	9.9	0.0	0.5	5.4	16.7	1.8	0.0	0.7	0.4	0.9	1.7	0.8	1.0	0.3	0.1	7.3	7.3	1.7	0.2	0.1	0.0	3.6	2.9	2.6	1.1	0.6	3.6	0.0	3.5	1.7	0.4	5.2	0.8	0.8	0.0	1.2	0.6	0.4	2.0	0.1	0.6	9.8	4.7	0.1	0.1	0.1	0.1	1.7	1.4	10.1	0.0	19.6	0.0	0.0	0.0	0.0	0.0	2.8	7.4	6.7	11.3	0.0	4.4	0.0	0.0	1.4	0.1	1.7	8.7	0.0	4.8	0.0	0.9	1.9	2.8	3.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.4	2.7	0.3	0.0	0.9	7.7	0.8	0.0	0.0	0.0	0.9	0.0	2.2	6.1	2.0	0.4	1.0	0.5	0.0	0.0	0.0	0.6	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	9.9	5.4	16.7	7.3	7.3	3.6	2.9	3.5	2.0	4.7	10.1	0.6	0.0	0.0	4.6	0.0	2.3	3.3	0.1	5.2	25.3	0.7	2.8	1.4	0.0	0.2	1.8	14.6	0.0	0.0	0.0	0.0	0.6	103.1	0.5	1.0	0.4	0.0	0.8	69.9	1.5	0.0	1.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	50.5	89.5	0.1	0.0	0.0	0.8	88.0	2.1	0.3	1.8	4.7	0.1	1.3	0.0	10.6	2.2	2.0	0.3	2.6	0.0	5.9	0.1	0.7	0.6	3.4	0.0	2.0	0.5	1.9	1.6	1.5	1.0	0.0	0.2	1.2	0.1	2.4
CNTNAP3	"CASPR3, CNTNAP3A, FLJ14195, KIAA1714"	ENSG00000106714	"Contactin associated protein family member 3"	Q9BZ76	9	39072767-39288315	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.1;Excitatory neurons: 18.6;Hepatic stellate cells: 30.0;Inhibitory neurons: 103.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	20	"neutrophil: 7.3"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"A549: 18.9;AF22: 22.5;TIME: 14.5;WM-115: 37.9"									HPA047731	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA047731: AB_2680137"	"unprognostic (9.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (5.74e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.93e-3)"	2.7	0.4	4.8	0.5	7.6	1.2	3.2	0.4	2.7	1.3	2.7	4.0	0.8	0.6	0.5	7.2	2.2	1.2	4.0	5.0	3.3	1.8	0.8	1.1	0.3	0.9	5.4	0.3	0.4	0.1	1.1	1.6	0.9	1.5	1.3	2.7	3.4	1.4	0.4	7.2	1.8	2.3	0.1	2.6	0.6	1.8	1.7	2.5	1.2	0.7	0.6	1.0	2.5	2.8	1.1	18.9	22.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	1.4	4.7	1.9	4.4	0.0	0.0	1.6	0.0	5.2	0.5	0.2	0.3	0.0	0.5	4.1	0.0	1.7	9.4	8.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.9	0.2	5.7	0.0	0.6	5.4	0.4	0.8	2.1	0.7	6.7	0.0	3.7	2.4	0.0	3.2	14.5	0.0	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	4.8	7.6	0.4	2.7	5.0	3.3	0.9	5.4	0.9	0.1	1.7	2.8	8.0	3.2	1.7	26.1	0.0	6.2	4.0	1.8	18.2	1.3	0.9	3.0	3.5	4.3	1.5	1.8	2.1	0.8	0.0	0.1	0.0	0.4	1.9	1.4	0.7	7.5	3.5	0.0	18.6	0.2	2.5	1.2	0.0	0.2	0.0	0.1	30.0	1.3	0.1	0.0	103.1	0.3	0.0	1.6	0.8	0.9	0.3	0.2	0.0	13.1	0.0	10.5	0.0	3.0	13.3	0.7	0.0	0.0	1.2	1.4	0.0	1.9	4.1	0.7	0.0	0.5	0.9	1.7	8.8	10.4	7.7	0.7	0.4	0.0	0.1	2.7
COP1	"CFAP78, FAP78, FLJ10416, RFWD2, RNF200"	ENSG00000143207	"COP1 E3 ubiquitin ligase"	Q8NHY2	1	175944831-176207286	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 28.1;Extravillous trophoblasts: 33.5;Syncytiotrophoblasts: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.99e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	14.2	9.5	5.9	12.0	7.1	16.8	12.7	11.4	9.1	12.1	8.4	18.1	13.8	11.8	9.8	14.2	9.4	9.5	9.8	8.5	5.9	12.4	16.6	12.5	15.7	4.6	5.0	8.7	13.2	10.5	8.0	11.2	5.0	10.1	16.7	8.6	13.1	8.5	13.6	17.5	13.9	11.0	5.7	16.7	13.7	15.6	6.1	14.9	10.6	7.4	16.8	14.7	11.9	8.8	35.3	17.5	22.1	13.8	23.0	22.6	56.1	21.7	22.0	17.7	18.6	30.0	28.1	59.4	25.8	20.9	18.9	32.3	16.9	27.0	17.7	23.7	17.0	22.6	19.4	28.0	18.9	49.2	33.0	16.8	28.9	17.6	19.8	17.9	26.6	21.7	43.9	24.9	24.8	42.5	27.0	28.2	47.4	55.8	2.0	26.1	20.4	40.2	26.8	93.7	22.6	41.6	27.8	44.9	35.9	37.4	32.1	69.1	40.4	19.4	16.1	28.3	23.4	35.3	62.7	49.8	19.1	26.7	26.9	8.5	3.0	12.0	1.9	3.7	1.4	1.7	2.0	1.4	2.1	1.5	2.7	2.0	14.1	0.6	3.4	1.1	1.7	1.0	5.9	7.1	11.4	9.1	8.5	5.9	4.6	5.0	5.0	5.7	6.1	8.8	15.8	22.4	14.5	0.0	4.4	0.0	0.0	0.0	0.0	0.0	15.4	10.9	0.0	0.0	3.1	9.2	0.0	28.1	12.2	0.0	21.5	14.8	0.0	17.9	14.6	7.2	0.0	0.0	0.0	22.7	33.5	7.4	0.0	20.1	7.6	18.1	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	21.8	0.0	0.0	3.1	0.0	0.0	22.1	4.4	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	31.3	6.7	13.8	0.0	0.0
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 37.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 50.7;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.0	17.0	2.8	8.0	3.2	11.8	5.8	3.5	3.3	7.9	3.6	14.2	9.5	6.3	7.5	10.4	4.4	4.3	15.0	3.0	3.5	5.6	13.6	7.9	6.4	3.6	3.5	6.5	6.5	6.0	4.0	8.4	3.8	6.6	14.2	4.0	7.8	5.0	29.1	10.8	9.1	6.9	4.1	10.1	5.5	3.5	3.9	3.6	5.7	37.5	7.1	7.9	6.5	4.9	26.1	14.7	14.1	27.4	10.5	11.9	9.7	16.1	27.0	29.7	34.4	10.5	38.7	17.2	11.7	28.4	24.6	18.6	23.9	26.0	38.7	17.2	14.8	15.3	22.3	15.4	11.7	31.3	73.5	15.9	16.3	14.2	24.8	8.9	30.7	9.7	10.0	21.4	29.3	27.4	8.6	21.7	10.9	30.6	19.9	14.1	11.4	22.1	45.4	13.8	10.3	6.3	19.0	24.5	9.2	6.7	15.4	18.8	21.0	14.6	14.6	11.1	23.4	5.7	5.2	10.2	29.5	36.8	20.2	2.1	28.8	4.0	2.7	26.8	1.9	6.2	3.0	2.5	21.1	6.9	2.1	3.2	9.8	6.7	33.5	11.2	4.1	13.6	2.8	3.2	3.5	3.3	3.0	3.5	3.6	3.5	3.8	4.1	3.9	4.9	5.4	0.0	4.2	15.7	11.5	6.6	12.4	9.8	4.6	5.9	6.3	5.6	19.5	2.8	10.7	9.2	0.0	25.4	7.1	14.0	31.3	6.7	0.8	7.6	19.5	6.1	4.8	14.1	12.8	10.8	30.0	9.0	6.6	9.2	0.0	17.2	9.3	15.0	50.7	1.7	20.1	15.3	8.2	53.2	7.9	0.8	3.7	25.2	7.2	33.7	21.8	12.6	6.2	25.6	15.6	5.4	15.4	4.9	4.3	12.6	11.0	9.9	6.2	4.8	0.0	7.3	9.7	18.1	19.7	16.7	12.6	12.4	9.6	35.5	26.7	12.9
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	36.1	32.6	20.9	38.6	23.2	34.0	35.9	28.2	29.6	36.5	29.3	48.3	39.1	35.8	26.6	50.0	39.9	31.3	54.0	25.7	21.0	41.0	31.8	31.6	41.2	20.6	21.1	41.5	46.9	59.1	21.2	42.4	21.1	35.8	40.7	32.9	41.1	37.7	110.5	34.2	40.5	39.1	18.8	30.2	49.5	65.2	22.3	51.6	39.6	86.4	46.6	47.4	28.5	27.3	209.5	170.4	152.9	96.0	61.1	103.8	103.5	117.9	116.1	125.8	139.5	178.5	120.0	179.1	74.2	90.1	179.1	147.8	162.1	167.4	187.2	62.6	57.7	247.3	44.7	177.7	102.5	228.1	51.3	99.5	173.3	105.8	316.0	122.2	139.5	146.4	248.9	112.6	123.8	64.2	262.0	73.7	227.4	173.4	97.6	149.8	140.5	140.9	112.9	128.5	163.9	132.3	97.2	184.0	174.8	120.7	120.4	83.9	142.7	136.0	118.4	90.0	178.5	120.6	311.8	174.1	65.8	119.5	138.6	40.5	23.8	28.7	18.2	32.3	22.4	23.0	18.0	17.6	31.5	22.5	17.9	17.4	14.9	25.1	33.5	25.7	20.4	20.8	20.9	23.2	28.2	29.6	25.7	21.0	20.6	21.1	21.1	18.8	22.3	27.3	50.7	64.1	84.6	51.9	46.1	41.0	40.0	43.8	45.5	49.4	42.1	36.1	59.4	41.5	75.8	44.1	31.3	42.2	50.5	43.5	41.1	68.5	135.5	67.6	77.0	44.5	35.2	59.3	65.6	50.6	54.4	46.3	40.2	75.7	63.8	108.6	27.1	31.1	33.2	60.6	69.3	41.8	46.8	39.2	30.3	140.0	41.0	45.3	14.2	51.5	61.7	38.6	37.0	73.9	73.6	66.6	34.4	36.9	49.6	57.2	43.2	68.8	65.5	27.8	52.6	43.6	56.8	94.2	68.7	52.3	50.2	61.4	38.9	81.2	40.6	59.4
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562238-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 83.2;choroid plexus: 65.2;retina: 28.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 67.6;Muller glia cells: 94.7;Oligodendrocyte precursor cells: 233.7"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.6;HEK 293: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	0.9	0.8	58.3	0.2	62.4	0.1	0.6	33.6	83.2	0.3	65.2	1.1	0.0	0.3	0.1	0.3	0.3	0.1	0.5	62.5	49.7	0.2	0.2	3.2	0.2	41.2	45.6	0.2	0.3	0.3	1.7	0.8	45.8	0.4	0.2	28.3	0.3	0.0	0.5	1.1	0.3	0.4	37.0	0.0	0.4	1.9	48.0	0.1	0.4	0.0	0.1	0.1	0.2	46.1	0.3	1.7	32.6	5.7	0.6	0.0	0.9	0.6	0.1	1.2	0.3	0.3	2.0	0.1	2.5	0.1	2.4	0.5	2.7	0.3	0.3	0.0	8.8	0.5	1.4	0.0	0.0	0.4	1.4	0.0	1.1	0.1	0.0	0.9	0.1	1.1	6.6	0.3	0.1	1.5	0.2	0.4	3.1	2.4	3.3	0.5	0.2	0.7	1.4	1.1	3.4	1.5	2.1	4.1	0.1	0.9	1.6	3.1	0.3	0.1	6.5	0.1	1.9	0.8	0.8	0.0	0.5	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	62.4	33.6	83.2	62.5	49.7	41.2	45.6	45.8	37.0	48.0	46.1	0.7	3.2	2.0	67.6	0.1	0.8	0.1	0.0	0.0	28.6	2.2	1.8	1.3	0.0	0.0	0.0	6.2	0.2	0.0	0.5	0.0	0.2	2.0	0.6	0.6	0.3	1.8	0.0	18.6	0.0	0.2	0.5	0.0	2.0	0.0	6.1	0.0	0.5	0.2	6.7	25.0	0.3	0.0	0.0	0.2	0.6	0.3	0.2	0.0	7.5	0.0	94.7	0.0	233.7	9.9	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	22.7	0.0	0.8	0.8	13.5	3.3	0.0	0.6	0.1	0.2	0.2	0.4	0.1
CXADR	CAR	ENSG00000154639	"CXADR Ig-like cell adhesion molecule"	P78310	21	17513043-17593579	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 323.4;Proximal enterocytes: 263.0;Suprabasal keratinocytes: 343.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 93.4;Hep G2: 63.0;NTERA-2: 109.1;RT4: 104.4"					"Low region specificity"	"Detected in all"			"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted - unknown location"	NA	NA		18000	"Cluster 17: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	3.6	2.9	7.0	2.8	8.7	2.6	9.8	6.6	10.8	7.7	22.8	22.5	42.3	5.3	15.2	14.5	10.6	18.3	9.3	8.9	7.1	8.3	49.3	13.6	0.7	10.4	6.8	0.4	15.8	6.8	4.7	0.3	9.3	15.1	25.6	4.9	15.4	14.2	0.4	53.4	42.6	3.3	9.7	2.4	30.9	12.5	7.3	1.5	22.1	0.0	4.1	25.6	10.9	17.7	16.8	9.0	44.6	0.1	0.0	0.0	26.7	0.2	0.2	0.7	2.7	93.4	14.6	6.2	19.7	0.0	13.3	28.1	22.8	6.2	1.0	9.3	19.0	0.1	24.1	63.0	2.9	1.8	0.1	0.0	24.6	1.3	0.4	10.8	9.0	5.5	0.3	0.4	0.0	1.1	3.7	0.1	109.1	15.2	0.0	0.1	15.2	12.5	38.7	104.4	18.5	12.3	10.9	12.6	6.7	45.8	25.4	0.3	0.5	0.2	25.8	0.4	6.6	4.5	7.7	0.4	3.6	0.1	0.6	1.0	0.1	0.1	0.1	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.6	0.2	0.3	0.2	0.0	0.0	0.1	0.2	7.0	8.7	6.6	10.8	8.9	7.1	10.4	6.8	9.3	9.7	7.3	17.7	0.2	141.1	79.0	2.6	1.0	323.4	172.7	110.6	132.6	16.9	58.6	28.2	29.8	161.5	106.6	103.0	27.1	0.8	0.3	238.4	5.9	130.0	5.3	118.9	8.3	4.8	80.8	9.9	60.4	93.7	0.2	8.6	94.3	128.9	5.7	1.1	47.8	127.7	0.6	0.0	43.0	107.5	81.4	22.9	13.1	7.7	2.1	3.3	23.2	40.3	0.7	13.4	0.0	78.9	161.4	93.4	155.3	0.0	1.6	125.1	263.0	4.0	85.6	11.2	6.6	0.2	5.3	6.4	24.5	117.0	343.8	0.7	4.3	0.5	107.0	202.7
CYP39A1		ENSG00000146233	"Cytochrome P450 family 39 subfamily A member 1"	Q9NYL5	6	46549580-46652830	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 99.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 62.9;Late spermatids: 20.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 6.5;hTCEpi: 13.6;OE19: 6.1;SiHa: 8.4;U-698: 10.4"	"Region enhanced"	"Detected in all"		"olfactory bulb: 22.9"	"Low region specificity"	"Detected in all"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.33e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.46e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.33e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	3.0	2.5	2.1	1.0	2.7	0.0	5.4	3.5	2.9	3.7	5.3	2.7	0.8	3.6	21.0	3.3	4.1	6.3	3.9	2.0	2.1	5.7	99.2	3.3	0.5	2.3	2.3	11.5	5.7	15.3	2.9	0.4	2.1	14.8	3.6	4.1	23.5	2.6	0.6	15.9	1.6	2.4	2.4	0.7	2.8	4.2	2.4	0.4	6.1	1.2	1.4	2.7	3.0	2.9	0.2	0.4	0.3	1.8	0.3	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.5	6.5	4.4	0.0	0.9	1.7	0.8	1.4	0.0	0.0	2.8	0.0	1.7	1.8	4.0	0.0	0.0	0.5	13.6	0.0	1.6	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	1.5	0.5	1.1	0.1	2.9	4.0	0.7	0.0	8.4	0.0	0.2	0.4	1.5	0.0	0.0	0.2	0.9	0.0	0.1	0.0	0.0	10.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.7	3.5	2.9	2.0	2.1	2.3	2.3	2.1	2.4	2.4	2.9	3.3	16.0	1.5	3.9	0.2	4.0	8.8	2.7	2.8	1.4	4.6	6.5	5.8	10.0	4.3	3.7	2.1	0.0	0.0	1.1	5.9	2.9	12.7	4.4	1.0	3.5	0.0	5.3	3.2	0.4	0.9	4.5	1.5	3.1	0.0	2.7	1.1	62.9	0.2	0.0	2.0	4.0	10.2	2.5	0.9	20.1	6.2	0.3	3.6	8.4	0.0	8.6	0.0	1.0	7.2	0.5	2.7	9.4	0.0	7.9	0.3	5.3	7.2	1.5	0.0	1.9	2.3	0.7	0.8	2.6	15.3	0.0	0.2	6.3	2.5	8.1
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;placenta: 12.9"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 58.2;Syncytiotrophoblasts: 216.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;CACO-2: 2.7;hTCEpi: 1.8;NTERA-2: 2.2;OE19: 11.2;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"basal ganglia: 16.9;cerebral cortex: 21.4;hippocampal formation: 16.8"	HPA030251	Enhanced	Supported				NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA030251: AB_10611108"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	2.3	3.3	3.7	0.4	19.4	0.0	0.6	2.9	6.2	1.7	1.4	1.0	0.8	2.7	0.1	1.5	1.7	0.4	5.2	2.7	2.7	3.6	5.8	1.6	0.4	4.1	3.5	0.1	2.9	0.0	0.6	12.9	4.6	7.3	0.3	5.8	6.5	0.4	0.2	5.7	0.6	0.2	2.8	0.0	0.7	1.0	4.1	1.9	0.3	0.0	0.6	1.1	1.2	3.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	19.4	2.9	6.2	2.7	2.7	4.1	3.5	4.6	2.8	4.1	3.0	0.0	0.0	2.0	0.0	0.0	3.1	1.9	0.8	0.0	10.7	0.1	3.0	0.6	1.5	1.3	1.8	0.0	58.2	0.0	0.1	0.0	1.3	0.0	11.8	0.5	0.7	5.3	0.0	0.1	0.2	6.1	3.4	0.0	11.0	0.0	3.3	0.0	0.3	5.3	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	3.6	6.5	0.0	26.3	0.0	0.0	0.1	0.3	1.2	0.0	0.0	1.1	0.0	5.7	0.0	0.9	0.0	0.5	0.1	0.0	0.3	0.0	1.4	216.3	0.2	0.0	1.9	0.1
DAPP1	BAM32	ENSG00000070190	"Dual adaptor of phosphotyrosine and 3-phosphoinositides 1"	Q9UN19	4	99816827-99870190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.2;lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;Langerhans cells: 188.5;monocytes: 235.5;Respiratory ciliated cells: 88.6;Urothelial cells: 221.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;RPMI-8226: 70.2;SK-BR-3: 30.6;U-698: 46.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033822, HPA046074"	Approved					NA	NA		56000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB033822: AB_2245677, HPA046074: AB_2679525"	"unprognostic (9.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.60e-2)"	1.6	1.0	0.5	22.6	0.9	15.5	3.7	0.4	0.5	6.9	0.6	3.1	2.1	8.4	1.0	29.2	5.2	11.9	0.5	0.5	0.6	0.7	1.5	6.3	34.6	1.0	1.0	0.4	0.4	0.2	0.2	6.8	1.1	2.8	3.2	0.1	8.6	0.8	0.9	13.7	6.3	13.5	0.8	16.6	6.5	0.4	0.7	10.2	0.6	1.3	38.5	14.9	12.9	1.5	22.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	22.5	23.8	0.3	0.0	0.1	12.8	0.0	25.3	0.0	61.2	0.0	24.3	0.0	0.0	0.0	9.4	1.0	0.0	11.3	0.0	7.5	0.0	0.0	1.0	1.2	21.7	0.0	0.2	0.1	6.7	0.0	0.0	0.4	0.1	0.1	70.2	4.6	16.3	0.1	0.0	0.0	30.6	0.0	0.2	0.4	10.1	0.0	0.0	0.4	0.0	0.1	8.3	3.2	46.4	0.1	6.5	0.0	25.0	70.2	71.0	2.3	62.6	2.5	90.9	11.4	4.0	75.9	98.7	12.5	4.5	138.1	17.8	57.3	32.4	25.2	65.3	0.5	0.9	0.4	0.5	0.5	0.6	1.0	1.0	1.1	0.8	0.7	1.5	0.3	3.2	3.0	0.0	92.0	61.8	30.2	51.4	16.5	0.1	10.1	5.0	0.8	2.8	43.2	9.2	0.0	2.6	13.3	8.4	0.0	6.2	0.3	37.1	0.8	1.2	1.2	9.4	0.4	3.1	14.1	1.4	14.8	9.0	8.2	0.2	0.7	0.7	25.1	0.0	0.1	1.8	22.4	32.0	188.5	0.9	0.0	86.0	12.4	5.6	235.5	0.0	7.2	0.0	0.1	18.9	17.6	0.0	60.2	24.3	0.2	0.1	88.6	0.2	0.0	0.9	4.2	0.2	0.5	40.4	70.3	3.4	17.2	0.1	2.2	221.2
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239217	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;monocytes: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: AB_2683708"	"prognostic favorable (7.29e-4)"	"prognostic favorable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	13.2	22.5	2.6	8.2	3.2	11.6	13.5	3.4	3.6	12.5	3.4	12.8	7.6	12.7	11.7	24.8	17.6	12.5	6.8	2.5	2.4	4.4	27.0	12.2	14.7	3.4	2.7	11.6	14.4	4.8	4.7	6.8	3.5	9.7	14.9	2.3	14.4	11.7	6.2	46.7	10.2	13.9	2.7	11.3	9.5	4.5	3.2	23.5	5.5	6.9	17.0	11.2	14.1	3.6	23.7	62.3	25.9	19.3	16.6	32.7	29.9	26.0	58.8	32.0	37.1	10.1	14.1	56.6	5.3	23.2	23.6	40.8	14.6	51.8	15.7	14.5	27.5	13.3	55.7	46.7	15.8	15.9	34.4	43.4	58.0	15.9	35.2	10.2	94.2	14.7	3.5	27.0	52.7	44.4	60.4	7.7	8.4	31.1	22.3	30.3	5.6	30.6	13.5	22.7	13.2	16.7	31.2	8.7	8.1	30.8	56.1	5.5	41.2	96.8	44.1	21.3	12.6	27.6	22.4	12.5	37.0	20.2	35.9	9.8	12.8	20.2	19.3	18.4	18.8	18.3	20.1	18.8	10.4	14.5	14.8	15.7	3.7	14.1	15.8	0.3	47.7	15.9	2.6	3.2	3.4	3.6	2.5	2.4	3.4	2.7	3.5	2.7	3.2	3.6	13.8	16.0	22.2	7.8	25.1	38.9	39.7	28.1	75.1	5.0	18.0	25.8	7.8	11.5	16.3	5.5	10.4	3.6	21.3	11.1	9.8	12.5	1.5	5.2	8.1	19.5	7.7	19.1	6.6	13.8	9.0	16.0	18.3	9.5	22.8	31.2	15.0	16.6	17.5	1.7	1.4	12.6	16.2	17.5	12.8	2.1	19.0	16.8	19.6	24.4	135.5	9.6	35.0	1.0	10.6	19.9	9.8	10.5	34.1	8.9	15.7	7.7	13.9	12.8	0.0	12.1	14.0	3.1	8.6	34.5	30.3	1.5	34.3	25.4	16.5	26.5
DLG2	"chapsyn-110, PPP1R58, PSD-93, PSD93"	ENSG00000150672	"Discs large MAGUK scaffold protein 2"	Q15700	11	83455012-85627922	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 3292.3;Inhibitory neurons: 2602.7;Oligodendrocyte precursor cells: 2331.8;Oligodendrocytes: 4213.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.2;SH-SY5Y: 8.1;T-47d: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021307, HPA023896, CAB072341"	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Vesicles	"CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353"	"unprognostic (2.61e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.44e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.61e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.84e-1)"	"unprognostic (7.66e-6)"	"unprognostic (2.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.89e-2)"	1.6	11.0	29.5	1.1	48.7	0.3	2.1	3.6	55.8	1.8	0.0	2.3	1.2	2.9	4.1	7.5	5.7	2.1	3.0	64.4	18.1	3.6	2.8	1.7	1.1	13.5	8.2	5.7	3.3	7.3	10.0	2.4	10.3	4.0	1.4	25.4	3.1	4.6	0.8	20.2	1.2	2.2	11.9	2.5	1.5	8.1	10.5	7.3	15.5	0.7	2.9	1.7	2.6	88.4	0.6	0.3	0.9	0.5	0.6	0.7	8.2	0.2	0.5	0.4	0.3	7.4	1.1	1.3	1.3	0.4	0.5	0.8	2.3	0.7	0.4	0.8	0.9	1.3	5.0	0.2	0.1	0.4	1.1	0.5	0.5	1.0	1.0	0.4	0.5	1.9	1.2	3.5	0.7	0.9	0.6	1.3	6.0	0.8	1.3	1.4	2.0	0.9	0.4	0.3	5.9	8.1	0.8	5.1	0.4	7.2	21.2	0.0	0.3	2.2	1.8	2.1	0.3	0.8	2.9	5.6	0.8	0.7	0.2	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.1	0.2	0.0	0.6	0.6	0.2	0.0	0.0	0.1	0.5	0.0	0.0	29.5	48.7	3.6	55.8	64.4	18.1	13.5	8.2	10.3	11.9	10.5	88.4	7.0	3.2	10.4	742.8	1.3	3.3	3.6	0.3	9.1	298.1	4.4	5.2	8.3	2.8	1.8	7.3	275.2	7.9	1.8	1.5	9.8	0.7	21.5	1.3	2.7	3.6	4.2	0.0	3292.3	0.4	0.5	7.4	1.1	2.4	0.0	1.6	2.2	4.6	4.0	23.5	2602.7	1.1	0.0	0.3	0.0	16.4	7.8	0.8	1.8	487.2	0.6	11.0	0.0	2331.8	4213.8	0.4	0.1	6.4	0.1	2.0	0.6	2.7	0.9	48.2	6.6	7.1	4.1	11.3	3.2	6.2	8.5	2.1	1.7	12.1	0.9	0.8
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020396-97024950	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 14.1;placenta: 11.7;skin 1: 21.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.9;Endometrial ciliated cells: 217.8;Extravillous trophoblasts: 245.2;Glandular and luminal cells: 191.2;Syncytiotrophoblasts: 314.8"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 53.7;HAP1: 27.2;SuSa: 13.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory bulb: 29.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 7.5;olfactory bulb: 18.0"	HPA005670	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.5	0.3	2.1	0.2	3.9	0.0	0.9	0.2	3.4	7.6	0.4	0.6	0.3	14.1	1.0	1.9	1.3	0.4	0.5	1.5	4.5	0.5	0.0	0.2	1.7	0.2	0.3	1.6	0.0	0.2	0.8	11.7	0.3	1.7	0.0	0.0	3.3	2.8	0.3	21.2	0.1	0.9	0.3	0.1	0.1	0.9	1.5	1.8	1.5	0.0	2.1	0.7	3.0	1.3	0.0	0.0	0.0	8.2	0.0	0.0	53.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.2	27.2	0.0	0.0	0.0	4.6	0.0	0.6	0.4	0.0	0.0	0.0	0.1	8.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.0	3.6	1.5	2.1	0.2	0.0	0.0	13.4	0.0	0.0	0.0	1.7	0.3	0.4	0.0	0.0	0.0	0.0	3.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.2	3.4	1.5	4.5	0.2	0.3	0.3	0.3	1.5	1.3	1.4	0.0	0.0	0.0	0.0	9.8	1.1	1.7	0.6	0.0	0.3	0.6	0.2	0.0	0.1	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.2	217.8	13.3	2.9	0.0	0.0	0.1	0.0	245.2	1.5	0.0	191.2	0.0	1.6	0.0	0.0	16.9	0.0	12.8	0.0	0.0	0.0	1.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	59.2	0.2	8.0	4.2	11.6	7.9	20.6	314.8	1.6	0.1	0.0	1.6
DMTN	"DMT, EPB49"	ENSG00000158856	"Dematin actin binding protein"	Q08495	8	22048995-22082527	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 192.5"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 248.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 1.7;MAIT T-cell: 1.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 1.6;naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.5;neutrophil: 1.2;T-reg: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"A549: 68.9;HEL: 225.9;Hep G2: 63.9;HMC-1: 65.6;OE19: 67.3;RPTEC TERT1: 87.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024290, HPA058487"	Uncertain					NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA024290: AB_1847601, HPA058487: "	"unprognostic (6.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (3.85e-9)"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.07e-2)"	35.7	29.8	104.2	6.1	134.6	136.6	21.8	0.0	192.5	13.5	0.0	33.1	9.2	15.3	14.4	18.9	30.4	13.5	71.5	142.1	36.9	67.5	28.2	20.1	3.4	27.0	14.0	3.4	29.6	54.9	109.6	7.4	27.1	25.0	15.2	23.0	22.9	20.4	66.4	24.3	14.0	14.0	0.0	19.3	23.8	11.7	32.4	3.0	39.1	41.4	3.7	12.9	12.4	90.5	44.1	68.9	0.5	1.4	1.1	0.3	5.4	4.6	4.3	14.5	4.3	29.9	26.7	0.4	43.8	0.8	0.9	14.8	2.1	2.7	6.5	0.4	13.0	225.9	5.3	63.9	1.3	0.1	65.6	0.7	29.3	0.2	0.3	8.5	14.7	2.0	21.7	2.2	0.1	18.9	5.7	0.5	1.8	67.3	6.1	0.0	0.6	3.1	87.2	12.3	15.6	21.8	7.3	0.9	3.2	3.5	11.2	2.2	26.1	0.0	22.0	0.3	24.0	0.1	0.2	0.7	0.3	0.2	15.4	0.0	0.1	0.2	1.7	0.0	1.7	0.0	3.8	1.6	0.1	0.0	1.5	1.5	1.2	0.0	0.0	0.3	3.3	9.3	104.2	134.6	0.0	192.5	142.1	36.9	27.0	14.0	27.1	0.0	32.4	90.5	9.3	3.2	10.7	10.7	1.5	2.3	4.0	3.9	1.2	34.6	9.9	5.7	37.8	0.0	5.1	7.3	12.5	0.1	2.7	15.3	19.6	11.4	12.7	11.2	1.7	10.2	20.5	248.6	45.7	11.4	1.7	2.4	7.7	12.7	0.0	4.1	3.9	15.8	0.5	28.6	29.7	8.7	0.0	1.0	1.6	7.7	0.3	44.5	14.2	5.6	1.3	2.6	0.0	1.5	4.3	18.2	10.0	2.6	1.4	3.7	1.8	29.6	9.3	7.3	0.0	1.4	5.7	1.4	2.4	3.8	5.7	0.1	6.4	0.3	13.3	4.8
DNAH3	"DKFZp434N074, DLP3, Dnahc3b, Hsadhc3"	ENSG00000158486	"Dynein axonemal heavy chain 3"	Q8TD57	16	20933111-21159441	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.2;fallopian tube: 5.1;testis: 4.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 42.7;Endometrial ciliated cells: 31.0;Late spermatids: 17.1;Respiratory ciliated cells: 77.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA062493			Approved	"Nuclear membrane,Intermediate filaments"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane"	"Intermediate filaments"	"HPA062493: "	"unprognostic (1.68e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.57e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.4	0.1	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.4	0.5	0.0	0.0	1.2	0.0	2.2	2.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	4.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.4	0.5	2.2	2.1	1.4	1.5	0.5	0.5	0.0	0.0	1.1	0.7	0.0	0.3	0.7	2.0	0.0	0.0	0.1	0.1	1.7	0.0	6.3	0.0	0.0	0.3	0.0	2.0	0.0	0.0	42.7	31.0	0.2	0.3	0.0	0.0	2.9	0.0	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	3.6	1.3	0.0	0.0	0.0	17.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	2.5	1.7	0.0	0.8	0.0	0.0	0.5	1.3	0.0	77.8	0.0	0.0	0.2	1.0	0.9	8.8	0.5	0.6	0.0	0.1	0.0	1.9	0.3
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 138.4;tongue: 144.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 673.9;Late spermatids: 1608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 33.6;CAPAN-2: 43.3;HeLa: 47.3;MCF7: 33.6;RT4: 85.2;SCLC-21H: 53.3;SiHa: 42.7;THP-1: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"CAB004646: AB_426011, HPA041790: AB_2677674"	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	16.5	20.0	60.6	14.0	67.7	63.7	12.6	62.6	138.4	14.1	45.6	18.0	13.8	8.3	20.2	15.8	38.9	11.2	123.3	68.6	93.1	26.7	3.3	19.7	11.3	65.7	73.3	12.1	6.6	7.4	30.9	9.5	89.8	26.7	18.5	33.0	15.6	15.6	123.2	28.6	16.3	19.6	59.8	13.5	24.2	78.3	73.5	9.4	9.6	144.6	12.4	29.6	13.6	71.3	33.6	0.2	0.0	0.0	0.0	0.0	0.1	4.1	0.0	1.1	0.5	0.0	43.3	0.0	0.3	3.2	0.0	31.3	0.0	0.0	0.1	0.1	0.0	19.9	47.3	0.0	9.4	0.0	20.6	3.6	4.1	2.6	0.0	0.0	6.6	0.0	0.0	0.0	0.4	33.6	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.1	85.2	53.3	0.0	42.7	8.6	3.6	2.3	32.4	39.8	0.5	0.0	8.7	4.0	0.4	0.6	2.4	0.0	0.1	4.2	0.0	0.0	0.3	1.1	0.6	0.3	1.0	0.7	0.9	0.9	0.4	0.1	1.7	1.4	0.0	0.1	0.4	0.2	0.5	0.6	60.6	67.7	62.6	138.4	68.6	93.1	65.7	73.3	89.8	59.8	73.5	71.3	41.9	6.4	4.8	12.7	10.0	28.8	209.9	14.0	2.2	19.6	44.6	29.2	43.6	2.8	33.5	7.3	81.3	1.9	6.7	55.5	1.9	1.3	673.9	124.0	11.4	18.9	100.3	92.8	16.6	2.4	3.8	18.3	21.4	41.8	36.9	7.5	6.8	0.2	16.5	6.7	24.0	34.9	10.2	9.5	81.7	1608.0	10.2	51.7	51.6	6.5	3.5	10.3	6.2	15.1	19.0	5.1	55.3	11.3	3.7	115.8	15.8	7.2	138.9	22.6	6.6	17.4	20.2	33.8	27.7	16.9	46.7	6.8	37.1	6.9	42.1	190.1
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526281	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 16.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 17.3;Gastric mucus-secreting cells: 13.7;Intestinal goblet cells: 17.3;Paneth cells: 13.9;Proximal enterocytes: 44.2;Undifferentiated cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.8;Hep G2: 18.4;hTCEpi: 6.1;OE19: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039158, HPA046763"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"		"HPA039158: AB_10960125, HPA046763: "	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.4	0.0	6.3	16.4	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	5.6	0.0	0.4	0.0	0.0	1.1	13.9	0.5	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	1.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.6	0.1	5.8	0.1	0.0	0.0	0.5	0.2	18.4	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	15.5	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.9	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.5	0.1	4.5	4.6	0.4	0.1	0.0	0.3	1.5	3.5	0.0	2.1	1.6	0.0	17.3	0.0	0.0	0.0	0.2	0.1	0.0	2.4	0.0	0.6	0.0	0.8	0.6	13.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	17.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	13.9	0.0	0.4	0.0	44.2	0.0	5.0	0.9	0.0	0.1	0.1	0.6	0.3	3.1	0.0	1.1	0.1	0.0	12.5	0.2
DR1	"NC2-BETA, NC2B, NCB2"	ENSG00000117505	"Down-regulator of transcription 1"	Q01658	1	93345907-93369493	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050785, HPA055308"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA050785: AB_2681237, HPA055308: AB_2682779"	"unprognostic (1.46e-1)"	"unprognostic (9.62e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.95e-7)"	"unprognostic (8.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.60e-1)"	21.8	18.9	9.8	28.8	9.6	59.1	16.8	12.5	9.3	17.7	23.7	18.2	27.2	21.0	11.1	30.0	14.2	23.1	27.0	8.7	10.8	21.8	20.4	19.6	43.3	9.9	9.8	15.9	18.8	16.9	12.1	32.0	9.5	17.1	16.3	14.1	19.5	14.0	50.4	29.4	22.4	19.2	10.3	27.0	30.2	55.7	10.5	47.7	18.7	42.9	30.8	27.3	22.6	10.5	97.1	29.8	46.8	60.6	42.3	47.9	57.5	76.5	46.6	50.9	54.0	34.9	34.1	101.9	86.4	56.7	69.3	50.1	56.7	53.0	74.6	86.4	53.0	85.8	58.7	38.4	67.3	102.1	60.6	33.7	62.4	71.2	102.2	53.1	45.9	60.0	90.0	95.7	61.0	29.8	97.6	32.1	78.1	33.4	72.1	83.5	103.2	104.0	36.3	58.0	45.3	57.6	65.1	59.7	80.6	42.2	42.2	79.4	72.1	91.5	73.0	90.7	116.0	54.9	65.6	105.5	26.3	80.3	38.2	95.2	46.2	82.1	35.3	52.7	39.2	36.9	38.8	40.4	55.9	31.5	38.6	37.8	62.8	35.5	47.4	45.4	57.1	41.3	9.8	9.6	12.5	9.3	8.7	10.8	9.9	9.8	9.5	10.3	10.5	10.5	36.2	28.9	22.1	10.1	43.5	171.3	38.0	38.7	47.3	32.0	29.1	24.1	33.9	22.8	27.9	36.8	25.0	74.5	84.6	42.8	45.0	31.4	183.1	18.4	33.7	37.5	20.8	59.3	8.4	27.7	73.6	34.3	38.2	24.2	48.9	19.7	29.3	27.6	53.0	50.5	8.7	42.6	10.2	50.8	82.8	106.2	28.3	55.2	44.4	15.0	68.0	16.0	69.0	7.5	10.8	52.9	25.9	26.4	31.9	51.6	29.8	40.7	17.6	25.3	32.9	27.7	42.0	163.2	41.2	69.4	160.5	109.9	59.8	26.2	26.9	79.2
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 4098.6;Respiratory ciliated cells: 2679.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	Yes		890000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	268.6	261.9	912.5	186.7	967.7	126.8	268.0	895.2	1292.9	354.2	894.7	325.8	162.8	319.4	322.3	719.9	544.2	242.7	257.5	975.4	944.7	352.6	238.4	222.6	241.6	896.1	898.5	247.0	225.1	228.2	309.7	259.2	914.2	225.9	327.4	181.3	245.4	264.6	85.6	626.7	206.3	390.1	935.1	185.2	244.5	360.3	909.7	306.5	176.1	163.9	357.8	389.8	474.4	1001.2	721.6	811.4	779.2	600.8	677.1	713.6	250.8	968.0	451.6	785.6	466.7	770.8	472.3	400.6	510.3	945.1	753.0	629.6	949.3	818.3	781.0	528.3	617.9	390.4	532.9	1062.5	676.2	412.8	620.5	436.2	863.0	584.6	477.5	855.7	831.8	421.5	502.0	446.1	1056.8	960.1	541.4	894.8	642.2	917.7	935.7	543.0	403.0	499.2	1143.1	659.8	535.2	392.0	789.3	677.7	926.6	812.6	673.6	595.3	635.2	592.3	502.1	525.6	852.2	264.0	562.8	404.6	656.8	645.1	776.6	516.6	291.9	384.2	200.6	303.3	155.3	310.4	207.2	211.7	281.8	219.0	132.0	165.7	50.1	282.9	334.8	461.6	373.5	353.0	912.5	967.7	895.2	1292.9	975.4	944.7	896.1	898.5	914.2	935.1	909.7	1001.2	810.1	195.5	101.9	79.3	341.4	922.2	359.1	1275.0	356.8	138.4	800.0	949.4	170.8	303.1	764.6	399.1	83.4	524.6	484.1	689.9	1113.2	691.2	1407.2	1842.5	528.5	541.9	480.8	332.9	111.2	538.9	897.4	538.5	240.5	488.1	316.7	611.9	521.9	499.0	732.1	85.8	62.8	801.6	1121.0	329.4	706.1	4098.6	516.6	466.3	595.9	42.2	701.6	164.0	248.2	47.3	156.4	754.9	798.6	701.8	234.9	304.7	533.4	1125.0	2679.6	193.5	368.1	440.7	1016.3	961.5	721.4	1005.4	1610.1	1006.6	396.6	586.3	498.2	389.6
EEF2K	"CaMKIII, eEF-2K"	ENSG00000103319	"Eukaryotic elongation factor 2 kinase"	O00418	16	22206278-22288738	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 49.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 69.1;Late spermatids: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;HL-60: 1.6;HMC-1: 1.8;NB-4: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007818, HPA056061"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB007818: AB_598150, HPA056061: AB_2683021"	"unprognostic (4.79e-2)"	"unprognostic (6.10e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	19.8	7.1	1.0	0.4	0.9	0.7	15.9	1.5	2.2	17.2	0.7	20.1	0.3	14.3	0.7	9.1	13.1	0.3	9.2	0.9	1.2	3.6	7.8	9.0	0.5	1.1	0.9	8.2	12.9	0.0	5.2	0.4	1.2	19.6	0.2	0.3	15.0	0.2	24.9	49.0	8.1	0.3	0.9	8.0	9.8	2.3	1.4	0.0	6.3	0.0	0.2	18.8	15.4	1.1	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.6	0.2	1.0	0.0	1.6	1.8	0.0	0.4	0.1	0.1	0.3	0.1	0.1	0.2	1.3	0.0	0.0	0.1	1.6	0.1	0.4	0.0	0.4	1.0	0.2	0.4	0.0	0.3	0.6	0.0	0.0	0.2	0.1	0.2	0.5	0.5	0.7	0.3	1.4	0.0	0.3	0.1	0.3	1.0	1.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.1	0.0	1.0	0.9	1.5	2.2	0.9	1.2	1.1	0.9	1.2	0.9	1.4	1.1	43.7	22.4	13.3	22.5	7.3	12.6	9.6	3.9	31.3	69.1	15.4	9.3	17.3	12.8	9.8	9.2	14.6	16.3	12.7	24.2	0.0	4.9	42.9	42.4	12.6	18.4	3.0	7.6	21.2	13.4	11.7	19.2	26.0	34.9	29.2	12.0	22.5	17.7	18.7	1.7	37.4	12.3	4.1	15.3	16.2	76.6	14.3	8.7	8.8	15.9	7.9	6.1	6.2	31.7	8.6	10.2	26.3	15.8	19.6	6.6	12.5	4.0	14.9	21.6	6.6	43.5	10.0	1.3	4.2	16.9	23.0	7.8	7.8	5.7	8.1	6.7
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
EIF4ENIF1	"2610509L04Rik, 4E-T, Clast4, FLJ21601"	ENSG00000184708	"Eukaryotic translation initiation factor 4E nuclear import factor 1"	Q9NRA8	22	31436977-31496108	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.6;Late spermatids: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001619, HPA002078"	Enhanced		Enhanced	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA001619: AB_1078727, HPA002078: AB_1078728"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.45e-2)"	12.5	11.9	14.3	10.4	14.8	14.3	11.9	19.7	17.3	15.9	11.4	19.4	11.4	15.0	13.0	14.0	13.8	7.8	13.2	15.3	15.0	12.3	8.4	12.1	12.6	13.6	14.7	15.0	10.5	16.7	10.8	13.6	14.3	13.5	11.5	18.0	12.1	13.2	20.2	15.7	11.8	12.1	11.6	12.3	12.3	34.7	13.8	12.9	13.5	14.5	14.9	15.6	14.3	17.3	19.8	11.6	29.4	16.0	16.1	14.2	11.7	13.7	16.8	21.4	19.8	13.4	7.0	25.3	7.9	20.7	14.3	19.1	26.9	12.5	19.7	20.2	27.0	10.3	20.0	15.4	16.7	41.0	17.9	16.6	16.9	15.8	17.8	19.5	18.4	14.8	25.4	27.0	20.3	22.4	27.8	20.3	13.5	18.3	9.5	31.1	24.5	26.0	21.7	14.7	22.6	20.9	18.9	15.4	14.5	19.4	16.4	16.1	20.5	14.3	18.6	14.4	15.5	19.3	20.4	25.1	13.7	14.8	17.1	1.3	2.4	1.2	3.4	3.0	3.5	4.8	1.8	3.3	2.2	2.0	1.8	3.2	2.0	1.0	8.1	4.4	1.4	1.9	14.3	14.8	19.7	17.3	15.3	15.0	13.6	14.7	14.3	11.6	13.8	17.3	8.4	12.8	15.2	23.2	10.6	7.4	7.3	6.2	15.4	18.0	9.6	8.9	22.7	10.0	8.5	12.9	12.5	9.8	13.8	8.6	9.8	8.9	54.6	8.0	12.8	10.2	12.0	12.4	21.0	6.4	5.5	8.1	12.2	13.0	6.3	23.1	11.0	8.9	8.0	18.5	20.5	10.8	8.2	9.5	6.2	98.9	14.6	7.5	7.2	13.1	14.5	8.1	14.4	20.1	20.2	10.2	3.6	15.4	10.3	10.7	5.7	9.4	6.3	13.7	6.6	11.8	11.0	38.7	13.3	10.7	10.5	6.7	8.2	9.0	8.1	8.0
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 348.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol		NA	NA		330000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705"	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	86.2	91.8	24.8	75.7	22.2	84.0	69.0	17.9	22.2	66.6	34.1	81.8	62.0	71.3	32.7	126.8	59.6	50.9	90.8	23.3	29.8	53.9	113.0	74.2	55.7	38.5	36.1	57.5	96.2	99.3	57.4	59.4	32.4	62.2	56.5	22.3	93.1	59.2	348.3	116.7	67.2	74.7	24.4	58.2	79.9	64.8	37.4	49.1	71.3	177.0	63.2	76.0	85.3	16.6	559.0	232.3	173.1	205.7	196.9	192.5	322.5	298.6	204.1	315.4	238.8	486.5	173.7	348.4	381.9	367.6	358.5	292.7	322.6	365.8	230.5	375.1	345.8	321.3	226.1	206.4	173.4	321.4	212.2	199.6	206.8	292.4	268.8	152.8	278.3	128.8	239.6	267.2	205.7	403.4	219.7	105.3	368.9	241.3	180.8	221.7	183.4	281.9	156.8	331.8	197.7	174.6	258.1	415.6	187.6	144.6	445.2	206.5	364.1	227.2	228.9	297.3	567.9	203.8	263.2	629.0	260.5	271.4	258.3	8.3	16.0	6.7	11.7	14.4	10.8	7.7	7.8	9.6	12.8	9.2	6.9	7.6	5.6	8.7	21.0	18.1	6.0	12.7	24.8	22.2	17.9	22.2	23.3	29.8	38.5	36.1	32.4	24.4	37.4	16.6	63.9	76.9	72.6	23.8	41.7	59.1	78.2	58.0	70.6	24.2	69.3	46.2	109.4	50.1	72.3	62.5	14.6	64.0	37.6	135.5	13.7	98.8	151.6	53.0	67.1	69.3	55.7	82.7	10.8	135.3	74.8	64.5	75.4	85.6	48.0	163.8	43.5	152.8	66.8	21.9	12.9	97.2	50.8	40.8	39.9	202.7	73.0	48.9	33.8	14.0	53.0	23.2	30.9	4.0	10.1	149.0	69.0	56.1	112.9	96.8	77.0	45.4	51.4	23.2	78.9	81.6	78.9	24.8	41.4	120.7	91.8	79.6	46.0	94.8	108.4	95.6
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772605-43777315	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.7;skin 1: 25.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Gastric mucus-secreting cells: 4.6;Proximal enterocytes: 6.5;Squamous epithelial cells: 21.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 10.5;naive B-cell: 15.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 15.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 73.8;OE19: 28.5;T-47d: 39.0;U-698: 149.9"	"Region enriched"	"Detected in single"	11	"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA028938, HPA073494"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA028938: AB_10795352, HPA073494: "	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.5	0.9	1.0	9.7	1.0	0.2	5.2	1.0	1.1	1.6	4.7	8.0	14.1	0.6	1.1	4.5	3.9	0.7	0.5	1.0	1.1	1.4	0.7	1.5	49.7	1.0	1.1	1.7	0.4	1.6	0.5	3.7	1.1	2.0	12.3	0.1	2.2	1.0	0.4	25.0	12.9	1.0	1.0	1.0	1.8	16.2	1.4	1.5	0.7	1.9	57.7	0.7	0.8	1.1	2.1	0.2	0.6	1.1	4.9	1.2	0.4	0.2	1.3	2.8	3.1	0.0	1.3	73.8	0.1	1.2	0.1	13.7	1.3	0.7	1.4	1.6	7.3	0.4	2.6	4.6	1.0	0.1	0.0	1.4	12.3	0.7	0.2	0.2	1.1	0.4	0.2	0.0	0.7	4.0	1.5	1.4	0.1	28.5	2.4	0.8	0.0	0.0	1.8	0.0	9.5	0.0	1.7	21.5	0.0	0.3	39.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	149.9	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	10.5	0.6	0.1	0.0	15.9	1.1	0.2	0.0	0.1	0.0	2.2	0.6	0.6	1.0	1.0	1.0	1.1	1.0	1.1	1.0	1.1	1.1	1.0	1.4	1.1	0.1	0.0	0.0	0.0	2.2	0.4	0.1	0.2	5.2	0.0	0.7	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.3	1.2	0.0	0.1	1.8	0.4	0.1	0.2	0.0	0.4	0.1	0.7	0.0	0.5	4.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.5	0.0	0.0	0.5	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	6.5	0.1	3.1	0.0	0.0	0.2	0.4	0.2	0.2	21.0	1.0	0.3	0.1	0.1	2.3	0.2
EMP2	XMP	ENSG00000213853	"Epithelial membrane protein 2"	P54851	16	10528422-10580632	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 230.6"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014711, HPA070816"	Approved		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA014711: AB_1848147, HPA070816: "	"unprognostic (1.75e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (9.27e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (2.85e-8)"	"unprognostic (9.54e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.52e-2)"	56.8	9.7	15.5	12.4	15.5	0.7	49.5	14.8	17.1	51.0	18.6	48.0	15.5	25.9	45.5	152.1	35.5	17.7	64.1	13.6	15.6	20.3	83.2	230.6	5.7	16.1	16.8	54.9	13.7	32.8	13.3	23.0	16.0	38.8	34.1	2.0	39.2	17.3	22.5	140.6	28.3	22.3	15.2	16.0	39.1	7.2	18.8	5.3	27.7	25.4	32.8	39.6	72.9	15.7	28.7	39.1	15.9	18.9	35.0	30.0	31.3	40.0	36.8	23.9	35.7	128.5	98.2	0.2	12.6	48.4	17.2	123.9	41.1	49.8	31.3	0.1	26.1	0.1	76.6	72.1	6.1	0.2	0.4	18.4	13.1	31.9	3.2	5.4	10.1	0.1	9.6	2.6	66.9	268.1	0.4	0.6	18.3	46.4	9.5	7.5	18.2	61.7	5.5	182.0	22.0	25.0	49.6	256.2	15.2	45.2	156.6	6.2	5.7	75.5	32.2	25.6	22.7	0.8	1.0	0.2	33.2	0.5	75.7	1.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	1.1	0.3	0.3	0.3	0.2	0.1	15.5	15.5	14.8	17.1	13.6	15.6	16.1	16.8	16.0	15.2	18.8	15.7	239.7	4163.5	368.4	13.1	3.1	356.9	137.9	172.2	111.0	2.3	105.0	94.0	53.1	100.1	255.8	42.3	0.0	74.2	3.1	119.5	0.0	3.8	8.0	78.8	30.9	183.9	104.9	0.0	0.7	67.0	17.8	152.7	46.4	51.9	36.7	68.7	161.0	235.1	10.1	0.0	0.6	207.8	81.4	19.6	136.5	9.3	190.7	17.0	87.2	41.2	33.6	5.7	0.0	22.6	0.6	32.9	158.4	276.1	1.6	86.0	21.0	0.2	142.8	2.2	52.6	256.3	129.3	5.7	12.9	319.5	1174.3	48.0	9.3	73.3	178.5	221.4
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
EPB41L4A	NBL4	ENSG00000129595	"Erythrocyte membrane protein band 4.1 like 4A"	Q9HCS5	5	112142441-112419313	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 64.3;Oligodendrocyte precursor cells: 164.4;Oligodendrocytes: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 30.1;HeLa: 36.5;RT4: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036580	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Nucleoplasm	"HPA036580: AB_10669908"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.40e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.65e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-1)"	8.7	4.5	4.8	3.2	5.7	3.6	5.3	4.1	4.8	4.1	9.0	4.0	2.6	4.3	12.7	10.1	7.4	13.8	9.2	6.0	5.1	11.7	3.3	7.7	3.3	5.7	4.6	5.7	4.9	8.0	0.5	9.3	4.8	5.8	4.8	16.0	7.2	5.4	4.2	8.8	3.4	2.7	4.9	4.7	5.6	6.1	4.8	3.6	13.5	4.2	3.6	5.1	2.3	4.8	0.8	5.5	14.3	1.5	0.0	0.0	2.9	2.1	0.0	0.0	0.0	3.0	12.3	6.2	30.1	0.0	0.8	7.4	1.1	6.9	0.0	1.0	5.0	9.8	36.5	2.0	0.1	2.6	3.1	0.0	3.0	0.0	0.0	1.6	9.2	1.7	1.9	5.6	0.0	1.8	4.6	3.5	2.7	1.2	1.1	2.3	10.7	1.3	8.4	21.6	11.8	6.1	10.7	5.2	4.5	9.8	15.9	1.4	15.7	0.7	2.4	1.9	4.4	5.6	1.3	4.6	1.4	5.2	0.8	0.5	0.2	0.1	2.0	0.3	1.1	1.4	0.6	0.6	0.2	1.6	0.9	1.8	0.2	0.1	0.5	0.1	0.6	0.5	4.8	5.7	4.1	4.8	6.0	5.1	5.7	4.6	4.8	4.9	4.8	4.8	55.9	28.9	7.7	17.3	4.7	6.0	16.8	11.2	13.6	5.0	11.2	4.7	8.3	64.3	24.2	14.7	4.2	7.4	4.5	8.5	11.7	15.0	20.8	19.7	3.1	35.2	1.2	2.1	28.6	7.5	0.7	8.4	7.1	17.1	8.8	11.9	34.6	1.7	2.7	1.7	31.8	6.3	16.2	4.6	2.1	23.0	1.8	1.8	3.6	56.2	3.2	8.2	14.4	164.4	65.4	14.1	10.9	1.9	6.5	13.7	1.9	30.4	39.5	32.1	0.0	8.7	6.0	1.8	9.1	16.0	8.1	2.5	3.7	2.2	7.5	19.1
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 198.8;dendritic cells: 53.7;Early spermatids: 42.2;Excitatory neurons: 47.9;Inhibitory neurons: 44.3;Late spermatids: 41.2;Oligodendrocyte precursor cells: 77.9"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"neutrophil: 24.0;plasmacytoid DC: 23.3"	"Group enriched"	"Detected in many"	33	"dendritic cells: 23.3;granulocytes: 24.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 63.9;HMC-1: 35.5;RPTEC TERT1: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	1.0	0.6	4.7	0.8	18.7	0.7	3.2	40.6	12.8	1.8	0.0	3.2	1.4	2.2	0.9	1.9	1.3	1.7	0.3	7.0	5.1	1.3	1.6	0.3	1.9	5.0	14.4	0.7	0.3	0.2	1.0	0.2	5.5	1.7	0.5	4.2	2.2	2.7	4.9	4.8	0.7	0.7	0.9	1.9	0.6	10.8	12.0	0.7	7.0	10.3	1.7	1.5	1.0	4.2	0.0	0.0	8.4	0.1	0.2	0.0	0.0	6.6	0.1	0.3	0.1	0.1	0.0	1.1	1.6	3.4	0.6	0.1	5.5	0.0	1.2	63.9	0.8	4.8	0.0	0.0	0.0	0.0	35.5	0.1	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.3	4.7	0.2	0.0	0.3	2.4	1.2	0.1	0.0	0.9	0.2	16.5	0.0	1.1	0.2	0.0	0.1	0.0	1.1	0.1	0.7	0.5	1.1	3.4	0.7	7.9	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	23.3	0.0	0.2	4.7	18.7	40.6	12.8	7.0	5.1	5.0	14.4	5.5	0.9	12.0	4.2	1.9	0.0	0.0	198.8	1.0	3.7	0.0	0.0	0.0	1.9	0.8	12.3	1.6	0.0	0.0	0.0	10.4	0.0	53.7	0.0	0.0	0.8	42.2	0.1	0.5	2.8	0.0	0.0	47.9	0.4	0.1	0.4	0.0	0.1	0.0	3.3	0.4	7.0	0.4	0.0	44.3	0.0	0.0	0.0	0.8	41.2	0.6	0.8	1.8	8.4	0.1	16.9	0.0	77.9	5.6	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.3	0.8	0.5	1.6	0.0	5.8	0.0	0.2	3.0	0.3	0.2
EPN2	"EHB21, KIAA1065"	ENSG00000072134	"Epsin 2"	O95208	17	19215615-19336715	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Oligodendrocyte precursor cells: 868.6;Oligodendrocytes: 258.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 10.9;eosinophil: 29.0;neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 29.0"	"Cell line enhanced"	"Detected in many"		"SuSa: 127.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049809, HPA053360"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA049809: AB_2680893, HPA053360: AB_2682126"	"unprognostic (1.38e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.13e-5)"	"unprognostic (1.32e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (8.15e-5)"	20.5	13.9	62.1	9.7	64.9	11.5	16.7	50.4	62.8	36.3	32.7	28.3	9.6	29.5	11.5	40.3	26.6	14.6	32.5	62.6	56.2	21.3	9.3	18.6	6.5	61.6	63.6	22.5	14.6	15.3	18.1	21.6	57.5	23.6	9.5	19.1	17.9	23.4	22.4	50.1	13.3	22.5	46.6	14.3	15.9	19.7	63.6	4.7	17.8	17.0	8.4	27.0	33.8	91.6	31.3	30.4	43.9	19.2	22.8	36.3	34.5	29.4	18.9	17.9	15.3	20.2	9.2	4.9	28.2	29.5	16.8	29.0	19.8	22.1	21.9	23.6	21.2	3.2	20.3	9.2	23.7	1.4	13.1	20.5	19.5	28.3	22.7	23.2	38.8	6.6	8.6	3.9	15.8	22.5	1.3	2.1	11.1	41.3	19.8	7.1	18.8	8.1	21.0	8.6	13.0	28.8	20.9	13.9	14.7	127.9	21.0	4.0	35.6	19.7	22.3	30.9	12.9	6.7	4.3	3.9	54.0	0.5	31.1	10.9	1.3	29.0	1.6	0.8	1.2	3.0	1.1	1.3	0.5	3.4	1.3	1.2	9.0	0.7	1.0	0.6	1.0	0.7	62.1	64.9	50.4	62.8	62.6	56.2	61.6	63.6	57.5	46.6	63.6	91.6	60.0	54.5	29.3	74.4	13.7	24.1	36.6	21.2	43.9	68.3	32.8	33.4	44.5	25.8	25.0	38.6	47.9	27.6	3.3	7.2	27.4	22.5	36.8	69.2	35.0	42.5	6.0	13.5	51.3	8.4	39.8	36.1	15.8	40.6	14.0	37.3	15.0	10.4	8.4	35.3	45.0	16.8	10.2	5.1	6.2	72.7	46.6	5.9	5.4	54.4	1.6	38.3	2.1	868.6	258.3	23.3	14.9	39.5	14.4	32.0	7.0	14.2	43.2	82.3	26.3	50.5	63.7	45.8	38.3	63.9	48.9	21.9	7.4	35.0	7.8	40.1
EXOC2	"FLJ11026, SEC5L1, Sec5p"	ENSG00000112685	"Exocyst complex component 2"	Q96KP1	6	485154-693139	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.8;Inhibitory neurons: 80.1;Microglial cells: 68.4;Oligodendrocytes: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032093			Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA032093: AB_10611964"	"unprognostic (1.61e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.20e-1)"	10.2	8.3	11.0	11.5	11.7	6.6	10.9	11.4	11.2	10.1	11.6	9.1	8.6	8.7	5.2	12.2	6.5	8.9	11.6	11.2	11.5	9.3	10.3	11.3	13.4	11.6	11.6	7.8	6.6	11.6	8.2	18.0	12.5	7.9	10.0	13.4	8.0	7.9	10.1	11.8	9.3	9.2	11.0	13.1	8.9	16.1	11.3	18.6	14.2	10.4	14.1	10.8	9.1	14.4	21.0	15.2	26.0	28.5	23.2	20.8	15.7	18.5	21.5	21.7	25.8	20.4	11.0	15.5	44.0	22.3	32.7	17.7	29.2	32.2	25.7	48.4	30.9	19.8	18.5	20.4	29.1	21.2	18.8	18.1	25.9	15.5	18.0	21.4	36.9	30.0	39.4	11.1	27.3	18.1	28.6	20.6	26.4	18.6	15.1	26.6	22.5	31.3	19.5	22.4	25.4	14.9	14.8	9.0	29.1	48.4	23.2	12.9	54.1	19.6	14.1	24.6	17.4	27.2	56.8	16.4	19.8	17.4	61.0	11.6	9.0	10.2	17.1	11.0	20.9	13.5	17.2	18.3	14.1	14.5	16.2	15.7	2.8	14.8	17.7	11.1	21.1	14.4	11.0	11.7	11.4	11.2	11.2	11.5	11.6	11.6	12.5	11.0	11.3	14.4	12.6	3.2	14.5	35.6	15.9	4.8	3.8	6.2	6.2	9.0	10.1	9.3	8.6	2.8	6.5	5.5	8.4	16.0	18.5	6.1	7.9	6.2	11.0	7.3	7.0	11.1	2.4	8.2	75.8	5.1	7.1	7.6	6.1	8.2	5.1	11.8	8.6	8.2	10.0	8.4	80.1	6.8	12.2	9.0	5.8	3.8	6.8	8.7	5.4	68.4	10.8	4.6	13.4	49.3	73.4	6.9	5.1	9.1	11.3	6.4	4.1	8.2	9.0	9.3	0.0	7.3	8.9	21.8	17.5	9.9	7.7	12.9	18.3	7.4	5.9	6.0
EXT1	"LGCR, LGS, ttv"	ENSG00000182197	"Exostosin glycosyltransferase 1"	Q16394	8	117794490-118111826	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant, Hereditary multiple exostoses, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 229.6;Inhibitory neurons: 421.4;Microglial cells: 144.3;Oligodendrocyte precursor cells: 162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 95.5;fHDF/TERT166: 82.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044394	Uncertain					NA	Yes		17000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA044394: AB_10963838"	"unprognostic (1.29e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.70e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.85e-1)"	5.1	4.2	2.0	5.2	2.5	1.1	4.3	2.3	2.3	7.6	3.9	7.7	14.1	4.9	2.9	5.5	3.8	5.8	7.0	3.4	1.3	3.8	13.3	7.9	3.0	1.1	2.1	5.0	5.5	3.3	1.8	11.1	1.0	5.0	8.2	2.7	3.2	7.7	1.5	7.8	11.7	6.1	1.4	5.1	5.3	2.4	1.2	3.0	5.2	2.4	3.8	11.8	4.2	1.9	29.3	8.5	13.5	5.5	22.8	23.0	5.9	51.5	95.5	40.9	39.4	10.0	3.1	0.5	24.8	82.1	24.0	19.8	5.0	31.4	55.7	12.5	9.9	1.5	5.9	6.5	10.0	0.0	1.6	10.8	10.8	38.8	38.5	47.7	28.1	2.9	0.9	7.4	18.7	3.2	1.8	0.2	4.6	13.7	10.1	0.0	4.1	1.3	23.1	7.6	4.5	4.0	8.0	3.9	9.2	32.6	5.3	0.5	32.0	35.2	28.7	32.0	15.8	5.5	5.1	2.4	36.5	0.0	9.2	0.1	0.4	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.3	0.1	2.0	2.5	2.3	2.3	3.4	1.3	1.1	2.1	1.0	1.4	1.2	1.9	21.1	19.2	6.0	127.3	3.0	54.8	23.0	27.7	10.2	23.6	7.8	10.8	6.5	24.3	13.7	7.3	14.6	6.5	5.1	49.2	0.0	37.3	1.8	17.7	37.1	25.9	4.8	1.7	229.6	20.1	3.9	32.6	11.7	18.2	7.0	108.3	16.8	32.9	2.5	10.1	421.4	25.5	4.1	37.9	13.9	2.7	17.4	9.6	19.6	144.3	8.1	5.9	4.1	162.8	101.8	27.4	16.1	36.1	5.3	19.3	44.9	4.9	14.2	22.4	0.0	17.1	36.4	0.6	5.1	12.6	47.3	12.2	4.2	35.0	26.3	26.8
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819368	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		42000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	88.2	186.6	100.7	98.4	99.5	135.2	59.8	86.0	96.8	77.1	224.4	133.5	158.8	35.6	78.4	260.3	114.6	116.1	116.3	96.2	95.6	159.1	57.9	173.2	185.6	97.6	105.3	44.7	112.6	447.4	42.8	233.0	91.7	81.4	103.6	10.7	89.9	72.2	46.9	187.8	257.1	36.6	99.3	75.6	273.7	55.9	98.9	108.8	126.1	25.5	216.3	219.0	98.6	91.1	668.3	355.4	86.5	125.0	9.3	10.3	502.7	204.7	67.1	225.7	189.2	420.9	357.7	667.1	197.2	235.2	108.5	497.7	172.2	228.0	259.5	235.3	111.2	14.0	204.9	187.5	223.2	167.7	98.9	16.6	172.9	212.9	205.1	191.4	150.2	90.8	134.9	316.7	132.3	175.9	239.3	199.6	144.5	180.6	117.6	176.9	40.7	152.5	462.1	198.6	156.3	127.2	358.5	507.7	37.9	391.5	124.1	218.5	195.3	72.6	233.4	101.1	319.9	216.5	212.8	566.9	45.4	84.9	88.5	177.2	83.4	103.7	195.9	190.8	233.2	466.5	205.6	245.1	181.9	389.7	108.6	146.3	36.2	133.6	202.9	84.5	385.7	298.2	100.7	99.5	86.0	96.8	96.2	95.6	97.6	105.3	91.7	99.3	98.9	91.1	47.4	951.9	547.8	111.3	799.6	614.7	809.5	202.4	247.0	11.2	240.4	144.4	311.0	154.4	726.2	156.3	0.0	406.1	372.4	806.8	97.8	302.3	10.2	782.9	75.4	71.0	159.9	46.5	0.4	256.1	560.3	213.1	500.5	844.5	119.0	40.8	25.4	37.5	113.3	0.0	0.5	415.3	179.0	79.1	820.5	32.8	135.5	297.5	321.9	12.2	110.5	35.7	62.8	2.0	0.7	618.3	631.2	294.2	564.9	416.7	694.2	238.1	1248.4	5.1	249.8	205.5	136.3	52.5	61.7	430.4	726.5	1243.4	483.8	102.3	312.9	1142.8
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960267	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 202.4;Excitatory neurons: 296.7;Inhibitory neurons: 278.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 269.9;Oligodendrocytes: 424.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Supported	Nucleoplasm		NA	NA		12000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	18.2	16.8	21.0	9.2	22.0	21.0	18.5	21.8	27.5	18.9	18.7	23.7	12.4	18.2	11.7	23.1	15.7	8.7	34.9	22.3	22.1	21.5	23.6	14.9	13.1	21.5	21.5	19.9	26.2	23.2	20.6	10.6	22.0	18.5	12.7	19.6	18.1	16.3	67.9	28.1	16.4	13.4	21.8	14.0	18.2	47.8	21.2	22.2	18.3	37.6	14.1	21.4	18.7	25.9	37.4	27.1	23.1	39.3	22.4	21.1	33.9	35.5	32.1	53.9	48.8	30.4	26.0	59.9	25.7	30.5	47.5	27.2	37.3	33.1	45.9	40.1	33.5	49.9	33.5	31.6	36.4	54.3	28.5	19.8	29.4	57.0	69.4	27.8	29.5	44.5	58.9	0.2	28.1	15.0	56.6	43.0	30.6	49.3	19.2	52.1	50.7	0.0	54.9	33.1	0.3	28.6	32.3	64.9	56.4	32.0	20.4	64.1	18.2	30.4	37.3	37.8	0.2	45.1	50.6	69.3	0.0	77.6	35.7	1.1	2.1	4.9	4.0	2.7	5.5	2.5	3.6	4.0	3.6	4.2	4.3	2.8	0.7	4.3	3.5	2.9	6.1	1.6	21.0	22.0	21.8	27.5	22.3	22.1	21.5	21.5	22.0	21.8	21.2	25.9	17.9	6.4	18.2	202.4	26.9	21.4	38.5	27.8	33.6	19.9	16.9	16.9	43.9	11.5	27.2	16.5	27.1	14.2	18.0	13.1	29.4	8.8	75.1	15.1	15.6	14.2	11.4	44.6	296.7	11.6	28.2	16.0	29.0	16.9	5.7	19.2	10.4	18.2	11.4	16.8	278.9	17.8	6.1	13.6	18.0	117.2	11.1	15.4	16.0	177.1	8.9	20.0	15.5	269.9	424.4	8.5	9.7	10.9	35.4	18.3	20.0	28.3	32.7	33.0	6.6	26.2	20.3	36.9	15.6	37.9	28.1	15.3	27.9	19.6	21.6	34.1
FAM104A	FLJ14775	ENSG00000133193	"Family with sequence similarity 104 member A"	Q969W3	17	73207353-73236753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 44.8;testis: 153.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1305.1;Late spermatids: 1771.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021459, HPA079514"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA021459: AB_1848361, HPA079514: "	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	16.6	11.7	13.1	14.1	13.0	44.8	15.3	16.9	14.0	14.4	11.1	14.7	12.6	11.7	12.5	17.8	11.1	10.4	12.4	12.9	11.3	10.8	13.9	12.8	17.8	12.0	11.5	12.2	15.0	12.2	16.0	17.8	11.5	14.1	12.4	14.0	12.3	11.1	17.1	21.6	12.8	11.2	11.4	17.0	21.7	153.0	12.6	20.9	11.8	12.0	16.9	13.4	14.8	13.7	41.8	33.5	16.7	31.0	24.7	23.1	54.1	33.4	34.7	35.9	36.9	28.3	26.3	24.3	26.7	32.2	35.0	26.0	21.4	24.3	38.7	28.6	28.7	35.4	29.1	43.5	32.9	31.1	58.1	24.6	31.6	31.9	23.2	23.7	42.6	28.8	28.0	39.6	43.6	28.5	55.7	21.5	22.9	30.7	42.5	30.1	46.3	23.5	27.6	33.7	27.3	36.1	19.6	28.2	36.7	31.0	39.4	31.8	29.8	42.3	49.1	29.1	39.4	38.5	41.5	29.8	37.9	33.7	31.9	72.4	49.4	87.7	57.1	44.6	55.5	53.5	69.6	65.7	48.8	55.8	50.1	60.9	81.9	68.9	49.8	31.7	128.5	82.5	13.1	13.0	16.9	14.0	12.9	11.3	12.0	11.5	11.5	11.4	12.6	13.7	37.1	9.6	10.2	7.5	24.2	57.0	20.7	42.3	17.6	17.7	22.5	21.1	5.6	22.8	26.9	22.0	6.2	122.3	23.0	20.8	31.3	32.7	1305.1	21.9	16.0	23.9	19.8	103.6	14.2	25.3	70.1	19.4	28.5	24.6	29.2	20.4	18.2	18.5	35.6	26.9	14.1	22.9	26.4	21.8	34.2	1771.9	35.1	25.5	24.9	10.3	32.2	20.2	33.0	10.6	11.3	32.1	20.1	24.0	30.4	32.8	26.4	18.9	27.4	19.7	6.6	14.8	43.7	277.3	60.7	29.9	65.8	324.9	32.7	21.3	20.7	51.8
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 625.3;Distal tubular cells: 540.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA075611"	Approved		Supported	Mitochondria		NA	NA		19000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA035856: AB_10611965, HPA075611: "	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favorable (3.93e-4)"	49.0	105.7	54.8	31.3	60.2	39.9	43.9	57.3	82.2	84.5	57.1	145.9	56.1	49.5	59.4	207.6	49.7	46.2	174.2	57.1	58.5	107.6	200.3	32.0	32.9	55.9	57.2	84.3	133.9	116.6	51.0	17.6	55.6	74.6	149.0	83.5	59.8	49.2	141.0	89.8	56.3	44.6	56.6	31.7	93.2	43.6	58.8	34.7	44.1	142.6	42.7	76.9	131.5	55.6	132.0	27.7	40.4	75.6	72.1	66.4	20.7	52.9	46.8	49.0	123.9	69.4	58.7	142.1	89.2	18.2	40.3	89.8	73.5	128.1	130.0	74.0	55.1	115.6	44.0	125.8	47.4	114.0	39.6	77.3	65.5	46.7	97.9	164.3	66.0	137.7	79.2	55.6	71.1	52.0	116.9	137.9	59.5	294.9	144.4	69.5	57.8	186.9	144.3	314.9	60.1	48.1	39.4	92.4	114.3	59.9	57.9	55.7	47.0	48.4	34.6	28.7	55.6	108.8	39.9	144.8	143.3	109.7	22.8	9.9	25.8	75.7	58.3	68.2	86.9	75.3	79.5	74.0	84.6	68.1	85.1	88.6	8.5	50.6	75.9	70.4	80.4	38.8	54.8	60.2	57.3	82.2	57.1	58.5	55.9	57.2	55.6	56.6	58.8	55.6	55.7	28.9	46.0	41.1	68.2	128.1	155.3	625.3	82.0	31.5	80.6	109.5	338.4	84.4	188.6	130.6	47.9	51.4	47.9	477.5	540.0	148.2	102.5	82.0	30.1	49.8	106.9	47.7	33.0	177.6	47.8	78.7	84.6	79.2	85.7	59.3	44.6	280.4	92.7	38.7	30.4	374.3	240.1	66.7	108.9	33.1	134.5	61.2	104.9	7.5	108.9	79.7	45.3	22.1	21.6	141.6	313.2	148.6	61.2	121.4	186.2	466.2	95.5	29.9	105.2	83.2	315.3	146.4	68.3	315.1	132.8	47.2	66.0	121.1	358.4	210.9
FAM220A	"ACPIN1, C7orf70, MGC12966, SIPAR"	ENSG00000178397	"Family with sequence similarity 220 member A"	Q7Z4H9	7	6329411-6348981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 89.7;testis: 55.9"	"Group enriched"	"Detected in many"	13	"Early spermatids: 280.0;Late spermatids: 363.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055050			Approved	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA055050: AB_2682684"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (3.71e-2)"	7.1	8.6	13.6	6.9	14.7	2.6	8.3	17.5	17.0	9.1	9.3	6.2	5.4	10.3	7.4	11.5	7.6	7.6	13.8	15.3	13.6	8.2	6.4	6.2	9.9	11.7	12.7	10.7	9.8	19.2	0.6	7.9	12.4	8.0	5.3	11.5	8.4	8.3	89.7	10.1	4.9	9.3	12.5	7.9	6.1	55.9	13.7	12.0	11.7	39.1	10.4	9.6	0.5	13.4	26.9	16.6	11.9	28.0	27.0	22.7	13.1	13.4	16.6	15.9	18.5	10.5	14.6	22.2	15.1	15.9	31.8	19.2	18.2	11.3	20.6	15.5	11.7	7.3	10.0	12.6	29.2	13.5	10.8	12.7	37.5	11.9	28.5	15.3	15.0	16.4	14.6	20.7	13.9	20.9	8.4	24.7	27.8	14.0	21.4	21.6	17.9	18.7	14.7	9.6	12.1	21.0	18.8	23.0	28.6	23.9	22.1	34.9	11.4	12.5	28.5	20.6	17.5	19.7	37.2	23.2	14.6	24.1	39.3	6.6	4.2	8.0	4.7	3.5	4.4	9.1	5.4	6.5	7.7	7.7	8.4	6.8	2.0	12.9	3.8	6.8	6.6	3.7	13.6	14.7	17.5	17.0	15.3	13.6	11.7	12.7	12.4	12.5	13.7	13.4	4.1	3.2	1.1	1.3	8.1	7.8	4.9	6.2	12.0	2.9	6.0	6.9	9.2	0.0	8.2	1.8	6.2	6.3	5.4	3.8	1.9	4.9	280.0	6.0	5.5	4.6	6.1	7.8	4.7	4.8	7.5	6.8	7.7	4.8	1.3	4.4	6.4	3.5	6.2	0.0	4.7	4.2	4.1	6.8	10.5	363.4	8.4	7.4	3.6	2.8	7.1	5.2	6.2	4.0	3.9	4.8	2.1	13.2	3.9	5.5	3.3	2.8	3.4	2.3	0.0	6.3	5.4	23.7	11.4	10.3	10.1	8.2	5.2	3.9	3.4	6.7
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292425	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 33.3;skin 1: 42.3;vagina: 15.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 27.9;Basal squamous epithelial cells: 17.6;Early spermatids: 11.8;Squamous epithelial cells: 26.1;Suprabasal keratinocytes: 64.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 9.9;head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 28: Keratinocytes - Keratinization"			"CAB034227: AB_1562876, HPA049978: AB_2680979"		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.2	5.3	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	4.2	0.0	0.1	42.3	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	2.1	0.6	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	27.9	1.1	0.0	17.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.2	6.5	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.3	1.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	26.1	64.2	0.0	0.0	0.0	0.1	1.9
FBXO27	"Fbg5, Fbx27"	ENSG00000161243	"F-box protein 27"	Q8NI29	19	38990714-39032785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 37.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Suprabasal keratinocytes: 17.8;Syncytiotrophoblasts: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 35.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA046800, HPA062242"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA046800: AB_2679813, HPA062242: AB_2684723"	"prognostic favorable (2.15e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (1.48e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.80e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.04e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.21e-2)"	13.3	3.7	17.5	2.1	15.9	2.7	6.2	23.8	18.7	6.3	6.4	6.8	2.2	4.7	2.4	15.4	5.3	5.5	19.6	15.4	8.9	6.4	7.5	3.2	3.7	10.7	6.7	10.2	4.8	2.5	4.1	3.8	9.1	8.9	8.7	4.9	7.4	7.8	1.6	37.5	4.9	7.4	4.9	3.1	3.8	4.7	11.1	4.0	4.6	2.4	4.0	7.7	9.7	13.1	9.1	11.4	0.3	7.2	15.3	0.8	3.3	1.2	6.7	5.2	4.9	3.8	3.4	0.9	17.5	10.3	9.0	15.5	0.6	6.6	3.4	0.8	0.4	0.3	3.0	0.6	2.7	0.9	2.5	5.5	10.2	5.4	0.4	8.2	3.3	0.4	5.4	1.2	7.2	8.1	0.6	1.4	8.1	3.0	20.4	0.2	0.1	1.1	3.4	35.3	0.4	10.8	17.7	2.2	0.1	4.8	9.2	1.7	4.0	0.5	0.4	0.3	0.9	3.5	8.9	1.9	9.0	0.2	0.3	1.1	0.3	0.2	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.6	0.4	0.3	1.7	1.7	0.2	0.5	0.3	0.2	17.5	15.9	23.8	18.7	15.4	8.9	10.7	6.7	9.1	4.9	11.1	13.1	0.2	3.2	15.0	2.3	0.1	5.9	4.1	1.4	9.1	7.5	3.8	4.2	9.5	7.2	6.4	1.8	0.0	36.1	0.5	0.2	1.9	1.5	3.7	1.9	3.6	3.2	0.0	0.0	4.8	0.8	4.8	2.7	6.1	1.6	7.6	2.3	1.4	3.2	4.9	8.4	4.6	0.2	8.2	0.3	4.9	2.5	2.8	2.1	0.0	1.0	1.1	5.6	0.0	3.0	4.1	0.3	0.0	4.1	1.9	2.3	6.9	7.3	4.7	3.0	0.0	1.8	1.5	6.4	2.0	13.5	17.8	27.0	1.3	0.4	0.2	5.3
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114111-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003289	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Focal adhesion sites"	"HPA003289: AB_2666879"	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	10.9	7.5	6.5	8.3	7.3	8.9	12.3	8.8	10.5	10.9	7.4	10.3	8.5	10.0	7.9	12.4	8.2	9.5	8.1	7.6	9.1	13.6	17.4	8.9	10.5	8.5	7.4	11.3	7.6	13.7	4.4	9.0	8.8	10.0	10.6	8.3	7.9	8.5	12.5	21.1	7.7	9.8	8.0	8.9	8.5	7.8	7.8	10.9	9.8	14.2	10.6	11.5	9.0	8.9	24.6	10.6	16.2	17.4	16.6	19.0	26.7	24.3	19.7	16.0	15.2	14.9	18.7	11.8	24.4	22.3	10.3	20.9	24.2	23.4	27.4	17.0	27.0	15.0	12.8	10.7	20.7	28.3	18.8	18.6	27.7	23.2	41.9	18.8	27.1	15.0	24.8	16.4	29.1	8.1	14.9	14.4	38.6	32.3	22.8	15.7	23.1	22.3	30.2	16.1	26.2	28.1	25.1	38.0	27.4	16.9	20.2	28.2	31.2	19.8	15.0	25.0	46.1	17.8	22.3	18.0	24.5	13.7	39.3	7.4	6.5	11.8	5.8	6.0	7.2	8.9	5.9	6.8	7.8	9.0	5.9	6.6	4.2	8.6	6.9	3.5	8.8	4.6	6.5	7.3	8.8	10.5	7.6	9.1	8.5	7.4	8.8	8.0	7.8	8.9	15.0	6.4	10.6	22.5	16.8	34.3	25.5	11.3	9.6	20.5	14.7	11.7	11.4	7.2	13.5	11.0	22.9	14.2	12.3	17.2	9.8	13.2	30.3	15.9	13.0	16.4	18.5	17.4	48.8	11.5	13.1	12.7	7.1	22.9	14.0	12.6	14.3	23.4	13.9	18.5	43.8	12.7	14.2	17.7	16.3	14.8	13.1	16.8	28.4	34.7	16.4	12.6	7.2	45.8	43.7	17.7	12.2	13.2	15.4	21.5	12.0	22.8	11.5	18.6	13.1	14.9	12.7	24.7	26.8	17.2	39.1	23.0	18.9	10.9	14.6	30.7
FBXO42	"Fbx42, KIAA1332"	ENSG00000037637	"F-box protein 42"	Q6P3S6	1	16246840-16352480	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025071	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA025071: AB_1848461"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (3.22e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.78e-3)"	"unprognostic (3.91e-2)"	14.1	12.6	17.4	8.8	16.4	9.3	12.9	20.0	18.0	21.7	14.7	15.1	7.6	19.8	12.9	18.2	18.6	11.8	16.9	16.5	17.6	11.8	14.2	13.6	12.5	16.9	16.3	18.2	15.3	14.0	16.2	12.1	17.8	19.3	10.6	16.7	13.5	15.0	22.6	28.1	11.1	17.9	14.9	13.7	12.1	11.6	16.8	18.1	14.6	22.3	14.3	18.9	17.9	16.4	15.4	8.2	19.4	19.8	23.1	15.0	8.5	15.6	23.5	22.0	21.4	7.7	13.9	16.2	13.6	21.7	15.1	13.6	19.8	14.8	17.9	18.7	9.3	15.2	12.5	8.8	27.5	18.1	19.0	16.1	33.5	19.4	27.8	20.0	22.3	20.0	16.5	22.1	15.8	10.5	17.5	15.8	8.5	20.3	9.2	19.6	11.9	14.5	14.8	4.3	18.3	12.0	17.6	14.6	18.8	17.7	11.9	14.0	14.0	11.1	9.8	18.4	12.3	10.9	11.9	16.3	14.7	23.5	15.6	9.0	11.8	18.5	11.7	16.3	8.7	8.5	8.7	7.5	14.0	14.1	9.8	8.7	10.5	12.4	12.7	6.1	12.4	7.9	17.4	16.4	20.0	18.0	16.5	17.6	16.9	16.3	17.8	14.9	16.8	16.4	9.2	12.8	11.8	47.0	16.0	25.9	6.1	13.5	22.2	21.7	7.1	7.1	20.6	15.7	9.4	12.9	45.9	11.0	16.6	6.7	0.0	8.5	9.4	21.7	15.5	9.9	10.7	10.8	63.9	7.6	15.6	14.7	11.7	33.1	2.5	12.8	9.7	9.6	13.8	28.6	65.9	5.6	10.2	15.1	28.1	10.2	14.9	13.4	1.8	35.6	19.2	11.0	15.5	60.8	53.0	8.4	7.6	11.3	17.7	10.4	8.8	3.8	6.4	20.4	13.1	23.1	13.4	13.5	9.7	18.9	34.7	26.3	16.0	9.8	8.3	5.5
FBXO48		ENSG00000204923	"F-box protein 48"	Q5FWF7	2	68459422-68467294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Alveolar cells type 2: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA049775, HPA054782"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies"		"HPA049775: AB_2680874, HPA054782: AB_2682599"	"unprognostic (2.90e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.89e-2)"	1.1	1.2	1.3	1.4	1.8	0.7	1.3	1.5	1.5	1.1	1.2	1.1	1.8	0.8	1.1	1.1	0.7	0.8	0.7	1.3	1.2	1.4	2.0	1.0	1.7	1.5	1.4	1.7	0.8	1.3	0.5	1.2	1.7	0.8	1.2	3.0	1.3	0.7	3.1	2.5	1.5	0.6	1.2	1.8	1.3	1.0	1.7	1.2	1.1	1.8	1.8	0.7	0.9	2.7	2.1	0.7	1.3	0.9	1.6	1.8	0.9	1.5	1.8	1.4	1.6	1.0	0.9	2.6	1.0	0.7	1.9	1.1	1.2	1.2	2.7	3.5	1.3	1.3	0.7	0.5	0.7	0.6	1.5	0.8	2.1	2.0	1.7	0.7	0.6	4.3	0.6	4.9	1.1	0.4	1.5	1.9	0.7	1.4	1.0	1.3	2.3	1.7	1.1	0.6	1.3	0.9	0.7	0.3	1.7	1.1	0.4	0.6	0.6	1.6	1.5	2.0	1.6	3.9	2.5	1.1	1.0	1.1	1.2	2.6	0.7	0.9	1.0	0.7	1.0	0.9	1.7	1.0	0.4	1.0	1.2	1.2	1.4	1.0	1.3	0.9	2.1	0.6	1.3	1.8	1.5	1.5	1.3	1.2	1.5	1.4	1.7	1.2	1.7	2.7	9.1	32.1	52.0	1.3	6.4	7.1	5.0	3.1	9.1	3.9	7.7	10.4	11.7	7.2	16.3	5.5	2.1	4.2	4.5	7.1	11.7	3.2	1.7	4.0	3.1	8.2	3.0	4.0	0.8	3.3	3.5	6.8	3.1	4.1	12.6	2.1	5.3	7.1	4.1	3.3	0.8	6.2	0.0	5.1	6.6	1.0	4.1	8.7	1.8	0.0	2.5	2.2	2.1	1.5	1.7	3.1	2.7	1.5	5.8	3.4	7.4	9.2	12.9	5.7	0.0	5.5	3.9	18.0	11.1	6.7	8.0	1.6	8.1	2.8	3.5	3.9
FBXO6	"FBG2, FBS2, FBX6, Fbx6b"	ENSG00000116663	"F-box protein 6"	Q9NRD1	1	11664200-11674354	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.6;Late spermatids: 117.8;NK-cells: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA051175	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA051175: AB_2681372"	"unprognostic (3.23e-3)"	"unprognostic (2.58e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (2.65e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (5.90e-4)"	6.5	10.7	9.9	11.8	10.1	20.3	6.7	10.3	12.4	7.6	8.2	7.6	13.5	5.0	6.0	10.3	14.1	8.7	10.0	9.8	11.5	7.8	18.5	11.4	18.3	9.9	10.5	5.9	13.8	13.5	6.1	2.6	9.7	8.7	6.8	3.6	13.0	8.4	18.7	9.5	8.2	7.4	10.0	13.0	9.8	10.8	12.6	7.1	6.7	14.5	11.1	9.5	7.0	9.8	10.0	7.3	0.8	0.4	2.1	6.8	4.5	4.2	6.6	20.1	9.2	7.6	8.3	0.3	18.7	7.0	5.5	0.2	6.8	7.5	1.5	26.3	1.0	0.2	1.0	7.7	15.4	9.4	0.1	7.9	15.8	2.5	6.3	4.3	2.6	10.3	22.7	18.7	1.8	19.1	3.4	7.8	0.8	10.2	9.7	2.3	0.1	0.7	6.9	1.4	1.6	2.0	9.3	10.9	14.3	1.8	10.5	10.2	2.0	1.0	0.8	2.7	0.3	10.0	7.5	3.9	1.2	21.6	1.8	17.1	49.5	65.0	47.0	75.0	25.4	15.3	12.0	31.3	66.5	15.0	7.1	23.7	41.4	41.4	91.0	27.3	13.1	36.6	9.9	10.1	10.3	12.4	9.8	11.5	9.9	10.5	9.7	10.0	12.6	9.8	6.0	6.4	6.9	3.3	8.4	7.0	6.6	14.6	4.0	4.3	8.3	7.4	6.8	2.8	15.0	9.2	2.1	1.1	19.5	10.7	0.0	14.5	60.6	15.7	4.5	4.0	4.9	1.7	1.8	38.5	9.2	7.8	8.6	5.3	3.8	2.2	8.2	19.9	26.2	5.0	2.6	8.3	8.2	15.4	34.7	117.8	8.1	18.3	7.2	1.0	37.8	9.0	60.8	0.0	1.3	13.0	10.8	11.3	12.2	11.3	14.3	15.6	36.5	7.8	0.0	3.3	4.0	4.0	11.9	7.3	9.8	1.8	16.0	1.8	9.2	11.2
FDXR	"ADR, ADXR"	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 343.1"	"Group enriched"	"Detected in many"	7	"Granulosa cells: 329.3;Theca cells: 794.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 89.5;Hep G2: 173.5"					"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	3.9	343.1	6.9	2.4	8.4	2.2	3.8	7.8	8.1	7.8	8.6	9.7	4.6	6.7	5.1	26.0	12.9	4.1	6.0	6.6	6.7	6.5	14.9	5.3	2.9	7.6	7.9	20.5	12.9	5.9	4.1	3.0	7.5	6.7	3.2	0.5	7.1	4.4	7.7	16.4	5.6	2.3	7.4	33.9	7.6	45.6	7.0	4.7	6.0	1.7	2.5	6.2	10.5	7.5	12.5	65.6	9.6	10.8	6.8	9.1	89.5	14.8	15.9	8.6	17.1	18.3	10.8	29.6	2.6	6.2	4.8	24.9	6.9	18.4	2.5	27.9	15.2	22.6	10.6	173.5	19.0	5.0	75.1	29.2	20.3	9.1	3.1	7.0	43.9	10.9	36.1	4.8	13.4	53.4	19.7	10.6	5.5	11.8	14.5	10.6	16.4	16.2	7.1	21.0	5.2	12.1	10.0	21.7	11.2	10.9	47.4	4.7	20.5	5.9	51.9	9.4	7.4	12.7	2.3	6.5	16.1	7.7	20.6	1.7	6.0	5.0	5.6	4.5	5.0	4.8	5.1	6.8	7.3	2.4	4.4	5.4	2.0	10.3	3.4	1.4	15.4	5.2	6.9	8.4	7.8	8.1	6.6	6.7	7.6	7.9	7.5	7.4	7.0	7.5	4.0	3.2	3.9	7.5	8.2	9.7	17.8	42.6	17.1	4.9	6.6	8.4	3.8	5.7	23.3	9.2	4.2	53.2	2.8	18.6	5.9	11.1	6.5	28.2	4.3	4.6	7.1	4.0	1.4	7.9	18.9	12.9	13.7	3.5	5.7	329.3	12.5	13.9	23.1	3.3	2.2	13.1	36.7	6.2	2.7	14.9	5.9	4.6	5.4	1.0	3.9	11.4	8.2	3.0	1.3	9.0	16.9	4.5	7.1	5.2	24.9	21.7	73.6	5.1	0.0	6.2	18.3	6.3	6.1	33.7	18.2	46.1	8.6	794.1	20.3	17.4
FERMT1	"C20orf42, FLJ20116, KIND1, UNC112A, URP1"	ENSG00000101311	"Fermitin family member 1"	Q9BQL6	20	6074845-6123030	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 121.3;Oligodendrocyte precursor cells: 229.7;Pancreatic endocrine cells: 384.1;Undifferentiated cells: 95.2"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 84.3;HaCaT: 95.4;HBEC3-KT: 100.2;OE19: 75.1;RT4: 54.4"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 2.0"	"Not detected"	"Not detected"			"HPA039778, HPA041966"	Approved					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA039778: AB_10805593, HPA041966: AB_10795387"	"unprognostic (1.08e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (4.38e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.33e-2)"	0.6	11.4	1.4	9.3	2.2	0.3	1.5	1.5	1.4	2.1	0.0	24.6	14.8	2.3	0.8	12.8	3.5	2.6	1.0	1.6	2.0	4.0	0.3	1.0	0.0	3.1	2.8	4.2	2.7	12.5	0.2	4.8	3.2	5.0	35.8	0.0	1.9	4.3	0.1	17.6	11.0	2.0	2.6	0.4	13.0	0.5	2.2	2.4	2.9	0.3	5.1	6.8	3.4	3.4	53.4	14.4	0.0	0.0	0.4	5.0	18.5	2.8	0.1	1.9	0.8	24.8	84.3	0.0	14.1	2.9	6.3	95.4	36.8	100.2	2.0	0.0	2.6	8.2	10.7	26.8	1.2	0.0	2.5	4.8	43.6	11.5	24.0	0.4	1.2	0.3	0.0	0.2	2.4	1.4	0.0	2.4	11.5	75.1	41.1	0.0	12.5	29.9	9.9	54.4	7.7	0.9	8.8	0.3	0.0	0.7	8.4	2.2	0.4	5.1	3.4	0.7	39.5	0.2	0.1	0.1	3.7	9.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	1.5	1.4	1.6	2.0	3.1	2.8	3.2	2.6	2.2	3.4	0.1	0.0	0.6	0.3	0.0	41.4	51.5	44.8	121.3	0.0	3.4	16.3	1.3	8.6	16.0	0.0	0.0	65.0	0.1	61.2	1.9	34.5	0.1	4.0	31.8	0.6	15.6	8.4	2.3	40.3	31.3	7.5	46.9	2.0	0.0	13.5	0.4	0.4	4.9	0.0	2.2	49.0	2.0	0.0	0.8	1.1	10.8	1.5	1.8	7.5	0.1	0.0	0.0	229.7	0.5	384.1	23.5	3.0	1.4	20.1	13.9	15.8	5.7	0.0	0.0	6.2	2.9	0.2	0.6	80.6	43.0	7.3	1.0	6.2	95.2	44.8
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 273.8;choroid plexus: 198.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 13.2;eosinophil: 3.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		1200000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	5.7	21.3	103.9	8.2	186.8	0.3	22.9	178.9	198.9	19.7	198.1	44.8	10.4	54.6	15.3	25.2	29.6	31.3	5.6	109.9	124.7	26.3	41.0	30.9	2.9	250.9	185.9	18.0	31.0	61.0	6.8	15.7	220.5	27.4	21.2	1.2	59.1	54.6	0.5	109.3	12.2	43.6	165.5	0.8	22.5	7.6	148.0	10.1	54.6	0.2	9.1	16.6	27.4	273.8	7.2	0.4	30.2	189.0	0.1	0.0	60.9	0.4	0.0	0.0	0.0	49.6	1.1	0.1	12.5	2.8	0.1	55.6	63.7	13.0	0.0	0.1	12.7	0.0	0.2	1.2	1.5	0.2	11.7	0.1	26.2	0.0	0.6	0.0	0.0	0.3	0.2	0.2	0.0	11.7	0.2	0.1	57.8	8.7	0.0	0.1	0.0	7.5	18.0	15.8	0.5	0.5	0.4	33.4	0.0	36.6	49.3	0.0	0.1	0.3	8.5	0.2	0.7	0.1	0.1	0.0	0.3	0.0	0.5	13.2	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	103.9	186.8	178.9	198.9	109.9	124.7	250.9	185.9	220.5	165.5	148.0	273.8	1.4	19.2	36.0	228.2	0.6	40.1	34.3	18.4	58.6	0.2	8.7	25.4	9.1	213.1	38.4	36.8	0.0	16.5	0.3	7.3	0.0	7.4	4.1	28.1	4.4	1.0	2.4	2.7	14.8	0.2	3.0	9.0	13.3	53.1	0.0	0.1	1.8	5.0	2.3	0.0	31.2	40.8	10.2	0.6	4.4	9.6	1.2	1.1	5.4	10.3	0.6	2.0	1.0	6.0	562.5	0.7	3.0	6.0	0.1	15.0	1.8	13.6	15.3	0.2	0.0	1.6	2.6	0.7	9.9	18.7	27.7	4.0	1.5	0.4	3.8	31.4
FOXJ1	"FKHL13, HFH-4, HFH4"	ENSG00000129654	"Forkhead box J1"	Q92949	17	76136333-76141245	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 43.4;choroid plexus: 80.1;fallopian tube: 53.2"	"Group enriched"	"Detected in many"	8	"Endometrial ciliated cells: 234.7;Respiratory ciliated cells: 124.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 29.9;CAPAN-2: 25.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 43.1"	HPA005714	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA005714: AB_1078902"	"prognostic favorable (9.39e-4)"	"unprognostic (4.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.71e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-1)"	0.0	0.0	12.2	0.1	12.7	0.3	0.0	13.0	10.8	6.6	80.1	0.6	0.3	2.2	0.5	0.3	53.2	0.0	0.0	14.6	18.3	3.4	0.0	10.4	0.0	36.7	43.4	0.2	0.9	0.0	2.2	0.0	25.2	0.5	0.2	0.4	0.1	2.5	0.4	0.8	0.2	0.0	23.3	0.0	0.5	16.7	22.6	0.2	3.0	0.0	0.0	0.9	0.1	14.9	0.0	0.5	1.7	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	3.1	25.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	12.2	12.7	13.0	10.8	14.6	18.3	36.7	43.4	25.2	23.3	22.6	14.9	2.2	9.6	3.1	1.0	2.3	0.8	1.0	4.4	0.0	0.4	5.6	4.2	0.9	1.5	12.0	9.2	4.2	0.2	4.8	1.0	0.0	0.6	21.4	234.7	4.5	0.7	1.8	3.0	0.0	0.0	0.6	1.6	4.1	10.7	1.3	0.1	0.4	0.0	0.1	0.0	0.1	3.2	4.1	0.6	0.0	19.1	0.3	1.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.8	0.4	1.3	0.5	0.2	3.5	124.0	8.7	0.0	1.8	3.5	20.7	2.0	0.8	0.9	0.3	3.5	1.1	2.3	0.7
FOXJ2	FHX	ENSG00000065970	"Forkhead box J2"	Q9P0K8	12	8032716-8055517	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008723	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA008723: AB_1078903"	"unprognostic (1.68e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (9.01e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.02e-2)"	13.8	8.3	6.6	8.7	6.7	15.5	12.3	14.3	11.9	15.5	4.6	14.8	7.3	17.7	8.0	8.8	14.4	8.1	14.7	6.7	6.6	7.3	5.9	12.1	8.3	6.3	6.2	16.8	10.0	15.4	8.5	11.0	6.1	10.6	7.7	9.3	9.5	12.8	25.2	17.5	10.1	14.7	5.1	10.8	11.3	5.8	6.2	10.7	9.9	20.6	9.1	13.5	12.3	7.0	12.4	10.3	11.1	14.0	12.6	13.8	24.3	17.5	17.8	16.7	12.4	14.8	13.3	0.2	3.2	21.3	15.4	13.2	10.0	11.7	17.8	21.6	6.8	16.4	11.8	5.1	15.8	7.4	43.9	12.2	17.2	21.7	31.5	17.4	12.1	13.0	12.2	8.0	13.7	9.6	10.5	6.6	12.6	18.4	6.8	11.2	17.2	6.0	7.0	8.2	4.6	6.3	22.0	15.1	7.6	23.1	3.5	8.8	11.0	20.3	24.8	14.5	10.7	6.4	6.8	8.1	13.1	5.9	12.3	2.5	1.4	2.2	1.5	1.1	1.9	0.8	1.5	1.7	1.8	1.5	1.7	1.5	2.7	2.8	1.5	1.7	1.2	1.2	6.6	6.7	14.3	11.9	6.7	6.6	6.3	6.2	6.1	5.1	6.2	7.0	14.1	16.0	13.1	6.2	9.1	18.9	4.5	5.5	14.8	10.7	10.4	9.1	19.9	12.8	4.0	0.0	8.4	5.5	7.7	7.1	0.0	5.9	0.4	4.0	14.0	12.8	4.9	13.7	6.1	7.5	3.1	12.0	7.7	7.2	3.8	16.1	18.9	9.5	10.1	8.4	6.4	8.4	4.1	13.2	23.0	0.9	10.5	13.9	7.2	6.5	14.2	4.0	11.3	3.0	5.7	10.3	4.4	17.0	6.7	9.8	5.0	2.4	2.9	7.5	19.7	9.9	8.4	1.4	6.4	14.2	21.5	6.2	12.3	8.1	7.4	5.3
FRMD4A	"bA295P9.4, FLJ10210, FRMD4, KIAA1294"	ENSG00000151474	"FERM domain containing 4A"	Q9P2Q2	10	13643706-14462142	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.8"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 1527.6;Inhibitory neurons: 1622.8;Microglial cells: 1329.4;Oligodendrocyte precursor cells: 442.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 134.0;HUVEC TERT2: 105.8;TIME: 191.6;WM-115: 163.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038449	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA038449: AB_10669539"	"unprognostic (6.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.51e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.84e-1)"	60.8	5.2	38.9	11.7	28.1	5.4	18.7	0.0	29.2	8.6	0.0	13.1	5.7	5.7	4.0	9.4	8.8	9.6	16.7	24.1	8.5	19.5	12.2	14.2	9.1	15.6	10.9	6.8	15.5	2.4	8.7	22.5	6.2	10.3	6.4	14.1	13.6	10.2	8.1	32.0	7.4	6.5	10.0	32.8	7.9	8.8	14.4	15.6	8.1	7.3	8.4	10.4	8.9	18.9	7.0	7.1	90.1	0.5	12.3	22.0	16.9	40.8	36.5	35.2	48.7	12.1	4.2	0.1	28.3	21.5	48.6	13.5	0.3	3.3	30.7	0.3	9.9	1.4	0.9	0.2	11.0	0.5	1.1	12.8	3.2	134.0	16.4	98.9	105.8	3.1	13.6	0.4	64.7	8.5	4.6	0.8	24.6	0.3	9.6	0.4	30.8	0.2	16.6	5.8	4.3	15.9	0.2	32.7	64.4	16.1	18.5	3.3	191.6	48.8	17.4	47.6	49.3	0.3	0.4	0.3	41.7	1.0	163.4	0.1	0.1	0.0	0.0	0.1	0.1	0.8	0.3	0.1	0.0	2.3	0.3	0.0	0.3	0.2	0.0	0.4	0.4	0.0	38.9	28.1	0.0	29.2	24.1	8.5	15.6	10.9	6.2	10.0	14.4	18.9	48.6	32.1	2.6	168.1	1.7	35.1	13.1	3.0	9.1	54.2	17.1	14.4	11.4	45.8	4.1	33.1	18.8	69.6	0.4	1.1	11.7	15.8	42.5	13.1	5.5	44.0	4.8	81.7	1527.6	4.0	42.1	14.9	4.6	26.9	15.2	58.1	44.3	6.2	35.9	80.8	1622.8	3.4	6.1	95.6	19.9	98.8	2.1	25.5	16.0	1329.4	2.7	46.0	0.0	442.3	61.0	1.8	1.4	1.9	0.9	8.0	0.3	2.7	2.5	12.9	13.1	41.2	45.5	1.3	2.1	20.6	32.7	28.7	3.0	5.3	5.4	4.3
FSTL4	KIAA1061	ENSG00000053108	"Follistatin like 4"	Q6MZW2	5	133196455-133612541	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 390.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 57.2;U-266/70: 19.3;U-266/84: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045920	Uncertain		Uncertain	Mitochondria	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA045920: AB_10965844"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.02e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.25e-2)"	0.1	1.3	5.5	0.6	5.5	1.9	0.6	8.5	11.2	0.3	0.0	1.1	0.7	0.2	1.5	1.9	0.9	0.5	0.3	3.1	3.2	2.8	0.1	1.2	0.3	0.0	6.2	0.4	1.9	3.1	2.3	3.8	0.0	1.6	1.1	3.9	0.7	0.0	0.9	3.4	0.8	0.2	0.0	0.4	1.4	1.7	21.4	1.3	0.8	0.5	1.1	6.0	0.9	7.8	7.5	13.1	1.4	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	12.5	1.7	0.7	10.5	0.0	1.3	0.2	1.7	0.5	0.0	0.9	0.6	0.6	13.9	1.1	0.0	0.0	0.7	0.3	1.8	0.0	0.1	0.3	0.0	0.5	5.9	7.0	0.0	12.7	1.5	0.6	14.4	14.2	1.6	0.6	1.3	14.1	0.0	15.0	57.2	1.6	2.9	2.4	0.3	12.2	4.6	0.5	0.3	0.6	2.4	0.8	0.4	19.3	20.7	0.5	0.2	0.1	0.4	1.1	0.2	0.1	0.2	0.0	0.5	0.6	0.4	0.3	0.1	0.5	0.4	0.2	0.5	0.2	0.2	0.3	0.3	0.3	5.5	5.5	8.5	11.2	3.1	3.2	0.0	6.2	0.0	0.0	21.4	7.8	0.0	0.0	3.1	21.5	1.0	1.7	2.5	0.2	4.0	10.1	0.6	0.3	9.6	0.0	4.4	0.0	14.6	0.4	0.1	0.0	0.0	0.2	35.9	1.2	0.2	0.6	9.0	0.0	390.3	0.0	0.0	0.4	0.0	0.1	0.0	1.4	0.0	0.0	0.1	1.7	57.9	0.4	0.0	0.0	0.0	20.4	0.3	1.2	10.6	8.4	0.0	3.0	0.0	21.1	4.5	0.6	0.0	0.7	0.0	0.4	0.2	2.5	3.7	2.6	6.6	0.0	1.1	0.5	0.7	3.3	1.6	0.0	0.4	0.9	0.1	2.9
FUT10		ENSG00000172728	"Fucosyltransferase 10"	Q6P4F1	8	33370824-33473146	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 140.0;Early spermatids: 248.8;Late spermatids: 334.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053970, HPA058655"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Endoplasmic reticulum, Golgi apparatus"		"HPA053970: AB_2682327, HPA058655: AB_2683789"	"unprognostic (6.02e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.76e-4)"	"unprognostic (3.06e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.01e-3)"	1.9	2.2	4.3	1.0	4.7	0.8	3.4	4.2	4.2	4.0	2.0	2.5	2.5	3.1	1.2	1.9	3.3	1.8	1.7	3.0	3.3	3.1	2.0	2.4	1.8	4.3	5.5	5.2	2.6	5.1	1.3	3.5	3.3	2.2	2.7	5.2	2.7	2.1	0.6	3.2	2.6	2.9	2.7	1.5	2.3	1.5	4.8	2.9	2.8	1.2	2.2	2.2	2.2	2.5	2.4	4.5	6.8	8.3	10.8	10.8	3.4	4.3	7.1	4.2	5.4	6.3	3.6	2.7	5.1	5.8	3.5	5.9	10.4	4.1	4.1	5.8	3.8	8.6	3.6	7.0	4.9	1.9	2.9	8.0	7.0	1.1	5.4	8.8	8.6	4.4	8.0	3.2	3.9	1.4	6.6	2.8	9.1	6.4	3.0	4.8	5.1	1.4	6.1	5.4	2.4	2.3	2.5	3.7	5.1	7.0	3.8	1.9	6.6	3.2	1.4	8.1	3.6	1.3	2.2	1.8	2.0	5.4	3.4	0.4	0.6	0.7	1.3	0.2	1.4	1.0	0.7	1.2	1.3	0.3	0.8	0.8	0.4	1.6	0.2	0.7	1.7	0.6	4.3	4.7	4.2	4.2	3.0	3.3	4.3	5.5	3.3	2.7	4.8	2.5	4.5	3.2	2.0	140.0	2.5	2.7	2.7	3.4	4.0	2.9	3.7	3.8	2.5	2.8	3.2	3.7	10.4	12.0	3.0	1.5	1.9	4.5	248.8	2.8	5.7	3.8	3.6	3.8	16.3	4.0	7.0	5.8	6.1	3.0	5.7	10.1	5.3	3.6	3.4	3.3	20.2	3.2	4.1	2.2	1.8	334.2	6.8	2.2	1.8	29.0	3.0	29.9	5.2	44.2	16.4	4.0	1.0	4.9	5.0	1.4	5.3	3.0	2.0	11.0	0.0	5.7	4.6	7.0	2.7	5.5	1.7	6.0	2.6	6.5	3.6	1.3
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 615.1;skeletal muscle: 1234.9;tongue: 466.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 718.3;Proximal tubular cells: 417.4"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 176.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved					NA	NA		420000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA051806: AB_2681619"	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	14.0	26.6	69.4	4.5	74.5	8.8	15.6	68.6	79.1	16.5	53.4	10.9	3.2	10.0	141.9	23.0	14.7	9.9	98.1	67.3	67.1	72.0	615.1	8.1	7.7	71.8	68.3	22.8	229.8	37.8	37.4	4.9	70.4	36.5	2.2	15.0	42.6	17.5	1234.9	32.8	6.4	4.6	68.8	10.7	31.8	55.0	76.1	24.8	22.2	466.4	4.3	12.9	15.3	94.5	21.6	24.1	25.2	56.9	30.9	37.3	34.3	25.2	41.2	31.8	28.7	54.8	15.1	11.3	17.2	30.0	3.8	9.1	39.8	15.5	8.5	81.5	46.2	34.9	20.3	176.7	18.2	0.7	11.5	41.8	5.5	33.8	0.1	44.0	6.9	43.0	50.6	26.6	52.6	22.1	103.9	12.0	28.6	10.7	75.4	103.1	22.3	81.4	38.1	19.5	8.4	58.5	1.9	14.3	32.0	16.1	65.3	48.1	12.2	34.6	35.6	1.9	11.6	119.0	24.8	19.5	32.2	46.1	40.7	3.7	2.5	15.3	18.8	3.4	27.3	22.0	26.3	23.8	11.2	32.3	40.6	30.8	1.5	18.2	6.1	47.3	15.8	14.9	69.4	74.5	68.6	79.1	67.3	67.1	71.8	68.3	70.4	68.8	76.1	94.5	9.2	0.0	7.2	5.5	18.0	58.9	42.1	57.8	116.7	41.0	60.3	99.9	99.3	127.2	12.9	16.5	56.3	35.7	15.4	0.8	92.0	39.9	5.2	6.5	7.4	9.2	7.2	35.8	7.4	33.6	41.2	30.9	10.2	4.0	4.5	43.3	18.9	718.3	81.7	18.5	10.1	1.5	6.1	29.5	13.3	16.0	83.9	13.9	32.0	3.7	4.7	57.3	10.3	4.0	36.7	13.5	0.1	139.5	12.5	24.1	0.1	417.4	6.1	61.7	32.9	77.8	47.1	4.3	22.6	42.1	42.9	12.0	19.7	31.1	3.3	23.2
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	16.7	15.1	13.1	23.6	14.0	32.6	15.4	11.0	12.6	13.6	17.1	19.5	22.8	14.8	8.7	22.0	12.3	14.4	12.3	16.7	13.5	16.1	17.1	21.7	19.8	17.6	14.4	11.4	21.6	15.1	14.9	17.8	14.3	10.7	11.3	8.4	15.5	11.0	17.9	30.0	24.8	8.3	14.4	22.2	17.8	33.0	14.8	19.5	14.7	6.9	13.6	15.1	16.4	12.7	60.7	50.8	46.5	69.3	18.9	19.7	97.5	46.7	31.6	47.7	45.4	92.8	62.6	117.9	69.5	47.1	31.6	49.6	43.6	41.5	27.6	40.6	47.7	87.1	49.4	51.8	46.2	97.6	72.1	31.3	30.2	49.9	40.0	15.8	48.2	66.9	141.1	37.1	28.1	68.5	115.9	38.7	98.3	55.8	45.9	121.9	46.6	54.9	24.9	79.0	87.7	48.9	40.4	48.6	57.5	30.2	44.0	40.3	94.9	89.9	43.3	106.8	88.5	46.1	62.9	125.3	56.2	80.9	53.7	4.6	2.9	3.2	3.2	1.5	1.9	2.3	1.9	2.7	1.3	1.5	1.4	1.6	7.8	2.7	3.3	3.0	1.3	2.3	13.1	14.0	11.0	12.6	16.7	13.5	17.6	14.4	14.3	14.4	14.8	12.7	35.7	12.8	19.2	24.5	24.1	55.7	22.3	14.2	26.2	16.1	33.5	21.5	13.5	24.3	15.4	14.7	18.8	23.7	66.3	53.4	13.7	21.9	21.8	43.9	42.8	31.4	15.6	21.0	14.9	30.6	36.8	21.9	29.0	69.5	17.1	22.1	29.3	27.9	27.7	23.5	21.4	28.9	24.4	27.3	42.1	18.5	15.5	27.7	32.0	35.6	28.5	18.2	53.5	17.1	21.6	46.4	28.8	13.9	19.5	24.1	30.2	29.9	15.8	18.3	19.7	40.5	25.8	18.4	41.4	39.5	55.5	36.7	39.3	28.2	32.2	28.2
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2099.3;liver: 2804.2;pancreas: 2935.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.4	21.4	133.9	12.4	138.4	1.8	25.4	152.5	216.5	9.9	94.3	19.6	175.5	8.4	10.5	25.1	11.6	47.7	57.2	131.1	140.9	2099.3	2804.2	7.3	18.4	148.0	135.4	165.2	2935.3	2.7	8.3	74.7	153.4	12.4	11.5	7.5	57.5	15.1	142.5	137.6	110.2	14.5	149.2	33.6	99.2	78.2	140.4	12.6	63.0	46.9	29.7	18.0	15.5	181.2	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	133.9	138.4	152.5	216.5	131.1	140.9	148.0	135.4	153.4	149.2	140.4	181.2	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.1;EFO-21: 20.3;HDLM-2: 25.9;HUVEC TERT2: 18.1;RT4: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042682, CAB045975"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB045975: AB_10584474, HPA042682: AB_2678113"	"prognostic favorable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.10e-5)"	66.6	89.2	3.1	31.8	3.2	8.0	64.6	2.8	4.7	80.4	2.5	100.4	15.0	63.4	11.7	41.2	64.4	22.7	21.4	2.5	4.6	27.3	27.7	89.7	26.2	8.8	5.1	60.5	7.5	27.9	13.8	8.1	5.7	54.6	18.4	0.5	34.6	20.6	53.8	55.4	62.0	31.8	3.7	51.1	46.0	9.0	6.4	9.3	21.1	16.5	15.9	83.8	65.4	4.0	5.4	0.1	0.0	0.0	19.1	12.5	1.9	2.1	17.0	2.1	6.8	0.0	5.0	0.0	20.3	14.0	14.8	0.7	0.0	0.1	1.3	25.9	0.0	0.1	3.1	1.3	2.6	0.5	0.9	14.1	0.0	5.1	0.0	9.3	18.1	0.0	0.3	0.4	7.4	0.0	0.0	4.3	0.0	4.6	0.1	0.0	7.5	0.0	3.7	21.6	0.0	0.2	7.4	1.5	0.1	0.5	0.1	1.0	13.9	2.7	0.1	3.1	1.5	14.0	0.0	0.0	6.9	0.1	0.1	19.1	31.4	10.9	34.4	42.8	43.3	4.7	32.4	32.9	11.6	3.4	24.3	25.4	139.4	26.7	77.8	0.6	79.1	32.5	3.1	3.2	2.8	4.7	2.5	4.6	8.8	5.1	5.7	3.7	6.4	4.0	35.4	25.6	34.3	0.7	21.5	46.5	123.5	24.9	18.2	0.2	56.1	30.4	4.1	27.1	27.1	18.4	0.0	40.2	47.7	41.9	0.0	113.9	35.7	59.6	39.7	60.5	10.2	8.2	0.6	73.2	51.2	41.2	18.3	152.4	47.4	2.5	28.2	30.5	33.2	0.0	1.1	15.7	8.2	84.5	29.4	33.3	4.7	81.1	8.8	14.0	60.6	0.5	110.2	1.5	0.1	73.2	25.9	8.6	17.3	80.3	128.3	12.2	27.5	0.2	19.7	81.9	45.2	1.8	4.6	24.9	61.8	57.7	81.8	33.3	15.3	87.0
GFUS	"FX, P35B, SDR4E1, TSTA3"	ENSG00000104522	"GDP-L-fucose synthase"	Q13630	8	143612618-143618048	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 32.1;Cytotrophoblasts: 82.1;Extravillous trophoblasts: 156.4;Hofbauer cells: 69.9;Syncytiotrophoblasts: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		850000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	36.3	37.2	21.6	27.7	21.1	52.3	34.0	21.4	25.9	28.6	21.7	45.9	69.2	24.8	19.2	88.7	24.0	29.3	32.1	20.7	21.3	37.5	86.6	28.4	29.1	23.5	21.9	19.0	99.5	22.8	44.0	24.4	22.8	45.0	37.6	6.5	70.9	24.2	30.2	81.5	52.4	19.4	20.2	35.7	111.4	49.4	21.0	26.6	32.1	18.4	27.1	31.0	36.0	22.5	85.6	67.1	29.2	99.7	28.6	26.1	54.1	70.3	73.0	50.2	38.1	78.5	94.3	37.5	64.6	52.5	21.2	60.6	47.8	100.8	23.2	101.7	53.8	58.7	103.0	93.4	57.2	42.2	67.1	30.3	47.4	31.7	127.3	42.2	84.3	61.9	66.4	57.0	41.2	267.5	39.8	53.2	45.8	267.7	87.1	47.1	26.3	122.3	106.1	94.8	67.3	45.9	53.3	100.2	73.0	23.0	133.5	58.8	75.5	34.8	132.0	35.1	67.6	34.1	30.2	29.0	52.8	91.6	54.7	34.9	27.4	42.9	40.3	38.5	43.0	35.2	43.1	46.8	30.1	40.1	31.5	38.5	31.0	63.6	33.8	54.5	57.5	45.7	21.6	21.1	21.4	25.9	20.7	21.3	23.5	21.9	22.8	20.2	21.0	22.5	32.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	82.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	156.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	87.7	1.7	0.0	0.0	0.0
GID4	"C17orf39, VID24"	ENSG00000141034	"GID complex subunit 4 homolog"	Q8IVV7	17	18039408-18068405	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 69.1"	"Group enriched"	"Detected in many"	12	"Early spermatids: 665.5;Late spermatids: 1287.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044348	Uncertain		Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA044348: AB_10959602"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.65e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	7.6	5.1	8.3	4.7	7.7	5.8	6.0	9.6	8.6	6.7	5.0	10.0	4.2	7.3	6.5	11.6	6.1	5.1	10.1	7.5	6.6	5.9	5.5	5.3	5.5	7.7	7.6	7.8	7.6	10.5	3.0	6.5	7.7	6.7	4.6	5.7	7.9	7.9	27.7	12.4	4.6	8.5	7.0	5.7	5.8	69.1	7.8	7.2	6.7	14.4	6.0	8.8	7.3	7.7	11.8	12.1	6.7	10.9	17.2	16.8	11.4	9.6	15.6	10.5	11.8	10.2	4.5	14.9	8.1	11.3	9.6	13.1	9.8	10.6	13.7	8.1	19.6	6.6	9.5	7.5	14.9	3.9	11.1	12.5	18.6	10.5	16.3	13.9	11.8	20.9	6.0	4.1	8.6	3.0	12.8	8.4	5.9	14.4	8.8	10.8	23.9	14.8	7.2	4.6	5.0	7.6	6.5	5.7	7.2	64.9	3.6	5.0	10.0	6.7	3.8	15.7	4.9	7.3	6.7	3.2	9.6	6.7	8.8	4.3	1.1	3.6	1.2	0.6	1.3	2.6	1.1	1.2	0.9	2.0	1.3	1.4	2.9	2.0	0.8	1.6	1.9	0.6	8.3	7.7	9.6	8.6	7.5	6.6	7.7	7.6	7.7	7.0	7.8	7.7	8.7	0.0	1.1	5.2	6.0	11.1	7.5	4.5	4.6	5.8	6.4	7.0	12.4	5.7	3.1	1.8	4.2	8.3	6.1	4.1	9.8	5.3	665.5	5.4	9.5	8.4	1.2	17.2	8.2	5.7	15.2	8.0	1.1	5.5	5.7	10.7	8.2	6.8	7.3	16.8	8.1	4.9	0.0	9.5	7.7	1287.8	12.8	7.4	7.2	11.2	9.7	5.4	10.3	9.5	9.8	9.1	1.6	15.8	5.0	16.3	6.9	11.4	3.5	3.9	13.1	8.6	9.0	78.1	26.3	7.2	18.2	15.5	5.9	7.0	4.4	8.0
GIPC1	"C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2"	ENSG00000123159	"GIPC PDZ domain containing family member 1"	O14908	19	14477760-14496149	"Human disease related genes, Predicted intracellular proteins"			"Congenital muscular dystrophy, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 345.8"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 501.1;Pancreatic endocrine cells: 296.7;Paneth cells: 285.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043958, HPA061786"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		11000	"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA043958: AB_10963436, HPA061786: AB_2756319"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	51.0	54.8	80.0	22.4	91.5	3.3	54.3	88.7	94.4	99.8	64.7	120.2	24.7	53.7	17.6	345.8	48.9	23.4	66.1	74.5	82.1	104.1	58.4	76.3	15.9	89.4	91.4	34.4	43.5	20.8	56.0	28.7	88.1	63.6	41.1	17.9	100.9	31.0	65.1	150.2	45.5	17.5	82.0	37.7	78.7	24.9	91.1	18.6	55.8	23.3	21.0	74.1	140.1	92.3	328.1	148.6	44.7	70.6	40.6	40.7	35.2	119.7	59.8	96.7	87.3	80.3	120.6	4.7	220.3	85.2	64.6	183.8	38.7	100.6	32.6	33.8	69.0	63.9	100.7	79.7	123.7	6.9	75.3	46.7	98.5	58.8	51.3	57.4	66.0	47.2	30.1	54.4	49.9	243.8	21.3	13.3	48.6	182.1	147.8	21.7	37.4	43.7	121.6	281.6	41.8	46.2	67.1	163.2	157.0	23.1	102.5	35.1	115.4	135.7	74.6	191.7	130.1	50.5	70.5	17.3	113.9	51.9	146.2	3.0	0.7	0.1	5.1	1.1	4.7	1.9	5.1	5.1	1.1	0.8	4.2	3.3	0.3	1.5	0.5	3.6	12.0	1.7	80.0	91.5	88.7	94.4	74.5	82.1	89.4	91.4	88.1	82.0	91.1	92.3	30.6	28.9	15.2	22.9	8.3	113.9	77.4	52.1	35.9	69.8	73.6	31.6	14.8	37.1	62.8	82.8	35.5	36.3	19.3	501.1	52.8	167.9	1.1	92.2	30.5	32.4	43.1	1.7	28.8	164.3	77.1	32.6	69.3	76.8	10.2	37.3	23.2	18.0	55.9	75.7	32.2	87.8	42.7	10.8	29.8	2.4	20.5	16.1	58.7	10.3	23.4	73.3	18.6	17.1	71.6	296.7	285.4	25.2	6.8	120.4	36.0	52.7	38.0	46.0	19.7	18.1	44.5	6.4	20.4	107.0	169.8	25.7	22.9	47.7	138.1	199.7
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.0;kidney: 41.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 122.1;Proximal tubular cells: 267.7;Undifferentiated cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.1;HaCaT: 6.0;Hep G2: 23.0;HUVEC TERT2: 23.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	3.9	23.8	0.5	1.7	0.4	0.3	3.0	0.4	0.5	1.8	0.5	15.6	38.0	2.1	0.9	2.1	3.1	5.5	1.5	0.5	0.4	41.4	18.4	2.7	0.8	0.4	0.4	2.4	18.1	2.3	0.9	3.5	0.4	1.7	14.9	0.1	4.2	0.9	1.1	4.7	38.0	2.8	0.4	27.9	6.0	1.0	0.5	0.4	1.0	1.6	0.8	2.0	1.9	0.4	0.0	0.0	0.0	0.1	2.4	6.1	0.0	1.0	0.0	0.5	1.1	5.1	3.3	1.5	0.1	0.5	0.0	6.0	0.0	0.0	3.2	0.2	0.0	0.8	0.0	23.0	1.2	0.0	0.0	1.0	0.1	3.5	0.1	0.0	23.5	0.0	0.0	0.1	2.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.4	33.6	0.0	1.3	2.0	2.0	12.9	2.4	0.9	4.0	0.4	5.2	1.5	3.2	27.1	2.5	9.2	2.1	6.7	0.0	43.7	33.2	11.8	2.5	13.3	0.9	21.6	3.0	0.4	14.7	33.0	3.1	2.9	8.6	7.2	0.0	5.9	22.9	43.3	13.2	0.0	15.2	34.4	0.0	0.8	1.9	1.2	1.2	2.1	0.0	14.0	1.0	0.0	0.0	4.5	8.9	16.5	39.3	0.0	0.0	0.8	122.1	267.7	11.7	0.5	0.0	1.3	1.3	0.6	2.5	7.9	21.7	1.6	1.3	32.4	63.8	6.0
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1 RNA export mediator"	Q53GS7	9	128504719-128542288	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	11.6	14.0	9.2	15.7	9.2	15.1	15.7	12.4	11.3	13.0	13.4	17.4	16.2	11.6	10.8	16.4	14.1	7.8	14.9	8.9	8.8	14.1	16.3	12.3	20.4	8.7	9.2	16.2	9.5	17.6	14.1	9.2	8.6	11.8	18.3	16.5	11.1	12.4	22.5	19.1	15.8	12.9	8.4	15.2	12.9	32.0	9.3	25.9	13.3	12.4	22.2	12.8	12.3	8.9	29.6	54.5	26.2	44.9	25.3	25.5	34.6	29.2	24.9	40.2	28.4	36.8	20.1	59.6	23.0	33.0	38.6	101.4	45.9	41.7	34.5	56.9	29.8	30.6	57.8	34.6	28.5	49.9	38.8	18.1	39.7	45.6	48.5	22.3	22.9	54.7	44.7	51.0	46.7	68.6	49.5	35.2	22.2	79.1	46.7	49.8	64.2	79.0	27.3	26.1	30.9	23.1	71.3	42.7	25.9	21.1	78.9	34.9	17.0	42.5	28.1	50.2	41.2	50.9	131.9	45.9	39.9	37.5	46.8	40.0	21.1	24.4	22.1	26.0	18.1	13.4	17.2	20.0	22.1	20.5	15.2	17.7	18.0	27.4	27.5	13.0	22.3	19.8	9.2	9.2	12.4	11.3	8.9	8.8	8.7	9.2	8.6	8.4	9.3	8.9	4.0	9.6	9.0	11.1	11.4	6.5	5.3	10.4	8.6	7.6	8.8	7.6	13.0	5.7	7.2	7.3	8.4	16.1	6.9	13.2	5.9	11.7	77.0	12.2	7.4	3.6	5.4	12.0	14.0	6.2	11.7	7.6	10.2	9.4	9.5	10.9	4.6	14.2	15.7	10.1	15.5	12.7	8.2	15.1	5.7	58.1	10.2	13.5	3.6	10.3	20.0	8.9	15.5	18.1	15.5	8.3	8.0	6.4	13.4	6.1	16.3	13.7	12.6	8.6	13.1	7.7	7.3	51.3	25.5	14.4	6.8	13.3	12.1	7.1	14.1	5.4
GNA15	GNA16	ENSG00000060558	"G protein subunit alpha 15"	P30679	19	3136033-3163749	"Plasma proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 75.6;esophagus: 108.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 141.5;Langerhans cells: 190.6;Macrophages: 78.3;Suprabasal keratinocytes: 95.8;Urothelial cells: 173.8"	"Group enriched"	"Detected in all"	4	"cervical cancer: 39.9;head and neck cancer: 46.4;lung cancer: 17.3;pancreatic cancer: 11.9;urothelial cancer: 31.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 67.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 67.1;granulocytes: 19.4;monocytes: 29.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 65.4;HMC-1: 152.1;MOLT-4: 162.4;NB-4: 59.8;REH: 119.3;THP-1: 62.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043113	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA043113: AB_10967343"	"prognostic favorable (7.57e-5)"	"unprognostic (6.06e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (4.26e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.07e-1)"	6.8	3.1	4.0	12.4	3.8	75.6	4.6	4.0	7.3	13.3	4.7	2.5	1.7	1.3	0.4	108.8	2.4	4.6	1.9	4.1	4.1	2.0	1.4	13.1	4.2	5.4	4.5	0.8	1.2	0.4	1.4	7.6	5.1	11.6	1.8	0.1	19.5	2.5	0.6	50.8	2.5	3.1	4.9	8.8	4.3	1.4	6.6	32.0	1.2	0.9	12.1	28.1	41.6	6.4	44.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	18.7	0.1	0.1	0.0	0.1	36.2	0.0	65.4	0.0	0.1	0.0	19.1	0.1	0.0	0.0	27.2	152.1	0.0	40.0	0.2	26.2	0.0	0.0	16.6	0.1	0.3	0.0	0.0	162.4	59.8	0.1	2.9	0.0	119.3	0.0	0.2	0.0	23.6	0.2	0.0	4.6	0.2	0.2	0.0	0.0	62.1	0.1	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.3	29.8	0.1	19.4	29.1	14.3	0.0	21.8	1.1	0.0	2.0	0.3	28.8	0.0	0.0	0.0	6.9	4.4	15.5	67.1	8.7	13.3	4.0	3.8	4.0	7.3	4.1	4.1	5.4	4.5	5.1	4.9	6.6	6.4	1.0	9.6	8.8	0.0	2.2	67.2	141.5	65.5	9.1	0.2	7.4	3.7	0.5	0.0	39.0	3.7	0.0	0.5	27.6	0.5	0.0	0.7	0.5	1.4	0.5	3.1	6.6	21.0	1.3	0.0	0.8	2.5	3.6	3.9	34.3	0.0	0.7	0.0	66.5	0.0	0.4	2.2	57.0	36.2	190.6	0.8	0.0	78.3	21.4	7.5	32.0	0.0	0.0	0.0	0.2	13.2	0.3	0.0	3.6	69.3	0.0	0.1	21.7	0.1	19.7	0.3	3.3	4.0	2.0	38.0	95.8	0.4	19.6	0.1	1.4	173.8
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548615-109600195	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 350.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: AB_2677870"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	12.7	8.2	5.8	14.2	6.1	27.7	11.9	7.3	7.5	10.9	8.6	11.8	10.4	12.1	8.0	21.8	8.0	11.3	4.2	6.0	6.5	11.2	15.3	9.7	14.1	6.7	5.9	8.8	9.3	8.9	1.8	14.8	6.8	10.3	11.8	17.8	7.7	9.0	3.8	18.4	10.6	13.6	6.3	11.4	9.0	8.7	6.2	14.2	8.0	5.5	15.9	15.5	4.0	7.3	48.3	16.4	31.0	17.3	28.4	35.0	25.7	35.3	28.6	36.0	35.5	24.4	16.1	25.3	22.4	37.6	21.6	24.5	30.0	35.3	49.4	29.2	18.0	22.1	26.3	21.9	25.1	34.9	18.8	25.2	30.4	41.3	27.8	24.2	42.8	19.1	29.8	24.2	35.5	32.9	27.3	28.4	31.3	23.0	19.1	19.2	73.6	16.6	37.4	35.4	19.5	34.9	24.7	27.6	39.4	22.8	21.1	30.5	36.7	29.4	40.7	44.9	39.2	25.6	30.2	29.2	47.6	34.4	47.1	32.4	29.7	57.8	21.1	44.3	22.4	20.1	20.4	20.6	31.9	17.1	16.8	19.4	53.8	19.9	44.6	14.2	23.8	36.3	5.8	6.1	7.3	7.5	6.0	6.5	6.7	5.9	6.8	6.3	6.2	7.3	104.0	44.8	31.5	17.0	76.6	151.2	104.3	92.2	63.2	29.9	67.7	45.3	14.3	37.1	61.0	58.8	350.3	80.3	98.8	63.9	64.6	97.9	14.7	65.5	71.5	82.6	84.3	43.8	37.5	101.7	153.7	69.2	55.5	110.9	46.3	50.1	56.7	57.2	107.9	25.2	36.4	72.3	59.0	115.0	106.9	9.4	48.7	127.4	74.7	31.9	102.4	47.9	45.3	35.7	31.3	101.6	58.9	47.4	66.3	72.5	48.9	53.5	51.7	26.2	52.6	59.0	77.6	68.6	54.7	82.1	188.4	106.9	94.3	51.7	63.5	143.0
GNB4		ENSG00000114450	"G protein subunit beta 4"	Q9HAV0	3	179396088-179451476	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 81.1;Kupffer cells: 98.1;Macrophages: 66.8;Microglial cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 143.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018383, CAB018737, HPA040736"	Supported		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: AB_2677106"	"unprognostic (2.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (1.90e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.80e-3)"	14.9	6.3	8.7	21.9	19.2	33.7	12.4	7.3	11.2	11.5	2.9	9.5	5.9	9.2	3.7	21.9	7.0	15.2	13.9	9.6	8.7	5.9	7.8	16.0	17.7	15.5	8.5	5.8	2.8	2.7	3.0	21.8	14.5	4.5	8.6	2.0	4.7	4.0	3.1	34.1	6.4	23.5	14.5	18.1	7.4	4.3	10.9	7.9	6.3	5.7	11.5	13.2	6.8	19.7	33.4	15.4	37.7	0.8	23.8	41.5	44.1	46.7	33.1	54.1	61.3	0.8	3.7	61.6	9.9	54.3	49.7	0.6	36.4	43.1	56.7	143.6	29.2	71.3	54.9	0.7	23.4	62.3	16.2	32.9	6.6	42.4	21.6	12.0	59.3	13.7	18.7	0.8	42.8	1.3	32.8	24.3	18.9	0.2	19.3	61.4	49.2	25.3	34.9	1.9	7.0	20.5	37.5	33.0	61.1	23.0	67.5	26.1	45.3	45.1	27.4	13.6	61.6	0.3	0.9	0.8	24.7	52.8	35.4	5.6	21.3	11.0	0.2	27.8	0.1	6.7	0.4	0.3	24.9	13.6	0.4	0.3	14.5	3.4	23.5	12.8	0.6	8.8	8.7	19.2	7.3	11.2	9.6	8.7	15.5	8.5	14.5	14.5	10.9	19.7	40.0	25.6	12.8	17.9	20.1	18.7	1.8	2.5	13.6	1.7	14.3	12.3	15.6	0.0	12.3	3.7	6.2	13.8	11.5	0.1	3.9	1.1	1.2	15.6	22.9	42.9	0.0	22.9	18.6	1.6	18.7	26.6	3.6	10.8	10.8	16.2	53.2	0.9	81.1	1.7	18.4	0.0	2.0	98.1	17.4	1.4	10.2	66.8	14.2	91.8	59.9	0.8	2.1	11.6	7.7	2.8	0.0	15.8	8.1	2.6	0.2	0.2	11.3	4.0	26.3	9.9	41.8	2.3	16.8	23.4	25.4	4.1	2.9	14.7	0.0	1.3
GNG12		ENSG00000172380	"G protein subunit gamma 12"	Q9UBI6	1	67701475-67833467	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 243.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA057790, HPA062208"	Enhanced	Supported	Approved	Mitochondria		NA	NA		550000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA057790: AB_2683527, HPA062208: AB_2684711"	"unprognostic (5.18e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.46e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.46e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.14e-3)"	63.4	57.0	14.4	28.5	12.3	0.3	50.1	10.4	14.0	59.3	13.5	68.4	122.0	59.7	27.7	82.0	43.4	59.3	34.5	13.7	19.5	79.2	44.8	34.3	12.0	21.9	29.1	47.9	25.2	54.7	13.1	60.2	16.9	38.3	65.7	6.6	26.6	47.6	12.9	80.4	110.8	73.9	18.6	56.2	42.7	17.7	16.4	15.9	59.8	19.7	22.7	56.5	46.5	18.7	60.5	55.5	58.0	31.5	241.2	207.9	59.5	182.9	237.2	157.9	141.0	26.5	58.2	0.1	75.9	258.0	98.8	44.2	36.6	150.0	275.7	0.5	28.1	1.0	46.0	0.1	96.0	0.1	3.0	125.7	87.8	168.7	221.8	221.1	251.9	0.0	3.6	0.3	175.6	10.2	0.1	0.5	44.1	65.7	68.3	0.3	119.6	0.9	151.8	53.5	13.2	26.8	126.8	52.1	248.4	48.8	26.9	1.1	326.7	182.5	118.8	332.0	114.5	3.0	0.3	0.5	115.3	7.1	252.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	12.3	10.4	14.0	13.7	19.5	21.9	29.1	16.9	18.6	16.4	18.7	49.7	54.5	32.2	54.5	2.1	201.3	78.8	53.3	78.6	2.1	52.4	37.1	26.7	35.8	42.8	58.8	6.2	61.8	0.9	243.1	74.3	96.2	14.6	51.8	20.6	67.0	34.7	5.3	0.5	138.5	105.6	82.6	45.3	49.3	3.8	21.3	76.1	45.6	27.9	3.3	15.3	56.3	30.5	18.2	32.4	16.6	71.4	6.2	78.2	21.5	3.6	3.0	0.0	63.3	1.3	143.7	99.9	75.6	0.2	119.9	227.3	177.9	79.2	18.9	52.6	54.8	71.7	1.8	18.8	83.1	216.8	175.9	4.5	107.1	61.8	109.1
GPBP1L1	SP192	ENSG00000159592	"GC-rich promoter binding protein 1 like 1"	Q9HC44	1	45627304-45688113	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028593	Approved		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites, Cytosol"	"HPA028593: AB_10602906"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.44e-3)"	"unprognostic (6.60e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.42e-3)"	"unprognostic (9.79e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.51e-1)"	"unprognostic (7.56e-3)"	"unprognostic (6.13e-2)"	28.7	26.7	25.2	31.0	29.4	49.3	40.9	27.3	28.0	35.0	26.1	57.3	54.0	35.6	37.6	45.0	36.2	30.3	41.7	23.6	27.1	47.0	66.3	39.2	39.9	27.7	28.3	30.6	39.3	41.7	25.5	34.1	28.2	35.8	61.2	27.4	42.4	36.1	46.2	47.2	56.7	36.3	26.8	36.9	42.6	57.9	27.4	54.7	48.7	54.9	49.5	35.6	36.7	32.8	41.1	24.7	42.1	44.9	48.4	47.1	57.5	31.9	52.2	44.8	56.1	25.2	44.8	56.3	40.5	43.7	46.9	42.0	46.6	47.8	56.3	64.4	33.4	73.7	28.9	39.2	66.7	74.2	65.1	34.6	102.0	35.3	99.4	60.2	57.7	71.0	63.7	48.7	51.6	22.0	66.2	65.8	60.4	54.8	27.7	43.0	55.1	41.9	51.5	40.2	51.9	34.7	52.6	76.6	83.5	81.6	35.1	86.2	49.8	32.0	33.6	35.2	48.9	47.2	46.9	41.3	34.0	60.6	34.5	24.0	21.6	40.3	21.6	27.3	22.9	16.5	20.9	21.1	23.0	14.1	22.6	22.4	22.6	26.6	30.6	13.1	26.4	21.1	25.2	29.4	27.3	28.0	23.6	27.1	27.7	28.3	28.2	26.8	27.4	32.8	43.3	60.9	24.4	54.5	45.1	64.9	41.2	28.3	59.2	23.5	51.3	33.5	46.9	41.5	34.3	60.7	35.5	26.2	47.5	96.8	50.9	33.0	23.4	38.1	32.2	38.6	38.3	62.1	48.5	38.9	33.7	25.4	44.9	47.5	59.6	24.3	37.5	81.3	25.0	37.0	49.0	67.2	32.6	49.9	51.6	17.6	20.5	46.1	23.2	70.3	41.3	18.2	45.3	50.8	93.8	51.2	57.0	21.4	36.6	62.8	75.5	58.7	33.0	32.9	19.7	22.4	42.0	78.9	75.3	71.7	67.8	45.4	47.1	27.7	68.6	78.2
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435663-240468076	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 226.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 199.8;Syncytiotrophoblasts: 102.7;Urothelial cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030571, HPA070449"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		9500000		"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322, HPA070449: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.78e-5)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	36.8	78.5	42.8	9.0	37.0	0.4	30.7	25.3	64.4	44.5	3.1	36.7	5.8	37.1	9.3	88.4	30.8	8.5	145.2	41.7	28.5	47.6	35.7	21.9	1.4	29.2	30.4	45.1	25.8	9.8	55.7	29.0	26.3	67.8	3.5	5.0	35.2	22.5	134.2	226.0	17.4	16.4	11.3	15.6	23.0	48.7	46.0	9.1	15.7	35.3	6.6	35.1	62.3	24.8	69.0	92.9	21.6	56.7	64.3	61.5	87.3	161.5	78.8	18.3	21.2	33.3	74.9	1.8	21.8	172.0	100.1	186.0	11.7	114.7	3.8	33.3	9.8	0.1	80.7	41.7	92.2	1.6	6.2	54.3	73.4	41.2	21.3	38.1	9.7	3.4	0.4	3.3	47.5	36.0	1.3	0.6	33.7	7.7	20.5	12.3	98.2	16.1	15.0	109.6	21.5	14.4	105.7	91.9	10.1	19.3	29.1	7.0	45.6	97.3	162.3	46.9	67.8	0.7	0.4	0.8	69.4	1.7	111.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	37.0	25.3	64.4	41.7	28.5	29.2	30.4	26.3	11.3	46.0	24.8	1.2	16.0	6.1	45.7	0.7	45.9	69.6	62.2	56.3	22.4	8.3	18.2	53.2	21.5	34.0	25.8	2.1	73.7	0.3	3.7	7.9	27.8	0.9	6.2	24.7	2.8	0.0	0.0	53.0	10.8	199.8	21.0	1.5	8.9	4.5	49.4	11.0	26.3	9.1	25.2	45.0	7.0	16.2	0.6	7.7	3.8	19.0	1.2	35.6	5.6	1.6	24.9	1.0	18.6	8.9	17.6	0.9	7.5	0.9	67.0	0.5	2.3	30.2	6.4	26.3	33.9	38.2	2.2	9.9	44.8	46.2	102.7	1.9	14.5	3.6	110.5
GPKOW	"GPATC5, GPATCH5, Mos2, Spp2, T54"	ENSG00000068394	"G-patch domain and KOW motifs"	Q92917	X	49113407-49123735	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000287, HPA001894"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000287: AB_1079015, HPA001894: AB_1079014"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	17.6	15.9	21.5	11.7	22.6	16.1	16.4	22.7	21.8	14.7	14.0	17.0	14.3	16.9	11.8	14.7	15.1	10.3	18.6	19.8	21.2	15.5	14.5	13.8	14.9	24.2	23.6	13.6	12.1	19.0	17.2	13.8	23.9	12.7	12.6	11.9	13.8	16.5	34.8	20.4	14.1	13.8	22.4	15.4	15.5	7.2	25.2	17.7	13.4	25.4	14.4	16.2	14.2	24.4	36.5	38.1	24.9	20.9	21.6	18.6	27.0	23.1	25.9	36.0	38.0	27.9	35.5	15.2	17.4	28.6	36.8	25.2	27.9	27.3	23.4	32.2	29.8	15.8	31.4	19.9	25.8	18.9	32.1	20.4	34.3	28.8	29.2	21.1	27.4	30.0	19.8	23.1	23.8	59.5	26.0	31.5	17.6	19.5	30.0	32.2	27.4	41.5	18.5	45.8	20.8	24.1	26.9	25.2	25.4	26.1	48.5	24.5	30.7	20.7	31.2	30.4	22.1	35.4	26.1	20.7	26.7	31.1	32.7	26.2	22.3	28.9	37.2	31.4	30.3	20.5	28.6	27.8	22.6	34.8	24.3	22.4	17.3	25.0	35.9	20.8	31.1	20.2	21.5	22.6	22.7	21.8	19.8	21.2	24.2	23.6	23.9	22.4	25.2	24.4	10.9	19.2	11.0	7.2	10.5	8.0	14.1	21.8	4.6	14.8	6.4	5.5	13.1	21.5	19.1	7.3	4.2	28.4	16.3	16.2	15.6	26.2	1.1	15.6	10.0	13.4	7.8	22.5	2.8	25.2	20.5	11.7	14.3	10.6	11.4	10.4	11.7	14.5	16.7	5.0	2.8	12.1	18.3	10.9	9.3	1.7	15.5	8.7	5.4	2.8	13.2	20.9	28.8	2.0	3.9	25.6	23.2	15.1	9.4	9.4	19.5	20.5	12.7	13.4	39.5	12.9	13.0	9.9	18.4	6.1	9.9	43.8	16.7	10.6	11.0	12.8
GRID2IP		ENSG00000215045	"Grid2 interacting protein"	A4D2P6	7	6497462-6551436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"brain: 31.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.8;Inhibitory neurons: 2.9;Oligodendrocyte precursor cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"thalamus: 31.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"REH: 3.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 22.4;thalamus: 7.2"	"Low region specificity"	"Detected in all"			HPA045381			Approved	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA045381: AB_10962495"	"unprognostic (1.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.19e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.17e-1)"	0.0	0.4	6.7	0.1	6.2	0.2	0.2	10.7	1.4	0.1	0.0	0.3	0.4	0.1	0.0	0.3	0.2	0.1	0.1	0.1	7.9	0.2	0.0	0.2	0.1	2.4	9.8	0.1	0.5	0.5	0.9	0.0	1.9	0.5	0.1	0.5	0.4	0.3	0.0	0.7	0.3	0.0	0.0	0.3	0.4	0.3	31.9	0.2	0.3	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.3	0.0	3.6	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	6.2	10.7	1.4	0.1	7.9	2.4	9.8	1.9	0.0	31.9	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.6	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.5	0.1	0.0	0.1	0.0	0.4	2.8	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.5	1.3	0.1	0.0	0.0	0.3	0.2	0.4	0.1	0.0	1.0	0.0	0.0	0.1	0.8	0.2	1.2	0.0	0.0	0.1	0.9	0.1	0.2
GSTO2		ENSG00000065621	"Glutathione S-transferase omega 2"	Q9H4Y5	10	104268873-104304950	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 133.1;Early spermatids: 314.6;Late spermatids: 442.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 16.9;CAPAN-2: 17.1;hTCEpi: 16.2;hTERT-HME1: 18.3;OE19: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA048141	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"			"HPA048141: AB_2680281"	"unprognostic (5.77e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.10e-7)"	"unprognostic (4.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.47e-1)"	0.5	3.5	5.0	0.3	5.7	2.0	5.2	3.4	5.3	4.3	0.4	4.4	2.8	2.2	4.9	11.8	4.3	1.2	0.6	4.4	4.1	14.0	2.8	2.4	0.3	2.2	2.5	5.4	16.7	5.0	14.6	1.0	2.6	8.3	3.1	6.0	7.5	3.2	1.4	14.8	3.5	1.2	1.1	0.5	10.9	35.9	4.3	2.2	7.0	1.3	0.7	3.8	7.5	5.3	10.2	1.4	0.5	0.6	0.6	1.3	1.4	9.6	16.9	4.7	4.9	0.6	17.1	1.6	4.0	0.8	0.5	10.7	0.5	5.3	1.2	1.1	3.2	0.5	3.1	2.4	2.1	0.7	0.7	1.7	16.2	0.3	18.3	1.3	0.8	1.7	1.5	2.9	1.3	12.3	0.1	0.5	1.7	22.1	1.1	0.5	0.7	0.3	4.6	6.5	0.6	1.1	3.3	2.4	2.9	0.8	12.6	0.3	2.4	1.5	5.1	0.6	0.5	2.8	6.4	0.4	1.5	0.8	0.5	0.2	0.1	0.7	0.5	0.2	0.3	0.3	0.5	0.3	0.0	0.5	0.7	0.4	1.7	1.0	0.1	0.3	1.2	0.2	5.0	5.7	3.4	5.3	4.4	4.1	2.2	2.5	2.6	1.1	4.3	5.3	3.6	3.2	21.0	13.1	1.3	34.2	62.1	94.5	50.1	19.0	61.7	78.2	3.0	21.5	46.4	40.5	16.7	14.4	3.8	12.8	133.1	30.6	314.6	26.9	7.6	5.4	54.2	3.6	33.9	63.3	9.9	4.7	31.6	37.6	2.5	3.3	15.7	3.6	1.8	0.0	28.7	34.0	50.8	1.6	3.7	442.8	2.8	2.7	17.8	1.9	2.1	11.1	1.0	24.1	20.1	31.6	29.1	9.8	0.9	25.6	27.1	43.8	31.2	23.0	6.6	3.1	7.4	22.0	8.9	46.0	47.3	6.7	4.3	11.6	40.7	58.0
GTF2F2	"BTF4, RAP30, TFIIF"	ENSG00000188342	"General transcription factor IIF subunit 2"	P13984	13	45120510-45284893	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006912	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Microtubules	"HPA006912: AB_1080256"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (3.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (6.44e-3)"	10.9	16.6	12.4	11.0	13.2	18.3	12.9	12.4	14.9	13.5	18.1	18.3	10.4	11.6	15.4	16.5	10.0	8.4	20.0	13.1	13.2	15.0	11.3	9.6	13.4	12.3	13.0	12.1	10.7	14.1	12.9	11.0	12.4	10.7	14.2	9.9	12.2	13.0	25.0	24.9	10.0	12.9	13.5	10.2	11.3	13.3	13.0	14.8	11.4	15.8	14.4	15.5	14.8	15.6	43.2	15.9	29.3	21.8	17.6	25.8	24.3	46.2	30.2	46.1	44.9	26.8	65.7	42.9	25.4	33.9	44.8	46.9	44.3	37.1	66.7	32.6	38.4	50.8	20.7	35.2	28.1	57.0	27.9	21.8	55.9	34.4	57.8	52.0	29.9	32.9	36.6	15.8	125.6	24.2	42.0	65.2	34.8	68.6	38.3	39.0	22.2	24.8	101.4	15.0	15.6	26.0	23.5	22.9	39.8	27.5	18.6	45.9	23.7	38.6	33.1	30.8	79.9	10.0	14.6	42.7	44.9	36.1	41.2	16.2	15.9	29.9	10.3	16.7	12.4	17.3	12.1	12.4	18.8	17.8	13.5	13.5	22.5	18.9	18.9	14.7	14.7	10.1	12.4	13.2	12.4	14.9	13.1	13.2	12.3	13.0	12.4	13.5	13.0	15.6	21.6	41.7	32.1	41.1	36.0	75.1	82.8	80.2	35.9	19.2	27.3	30.2	79.4	10.0	41.6	11.0	4.2	33.0	25.7	29.0	49.0	49.7	93.0	34.9	37.5	27.6	28.2	32.6	23.7	33.6	49.4	28.9	13.7	56.8	39.3	25.6	18.2	21.4	49.1	8.4	35.1	26.4	50.8	27.1	38.2	82.3	24.2	32.0	76.5	36.5	38.2	36.8	27.8	57.8	48.9	48.5	30.3	31.6	30.4	88.3	22.6	42.7	29.4	21.5	6.6	35.6	32.3	68.6	83.9	34.5	72.7	33.8	28.8	33.5	40.7	75.1
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	4.9	4.4	4.3	4.6	5.0	6.9	8.4	9.2	4.3	7.3	3.6	5.3	3.9	6.6	5.5	6.7	6.6	5.2	5.8	4.5	5.2	6.0	5.3	5.7	5.0	3.4	4.8	10.3	6.1	9.4	3.2	6.4	3.7	6.2	5.4	5.5	7.3	5.7	5.8	9.8	3.6	6.2	3.6	4.5	5.8	8.3	5.6	8.1	9.5	8.0	6.6	5.0	3.8	3.8	15.2	21.7	25.8	22.5	12.3	14.4	20.0	15.1	18.4	19.6	14.4	25.4	10.9	22.7	9.8	18.6	18.1	33.8	39.8	23.6	21.1	15.4	19.1	19.0	28.9	10.8	12.8	28.6	12.4	11.4	17.6	20.4	26.1	11.6	16.8	15.1	32.7	11.4	14.0	24.6	17.8	13.3	33.1	22.2	21.4	17.6	31.1	20.6	14.3	12.5	36.3	24.6	25.9	25.8	15.9	15.8	35.4	12.1	17.8	32.9	18.7	15.1	21.6	4.9	12.3	25.1	13.5	17.8	20.7	0.0	0.3	0.2	0.5	0.3	0.4	0.5	0.4	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.2	0.5	0.4	0.2	4.3	5.0	9.2	4.3	4.5	5.2	3.4	4.8	3.7	3.6	5.6	3.8	9.9	19.2	11.5	2.3	7.8	30.7	6.9	6.9	21.6	15.5	19.1	14.7	14.6	1.5	6.7	3.7	14.6	7.5	9.0	6.6	7.9	8.3	6.5	21.5	26.2	11.6	13.1	8.2	3.2	6.3	7.5	13.0	8.6	17.7	1.3	17.1	10.0	8.6	6.3	20.2	3.1	8.1	10.2	7.6	9.3	3.7	19.0	6.3	3.6	1.9	7.1	11.9	7.2	1.0	2.1	5.8	7.0	19.2	10.7	11.6	3.8	6.6	16.2	16.9	0.0	18.8	10.9	16.7	13.8	22.1	40.1	6.4	8.8	18.2	9.0	6.4
HIVEP1	"CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A"	ENSG00000095951	"HIVEP zinc finger 1"	P15822	6	12008762-12164999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050724, HPA067457"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Mitochondria, Cytosol"	"HPA050724: AB_2616457, HPA067457: "	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.65e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.38e-1)"	7.2	2.3	0.8	8.0	3.0	16.7	5.5	0.7	3.0	7.4	6.5	6.4	5.0	5.9	4.5	7.4	6.1	7.3	3.8	2.2	0.8	4.5	11.7	6.3	8.0	1.3	2.8	6.5	6.7	10.5	3.3	4.9	0.5	6.9	6.6	5.8	4.8	5.8	2.8	5.7	5.2	6.2	0.0	6.0	4.9	4.8	1.2	9.1	4.9	6.2	8.3	9.3	3.3	1.6	8.1	5.9	7.5	4.2	5.8	7.3	7.2	6.4	5.5	5.2	5.7	3.8	4.2	6.7	13.6	7.8	12.4	7.6	7.4	9.2	7.1	14.6	4.3	3.1	5.6	3.7	4.7	3.7	2.5	5.1	9.0	10.6	16.3	11.0	15.5	4.6	32.9	7.5	11.5	6.0	5.9	3.3	6.4	2.8	2.7	3.2	9.8	10.7	3.1	8.7	7.1	5.2	15.9	12.8	4.3	16.6	7.6	4.7	25.2	13.0	5.8	12.3	7.4	30.0	27.3	12.0	4.0	4.8	5.5	2.4	1.8	2.1	1.2	2.0	0.9	3.1	2.0	0.8	1.2	4.8	3.4	2.1	11.7	3.3	5.2	9.0	4.4	0.7	0.8	3.0	0.7	3.0	2.2	0.8	1.3	2.8	0.5	0.0	1.2	1.6	40.2	28.9	16.9	74.7	35.6	32.2	25.4	7.4	30.7	20.4	12.3	10.9	10.4	17.2	17.6	7.3	12.5	3.4	18.7	17.5	3.9	5.6	2.5	37.7	16.4	20.3	10.8	6.5	94.6	7.2	1.8	25.2	22.4	51.0	7.6	7.0	6.4	12.3	5.9	21.9	68.3	14.4	4.1	9.6	47.9	1.8	3.7	23.1	19.6	44.0	29.6	13.1	5.2	59.3	25.0	11.5	10.3	4.5	33.6	25.2	6.7	2.5	16.7	9.7	0.0	21.0	17.1	3.9	3.5	18.7	33.4	5.2	18.8	6.6	8.6	23.7
HIVEP3	"FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C"	ENSG00000127124	"HIVEP zinc finger 3"	Q5T1R4	1	41506365-42035925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.6"	"Group enriched"	"Detected in many"	5	"Astrocytes: 83.9;Excitatory neurons: 219.6;Inhibitory neurons: 271.9;Microglial cells: 163.9;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 196.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.8;hTEC/SVTERT24-B: 9.5;Karpas-707: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005728	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA005728: AB_10612117"	"unprognostic (2.87e-3)"	"unprognostic (2.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	1.6	0.6	0.8	2.1	2.1	1.6	1.4	1.4	1.6	0.4	0.0	0.5	0.4	0.4	0.3	1.9	0.5	0.7	0.8	2.0	0.0	1.0	0.3	1.9	1.7	0.7	0.4	0.5	0.8	0.4	2.1	0.6	1.0	1.4	0.5	0.6	1.6	0.3	0.6	4.6	0.6	0.8	0.1	1.1	0.7	0.3	0.5	6.6	1.5	0.4	2.1	1.8	0.5	0.3	1.9	0.6	0.2	1.8	2.2	1.0	0.0	0.9	0.2	2.3	4.0	0.1	0.3	4.0	0.6	1.0	1.5	2.7	0.4	0.4	3.1	18.8	0.5	0.2	0.9	0.0	0.4	0.3	0.3	5.6	0.4	9.5	1.1	0.6	0.5	1.3	0.0	11.0	1.8	1.2	3.0	0.8	0.6	0.6	2.3	2.0	2.9	2.2	1.5	0.4	2.0	0.6	2.6	0.7	0.5	1.1	0.9	3.4	3.4	2.0	2.2	0.6	4.6	3.3	1.4	2.6	8.1	0.2	7.5	0.0	0.5	0.0	0.6	1.1	0.1	0.1	0.2	0.3	0.4	0.4	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.4	0.8	2.1	1.4	1.6	2.0	0.0	0.7	0.4	1.0	0.1	0.5	0.3	5.9	6.4	10.5	83.9	9.6	23.7	26.5	4.3	17.6	16.4	15.1	11.0	6.9	5.7	8.2	1.8	2.1	0.4	17.6	3.5	1.9	3.1	9.9	1.2	7.7	7.5	3.6	4.4	219.6	2.7	4.4	11.1	1.5	2.8	1.3	0.2	11.4	2.5	6.2	25.2	271.9	1.2	2.0	6.5	17.3	31.9	8.7	15.0	5.4	163.9	9.1	16.0	27.8	83.9	196.0	3.1	0.1	4.1	3.3	15.5	1.9	3.2	1.1	3.5	6.6	23.9	7.4	11.3	8.6	23.7	8.7	0.8	14.5	10.0	0.9	11.1
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	P04439	6	29941260-29945884	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 3747.8;Proximal enterocytes: 5267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 1363.9;fHDF/TERT166: 360.3;HBEC3-KT: 366.7;RPMI-8226: 372.1;U-266/70: 344.6"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA		170000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	635.4	714.2	15.0	34.8	15.5	137.7	566.7	14.7	36.5	504.9	18.0	737.5	278.3	476.1	181.1	366.8	390.3	239.9	473.4	14.6	17.0	687.0	392.0	1007.3	132.0	19.1	15.8	338.8	200.0	18.5	406.5	52.1	16.5	370.9	94.6	9.9	364.1	1.2	246.5	673.3	959.1	14.5	16.8	1413.1	442.2	132.6	18.0	138.9	531.9	14.5	178.3	412.3	466.8	18.3	1363.9	35.0	0.0	0.0	205.9	193.7	1.4	1.4	2.5	2.1	2.3	0.2	0.1	4.0	0.6	360.3	179.1	31.2	0.2	366.7	0.5	3.1	13.5	237.5	9.5	7.4	11.2	0.5	14.4	2.0	0.0	2.5	1.1	0.6	0.2	177.8	0.4	1.4	0.5	0.0	1.1	24.3	2.9	0.2	4.1	27.5	2.5	372.1	246.7	276.5	0.6	12.4	29.3	0.2	11.8	82.8	1.6	30.4	5.8	18.7	0.8	5.8	4.0	344.6	92.6	77.7	0.4	199.9	0.2	321.6	119.0	182.7	164.7	95.5	134.8	96.9	125.4	146.3	18.6	64.3	86.5	119.2	248.7	133.1	109.6	54.6	222.2	191.9	15.0	15.5	14.7	36.5	14.6	17.0	19.1	15.8	16.5	16.8	18.0	18.3	1622.4	371.8	478.6	22.9	1316.2	856.4	886.2	1417.5	228.8	30.8	289.6	188.5	147.4	936.5	952.5	503.9	6.2	18.3	1879.4	2631.8	88.0	3747.8	52.2	239.4	374.0	1717.8	955.2	499.4	3.6	1310.0	18.5	743.5	853.7	556.2	603.0	253.3	1266.2	276.4	1840.9	37.0	19.3	1755.3	1265.4	1575.0	1124.0	95.6	704.6	1419.1	635.0	67.5	3258.0	170.4	3201.9	49.3	16.1	1802.9	2452.4	484.1	1110.7	1026.6	5267.3	294.9	609.6	24.4	558.8	397.3	579.2	197.4	23.8	216.5	947.7	31.7	2234.9	1021.3	1225.4	1262.8
HLA-B	AS	ENSG00000234745	"Major histocompatibility complex, class I, B"	P01889	6	31353872-31357188	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 2493.7"	"Cell type enhanced"	"Detected in all"		"monocytes: 5683.6;NK-cells: 7881.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 638.3;EFO-21: 547.1;U-266/70: 1285.6;U-698: 377.2"									CAB015418	Enhanced					NA	NA		190000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB015418: AB_831547"	"unprognostic (2.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.16e-3)"	"unprognostic (8.51e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.69e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.83e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-2)"	944.9	581.6	5.5	429.4	8.1	53.5	850.0	5.5	14.4	552.0	6.0	912.0	4.7	567.1	222.1	434.4	488.6	461.2	563.1	4.6	6.7	731.7	488.9	1646.3	1061.9	9.6	10.4	296.9	268.7	24.2	288.3	106.6	7.5	439.2	238.5	8.1	485.9	3.8	237.9	936.4	1295.6	75.4	7.7	2493.7	540.1	132.6	6.7	4.4	593.2	3.8	414.9	476.2	582.0	7.9	638.3	0.0	0.0	0.1	13.5	98.9	3.8	0.5	1.2	0.5	1.1	0.0	1.9	22.7	547.1	111.0	203.2	231.9	116.4	112.4	0.0	2.3	29.9	8.3	0.8	0.0	79.8	0.2	2.4	200.2	0.5	0.0	13.9	183.3	0.4	39.8	1.3	30.2	0.0	0.3	1.5	161.4	0.6	0.0	0.1	19.7	3.4	4.7	163.5	0.6	0.9	3.7	5.5	1.4	1.4	0.2	32.6	6.2	134.7	21.4	4.8	4.9	2.3	1285.6	291.0	377.2	1.1	6.5	0.6	141.1	196.5	232.6	233.0	163.6	215.7	162.4	194.8	198.8	150.8	113.0	150.9	212.0	420.5	179.3	123.6	127.3	213.1	400.2	5.5	8.1	5.5	14.4	4.6	6.7	9.6	10.4	7.5	7.7	6.7	7.9	2836.3	913.5	1007.9	14.0	2936.9	1165.9	761.2	1139.6	396.1	27.7	533.2	550.2	168.5	1382.6	948.3	388.1	6.2	31.4	3876.2	3264.3	68.4	4206.8	63.9	311.6	349.2	2480.7	836.0	550.3	1.4	1771.3	182.3	777.7	1044.4	773.2	620.5	212.5	2189.2	701.5	2602.0	60.6	3.4	2121.8	1129.1	4229.7	2158.6	65.7	644.9	2674.7	891.2	126.5	5683.6	209.2	7881.6	25.1	3.9	2085.3	2327.5	306.9	2983.6	993.4	4541.4	183.9	829.4	27.3	1314.8	356.3	729.7	652.9	91.6	360.3	1004.3	50.9	3661.2	1219.5	1527.4	1161.2
HLF	MGC33822	ENSG00000108924	"HLF transcription factor, PAR bZIP family member"	Q16534	17	55264960-55325187	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 122.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 120.7;Excitatory neurons: 77.5;Hepatocytes: 156.8;Horizontal cells: 92.5;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 53.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 163.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA068156: AB_2685963, HPA071210: AB_2686361"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	15.1	21.5	9.8	1.9	23.1	0.4	15.4	0.0	53.3	14.4	0.0	18.0	1.4	14.4	11.0	26.3	12.2	7.8	24.1	17.6	0.0	12.7	122.4	13.4	2.2	0.0	0.6	50.0	2.9	4.0	9.9	1.0	0.0	13.2	3.4	43.2	24.1	12.4	7.7	16.7	4.3	12.3	0.0	8.2	6.1	4.1	3.9	3.4	34.3	9.9	7.7	12.3	7.8	17.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.9	0.5	0.0	0.0	0.0	0.4	0.2	0.0	27.3	0.7	0.0	0.1	163.0	0.1	0.9	0.2	0.1	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.6	1.1	0.0	0.1	0.0	2.4	0.0	0.4	0.4	13.0	0.1	11.1	0.6	0.0	7.2	0.2	0.0	0.2	0.0	0.1	0.8	0.2	0.6	0.5	5.1	4.9	0.0	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.8	23.1	0.0	53.3	17.6	0.0	0.0	0.6	0.0	0.0	3.9	17.2	13.8	3.2	42.8	22.2	0.4	22.3	4.4	1.4	56.9	120.7	5.9	16.4	38.6	12.8	6.3	7.3	10.4	0.1	0.5	0.0	11.7	1.9	1.3	0.1	6.2	19.7	3.0	0.8	77.5	0.9	0.0	17.6	0.0	0.6	0.0	0.5	6.1	156.8	0.1	92.5	36.6	0.6	0.0	3.5	4.0	4.7	28.3	0.7	10.6	74.0	0.1	60.7	0.0	24.6	6.9	0.4	0.0	39.1	1.5	1.3	2.8	23.3	1.0	15.0	13.1	4.5	7.4	0.4	5.0	33.7	27.6	1.2	3.8	0.5	0.4	0.4
HMCES	"C3orf37, DC12, SRAPD1"	ENSG00000183624	"5-hydroxymethylcytosine binding, ES cell specific"	Q96FZ2	3	129278828-129306186	"Predicted intracellular proteins"	"DNA damage"	"DNA-binding, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 124.9;Spermatocytes: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044968	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA044968: AB_2679160"	"unprognostic (9.18e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.16e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.08e-3)"	35.8	22.0	27.6	37.3	32.5	37.8	32.9	26.6	32.4	25.8	22.4	36.1	29.4	24.0	23.0	41.7	27.0	21.1	40.3	29.8	30.1	27.4	53.7	27.1	99.7	27.3	27.6	28.3	15.3	68.9	22.2	20.9	27.6	24.6	30.9	27.7	26.8	26.2	57.7	35.5	28.8	23.2	26.4	29.8	26.4	39.9	32.5	57.1	22.4	48.5	131.0	28.5	28.8	27.1	149.4	66.2	74.4	85.9	90.6	37.8	66.8	51.2	41.5	73.1	56.6	105.0	67.9	286.0	53.9	46.9	57.2	106.3	94.8	110.8	83.7	58.0	51.2	59.7	52.7	76.0	38.8	52.1	41.9	36.7	56.6	61.1	60.2	35.6	45.5	63.5	61.2	244.2	40.9	197.3	74.8	45.1	48.4	108.5	42.8	66.6	63.8	50.5	77.0	88.8	74.0	45.6	114.4	70.8	70.6	45.6	121.0	52.1	36.8	36.3	63.7	87.3	66.5	135.8	87.2	289.3	43.4	41.9	41.1	35.5	25.5	65.0	30.4	27.4	31.6	37.5	36.7	36.3	26.3	62.1	36.1	40.0	52.5	27.2	40.9	28.1	48.0	31.2	27.6	32.5	26.6	32.4	29.8	30.1	27.3	27.6	27.6	26.4	32.5	27.1	26.1	32.1	25.6	11.4	23.5	58.2	71.2	72.4	54.7	21.5	18.8	16.1	35.6	30.0	30.4	22.0	10.4	49.2	32.0	30.8	37.2	39.6	8.6	16.0	10.2	27.8	21.0	28.2	13.6	47.0	37.6	23.3	17.9	15.7	22.2	11.0	20.7	26.1	19.7	26.9	14.7	17.3	32.6	8.1	39.4	8.6	24.5	15.7	58.7	10.3	16.4	38.6	25.7	7.1	10.6	33.8	16.9	31.2	124.9	37.3	19.9	21.1	25.2	12.5	13.1	21.0	27.1	127.8	83.6	30.7	43.9	35.0	47.3	23.9	30.7	61.0
HNRNPAB	"ABBP1, FLJ40338, HNRPAB"	ENSG00000197451	"Heterogeneous nuclear ribonucleoprotein A/B"	Q99729	5	178204533-178211163	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046688	Approved		Enhanced	Nucleoplasm		NA	NA		460000	"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA046688: AB_10964924"	"unprognostic (2.23e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.17e-3)"	"prognostic favorable (9.79e-4)"	"unprognostic (9.12e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.08e-1)"	86.7	103.2	33.2	92.5	34.9	139.7	63.9	35.6	37.0	66.0	37.3	144.7	98.2	75.5	43.8	122.0	64.4	51.1	83.1	32.4	39.1	91.9	88.3	69.1	95.7	36.9	35.4	56.7	55.4	76.2	46.2	64.0	36.9	59.8	119.0	27.1	68.1	54.0	119.0	115.4	88.9	74.4	35.5	79.9	85.5	38.2	36.9	117.0	52.0	58.7	102.7	122.3	72.7	38.5	347.4	282.5	424.1	414.7	153.8	134.6	613.2	378.5	174.3	296.9	317.2	525.4	251.8	555.2	340.3	204.7	361.1	223.2	373.1	516.7	363.8	865.9	439.5	349.8	223.7	325.1	153.7	446.1	285.6	134.0	239.2	267.3	266.8	122.3	270.3	218.4	290.1	245.7	302.0	934.2	542.6	429.7	389.5	354.0	401.7	436.3	255.6	329.8	254.2	364.8	389.5	302.4	295.2	407.9	278.8	264.0	244.7	270.7	244.0	359.7	305.2	256.2	527.8	285.4	360.2	649.3	145.2	488.2	298.8	3.2	4.4	15.7	5.1	7.0	5.7	5.9	4.1	6.0	4.4	5.2	3.9	4.7	0.8	5.8	7.5	10.9	4.8	2.2	33.2	34.9	35.6	37.0	32.4	39.1	36.9	35.4	36.9	35.5	36.9	38.5	124.7	32.1	41.0	4.6	115.4	281.6	212.1	42.7	243.0	26.5	129.6	141.3	45.9	41.5	42.7	49.7	18.8	106.3	148.5	251.2	50.9	118.9	9.3	112.4	225.6	107.1	119.2	273.2	3.5	151.7	208.9	110.1	167.7	124.7	44.5	102.0	53.6	101.2	101.0	16.8	4.3	219.0	48.8	67.0	129.9	11.1	74.0	109.9	67.6	8.4	56.2	34.7	76.2	3.5	6.1	204.2	138.2	88.0	179.6	275.0	90.5	116.8	25.8	28.3	78.9	149.7	173.6	81.6	122.4	362.5	339.8	114.4	129.7	238.1	247.9	235.5
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836370-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm		NA	NA		420000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905"	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	112.5	108.5	43.8	69.7	46.1	195.1	110.3	49.4	47.4	114.0	42.9	115.2	72.7	119.9	48.0	134.4	97.6	37.4	100.2	41.8	44.5	96.6	98.8	117.7	84.2	47.0	42.9	103.8	87.5	67.7	70.6	57.6	47.5	81.5	76.4	53.2	99.8	45.7	125.7	142.3	113.4	79.9	47.2	113.5	104.3	83.7	46.9	128.8	101.7	57.3	114.5	101.9	111.6	59.4	293.6	214.8	256.4	157.9	94.8	108.7	257.7	233.3	138.9	187.1	177.4	229.9	189.7	436.8	196.2	130.5	152.1	167.0	299.6	228.9	270.7	354.4	231.0	349.9	128.3	205.9	101.2	334.0	228.2	122.7	106.9	187.1	182.1	108.8	209.4	186.7	353.7	200.0	197.6	216.0	347.7	202.9	307.6	186.6	185.6	440.8	296.4	271.7	212.1	203.8	218.6	226.0	225.1	157.7	90.0	172.2	213.4	176.7	207.1	194.9	238.1	184.2	349.4	224.0	312.5	473.1	128.4	293.1	220.0	1.2	1.9	1.2	2.6	3.0	2.0	1.7	2.0	1.7	2.6	2.2	2.0	1.7	1.9	1.8	2.5	5.1	2.6	1.1	43.8	46.1	49.4	47.4	41.8	44.5	47.0	42.9	47.5	47.2	46.9	59.4	62.2	22.4	53.8	40.1	105.1	35.4	52.1	18.0	135.5	76.7	63.6	47.6	22.9	31.5	29.1	22.0	64.6	42.9	100.0	59.0	7.9	37.4	15.9	61.2	64.8	48.7	62.9	83.3	38.0	44.1	35.3	57.0	91.7	88.4	39.3	33.8	43.5	63.0	27.4	33.7	39.0	70.4	12.2	63.7	35.1	11.7	28.3	60.3	26.6	31.9	42.4	39.0	48.4	31.2	56.3	44.1	45.6	22.6	123.0	55.6	55.4	23.9	25.5	78.7	19.7	64.1	59.0	25.5	22.1	117.6	47.5	52.3	95.0	42.4	70.2	41.9
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.4"	"Group enriched"	"Detected in all"	6	"Early spermatids: 309.7;Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	6.1	4.9	4.6	4.7	6.2	1.5	6.7	5.9	5.8	6.5	4.0	6.7	7.3	5.3	8.0	9.8	7.0	5.2	7.8	4.8	5.5	9.4	6.2	6.1	4.6	6.8	5.5	9.9	7.8	8.8	3.6	5.7	6.3	6.5	6.2	6.0	7.0	9.6	9.0	7.7	5.0	7.2	4.9	5.6	7.8	34.4	6.7	9.4	7.3	14.9	7.9	10.9	5.7	6.4	7.0	7.2	13.0	12.3	19.8	8.7	14.8	7.2	9.4	6.8	8.7	3.3	14.6	15.2	6.1	7.1	16.0	23.3	17.3	18.0	8.5	8.4	6.6	5.2	6.0	14.1	25.8	7.6	4.4	13.5	17.7	5.4	11.8	15.1	13.1	17.0	15.6	6.0	11.8	16.1	5.9	5.2	5.3	21.3	4.1	9.2	9.7	6.7	12.5	28.5	4.2	5.2	6.9	19.3	7.8	19.7	12.0	8.9	14.6	4.7	2.1	5.9	3.3	25.1	11.3	5.0	2.5	5.5	7.2	2.9	5.0	7.3	3.5	4.5	2.8	2.6	3.0	2.9	4.8	2.3	3.2	3.9	0.8	2.4	3.4	2.9	4.1	2.9	4.6	6.2	5.9	5.8	4.8	5.5	6.8	5.5	6.3	4.9	6.7	6.4	3.7	6.4	7.0	4.6	5.6	2.8	18.4	19.9	9.1	5.8	7.0	5.7	6.9	12.8	14.4	23.9	6.2	6.9	4.6	6.8	13.7	11.0	309.7	4.4	4.2	5.7	3.6	5.0	1.9	10.9	6.6	5.2	13.7	6.9	3.8	8.2	5.3	6.9	8.7	10.1	2.0	9.2	8.2	6.1	5.1	78.9	6.8	5.8	3.6	6.5	15.1	6.9	5.2	3.0	6.8	9.1	5.5	7.5	6.1	16.3	8.6	19.8	12.9	3.7	6.6	4.7	4.7	15.2	5.3	10.1	5.1	9.3	4.2	3.8	7.9	29.1
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162438-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Endometrial stromal cells: 31.1;Enteroendocrine cells: 39.4;Proximal tubular cells: 75.1;Suprabasal keratinocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 6.7;myeloid DC: 5.6;NK-cell: 11.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.6;granulocytes: 6.7;NK-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 124.4;PC-3: 43.9;RPTEC TERT1: 42.0;SCLC-21H: 113.4;U-937: 42.3"	"Not detected"	"Not detected"							"HPA061982, HPA076200"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA061982: AB_2684651, HPA076200: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	4.7	5.9	0.0	2.8	0.0	2.5	6.9	0.0	0.2	12.7	0.0	22.0	0.0	17.0	5.6	1.0	19.6	0.0	0.0	0.0	0.0	28.4	0.0	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.1	14.1	3.9	0.0	0.0	4.5	16.1	25.7	14.8	1.9	0.2	0.9	0.2	0.0	0.0	1.9	0.1	0.0	0.0	16.8	13.8	0.2	37.7	0.0	0.0	18.4	6.0	4.4	0.0	14.6	11.7	1.2	1.2	2.4	1.4	0.3	1.4	7.9	0.0	34.7	23.5	0.0	1.2	0.0	124.4	0.3	1.1	0.0	0.6	0.0	0.5	6.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	43.9	8.1	0.0	0.0	42.0	0.7	113.4	0.0	15.6	0.0	0.3	0.6	0.0	31.3	1.4	0.0	11.4	14.0	0.2	0.0	0.0	0.0	0.0	42.3	0.0	6.7	0.8	0.0	1.3	0.2	0.2	0.1	0.0	0.1	5.6	0.9	0.2	0.0	0.8	11.5	0.3	1.8	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	6.2	0.0	0.0	0.0	2.0	25.1	14.9	0.0	3.4	0.0	12.2	14.7	0.5	0.0	0.0	18.4	0.0	0.2	2.9	10.5	54.8	0.0	0.0	1.0	31.1	4.3	39.4	16.6	0.0	0.0	0.3	4.8	0.0	0.6	0.0	0.0	0.7	0.0	0.3	0.0	0.0	21.7	0.0	3.4	4.2	0.0	0.0	1.9	5.4	0.0	0.8	0.0	2.1	0.0	0.0	0.0	20.2	0.0	0.9	19.4	13.3	75.1	0.0	0.0	0.0	3.0	4.6	0.0	1.0	2.6	27.6	0.3	2.2	0.3	21.4	14.2
HS3ST6	HS3ST5	ENSG00000162040	"Heparan sulfate-glucosamine 3-sulfotransferase 6"	Q96QI5	16	1911475-1918415	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 75.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 10.7;Horizontal cells: 21.9;Suprabasal keratinocytes: 9.1;Urothelial cells: 24.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"A549: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (5.72e-2)"	"prognostic favorable (3.73e-4)"		"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"		"unprognostic (1.19e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.99e-3)"		"unprognostic (2.10e-2)"		"unprognostic (6.55e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.26e-1)"	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.5	0.0	0.0	0.0	14.4	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	1.4	0.0	0.0	1.9	0.0	0.3	75.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.1	4.1	10.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	3.4	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.7	1.8	0.0	0.2	0.0	6.3	0.0	0.0	4.5	10.7	0.5	0.1	0.0	0.0	0.1	0.0	0.4	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	21.9	0.1	0.9	4.1	0.0	1.5	1.4	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.0	0.0	2.7	0.2	0.2	5.0	0.2	0.0	0.0	0.3	0.0	0.0	4.5	9.1	0.1	0.1	0.0	1.7	24.9
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204655-33206831	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 125.2;Proximal tubular cells: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 79.5;T-47d: 62.0;U-266/70: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		97000	"Cluster 35: T-regs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	9.6	24.6	10.1	6.5	10.5	9.7	17.0	9.9	11.3	13.7	10.9	18.0	19.7	7.2	29.4	25.5	23.6	7.9	20.3	9.6	10.8	30.7	67.4	11.2	10.5	11.3	11.9	8.6	55.3	42.2	14.1	5.6	12.3	11.3	16.2	11.8	25.1	16.5	20.8	25.9	18.8	7.3	11.4	12.1	15.1	5.9	10.8	13.3	32.9	25.0	15.1	9.8	12.8	11.3	7.0	15.0	6.8	9.3	2.3	4.4	1.3	0.8	4.7	0.1	0.1	5.8	17.5	45.4	11.2	1.2	2.2	29.1	7.2	11.7	1.0	8.6	0.0	2.6	14.0	27.1	20.0	0.0	3.8	5.0	28.9	0.2	49.4	0.4	2.1	13.6	0.3	46.2	4.1	9.4	31.2	1.3	2.1	23.3	2.9	11.0	1.2	79.5	27.8	1.3	12.1	7.6	2.9	34.3	7.6	4.6	62.0	1.8	1.3	0.7	7.3	0.6	0.4	65.5	42.4	16.6	3.1	1.0	1.7	0.1	5.8	2.0	18.7	13.4	30.0	16.6	24.0	29.2	11.6	13.1	26.4	28.5	0.7	16.8	14.6	20.8	21.8	26.7	10.1	10.5	9.9	11.3	9.6	10.8	11.3	11.9	12.3	11.4	10.8	11.3	12.5	19.2	21.6	3.3	18.6	29.7	28.3	55.0	21.6	12.4	31.3	34.8	31.8	48.6	25.9	22.0	6.2	29.9	9.7	21.2	125.2	27.9	6.3	20.0	6.0	10.1	18.0	12.8	0.3	32.4	12.9	9.1	16.3	13.7	7.0	9.8	10.0	83.2	17.4	1.7	0.5	26.6	20.3	10.3	16.4	18.1	7.5	7.9	49.8	1.0	8.1	32.6	6.2	1.0	0.7	21.9	21.1	6.0	47.6	15.4	74.8	137.2	33.3	14.8	0.0	11.3	9.8	8.1	8.5	40.0	37.2	17.4	18.0	29.8	44.4	31.5
IFNLR1	"CRF2/12, IFNLR, IL-28R1, IL28RA"	ENSG00000185436	"Interferon lambda receptor 1"	Q8IU57	1	24154168-24187959	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 17.4;Proximal enterocytes: 18.2;Urothelial cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 4.9;naive B-cell: 5.9;plasmacytoid DC: 11.3"	"Group enriched"	"Detected in many"	5	"B-cells: 5.9;dendritic cells: 11.3"	"Cell line enhanced"	"Detected in many"		"U-266/70: 51.4;U-266/84: 19.4;U-698: 40.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA017319	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA017319: AB_1851708"	"prognostic favorable (5.12e-4)"	"unprognostic (7.16e-2)"	"unprognostic (8.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.66e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-1)"	0.4	2.2	1.1	2.8	1.2	0.6	2.6	6.2	1.1	1.7	2.2	3.8	5.8	0.9	1.9	3.6	1.8	2.1	3.1	0.8	2.6	3.0	8.4	2.9	7.8	2.5	2.2	1.3	5.0	5.2	5.9	0.3	2.5	3.4	4.0	1.8	4.5	2.1	3.6	7.3	9.2	0.4	1.9	2.8	2.9	1.0	2.7	1.4	4.4	1.3	9.7	2.1	2.3	2.7	6.7	1.3	0.0	0.0	0.0	0.0	1.6	0.0	0.6	1.2	1.0	11.3	1.9	14.3	15.1	0.0	5.4	5.0	6.6	11.6	0.9	3.0	3.5	0.0	2.3	3.4	0.0	0.0	0.0	0.0	3.8	0.3	3.5	2.5	0.0	2.9	0.3	0.0	0.0	1.6	0.2	0.4	14.0	0.5	4.1	0.1	0.0	1.2	2.6	2.8	2.0	1.3	3.5	2.0	1.4	2.4	2.7	0.1	0.0	0.0	2.7	0.0	0.1	51.4	19.4	40.8	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	4.9	0.3	1.4	0.0	5.9	0.5	1.4	0.0	0.0	0.0	11.3	0.3	0.5	1.1	1.2	6.2	1.1	0.8	2.6	2.5	2.2	2.5	1.9	2.7	2.7	0.5	0.0	4.8	2.3	5.9	11.1	10.0	4.1	12.5	3.4	1.4	3.2	3.5	2.8	2.3	1.8	0.0	0.6	5.3	17.4	3.9	2.9	2.2	3.4	0.2	0.5	0.0	0.0	2.2	2.3	1.0	0.8	3.1	2.7	0.0	1.5	0.0	8.4	2.3	0.0	2.8	4.1	0.0	0.8	1.9	4.3	0.3	3.0	0.0	2.8	5.5	2.9	0.0	0.5	0.1	2.4	6.1	0.0	12.5	4.3	18.2	2.3	5.1	2.3	0.0	0.0	0.6	0.0	0.7	8.3	12.6	0.3	2.2	0.1	3.3	17.2
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	"Inhibitor of nuclear factor kappa B kinase subunit epsilon"	Q14164	1	206470476-206496889	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 47.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015788, CAB025983"	Approved		Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB025983: , HPA015788: AB_1851566"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.78e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (1.48e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.84e-2)"	2.4	3.7	2.6	16.7	4.6	8.7	3.1	2.0	3.2	4.1	1.9	7.8	7.4	1.7	3.9	14.6	2.8	5.1	1.4	2.7	3.3	3.4	1.6	4.1	24.3	4.1	3.6	1.2	3.4	1.0	1.9	2.6	3.9	3.6	7.7	0.1	6.9	2.1	0.5	15.0	8.0	2.5	2.7	14.2	7.2	0.7	4.4	16.5	4.5	0.3	20.4	8.4	6.8	4.6	17.8	13.9	3.7	0.4	6.7	9.2	3.9	7.1	22.3	9.4	10.4	11.5	26.9	35.3	18.6	14.5	11.5	23.0	0.1	18.1	2.2	5.5	3.5	4.7	8.8	7.6	8.4	29.5	14.8	12.2	3.2	7.7	1.7	10.9	14.2	9.4	2.3	10.0	10.5	3.6	19.2	47.7	5.2	4.3	10.9	9.7	4.3	27.7	10.7	29.4	0.0	0.0	2.9	22.9	4.2	4.5	13.8	20.3	26.5	9.0	5.5	6.9	8.5	3.5	1.8	23.3	17.1	24.2	3.7	12.2	32.8	0.6	21.2	23.3	14.8	26.4	32.4	30.1	9.5	14.0	25.7	27.3	2.2	23.9	13.4	3.2	52.8	28.6	2.6	4.6	2.0	3.2	2.7	3.3	4.1	3.6	3.9	2.7	4.4	4.6	0.4	0.0	4.5	0.7	13.7	1.9	3.6	37.8	1.8	0.0	4.3	3.7	0.9	4.3	16.3	0.0	0.0	4.2	7.9	11.7	0.0	12.1	3.3	1.5	0.9	0.7	3.6	4.4	1.5	12.6	5.2	3.4	17.3	2.4	5.1	3.7	2.2	0.8	13.8	0.0	1.5	6.4	8.2	12.9	0.7	7.0	0.9	16.0	7.2	1.9	9.0	0.0	14.4	1.0	0.2	15.9	21.5	0.7	6.4	3.2	10.7	3.5	14.5	0.0	0.0	0.7	3.1	0.3	0.9	11.1	4.8	1.5	15.8	3.9	10.2	11.6
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 110.7;skin 1: 163.3;vagina: 66.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 36.8;Basal respiratory cells: 115.8;Basal squamous epithelial cells: 60.9;Club cells: 43.0;Early spermatids: 57.0;Late spermatids: 28.8;Squamous epithelial cells: 56.5;Suprabasal keratinocytes: 38.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 86.0;HBEC3-KT: 140.0;HHSteC: 91.8;hTCEpi: 555.6;hTERT-HME1: 102.6"	"Not detected"	"Not detected"							HPA063914			Approved	Vesicles,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Cytosol	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	2.3	0.2	0.1	0.0	0.2	0.0	10.3	0.1	0.6	24.3	0.1	0.6	0.0	0.2	0.0	110.7	0.4	0.0	0.6	0.1	0.1	0.2	5.4	0.5	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.4	0.2	2.2	0.5	0.0	13.6	0.2	1.0	163.3	0.4	0.0	0.1	0.3	0.5	3.7	0.2	2.0	0.5	0.9	9.5	1.3	66.2	0.2	27.2	0.0	0.1	0.4	15.4	64.9	2.6	0.6	1.8	0.3	1.2	2.7	3.4	0.2	14.9	9.7	1.0	86.0	0.0	140.0	0.7	0.4	0.0	0.3	19.5	0.0	91.8	0.2	0.2	11.5	555.6	4.5	102.6	0.7	0.1	0.1	0.3	0.1	0.0	0.0	0.6	0.0	0.4	2.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	54.6	0.0	2.8	4.7	0.5	0.9	0.0	0.2	1.8	0.5	0.5	0.1	0.2	0.2	8.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.7	0.0	0.0	0.7	0.0	36.8	1.7	115.8	60.9	0.0	0.3	0.5	0.4	0.0	43.0	0.0	0.0	1.7	0.8	0.8	0.0	0.9	57.0	0.7	0.4	0.9	0.0	0.0	1.0	0.2	1.4	3.9	0.0	0.8	0.0	0.2	0.0	2.2	0.4	0.0	1.2	0.7	10.2	0.3	6.6	28.8	0.3	0.6	3.6	1.0	1.7	0.0	1.0	1.0	0.2	1.0	0.1	0.7	0.4	1.3	0.2	0.3	5.5	0.0	0.0	0.6	3.6	1.7	1.9	56.5	38.1	1.6	0.6	0.2	0.5	5.3
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030877	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 359.1;skeletal muscle: 257.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 440.3;Extravillous trophoblasts: 272.2;Proximal tubular cells: 498.6;Squamous epithelial cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 26.0;neutrophil: 31.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 9.0;granulocytes: 31.3;monocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 258.2;OE19: 299.8;SiHa: 155.1"	"Low region specificity"	"Detected in all"							HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	19.8	11.1	2.5	12.3	3.2	31.5	14.8	1.8	4.4	31.0	5.3	50.0	22.4	16.2	1.7	131.2	16.3	19.9	29.5	2.5	2.4	129.4	47.4	23.2	5.7	2.2	2.4	7.8	359.1	5.3	11.1	22.0	2.1	13.7	30.7	0.8	31.0	5.9	257.1	150.0	29.2	15.6	2.3	19.0	53.7	2.9	2.6	5.0	17.4	89.8	7.3	61.0	50.8	2.3	29.3	41.7	11.3	20.4	14.1	10.5	258.2	7.2	18.4	2.9	4.2	35.4	21.7	6.1	17.4	10.1	24.1	19.8	13.2	6.9	0.8	33.5	22.5	0.0	56.0	30.6	8.3	47.5	2.3	23.9	36.3	10.0	5.2	8.5	3.9	30.7	7.4	0.0	10.7	31.8	19.4	27.1	40.5	299.8	42.7	36.0	29.6	28.6	122.1	15.6	15.0	0.3	155.1	35.8	16.2	14.5	33.3	58.5	0.0	5.6	11.5	73.7	7.3	24.5	66.3	17.9	24.0	31.7	9.6	9.4	11.4	26.0	0.7	8.7	0.3	1.5	0.7	0.2	9.0	0.3	0.3	0.5	31.3	0.1	5.8	6.7	1.1	3.1	2.5	3.2	1.8	4.4	2.5	2.4	2.2	2.4	2.1	2.3	2.6	2.3	9.2	19.2	32.7	17.6	7.8	105.5	22.7	32.1	159.4	0.7	16.8	20.2	11.6	72.9	16.1	22.0	0.0	52.5	5.8	72.9	440.3	83.4	2.8	5.7	20.2	6.9	17.5	15.3	4.7	110.6	272.2	16.1	65.2	30.4	2.5	13.4	10.0	66.8	42.5	0.0	1.8	90.2	65.1	37.7	17.0	7.1	4.7	34.2	14.2	5.6	25.5	22.3	2.1	0.5	0.5	56.1	50.1	3.8	8.6	42.9	36.9	498.6	12.3	1.0	105.2	16.0	27.6	0.8	10.1	202.1	141.4	106.3	6.1	14.0	84.4	52.8
INO80C	"C18orf37, FLJ38183, hIes6, IES6"	ENSG00000153391	"INO80 complex subunit C"	Q6PI98	18	35452230-35497979	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 184.7;Pancreatic endocrine cells: 165.1;Spermatocytes: 209.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049060	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA049060: AB_2680617"	"unprognostic (3.40e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (5.56e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.14e-3)"	"unprognostic (5.38e-2)"	18.0	17.4	23.2	14.5	24.4	46.2	16.0	24.9	23.7	18.4	30.9	21.1	18.4	12.0	13.6	45.7	13.7	13.0	25.6	23.2	31.1	21.8	19.2	17.5	26.2	22.2	23.1	9.8	13.3	8.0	29.2	20.7	24.2	13.9	21.8	33.6	20.7	9.2	42.4	40.5	18.6	11.0	21.0	31.2	30.4	92.2	31.5	21.9	15.2	30.7	29.2	21.4	20.8	23.6	46.5	30.1	27.1	14.9	9.5	23.6	29.7	17.5	13.2	27.3	36.5	37.5	38.7	77.4	36.6	11.9	41.6	31.3	52.4	112.7	24.8	22.9	28.3	97.8	36.0	40.7	21.0	57.4	60.1	10.7	31.9	70.7	37.9	33.7	80.0	32.3	30.4	27.8	44.7	49.3	36.4	48.5	34.6	32.2	18.0	28.5	19.2	26.5	58.4	58.9	37.3	25.8	27.9	31.6	23.4	41.8	31.5	46.1	51.5	30.9	13.5	24.0	32.3	24.1	28.4	137.8	25.2	52.7	19.2	21.3	14.8	35.6	12.3	20.6	12.2	24.9	17.0	16.3	22.2	17.8	17.2	14.2	23.0	12.4	18.3	33.5	21.7	11.8	23.2	24.4	24.9	23.7	23.2	31.1	22.2	23.1	24.2	21.0	31.5	23.6	40.2	6.4	10.1	5.9	19.5	24.0	22.1	72.3	18.8	4.4	16.3	15.2	17.8	18.6	31.6	12.9	4.2	59.8	14.0	81.4	31.3	43.9	184.7	16.7	6.6	30.5	15.0	29.0	15.6	40.0	105.1	14.1	41.8	14.4	20.3	9.0	22.1	16.6	52.2	5.0	11.3	20.4	36.7	17.9	15.0	49.6	6.2	16.4	23.2	6.5	14.1	22.8	14.4	9.0	10.9	165.1	76.0	7.2	26.4	20.7	48.8	80.9	31.5	14.1	0.0	18.5	15.6	209.0	40.3	35.3	39.9	73.2	16.4	11.9	35.9	34.7
IRX5	IRX-2a	ENSG00000176842	"Iroquois homeobox 5"	P78411	16	54930865-54934485	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Vision"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.0;skin 1: 16.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 40.3;Breast myoepithelial cells: 55.5;Granulosa cells: 43.8;Muller glia cells: 43.1;Squamous epithelial cells: 33.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.1;T-47d: 36.6;THP-1: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047130			Approved	"Nuclear speckles,Microtubules,Cytosol"		No	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"	"Microtubules, Cytosol"	"HPA047130: AB_10962983"	"unprognostic (2.63e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.38e-3)"	"prognostic favorable (4.59e-4)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.28e-2)"	1.7	0.6	1.3	0.0	1.5	0.0	14.0	4.1	0.4	1.8	0.3	0.2	0.0	0.1	0.0	7.2	0.2	0.1	9.8	0.3	1.9	6.9	0.0	6.4	0.0	3.6	4.1	0.3	0.1	0.3	0.4	0.0	3.1	3.4	0.0	1.3	10.2	0.2	1.4	16.9	0.0	0.0	3.6	0.0	2.6	0.7	4.6	0.3	0.1	1.1	0.0	0.6	5.9	3.5	0.8	0.5	8.6	3.2	3.1	0.6	0.4	3.3	8.2	1.1	0.8	1.9	0.8	0.0	0.7	4.5	0.3	8.4	3.0	3.6	0.6	6.0	4.1	0.9	3.4	0.0	0.1	2.0	3.3	0.8	15.1	5.4	2.3	1.5	0.0	4.8	0.5	0.0	6.2	3.3	9.6	12.3	0.1	1.3	2.4	5.0	4.4	0.5	27.1	0.2	2.9	3.0	1.4	7.3	3.9	0.0	36.6	20.2	0.5	5.9	0.2	4.2	1.3	3.6	2.3	2.9	9.6	3.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	4.1	0.4	0.3	1.9	3.6	4.1	3.1	3.6	4.6	3.5	2.4	9.6	21.9	0.0	0.1	8.3	9.7	6.7	15.9	8.6	40.3	55.5	11.1	0.0	15.4	0.0	0.0	0.2	1.0	0.2	0.0	0.3	1.0	9.6	1.2	1.6	0.0	0.0	0.0	0.6	0.0	5.3	7.7	12.2	0.0	43.8	0.0	0.0	0.2	1.7	0.0	0.8	4.1	0.0	2.7	2.4	0.0	0.6	5.4	0.0	0.0	43.1	0.0	0.0	0.0	2.9	0.3	0.0	0.3	4.8	0.0	1.5	13.0	1.9	0.0	8.3	5.2	0.7	2.8	33.9	8.0	0.0	0.4	0.0	0.5	8.5
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246069-15522042	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 195.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 34.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 73.8;SuSa: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	7.3	4.7	6.7	9.2	7.1	57.8	6.0	23.6	8.7	5.3	3.7	5.0	5.7	5.0	6.7	13.7	3.9	4.4	6.4	7.5	6.2	4.1	3.6	7.2	9.0	7.1	6.8	5.7	3.5	3.6	4.4	7.1	7.8	4.5	4.6	20.0	6.4	3.3	11.8	13.4	6.8	4.1	5.2	10.6	7.0	16.0	8.0	20.0	3.8	4.3	9.8	5.8	6.8	8.2	12.4	8.5	34.0	19.6	4.1	4.0	33.5	3.5	8.3	4.5	5.5	8.8	9.4	6.5	12.3	7.1	6.8	6.3	8.0	20.1	4.1	13.0	12.4	23.3	10.6	11.6	4.6	23.9	26.3	5.7	12.3	6.6	26.2	13.4	4.7	73.8	30.5	10.8	2.7	12.6	47.6	44.6	36.4	6.1	3.8	20.9	10.4	18.6	4.2	13.0	26.2	15.0	7.3	24.9	32.1	78.1	8.7	25.0	8.5	20.6	11.4	11.5	12.3	6.9	17.8	11.7	7.0	21.9	26.6	10.1	3.8	3.2	3.4	2.4	2.9	2.5	1.6	2.1	3.1	3.4	2.1	2.9	13.2	4.9	2.7	4.4	1.4	2.1	6.7	7.1	23.6	8.7	7.5	6.2	7.1	6.8	7.8	5.2	8.0	8.2	30.1	6.4	12.8	175.3	40.7	80.4	10.7	23.0	31.9	74.2	28.3	23.1	10.5	15.7	17.1	5.5	87.6	27.0	62.9	10.0	1.9	8.2	89.2	30.7	18.0	27.1	26.8	50.9	125.9	4.4	25.0	17.6	19.9	77.5	25.3	14.8	15.7	13.8	24.0	154.8	124.4	16.4	16.2	61.3	195.0	40.8	8.7	89.5	26.6	97.4	49.1	134.0	54.6	136.7	136.6	15.6	9.3	8.6	34.9	6.8	16.6	3.8	8.7	89.7	6.6	18.1	23.6	9.4	71.1	43.4	151.6	25.2	43.2	17.4	14.7	15.4
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 406.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 767.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA		40000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	26.1	74.9	44.0	87.5	43.7	83.5	21.3	49.4	54.7	44.1	31.0	140.1	119.2	18.0	7.3	225.1	15.5	63.7	23.3	44.3	54.4	72.2	49.1	49.3	87.6	38.6	42.8	13.4	22.6	6.7	24.3	66.3	49.3	28.3	70.4	17.0	62.1	27.8	96.1	40.7	141.6	23.4	34.3	100.5	134.2	406.9	53.1	88.0	16.1	24.3	91.5	93.9	75.7	36.3	775.3	743.0	371.8	384.7	75.5	75.2	309.5	391.8	111.5	364.6	278.0	614.8	449.1	210.1	247.4	303.0	401.7	446.5	344.3	481.9	278.5	215.7	438.3	336.1	275.2	624.8	177.5	256.3	318.3	117.1	218.4	307.3	308.7	107.1	672.2	388.7	197.3	431.3	335.4	561.4	845.0	248.7	216.9	627.8	979.0	520.8	447.5	326.8	392.7	479.1	465.4	373.8	553.8	293.3	213.4	393.8	786.0	154.9	395.1	214.3	615.7	305.0	469.0	165.9	298.1	332.5	186.9	233.4	254.4	241.7	127.0	372.6	79.6	187.8	57.2	102.3	109.3	96.8	100.7	57.2	51.6	76.1	767.6	74.5	206.7	67.4	202.6	118.4	44.0	43.7	49.4	54.7	44.3	54.4	38.6	42.8	49.3	34.3	53.1	36.3	61.6	25.6	18.1	0.0	36.2	0.0	0.0	0.0	0.0	0.0	81.8	133.2	0.0	0.0	18.0	246.5	0.0	137.6	171.2	0.0	99.7	371.3	0.0	113.2	79.7	32.9	0.0	0.0	0.0	437.2	1344.2	40.4	0.0	194.0	7.6	179.6	0.0	0.0	319.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	375.7	0.0	0.0	0.0	0.0	1434.1	0.0	0.0	13.9	0.0	0.0	203.3	16.8	0.0	0.0	0.0	76.2	0.0	0.0	0.0	0.0	96.9	73.9	95.0	0.0	0.0
KAT5	"cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5"	ENSG00000172977	"Lysine acetyltransferase 5"	Q92993	11	65711996-65719604	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016953, HPA074328"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Vesicles, Cytosol"	"HPA016953: AB_1851277, HPA074328: "	"unprognostic (2.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.10e-13)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-2)"	31.6	30.0	38.7	23.8	41.0	52.9	32.1	41.7	48.8	39.5	38.6	43.6	21.6	45.1	33.7	34.9	44.9	20.5	32.4	37.9	38.9	32.9	26.3	29.5	28.0	40.0	39.5	39.2	32.7	45.6	33.7	29.9	41.2	33.1	27.0	31.0	29.6	36.3	42.8	47.6	32.2	35.2	40.0	34.3	35.9	45.2	39.9	39.3	38.2	34.6	30.2	39.5	34.8	43.8	37.2	44.1	40.1	29.6	31.3	32.7	41.1	26.7	43.6	44.0	38.0	32.6	42.2	34.3	36.2	47.4	47.5	30.8	50.8	45.1	26.4	44.4	32.5	50.6	36.3	38.9	44.6	55.7	56.4	35.2	49.7	28.9	59.0	33.7	28.1	39.1	52.5	51.1	42.0	68.2	45.7	62.3	33.9	26.8	28.4	38.2	26.5	63.3	40.6	56.2	37.1	38.9	25.4	46.5	51.2	20.8	45.9	34.2	36.3	33.9	30.4	27.6	28.0	38.7	43.7	50.4	29.7	27.0	29.3	42.7	33.6	58.8	33.4	32.0	29.6	28.2	28.8	34.2	34.1	30.4	36.5	29.8	34.8	35.8	34.6	20.9	31.0	36.4	38.7	41.0	41.7	48.8	37.9	38.9	40.0	39.5	41.2	40.0	39.9	43.8	17.6	12.8	17.5	10.7	26.0	21.2	44.2	60.2	17.6	44.9	17.3	15.0	1.0	25.8	33.8	29.5	31.3	51.3	25.6	27.1	35.2	42.2	11.1	20.2	14.2	18.7	30.4	12.4	7.5	51.5	42.6	21.1	20.4	19.8	33.7	27.0	18.2	10.9	36.3	38.7	8.7	25.1	42.7	17.6	15.2	11.1	28.0	20.4	42.7	3.7	38.8	40.3	33.0	7.1	13.8	39.4	30.6	38.7	10.4	24.2	23.3	32.6	30.0	44.8	46.0	27.6	27.0	61.1	27.8	14.6	21.3	102.5	21.6	29.2	26.2	31.0
KAT7	"HBO1, HBOA, MYST2, ZC2HC7"	ENSG00000136504	"Lysine acetyltransferase 7"	O95251	17	49788648-49835026	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044470, HPA071116"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA044470: AB_10965785, HPA071116: "	"unprognostic (1.30e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.20e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.68e-2)"	17.6	14.2	16.1	8.1	16.9	40.9	16.6	24.2	21.5	20.1	15.1	20.9	7.2	22.6	12.2	20.4	20.3	6.6	22.8	16.5	14.8	17.7	11.7	14.5	10.4	13.6	12.3	20.9	12.4	23.5	17.1	10.0	15.5	17.5	10.0	19.2	17.8	14.0	37.7	25.5	16.0	12.4	10.3	15.9	16.0	38.6	14.9	17.4	21.1	20.1	13.5	22.5	19.0	18.7	17.1	22.6	22.5	17.3	10.1	14.3	27.2	11.2	16.5	24.7	18.7	35.9	11.5	17.8	21.8	13.7	24.7	16.7	23.0	12.8	32.5	18.6	20.3	20.7	14.8	17.8	15.0	21.6	17.2	13.3	16.6	21.1	25.3	14.4	22.7	16.0	23.6	18.9	27.4	28.8	26.4	23.2	79.0	38.4	20.2	20.6	34.7	18.2	12.8	17.6	25.7	15.7	7.6	9.2	14.9	40.5	38.6	22.9	8.8	24.5	13.3	16.0	19.4	21.4	32.7	23.3	17.3	13.6	23.3	17.1	6.8	9.5	8.3	5.4	10.6	5.8	7.8	8.5	7.0	6.1	9.3	8.5	10.1	11.7	7.1	4.3	8.5	7.9	16.1	16.9	24.2	21.5	16.5	14.8	13.6	12.3	15.5	10.3	14.9	18.7	16.0	25.6	21.3	9.4	23.6	16.8	11.7	10.1	25.0	32.6	18.5	16.6	28.5	20.0	15.6	27.6	31.3	22.7	27.6	11.7	9.8	11.9	23.1	22.4	21.0	18.7	25.1	25.4	14.8	7.5	14.5	15.3	15.3	29.9	24.1	18.2	15.4	10.4	13.3	45.4	16.7	13.4	12.2	22.6	13.2	16.5	16.8	15.9	14.2	10.3	19.1	16.5	25.7	13.0	18.3	10.0	8.9	18.4	18.6	15.4	12.8	10.2	18.6	25.1	39.5	21.2	24.2	73.7	31.6	17.9	20.0	33.8	28.4	15.2	12.1	10.2
KCNK1	"DPK, K2p1.1, TWIK-1"	ENSG00000135750	"Potassium two pore domain channel subfamily K member 1"	O00180	1	233614106-233672514	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 157.8;Horizontal cells: 200.2;Prostatic glandular cells: 222.9;Urothelial cells: 371.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	69	"plasmacytoid DC: 6.9"	"Lineage enriched"	"Detected in single"	69	"dendritic cells: 6.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 64.7;SCLC-21H: 62.5;U-266/70: 137.3;U-266/84: 134.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 117.0"	"HPA016049, CAB022588"	Approved		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB022588: , HPA016049: AB_1855571"	"unprognostic (7.06e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.64e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.84e-4)"	"unprognostic (4.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (7.29e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	3.9	4.1	17.7	2.9	19.8	0.3	5.7	58.0	28.4	7.8	50.4	15.7	16.9	6.1	30.9	20.9	10.9	12.1	41.0	24.3	13.7	9.2	12.1	4.4	1.0	23.5	17.8	7.3	5.5	16.2	22.2	6.8	24.1	6.4	13.9	18.5	15.1	11.3	0.4	13.3	12.6	3.8	15.4	0.9	38.1	0.9	16.3	0.5	7.2	0.9	4.4	11.5	14.4	21.3	33.2	18.3	0.1	0.0	0.0	0.0	50.2	8.8	0.0	0.0	0.0	0.0	52.9	0.0	20.7	6.8	7.3	47.1	8.9	15.2	0.0	0.1	15.8	0.0	64.7	0.0	0.5	0.0	1.8	3.9	17.0	0.0	12.4	1.1	0.2	17.7	7.9	15.0	0.0	12.6	12.2	0.1	10.9	38.5	41.0	0.0	2.7	3.7	16.0	28.4	62.5	11.8	33.5	14.3	0.0	1.0	4.1	0.1	0.0	0.1	25.8	0.0	1.0	137.3	134.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	17.7	19.8	58.0	28.4	24.3	13.7	23.5	17.8	24.1	15.4	16.3	21.3	0.4	9.6	22.9	5.9	0.6	63.3	136.7	32.6	3.4	2.9	23.0	6.0	54.7	12.8	44.6	18.4	4.2	0.5	3.0	91.0	1.9	29.2	1.1	52.7	26.4	3.5	29.3	0.0	157.8	48.3	14.0	31.2	50.4	89.3	0.0	15.0	0.0	8.9	0.6	200.2	61.0	56.3	24.4	0.3	4.4	0.2	1.5	1.0	10.6	12.2	0.0	72.6	0.0	36.2	73.2	96.3	82.4	0.0	0.2	222.9	10.6	8.8	42.9	5.1	0.0	2.3	6.9	0.6	3.2	19.1	47.6	0.8	1.4	0.5	31.2	371.6
KCNS1	Kv9.1	ENSG00000124134	"Potassium voltage-gated channel modifier subfamily S member 1"	Q96KK3	20	45091214-45101127	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 22.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Cholangiocytes: 7.2;Collecting duct cells: 1.8;Excitatory neurons: 6.2"	"Cancer enriched"	"Detected in many"	5	"cervical cancer: 6.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 22.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.3;HHSteC: 2.1;hTEC/SVTERT24-B: 1.0;THP-1: 1.8;U-87 MG: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.46e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.11e-4)"	"unprognostic (8.91e-3)"	"unprognostic (6.01e-3)"	"unprognostic (7.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.65e-2)"	"unprognostic (6.35e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.39e-1)"	0.0	0.4	0.9	0.1	2.9	0.1	0.2	0.0	22.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.1	4.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	1.5	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.3	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.4	0.4	0.1	0.1	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.8	0.0	0.9	0.2	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	2.9	0.0	22.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	2.0	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.1	1.1	7.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1
KCTD15	MGC25497	ENSG00000153885	"Potassium channel tetramerization domain containing 15"	Q96SI1	19	33795933-33815763	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.4;Granulosa cells: 94.8;Hepatic stellate cells: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.8;eosinophil: 5.9;intermediate monocyte: 3.3;myeloid DC: 2.5;non-classical monocyte: 4.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.5;granulocytes: 5.9;monocytes: 4.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050822			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA050822: AB_2681250"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.65e-8)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.30e-2)"	19.2	6.3	29.4	11.3	28.0	6.1	14.2	24.9	34.9	38.8	15.0	41.3	7.0	43.1	3.2	34.8	36.1	10.8	19.1	28.7	29.6	24.7	12.9	24.7	3.0	26.0	30.2	22.7	32.5	4.5	10.3	11.0	24.2	25.0	6.0	15.2	11.6	19.0	6.0	73.2	15.7	20.7	25.8	17.4	23.3	10.5	30.2	1.3	23.0	6.4	4.1	32.0	31.3	23.3	16.7	37.5	33.2	50.8	10.8	5.7	26.2	21.6	4.0	11.7	6.1	21.2	11.1	0.1	47.6	30.3	5.5	19.3	24.3	16.9	4.4	18.1	42.7	68.5	25.3	20.7	29.8	13.3	12.0	11.2	69.4	4.5	26.5	0.0	23.2	9.8	17.3	0.4	2.0	42.0	0.5	37.8	30.4	27.9	62.8	32.0	17.9	6.3	13.3	7.5	25.7	88.0	42.0	59.0	80.0	14.1	43.7	34.7	38.3	54.7	48.9	1.1	3.8	40.9	2.3	27.2	0.1	23.0	68.4	0.6	1.8	5.9	0.0	3.3	0.1	0.0	0.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.5	0.7	29.4	28.0	24.9	34.9	28.7	29.6	26.0	30.2	24.2	25.8	30.2	23.3	17.8	0.0	1.7	44.4	0.3	15.8	3.3	4.1	10.8	3.5	5.4	5.0	3.2	1.5	2.9	0.0	10.4	0.2	0.4	0.9	3.9	0.7	0.7	3.4	15.1	15.3	1.2	4.2	1.9	8.4	0.4	5.5	1.5	2.5	8.8	94.8	27.8	2.0	1.2	1.7	5.3	3.6	0.0	3.7	5.4	1.9	4.4	3.7	5.4	4.7	3.1	5.0	0.0	11.1	0.3	2.1	1.0	9.1	0.1	3.9	0.3	0.2	0.7	11.7	0.0	3.1	8.7	0.0	1.9	14.3	19.5	0.3	0.7	2.4	1.9	3.1
KDM2A	"CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA"	ENSG00000173120	"Lysine demethylase 2A"	Q9Y2K7	11	67119263-67258082	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012272, HPA044251"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB012272: , HPA044251: "	"unprognostic (7.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"unprognostic (9.45e-3)"	19.5	13.2	10.7	27.2	10.6	47.1	19.7	18.0	12.1	24.3	14.1	23.3	14.7	29.1	17.4	31.9	19.3	19.0	17.4	10.6	11.2	14.3	19.9	24.0	27.5	12.6	10.7	24.5	13.0	16.1	13.1	18.0	10.9	21.6	17.1	18.5	21.3	19.2	33.8	29.4	23.9	24.0	9.7	27.0	18.9	29.0	11.9	27.8	19.0	24.5	28.7	23.9	25.9	10.9	49.9	31.8	17.6	27.7	17.1	27.0	13.5	21.5	26.6	41.0	27.9	48.7	25.4	38.8	37.5	33.3	23.8	48.2	31.3	22.5	33.1	66.4	13.4	28.9	39.2	11.7	16.9	24.5	38.1	21.7	23.9	39.4	25.7	20.7	29.9	22.7	27.4	54.4	18.6	35.4	32.5	18.1	36.1	29.8	25.6	39.9	29.4	21.4	14.7	33.7	24.2	18.9	71.0	38.6	39.0	21.6	59.9	23.9	38.7	25.0	16.7	34.5	18.8	29.3	35.4	25.4	22.0	17.2	17.8	0.4	1.1	0.3	2.5	0.8	2.7	3.6	1.9	2.3	0.6	3.6	1.9	1.9	2.7	2.7	0.5	0.9	2.6	1.9	10.7	10.6	18.0	12.1	10.6	11.2	12.6	10.7	10.9	9.7	11.9	10.9	41.4	38.5	35.8	75.1	56.6	41.2	23.3	23.4	75.7	75.3	40.3	30.9	31.1	34.3	31.0	16.5	137.6	23.9	77.5	43.2	0.0	17.3	20.6	84.8	63.0	38.4	31.8	22.1	89.4	14.5	13.4	32.4	42.8	112.3	27.3	42.1	29.3	35.5	21.5	95.9	89.8	27.5	24.4	46.5	59.6	11.2	21.5	49.1	19.6	104.0	43.3	19.8	33.0	96.0	99.5	25.9	25.5	23.0	72.5	37.2	21.2	10.3	40.0	111.7	19.7	40.2	32.3	52.0	38.1	78.7	47.7	32.3	66.9	33.8	29.5	48.7
KDM4C	"GASC1, JMJD2C, KIAA0780, TDRD14C"	ENSG00000107077	"Lysine demethylase 4C"	Q9H3R0	9	6720863-7175648	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 206.9;Inhibitory neurons: 235.9;Microglial cells: 148.0;Oligodendrocyte precursor cells: 189.0;Oligodendrocytes: 347.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069357			Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA069357: AB_2686128"	"unprognostic (1.56e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.64e-3)"	10.0	9.6	9.8	12.8	12.0	30.1	11.3	30.6	11.5	10.2	13.5	13.7	13.1	10.4	11.8	10.1	10.3	9.7	7.8	9.9	11.1	8.7	11.1	10.6	19.1	13.8	11.7	11.5	16.1	17.8	11.8	8.9	13.3	9.9	16.1	28.9	11.6	8.8	8.3	15.2	14.4	10.8	9.7	13.9	15.1	9.8	11.9	23.6	13.4	6.0	18.8	10.3	10.7	16.4	17.2	9.8	4.0	6.0	13.4	14.3	11.8	7.6	9.6	8.5	8.1	11.3	9.1	20.1	4.6	10.3	8.7	5.1	8.6	12.8	11.1	60.6	7.4	27.9	13.8	15.1	12.4	10.8	18.5	12.5	8.4	6.7	14.0	21.1	10.4	16.4	4.7	13.4	9.3	8.3	18.0	40.4	7.0	18.0	3.8	10.8	3.4	12.9	12.3	9.2	14.0	8.3	7.1	12.7	6.8	10.7	6.6	17.5	11.0	8.4	4.0	9.9	7.5	10.2	8.1	21.3	8.2	10.0	3.3	7.5	7.1	13.5	9.6	7.7	11.2	12.1	10.4	11.2	9.6	13.8	11.3	8.8	1.6	11.2	13.1	3.7	10.0	8.0	9.8	12.0	30.6	11.5	9.9	11.1	13.8	11.7	13.3	9.7	11.9	16.4	11.3	6.4	14.4	110.4	40.6	19.9	7.9	10.5	18.8	22.6	11.2	8.0	9.2	11.5	9.2	7.3	45.9	5.2	22.7	10.3	3.9	7.0	84.8	10.0	12.2	9.4	9.7	42.1	206.9	6.2	5.3	6.9	34.7	16.8	8.8	6.0	6.8	13.0	6.7	11.8	235.9	14.7	6.1	10.0	19.4	83.3	9.6	16.5	7.2	148.0	15.0	3.3	19.6	189.0	347.2	7.6	9.5	9.4	27.1	6.2	14.1	4.0	10.8	28.3	13.1	7.3	7.6	6.6	5.4	14.4	23.9	5.9	28.2	6.2	8.1	8.0
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 324.2;skin 1: 239.8;vagina: 186.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 152.1;Club cells: 217.9;Late spermatids: 339.0;Prostatic glandular cells: 234.8;Squamous epithelial cells: 176.4;Suprabasal keratinocytes: 217.1;Urothelial cells: 186.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 53.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 13.0;HaCaT: 41.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	NA	NA		1800000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	28.4	0.2	0.0	0.4	0.0	0.0	17.1	0.9	0.1	109.8	44.5	1.9	0.7	7.2	2.6	324.2	34.2	59.3	2.0	1.7	0.0	0.3	0.8	18.9	0.0	0.2	0.1	1.6	89.1	0.0	8.8	0.0	0.3	64.9	0.6	0.7	169.5	4.2	1.9	239.8	1.4	0.3	0.0	0.1	113.3	14.4	0.6	2.5	0.4	0.3	27.2	1.4	186.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.4	0.1	13.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.7	0.0	0.2	0.1	0.3	0.0	0.6	0.0	0.2	86.6	10.4	0.0	0.4	106.9	152.1	131.6	13.1	0.2	33.4	35.3	0.8	88.6	217.9	0.0	0.0	0.0	0.0	0.1	0.0	9.2	111.6	4.7	1.1	3.8	20.3	0.0	0.0	130.2	0.0	9.1	91.3	15.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	10.7	118.0	0.0	11.4	339.0	2.8	1.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	79.4	0.0	0.4	0.5	234.8	0.1	0.0	26.9	1.3	0.0	0.2	7.9	2.1	2.5	176.4	217.1	0.0	1.7	0.0	0.4	186.1
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 118.0;skin 1: 87.1;vagina: 47.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 66.0;Suprabasal keratinocytes: 180.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 88.3;CAPAN-2: 112.2;HaCaT: 83.5"	"Region enriched"	"Detected in all"	5	"hippocampal formation: 36.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		3200000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	5.7	0.0	0.1	0.0	0.0	0.0	8.4	0.8	0.7	24.7	0.2	0.0	0.0	0.9	0.4	118.0	13.2	0.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	17.1	0.1	0.7	87.1	0.0	0.1	0.0	0.2	0.1	1.2	0.2	1.1	0.5	0.0	9.6	0.0	47.2	0.5	88.3	0.0	0.0	0.6	0.0	0.0	12.3	0.0	0.0	0.0	0.0	1.7	112.2	0.0	2.2	0.0	0.1	83.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	10.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.0	0.0	0.7	0.2	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.3	66.0	0.0	0.4	14.8	0.0	13.0	15.6	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.7	11.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	5.0	1.8	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	2.8	6.2	21.1	180.1	0.0	0.2	0.0	0.2	0.1
KMT2E	"HDCMC04P, MLL5"	ENSG00000005483	"Lysine methyltransferase 2E (inactive)"	Q8IZD2	7	105014190-105115019	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042866, HPA056125"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear bodies"	"HPA042866: , HPA056125: AB_2683044"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	23.0	16.4	17.6	28.8	23.6	69.9	22.5	53.6	26.1	28.9	11.6	29.0	22.7	33.4	22.1	22.7	24.8	24.5	21.1	16.9	25.9	18.7	16.4	27.9	31.4	19.0	19.2	43.8	22.8	23.1	11.5	26.8	17.7	24.9	28.5	40.5	25.5	23.0	15.0	30.3	22.3	26.8	14.4	33.4	26.7	18.6	17.1	35.6	27.4	22.9	33.0	27.9	14.3	34.4	35.7	24.8	49.3	43.5	29.3	34.5	12.3	24.3	38.2	21.0	25.5	19.0	30.1	28.8	24.7	30.0	27.7	26.2	27.1	25.7	35.0	45.8	17.4	27.0	31.6	19.2	28.1	39.7	34.8	24.2	23.3	28.6	30.6	38.6	40.2	32.3	39.9	76.9	28.7	26.5	62.1	35.0	17.9	19.1	19.1	53.4	30.3	33.5	23.0	34.5	28.8	36.1	35.7	32.3	20.2	32.8	13.6	23.5	47.2	50.0	33.1	57.5	26.4	61.6	50.8	63.5	34.3	29.5	36.3	246.8	73.2	173.1	118.3	56.2	114.6	153.9	109.7	103.0	53.8	152.0	106.0	100.0	290.3	89.9	94.4	103.2	101.5	71.7	17.6	23.6	53.6	26.1	16.9	25.9	19.0	19.2	17.7	14.4	17.1	34.4	169.3	141.1	158.4	108.4	283.5	146.6	115.5	119.2	118.4	236.4	93.4	81.5	102.9	85.8	124.6	115.8	252.3	40.5	278.0	138.0	35.2	82.2	27.0	77.8	89.3	205.6	100.0	90.5	160.2	68.1	50.4	128.8	91.7	112.4	247.9	78.2	119.2	33.6	60.4	185.1	148.9	96.4	89.5	91.8	348.4	27.3	141.1	152.2	140.5	148.9	147.5	104.1	255.4	189.0	236.2	80.7	102.9	131.7	223.1	149.7	82.6	32.4	78.3	297.5	124.9	136.7	168.3	100.0	76.4	86.1	134.7	65.3	278.3	58.2	115.4	159.9
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409353	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA064495: AB_2685273"	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	13.7	10.1	22.6	15.3	22.1	39.2	13.1	20.8	23.2	22.2	18.7	17.7	12.8	21.3	12.9	40.7	21.7	13.6	17.0	22.2	20.6	13.7	14.0	15.5	15.4	22.4	22.7	12.0	19.7	11.4	10.7	16.5	22.9	30.2	14.4	11.7	24.0	19.7	24.4	28.1	15.6	16.7	21.4	16.8	16.9	7.9	23.3	17.9	25.7	15.3	16.6	16.6	25.7	23.9	37.3	24.3	27.8	43.5	18.1	30.9	40.1	57.4	26.3	32.0	26.9	28.8	21.9	84.9	33.1	37.5	11.7	35.8	41.6	21.7	33.3	39.3	45.0	68.8	26.4	15.2	26.5	54.8	18.8	15.1	27.1	34.7	32.8	30.2	26.2	36.4	136.8	38.1	27.5	29.9	58.1	84.9	13.8	34.6	29.0	70.4	22.1	24.1	22.8	43.4	37.9	30.9	51.3	28.3	28.6	23.6	39.6	75.3	32.4	35.2	26.0	42.3	42.3	23.0	25.9	75.9	24.6	29.6	29.9	2.3	1.2	4.3	1.3	2.1	2.7	1.7	1.6	2.1	1.0	1.1	0.9	1.1	1.8	2.3	2.1	2.0	1.5	0.3	22.6	22.1	20.8	23.2	22.2	20.6	22.4	22.7	22.9	21.4	23.3	23.9	34.5	12.8	14.5	0.0	12.7	0.0	17.6	0.0	20.5	20.8	32.0	27.3	0.0	7.2	6.8	27.6	6.2	15.1	22.4	10.4	7.9	9.2	10.1	46.8	43.8	20.7	4.9	62.1	0.0	9.4	16.6	14.7	15.8	41.1	2.5	21.3	30.4	19.5	17.7	3.3	0.0	22.2	0.0	16.8	0.0	3.2	16.1	19.6	0.0	0.0	3.4	28.7	7.2	0.0	0.0	13.6	9.6	42.9	15.9	24.1	14.3	13.1	11.7	17.9	6.6	23.2	19.7	9.7	10.2	38.8	0.0	14.2	14.5	18.4	12.7	22.5
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108056-32176563	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	14.2	15.4	12.8	11.0	13.9	20.5	13.1	12.4	15.1	15.4	12.7	17.7	8.8	17.1	12.8	18.8	14.2	8.8	22.0	13.8	17.2	13.8	15.8	15.1	11.1	15.7	16.3	13.4	13.4	24.6	14.3	16.6	18.2	13.9	13.0	17.1	13.4	14.3	39.3	18.5	12.5	17.8	12.0	12.0	14.8	20.2	14.6	12.8	13.5	23.7	14.8	15.6	15.6	14.5	32.0	24.8	21.6	28.0	32.5	28.4	25.3	25.2	29.5	36.0	34.5	27.8	33.9	26.5	29.1	45.6	21.6	26.7	33.5	38.5	45.6	27.0	18.4	27.4	36.4	22.6	28.7	30.4	21.5	28.9	35.8	44.6	42.3	30.3	38.1	20.5	27.0	23.7	34.4	17.5	24.6	17.3	50.5	20.6	18.3	24.5	31.0	21.7	31.4	28.9	20.7	17.4	45.8	27.1	25.0	52.6	19.2	15.9	44.5	33.1	22.7	43.8	36.6	16.9	20.7	20.3	36.3	27.8	32.4	3.2	7.4	7.2	7.7	9.1	7.5	5.3	6.5	6.0	6.0	6.1	7.4	7.2	4.2	3.8	9.9	6.7	7.3	5.3	12.8	13.9	12.4	15.1	13.8	17.2	15.7	16.3	18.2	12.0	14.6	14.5	27.9	41.7	41.5	33.0	36.1	63.6	36.9	37.6	22.2	48.6	44.7	26.7	32.7	37.1	32.4	29.5	58.4	45.4	42.4	29.5	17.6	36.2	294.2	41.0	44.6	40.4	46.1	52.8	62.5	31.6	41.6	35.7	25.5	49.3	13.9	31.3	36.0	77.3	30.4	52.2	58.4	36.0	24.4	36.8	44.8	65.2	34.2	29.3	24.9	30.0	41.4	29.0	47.4	40.7	54.3	46.1	26.4	40.6	24.1	56.7	25.3	33.2	48.2	44.7	32.9	53.1	36.7	78.7	56.2	31.2	85.1	135.7	31.7	31.8	35.6	59.0
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2964216-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 4.1;skin 1: 7.7"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 14.1;Basal squamous epithelial cells: 23.3;Intestinal goblet cells: 14.0;Rod photoreceptor cells: 10.9;Spermatocytes: 9.7;Spermatogonia: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 29.3;MCF7: 15.0;RPMI-8226: 28.8;T-47d: 14.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoli		"HPA003223: AB_1079217"	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.1	0.1	0.7	0.3	0.7	0.7	0.1	0.0	0.6	1.5	0.0	0.3	0.1	0.1	0.1	2.0	0.3	0.1	0.0	1.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.0	4.1	0.4	0.0	0.3	7.7	0.6	0.0	0.0	0.2	0.2	1.7	0.0	2.1	0.0	0.0	0.8	0.0	0.5	0.1	1.8	1.1	0.4	10.2	0.0	0.0	1.5	0.6	0.0	0.0	0.0	4.2	1.5	7.8	2.1	0.0	1.1	8.6	1.3	0.7	0.0	1.1	1.2	0.5	2.9	2.6	0.0	0.6	29.3	0.2	0.0	0.0	0.1	0.9	0.0	0.8	3.3	2.9	0.0	15.0	1.8	3.5	2.9	3.0	2.2	4.7	11.8	28.8	0.1	0.3	2.9	1.8	2.0	4.7	5.2	0.4	14.9	2.8	0.2	0.9	12.2	1.0	0.7	5.3	1.3	4.7	0.4	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.7	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.4	14.1	0.9	0.3	23.3	0.4	1.0	0.9	0.9	0.0	0.0	0.0	6.2	0.2	0.0	1.1	0.0	0.1	0.7	0.4	0.1	0.1	0.0	0.0	0.4	2.7	1.8	0.1	0.0	0.9	4.5	0.0	0.0	0.0	0.1	0.0	0.1	14.0	0.0	0.0	0.6	0.6	0.0	0.2	3.6	0.0	0.1	0.5	0.0	0.0	0.0	0.2	1.3	0.0	0.1	2.1	0.5	0.0	0.0	10.9	0.0	0.0	0.3	9.7	18.0	1.2	5.5	0.1	0.6	0.0	0.5	0.4
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652211	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"skin 1: 4660.3"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 265.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 23.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in single"		"HEL: 2.0"	"Group enriched"	"Detected in some"	6	"amygdala: 1.7;hippocampal formation: 2.7"	"Not detected"	"Not detected"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"		NA	NA		9700000000	"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	3.0	0.5	0.0	0.1	0.0	1.0	81.9	0.0	0.0	0.8	0.0	0.9	1.6	0.4	0.3	1.1	0.1	0.0	1.7	0.0	0.0	0.5	1.2	1.0	0.5	0.0	0.0	0.5	1.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	1.6	0.0	47.8	4660.3	0.8	0.0	0.0	0.5	0.7	1.0	0.0	6.8	0.8	0.0	6.1	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	9.5	0.0	0.0	0.1	8.8	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	265.4	0.1	1.0	0.0	0.6	0.1
KRT3	"CK3, K3"	ENSG00000186442	"Keratin 3"	P12035	12	52789685-52796117	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 3.0;salivary gland: 10.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.7;head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 9.4;HMC-1: 5.6"					"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"							NA	NA		280000000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (1.03e-1)"	"unprognostic (2.68e-2)"		"unprognostic (2.42e-2)"		"unprognostic (2.75e-1)"		"unprognostic (9.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"			"unprognostic (3.89e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520530	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 5865.0;skin 1: 5885.4;vagina: 2150.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 5870.1;Basal prostatic cells: 1037.6;Basal squamous epithelial cells: 1571.3;Squamous epithelial cells: 4370.9;Suprabasal keratinocytes: 2020.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1863.2;head and neck cancer: 3340.4"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	326	"plasmacytoid DC: 32.6"	"Lineage enriched"	"Detected in single"	326	"dendritic cells: 32.6"	"Group enriched"	"Detected in some"	7	"HaCaT: 3368.0;HBEC3-KT: 5990.5;hTCEpi: 13326.8"					"Region enriched"	"Detected in many"	8	"spinal cord: 36.4"	"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		3600000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	10.0	1.7	0.2	1.8	0.8	4.6	252.5	0.7	0.5	826.2	58.9	1.9	0.0	2.0	97.2	5865.0	12.5	2.0	3.8	1.7	0.0	1.3	3.5	6.4	3.0	0.1	0.0	2.2	4.7	0.1	8.2	2.0	0.1	125.8	0.0	0.0	880.3	100.0	9.9	5885.4	1.8	0.6	0.1	1.7	5.0	2.1	0.6	527.1	3.0	0.3	648.6	93.2	2150.9	0.4	50.6	0.0	0.0	0.0	2.3	0.2	0.8	0.0	0.0	0.0	0.0	1.0	0.3	2.4	0.5	0.2	0.0	3368.0	0.2	5990.5	0.2	0.0	0.0	0.2	0.1	0.0	0.6	1.4	2.8	0.3	13326.8	0.6	1049.7	0.0	0.8	0.0	1.8	4.0	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.2	1.0	1.2	0.8	0.9	0.0	0.1	1.2	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.5	0.2	10.1	1.0	0.9	4.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.1	0.2	0.8	0.7	0.5	1.7	0.0	0.1	0.0	0.1	0.1	0.6	0.4	1.7	0.0	1.1	0.0	0.4	5870.1	1037.6	627.1	1571.3	0.0	43.6	226.2	0.5	0.0	180.7	0.0	0.0	0.0	39.8	0.0	0.0	0.5	0.8	31.3	1.2	26.4	0.0	0.0	0.5	0.0	0.0	29.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	273.6	0.1	0.6	7.3	286.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	22.2	789.7	0.0	0.1	34.8	0.0	0.0	0.2	33.4	0.0	0.0	4370.9	2020.2	0.0	17.8	0.0	0.1	459.8
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703524	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 273.0"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 20.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"HaCaT: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"		NA	NA		1200000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Nuclear membrane, Plasma membrane"		"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.6	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	273.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.2	0.0	0.0	0.0	0.0	0.0
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312229	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 60.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	4.6	2.5	2.9	2.2	2.9	2.7	3.7	6.1	5.5	2.3	1.3	4.3	4.7	2.4	3.0	5.1	3.1	2.0	5.2	2.7	2.5	19.6	12.6	1.8	2.6	1.2	2.4	2.5	3.9	6.1	2.3	1.7	1.1	3.3	5.0	11.4	2.8	3.2	15.5	5.1	3.6	2.5	1.2	1.3	4.3	3.9	2.4	3.0	4.8	14.7	3.4	2.4	2.3	4.1	24.3	16.6	6.8	6.6	3.3	2.2	19.1	7.9	4.4	12.2	14.3	26.8	10.8	19.0	9.0	3.2	9.7	17.4	20.6	8.2	13.5	15.2	11.9	41.1	10.9	3.7	3.1	14.7	13.7	2.0	5.2	8.1	7.0	3.1	5.3	19.3	14.7	11.6	3.2	29.0	16.7	6.7	9.9	20.6	17.6	15.6	22.0	14.8	11.4	28.0	13.8	9.9	23.3	17.5	10.4	9.0	22.9	4.0	5.0	7.7	21.5	9.0	10.6	10.5	25.6	26.3	4.3	7.3	8.8	8.6	0.4	0.9	0.9	0.1	2.2	0.8	1.1	1.0	0.6	0.6	1.3	1.7	0.5	1.7	0.1	1.0	1.6	0.5	2.9	2.9	6.1	5.5	2.7	2.5	1.2	2.4	1.1	1.2	2.4	4.1	1.9	41.7	19.2	16.6	5.1	3.7	2.7	2.1	8.6	15.5	3.9	2.2	14.7	2.8	20.4	12.9	56.3	6.4	6.1	4.8	15.6	3.8	35.1	5.2	2.8	4.6	7.8	7.4	60.5	4.2	6.6	5.3	7.7	5.6	18.9	6.0	2.9	14.2	2.1	11.8	61.4	4.3	0.0	2.7	0.6	8.8	2.5	3.3	1.8	13.1	2.4	6.1	7.2	20.6	18.9	2.5	3.6	4.5	3.3	2.7	6.0	21.7	18.4	40.3	0.0	5.8	3.9	14.3	12.6	10.5	6.3	4.9	5.0	4.6	7.6	2.1
L3MBTL4	"FLJ35936, HsT1031"	ENSG00000154655	"L3MBTL histone methyl-lysine binding protein 4"	Q8NA19	18	5954706-6415237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 160.4;Late spermatids: 85.8;Microglial cells: 78.7;Oligodendrocyte precursor cells: 191.5;Oligodendrocytes: 252.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.4;Karpas-707: 4.8;RPMI-8226: 11.6;SCLC-21H: 5.3;SH-SY5Y: 5.8;U-2 OS: 3.4"	"Low region specificity"	"Detected in some"							"HPA064194, HPA069042"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA064194: AB_2685208, HPA069042: AB_2686071"	"unprognostic (1.33e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	3.0	4.3	7.1	1.8	11.5	1.6	4.9	0.2	8.4	4.3	0.6	2.1	3.0	3.2	3.6	3.6	4.2	2.5	4.9	3.8	6.8	7.1	8.8	3.9	2.0	3.3	8.2	8.5	6.5	8.5	3.2	0.7	4.7	2.0	2.0	1.7	3.4	2.9	1.0	7.3	3.5	1.3	1.6	2.9	3.2	12.7	6.6	2.9	5.8	1.3	1.6	1.4	4.1	14.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	2.4	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.0	1.4	3.1	0.0	11.6	0.0	2.0	5.3	5.8	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	3.4	0.1	1.4	0.1	0.0	0.0	1.3	0.0	1.7	0.3	1.1	0.0	0.7	0.3	0.0	0.5	0.1	0.1	0.7	2.5	0.1	0.2	0.1	3.6	0.8	0.1	0.0	0.5	7.1	11.5	0.2	8.4	3.8	6.8	3.3	8.2	4.7	1.6	6.6	14.0	6.5	3.2	12.2	56.2	4.8	7.8	7.0	0.8	10.2	2.2	4.5	4.8	6.4	11.5	4.1	5.5	16.7	0.1	2.7	0.3	3.9	7.4	62.5	8.1	1.2	3.6	11.4	0.8	33.9	5.2	0.0	3.4	1.5	16.9	1.3	15.4	2.5	10.0	3.2	0.0	160.4	1.5	0.0	3.2	5.3	85.8	10.2	2.9	1.8	78.7	27.2	1.8	25.7	191.5	252.9	3.5	1.9	12.8	1.5	10.3	3.5	8.1	1.2	0.6	6.6	6.9	7.2	9.3	2.4	6.5	8.2	0.1	2.1	0.5	2.5	4.6
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 74.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		880000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	"Nuclear membrane"	"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	16.7	6.5	23.3	17.3	25.9	9.8	13.7	29.3	22.4	9.9	11.1	23.1	15.5	9.4	2.2	11.4	6.1	11.8	13.1	17.4	30.1	9.0	2.5	14.4	18.6	34.1	35.6	1.8	74.4	3.0	3.7	6.5	24.8	17.1	12.0	3.0	33.4	4.6	4.6	58.2	17.2	5.8	25.0	20.9	37.8	4.2	38.1	5.8	6.7	3.6	10.8	12.2	13.8	23.6	1.5	14.3	18.4	2.5	2.0	1.7	1.2	5.4	2.8	4.7	5.9	6.0	37.7	1.1	16.7	14.8	8.1	27.1	2.9	5.1	2.3	8.6	0.6	4.3	7.7	3.2	0.1	6.2	7.7	3.3	12.6	7.8	0.8	3.2	1.9	0.3	0.7	0.2	3.6	34.5	0.1	8.7	22.4	46.4	10.3	1.8	46.0	2.9	1.8	4.5	16.9	4.2	6.2	1.4	0.3	4.7	10.2	7.3	4.5	10.5	49.7	0.4	15.4	0.2	0.0	1.4	11.8	16.4	2.0	6.3	5.3	12.7	1.8	6.9	2.0	1.1	1.7	0.9	2.3	2.0	1.8	1.8	2.8	1.3	6.6	0.6	4.2	1.7	23.3	25.9	29.3	22.4	17.4	30.1	34.1	35.6	24.8	25.0	38.1	23.6	23.3	6.4	6.0	18.9	15.6	6.8	2.5	10.6	3.4	8.5	5.3	12.4	3.6	5.7	2.8	0.0	0.0	0.1	40.3	23.1	0.0	1.2	0.1	2.4	8.5	16.0	87.4	2.7	0.0	6.4	0.3	5.7	30.5	1.2	17.7	0.1	13.9	0.6	7.0	0.0	0.1	34.5	6.1	30.4	13.8	0.5	1.8	30.6	3.6	11.2	38.2	31.3	19.6	1.5	0.1	21.7	3.1	0.0	12.6	2.2	8.8	0.4	1.2	0.8	0.0	0.6	5.0	0.3	3.1	0.6	4.0	0.0	15.9	0.5	15.3	0.7
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461823-124617888	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 198.8;choroid plexus: 104.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 114.9;Late spermatids: 163.3;Proximal tubular cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		820000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	12.9	32.0	135.1	8.2	173.7	10.5	13.0	159.3	190.6	18.5	104.0	27.1	23.4	20.2	13.4	24.1	10.0	10.2	17.5	129.7	156.5	28.4	60.2	9.2	11.8	179.2	165.8	9.0	15.9	9.2	14.5	8.6	170.7	14.0	8.5	7.5	18.3	12.5	10.2	15.3	21.1	10.2	151.1	14.0	20.1	24.2	156.3	9.7	29.4	4.8	15.2	14.7	16.1	198.8	24.7	12.0	4.7	12.1	18.2	14.7	12.8	8.2	18.0	5.5	10.0	2.1	22.4	24.4	19.7	13.5	6.1	26.1	1.4	4.7	5.7	5.4	16.3	17.6	4.1	11.4	18.5	3.6	27.6	11.0	20.0	5.4	13.0	16.0	8.8	21.4	8.9	9.5	6.9	24.5	12.0	11.3	8.5	10.4	6.8	12.4	5.3	31.8	12.1	3.2	2.7	14.2	6.3	22.6	8.2	6.5	17.2	0.6	4.2	8.5	12.2	7.2	2.3	7.9	2.5	7.8	7.7	6.8	2.0	8.1	28.8	25.3	16.1	24.5	20.8	41.0	18.7	17.2	35.6	43.3	22.4	16.0	4.8	7.9	29.0	13.4	32.1	24.4	135.1	173.7	159.3	190.6	129.7	156.5	179.2	165.8	170.7	151.1	156.3	198.8	5.0	3.2	14.8	22.9	29.1	7.4	9.4	22.1	13.1	6.0	19.8	19.8	15.8	12.8	19.4	7.3	0.0	54.2	6.2	17.9	33.2	5.3	114.9	17.7	12.7	4.6	9.5	19.8	29.4	2.3	24.7	11.2	19.9	8.2	10.8	23.3	6.1	61.1	26.5	11.8	27.8	21.3	24.4	16.0	8.1	163.3	5.9	12.9	17.8	8.4	15.6	9.8	8.2	15.6	76.4	3.3	30.2	10.5	19.7	6.7	80.5	93.8	24.9	6.4	13.1	5.2	9.5	33.1	11.3	30.7	5.4	24.2	12.1	12.4	23.0	16.3
LINS1	"LINS, MRT27, WINS1"	ENSG00000140471	"Lines homolog 1"	Q8NG48	15	100559369-100603230	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038578, HPA038579"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA038578: AB_2676095, HPA038579: AB_10697393"	"unprognostic (9.87e-2)"	"unprognostic (3.32e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.28e-2)"	4.2	4.1	2.5	8.3	2.2	5.7	7.7	3.1	3.3	7.2	2.8	5.8	4.1	6.6	9.4	7.0	5.4	4.4	3.1	2.4	1.7	6.0	5.5	6.2	11.5	1.6	1.4	6.4	5.4	6.1	3.5	6.4	1.8	6.1	7.0	6.6	5.1	4.6	4.3	6.9	4.5	6.2	1.1	8.4	6.3	7.6	2.3	9.1	8.4	5.1	10.0	5.8	4.9	2.8	4.4	6.6	8.2	8.2	5.9	8.0	7.5	6.8	7.6	7.6	8.1	6.2	8.4	11.6	3.9	6.2	5.7	18.5	7.8	8.6	7.9	4.0	11.1	10.4	10.7	4.9	4.9	8.9	6.3	7.7	7.4	5.9	9.4	7.6	9.0	6.4	17.3	9.1	4.7	5.7	5.3	7.6	9.6	16.7	8.1	7.8	13.1	10.8	6.6	11.8	4.2	5.5	6.3	6.1	10.2	10.4	10.3	6.7	6.5	9.5	8.5	6.8	8.9	9.7	13.4	10.5	6.1	11.4	7.7	12.4	7.9	11.7	16.3	7.5	23.9	12.7	25.7	18.1	8.4	11.9	35.0	25.1	10.4	15.0	6.7	6.8	17.6	10.5	2.5	2.2	3.1	3.3	2.4	1.7	1.6	1.4	1.8	1.1	2.3	2.8	7.7	19.2	5.9	0.0	16.6	0.0	9.7	0.0	11.4	16.1	11.3	8.3	0.0	5.7	2.5	12.9	18.8	8.8	20.4	4.9	5.9	5.9	10.8	6.6	11.4	5.7	4.9	11.6	0.0	5.1	5.5	7.2	15.3	6.3	1.3	10.3	7.1	7.6	15.3	16.8	0.0	5.8	0.0	6.0	0.0	1.7	12.2	6.9	0.0	0.0	7.9	9.3	26.8	0.0	0.0	5.4	3.2	7.2	12.5	9.0	10.5	4.7	7.3	16.0	13.1	8.5	5.8	20.7	12.9	9.9	0.0	12.4	29.8	18.9	4.8	7.5
LIPK	"bA186O14.2, LIPL2"	ENSG00000204021	"Lipase family member K"	Q5VXJ0	10	88724544-88752756	"Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 32.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SK-BR-3: 2.6"	"Not detected"	"Not detected"												"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 8: SK-BR-3 - Unknown function"					"unprognostic (7.65e-2)"	"unprognostic (8.64e-2)"				"unprognostic (3.57e-2)"		"unprognostic (3.19e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.13e-1)"						"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
LPAR5	"GPR92, GPR93, KPG_010, LPA5"	ENSG00000184574	"Lysophosphatidic acid receptor 5"	Q9H1C0	12	6618835-6635960	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.5;Hofbauer cells: 38.0;Microglial cells: 33.7;Proximal enterocytes: 18.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 18.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 83.8;T-cells: 66.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.5;HEL: 19.6;HMC-1: 26.0;K-562: 14.8;OE19: 9.4;U-698: 13.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA013170	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA013170: AB_1849314"	"unprognostic (1.94e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (7.99e-3)"	"unprognostic (5.43e-1)"	"prognostic favorable (6.56e-5)"	"unprognostic (7.43e-2)"	1.9	2.5	6.0	5.3	6.1	1.0	1.3	6.1	5.9	5.8	3.4	8.9	9.7	0.5	2.7	20.9	1.6	1.7	4.1	5.4	6.8	0.7	1.3	1.9	8.9	10.3	8.9	0.7	0.5	0.8	1.0	5.4	9.4	1.0	8.3	0.2	5.5	1.3	0.2	6.9	8.9	1.0	10.2	9.3	7.2	1.6	11.8	2.6	1.6	0.1	12.4	2.1	9.6	14.4	5.8	0.7	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	10.5	4.3	1.3	0.0	0.1	7.0	0.0	3.2	0.0	0.0	0.0	19.6	0.6	0.4	0.0	0.0	26.0	0.0	3.5	0.1	1.5	0.0	0.0	4.0	14.8	0.0	0.0	0.5	0.6	6.1	0.1	9.4	1.0	4.8	0.0	0.0	0.0	3.3	0.1	0.1	3.0	0.0	0.0	1.1	0.0	2.2	0.1	0.0	3.9	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	10.4	0.3	0.1	66.8	3.4	51.2	83.8	11.2	40.2	17.3	82.7	10.8	24.6	0.8	4.6	6.1	1.1	18.0	20.1	6.0	6.1	6.1	5.9	5.4	6.8	10.3	8.9	9.4	10.2	11.8	14.4	0.2	0.0	0.0	0.0	26.5	1.5	0.4	3.9	1.8	0.0	0.6	0.5	2.8	1.5	4.4	1.8	0.0	0.3	2.8	16.9	0.0	0.3	4.9	0.4	0.1	1.5	1.2	0.8	0.2	0.9	0.2	0.6	3.6	0.7	16.5	0.0	1.1	0.2	38.0	0.0	0.3	11.1	2.0	15.6	7.0	14.5	0.0	13.9	0.0	33.7	4.6	0.1	17.5	0.5	0.1	9.4	16.8	0.0	2.7	0.7	18.4	0.1	0.6	0.1	0.0	0.1	0.2	0.6	1.4	10.3	1.3	0.5	6.9	0.0	13.0	2.2
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264435-151015727	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		340000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.3	10.7	3.4	9.3	6.9	11.1	22.7	11.1	3.8	13.1	18.6	16.7	13.3	6.9	14.2	13.9	15.2	9.9	8.3	2.9	2.2	23.5	13.4	11.0	15.8	5.1	4.5	8.9	13.5	34.2	6.5	7.0	6.1	20.0	17.4	14.9	13.8	8.9	7.2	19.3	11.5	6.6	3.4	9.6	17.0	9.4	3.7	18.7	19.1	8.9	17.7	12.3	7.0	6.3	27.6	14.3	11.9	11.1	12.2	18.5	17.0	6.0	15.8	10.9	10.2	30.9	35.6	33.7	7.2	8.6	7.5	13.7	22.1	36.6	15.3	25.9	15.8	20.8	19.8	19.0	7.5	29.0	16.2	14.6	21.1	16.0	24.6	23.9	32.9	14.8	22.4	24.3	12.9	21.9	21.9	7.7	10.7	23.7	10.3	18.4	12.0	12.6	42.0	33.7	39.3	13.0	15.1	32.1	7.4	18.1	32.4	6.1	17.2	16.8	12.2	8.7	11.4	20.9	20.5	20.5	26.2	16.0	6.6	5.7	0.6	1.2	5.0	0.2	3.3	4.9	3.3	4.7	1.0	2.1	2.3	4.0	0.1	3.2	2.1	2.1	4.6	1.8	3.4	6.9	11.1	3.8	2.9	2.2	5.1	4.5	6.1	3.4	3.7	6.3	10.4	16.0	14.9	148.5	42.5	17.5	16.4	21.0	28.5	33.5	30.8	18.2	55.9	21.5	21.5	51.5	148.0	23.7	37.7	19.7	9.8	15.2	25.5	51.2	11.0	13.3	42.0	40.2	213.7	13.5	10.6	12.8	56.6	61.8	6.3	22.4	10.0	20.5	6.1	30.3	192.6	23.8	24.4	11.1	12.8	5.5	9.6	17.7	16.0	161.1	8.2	17.7	46.4	239.8	217.4	17.2	20.2	10.1	38.3	22.4	22.0	15.8	36.7	72.6	6.6	13.7	9.8	16.6	22.3	37.3	23.7	24.2	45.6	25.9	27.2	24.0
LRIT2	"AC022389.4, LRRC22"	ENSG00000204033	"Leucine rich repeat, Ig-like and transmembrane domains 2"	A6NDA9	10	84220571-84225544	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"retina: 59.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.5;Cone photoreceptor cells: 8.4;Rod photoreceptor cells: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037788	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA037788: AB_10672393"			"unprognostic (3.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.99e-1)"	"unprognostic (9.44e-2)"				"unprognostic (2.36e-1)"			"unprognostic (1.76e-2)"		"unprognostic (2.41e-1)"			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	59.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC61	"FLJ31392, HSPC295, MGC3036"	ENSG00000127399	"Leucine rich repeat containing 61"	Q9BV99	7	150323263-150338156	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 80.6;Hep G2: 53.3;NTERA-2: 67.0"	"Low region specificity"	"Detected in all"							HPA019355	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA019355: AB_1853339"	"unprognostic (4.05e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.69e-3)"	4.0	18.3	9.5	4.5	8.4	1.6	4.5	6.9	8.7	7.5	9.8	5.7	4.3	6.5	2.0	8.8	14.5	4.0	4.1	7.7	13.1	12.1	23.4	4.4	7.3	9.7	10.1	15.2	11.2	11.4	13.5	3.8	10.4	6.6	1.9	2.8	5.3	4.3	2.2	6.8	5.8	2.0	8.2	6.1	6.1	9.1	13.4	11.5	8.7	2.3	3.9	4.7	6.5	6.7	20.0	0.5	0.6	0.1	0.0	0.0	9.0	0.2	0.0	2.4	7.8	37.9	19.4	6.2	8.2	0.3	0.0	17.6	0.0	0.0	1.3	80.6	24.4	7.4	23.5	53.3	13.8	0.0	3.7	1.6	7.9	0.0	0.0	0.6	0.1	40.2	25.9	11.5	0.0	36.5	37.5	3.2	67.0	13.8	0.0	0.0	0.1	16.5	5.7	13.2	34.6	33.4	33.6	7.2	13.7	5.6	5.6	4.5	0.1	0.0	0.1	0.0	0.1	12.5	4.4	0.0	0.0	0.0	0.0	2.8	2.9	8.5	10.8	1.1	8.3	8.7	7.3	8.2	3.0	10.7	7.0	8.4	13.1	8.7	1.3	17.9	12.7	5.7	9.5	8.4	6.9	8.7	7.7	13.1	9.7	10.1	10.4	8.2	13.4	6.7	0.3	6.4	1.5	2.3	7.1	1.1	4.7	16.5	8.6	7.8	8.0	8.9	2.2	11.5	6.8	16.5	0.0	25.2	11.1	9.4	19.6	27.3	5.7	20.9	1.6	1.7	19.3	3.8	1.7	28.4	24.5	4.7	7.1	5.8	1.3	22.9	1.8	22.6	6.0	13.5	3.6	6.7	18.3	1.3	0.0	16.3	10.2	3.3	3.6	0.0	16.5	13.7	11.3	4.5	0.3	27.9	11.2	5.7	3.5	4.0	11.7	48.7	20.1	4.5	0.0	5.3	3.2	20.8	23.7	8.1	2.7	27.0	7.4	9.0	10.6	3.0
LSP1	WP34	ENSG00000130592	"Lymphocyte specific protein 1"	P33241	11	1850904-1892267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 224.7;lymphoid tissue: 245.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 492.2;Langerhans cells: 553.6;monocytes: 1505.6;NK-cells: 352.2;Plasma cells: 338.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 278.5;HDLM-2: 978.9;Karpas-707: 215.4;RPMI-8226: 500.2;U-937: 173.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017781, HPA019693"	Enhanced					NA	NA		1600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"			"CAB017781: , HPA019693: AB_1853387"	"unprognostic (7.53e-3)"	"prognostic favorable (3.56e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (2.54e-4)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (1.43e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.29e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-2)"	75.6	224.7	2.1	148.8	2.6	167.3	51.2	2.4	6.4	63.8	5.3	39.2	33.6	36.8	3.8	42.5	41.7	32.6	48.2	3.8	3.4	6.4	12.1	49.8	154.8	6.0	2.6	5.3	10.7	3.8	7.4	21.8	4.5	13.4	22.3	1.0	52.8	8.1	28.4	98.0	76.6	12.5	4.3	245.0	52.1	8.1	6.0	65.5	24.7	29.4	85.0	83.7	51.4	11.6	0.3	1.2	0.0	0.0	41.0	125.2	0.4	0.0	0.0	0.0	0.0	0.1	0.2	278.5	1.5	0.2	0.3	0.4	0.0	0.0	0.0	978.9	0.0	0.5	0.2	0.4	7.9	1.0	0.9	32.0	0.5	0.1	1.3	0.4	0.1	2.2	0.9	215.4	24.7	0.1	19.6	28.2	0.5	0.0	0.0	1.1	13.6	500.2	0.0	0.0	0.4	3.3	0.2	0.0	0.3	0.0	0.3	0.9	0.5	0.7	4.6	0.3	0.8	1.0	0.7	38.4	0.4	173.0	0.3	365.1	803.6	785.5	384.3	863.3	222.6	452.1	249.1	346.8	896.6	298.8	161.3	260.8	1574.3	279.6	888.2	669.7	491.4	1293.0	2.1	2.6	2.4	6.4	3.8	3.4	6.0	2.6	4.5	4.3	6.0	11.6	18.3	16.0	7.9	0.0	312.8	118.3	14.0	43.0	76.8	0.8	3.9	4.3	2.7	8.6	37.6	3.7	0.0	3.6	295.4	0.4	1.9	1.3	3.4	1.2	13.3	11.4	1.2	40.6	0.2	8.9	4.4	160.4	15.3	1.4	12.6	0.9	11.0	2.3	492.2	1.7	0.2	0.8	16.2	118.4	553.6	7.8	89.8	310.9	65.8	0.0	1505.6	0.2	352.2	0.5	0.1	1.4	1.4	30.1	338.4	1.1	1.2	12.9	36.6	1.0	0.0	182.1	15.9	0.4	1.3	16.7	114.7	6.4	310.1	92.7	3.2	67.3
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000753-96043520	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 207.2;Kupffer cells: 255.8;monocytes: 245.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		86000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	40.2	66.9	24.6	64.5	25.5	180.4	53.6	29.4	30.6	55.6	33.8	48.2	78.1	51.1	38.4	110.1	61.7	40.3	35.5	25.0	27.8	58.1	43.9	190.8	64.1	26.3	25.4	110.5	54.9	53.3	37.4	27.4	26.0	41.1	49.6	36.9	41.2	40.9	45.0	67.8	60.5	58.3	25.7	57.8	46.6	19.9	28.1	49.2	49.4	45.0	96.4	51.9	52.7	33.0	85.2	90.4	123.5	73.4	104.2	115.1	53.8	33.7	101.8	67.5	78.1	66.6	72.0	190.0	42.0	51.9	52.8	108.3	103.4	140.1	92.3	63.3	97.0	68.5	54.3	81.8	61.8	35.7	39.4	110.1	118.4	91.9	114.5	305.3	134.9	101.1	42.9	32.5	98.7	59.2	96.7	115.0	145.8	100.7	115.5	88.9	90.5	109.7	125.7	107.7	63.9	75.5	64.2	80.4	78.3	95.1	98.7	44.7	49.0	28.3	47.6	40.2	38.2	42.8	79.4	85.4	19.1	66.2	22.3	4.4	662.9	17.7	33.4	699.2	63.4	126.1	46.6	43.4	282.3	157.5	65.0	50.5	46.0	120.4	638.8	70.4	51.2	591.5	24.6	25.5	29.4	30.6	25.0	27.8	26.3	25.4	26.0	25.7	28.1	33.0	32.8	38.5	135.0	15.3	82.8	51.9	64.8	96.6	52.3	21.4	41.8	41.1	25.3	25.8	110.2	38.6	33.3	29.3	47.9	17.6	74.3	42.9	74.3	18.4	20.8	38.2	21.6	50.5	21.3	28.0	28.2	29.7	38.2	27.3	7.6	31.5	57.8	21.7	207.2	11.8	18.5	40.4	40.7	255.8	76.6	16.4	36.7	183.3	21.4	10.3	245.5	35.5	26.8	19.6	17.5	20.8	27.1	41.0	40.1	35.4	73.2	69.3	45.0	55.6	6.6	26.7	35.4	46.9	11.6	108.0	74.9	20.8	39.1	32.9	70.4	49.7
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465608	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 1066.8;skin 1: 669.3;vagina: 487.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 504.7;Squamous epithelial cells: 811.7;Suprabasal keratinocytes: 2306.1;Syncytiotrophoblasts: 715.8;Urothelial cells: 642.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 158.5;head and neck cancer: 235.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 5.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.6;granulocytes: 2.1;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5;HaCaT: 99.5;MCF7: 114.2;RT4: 108.2;SK-BR-3: 158.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA		7600000	"Cluster 32: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Endoplasmic reticulum, Vesicles"		"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	1.7	3.5	0.7	1.7	0.8	6.6	32.1	0.6	1.0	259.1	1.4	1.1	0.5	7.6	1.8	1066.8	3.5	1.3	1.3	0.7	0.9	2.9	1.2	1.6	2.6	0.7	0.8	8.9	1.3	1.8	2.3	12.3	0.7	11.9	0.7	1.0	183.3	1.3	2.8	669.3	1.6	0.8	0.7	2.1	3.3	1.1	0.8	12.2	1.2	0.2	131.9	55.0	487.0	0.7	38.6	0.6	0.2	0.6	0.3	0.0	15.3	1.5	3.9	1.4	1.9	0.5	42.5	0.4	1.7	1.1	5.6	99.5	0.2	4.4	0.7	0.0	0.3	0.7	4.5	0.8	0.4	0.0	0.9	1.7	37.2	0.2	0.3	1.7	0.0	3.1	0.2	0.1	0.1	114.2	0.9	0.0	0.2	24.3	8.3	0.5	0.0	0.2	1.0	108.2	0.1	0.3	0.5	158.9	1.8	4.7	17.7	0.1	0.0	0.0	0.7	0.5	0.7	0.6	3.0	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.8	0.0	1.1	0.1	2.9	1.1	2.6	0.0	5.5	4.7	2.1	0.0	0.0	0.3	0.9	1.2	0.7	0.8	0.6	1.0	0.7	0.9	0.7	0.8	0.7	0.7	0.8	0.7	0.9	0.0	1.1	0.0	1.3	504.7	102.5	161.2	111.0	0.7	66.6	38.0	0.6	2.8	72.6	14.7	0.0	96.5	2.1	0.9	1.9	1.6	0.1	4.5	4.4	7.5	0.0	0.4	0.0	0.2	87.2	18.1	3.6	24.5	5.7	0.5	0.0	0.3	14.0	3.3	0.1	2.2	24.4	0.3	139.8	0.0	0.6	23.2	147.7	0.0	0.7	4.5	0.0	0.0	0.2	4.7	0.2	0.4	0.0	40.4	0.3	0.7	5.7	0.5	0.0	1.5	10.5	0.1	0.9	811.7	2306.1	715.8	9.6	0.5	1.1	642.9
MAB21L3	"C1orf161, FLJ38716"	ENSG00000173212	"Mab-21 like 3"	Q8N8X9	1	116111755-116135240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;esophagus: 7.0;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 48.3;Club cells: 18.5;granulocytes: 17.7;Oligodendrocytes: 31.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;EFO-21: 13.4;RT4: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 6.2"	HPA039551			Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA039551: AB_2676565"	"unprognostic (9.25e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-3)"	"unprognostic (5.23e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.61e-2)"	0.1	0.0	0.8	0.1	1.4	0.6	0.3	2.0	5.2	1.7	0.0	1.5	0.2	0.2	0.1	7.0	0.0	0.0	0.0	1.0	0.8	1.3	1.7	0.2	0.1	1.5	2.1	0.1	0.0	0.0	0.0	0.7	3.5	0.8	1.3	1.3	0.8	0.6	0.3	6.2	0.3	0.0	0.5	0.2	0.2	0.4	3.3	0.2	0.1	0.1	0.6	0.6	2.9	5.3	2.6	0.0	0.4	0.2	0.0	0.0	4.6	0.2	0.1	0.0	0.0	0.3	0.7	1.8	13.4	0.0	0.1	2.5	0.1	0.1	0.0	0.4	0.0	0.4	0.2	2.7	0.0	0.5	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.5	1.3	0.0	0.2	0.2	0.2	1.1	0.4	0.9	0.4	0.5	0.2	0.5	14.4	0.3	0.3	2.0	1.4	0.3	1.4	1.6	0.3	0.2	0.6	1.1	0.3	0.2	1.2	2.2	0.7	0.3	0.2	0.7	0.9	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.6	0.1	0.1	1.5	1.2	0.1	0.3	0.0	0.0	0.8	1.4	2.0	5.2	1.0	0.8	1.5	2.1	3.5	0.5	3.3	5.3	0.1	44.8	48.3	2.0	0.0	0.6	2.5	0.4	0.6	0.1	0.1	0.0	0.4	0.0	18.5	3.7	0.0	6.3	0.0	5.3	1.9	0.1	0.6	3.1	0.3	2.9	0.0	0.0	13.2	0.2	0.6	4.4	0.0	4.8	17.7	0.0	0.0	0.5	0.3	0.0	10.1	1.2	6.1	0.3	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.2	0.0	6.0	31.6	0.0	1.1	0.0	0.0	0.8	1.2	0.9	13.2	0.3	0.0	0.1	0.2	0.0	0.2	3.7	1.7	13.7	2.6	0.1	1.4	0.5
MAF	c-MAF	ENSG00000178573	"MAF bZIP transcription factor"	O75444	16	79585843-79600737	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Mental retardation, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 407.6;Hofbauer cells: 273.6;Inhibitory neurons: 378.7;Kupffer cells: 394.7;Proximal enterocytes: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 38.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 38.1"	"Group enriched"	"Detected in some"	13	"Karpas-707: 207.0;RPMI-8226: 355.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010296, HPA028289"	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB010296: AB_638562, HPA028289: AB_10602024"	"unprognostic (6.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (4.54e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.56e-3)"	27.8	15.4	14.6	20.7	14.5	4.0	17.3	10.3	13.5	35.0	14.2	11.4	70.3	23.5	6.0	22.6	20.1	16.7	6.8	13.7	13.0	48.2	25.7	18.8	30.9	19.0	22.6	39.2	3.2	50.8	5.3	36.1	17.6	18.4	10.7	4.7	11.8	15.4	49.6	57.8	83.0	17.8	18.7	26.0	13.0	10.0	28.7	17.9	23.1	19.8	23.9	17.7	30.5	29.8	0.0	0.0	22.4	0.0	0.8	0.0	0.5	2.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	1.2	0.0	0.8	0.7	0.4	0.0	7.2	8.3	0.0	0.0	0.2	1.0	0.1	14.3	0.1	6.4	0.0	0.2	0.0	0.0	0.3	2.4	207.0	1.5	0.1	0.2	0.4	13.5	0.0	0.0	0.1	6.2	355.1	0.0	1.9	0.5	0.3	0.9	0.2	0.6	8.7	0.2	0.0	4.5	0.0	6.9	0.5	0.9	0.0	0.0	0.0	0.9	0.0	1.4	38.1	0.3	0.0	1.1	1.1	8.6	0.0	3.2	2.7	0.1	0.0	0.2	0.5	0.0	0.9	0.3	0.0	4.7	0.6	14.6	14.5	10.3	13.5	13.7	13.0	19.0	22.6	17.6	18.7	28.7	29.8	40.2	9.6	14.6	24.8	10.4	88.3	3.7	30.1	51.2	9.7	8.5	33.1	8.2	57.2	7.7	3.7	0.0	1.7	71.5	18.2	11.7	1.7	1.1	8.1	114.1	42.7	3.0	8.4	5.1	0.8	3.0	73.0	12.8	6.6	22.1	73.0	407.6	63.7	273.6	0.0	378.7	8.9	16.2	394.7	57.9	9.0	149.8	127.2	44.4	122.7	2.7	78.1	40.2	67.3	20.0	4.0	9.9	115.1	48.1	33.9	288.9	146.6	3.0	2.7	13.1	42.7	40.0	1.1	2.0	107.4	141.2	4.2	122.2	28.0	10.1	5.4
MALL	BENE	ENSG00000144063	"Mal, T cell differentiation protein like"	Q13021	2	110083870-110116022	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 368.5;intestine: 235.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 857.8;Ductal cells: 299.2;Pancreatic endocrine cells: 354.9;Paneth cells: 374.4;Proximal enterocytes: 742.2;Urothelial cells: 426.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 8.4;neutrophil: 2.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"A-431: 267.4;A549: 269.9;CAPAN-2: 347.7;fHDF/TERT166: 380.9;HaCaT: 276.4;PC-3: 158.3"	"Not detected"	"Not detected"							HPA051410	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA051410: AB_2681474"	"unprognostic (5.17e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.50e-3)"	17.2	2.9	3.9	17.2	3.7	2.4	13.4	3.6	3.8	58.2	4.7	114.1	235.4	6.3	5.7	368.5	8.4	20.3	18.6	3.6	4.9	7.0	3.1	79.9	6.1	4.1	4.2	2.0	4.4	97.8	2.6	9.3	4.6	18.9	95.1	0.4	40.8	4.2	6.3	43.7	218.8	14.4	4.9	5.0	9.2	9.7	6.9	3.1	28.6	10.8	55.0	98.6	148.1	4.2	267.4	269.9	0.2	0.9	0.1	0.1	0.8	48.5	2.1	0.2	0.2	44.3	347.7	0.6	127.6	380.9	0.1	276.4	0.0	12.6	0.1	0.7	0.2	1.8	7.3	0.1	1.9	0.1	0.6	4.8	13.9	1.2	0.0	0.0	111.9	0.0	0.1	0.4	0.0	10.0	0.0	1.0	0.2	117.8	158.3	0.1	0.1	1.2	30.4	15.3	0.7	0.2	0.2	9.3	0.7	0.4	0.3	1.4	130.9	0.4	0.9	0.7	0.8	0.3	0.4	31.7	0.4	0.4	0.2	8.4	0.4	0.6	0.2	0.2	0.2	0.5	0.5	0.4	0.2	0.5	0.3	0.5	2.5	1.2	0.1	0.4	0.3	0.3	3.9	3.7	3.6	3.8	3.6	4.9	4.1	4.2	4.6	4.9	6.9	4.2	45.1	41.7	185.9	0.3	2.0	16.4	107.2	38.6	3.4	0.0	10.9	6.1	3.2	2.8	64.6	1.8	0.0	0.3	0.4	857.8	0.0	299.2	26.3	3.2	1.8	50.6	17.5	0.0	0.8	66.1	0.1	8.2	2.6	7.6	7.0	0.4	33.9	0.5	8.2	0.0	0.1	51.2	30.5	0.9	3.8	9.7	2.5	2.9	14.2	2.8	1.0	0.1	0.0	0.0	0.0	354.9	374.4	1.2	0.0	187.4	742.2	14.6	19.4	0.1	0.0	1.1	5.6	27.2	1.3	57.9	13.2	0.5	2.4	0.6	97.4	426.0
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671465-58754477	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: AB_2680389"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	7.1	2.5	2.9	11.2	2.8	10.5	6.3	4.8	3.6	7.7	4.2	5.1	3.6	5.4	4.2	12.5	5.1	5.8	5.4	3.1	4.1	6.7	6.9	7.3	21.1	3.2	2.6	5.3	4.0	5.3	4.7	4.0	3.0	11.5	5.5	8.7	5.8	3.8	8.3	9.4	7.7	4.2	3.0	11.5	4.6	8.2	4.1	15.6	5.3	2.8	23.1	7.1	9.6	3.6	11.4	16.0	16.8	5.2	3.1	6.7	9.2	19.7	12.1	15.7	12.6	13.8	13.5	27.0	10.3	24.0	11.1	12.0	10.8	7.6	20.8	17.0	6.8	9.7	9.0	21.8	4.0	20.1	11.4	4.0	12.2	11.8	10.4	6.6	3.4	7.7	15.3	42.3	9.6	3.3	4.7	9.7	6.3	4.1	7.1	14.8	11.5	19.7	88.9	2.8	2.5	4.5	11.7	6.0	9.3	12.0	5.1	12.2	5.7	22.6	9.1	7.1	20.8	38.5	54.4	16.3	10.6	15.6	9.9	0.3	0.5	0.2	0.7	0.7	0.6	1.1	1.4	0.8	0.7	2.1	1.0	0.8	0.3	0.5	0.5	1.3	0.8	0.4	2.9	2.8	4.8	3.6	3.1	4.1	3.2	2.6	3.0	3.0	4.1	3.6	35.0	22.4	19.2	24.2	67.8	33.0	32.3	4.8	26.2	14.7	13.6	11.0	14.4	10.0	7.0	11.0	85.5	6.2	53.2	11.1	3.9	16.6	12.7	10.4	17.5	31.1	6.7	0.8	61.3	8.5	6.0	15.7	13.7	24.7	31.7	28.1	10.4	11.1	11.8	55.5	42.9	8.6	8.2	21.0	96.5	8.0	10.2	55.9	12.4	34.7	79.5	26.2	20.6	52.3	11.9	16.2	21.9	7.2	42.2	46.6	8.0	30.7	5.8	18.1	19.7	16.1	12.9	40.1	35.6	25.4	24.7	9.0	55.2	5.7	10.7	38.1
MAML3	"CAGH3, GDN, KIAA1816, MAM2, TNRC3"	ENSG00000196782	"Mastermind like transcriptional coactivator 3"	Q96JK9	4	139716753-140154184	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 125.6;Microglial cells: 355.1;Oligodendrocytes: 150.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 16.8"	"Immune cell enhanced"	"Detected in many"		"basophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;NK-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.0;SCLC-21H: 15.7;SH-SY5Y: 23.9;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037717	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA037717: AB_10794323"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.89e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.88e-1)"	3.3	3.4	1.5	2.4	0.9	3.2	3.4	16.8	2.1	5.0	0.1	3.8	4.8	6.7	5.3	5.9	5.5	4.1	2.0	2.2	2.8	2.0	2.6	3.8	2.6	3.4	2.3	8.6	6.8	3.3	4.5	5.0	3.4	4.9	3.9	1.7	5.9	4.5	1.7	7.8	4.5	6.0	2.4	3.3	3.4	3.0	2.2	6.0	4.3	2.1	2.3	3.6	5.1	2.2	0.5	8.1	5.4	2.7	2.1	4.4	4.9	1.0	4.4	0.5	0.3	3.2	2.2	1.8	0.4	0.8	0.3	0.1	2.1	1.8	0.3	0.0	1.2	5.9	1.9	0.3	0.4	2.8	8.7	4.3	1.5	0.1	0.9	3.3	15.0	0.1	1.6	0.0	0.3	0.9	0.5	1.2	1.4	3.6	3.5	3.5	0.5	3.6	2.5	11.2	15.7	23.9	0.0	4.2	5.5	4.2	2.3	0.8	13.1	0.6	1.3	0.1	1.7	2.9	3.5	0.1	0.8	9.2	20.2	12.2	1.5	2.9	0.0	1.1	0.1	0.0	0.0	0.0	1.5	0.4	0.4	0.4	3.6	3.4	0.9	1.2	0.0	1.2	1.5	0.9	16.8	2.1	2.2	2.8	3.4	2.3	3.4	2.4	2.2	2.2	21.2	3.2	11.5	39.5	3.1	8.0	8.1	4.2	7.4	4.6	12.6	9.3	3.0	11.5	8.7	5.5	18.8	5.8	3.9	13.6	5.9	5.1	3.6	12.6	9.4	11.7	14.9	9.4	60.2	5.1	7.3	5.3	8.6	19.9	19.6	34.4	13.2	17.5	7.5	11.8	125.6	12.1	2.0	22.6	13.3	9.0	4.1	19.6	3.6	355.1	18.3	3.1	1.0	7.5	150.8	3.0	14.0	3.8	2.1	5.7	8.2	6.1	7.2	3.7	0.0	2.9	13.7	0.5	2.2	19.0	13.5	8.2	5.3	8.5	11.0	8.9
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815549-56896152	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 210.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 52.5;THP-1: 51.0"	"Region enriched"	"Detected in all"	6	"olfactory bulb: 18.2"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 57: B-cells - Immune response"	Cytosol		"CAB004500: AB_627926, HPA046509: AB_2679678"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	5.5	3.8	3.0	13.3	2.6	24.0	20.1	4.0	2.1	7.0	6.2	5.4	6.3	7.5	6.6	10.0	9.7	5.7	3.7	2.1	2.7	9.9	6.0	7.5	18.1	3.9	3.2	7.2	9.8	7.1	1.3	11.4	3.7	5.4	6.3	26.9	18.5	8.3	1.7	19.7	6.5	5.7	3.8	20.5	8.1	8.3	3.5	9.9	16.2	4.4	24.0	6.7	6.4	3.9	13.3	7.9	12.1	8.1	1.9	1.5	20.3	2.5	3.3	7.6	10.6	37.1	9.7	11.9	0.9	3.0	6.5	6.7	10.1	4.6	10.5	4.0	4.4	6.6	3.4	17.5	4.7	10.6	17.6	1.9	4.8	2.4	3.8	2.1	3.3	4.0	5.8	20.7	2.0	5.8	7.4	14.2	5.6	6.8	1.0	11.5	8.6	41.1	13.2	13.6	5.1	52.5	7.6	9.5	21.5	10.7	26.0	51.0	9.8	0.7	6.4	2.9	4.7	15.0	8.2	22.1	1.2	6.1	13.2	6.3	3.1	0.7	0.8	4.5	0.7	4.0	2.4	1.1	1.8	3.3	1.5	0.5	1.7	1.7	4.9	1.0	3.8	1.7	3.0	2.6	4.0	2.1	2.1	2.7	3.9	3.2	3.7	3.8	3.5	3.9	20.8	6.4	9.8	17.9	102.5	52.4	15.1	17.1	43.9	14.9	73.2	30.6	3.5	48.6	15.9	36.8	47.9	15.1	31.9	7.3	7.9	18.9	2.0	25.0	20.6	24.0	10.2	14.5	11.7	14.8	8.6	10.7	14.3	43.7	7.6	20.0	21.8	15.0	32.3	28.6	31.8	11.4	6.1	76.0	48.4	3.6	5.3	66.5	37.4	69.3	99.1	11.6	9.2	210.1	12.5	12.9	7.7	1.9	41.5	14.8	10.6	20.7	11.0	38.5	6.6	9.3	11.9	8.6	17.9	69.1	54.7	6.7	31.6	15.4	9.7	12.0
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21759657-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 341.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069, CAB079930, CAB079932, CAB079933"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		140000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nuclear speckles"	"CAB004229: AB_627547, CAB079930: , CAB079932: , CAB079933: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (9.41e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.49e-2)"	31.1	33.1	64.8	35.9	84.4	41.2	29.8	37.3	80.9	31.4	32.9	36.1	25.8	29.6	30.1	43.0	29.0	28.9	42.2	91.3	46.4	42.1	34.2	38.5	36.8	29.1	45.1	29.2	38.1	51.7	12.0	33.1	35.9	32.8	36.2	30.3	28.9	32.7	38.1	45.0	29.5	39.1	43.8	40.5	33.9	43.7	60.1	44.4	46.1	41.9	41.9	35.5	18.9	43.2	78.7	48.0	60.5	37.2	75.9	76.7	25.9	84.7	77.5	73.2	72.0	43.8	40.8	45.8	41.3	112.7	67.5	74.6	73.9	67.9	97.8	180.4	72.1	78.9	43.0	67.7	73.5	113.2	80.5	56.9	60.1	89.4	81.6	58.0	101.7	45.4	341.9	50.5	97.5	36.6	72.0	38.5	24.4	104.5	46.8	79.4	149.6	13.2	55.5	62.9	50.0	28.6	91.5	64.2	57.2	60.4	42.4	47.1	90.1	61.5	79.6	71.9	54.2	47.1	59.4	65.8	60.0	60.0	68.4	1.4	4.9	7.2	15.9	6.0	4.9	2.3	3.6	6.0	4.1	2.6	3.5	6.1	16.5	9.3	6.9	4.0	3.4	4.0	64.8	84.4	37.3	80.9	91.3	46.4	29.1	45.1	35.9	43.8	60.1	43.2	36.8	48.1	35.8	97.6	44.0	60.2	28.4	25.1	28.5	25.5	32.5	24.5	41.5	42.9	31.2	51.5	54.2	21.8	151.7	74.4	19.6	28.5	49.0	33.5	40.3	39.9	59.6	63.8	109.2	39.2	23.2	38.4	52.0	45.0	92.8	28.8	52.1	63.5	53.2	28.6	91.2	42.2	26.4	89.0	77.1	14.7	32.6	74.9	40.9	68.4	75.0	35.8	143.2	82.4	75.1	45.3	35.2	44.4	37.0	43.8	32.8	46.0	32.2	22.4	32.9	44.6	37.3	74.1	53.4	44.9	61.8	19.2	91.4	43.3	38.6	38.8
MB21D2	C3orf59	ENSG00000180611	"Mab-21 domain containing 2"	Q8IYB1	3	192796815-192917856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.8;Inhibitory neurons: 53.0;Langerhans cells: 85.0;Oligodendrocyte precursor cells: 68.9;Syncytiotrophoblasts: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 4.2;T-reg: 3.9"	"Lineage enriched"	"Detected in single"	9	"T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 114.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044026	Approved		Approved	Cytosol		NA	Yes			"Cluster 13: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA044026: AB_10962840"	"unprognostic (3.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (2.76e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.28e-2)"	3.7	4.2	2.5	3.2	2.8	1.3	3.4	3.3	3.1	2.8	1.6	3.0	8.8	5.1	1.9	2.0	3.6	4.7	4.0	2.8	2.3	4.2	1.5	3.6	1.2	2.1	2.0	4.1	1.9	2.3	3.5	13.3	1.8	1.9	2.9	2.0	1.5	1.9	2.7	4.7	9.3	5.6	1.5	2.2	3.5	7.1	1.9	1.4	1.7	1.6	1.7	8.8	2.4	2.3	26.6	3.7	6.3	19.0	3.9	5.8	11.2	18.8	17.5	33.4	19.9	17.0	4.2	0.0	11.0	46.6	13.8	11.5	14.6	4.8	36.2	114.8	8.1	3.3	1.8	2.0	7.4	0.4	1.6	7.6	7.4	9.4	5.8	2.7	6.6	3.3	0.2	1.5	5.8	19.8	0.3	0.0	13.1	14.4	45.9	0.6	10.5	5.6	7.8	15.1	9.8	5.0	4.1	12.8	1.9	12.9	19.9	0.4	2.1	6.3	18.4	11.1	36.3	48.1	41.0	0.0	4.4	4.0	8.6	0.0	0.2	0.0	0.2	0.3	1.9	0.1	4.2	1.0	0.4	0.0	2.6	0.7	0.0	0.0	0.0	0.0	3.9	0.9	2.5	2.8	3.3	3.1	2.8	2.3	2.1	2.0	1.8	1.5	1.9	2.3	2.9	6.4	0.5	16.6	1.2	9.2	0.9	2.0	1.2	10.9	4.6	3.2	1.8	1.5	3.2	0.0	2.1	63.8	0.3	2.4	0.0	6.5	0.2	12.4	2.0	7.7	10.2	0.0	28.6	0.2	9.5	5.9	1.5	15.9	0.0	5.8	9.7	0.2	5.6	8.4	53.0	2.8	4.1	3.8	85.0	1.4	3.1	10.4	14.2	17.8	13.4	1.1	0.0	68.9	30.6	2.2	6.1	6.0	4.2	0.8	15.4	9.6	2.8	1.3	13.1	3.3	4.5	1.8	16.5	1.8	8.7	110.4	3.3	5.4	3.7	2.6
MBNL3	"CHCR, FLJ11316, MBLX39, MBXL"	ENSG00000076770	"Muscleblind like splicing regulator 3"	Q9NUK0	X	132369317-132489968	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.3;placenta: 170.8"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 328.3;Hepatocytes: 119.6;Syncytiotrophoblasts: 344.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 123.8;Hep G2: 171.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001584	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Golgi apparatus"	"HPA001584: AB_1079326"	"unprognostic (3.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.37e-1)"	6.8	11.6	1.3	8.7	1.9	14.8	4.7	1.7	1.0	3.7	2.4	11.7	9.9	4.9	24.3	10.9	9.4	5.7	9.7	1.1	4.4	8.0	59.3	5.9	13.8	3.6	3.1	4.8	10.0	4.2	1.6	170.8	3.2	4.0	11.5	0.1	6.6	11.1	0.6	12.6	9.8	4.0	2.0	11.3	13.0	42.8	1.6	14.3	8.2	3.4	15.1	8.5	2.8	3.7	7.2	0.0	8.6	1.4	1.6	3.6	15.7	0.5	3.2	1.1	0.0	123.8	22.7	32.6	0.7	1.3	1.1	7.7	19.8	8.2	0.8	3.3	7.6	29.1	25.9	171.5	1.5	32.9	10.2	1.5	7.1	0.0	3.6	0.1	1.1	20.4	2.6	9.2	1.6	19.2	56.3	12.5	1.3	27.5	1.6	53.2	10.7	18.6	5.7	18.6	3.1	10.5	14.8	8.6	4.3	15.1	3.1	8.4	3.9	6.3	1.2	8.2	6.7	18.2	13.0	47.0	1.2	21.8	20.2	11.9	7.9	5.5	16.6	9.9	14.4	20.6	9.8	11.6	8.8	25.5	10.0	11.2	1.2	18.7	21.7	17.0	2.2	9.1	1.3	1.9	1.7	1.0	1.1	4.4	3.6	3.1	3.2	2.0	1.6	3.7	4.1	3.2	6.8	16.0	16.9	8.8	2.2	2.1	5.2	0.7	3.5	3.6	14.7	41.5	5.0	11.0	0.0	328.3	9.5	12.8	3.9	1.5	5.8	12.6	1.3	3.6	6.7	55.8	0.9	5.4	56.6	7.5	15.3	6.6	8.8	6.8	6.4	119.6	29.3	0.0	0.9	9.8	0.0	27.2	6.5	9.4	23.0	9.6	7.2	30.0	10.6	0.2	9.2	0.0	20.6	1.3	3.6	50.8	12.2	1.4	6.4	9.7	4.5	1.9	0.0	3.1	2.7	2.1	1.7	13.6	8.5	344.1	10.3	5.7	10.3	3.3
MCUR1	"C6orf79, CCDC90A, FLJ20958"	ENSG00000050393	"Mitochondrial calcium uniporter regulator 1"	Q96AQ8	6	13786557-13814568	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 81.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 238.5;Rod photoreceptor cells: 293.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078654	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA078654: "	"unprognostic (1.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (5.51e-4)"	"unprognostic (3.40e-1)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (5.86e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.39e-1)"	9.7	5.4	20.2	7.2	21.0	7.1	10.0	19.6	32.6	7.8	18.5	10.8	19.1	7.0	13.1	10.0	4.6	5.5	12.2	20.9	21.3	22.6	9.2	8.6	6.6	21.0	20.8	3.9	12.6	9.0	5.9	8.7	22.0	6.4	9.7	81.6	9.1	7.6	19.3	18.3	16.5	5.1	20.0	7.6	6.4	4.8	22.5	8.1	16.0	15.8	9.4	6.2	7.7	19.7	23.4	6.9	34.4	34.6	19.8	17.0	21.8	21.0	19.9	22.4	23.4	24.0	11.3	31.6	41.0	15.1	35.2	10.2	21.5	17.7	25.4	21.2	13.1	32.3	12.2	24.0	19.4	32.4	12.6	11.9	16.9	29.1	20.9	16.7	8.1	38.7	24.4	16.3	15.8	9.7	40.1	49.0	22.2	59.9	9.0	29.2	30.3	45.2	27.4	14.2	22.0	24.9	14.0	35.4	58.1	53.1	13.2	14.6	11.5	33.5	18.8	24.2	29.3	20.0	71.9	45.4	15.6	19.0	46.4	4.2	1.3	0.3	1.5	1.2	1.8	1.9	2.1	2.2	3.2	1.7	1.6	1.5	0.8	1.7	1.7	2.0	1.3	2.9	20.2	21.0	19.6	32.6	20.9	21.3	21.0	20.8	22.0	20.0	22.5	19.7	40.5	16.0	25.0	13.1	33.2	44.7	24.2	16.9	39.3	48.0	62.8	54.1	43.6	28.6	15.1	57.0	120.9	45.3	27.2	75.0	138.9	27.4	48.9	29.3	83.5	38.7	15.6	62.9	16.7	31.7	66.9	30.5	7.1	31.3	7.0	16.7	28.2	72.4	91.6	26.9	11.5	49.6	24.4	34.7	80.2	6.8	22.1	60.1	51.6	10.3	36.6	50.4	25.7	7.5	13.4	29.2	91.3	27.1	80.7	60.2	161.6	238.5	11.2	293.7	19.7	20.7	34.5	13.1	52.4	47.3	57.4	86.2	21.0	31.0	37.5	31.1
MEF2A	"RSRFC4, RSRFC9"	ENSG00000068305	"Myocyte enhancer factor 2A"	Q02078	15	99565417-99716466	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 262.8;Microglial cells: 708.3;Oligodendrocytes: 264.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004499, HPA046597"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004499: AB_627921, HPA046597: AB_2679714"	"unprognostic (1.89e-1)"	"unprognostic (8.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (6.93e-4)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-3)"	32.8	22.9	18.7	20.3	25.4	18.3	22.1	16.4	27.6	27.7	12.9	23.5	12.8	34.5	23.8	21.7	21.8	22.6	89.7	21.9	12.1	24.8	24.5	30.4	25.0	17.4	20.7	30.1	12.8	37.6	9.8	26.4	15.4	23.0	15.0	24.2	19.5	23.7	61.5	54.8	17.6	35.7	18.4	27.2	17.8	15.0	28.4	23.3	19.7	81.9	22.9	22.5	16.6	25.7	17.9	10.1	16.7	8.5	20.7	26.3	8.2	17.8	40.8	14.4	19.5	10.4	24.4	22.3	24.5	38.6	22.1	19.3	17.1	14.1	18.6	15.3	24.8	45.2	22.3	9.4	35.4	18.1	21.3	17.6	23.2	19.3	39.7	59.6	26.5	18.3	16.3	41.6	27.0	7.4	29.7	26.3	8.9	11.9	14.6	43.3	36.1	18.5	29.5	24.9	10.7	14.8	27.2	11.6	51.0	17.6	11.0	16.4	43.7	39.8	21.9	19.9	21.7	22.6	27.8	48.5	27.8	19.6	38.7	7.7	12.1	14.3	3.9	15.6	3.3	15.8	3.6	3.6	13.3	12.1	5.0	3.9	10.8	6.5	19.3	7.8	2.6	5.6	18.7	25.4	16.4	27.6	21.9	12.1	17.4	20.7	15.4	18.4	28.4	25.7	152.7	80.1	43.9	113.9	87.2	88.6	31.7	26.9	62.0	52.0	31.6	37.0	175.8	20.0	40.7	29.5	50.1	7.7	32.9	26.5	25.4	18.0	10.4	80.3	60.6	100.6	12.7	24.8	262.8	18.8	3.4	61.5	34.7	130.7	31.0	30.5	50.3	41.0	39.5	30.3	174.9	17.2	12.2	107.5	63.1	7.8	55.9	104.1	35.6	708.3	65.8	25.2	23.7	157.3	264.4	26.8	22.6	64.7	55.6	27.0	18.9	19.7	51.7	44.9	72.3	62.4	69.4	29.9	29.6	29.4	50.4	9.2	27.8	28.8	17.9	26.8
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824690	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	15.9	24.0	17.5	17.6	18.0	12.9	21.4	21.3	23.2	16.6	19.7	17.1	14.5	18.8	23.4	22.2	18.4	14.9	22.1	17.7	19.3	23.7	18.1	15.2	26.6	18.3	19.3	24.8	15.3	33.2	14.5	23.2	18.7	22.8	18.1	25.0	17.0	17.7	26.3	20.5	15.0	19.1	17.7	17.1	16.8	19.3	18.5	24.4	24.7	23.2	32.4	20.6	17.5	19.1	40.1	41.0	69.4	46.0	57.9	36.3	42.7	63.1	43.8	50.3	58.2	64.1	25.6	42.8	58.7	39.4	50.9	70.8	62.5	51.7	58.9	72.9	37.6	103.7	71.6	48.5	45.4	62.3	53.2	34.1	55.3	48.0	43.3	48.0	49.8	48.3	95.8	35.7	60.9	30.0	51.1	47.0	49.2	74.2	35.4	73.9	69.6	27.6	52.0	59.0	43.8	43.0	55.6	47.0	27.0	55.2	70.7	39.5	47.4	50.6	35.8	56.3	51.7	43.5	112.2	91.8	42.5	58.4	37.9	42.5	25.5	56.9	35.3	34.8	34.7	35.0	35.1	33.6	32.6	28.3	35.7	35.0	22.6	50.5	29.1	26.8	44.1	26.3	17.5	18.0	21.3	23.2	17.7	19.3	18.3	19.3	18.7	17.7	18.5	19.1	30.4	35.3	30.2	5.2	32.8	30.3	59.6	50.1	35.9	41.8	22.4	28.8	31.0	25.8	43.2	51.5	6.2	94.6	33.2	27.4	56.7	44.2	6.2	43.1	39.9	35.6	11.3	32.0	9.0	29.4	55.0	29.8	21.4	39.4	46.3	37.6	20.7	18.8	35.4	32.0	8.6	24.4	38.7	20.7	20.5	6.3	28.0	25.5	26.6	5.6	30.6	51.5	33.0	2.0	8.2	26.8	27.1	35.7	20.6	39.3	22.1	42.9	60.0	35.2	19.7	35.9	41.7	49.7	84.8	28.1	27.7	147.4	33.6	39.4	21.3	50.6
MFSD6	FLJ20160	ENSG00000151690	"Major facilitator superfamily domain containing 6"	Q6ZSS7	2	190408355-190509205	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 110.6;Respiratory ciliated cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022274	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA022274: AB_2142776"	"unprognostic (9.47e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.14e-2)"	"unprognostic (9.18e-2)"	20.8	40.3	29.1	12.7	31.7	7.6	21.3	37.0	40.3	21.8	0.0	31.8	19.8	10.5	32.8	40.6	19.5	15.8	17.9	35.5	27.6	10.8	2.3	26.4	14.8	45.8	48.3	4.1	16.8	64.5	35.4	8.6	52.4	23.0	28.9	14.9	30.8	32.3	6.4	29.8	24.6	14.4	28.6	20.9	32.1	7.9	38.3	19.9	38.9	14.2	20.6	22.9	21.5	51.2	25.1	15.2	0.5	5.2	10.6	13.6	20.4	12.7	25.3	8.4	10.5	5.6	31.1	39.1	5.8	26.4	15.6	41.5	7.4	22.1	9.5	79.7	11.6	20.9	14.2	2.9	4.2	8.3	6.4	2.1	39.3	12.5	8.1	27.1	3.0	30.5	5.4	42.2	2.2	9.7	38.8	1.8	3.4	27.1	16.1	8.6	1.2	34.1	15.9	45.1	47.5	12.2	17.9	41.7	24.9	1.7	13.6	9.5	12.6	1.4	2.9	16.6	19.7	19.3	8.6	13.8	13.5	16.9	6.9	4.6	1.1	0.4	1.4	0.3	1.5	1.6	1.8	2.0	1.5	0.7	0.9	1.9	0.1	2.1	0.5	0.7	3.5	0.8	29.1	31.7	37.0	40.3	35.5	27.6	45.8	48.3	52.4	28.6	38.3	51.2	48.6	32.1	20.0	7.2	7.6	6.4	11.5	11.7	10.8	9.7	16.8	9.8	21.4	5.7	30.3	23.9	8.4	0.2	14.9	25.1	0.0	13.2	46.8	27.9	5.9	26.7	35.4	7.8	55.7	20.5	0.2	8.9	31.1	22.5	24.0	8.7	16.1	0.8	4.0	28.6	47.9	42.7	12.2	4.0	8.0	13.7	5.6	12.3	8.8	11.2	9.7	6.8	3.1	41.7	110.6	24.9	20.8	5.3	14.9	13.5	13.6	1.0	88.5	7.9	0.0	16.7	7.2	1.0	1.4	28.8	18.3	0.0	17.0	18.6	21.1	22.7
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 441.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 194.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 276.3;OE19: 558.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010690, HPA010707"	Enhanced		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Endoplasmic reticulum"	"HPA010690: , HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	61.8	92.7	43.5	30.4	42.9	42.6	66.6	45.1	60.6	63.6	54.8	112.5	132.5	39.2	82.1	177.6	70.8	87.6	118.3	42.6	45.7	99.2	393.2	49.0	36.0	46.6	44.6	26.3	66.2	102.0	44.6	75.6	46.5	74.9	121.2	7.8	90.6	50.0	104.2	97.1	143.5	57.4	46.6	60.5	72.5	50.6	45.3	35.1	45.8	118.4	64.6	86.7	78.4	48.9	40.8	58.5	28.7	0.3	4.8	15.4	17.7	7.2	66.1	3.2	10.7	62.3	276.3	0.1	158.2	17.5	13.6	74.8	52.7	81.2	4.9	22.3	47.7	174.9	57.3	251.5	13.3	152.7	130.0	53.0	197.2	2.1	12.5	63.9	166.3	0.3	75.9	25.7	23.3	33.9	0.2	24.7	6.5	558.9	59.4	12.7	33.4	54.0	153.0	87.4	71.9	21.6	53.2	83.2	64.8	2.0	52.9	202.2	104.9	5.6	27.3	7.8	6.4	29.7	22.5	9.7	3.8	254.8	12.6	43.8	103.8	30.4	4.1	64.8	2.9	1.3	7.6	3.5	147.0	2.4	2.3	2.6	17.7	26.4	22.2	194.6	37.7	39.4	43.5	42.9	45.1	60.6	42.6	45.7	46.6	44.6	46.5	46.6	45.3	48.9	327.9	25.6	36.6	5.5	7.7	61.1	295.9	316.7	75.7	7.8	99.1	57.3	100.5	205.9	185.5	95.6	25.0	85.3	71.0	168.3	90.1	121.0	6.3	132.5	27.1	238.4	121.8	60.2	19.4	138.6	62.8	31.8	90.2	172.9	43.2	56.9	203.1	419.3	378.1	6.7	24.2	215.1	170.9	107.8	77.8	12.8	44.4	85.3	39.2	49.6	83.6	14.1	27.8	11.6	4.7	121.8	213.1	33.4	7.1	94.6	441.1	277.2	126.6	3.5	13.1	44.6	49.6	4.6	15.1	264.0	124.9	67.2	15.2	43.6	258.2	344.9
MID2	"FXY2, MRX101, RNF60, TRIM1"	ENSG00000080561	"Midline 2"	Q9UJV3	X	107825755-107931637	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 14.5;Inhibitory neurons: 21.5;Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	6	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 41.5;Karpas-707: 35.5;MCF7: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (8.28e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.69e-4)"	"unprognostic (6.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-1)"	"unprognostic (5.97e-3)"	11.2	9.2	5.2	3.9	6.1	0.4	7.2	4.4	4.2	8.3	4.2	6.0	1.8	9.4	8.0	13.6	8.8	7.7	3.1	3.5	12.1	6.0	5.4	6.4	4.4	7.4	7.1	9.3	9.6	12.9	3.2	4.4	9.1	10.3	3.6	14.8	11.1	9.6	12.9	9.6	2.6	15.8	6.3	3.8	4.4	2.1	9.0	2.3	13.2	18.5	5.2	10.6	7.5	4.8	8.4	7.1	0.2	11.2	8.8	12.3	0.1	5.9	15.0	5.0	3.6	0.6	1.5	0.0	7.5	11.7	8.3	5.2	4.1	12.1	1.1	0.0	5.5	0.0	4.2	0.0	13.5	0.0	0.0	8.0	13.3	0.1	14.5	9.1	41.5	0.5	0.0	35.5	5.6	26.8	0.1	0.0	1.2	0.3	13.0	0.0	3.2	0.0	6.3	7.5	0.6	0.0	12.6	0.5	18.6	3.9	4.6	0.5	8.2	0.0	2.1	9.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.8	1.4	0.0	0.2	1.6	1.1	0.0	0.0	0.0	0.0	0.1	0.4	5.2	6.1	4.4	4.2	3.5	12.1	7.4	7.1	9.1	6.3	9.0	4.8	3.1	3.2	0.0	8.1	0.4	3.1	3.3	0.9	4.0	1.9	2.3	1.8	0.6	1.5	1.1	0.0	0.0	0.0	0.3	0.3	1.9	1.8	1.1	1.0	1.7	2.6	0.0	0.0	14.5	1.5	0.0	1.5	1.1	1.5	0.0	0.3	2.2	1.8	0.1	0.0	21.5	0.2	0.0	0.0	0.0	1.4	0.0	0.2	3.6	7.5	0.0	0.8	0.0	8.0	7.4	1.1	0.0	0.7	1.1	4.2	0.5	0.8	2.3	3.9	0.0	1.9	2.1	0.2	0.4	3.9	3.7	0.0	1.7	0.8	0.4	11.4
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889400	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 108.0;Oligodendrocytes: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	6.3	9.6	3.7	6.2	4.3	5.3	11.1	3.2	5.0	7.5	13.4	12.9	8.8	7.2	12.4	11.5	17.3	7.7	18.4	14.4	4.0	25.4	12.0	7.1	5.1	4.0	5.0	5.4	8.2	14.6	5.4	4.7	4.6	10.9	13.1	6.1	9.7	8.7	13.9	21.4	7.6	7.8	4.0	4.3	8.6	9.8	3.7	6.0	11.1	16.9	7.8	7.7	6.4	4.9	14.6	16.1	7.8	18.4	17.4	23.4	16.6	10.3	16.0	15.1	12.7	21.7	28.1	17.0	10.2	8.4	13.3	35.8	18.1	21.6	18.8	9.9	11.5	7.4	7.0	18.8	14.3	17.5	3.9	11.6	26.4	15.7	13.9	12.7	19.2	12.7	14.5	2.7	24.0	10.8	12.6	9.8	10.8	64.8	16.1	13.8	21.0	14.8	33.7	9.6	18.2	6.1	11.0	17.8	21.8	9.8	18.3	9.7	10.7	9.2	7.6	15.3	11.2	2.6	4.0	9.1	15.9	8.8	11.7	0.0	3.0	1.3	7.4	3.7	9.3	8.7	7.1	6.8	6.5	7.2	6.7	6.7	0.0	10.3	12.0	5.5	5.2	4.0	3.7	4.3	3.2	5.0	14.4	4.0	4.0	5.0	4.6	4.0	3.7	4.9	2.5	16.0	8.6	18.9	5.9	39.9	7.7	13.8	6.2	3.6	6.2	5.8	108.0	11.5	12.6	9.2	6.2	9.8	2.4	8.2	29.4	23.4	8.2	26.0	8.5	5.4	6.0	4.6	43.8	10.6	9.3	8.0	7.1	8.5	2.5	4.2	3.6	5.9	9.7	15.2	47.5	7.1	14.2	3.5	5.0	7.4	6.8	4.3	5.4	12.2	3.4	5.5	5.2	18.1	62.8	8.6	7.0	8.6	4.9	7.5	6.6	25.6	46.3	11.4	0.0	7.3	5.7	9.7	19.0	10.1	42.3	5.1	4.0	8.9	13.6	5.6
MMAA	cblA	ENSG00000151611	"Metabolism of cobalamin associated A"	Q8IVH4	4	145599042-145660033	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 24.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037361, HPA058187"	Supported		Supported	Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA037361: AB_10672107, HPA058187: "	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.97e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.23e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.21e-4)"	4.1	3.2	1.4	3.0	1.9	1.7	4.2	2.7	2.3	3.0	1.3	5.8	7.4	2.4	4.0	4.1	2.7	3.8	3.3	1.5	1.4	7.3	24.5	3.7	3.1	1.3	1.5	2.3	2.0	4.2	0.7	2.8	1.3	2.3	5.3	1.9	3.5	2.8	4.7	3.8	6.2	2.6	1.2	3.5	3.6	4.5	1.3	5.2	3.1	6.0	3.7	4.7	0.8	1.6	2.5	1.4	4.0	2.1	8.4	9.8	1.1	7.1	4.0	2.3	1.4	1.7	4.3	12.1	2.1	4.4	1.1	2.2	2.0	4.4	1.7	7.5	0.8	4.0	1.3	1.5	6.5	5.6	3.3	5.5	6.1	2.6	5.8	3.7	7.2	8.1	1.1	4.6	5.1	3.4	7.2	1.4	1.5	6.2	2.7	3.7	2.2	1.4	13.3	1.3	1.9	1.4	3.5	6.0	3.3	2.4	3.9	1.5	7.0	2.8	1.4	5.0	1.6	2.2	2.0	3.3	4.4	5.5	2.8	3.9	3.1	3.0	4.5	6.1	4.0	3.1	5.3	4.6	3.2	2.6	4.0	5.3	0.5	4.8	7.4	3.3	5.2	2.3	1.4	1.9	2.7	2.3	1.5	1.4	1.3	1.5	1.3	1.2	1.3	1.6	3.6	12.8	5.6	5.5	3.6	2.9	10.4	7.7	5.7	3.4	3.0	2.4	7.6	14.3	13.0	11.0	2.1	7.9	6.5	7.7	15.6	11.1	10.5	5.0	4.5	4.1	2.4	1.7	5.7	12.5	2.8	4.8	7.1	5.7	8.2	3.4	7.9	31.8	4.9	0.0	5.7	6.5	8.2	4.1	1.6	6.3	4.7	3.6	1.8	3.7	5.6	2.3	9.2	8.0	7.4	8.4	7.3	3.0	2.8	6.5	10.9	21.1	6.8	1.6	0.0	4.2	3.8	8.7	5.2	4.4	1.1	7.7	4.5	5.7	6.7	12.2
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000212	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 79.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Alveolar cells type 2: 130.4;Cytotrophoblasts: 329.8;Syncytiotrophoblasts: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	13.4	30.9	24.8	7.8	35.5	11.8	12.2	47.8	51.0	12.1	17.8	8.5	10.4	11.5	16.3	9.6	10.4	10.1	7.0	32.4	22.4	10.8	21.1	8.8	5.6	11.1	11.4	17.4	15.1	11.7	6.2	79.9	16.6	12.4	10.8	22.3	10.9	11.5	20.2	18.7	10.0	11.4	3.9	6.0	8.4	20.2	16.6	5.6	10.2	10.3	7.0	7.5	11.1	55.7	29.8	121.0	11.4	26.4	35.0	40.3	60.5	28.7	30.8	14.6	18.3	64.6	13.1	3.7	14.2	30.5	23.9	22.5	39.8	25.5	17.1	4.6	23.0	6.4	40.7	27.1	25.6	4.7	13.9	20.8	24.3	19.6	28.6	85.7	13.1	4.1	3.9	41.4	32.7	26.7	10.7	6.4	8.9	82.0	45.2	4.2	22.9	4.3	47.0	23.3	9.2	11.5	35.4	33.9	23.0	15.9	19.7	5.0	12.6	22.5	21.4	44.7	15.7	11.1	16.2	11.5	24.0	3.8	16.2	8.3	1.5	1.8	1.9	1.3	1.7	1.7	1.9	1.5	0.7	2.7	2.1	1.7	3.7	1.5	1.7	2.5	1.5	0.4	24.8	35.5	47.8	51.0	32.4	22.4	11.1	11.4	16.6	3.9	16.6	55.7	8.6	131.4	130.4	6.2	5.1	17.5	19.1	4.9	21.1	5.4	11.5	9.5	3.0	10.0	61.8	5.5	4.2	329.8	10.4	3.6	21.5	9.9	0.9	6.2	11.5	13.6	1.8	0.4	4.2	7.4	28.2	33.4	10.2	15.5	66.3	10.3	7.5	24.0	23.4	1.7	6.5	10.5	6.1	2.1	5.0	1.8	11.1	8.2	12.4	3.7	0.3	6.7	3.1	15.1	8.7	7.5	6.7	11.7	5.8	16.4	4.4	12.7	62.2	7.2	26.3	16.9	12.0	9.9	26.6	19.7	16.1	257.8	11.9	10.1	10.1	11.8
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031627			Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA031627: AB_2673966"	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	7.6	13.2	3.4	9.7	3.7	4.7	7.6	2.9	3.4	10.2	4.7	10.9	22.1	10.2	9.5	13.2	13.5	9.4	5.2	3.1	6.2	10.3	19.4	9.1	8.5	4.7	4.1	9.7	8.2	12.8	11.2	23.6	4.0	11.5	10.7	3.0	14.3	11.2	3.1	27.2	20.2	10.8	4.1	12.1	10.7	16.6	5.4	16.2	9.8	4.2	7.0	9.3	10.8	3.4	29.5	17.9	10.4	40.2	8.3	23.5	39.1	19.8	46.5	56.9	80.7	33.2	31.7	0.0	13.2	27.4	21.1	30.5	39.7	47.4	19.6	32.4	24.2	20.2	26.7	37.8	35.3	8.5	19.3	39.9	14.2	34.6	10.9	37.4	49.2	40.7	27.2	9.8	17.8	54.7	32.7	6.6	23.4	12.2	18.1	57.9	26.2	1.3	26.4	31.9	4.4	15.0	40.9	27.5	31.5	20.2	21.4	19.4	29.7	17.6	31.0	12.4	17.8	11.3	3.3	0.1	34.9	17.4	51.4	0.9	3.5	0.7	12.5	10.3	12.4	2.1	10.8	11.1	6.8	1.5	10.3	8.0	1.1	12.7	12.2	1.0	10.2	7.6	3.4	3.7	2.9	3.4	3.1	6.2	4.7	4.1	4.0	4.1	5.4	3.4	13.0	9.6	10.5	26.4	6.3	8.8	10.4	15.5	8.0	2.4	7.8	7.0	4.1	8.6	17.4	16.5	0.0	54.7	5.6	29.2	3.9	15.5	5.9	5.8	7.3	16.9	15.0	3.8	4.1	15.5	18.4	9.4	23.9	7.0	1.3	36.5	16.8	18.3	15.8	5.0	2.3	18.0	12.2	7.5	6.0	6.2	9.3	10.3	3.6	12.2	14.4	15.1	10.3	18.1	3.3	12.4	26.9	7.5	3.6	11.1	46.2	13.9	18.4	1.1	13.1	4.0	7.4	2.7	3.4	11.7	7.0	38.2	9.2	22.4	15.5	12.1
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148917-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003413	Uncertain		Approved	Nucleoplasm,Cytosol		NA	No			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	11.9	9.4	6.0	21.3	8.7	57.9	13.8	18.8	8.6	14.7	5.0	12.9	13.3	15.2	9.2	12.7	15.5	12.8	9.5	6.3	7.3	11.3	14.1	14.5	33.1	6.5	7.2	20.9	11.5	15.3	8.0	13.1	9.2	12.0	12.7	14.8	13.0	11.5	12.6	11.4	14.8	12.1	6.0	25.8	14.7	17.4	7.2	60.3	17.0	17.2	31.7	13.3	10.1	12.1	26.5	7.5	20.8	23.2	14.4	15.6	33.1	16.1	16.0	14.9	14.9	19.4	15.0	52.1	21.2	14.3	17.0	20.4	24.6	16.2	23.5	25.3	11.9	59.6	19.8	11.0	14.8	51.7	26.1	12.6	17.7	11.7	34.0	14.2	15.1	48.1	22.0	47.7	12.5	15.8	93.8	26.7	25.3	14.7	13.1	40.5	33.5	35.3	7.1	21.2	25.2	16.8	37.7	16.1	26.5	16.2	14.7	28.5	20.6	19.0	15.0	17.4	15.1	47.5	28.0	78.7	15.9	20.2	13.2	5.1	2.5	4.1	5.1	2.9	6.2	3.1	4.7	6.0	2.7	5.4	9.6	6.4	5.9	5.1	2.2	1.5	3.9	4.2	6.0	8.7	18.8	8.6	6.3	7.3	6.5	7.2	9.2	6.0	7.2	12.1	15.0	19.2	11.2	18.9	30.4	28.0	15.6	5.6	23.3	12.9	15.8	9.5	15.2	8.6	7.0	12.9	4.2	8.9	47.1	9.3	3.9	5.1	4.1	9.6	15.3	13.9	18.0	23.1	28.0	5.6	6.3	14.7	9.2	12.9	7.0	12.6	16.8	23.4	8.5	16.8	31.6	14.1	2.0	24.2	25.4	3.7	9.3	18.9	21.4	37.5	21.4	8.0	30.9	39.2	55.1	6.4	5.6	8.6	27.8	14.5	7.7	7.4	5.7	9.7	6.6	18.6	12.3	16.0	12.5	22.8	26.7	4.8	36.2	8.5	12.2	14.0
MST1R	"CD136, CDw136, PTK8, RON, SEA"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 62.3;stomach 1: 42.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Distal enterocytes: 53.9;Gastric mucus-secreting cells: 108.6;Intestinal goblet cells: 25.7;Pancreatic endocrine cells: 31.2;Paneth cells: 30.3;Proximal enterocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 39.3;CAPAN-2: 98.8;HaCaT: 56.3;HBEC3-KT: 59.4;hTCEpi: 83.4;RT4: 67.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favorable (2.33e-5)"	5.1	0.3	1.1	5.1	1.1	0.2	3.8	1.1	1.7	5.7	1.3	26.5	25.2	1.3	1.2	17.5	1.7	11.4	3.2	1.1	0.9	3.4	1.1	9.5	2.5	0.9	0.8	1.0	5.8	0.1	2.7	0.8	0.9	4.7	20.1	0.2	5.4	1.0	1.3	62.3	23.9	2.0	0.8	1.6	42.6	8.4	0.9	8.8	3.4	0.7	5.6	9.2	11.5	1.0	39.3	14.4	0.1	0.6	0.0	0.0	2.2	0.5	0.1	0.0	0.0	4.1	98.8	1.7	8.8	0.5	0.1	56.3	0.0	59.4	0.0	0.9	1.0	0.1	25.9	0.9	0.9	0.0	1.2	0.3	83.4	0.2	11.7	0.2	0.1	0.2	0.8	0.3	0.0	5.1	0.1	0.1	0.3	33.1	34.6	2.9	0.0	1.1	35.8	67.9	1.0	0.1	11.5	22.6	0.2	0.1	17.7	0.9	0.3	0.0	0.3	0.3	0.1	0.5	0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	1.1	1.1	1.7	1.1	0.9	0.9	0.8	0.9	0.8	0.9	1.0	1.6	25.6	10.3	0.7	1.0	8.8	2.2	14.2	6.8	0.0	2.8	2.5	1.0	0.0	10.6	0.0	0.0	0.1	0.2	53.9	0.0	6.4	15.4	2.9	0.8	0.6	4.2	0.0	1.1	10.0	0.4	0.8	108.6	5.3	0.0	0.1	0.0	0.0	0.1	0.0	1.1	25.7	2.0	0.0	1.4	10.5	0.3	0.5	0.0	1.0	0.6	0.0	1.0	2.0	0.1	31.2	30.3	0.0	0.5	2.2	27.6	0.1	7.6	0.0	0.0	0.5	0.9	1.3	1.5	3.2	4.7	0.0	0.5	0.0	20.1	6.2
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765108	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 79.3;Excitatory neurons: 61.2;Inhibitory neurons: 58.1;Oligodendrocyte precursor cells: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 104.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018502, HPA075953"	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA018502: AB_1854185, HPA075953: "	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.7	7.2	11.3	11.1	13.0	11.9	12.5	11.7	13.0	9.3	7.1	10.2	9.0	7.9	7.1	20.6	9.7	7.2	12.2	17.3	10.8	8.3	9.0	9.5	21.8	7.5	10.0	8.5	10.0	17.9	9.2	14.2	7.6	10.9	9.4	22.1	12.4	10.9	22.9	21.4	10.4	7.3	9.2	14.3	10.7	8.0	11.9	31.3	10.0	16.0	25.5	12.6	13.5	8.7	32.3	20.3	21.5	17.7	4.9	5.7	28.8	28.1	36.0	28.0	39.4	19.8	24.9	70.2	40.1	22.9	27.1	28.4	43.9	40.8	43.2	28.4	26.3	4.4	31.6	8.5	14.5	20.7	14.6	15.6	27.7	30.8	0.4	26.8	17.1	22.9	13.8	17.5	20.3	27.7	30.6	5.3	9.9	35.9	30.3	16.0	34.1	31.2	22.0	36.4	31.9	19.9	10.7	23.7	8.8	17.0	30.3	11.8	21.7	18.3	14.6	2.3	42.1	22.2	24.6	104.8	3.7	13.3	14.4	0.0	0.5	5.0	2.1	0.9	1.5	1.7	2.3	1.9	1.4	1.9	2.0	2.8	1.5	3.9	0.9	5.0	3.2	1.2	11.3	13.0	11.7	13.0	17.3	10.8	7.5	10.0	7.6	9.2	11.9	8.7	3.7	16.0	6.5	79.3	11.4	11.2	11.0	8.0	6.8	0.0	7.8	5.5	8.2	2.8	7.5	5.5	0.0	10.1	19.3	4.6	0.0	5.9	0.0	10.0	3.7	3.6	9.6	6.5	61.2	6.6	7.3	4.5	7.7	9.2	1.3	4.8	2.9	8.0	4.6	0.0	58.1	5.5	8.2	9.4	8.8	1.7	5.6	4.8	3.6	30.0	6.2	0.0	8.2	54.8	22.6	10.6	8.6	5.3	7.9	11.0	3.8	3.1	8.4	0.0	6.6	6.7	3.9	2.5	3.0	10.3	16.8	10.4	8.8	5.9	5.9	12.5
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 191.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 487.2;Paneth cells: 306.4;Proximal enterocytes: 376.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 48.6;CAPAN-2: 59.4;HaCaT: 119.0;MCF7: 59.0;OE19: 61.7;RT4: 147.8;SK-BR-3: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		NA	NA		9600000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.97e-8)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	12.6	1.0	24.1	7.0	35.0	0.0	8.8	38.2	23.3	13.3	22.0	64.5	83.8	1.5	0.2	63.7	15.4	3.6	41.3	20.0	30.9	10.2	25.4	24.4	0.1	38.7	35.6	0.4	17.3	16.7	18.5	0.4	35.7	8.8	19.5	5.1	44.0	5.7	191.3	87.7	76.7	1.3	29.5	0.1	45.5	2.6	34.4	1.5	33.2	35.1	6.1	11.0	31.8	37.4	48.6	5.0	0.0	25.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.1	59.4	0.2	30.1	0.0	3.7	119.0	0.1	0.0	0.0	0.1	8.7	0.0	0.0	25.7	0.0	0.0	17.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	59.0	0.0	0.3	0.8	61.7	0.7	0.1	29.4	0.7	0.0	147.8	0.1	0.2	2.9	51.8	0.0	0.2	9.7	1.9	0.0	0.1	11.7	0.2	0.1	0.9	11.2	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	35.0	38.2	23.3	20.0	30.9	38.7	35.6	35.7	29.5	34.4	37.4	0.1	80.1	36.5	23.5	2.8	3.3	18.7	29.3	0.0	3.7	17.9	9.3	21.8	44.3	50.9	57.0	2.1	0.1	0.3	487.2	0.0	53.2	0.9	58.1	6.0	1.2	51.6	0.0	10.9	27.2	0.1	1.1	85.1	70.7	14.7	0.0	2.9	45.8	0.1	16.8	21.7	109.4	22.4	0.8	1.6	0.8	0.3	1.3	5.4	2.8	0.0	19.7	0.0	23.6	27.5	67.5	306.4	0.0	0.3	30.8	376.1	7.6	80.6	11.5	0.0	17.7	3.5	0.5	4.6	30.8	21.0	0.0	2.0	0.0	122.8	86.2
NAB1		ENSG00000138386	"NGFI-A binding protein 1"	Q13506	2	190646746-190692766	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 102.0;Suprabasal keratinocytes: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002738	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"HPA002738: AB_1079447"	"unprognostic (1.44e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.04e-3)"	"unprognostic (9.05e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.52e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.85e-2)"	29.3	20.3	19.4	23.5	16.7	18.6	34.8	50.4	23.5	28.1	7.4	22.8	15.8	32.3	50.1	36.3	27.5	28.0	28.5	18.7	9.7	19.9	37.8	22.8	26.8	13.4	13.2	26.0	17.9	23.5	21.1	26.4	14.9	18.5	25.6	41.4	20.7	20.9	8.0	66.7	17.1	25.2	14.9	19.8	37.9	26.0	13.8	21.2	37.9	17.2	26.3	31.2	24.2	25.9	35.5	25.8	65.0	22.6	24.5	42.7	111.0	35.5	55.7	26.4	29.8	62.8	38.4	39.6	40.6	28.3	48.9	88.4	37.4	45.9	51.8	126.1	31.0	46.7	96.3	30.2	15.8	19.8	22.4	24.6	70.4	55.9	17.1	37.4	41.5	23.9	46.3	33.2	40.6	17.4	28.7	20.0	22.8	38.4	35.2	35.0	46.7	15.9	19.3	34.5	57.9	46.9	41.8	13.9	37.3	82.8	11.4	30.6	29.0	54.5	43.0	31.0	21.6	25.7	30.3	29.5	57.3	17.6	43.7	0.0	1.3	0.6	1.3	1.1	1.9	0.7	1.3	1.7	0.9	0.4	1.4	1.5	2.9	2.6	3.7	0.8	3.3	0.8	19.4	16.7	50.4	23.5	18.7	9.7	13.4	13.2	14.9	14.9	13.8	25.9	24.1	6.4	21.2	14.0	5.9	102.0	23.1	24.6	31.3	26.1	19.7	19.7	18.2	11.5	29.8	12.9	12.5	4.3	9.2	11.4	3.9	10.3	1.4	17.5	10.8	30.1	14.4	12.0	37.2	8.0	11.1	25.2	21.4	23.4	20.3	14.2	44.6	25.7	6.7	6.7	21.2	17.5	14.2	17.3	77.4	3.2	13.4	20.7	39.2	24.4	10.6	12.4	11.3	29.1	28.3	10.2	26.3	14.7	14.9	30.5	4.8	5.1	22.3	15.5	46.0	24.6	39.2	1.7	27.3	55.7	138.9	1.2	16.7	7.3	16.0	29.9
NCOA6	"AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP"	ENSG00000198646	"Nuclear receptor coactivator 6"	Q14686	20	34689097-34825651	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 130.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004198, HPA050211"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004198: AB_1078228, HPA050211: AB_2681052"	"unprognostic (2.48e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.78e-5)"	"unprognostic (9.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.42e-2)"	10.2	9.0	5.2	9.1	6.7	14.0	9.2	12.7	12.4	10.8	4.8	12.9	13.2	10.7	12.2	11.7	11.3	8.8	9.2	6.1	8.2	9.9	8.4	10.4	8.9	6.3	4.6	11.6	12.6	22.0	10.0	13.5	4.6	9.8	14.5	26.7	12.9	11.3	12.7	13.5	12.0	13.2	2.3	9.4	11.4	18.8	7.4	18.1	13.8	13.1	10.3	10.4	10.5	9.6	25.2	14.7	32.6	19.7	17.5	19.4	21.3	12.0	15.3	21.1	16.9	37.9	17.2	17.7	12.9	21.5	25.8	30.0	29.3	20.2	23.9	9.0	13.2	41.6	16.7	22.4	19.3	23.5	29.4	14.8	36.5	19.8	24.5	14.6	20.2	20.1	21.5	23.7	17.7	16.3	37.5	14.8	6.7	21.0	21.1	24.9	39.3	15.9	15.6	16.6	27.2	18.5	22.0	52.5	20.5	15.0	22.2	18.5	20.0	34.1	20.7	25.6	20.2	26.9	24.3	20.0	22.5	13.5	15.5	1.1	0.6	2.5	0.9	0.5	0.8	1.0	0.8	0.8	1.1	0.8	0.7	0.5	1.5	0.7	0.7	1.0	0.5	0.5	5.2	6.7	12.7	12.4	6.1	8.2	6.3	4.6	4.6	2.3	7.4	9.6	17.3	25.6	16.0	54.9	11.0	17.0	9.1	10.6	13.6	28.8	14.3	10.9	20.1	18.6	11.6	16.5	29.2	13.0	12.2	31.9	5.9	12.5	23.5	16.4	21.3	14.0	10.8	13.3	50.9	12.4	12.1	14.5	15.8	23.3	6.3	18.5	13.9	12.1	10.8	33.7	58.8	17.4	20.3	12.2	10.3	17.3	18.0	13.0	10.6	45.9	17.6	11.5	13.4	54.3	130.4	15.4	12.4	13.5	14.2	16.9	20.3	9.3	17.5	29.8	26.3	16.6	16.9	25.6	27.1	19.2	20.9	15.9	13.1	13.6	17.6	14.6
NECAP2	FLJ10420	ENSG00000157191	"NECAP endocytosis associated 2"	Q9NVZ3	1	16440721-16460078	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 314.8;monocytes: 202.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028077	Approved		Approved	"Endoplasmic reticulum"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"HPA028077: AB_10601273"	"unprognostic (6.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.38e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.58e-2)"	38.1	37.9	28.4	51.7	31.0	29.0	34.3	30.7	32.8	31.6	29.5	30.9	23.4	22.8	19.2	43.5	32.8	30.5	22.2	27.0	30.4	33.2	31.7	51.7	77.6	34.6	29.5	36.8	22.1	23.7	19.8	59.9	31.5	25.4	29.5	14.2	26.6	21.0	8.6	45.7	32.0	30.2	32.0	73.3	30.5	33.7	32.5	55.9	25.7	12.8	63.3	44.4	31.1	32.7	54.1	29.2	30.5	36.0	60.6	65.0	17.9	59.6	83.3	76.8	67.9	32.1	87.1	47.8	70.4	111.2	35.4	35.8	43.1	60.3	63.9	100.0	44.3	46.7	33.4	44.6	78.9	59.8	41.7	73.0	61.6	54.7	44.9	66.2	129.1	54.4	67.0	153.7	69.1	35.3	55.8	63.3	26.6	41.1	41.9	61.2	27.0	79.6	76.9	30.5	19.1	48.6	46.4	27.1	61.9	45.1	30.9	66.1	148.0	49.2	26.8	57.4	41.1	72.5	74.5	47.9	41.6	85.7	49.0	90.2	173.1	112.3	96.1	241.2	95.6	108.8	165.8	114.5	120.1	98.8	168.2	106.6	68.2	121.6	274.7	71.0	214.7	269.9	28.4	31.0	30.7	32.8	27.0	30.4	34.6	29.5	31.5	32.0	32.5	32.7	53.6	22.4	25.0	10.1	47.6	52.3	34.1	60.4	27.3	25.7	37.9	35.1	7.0	22.8	32.2	20.2	314.8	49.0	42.5	34.6	23.5	71.3	61.1	27.0	29.5	67.8	18.7	40.8	7.0	54.2	62.0	33.3	23.9	27.6	27.8	33.0	96.4	11.0	125.7	15.2	7.7	31.8	36.7	94.5	81.8	34.3	29.8	60.5	24.9	7.5	202.0	23.8	55.6	11.6	11.4	121.9	45.8	33.8	24.3	46.6	30.8	22.8	37.4	54.3	39.5	14.7	27.2	26.8	27.4	33.3	56.0	49.4	59.4	72.7	24.0	58.8
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070998-161089558	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.9;skin 1: 113.6;vagina: 57.3"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 384.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 56.5;HaCaT: 37.0;MCF7: 24.0;OE19: 24.6;SK-BR-3: 47.8;T-47d: 31.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	No	No		170000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.4	0.1	0.1	0.5	0.1	0.7	13.7	0.3	0.2	26.5	0.0	1.5	0.7	1.2	6.9	98.9	2.9	3.8	0.1	0.1	0.0	3.1	0.1	3.5	0.1	0.1	0.1	0.0	4.5	0.4	0.6	12.2	0.1	9.4	1.7	0.1	33.6	4.3	0.6	113.6	0.6	0.1	0.0	0.0	8.8	0.6	0.3	0.8	0.2	0.0	14.5	16.8	57.3	0.4	10.9	0.4	0.0	0.1	0.0	0.1	56.5	0.1	0.1	0.1	0.2	0.0	14.6	0.0	0.2	0.0	0.1	37.0	0.0	1.2	0.2	0.0	0.5	0.0	0.8	11.1	0.0	0.1	0.7	0.0	14.6	3.0	3.6	0.1	0.0	0.0	0.0	0.1	0.1	24.0	0.1	0.1	0.1	24.6	0.0	0.0	0.0	0.1	0.0	17.5	0.0	0.2	0.2	47.8	0.0	6.4	31.1	0.0	0.0	0.1	2.4	0.5	0.2	0.2	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.2	6.4	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.6	17.8	0.0	0.0	8.1	16.5	0.0	39.4	0.4	0.0	0.0	41.7	0.0	28.1	2.9	0.6	0.0	0.0	0.0	30.0	67.1	1.2	0.0	43.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	67.1	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	384.2	0.4	0.1	0.0	0.0
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787345	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 68.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA073029: AB_2732216, HPA073916: AB_2732245"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.05e-1)"	9.5	27.8	29.2	5.9	28.8	2.3	9.5	27.7	27.9	13.1	23.8	8.6	2.8	9.5	12.5	6.9	15.0	5.7	14.6	29.6	35.6	12.8	16.3	7.4	7.1	32.0	34.3	11.1	11.2	9.0	17.9	6.4	36.8	11.3	4.8	13.4	10.0	8.1	24.5	15.8	6.8	8.5	31.9	12.4	6.9	26.1	36.1	4.7	11.8	13.7	6.9	9.8	8.8	28.3	8.2	22.9	14.1	27.7	6.6	12.2	6.3	13.0	10.6	12.2	8.4	7.1	8.8	3.2	4.9	15.7	26.3	7.1	13.5	14.1	16.7	9.7	6.7	11.3	5.7	13.9	5.3	5.0	8.2	10.8	20.7	10.7	9.9	11.8	11.6	3.7	16.1	10.8	15.0	8.6	0.9	5.2	12.6	33.9	12.1	14.4	18.1	8.8	14.4	12.3	21.5	17.0	10.2	5.3	19.1	11.2	8.4	0.7	14.3	13.9	19.8	3.8	18.4	10.0	22.3	5.7	36.6	16.7	28.8	0.7	2.2	0.2	12.7	3.9	17.5	21.9	12.9	15.3	4.6	16.9	18.7	16.8	1.3	15.1	2.0	8.3	9.3	7.0	29.2	28.8	27.7	27.9	29.6	35.6	32.0	34.3	36.8	31.9	36.1	28.3	7.2	0.0	5.8	6.2	14.0	8.5	17.1	8.0	13.6	32.3	13.1	7.7	19.6	14.3	7.0	7.3	16.7	18.6	5.6	1.5	33.2	21.1	1.1	6.9	8.4	8.9	10.1	10.3	6.3	23.3	15.8	10.3	3.1	3.8	2.5	14.9	7.9	23.6	15.1	8.4	6.9	6.1	14.2	6.9	6.6	2.1	14.0	6.8	14.2	0.0	6.6	38.9	11.3	6.0	3.7	15.1	1.0	24.5	3.8	15.3	0.8	32.2	6.8	17.1	6.6	11.8	10.2	19.0	68.1	8.3	12.8	5.3	9.7	8.9	6.2	12.0
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290512-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	16.8	16.8	13.7	15.6	14.5	21.9	20.6	20.4	17.6	15.5	15.9	17.1	16.9	17.4	15.7	18.3	15.4	12.4	23.4	13.8	15.0	14.6	27.7	16.0	22.3	13.7	12.8	21.9	15.8	23.4	13.5	13.5	13.5	16.5	19.1	19.4	17.9	16.0	37.7	25.5	17.5	15.7	10.9	18.2	15.8	12.2	14.0	26.3	22.9	26.5	25.2	16.8	15.7	18.2	29.8	24.0	21.4	20.3	31.3	35.1	21.5	27.6	27.4	30.6	30.5	21.7	11.9	46.0	17.0	32.0	20.5	16.3	38.8	29.8	28.4	33.9	18.9	24.1	58.2	24.5	38.1	43.3	25.6	32.7	48.9	26.1	65.4	27.3	18.9	25.6	37.6	38.3	32.2	20.9	28.3	40.7	34.7	21.9	26.8	30.0	23.3	25.2	20.7	28.1	29.3	20.6	27.5	29.3	15.9	25.1	17.0	42.7	23.8	24.8	20.6	18.1	30.4	20.4	19.9	44.6	27.3	21.5	14.4	35.9	5.5	10.4	9.8	8.9	10.5	13.0	10.7	10.8	9.0	10.3	11.8	11.9	3.5	9.3	7.4	15.4	7.6	6.7	13.7	14.5	20.4	17.6	13.8	15.0	13.7	12.8	13.5	10.9	14.0	18.2	16.0	60.9	42.5	35.3	41.9	8.4	24.6	12.5	21.6	29.3	13.2	13.5	36.9	22.8	35.4	27.6	54.2	12.5	17.2	20.6	7.9	16.1	65.9	16.7	19.0	14.9	9.1	25.2	59.7	13.2	11.8	18.5	26.5	19.8	18.9	15.7	17.5	32.4	15.0	21.9	59.0	23.9	12.2	19.4	10.2	17.0	18.3	19.0	3.6	47.8	16.4	13.7	16.5	37.7	55.0	12.4	21.6	23.0	47.1	25.3	23.3	8.2	43.7	32.2	13.1	27.3	17.5	16.1	14.8	20.9	11.2	18.1	20.9	19.2	16.7	21.0
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122677	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 5.0;Exocrine glandular cells: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 6.8;K-562: 6.1;SCLC-21H: 6.1"	"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (5.30e-4)"	1.2	1.4	2.0	0.8	2.3	1.1	2.0	1.5	2.6	0.8	0.8	1.5	1.4	0.8	2.6	1.1	1.4	0.6	1.8	2.4	1.9	0.8	4.1	1.2	0.6	2.5	1.8	1.4	1.8	1.2	1.2	0.5	2.7	1.2	1.3	2.0	2.3	1.0	2.6	3.8	1.9	0.8	1.6	1.1	1.3	0.7	2.0	1.0	1.6	1.5	0.8	0.9	0.8	3.6	2.6	1.5	0.6	0.0	1.3	1.2	0.0	2.6	0.8	0.9	0.5	0.1	2.1	0.0	6.8	1.9	0.2	3.0	0.0	1.7	0.7	0.1	0.9	0.4	1.0	0.1	2.0	0.0	1.7	2.1	2.5	1.0	0.9	0.6	2.1	0.0	6.1	0.1	2.1	2.8	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.1	1.4	2.8	6.1	0.1	5.3	4.3	1.6	0.6	3.1	1.7	0.4	0.2	1.3	1.8	0.1	0.1	0.0	0.1	0.1	0.0	2.6	0.5	4.4	0.4	0.6	4.9	0.8	2.3	1.1	0.5	4.7	1.3	1.5	1.0	0.3	1.6	2.3	0.6	1.3	1.8	2.0	2.3	1.5	2.6	2.4	1.9	2.5	1.8	2.7	1.6	2.0	3.6	0.8	0.0	2.2	0.3	0.2	1.9	1.4	1.4	1.8	0.4	1.5	2.0	0.9	1.5	2.3	0.0	0.0	0.4	0.0	0.2	0.0	2.9	0.0	0.6	1.3	0.3	3.5	5.0	1.0	3.7	0.0	0.8	1.5	0.5	1.3	0.8	0.4	1.1	1.2	0.0	0.7	0.3	0.0	0.8	0.6	0.0	0.6	1.5	1.8	1.0	0.5	1.1	0.0	1.5	1.2	2.0	0.3	0.0	0.0	0.2	0.6	1.2	0.8	1.0	0.0	0.3	0.8	0.2	0.2	1.3	1.8	0.4	0.1	1.1	0.5	0.5
NINJ1	NIN1	ENSG00000131669	"Ninjurin 1"	Q92982	9	93121496-93134251	"Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Cytolysis, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 286.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 539.9;Langerhans cells: 741.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1668.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 1668.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 197.5;MCF7: 191.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045063	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"			"HPA045063: AB_10964133"	"unprognostic (1.23e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.46e-3)"	60.9	129.8	51.0	39.9	48.9	286.9	53.0	47.9	58.7	47.6	50.2	60.1	27.0	36.5	20.2	25.7	47.6	39.2	64.0	44.2	51.9	100.4	118.0	65.0	41.5	54.5	53.2	35.9	35.0	137.7	59.2	66.6	53.3	58.9	16.5	6.1	77.3	56.2	38.0	80.4	37.6	36.0	57.6	89.9	42.5	37.6	57.2	30.5	71.4	30.0	19.6	100.5	37.9	59.2	45.0	68.2	13.2	30.0	47.4	19.1	51.6	30.2	85.9	43.5	26.7	29.5	15.5	0.6	15.0	29.7	47.6	44.8	14.7	84.6	9.4	103.3	28.7	6.8	17.2	197.5	163.7	4.8	13.8	62.5	80.9	41.1	22.5	132.4	41.3	16.3	5.0	49.6	9.9	191.1	13.9	13.8	18.7	51.9	53.0	24.6	10.3	79.0	35.0	18.6	4.3	18.4	67.3	105.4	41.9	22.0	81.9	31.3	31.1	15.8	44.6	33.2	22.9	26.2	11.4	1.0	48.2	14.8	12.1	152.9	313.3	824.9	69.8	315.4	94.5	7.8	65.0	59.3	75.9	2.4	76.5	55.1	1668.9	44.7	355.8	10.7	73.8	219.1	51.0	48.9	47.9	58.7	44.2	51.9	54.5	53.2	53.3	57.6	57.2	59.2	15.7	28.9	41.6	6.5	24.3	114.6	75.8	273.0	130.3	1.8	117.8	96.6	31.6	62.9	80.7	40.5	0.0	128.3	45.8	19.4	129.1	95.2	3.9	22.9	20.9	46.9	18.0	3.0	3.4	101.7	78.3	64.9	20.9	24.5	47.0	13.8	23.6	48.5	539.9	1.7	3.9	21.3	111.9	176.9	741.7	21.1	42.0	278.1	147.7	18.7	214.9	76.1	33.0	3.0	1.7	68.7	23.7	72.6	32.5	60.3	75.5	240.6	18.8	3.8	13.1	45.7	53.3	0.9	11.4	36.3	135.7	73.3	54.7	4.5	19.7	76.9
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.0;parathyroid gland: 39.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.6	18.4	11.0	0.1	16.9	1.2	2.1	7.4	40.0	4.9	2.2	1.1	2.2	5.0	0.9	1.0	3.2	1.9	2.3	12.4	9.2	6.6	1.6	1.8	0.6	7.5	7.6	1.5	11.0	39.2	18.5	0.5	10.0	6.6	1.0	5.7	2.7	1.4	0.3	2.2	1.2	3.6	2.3	12.5	1.9	5.1	7.1	2.9	25.3	0.3	0.4	2.0	2.3	13.5	3.9	0.5	0.2	0.2	0.9	0.0	1.5	0.5	0.5	2.4	4.9	1.6	3.6	0.0	1.1	0.0	0.2	17.7	0.5	0.0	1.4	0.1	0.5	14.5	1.0	32.4	3.1	1.9	1.3	0.5	2.3	0.0	0.3	3.7	0.0	9.5	0.5	0.0	0.1	0.0	0.2	3.9	0.7	6.4	0.4	0.3	1.4	0.8	5.6	0.1	3.8	0.2	0.0	0.1	4.6	0.0	0.7	11.2	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	11.0	16.9	7.4	40.0	12.4	9.2	7.5	7.6	10.0	2.3	7.1	13.5	0.1	0.0	1.1	1.0	0.7	0.1	9.7	3.7	0.6	29.4	3.1	5.2	2.1	5.7	8.8	0.0	20.9	0.1	0.5	0.6	3.9	9.4	15.1	1.1	0.3	0.6	11.4	0.4	21.3	8.0	0.2	1.7	1.5	1.1	0.0	1.4	2.5	0.5	4.6	6.7	21.9	2.1	2.0	0.0	0.3	14.4	0.6	0.9	10.6	1.9	1.0	0.9	0.0	2.5	1.6	4.3	0.8	0.4	0.6	3.4	0.5	14.6	7.7	4.2	0.0	0.4	1.6	0.5	0.9	1.1	1.1	0.3	2.7	7.6	1.2	5.8
NVL	NVL2	ENSG00000143748	"Nuclear VCP like"	O15381	1	224227334-224330189	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714"	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (5.77e-5)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	7.0	7.7	5.5	8.7	5.7	9.8	10.7	7.8	7.5	9.5	6.5	9.1	6.3	9.0	7.7	7.2	8.8	5.6	5.9	5.3	6.4	8.7	6.1	8.0	12.5	5.4	5.3	10.6	8.8	9.5	10.3	13.0	5.6	9.0	10.6	12.8	7.4	7.9	6.5	15.7	8.2	8.1	4.7	10.4	7.2	6.6	5.6	13.0	10.2	5.2	12.1	8.8	8.9	7.5	28.8	15.8	31.2	25.2	11.5	16.6	31.6	22.0	16.5	30.6	27.0	23.4	23.4	39.6	22.5	14.7	11.7	26.1	37.3	22.2	31.5	30.5	47.0	16.4	25.5	11.3	20.3	39.1	28.8	13.5	16.9	26.8	28.5	14.3	19.2	23.0	48.9	23.8	19.1	21.3	30.6	18.3	47.5	20.0	26.1	34.2	37.3	24.8	17.8	19.2	27.5	22.9	34.2	53.1	31.9	25.6	24.3	32.1	19.8	23.2	14.9	27.1	42.9	15.6	33.3	39.3	15.1	30.2	24.8	13.9	7.8	8.4	11.5	11.8	11.7	13.5	11.8	9.1	8.7	9.0	9.9	10.0	0.8	11.9	16.4	9.0	9.3	7.8	5.5	5.7	7.8	7.5	5.3	6.4	5.4	5.3	5.6	4.7	5.6	7.5	10.2	22.4	23.1	21.2	14.3	5.2	4.6	7.8	4.0	14.5	7.9	8.3	10.5	7.2	12.2	1.8	10.4	21.5	12.6	26.9	13.7	9.5	10.1	10.0	11.6	9.3	4.2	7.2	32.1	8.4	14.0	9.3	5.6	7.3	16.4	13.4	4.6	4.5	10.7	10.1	31.0	12.6	10.2	6.5	5.7	3.1	9.6	8.1	5.4	26.2	8.7	9.7	15.5	24.6	43.0	7.0	23.4	10.9	12.3	3.7	7.0	8.1	16.7	20.4	0.0	8.5	10.1	17.5	11.3	7.3	4.5	18.3	12.9	11.4	14.7	3.7
ODF3L1	MGC48986	ENSG00000182950	"Outer dense fiber of sperm tails 3 like 1"	Q8IXM7	15	75724041-75727688	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 22.6"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 111.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.0;HeLa: 1.2;U-87 MG: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (6.24e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.58e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.55e-4)"	"unprognostic (9.65e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.40e-2)"	"unprognostic (4.14e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.45e-2)"	1.4	0.1	0.3	0.3	0.2	0.3	1.1	1.3	0.4	0.6	0.4	1.4	0.5	1.2	0.1	1.2	1.0	2.6	1.1	0.4	0.1	0.2	1.1	1.6	0.1	0.1	0.5	0.2	0.4	0.1	1.1	0.2	0.1	0.4	0.4	0.0	0.1	0.1	0.1	1.7	0.8	0.9	0.0	0.3	1.7	22.6	0.2	0.6	1.4	0.0	0.1	0.9	0.2	0.1	0.0	1.0	0.3	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.9	0.0	0.6	0.0	0.7	0.4	0.0	1.2	0.2	0.2	0.0	0.0	0.6	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.3	0.4	0.4	0.1	0.1	0.5	0.1	0.0	0.2	0.1	0.1	0.0	1.1	0.0	0.4	6.1	9.7	0.9	0.0	0.0	0.6	0.3	0.0	0.0	2.5	0.0	0.0	1.6	0.1	0.7	0.0	0.3	111.2	2.7	0.5	0.3	0.0	0.0	0.1	0.0	0.9	2.1	1.5	1.8	0.0	0.2	1.1	0.3	0.4	0.0	0.0	1.2	0.0	0.0	2.7	11.9	0.0	1.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.7	0.8	0.9	1.6	0.7	0.3	0.0	6.6	2.7	1.0	8.0	0.4	0.0	6.5	1.9	0.4	0.1	0.5	4.1
OLFM2	"NOE2, OlfC"	ENSG00000105088	"Olfactomedin 2"	O95897	19	9853718-9936552	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 202.6;skin 1: 94.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.4;Basal keratinocytes: 125.0;Muller glia cells: 91.1;Oligodendrocyte precursor cells: 124.7;Suprabasal keratinocytes: 118.1"	"Cancer enhanced"	"Detected in all"		"glioma: 96.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 49.7"	"Group enriched"	"Detected in many"	26	"granulocytes: 49.7;T-cells: 17.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;ASC diff: 23.4;BJ hTERT+: 18.5;SH-SY5Y: 24.3;U-2 OS: 28.7;WM-115: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049961, HPA057771"	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		2700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA049961: AB_2680972, HPA057771: AB_2683524"	"unprognostic (1.42e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	36.8	30.7	130.8	3.4	134.5	0.2	25.0	118.5	202.6	17.2	80.7	4.8	2.1	16.7	4.5	5.6	11.1	6.7	10.1	134.0	127.3	9.2	41.9	10.1	7.9	152.5	168.8	9.7	11.2	9.6	19.1	7.1	162.0	10.1	1.1	24.6	10.0	13.4	1.8	94.8	3.8	6.7	130.0	2.5	2.2	10.7	123.2	16.5	13.2	1.0	4.8	3.0	14.1	120.7	0.0	3.7	3.0	25.6	23.4	14.3	1.7	5.6	18.5	1.2	1.5	0.3	2.4	0.1	2.3	4.2	2.1	1.5	9.8	1.7	0.1	0.1	2.1	0.0	0.2	0.3	0.1	0.0	4.3	7.5	1.5	0.1	0.2	0.7	0.1	4.8	0.3	0.3	0.0	8.2	0.3	0.2	15.8	2.5	0.0	0.1	0.0	0.0	0.0	0.9	0.1	24.3	0.9	0.1	5.2	9.7	0.9	0.0	0.3	10.5	28.7	0.1	0.1	0.0	0.0	0.0	0.3	0.0	25.6	21.2	0.0	49.7	6.2	0.0	6.6	0.0	7.0	5.5	0.0	0.0	13.5	8.9	0.5	1.2	0.0	0.1	17.0	2.9	130.8	134.5	118.5	202.6	134.0	127.3	152.5	168.8	162.0	130.0	123.2	120.7	12.9	0.0	0.0	108.4	0.3	125.0	4.7	5.9	8.6	4.9	6.9	13.8	0.8	7.2	0.4	7.3	0.0	0.1	1.0	0.1	1.9	0.9	8.6	0.9	2.2	4.3	1.2	0.4	27.3	2.4	0.0	17.2	0.0	1.0	4.5	6.5	1.4	24.7	0.3	1.7	51.0	0.2	2.0	0.3	32.6	52.8	13.7	0.6	17.8	15.0	0.4	91.1	7.2	124.7	3.5	4.1	0.0	9.8	0.5	7.9	0.0	0.2	0.2	3.7	0.0	7.4	24.3	3.0	10.4	1.4	118.1	0.1	7.7	0.6	0.1	2.9
OSBP	OSBP1	ENSG00000110048	"Oxysterol binding protein"	P22059	11	59574398-59615774	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039227, HPA043625"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		70000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039227: AB_2676401, HPA043625: AB_2678587"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"prognostic favorable (2.08e-5)"	"unprognostic (7.80e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.08e-7)"	"unprognostic (1.25e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	19.6	41.7	14.1	15.5	15.2	27.2	27.4	15.3	18.9	24.7	18.4	26.8	29.4	20.0	31.6	19.6	22.4	19.5	25.5	15.0	15.6	42.8	57.6	18.5	17.8	15.4	16.7	22.4	37.3	44.9	16.1	22.9	16.7	25.9	28.3	15.9	30.1	27.0	57.7	26.6	25.5	21.2	14.0	15.6	27.8	18.0	15.7	24.0	32.3	43.8	23.7	19.6	17.1	15.1	40.9	33.6	24.7	33.2	56.5	52.4	26.8	32.9	42.3	38.4	34.4	38.1	40.2	41.1	42.7	37.9	47.2	41.4	45.4	43.5	43.0	40.0	20.9	28.1	25.1	25.8	60.2	36.2	52.9	40.4	52.8	36.2	94.4	40.0	41.7	38.3	48.6	37.3	34.5	19.0	34.0	26.2	28.0	59.5	32.7	32.5	39.8	28.6	45.6	47.0	28.5	20.3	38.6	47.7	46.0	33.6	66.9	22.7	45.8	32.7	22.8	49.5	22.3	51.9	45.2	41.4	37.0	25.6	26.8	1.7	1.6	1.5	2.8	1.4	2.6	2.2	2.9	2.3	1.6	1.6	2.6	2.1	1.5	2.2	1.3	4.0	1.3	1.1	14.1	15.2	15.3	18.9	15.0	15.6	15.4	16.7	16.7	14.0	15.7	15.1	29.2	25.6	9.0	14.7	18.9	39.6	16.4	13.7	29.6	23.8	38.0	27.1	34.1	32.9	19.0	27.6	22.9	14.2	31.1	34.0	7.9	14.0	8.8	37.9	52.7	21.8	30.0	10.5	25.6	18.6	14.7	21.1	22.4	43.8	27.9	21.8	15.4	67.1	16.0	26.9	22.9	40.0	8.2	12.9	16.9	14.5	15.8	17.9	14.2	12.2	9.6	15.7	18.6	18.1	23.3	20.2	20.5	19.9	32.2	31.2	34.6	21.0	27.8	21.7	6.6	28.4	19.3	25.1	14.5	27.0	47.3	30.8	20.0	43.5	28.4	26.4
OSTF1	"bA235O14.1, OSF, SH3P2"	ENSG00000134996	"Osteoclast stimulating factor 1"	Q92882	9	75088514-75147265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 329.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 302.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020514	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA020514: AB_2670461"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (3.67e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.76e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	44.3	36.9	27.8	65.7	35.0	56.3	34.9	32.0	37.2	34.1	25.4	42.5	38.2	22.7	38.2	104.8	20.0	42.8	32.0	28.3	33.2	34.6	57.7	56.4	74.9	31.0	32.5	16.0	19.4	72.1	19.1	69.9	33.1	22.7	45.8	12.3	38.5	19.6	9.5	63.1	47.8	28.8	30.8	87.0	40.6	18.0	31.0	47.8	29.0	16.0	85.0	55.3	53.9	35.1	69.1	16.0	7.7	11.2	45.4	41.7	81.3	71.9	46.9	26.9	24.4	8.2	50.8	70.9	35.3	59.2	34.6	111.8	12.9	51.9	77.0	302.0	16.0	39.3	24.8	42.5	36.7	71.5	141.6	29.1	49.2	31.6	21.8	23.7	91.2	59.4	13.4	158.4	65.4	35.9	107.5	44.8	14.5	161.5	30.8	20.1	52.3	63.0	57.0	97.1	6.5	0.6	53.1	74.1	36.2	58.2	97.4	79.9	86.4	55.8	19.4	108.3	30.8	30.1	52.5	26.7	67.1	81.9	46.4	359.5	177.7	464.8	158.6	199.3	169.6	101.2	110.5	131.5	148.7	87.4	62.1	109.8	495.2	168.4	256.8	110.6	163.0	283.0	27.8	35.0	32.0	37.2	28.3	33.2	31.0	32.5	33.1	30.8	31.0	35.1	113.4	22.4	24.4	8.1	90.8	82.2	61.2	78.2	61.5	2.9	38.6	23.2	7.8	28.6	51.2	33.1	6.2	125.5	162.1	64.8	76.3	49.7	11.9	42.8	59.4	60.5	27.2	23.3	32.0	52.3	252.9	42.1	31.1	51.1	137.6	4.2	71.7	32.2	233.1	10.1	12.6	31.9	69.2	167.4	181.5	6.0	23.9	155.7	76.5	43.1	329.9	6.0	268.8	30.2	67.3	60.5	97.7	15.4	83.2	34.1	64.1	63.0	27.3	8.6	19.7	15.9	45.0	6.7	17.8	141.4	114.5	133.9	163.8	37.6	38.2	91.6
OTUD1	"DUBA7, OTDC1"	ENSG00000165312	"OTU deubiquitinase 1"	Q5VV17	10	23439075-23442377	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 149.0;Langerhans cells: 219.1;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.1;HaCaT: 36.5;SiHa: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038503, HPA038504"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA038503: AB_2676049, HPA038504: AB_10672712"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.61e-7)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-2)"	13.0	11.7	8.0	10.2	8.4	60.4	10.3	9.5	10.2	8.4	8.4	8.7	6.8	10.2	6.8	7.8	11.2	9.7	43.4	8.7	9.0	19.7	7.6	19.7	14.4	8.3	8.0	13.6	6.9	19.4	8.0	12.1	7.6	8.8	7.6	5.9	6.7	7.6	29.4	20.9	8.2	9.4	8.4	13.7	22.9	7.5	9.2	6.8	13.3	22.6	12.5	11.9	7.6	9.2	4.8	2.3	2.4	1.1	9.3	4.6	3.2	1.9	4.2	4.4	4.0	0.9	38.1	2.2	4.1	2.4	1.5	36.5	2.5	4.5	2.9	17.4	7.1	0.1	5.7	1.5	8.0	0.4	3.2	4.8	19.4	1.3	6.1	3.9	1.5	2.2	0.5	15.1	2.5	2.3	1.5	1.4	1.9	2.7	1.3	2.4	10.8	2.2	5.8	4.0	1.1	2.6	23.4	4.1	11.3	6.3	1.7	3.3	2.7	2.5	3.7	7.0	0.8	7.6	15.0	1.1	3.8	1.5	1.0	2.5	0.5	1.0	0.3	0.6	0.3	0.7	0.5	0.3	0.3	1.2	0.4	0.6	1.3	0.0	1.9	0.2	1.3	0.2	8.0	8.4	9.5	10.2	8.7	9.0	8.3	8.0	7.6	8.4	9.2	9.2	17.3	67.3	11.5	3.3	55.9	32.0	7.1	5.0	13.6	20.1	12.3	9.1	149.0	7.2	4.9	5.5	2.1	3.3	9.6	47.2	11.7	6.0	8.0	35.0	44.5	25.6	6.0	13.5	4.3	7.1	3.2	20.8	47.4	33.8	5.7	10.4	16.4	10.1	51.0	53.8	4.8	77.9	10.2	68.2	219.1	7.6	6.5	105.7	33.8	8.4	9.3	33.8	10.3	4.0	6.5	10.1	16.3	13.2	50.0	7.7	8.0	25.1	9.8	26.2	6.6	82.2	19.4	7.2	4.7	15.1	30.5	7.9	16.5	7.5	24.3	10.9
PAAF1	"FLJ11848, Rpn14, WDR71"	ENSG00000175575	"Proteasomal ATPase associated factor 1"	Q9BRP4	11	73876699-73931114	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 130.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 112.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039952, HPA040020"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA039952: AB_10793925, HPA040020: AB_2676802"	"unprognostic (3.13e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.42e-1)"	17.3	29.0	85.2	11.3	92.6	9.0	17.6	82.3	130.1	19.4	68.8	25.0	11.8	16.6	23.8	14.4	19.6	12.0	25.2	80.3	85.9	23.9	21.9	12.6	12.6	88.0	88.6	24.6	22.2	19.1	25.8	11.7	87.3	22.0	16.3	46.4	15.4	19.8	19.8	19.2	14.3	15.5	85.4	16.3	18.5	30.3	85.7	15.9	18.8	7.5	17.2	21.7	16.3	101.2	13.5	30.6	27.2	21.3	28.9	29.6	15.5	22.6	25.9	35.3	25.0	60.2	10.4	40.4	34.4	23.2	32.8	30.2	33.5	27.2	52.2	30.4	20.8	41.4	28.0	50.3	34.6	39.1	15.3	30.5	41.7	38.8	47.2	28.4	27.0	32.1	50.7	33.7	33.2	26.3	34.5	40.5	12.7	71.0	23.7	31.6	72.6	66.5	26.5	22.9	28.8	33.8	26.8	17.7	70.6	25.4	53.1	21.8	19.7	24.8	15.7	35.3	22.3	41.3	50.3	82.2	17.4	25.0	26.5	53.4	26.2	32.3	26.8	17.2	29.5	40.8	28.7	27.3	34.4	36.1	37.0	31.7	2.2	32.4	6.3	24.8	36.8	27.9	85.2	92.6	82.3	130.1	80.3	85.9	88.0	88.6	87.3	85.4	85.7	101.2	9.0	3.2	12.5	40.1	11.5	4.7	11.6	27.3	6.8	50.4	6.8	9.1	19.6	8.6	15.6	16.5	112.6	33.5	9.5	5.5	13.7	15.9	38.4	10.7	12.2	9.8	3.6	20.2	17.4	13.8	4.8	11.5	6.6	9.4	19.6	30.1	11.7	13.6	18.8	47.1	23.7	7.7	20.3	9.5	6.6	22.6	16.8	9.5	14.2	14.0	16.3	37.6	18.6	24.6	55.5	7.3	5.7	18.0	15.3	9.6	12.0	53.5	14.1	51.7	6.6	18.2	12.5	48.9	28.6	9.6	8.1	18.3	9.8	29.9	10.3	8.0
PAIP2B	KIAA1155	ENSG00000124374	"Poly(A) binding protein interacting protein 2B"	Q9ULR5	2	71182738-71227103	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 181.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 86.0;Early spermatids: 95.1;Hepatocytes: 67.1;Proximal tubular cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 15.8;SCLC-21H: 23.1"	"Low region specificity"	"Detected in all"							"HPA046784, HPA072371"	Approved		Approved	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA046784: AB_2679804, HPA072371: AB_2686514"	"unprognostic (8.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (8.17e-5)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.96e-12)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.61e-2)"	2.4	1.6	131.5	1.8	159.1	1.3	4.5	108.3	176.8	3.1	66.3	3.8	3.7	2.9	1.8	6.1	7.2	1.1	23.0	94.7	116.5	10.3	18.1	2.7	2.1	134.9	136.6	11.5	54.2	6.0	2.2	0.6	143.0	4.8	3.7	27.7	37.9	3.5	48.5	16.4	2.7	1.7	132.8	2.2	10.5	2.2	130.3	2.4	11.6	26.7	4.6	2.8	4.0	181.5	2.5	0.6	1.0	3.6	0.4	0.5	4.4	0.3	0.1	0.3	0.2	0.9	1.0	3.2	0.6	0.0	2.4	2.0	6.1	3.7	1.2	1.7	5.0	3.1	0.4	0.1	1.6	0.8	0.2	0.6	3.3	0.2	3.6	0.9	0.6	7.2	5.5	3.0	0.2	3.2	1.0	1.7	2.6	5.8	2.3	0.0	10.5	15.8	1.9	1.7	23.1	1.3	2.6	1.7	1.1	5.5	7.5	0.2	0.1	0.3	1.9	1.9	1.0	6.1	5.5	3.9	0.2	1.1	0.5	0.5	0.3	0.5	1.0	0.4	1.2	2.5	1.3	1.0	0.4	2.6	2.1	1.9	0.2	0.8	0.4	2.3	0.6	0.6	131.5	159.1	108.3	176.8	94.7	116.5	134.9	136.6	143.0	132.8	130.3	181.5	3.3	3.2	4.5	5.2	9.9	7.8	7.0	4.0	5.7	11.3	14.8	8.8	86.0	12.8	2.7	7.3	6.2	3.2	13.2	2.7	21.5	4.9	95.1	18.4	3.9	3.9	41.5	15.6	4.2	41.3	9.2	4.7	11.2	17.5	1.3	7.5	7.1	67.1	1.9	6.7	4.6	6.3	14.2	3.2	1.6	30.0	5.3	2.6	14.2	2.8	2.4	12.3	4.1	2.5	31.9	10.4	4.0	5.3	29.9	9.4	1.3	56.9	15.5	43.3	0.0	9.3	4.0	32.9	7.7	17.3	20.0	6.3	4.7	4.3	8.1	6.0
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40217428-40277487	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 25.6;skin 1: 28.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.2	8.2	11.6	0.4	15.9	0.9	2.1	8.5	16.6	4.5	0.0	1.3	1.5	0.9	1.0	25.6	4.3	1.1	8.3	17.6	3.0	4.7	0.3	2.5	0.9	1.4	1.1	0.6	8.0	8.0	12.1	7.6	1.9	4.4	1.1	0.8	6.1	3.8	4.5	28.2	1.5	0.3	1.8	0.9	3.9	17.7	3.0	0.5	7.5	1.3	1.9	3.5	9.4	5.4	3.9	0.0	0.2	0.0	0.0	0.0	6.0	0.0	0.2	0.7	0.7	26.5	2.9	0.1	3.6	0.0	1.3	32.2	4.5	6.9	0.3	0.2	1.0	0.0	3.0	0.2	0.0	0.1	0.3	0.0	19.4	0.3	4.5	0.2	0.0	5.5	1.8	0.3	0.0	4.5	0.0	0.5	0.5	3.9	2.9	0.2	0.2	2.9	1.5	8.4	7.3	2.0	2.6	10.9	0.3	1.7	1.7	10.3	0.0	0.3	0.6	0.0	0.3	0.1	0.3	0.1	0.7	0.6	0.2	1.2	0.1	1.2	2.3	0.1	0.8	0.6	0.1	1.9	0.3	0.1	0.1	0.4	0.5	0.9	0.1	0.1	0.0	0.6	11.6	15.9	8.5	16.6	17.6	3.0	1.4	1.1	1.9	1.8	3.0	5.4	0.0	0.0	4.2	0.7	0.3	9.8	9.6	4.8	8.6	3.5	2.8	2.9	0.0	4.3	5.4	5.5	0.0	52.7	2.1	0.3	13.7	4.4	8.6	3.3	0.4	0.3	4.9	0.0	8.9	4.3	3.0	0.7	0.5	5.1	0.0	0.7	0.0	0.0	4.1	0.0	7.3	1.1	2.0	0.6	0.9	5.8	1.8	0.3	1.8	1.0	0.0	1.3	16.5	0.5	0.3	2.5	1.0	1.9	0.1	5.2	0.2	0.2	3.9	0.2	0.0	0.3	0.4	1.9	3.3	13.9	19.0	9.0	1.0	0.8	2.0	11.3
PAQR7	"MPRA, mSR"	ENSG00000182749	"Progestin and adipoQ receptor family member 7"	Q86WK9	1	25861484-25875708	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 1939.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 75.5;HaCaT: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046936	Approved		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA046936: AB_2679869"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.47e-1)"	"unprognostic (4.59e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.54e-2)"	5.5	23.9	8.5	4.4	8.4	5.1	5.2	7.5	8.6	11.9	10.0	6.4	20.9	11.1	28.2	17.7	20.0	7.8	3.3	7.9	10.1	35.3	7.4	5.6	4.3	9.6	10.2	35.3	6.6	13.7	6.7	21.4	9.4	7.9	2.9	1.5	5.3	24.3	3.0	31.4	18.9	9.5	9.2	10.2	8.1	46.2	10.6	3.5	5.1	1.9	4.9	13.6	13.5	9.4	30.7	6.0	5.8	18.9	7.1	14.8	20.4	19.9	17.5	19.2	17.0	9.8	75.5	0.3	13.6	19.2	6.3	62.6	3.2	33.0	11.4	12.1	3.4	25.6	8.4	12.1	12.0	0.4	3.1	14.9	43.3	13.7	10.2	16.9	7.5	2.8	2.8	2.1	14.4	7.0	0.2	1.9	9.3	3.1	10.3	2.1	0.6	3.8	39.3	22.9	3.1	11.5	32.1	40.7	14.8	7.9	11.6	4.6	8.1	3.1	9.7	10.2	5.4	0.4	0.4	1.3	14.5	0.7	6.6	5.4	7.3	15.7	1.4	13.9	1.4	4.0	0.8	1.0	7.6	1.7	1.3	1.9	3.7	3.4	17.5	0.8	0.2	1.4	8.5	8.4	7.5	8.6	7.9	10.1	9.6	10.2	9.4	9.2	10.6	9.4	4.9	0.0	3.1	11.4	2.2	18.1	4.3	4.6	4.6	2.1	9.4	9.5	1.9	17.2	5.1	77.3	0.0	52.8	1.3	0.7	21.5	5.6	350.9	23.4	11.5	5.9	4.8	0.0	11.9	13.9	12.3	7.8	0.5	9.0	7.0	4.6	10.4	5.5	11.0	3.3	11.2	2.2	0.0	10.3	14.9	1939.3	19.9	7.8	21.4	7.5	7.6	1.6	0.0	8.5	4.0	6.4	3.0	15.1	0.7	3.1	27.9	70.2	8.6	0.6	13.1	4.3	4.7	11.6	10.0	4.7	13.1	35.7	1.6	5.8	3.7	3.1
PARS2	DKFZp727A071	ENSG00000162396	"Prolyl-tRNA synthetase 2, mitochondrial"	Q7L3T8	1	54756898-54764523	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 9.8;Early spermatids: 11.0;Spermatocytes: 10.5;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028308, HPA028314, HPA028518"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitochondria"		"HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.79e-3)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (6.48e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.72e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.64e-2)"	1.3	2.9	2.5	1.9	3.0	0.2	2.7	2.8	3.1	2.7	3.0	4.0	2.7	2.5	3.2	2.7	4.4	1.6	3.0	2.6	2.6	4.2	3.4	1.4	2.0	2.5	2.7	4.8	2.3	4.7	2.1	2.5	2.7	2.3	3.6	2.0	3.3	2.8	4.4	2.9	2.1	2.0	2.7	1.8	2.5	4.8	2.7	2.6	2.9	5.5	2.4	2.1	2.0	3.0	4.4	7.2	4.6	6.0	5.5	4.6	10.3	3.7	4.5	6.4	4.6	8.3	2.8	7.7	5.6	3.3	9.3	6.9	8.3	5.8	4.7	5.0	7.5	7.4	4.0	6.2	8.5	4.3	2.5	5.0	8.8	8.3	7.4	5.5	4.8	8.4	13.2	1.0	4.9	4.6	6.1	5.7	10.6	8.3	9.1	4.6	9.0	9.0	5.4	3.2	4.7	4.8	5.3	6.9	9.7	8.7	3.9	5.5	2.6	4.8	4.9	6.8	4.7	7.3	6.6	3.0	3.6	5.1	2.8	1.2	5.3	4.5	4.8	7.7	5.9	4.9	5.3	5.3	7.3	5.5	7.8	5.3	0.5	7.4	10.7	5.9	8.2	5.0	2.5	3.0	2.8	3.1	2.6	2.6	2.5	2.7	2.7	2.7	2.7	3.0	0.6	0.0	1.1	0.3	1.0	0.6	0.9	2.0	1.8	2.6	1.3	1.9	1.5	2.8	1.8	0.0	0.0	7.0	0.2	2.4	9.8	4.5	11.0	1.1	1.4	0.8	0.0	0.0	0.9	2.8	3.9	1.3	1.5	0.6	0.0	2.9	0.0	2.3	3.1	5.0	1.1	2.8	0.0	1.2	0.3	6.8	3.7	0.8	0.0	2.8	1.1	3.2	0.0	0.5	1.6	1.9	1.5	3.0	0.3	1.8	1.5	6.5	1.0	1.9	0.0	1.3	1.1	10.5	11.5	2.0	1.0	3.3	0.7	5.1	3.5	0.8
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 153.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 13.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 90.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 167.4"	"Group enriched"	"Detected in all"	5	"basal ganglia: 46.3;olfactory bulb: 161.9"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	10.9	56.0	10.4	12.9	14.6	6.9	10.0	17.4	13.2	27.2	7.0	47.9	6.8	9.8	20.0	11.8	14.2	22.5	38.0	7.2	15.0	7.1	18.1	13.0	8.0	19.7	21.0	58.2	18.8	153.1	12.6	6.7	19.4	30.9	13.7	28.0	11.8	28.0	8.5	19.4	14.3	22.6	18.8	12.8	21.5	8.2	15.3	16.7	35.1	5.7	6.9	20.7	21.9	21.7	11.6	11.0	50.0	43.1	13.1	19.1	8.5	29.9	16.8	19.2	14.5	14.3	21.1	11.3	3.6	22.1	20.8	8.5	28.3	12.3	38.3	12.4	20.5	9.7	7.9	5.8	17.2	9.6	15.5	9.5	13.7	14.5	10.0	45.3	23.1	7.2	0.4	10.3	43.5	5.9	10.0	4.9	35.8	14.2	7.4	18.9	73.3	1.5	15.6	6.4	25.9	45.1	20.2	3.8	9.4	18.8	15.7	90.1	26.6	40.0	10.2	23.8	57.1	7.2	12.8	11.5	19.7	15.2	20.6	2.3	1.7	2.2	0.8	1.4	0.9	1.0	0.9	0.7	1.9	1.5	1.7	0.7	1.4	3.2	1.3	13.9	0.8	1.0	10.4	14.6	17.4	13.2	7.2	15.0	19.7	21.0	19.4	18.8	15.3	21.7	7.3	9.6	16.7	17.9	10.0	22.7	10.3	3.0	6.8	7.5	11.5	8.3	60.3	2.8	8.6	12.9	37.5	0.6	20.7	1.3	7.9	13.5	15.2	1.1	14.0	11.9	11.5	6.3	44.3	2.5	0.9	23.4	5.6	1.5	16.5	9.4	9.7	12.6	15.3	42.1	19.3	5.7	6.1	29.0	23.7	11.4	19.9	22.9	7.2	91.8	13.6	11.5	6.2	136.2	192.2	3.1	12.1	11.3	3.8	13.0	0.9	2.8	8.5	43.1	0.0	5.3	13.0	33.7	16.0	10.4	26.3	0.4	10.5	8.7	3.4	8.7
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	31.4	24.4	15.2	30.0	16.0	45.3	21.0	16.6	15.8	16.7	17.8	25.7	60.3	19.1	13.9	31.0	15.6	20.7	46.4	15.5	21.1	18.3	20.7	22.5	22.9	18.8	18.0	15.8	16.8	22.7	12.9	20.1	18.5	16.6	22.9	14.4	19.3	18.6	73.8	43.0	49.1	23.0	17.5	25.9	24.2	22.4	18.1	18.1	17.2	42.1	26.8	21.0	19.8	17.1	92.6	36.6	25.8	37.2	52.2	53.9	37.0	68.2	47.1	59.2	51.8	92.3	32.8	23.9	215.2	78.1	60.2	71.4	40.5	52.1	50.4	42.1	28.6	68.6	40.6	39.5	45.2	34.3	56.7	47.4	40.0	55.9	39.6	35.4	63.0	21.0	38.3	53.3	58.1	79.6	19.9	17.3	21.4	55.7	53.0	34.5	31.0	37.5	35.7	53.6	25.4	18.3	44.5	79.5	44.2	32.8	114.1	37.2	88.5	45.5	25.2	61.8	92.7	45.8	101.1	44.1	69.6	43.8	56.9	9.6	9.2	10.4	8.8	9.3	7.5	7.2	6.5	9.7	9.1	6.3	4.2	6.3	21.0	9.4	11.0	5.9	14.9	5.2	15.2	16.0	16.6	15.8	15.5	21.1	18.8	18.0	18.5	17.5	18.1	17.1	24.7	16.0	25.7	15.3	19.9	14.5	9.4	19.7	14.2	15.9	14.1	9.4	70.1	20.0	17.5	14.7	25.0	11.9	27.3	36.4	13.7	24.8	76.3	17.8	22.9	23.2	22.1	12.2	20.4	22.9	17.7	17.0	23.4	15.6	20.8	16.1	26.7	35.6	37.4	8.4	22.7	24.2	6.1	34.6	27.1	67.6	19.9	33.9	19.6	20.6	39.4	13.1	39.1	16.1	17.6	24.6	21.1	28.2	27.2	12.0	67.2	23.2	33.9	12.8	26.3	15.0	19.0	46.0	13.2	30.0	21.5	18.6	25.6	25.5	23.8	12.2
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562993-100576739	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favorable (4.23e-4)"	20.8	22.0	19.1	27.1	21.6	22.9	23.0	21.6	24.3	18.9	16.6	27.3	17.0	24.1	37.2	36.8	22.5	21.3	30.6	18.4	21.3	28.4	18.5	18.4	25.3	21.8	24.7	21.1	11.4	23.4	10.5	23.4	21.7	27.0	28.9	21.1	16.9	23.2	58.8	36.8	17.3	38.6	20.8	17.0	17.6	22.8	22.1	22.4	21.4	34.3	34.0	33.1	17.5	22.2	41.8	58.7	59.9	52.2	19.3	27.4	67.5	51.3	32.5	92.9	58.1	74.2	25.5	68.6	74.0	62.3	122.3	34.2	76.0	50.2	74.0	110.6	65.8	72.0	31.8	89.7	50.8	77.3	73.2	29.8	92.0	82.0	52.3	24.2	58.9	52.8	61.1	43.8	70.7	74.6	75.8	117.7	77.9	45.6	86.6	72.5	63.2	48.0	58.2	98.7	55.9	49.6	41.0	54.7	59.0	48.6	42.3	53.0	45.8	56.4	60.1	44.8	72.2	26.4	54.1	68.3	34.4	90.5	45.7	82.3	64.8	80.2	63.1	124.4	72.8	92.5	95.0	70.4	114.9	78.1	97.7	75.4	7.0	93.9	161.7	64.0	113.6	87.3	19.1	21.6	21.6	24.3	18.4	21.3	21.8	24.7	21.7	20.8	22.1	22.2	37.4	19.2	25.2	1.6	39.5	65.6	36.6	79.2	52.9	13.0	24.8	36.2	40.9	18.6	46.1	14.7	6.2	70.8	61.5	16.0	60.7	50.6	37.0	38.9	26.6	30.2	19.8	21.7	2.3	39.1	51.2	22.6	19.4	34.6	92.9	25.4	12.5	17.0	59.7	11.8	2.0	24.0	89.5	17.8	80.7	14.3	14.6	54.4	35.6	3.7	104.3	19.7	40.2	2.0	4.5	31.8	18.6	33.4	27.7	33.2	19.7	77.9	28.1	16.5	52.6	23.8	54.1	5.5	66.9	63.2	57.5	52.4	91.8	24.5	31.3	32.4
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183582-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 1047.0"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 5516.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 148.8;RPTEC TERT1: 501.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	20.9	8.2	0.6	24.6	0.8	43.2	36.4	0.4	1.2	29.9	0.7	44.4	21.6	10.7	2.9	205.9	25.7	197.6	1.4	0.5	0.7	1047.0	6.8	29.5	0.4	0.4	0.5	0.7	99.9	0.0	1.1	3.9	0.7	12.1	30.9	0.0	203.4	8.6	1.6	153.1	66.4	3.1	0.4	3.7	63.4	1.4	0.9	1.9	1.5	0.6	60.2	20.0	66.6	0.4	54.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	41.5	0.0	148.8	0.0	0.0	0.7	0.0	0.5	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.6	501.3	0.0	0.0	0.0	0.5	4.3	0.0	0.0	1.4	0.0	0.0	0.1	1.2	0.1	0.4	0.3	0.6	0.3	0.1	0.1	0.0	0.0	3.4	0.3	0.6	1.1	0.2	0.0	0.0	0.0	1.7	0.4	0.2	0.0	6.6	0.7	0.1	1.5	1.1	144.5	0.6	0.8	0.4	1.2	0.5	0.7	0.4	0.5	0.7	0.4	0.9	0.4	1.6	76.9	47.4	0.0	31.2	14.1	13.3	489.8	7.4	0.0	152.9	105.5	0.1	303.1	413.3	233.6	0.0	0.1	1.7	118.8	414.8	1175.8	0.0	6.1	3.3	4.5	39.6	148.4	0.0	760.0	0.0	6.6	36.7	38.1	10.8	0.2	5.0	1.7	0.3	0.0	0.0	143.3	52.9	0.3	2.1	0.0	3.4	59.3	8.8	0.0	13.6	0.6	2.1	0.0	0.0	1115.2	91.0	0.0	0.1	38.9	106.2	5516.6	147.6	0.0	0.0	0.1	28.7	0.0	0.1	30.7	54.0	0.8	22.0	0.0	150.5	68.5
PELO		ENSG00000152684	"Pelota mRNA surveillance and ribosome rescue factor"	Q9BRX2	5	52787916-52804044	"Predicted intracellular proteins"	"Cell cycle, Cell division, Translation regulation"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 90.7;Sertoli cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031458	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoli fibrillar center"		"HPA031458: AB_10602141"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.40e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.21e-2)"	9.4	17.6	5.3	5.2	5.9	8.2	7.3	5.7	5.2	6.9	4.9	11.3	4.6	9.8	7.5	6.7	7.9	6.3	10.3	5.7	6.1	9.9	10.7	11.7	6.3	5.4	6.3	5.1	5.3	7.4	6.0	11.6	5.7	6.7	3.7	4.4	4.9	6.7	12.2	8.4	6.2	9.9	5.9	12.6	7.5	4.4	6.7	4.8	7.2	8.8	3.6	8.4	6.7	5.2	18.1	18.3	8.1	14.5	14.0	10.3	7.1	20.4	22.4	19.6	23.9	18.4	13.8	5.9	36.0	22.1	29.4	14.8	11.9	17.3	16.9	6.3	16.8	6.6	15.2	15.5	42.6	12.5	7.6	13.0	17.5	22.7	18.6	16.9	11.8	8.8	8.4	18.5	17.3	14.1	13.1	7.7	6.1	3.3	19.3	4.5	10.4	17.6	14.3	8.5	13.3	10.3	10.8	13.3	11.9	13.7	12.2	4.5	11.7	11.8	11.4	12.5	26.0	7.9	10.4	7.8	22.5	11.6	10.4	22.3	5.9	7.6	4.8	3.9	5.9	4.8	6.2	5.4	6.1	3.6	5.0	4.7	19.0	4.7	2.2	2.3	4.8	4.4	5.3	5.9	5.7	5.2	5.7	6.1	5.4	6.3	5.7	5.9	6.7	5.2	49.9	9.6	7.4	0.0	9.8	46.9	53.0	24.4	14.2	16.5	12.7	18.7	12.7	17.2	20.2	9.2	2.1	35.9	10.5	8.7	35.2	31.5	65.1	18.7	23.1	50.5	10.2	8.0	0.0	25.5	90.7	36.7	9.2	27.6	1.3	11.4	40.4	18.7	20.1	8.4	0.1	16.0	14.2	6.6	23.3	9.2	17.7	15.8	7.2	0.0	7.7	15.5	6.2	0.0	0.0	24.5	6.0	12.0	14.3	36.5	12.3	29.0	16.9	11.0	85.5	13.7	56.5	22.1	13.9	14.9	35.8	53.9	23.0	18.8	11.5	38.3
PGAP1	"Bst1, FLJ12377, SPG67"	ENSG00000197121	"Post-GPI attachment to proteins inositol deacylase 1"	Q75T13	2	196833004-196927796	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 19.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 89.6;Inhibitory neurons: 104.5;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.21e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.95e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.61e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.88e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.91e-2)"	3.9	8.4	10.2	1.1	11.7	2.0	3.8	8.9	12.1	3.5	4.6	3.0	3.7	3.0	3.1	3.5	2.8	1.5	3.2	7.9	19.2	1.7	1.2	4.5	1.1	6.8	15.1	9.3	4.4	2.8	9.2	3.3	7.3	3.2	2.8	13.0	2.2	2.2	1.4	12.3	4.3	2.2	4.4	1.4	2.0	1.5	17.8	1.7	2.1	1.4	1.1	3.0	3.9	5.8	1.5	0.6	15.2	8.3	6.8	4.1	2.5	1.9	1.4	1.1	1.3	0.8	1.6	1.8	2.4	2.8	2.4	2.8	4.0	4.3	1.7	9.0	5.2	1.2	4.0	4.1	1.8	2.6	2.0	3.0	3.0	1.9	2.2	7.9	6.6	5.9	0.3	3.0	4.2	0.6	2.4	3.3	7.1	2.4	3.5	3.7	3.8	0.5	2.4	13.8	12.6	10.0	1.3	1.9	2.4	9.0	1.9	1.0	7.6	5.1	2.2	2.5	2.6	2.7	1.5	2.4	3.9	1.2	5.1	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.7	0.7	0.1	0.2	0.6	0.5	0.2	0.1	0.0	0.0	0.9	0.0	10.2	11.7	8.9	12.1	7.9	19.2	6.8	15.1	7.3	4.4	17.8	5.8	9.3	3.2	2.6	37.9	12.7	34.4	13.5	21.4	30.1	43.3	5.4	5.6	6.8	2.8	6.9	25.8	25.0	37.4	4.6	5.8	0.0	1.4	8.3	11.9	14.5	9.7	38.9	3.2	89.6	3.7	9.1	15.8	14.3	4.3	4.5	8.8	4.2	4.4	6.2	13.5	104.5	13.6	8.2	1.9	14.9	4.8	14.3	3.0	7.2	23.4	1.3	17.5	3.1	130.2	58.7	0.9	8.2	15.8	8.2	11.4	12.4	1.6	16.7	41.1	6.6	12.0	33.8	11.0	8.2	23.4	30.0	15.9	18.5	8.1	24.0	11.9
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Metabolic proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 38.9;skin 1: 73.7;vagina: 21.4"	"Cell type enriched"	"Detected in single"	12	"Squamous epithelial cells: 4.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 8.9;head and neck cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"HaCaT: 3.8;HDLM-2: 1.6;hTCEpi: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	73.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	7.6	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0
PIGN	"MCD4, PIG-N"	ENSG00000197563	"Phosphatidylinositol glycan anchor biosynthesis class N"	O95427	18	61905255-62187118	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 323.7;Alveolar cells type 2: 372.2;Club cells: 138.4;granulocytes: 159.0;Oligodendrocytes: 123.2;Respiratory ciliated cells: 145.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039922, HPA040374"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA039922: AB_10805597, HPA040374: AB_10794738"	"unprognostic (1.93e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.71e-1)"	10.0	10.3	9.8	10.9	14.3	16.9	15.9	49.4	47.1	11.8	3.2	16.2	14.0	11.1	11.9	22.7	8.9	12.6	13.5	13.1	9.6	11.9	18.1	9.9	10.5	4.1	0.1	12.1	15.8	16.0	4.3	17.5	9.6	17.3	18.4	38.9	14.8	7.5	13.4	20.1	13.3	8.9	0.0	10.0	21.1	19.8	11.4	12.3	16.9	10.8	12.8	14.9	7.7	49.7	31.6	19.0	18.4	23.0	23.1	31.4	24.3	32.3	25.7	21.2	24.9	24.4	31.9	36.0	44.0	25.0	18.3	44.6	26.0	27.8	32.9	30.3	16.9	21.6	29.6	19.7	16.8	46.0	24.6	18.5	18.1	21.0	24.5	22.3	27.0	25.3	26.1	50.8	23.3	28.2	22.8	13.5	29.9	25.3	17.3	24.1	35.1	35.7	25.5	48.5	20.8	21.4	42.5	29.0	13.6	50.9	46.1	28.6	29.8	41.0	28.2	15.4	23.5	54.3	53.8	17.4	22.5	25.7	40.9	10.1	7.5	6.1	6.9	6.6	7.2	7.9	7.1	6.9	8.9	8.8	8.0	8.4	9.6	12.1	7.8	10.2	6.5	3.7	9.8	14.3	49.4	47.1	13.1	9.6	4.1	0.1	9.6	0.0	11.4	49.7	8.9	323.7	372.2	52.5	9.7	8.0	8.9	8.4	10.2	7.2	16.3	9.4	10.4	12.8	138.4	11.0	4.2	9.6	14.1	11.6	1.9	11.0	6.4	9.1	16.2	24.7	6.7	16.6	54.5	9.5	11.5	26.6	10.2	11.5	159.0	19.3	10.0	12.0	10.1	6.7	41.3	11.6	10.2	9.2	4.0	6.5	7.2	26.9	3.6	44.0	7.9	7.3	3.1	57.8	123.2	10.9	9.4	3.8	8.2	11.7	5.6	5.0	145.5	6.6	6.6	6.8	6.7	20.7	7.3	17.4	17.0	10.4	18.5	10.5	12.3	12.1
PITPNA	"PITPN, VIB1A"	ENSG00000174238	"Phosphatidylinositol transfer protein alpha"	Q00169	17	1517718-1562792	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000528	Uncertain		Approved	Vesicles,Cytosol		NA	NA		190000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (1.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (7.88e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (1.80e-6)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.81e-3)"	42.5	36.8	41.7	61.0	45.4	93.6	41.7	46.6	56.2	50.7	51.0	47.2	56.7	55.3	58.8	76.6	65.9	45.4	39.1	43.8	50.5	40.0	39.0	46.9	40.4	62.4	45.4	32.1	33.9	60.8	33.1	50.2	58.4	54.2	55.6	47.6	84.1	61.7	24.7	93.2	88.9	54.3	41.9	42.4	40.5	44.8	52.2	33.2	64.7	22.7	57.1	51.9	41.8	43.0	64.9	70.5	70.5	61.0	72.1	78.8	110.7	68.9	75.8	70.6	50.9	78.7	25.7	81.8	62.4	94.0	45.4	79.5	64.2	68.4	97.0	68.3	69.2	44.7	61.4	37.0	70.6	31.1	51.6	58.9	90.6	70.5	73.1	74.4	118.4	67.1	63.3	44.9	74.8	36.5	80.1	28.5	49.3	103.4	34.1	63.8	27.2	46.9	70.5	73.5	25.2	55.2	83.2	59.1	51.4	70.5	52.2	24.7	113.8	44.8	39.5	126.4	95.5	27.2	49.8	28.8	77.4	47.9	58.4	3.7	2.4	3.2	2.1	2.7	4.0	4.3	3.1	2.8	3.5	3.1	2.9	2.6	8.0	3.7	1.9	2.7	5.2	1.7	41.7	45.4	46.6	56.2	43.8	50.5	62.4	45.4	58.4	41.9	52.2	43.0	29.3	35.3	35.0	28.7	14.1	31.0	17.5	12.0	12.0	36.4	30.0	30.2	23.9	17.2	17.1	25.8	8.4	43.4	26.9	41.2	13.7	16.0	12.0	50.5	48.4	31.4	22.1	15.6	42.4	18.5	47.3	19.1	13.3	36.5	19.0	16.8	34.6	30.2	40.5	40.4	46.3	27.7	10.2	29.9	49.7	16.8	12.5	36.4	19.6	36.5	36.6	40.2	13.4	12.1	16.0	26.0	22.9	21.8	15.7	33.0	78.0	16.3	21.7	18.4	6.6	18.8	45.1	35.8	34.7	37.8	41.8	120.0	14.9	24.7	25.3	27.0
PKIA	PRKACN1	ENSG00000171033	"CAMP-dependent protein kinase inhibitor alpha"	P61925	8	78516340-78605267	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 1160.4;tongue: 953.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 104.8;Cardiomyocytes: 367.0;Excitatory neurons: 103.3;Inhibitory neurons: 78.2;Muller glia cells: 82.8;Oligodendrocyte precursor cells: 82.9"	"Cancer enhanced"	"Detected in many"		"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 21.4"	"Lineage enriched"	"Detected in many"	9	"T-cells: 21.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 63.9;HUVEC TERT2: 104.0;RT4: 100.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042791	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042791: AB_10795761"	"unprognostic (3.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.59e-6)"	"unprognostic (8.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.65e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.52e-3)"	2.5	9.5	44.4	5.6	49.3	2.7	4.1	41.4	49.2	2.2	11.9	3.5	1.2	3.1	3.0	21.5	5.3	8.2	185.9	49.8	44.0	4.7	0.2	8.6	7.6	25.4	34.3	5.8	1.4	108.1	8.0	1.6	36.0	20.3	2.8	33.7	6.2	5.3	1160.4	9.2	2.5	2.6	35.2	4.1	1.6	1.3	48.1	26.3	34.2	953.8	11.0	9.5	3.6	36.2	0.6	0.3	34.2	0.0	18.5	4.8	0.2	32.1	6.3	3.4	7.2	0.0	5.3	14.8	0.2	4.8	3.3	0.5	11.3	10.3	22.3	63.9	24.6	18.5	3.7	0.2	1.2	0.0	10.3	7.7	1.5	0.0	9.6	45.5	104.0	19.8	0.0	15.8	51.4	5.4	28.3	0.0	8.1	0.0	35.3	0.0	29.3	0.0	18.7	100.2	16.6	32.5	4.1	26.4	0.0	8.9	0.0	0.1	41.2	7.8	6.4	1.8	19.2	6.5	6.9	4.9	36.9	0.1	9.8	0.0	0.0	0.0	0.5	0.1	0.4	2.3	9.1	1.8	0.1	2.2	7.7	4.6	0.4	1.7	0.1	0.2	21.4	2.5	44.4	49.3	41.4	49.2	49.8	44.0	25.4	34.3	36.0	35.2	48.1	36.2	0.6	3.2	2.8	104.8	9.8	5.9	8.8	4.5	19.9	40.2	2.6	6.5	367.0	0.0	2.0	1.8	2.1	3.1	2.7	0.4	1.9	0.0	13.9	0.9	0.2	9.1	10.2	4.2	103.3	0.2	2.8	12.3	0.0	1.3	5.7	18.6	2.5	0.0	0.7	58.9	78.2	0.8	6.1	0.0	1.1	5.9	0.0	3.9	3.6	15.0	0.5	82.8	0.0	82.9	17.9	1.5	0.1	0.4	2.3	6.1	0.0	0.1	1.0	6.9	0.0	22.9	4.8	0.4	0.6	13.9	13.8	3.4	8.0	0.1	0.3	3.6
PLA2G4E	FLJ45651	ENSG00000188089	"Phospholipase A2 group IVE"	Q3MJ16	15	41981582-42051190	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 17.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 12.9;Basal keratinocytes: 18.1;Suprabasal keratinocytes: 44.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041105, HPA072562"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Cytosol"		"HPA041105: AB_2677300, HPA072562: "	"unprognostic (2.98e-1)"	"unprognostic (5.52e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.99e-2)"		"unprognostic (5.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-7)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	18.1	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.1	0.5	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	5.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	44.9	0.0	0.1	0.0	0.2	0.7
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 78.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 11.1;RT4: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.0	0.0	0.1	0.4	0.3	0.3	2.4	0.1	0.1	5.7	0.0	6.4	6.7	0.0	1.6	5.7	0.1	0.1	0.3	0.1	0.0	7.8	0.2	12.2	0.1	0.0	0.0	0.0	0.1	2.9	1.7	0.1	0.0	4.3	3.8	0.2	2.6	0.4	2.9	78.1	4.2	0.1	0.0	0.1	2.4	0.1	0.0	4.4	1.9	0.5	0.3	1.2	11.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.1	0.1	0.0	0.0	0.0	0.0	8.3	0.4	0.0	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	74.5	0.0	0.0	5.5	2.7	1.3	0.6	0.0	1.2	0.3	2.9	0.0	0.5	5.5	0.0	1.7	0.0	21.7	3.9	0.4	0.0	7.3	1.0	0.1	0.0	0.0	0.0	1.3	0.7	0.1	18.3	17.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	7.7	4.1	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	0.0	0.3	3.1	10.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	5.6	13.8	1.2	0.6	0.0	6.7	2.0
PLBD1	FLJ22662	ENSG00000121316	"Phospholipase B domain containing 1"	Q6P4A8	12	14503661-14567883	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 285.9"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 187.7;Hofbauer cells: 105.6;Kupffer cells: 109.4;Macrophages: 116.3;monocytes: 192.8;Paneth cells: 105.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 113.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 662.9;intermediate monocyte: 204.4;myeloid DC: 357.3;neutrophil: 443.8"	"Group enriched"	"Detected in all"	135	"dendritic cells: 357.3;granulocytes: 443.8;monocytes: 662.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 48.6;BEWO: 98.4;CAPAN-2: 245.6;MCF7: 46.3"	"Not detected"	"Not detected"							HPA040303	Enhanced				"Intracellular and membrane"	NA	NA		3400000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA040303: AB_2676922"	"unprognostic (9.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (4.80e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.44e-2)"	29.4	5.6	2.1	33.7	2.5	285.9	27.8	2.4	3.7	22.4	25.9	58.8	28.2	13.5	10.6	56.3	16.6	33.1	32.6	2.1	2.4	26.3	10.6	64.0	9.2	3.5	3.2	4.4	30.0	3.2	3.4	35.9	3.2	10.2	79.2	0.8	11.9	15.3	9.9	24.8	42.6	28.1	3.1	25.2	36.6	10.0	2.8	7.8	6.1	17.2	32.7	58.5	29.6	4.8	7.1	5.0	0.5	48.6	0.3	0.0	98.4	0.2	0.0	3.0	2.4	14.1	245.6	0.0	1.4	1.0	0.4	9.4	0.0	0.0	0.5	0.0	0.1	0.0	6.4	0.0	3.8	0.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.1	46.3	0.1	0.2	16.5	0.7	0.3	0.1	0.1	0.5	0.7	28.9	0.0	0.4	30.2	14.8	1.9	26.5	9.0	9.6	0.0	0.5	0.4	0.0	0.6	8.7	23.7	0.2	0.0	0.1	0.4	0.4	662.9	5.8	1.0	204.4	0.6	3.6	0.5	0.4	357.3	0.8	0.7	0.7	443.8	1.7	73.5	4.1	0.9	423.2	2.1	2.5	2.4	3.7	2.1	2.4	3.5	3.2	3.2	3.1	2.8	4.8	15.5	9.6	8.6	0.3	2.9	6.8	8.8	4.9	6.8	0.0	11.9	6.6	16.5	30.0	20.4	33.1	0.0	94.5	1.5	67.8	11.7	13.1	51.8	2.5	9.1	7.2	9.1	1.7	1.6	46.5	187.7	59.6	13.3	0.9	5.1	5.9	4.6	2.9	105.6	0.0	0.9	31.3	6.1	109.4	68.6	5.8	26.1	116.3	5.4	7.5	192.8	1.6	1.0	1.5	0.2	28.6	105.9	27.8	3.6	3.8	52.8	15.7	19.0	0.2	0.0	12.0	10.4	17.4	12.0	17.8	19.9	70.3	1.6	6.1	75.2	30.1
PLEKHF2	"FLJ13187, PHAFIN2, ZFYVE18"	ENSG00000175895	"Pleckstrin homology and FYVE domain containing 2"	Q9H8W4	8	95133785-95156685	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 84.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 102.6;U-698: 109.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024829	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA024829: AB_10603127"	"unprognostic (4.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.67e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-2)"	"unprognostic (5.94e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.61e-3)"	12.4	6.1	5.5	21.3	5.5	84.8	21.6	6.1	6.7	9.2	6.9	16.0	12.6	7.4	14.6	15.4	8.9	11.2	8.9	5.2	5.7	22.2	14.7	17.5	53.1	6.3	5.8	7.3	11.8	6.9	3.6	15.1	6.2	9.3	13.9	14.8	11.8	7.4	10.7	19.5	13.7	7.1	6.6	22.6	21.9	12.3	5.4	23.8	9.7	9.3	56.1	12.7	7.5	8.3	27.5	4.5	7.0	4.2	10.0	11.1	37.6	14.9	20.0	12.7	13.6	11.3	29.7	102.6	12.6	10.5	6.6	33.1	10.9	18.1	18.3	19.2	7.4	49.4	10.0	8.8	9.9	9.9	68.7	7.1	25.0	10.0	18.8	14.9	14.1	32.9	32.6	13.0	13.6	16.8	29.0	12.8	4.2	50.1	20.6	11.5	7.1	14.0	10.4	24.2	9.3	5.4	11.3	13.5	27.8	9.7	36.2	16.0	9.0	9.8	6.7	8.6	8.7	17.2	14.9	109.4	7.5	22.8	14.1	107.2	21.6	43.0	9.0	18.6	10.8	69.7	11.2	13.9	24.3	78.6	12.9	12.7	29.8	12.4	16.0	10.1	13.7	19.4	5.5	5.5	6.1	6.7	5.2	5.7	6.3	5.8	6.2	6.6	5.4	8.3	29.3	12.8	14.1	7.2	88.8	61.4	73.4	29.7	56.3	17.0	49.0	22.7	7.0	31.5	26.1	5.5	14.6	51.6	17.8	46.7	29.4	13.6	59.5	47.1	12.0	18.5	33.6	34.5	5.0	22.0	36.1	11.9	31.1	59.5	60.4	14.4	25.0	11.0	29.6	6.7	2.4	14.6	57.0	22.6	54.0	19.8	8.7	34.7	21.4	14.0	31.9	19.1	13.4	10.6	4.7	14.6	39.0	3.8	21.3	42.4	20.7	95.9	26.2	31.7	13.1	10.8	14.5	55.2	16.0	47.2	57.7	50.9	27.4	6.0	17.7	75.4
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966482-975865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 54.9;skin 1: 46.0;vagina: 24.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 29.6;Pancreatic endocrine cells: 38.5;Prostatic glandular cells: 37.9;Squamous epithelial cells: 19.2;Urothelial cells: 52.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 15.1;HaCaT: 26.0;SK-BR-3: 16.6"					"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	1.6	0.0	0.7	0.1	0.4	1.7	0.0	0.1	11.5	0.0	0.6	0.9	0.4	0.3	54.9	0.9	0.7	0.2	0.0	0.0	2.1	0.9	1.1	0.3	0.0	0.0	0.1	1.1	0.5	0.3	0.4	0.0	3.6	0.1	0.0	10.2	1.2	2.1	46.0	0.8	0.1	0.0	1.2	2.0	0.4	0.1	0.1	0.7	0.0	1.6	7.5	24.2	0.0	15.1	1.4	0.0	1.0	0.1	0.7	2.5	6.8	1.7	4.1	1.1	2.0	11.3	0.0	3.2	3.0	5.7	26.0	0.2	4.5	0.7	5.0	1.0	0.0	5.6	3.3	0.6	0.3	0.2	0.2	3.8	2.9	1.6	3.7	0.5	0.0	0.3	4.0	0.2	8.3	0.0	0.3	0.5	2.4	11.0	0.1	0.0	5.6	4.3	4.2	0.1	0.1	7.5	16.6	1.0	0.4	3.2	0.0	3.2	5.3	2.3	0.5	4.6	3.2	0.1	0.1	6.8	2.5	3.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.2	1.1	0.0	1.9	4.6	29.6	5.0	1.8	0.5	3.8	1.8	0.9	0.0	6.4	0.0	0.0	7.1	1.0	1.9	0.0	13.8	0.0	3.0	1.1	0.7	0.0	0.0	0.0	14.0	2.0	0.9	3.1	8.2	0.0	0.0	0.7	0.3	1.1	3.3	0.0	0.0	8.2	0.3	1.4	0.0	0.0	0.9	1.8	0.0	1.9	0.2	0.0	0.0	0.0	38.5	3.3	0.0	2.5	37.9	0.0	0.1	5.2	0.2	0.0	0.2	1.0	0.0	0.7	19.2	17.3	9.9	2.8	0.0	0.1	52.9
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.3;Alveolar cells type 1: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 3.7;plasmacytoid DC: 12.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 12.2;NK-cells: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA020433: AB_2670440, HPA076083: AB_2686773"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.72e-4)"	"prognostic unfavorable (7.04e-4)"	120.8	32.4	33.2	36.3	40.6	1.4	71.4	44.3	43.6	83.7	22.1	46.4	21.8	120.5	76.2	117.8	68.3	83.1	57.9	30.7	34.9	113.2	202.0	139.8	24.2	43.5	40.1	101.5	31.4	12.7	11.7	78.4	42.2	43.6	31.8	11.9	46.8	103.2	31.4	119.5	25.0	119.4	38.4	99.8	37.7	22.3	39.5	27.2	175.0	48.8	41.9	75.4	88.5	47.9	206.2	207.1	176.8	51.5	174.3	161.7	269.3	208.2	233.1	194.5	233.9	225.0	167.2	0.8	590.0	171.9	140.6	256.7	190.5	339.1	314.2	2.9	235.8	19.4	234.6	95.0	157.5	0.1	9.6	103.1	159.5	302.7	211.1	315.3	429.5	16.8	0.5	0.3	188.9	59.7	0.4	2.3	234.6	88.0	243.2	0.4	117.8	4.9	233.1	109.1	0.6	36.9	436.8	107.9	89.7	253.7	60.2	3.0	474.3	314.5	53.9	324.6	422.8	7.8	30.5	4.2	137.6	0.8	133.4	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.1	0.0	0.1	3.7	0.0	12.2	1.4	0.2	33.2	40.6	44.3	43.6	30.7	34.9	43.5	40.1	42.2	38.4	39.5	47.9	209.3	211.5	88.6	26.8	2.0	124.9	121.4	79.6	48.9	0.2	5.6	25.4	17.9	24.3	79.4	99.3	0.0	4.0	1.6	3.5	13.7	59.0	8.4	33.0	39.4	130.5	13.2	4.4	12.3	53.8	105.3	74.3	31.1	64.1	0.0	60.5	64.2	92.1	3.9	0.0	47.6	6.9	38.7	5.0	21.7	8.0	51.9	3.0	56.9	40.3	0.6	26.4	0.0	1.5	97.9	68.6	6.5	82.8	1.6	80.7	2.2	22.0	31.2	1.5	52.6	19.8	132.3	1.2	17.7	65.5	134.1	4.5	3.6	131.1	11.1	100.6
PMS2	"H_DJ0042M02.9, HNPCC4, MLH4, PMSL2"	ENSG00000122512	"PMS1 homolog 2, mismatch repair system component"	P54278	7	5970925-6009106	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010235, HPA066490, HPA070310"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250"	"unprognostic (5.13e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.23e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-2)"	5.3	5.1	6.7	5.3	7.2	5.8	6.5	6.3	7.6	4.8	2.8	4.8	5.7	4.9	5.0	5.3	5.7	4.0	4.1	7.4	5.8	10.4	4.7	4.4	8.4	5.3	5.6	5.7	3.9	11.0	4.6	4.8	5.5	5.2	4.7	8.4	5.7	5.5	4.5	11.9	5.3	5.3	4.4	5.9	5.0	4.0	5.2	8.8	9.2	3.5	8.9	5.1	4.9	7.0	15.1	16.7	12.9	32.2	9.0	13.6	10.9	7.8	5.8	6.6	5.6	14.0	9.9	28.2	8.7	10.9	17.2	19.6	19.2	6.6	8.0	11.3	7.2	12.0	12.5	10.1	15.9	15.8	9.4	15.1	14.8	5.4	22.3	11.4	13.7	15.2	22.9	12.6	11.9	15.5	5.2	17.1	13.3	7.6	9.6	16.3	15.3	14.0	16.4	11.0	11.9	25.7	13.3	23.0	16.2	18.0	27.1	11.8	12.4	9.3	21.2	14.2	14.6	19.8	32.8	27.5	7.2	15.3	22.9	5.0	2.9	1.9	4.5	4.1	4.9	3.4	3.5	3.8	3.0	3.4	4.4	3.4	1.4	2.3	1.8	3.1	3.4	3.4	6.7	7.2	6.3	7.6	7.4	5.8	5.3	5.6	5.5	4.4	5.2	7.0	12.2	12.8	8.2	11.4	13.6	5.0	9.3	10.9	15.9	13.2	10.7	11.3	3.2	12.8	9.7	11.0	22.9	9.4	15.2	1.8	35.2	5.5	9.9	11.0	14.6	10.1	5.4	8.4	14.0	3.3	6.3	6.6	8.2	11.8	5.1	11.4	7.9	7.6	5.2	30.3	12.2	2.2	10.2	7.1	5.9	6.6	12.8	6.3	7.2	5.6	8.7	7.8	20.6	3.5	8.3	4.7	2.6	10.1	9.6	12.6	2.2	39.5	9.3	14.3	26.3	10.0	8.0	34.5	11.7	10.5	8.1	12.7	11.4	11.9	2.6	11.1
PNPLA1	"dJ50J22.1, FLJ38755"	ENSG00000180316	"Patatin like phospholipase domain containing 1"	Q8N8W4	6	36243203-36313955	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 23.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.9;granulocytes: 4.5;Oligodendrocyte precursor cells: 1.5;Proximal enterocytes: 1.5;Proximal tubular cells: 3.8;Suprabasal keratinocytes: 3.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 69.8;eosinophil: 18.9"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 69.8"	"Cell line enriched"	"Detected in some"	4	"U-937: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.57e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-2)"	0.1	0.2	0.1	0.6	0.2	4.3	0.6	0.3	0.4	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	4.7	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	23.9	0.9	0.2	0.1	0.7	1.7	1.0	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	17.6	0.0	69.8	4.0	18.9	0.0	2.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.2	6.2	0.1	1.1	0.0	0.0	1.1	0.1	0.2	0.3	0.4	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.2	4.5	0.7	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.3	1.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.1	1.5	3.8	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	3.7	0.1	0.0	0.4	0.2	0.2
POLR1D	"AC19, MGC9850, RPA16, RPA9, RPAC2, RPO1-3"	ENSG00000186184	"RNA polymerase I and III subunit D"	"P0DPB5, P0DPB6"	13	27620742-27744237	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 819.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039337	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Golgi apparatus"		"HPA039337: AB_10672961"	"unprognostic (1.33e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	72.1	124.8	56.0	57.4	58.5	150.8	90.6	77.5	75.5	102.5	67.2	98.7	86.2	67.5	78.1	142.3	75.7	55.8	90.7	58.4	57.3	84.4	81.2	76.5	90.8	53.4	54.7	118.7	267.3	54.2	69.3	62.3	54.9	88.6	87.4	58.5	112.5	65.7	119.9	143.4	86.6	66.4	52.7	75.6	132.9	76.0	55.3	117.5	62.2	85.0	87.3	91.7	111.7	56.3	103.2	94.8	106.8	110.5	121.6	213.4	143.4	99.2	171.2	129.2	127.7	155.0	203.9	331.3	73.2	113.9	215.7	155.4	200.4	319.8	152.3	102.5	119.0	236.0	97.4	262.9	181.4	215.7	178.0	195.5	330.2	106.0	194.6	143.9	180.9	187.9	132.3	56.6	126.8	106.7	213.2	257.7	259.1	320.2	100.4	144.0	182.6	151.1	204.7	157.2	182.2	142.3	67.3	132.0	381.4	133.9	81.3	198.6	124.9	56.5	90.1	97.9	110.3	92.2	113.1	188.4	49.5	152.3	112.9	80.0	115.9	56.3	71.0	124.4	94.5	83.9	114.9	91.8	130.9	83.8	121.8	98.4	42.0	88.8	113.5	95.9	179.0	83.8	56.0	58.5	77.5	75.5	58.4	57.3	53.4	54.7	54.9	52.7	55.3	56.3	122.5	89.8	108.8	13.7	147.4	336.6	303.0	247.7	385.3	56.6	171.4	241.4	73.5	118.7	123.8	29.5	16.7	155.0	133.9	104.5	74.3	137.2	464.1	100.9	98.4	111.8	124.4	182.4	30.0	309.2	273.2	100.5	126.4	106.3	95.7	125.8	112.5	81.2	165.7	45.4	22.2	203.5	65.1	205.2	148.2	819.5	116.5	142.5	80.0	19.7	260.9	56.5	151.4	13.6	22.3	232.1	124.6	79.0	105.9	256.2	210.1	152.1	58.5	44.0	78.9	105.2	164.4	268.0	81.9	307.8	317.0	145.8	148.5	179.8	197.2	345.7
POLR3B	"C128, FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357748-106510198	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	4.5	8.7	3.1	4.8	4.4	5.2	5.0	4.3	4.6	4.7	3.7	5.3	4.2	4.6	5.2	8.6	5.1	3.6	5.8	3.4	2.9	6.8	9.0	4.7	4.1	2.2	2.3	7.5	4.9	11.1	2.4	6.7	2.3	5.6	5.7	6.2	4.7	4.0	6.5	11.0	3.4	5.4	2.7	3.3	5.4	6.1	3.2	4.7	6.0	8.3	5.6	4.9	4.3	3.6	16.2	7.6	16.4	7.8	13.9	13.1	22.9	21.9	13.0	15.2	11.6	14.0	4.4	20.6	7.7	14.2	5.6	14.8	19.5	19.2	18.5	16.6	13.1	15.7	10.1	12.0	9.2	26.1	17.0	11.7	13.4	15.1	17.3	10.3	11.5	9.8	24.5	6.5	11.2	12.0	19.1	8.7	17.8	11.9	28.5	11.6	9.8	13.5	8.6	21.8	17.3	9.6	13.6	18.2	13.4	10.8	17.0	7.9	11.0	8.3	10.0	13.6	13.1	8.1	22.4	30.3	3.8	15.9	9.2	5.6	2.0	1.5	2.0	2.2	2.7	2.1	2.2	2.2	2.6	1.3	3.0	1.9	1.3	2.1	2.2	0.9	2.7	1.7	3.1	4.4	4.3	4.6	3.4	2.9	2.2	2.3	2.3	2.7	3.2	3.6	2.4	0.0	9.2	14.4	4.7	1.8	1.7	4.5	4.6	6.0	3.4	3.7	10.3	2.8	7.0	5.5	6.2	11.0	3.8	3.8	1.9	5.1	7.1	3.9	7.0	3.3	4.2	3.8	22.3	4.6	9.3	4.4	9.2	3.9	5.1	4.8	3.6	11.0	3.1	3.3	24.1	5.6	2.0	1.6	0.3	5.2	3.7	2.4	3.6	9.4	1.0	2.4	2.1	17.1	22.4	3.8	1.1	4.9	4.9	1.5	1.7	3.4	7.2	7.2	6.6	6.9	4.1	16.5	10.9	8.9	3.0	7.4	4.1	7.2	5.1	1.2
PPP1R11	"CFAP255, HCG-V, HCGV, TCTE5, Tctex5"	ENSG00000204619	"Protein phosphatase 1 regulatory inhibitor subunit 11"	O60927	6	30066709-30070333	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 696.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	8	"cerebral cortex: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 51.5;AN3-CA: 65.6;fHDF/TERT166: 48.6;GAMG: 47.4;HBEC3-KT: 53.6;JURKAT: 76.7;RPTEC TERT1: 47.4;U-266/84: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043266, HPA060174"	Approved		Approved	Vesicles		NA	NA		43000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA043266: AB_2678400, HPA060174: AB_2684216"	"unprognostic (2.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-3)"	44.5	41.1	0.7	0.0	0.7	1.9	41.4	0.6	8.8	44.4	0.6	55.5	11.6	49.6	33.1	52.1	37.3	11.8	51.0	0.7	0.7	62.3	47.5	43.7	5.4	0.9	0.7	41.8	45.1	2.2	29.2	5.8	0.8	46.3	0.7	7.9	42.8	0.0	50.4	42.9	50.7	0.0	0.6	39.8	59.5	41.5	0.7	9.7	42.3	0.0	11.8	51.6	42.7	1.1	51.5	0.0	0.0	65.6	29.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	48.6	47.4	0.0	0.0	53.6	0.0	1.0	34.5	42.6	0.0	0.0	0.0	3.0	3.9	0.0	0.0	0.0	0.7	0.0	0.0	76.7	0.5	2.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.4	47.4	29.0	0.0	0.0	0.7	35.5	4.8	26.8	0.0	0.0	0.0	0.0	0.3	4.1	1.5	30.7	64.9	26.7	0.7	0.0	0.0	11.5	4.1	12.4	4.7	9.3	4.5	6.8	5.3	6.5	2.2	7.2	4.9	7.0	2.8	3.9	7.9	3.2	8.4	6.8	0.7	0.7	0.6	8.8	0.7	0.7	0.9	0.7	0.8	0.6	0.7	1.1	38.2	19.2	20.2	2.6	57.8	52.8	80.0	77.2	29.0	29.3	47.7	32.8	18.8	52.9	49.7	40.5	6.2	56.0	39.2	111.5	95.9	142.2	242.1	19.8	24.2	44.3	53.7	32.4	10.1	136.3	119.9	27.0	53.5	31.8	78.6	21.4	45.7	28.0	65.7	13.5	9.0	83.8	77.3	49.7	53.8	696.0	32.3	43.5	62.2	3.7	75.4	58.4	92.7	6.0	7.6	136.5	114.1	40.3	42.2	66.6	139.6	93.3	38.7	33.1	39.5	27.2	89.4	61.9	23.2	39.0	66.5	75.2	52.4	16.5	51.8	94.9
PPP1R7	sds22	ENSG00000115685	"Protein phosphatase 1 regulatory subunit 7"	Q15435	2	241149576-241183652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 968.8;Late spermatids: 1709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034500, HPA034501"	Supported		Approved	Nucleoli		NA	NA		960000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	Nucleoli		"HPA034500: AB_2674192, HPA034501: AB_10670965"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.07e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.23e-1)"	59.0	55.9	71.3	54.4	94.7	68.1	50.2	65.5	82.4	46.4	68.3	66.0	58.8	48.5	61.4	80.3	81.3	40.2	100.5	77.5	69.4	64.6	76.0	53.9	78.7	67.2	67.2	37.5	60.0	55.8	42.6	44.5	65.7	94.5	64.2	58.0	63.1	54.0	100.4	64.3	61.0	55.0	66.5	48.7	58.9	158.2	67.2	66.8	65.1	64.4	80.8	58.9	52.9	75.1	117.6	69.5	77.4	98.3	149.7	149.0	106.4	126.3	114.7	85.2	119.8	38.1	145.6	60.0	37.1	108.9	128.0	112.1	127.9	119.6	130.2	156.4	126.1	105.1	112.4	151.4	96.3	147.0	105.9	116.0	92.7	101.1	74.2	115.7	128.5	121.0	108.0	86.2	202.0	155.8	132.0	112.6	106.3	185.7	64.5	90.4	200.9	121.9	159.6	116.7	104.6	82.8	67.6	157.4	120.3	86.4	93.8	156.7	127.7	76.8	72.5	146.1	103.4	90.8	59.6	162.8	215.2	154.1	103.7	107.9	84.9	108.9	64.6	87.6	68.3	71.6	76.5	77.1	81.3	66.5	58.5	67.6	66.5	75.8	96.2	48.4	121.5	89.9	71.3	94.7	65.5	82.4	77.5	69.4	67.2	67.2	65.7	66.5	67.2	75.1	50.5	57.7	54.5	17.6	47.9	27.8	48.6	126.2	25.6	41.5	44.6	36.8	98.4	45.8	105.5	44.1	16.7	89.6	46.9	53.4	121.3	90.6	968.8	83.6	39.3	45.9	25.7	48.0	33.8	145.9	92.4	47.5	34.7	53.4	59.5	48.9	32.9	49.9	100.5	32.0	19.4	68.7	109.9	40.7	46.3	1709.4	51.0	49.4	87.2	13.1	63.7	78.6	80.3	18.1	21.9	94.5	71.3	67.4	54.5	52.1	81.7	120.8	112.2	58.9	72.3	35.1	65.6	315.5	122.5	45.9	38.1	71.6	57.9	117.2	55.3	56.0
PPP2R1A	"PP2A-Aalpha, PP2AA, PR65A"	ENSG00000105568	"Protein phosphatase 2 scaffold subunit Aalpha"	P30153	19	52190048-52229518	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Chromosome partition"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018599			Approved	Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB018599: AB_628178"	"unprognostic (1.78e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.76e-4)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.19e-2)"	98.5	300.7	305.0	60.5	311.1	58.1	98.7	292.0	394.2	126.9	261.4	115.7	91.5	126.8	101.0	164.4	126.8	63.2	322.8	342.6	299.4	156.9	106.0	87.5	72.7	308.9	301.1	163.7	100.7	129.9	123.9	69.1	312.8	123.3	82.2	89.8	99.8	92.2	239.7	119.3	98.5	96.0	280.1	87.6	106.0	67.2	331.7	76.9	107.9	170.7	90.0	123.5	121.9	299.2	153.6	248.4	210.9	182.0	166.9	173.4	105.3	130.3	173.2	174.1	151.1	129.3	122.1	132.5	91.0	213.9	95.7	108.8	228.0	197.9	100.6	101.3	562.8	99.6	126.9	148.2	152.6	105.6	93.1	234.3	163.8	163.5	149.2	162.9	167.9	92.1	114.3	96.8	196.3	178.6	159.6	215.4	204.6	162.2	218.4	148.6	118.3	152.5	285.0	251.7	153.3	161.3	149.0	160.1	100.3	136.3	141.9	197.3	153.1	133.2	120.5	65.7	154.2	96.9	151.5	160.0	143.1	109.7	170.5	172.6	172.0	169.4	143.9	212.2	131.0	143.1	126.3	134.3	192.8	157.1	101.6	119.6	103.7	228.6	199.0	119.7	177.5	255.6	305.0	311.1	292.0	394.2	342.6	299.4	308.9	301.1	312.8	280.1	331.7	299.2	55.3	44.8	35.4	21.5	76.0	70.4	99.0	178.0	56.9	114.0	64.5	71.1	100.2	74.4	99.5	119.5	25.0	203.7	47.3	157.0	117.4	213.5	4.4	77.5	79.7	72.4	107.0	39.7	27.4	155.7	259.9	85.7	77.5	100.7	68.5	96.7	65.0	52.8	146.2	144.7	39.5	128.8	144.5	68.1	39.3	10.4	72.4	58.0	53.4	17.8	103.7	118.0	62.8	25.6	29.9	168.2	189.0	85.4	60.3	88.3	147.5	135.3	80.6	61.5	78.9	49.2	90.3	16.5	68.8	74.4	63.2	182.0	64.2	99.7	185.2	104.2
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 189.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		42000	"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	53.7	37.7	56.1	32.4	92.9	73.6	27.1	38.0	127.3	27.3	0.0	27.6	25.7	31.0	26.1	30.0	23.3	28.0	20.6	99.0	24.2	21.4	58.2	27.7	40.2	23.5	18.4	24.9	20.7	17.0	18.3	36.6	24.9	26.3	27.8	189.9	24.9	30.1	88.8	33.6	23.9	35.3	14.4	34.2	24.8	20.6	30.0	42.6	23.8	31.0	40.5	32.9	28.6	64.5	61.5	51.7	69.7	48.4	47.4	54.3	70.5	86.3	75.9	98.8	86.8	75.9	55.4	85.7	28.7	61.4	69.5	41.8	74.4	64.8	120.0	59.4	52.9	284.0	38.3	71.1	93.1	111.9	92.2	55.1	57.6	76.9	78.0	55.9	67.2	72.2	67.8	96.8	73.2	53.8	96.1	99.4	81.9	52.0	44.4	69.1	90.6	139.9	61.7	66.1	91.4	64.2	50.4	72.3	65.9	45.0	33.9	51.8	69.5	84.6	76.5	64.2	75.1	53.8	62.6	124.7	61.3	115.2	54.0	1.5	0.5	1.3	0.2	0.3	0.5	0.2	0.3	0.1	0.5	0.3	0.3	0.5	2.7	0.3	0.6	0.7	0.3	0.4	56.1	92.9	38.0	127.3	99.0	24.2	23.5	18.4	24.9	14.4	30.0	64.5	37.0	9.6	12.7	81.6	40.4	74.8	11.6	7.0	72.8	22.2	21.0	13.1	17.9	10.0	7.7	16.5	52.1	11.7	34.0	20.5	11.7	7.1	20.0	19.9	23.0	34.0	15.1	52.8	151.2	8.7	17.2	24.2	18.8	29.1	19.7	11.2	15.4	19.2	24.7	11.8	93.1	15.6	4.1	40.0	105.1	7.7	9.9	54.7	35.6	105.9	21.2	27.8	18.6	72.9	77.5	12.9	10.6	8.6	39.2	17.3	12.6	20.1	5.8	92.7	13.1	14.4	29.8	2.9	6.1	64.0	70.5	12.0	39.9	14.2	13.2	21.3
PRCC	RCCP1	ENSG00000143294	"Proline rich mitotic checkpoint control factor"	Q92733	1	156750610-156800815	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.02e-2)"	31.9	31.8	43.4	29.7	45.2	41.9	31.4	44.5	50.4	32.4	42.3	36.6	27.0	34.5	23.1	39.7	29.7	23.0	37.6	45.7	42.0	36.7	34.2	29.6	36.3	43.3	42.8	30.9	29.0	34.7	28.1	29.0	43.7	33.5	22.5	26.6	30.4	24.1	63.4	43.2	30.9	27.3	41.3	37.4	31.8	27.0	43.3	37.5	31.0	34.4	30.7	32.6	32.2	46.9	79.1	67.3	51.6	59.5	42.5	33.8	89.8	53.8	52.8	59.3	50.8	106.2	65.0	80.6	90.4	43.1	34.1	80.3	74.7	57.0	45.3	101.6	97.4	59.1	47.4	68.4	52.5	81.9	66.6	48.1	64.7	51.5	46.6	45.7	55.2	52.5	99.7	72.1	41.8	140.2	94.1	94.6	124.9	108.9	82.0	81.6	45.7	108.7	62.5	74.0	91.6	163.4	57.0	140.6	92.4	84.4	102.7	129.8	51.1	59.3	61.9	66.0	89.6	184.6	298.5	124.1	58.7	52.2	56.1	46.9	28.6	57.4	27.5	29.9	26.5	24.0	24.7	30.0	32.5	27.6	24.0	25.2	27.7	30.2	37.1	38.9	27.1	26.0	43.4	45.2	44.5	50.4	45.7	42.0	43.3	42.8	43.7	41.3	43.3	46.9	22.2	9.6	16.4	12.7	32.0	52.4	38.2	52.1	46.1	19.8	31.1	24.4	13.0	18.6	29.4	20.2	22.9	63.1	36.0	27.2	21.5	39.4	13.5	21.4	21.9	30.2	34.3	16.6	15.9	32.2	63.4	28.7	24.5	23.2	17.1	28.9	25.4	16.0	44.0	28.6	14.4	26.9	40.7	22.6	27.4	10.4	30.4	28.4	21.4	9.4	44.9	16.9	30.9	18.1	25.4	35.5	34.2	28.6	48.8	43.8	29.8	29.9	21.5	19.8	32.9	32.2	29.2	43.3	46.2	39.6	51.3	101.1	30.3	32.4	29.4	39.2
PRKCB	"PKCÃŽÂ², PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835983-24220611	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;lymphoid tissue: 47.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 185.1;Bipolar cells: 208.6;Excitatory neurons: 877.7;Inhibitory neurons: 320.2;Kupffer cells: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	95	"amygdala: 28.9;basal ganglia: 53.9;cerebral cortex: 84.0;hippocampal formation: 35.3;white matter: 36.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 161.8;HMC-1: 154.8;K-562: 234.9;THP-1: 72.7;U-937: 64.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		380000	"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.4	1.6	28.9	30.8	53.9	32.1	1.5	0.5	84.0	4.2	0.0	9.7	5.9	3.8	0.6	3.5	3.8	4.4	1.1	35.3	0.0	2.8	4.2	7.8	47.1	0.0	0.0	0.6	1.0	0.2	1.4	2.7	0.0	7.3	5.1	18.2	1.5	10.2	0.8	5.5	19.4	7.2	0.0	46.2	5.7	8.4	0.0	47.2	4.5	1.0	40.0	8.7	1.7	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	1.0	0.0	0.3	0.5	0.5	0.0	0.0	0.0	3.2	161.8	7.5	0.0	0.0	23.6	154.8	0.0	0.7	0.0	0.0	0.0	0.0	27.3	234.9	0.6	0.0	0.0	52.1	51.4	1.5	0.0	0.0	49.0	0.4	9.5	0.5	14.1	27.2	0.0	0.2	0.2	2.4	0.8	0.0	72.7	1.1	0.0	0.3	0.1	0.0	4.1	0.0	1.4	0.2	64.4	0.3	39.3	13.3	27.8	24.8	20.0	11.5	44.2	15.9	29.9	11.3	40.0	13.0	32.0	39.1	39.9	28.6	33.8	12.7	15.5	28.9	53.9	0.5	84.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	36.6	1.1	3.2	4.9	21.5	185.1	6.0	4.1	0.1	0.6	208.6	0.9	0.8	2.0	2.8	1.8	1.8	2.1	0.2	166.3	1.4	0.0	0.0	26.5	0.1	0.1	4.1	0.0	26.3	877.7	0.2	0.3	1.7	1.5	0.1	71.5	1.9	11.4	3.1	50.5	79.1	320.2	1.5	0.0	221.9	20.5	11.7	0.0	100.9	3.6	110.5	154.4	10.8	120.5	102.1	132.5	0.0	9.6	0.4	61.8	1.0	6.7	0.8	1.6	9.9	0.0	4.4	1.6	3.4	3.6	0.5	14.3	0.8	68.1	0.2	3.8	4.5
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050411-2185395	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 708.3;Syncytiotrophoblasts: 1107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 16.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.5;OE19: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.7	11.1	23.6	4.6	25.7	2.1	5.6	58.0	41.3	4.3	0.0	13.2	29.3	2.2	7.8	16.0	9.5	4.4	9.7	23.7	10.2	16.0	11.0	31.6	8.0	18.6	8.3	2.7	12.5	14.7	17.6	43.8	19.0	8.4	11.3	14.8	10.8	3.9	0.3	13.8	28.0	1.6	5.6	10.5	8.9	31.9	7.2	3.7	21.8	0.6	7.8	5.8	8.0	24.8	14.7	9.7	3.4	17.2	0.0	0.0	44.5	1.2	0.5	11.1	0.7	23.8	31.0	0.1	27.4	3.9	9.4	25.4	20.5	25.5	7.9	1.0	21.8	0.0	15.2	33.5	3.2	0.1	11.0	0.6	14.9	0.0	8.6	0.0	0.0	4.0	6.6	0.2	0.2	17.9	0.9	0.0	6.4	41.9	22.5	0.0	0.0	5.1	18.6	16.0	24.1	18.7	11.6	27.5	5.2	28.7	17.7	4.0	0.0	0.1	13.1	0.1	0.1	6.8	1.3	0.3	1.2	0.3	16.8	0.3	0.0	16.3	0.5	0.3	2.5	0.3	0.9	0.6	0.0	0.4	0.8	0.3	1.1	0.9	0.0	0.3	0.9	0.3	23.6	25.7	58.0	41.3	23.7	10.2	18.6	8.3	19.0	5.6	7.2	24.8	0.9	121.8	72.2	2.3	6.5	13.0	11.8	11.0	10.2	27.1	11.3	11.0	1.4	5.7	21.1	7.3	4.2	118.7	7.5	48.9	7.9	12.3	224.4	14.0	4.7	6.3	10.2	6.6	39.5	10.7	66.3	3.1	17.9	11.7	8.2	12.5	10.0	16.5	14.5	62.2	35.2	25.5	10.2	0.8	2.9	708.3	9.6	4.4	7.2	2.8	4.5	19.1	8.2	13.0	41.3	14.2	45.7	8.6	7.4	19.5	78.4	24.7	22.1	25.9	0.0	0.3	4.1	28.3	28.4	13.4	13.4	1107.9	9.8	2.6	31.3	14.3
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890547-60906585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"		NA	NA		71000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	46.1	70.6	89.8	49.8	87.9	67.0	48.8	73.7	100.2	57.4	60.2	54.5	42.9	55.4	34.2	81.7	57.3	29.4	47.9	91.3	94.1	50.4	77.2	34.6	64.1	92.0	80.7	66.6	69.4	79.8	79.3	42.9	92.9	62.1	51.8	46.1	56.5	48.2	75.2	80.3	49.5	47.9	75.6	54.3	54.3	30.5	81.1	78.5	43.4	38.9	73.7	58.7	55.9	84.5	197.5	147.0	161.8	116.2	92.7	80.8	155.6	102.4	137.5	200.2	149.0	162.7	141.1	280.5	145.2	98.2	120.2	179.0	229.2	184.6	153.4	207.0	153.4	232.4	111.3	184.9	134.2	308.6	161.1	86.3	137.0	154.4	171.9	58.7	158.7	167.4	248.2	155.3	99.5	270.6	328.9	249.5	292.6	150.5	197.7	285.8	165.5	227.5	101.7	127.5	142.3	172.9	126.6	208.3	178.0	73.1	225.8	170.2	101.9	89.6	147.2	161.8	171.2	147.2	223.3	287.9	111.6	208.6	138.6	4.2	7.8	2.0	2.4	3.8	1.7	0.9	1.8	1.7	3.6	2.4	2.2	2.0	0.5	1.8	2.3	3.9	1.7	1.0	89.8	87.9	73.7	100.2	91.3	94.1	92.0	80.7	92.9	75.6	81.1	84.5	15.8	19.2	23.7	10.1	26.7	42.1	35.2	40.2	33.0	32.0	24.6	19.4	17.6	20.0	28.6	27.6	10.4	94.7	16.2	20.4	27.4	48.5	21.6	21.4	19.7	27.3	39.0	45.2	19.8	51.6	90.2	24.9	23.4	28.4	22.8	25.4	20.0	46.1	46.3	62.2	22.2	40.0	32.6	23.0	21.6	3.6	37.0	19.3	26.6	11.2	41.2	25.4	21.6	10.1	11.8	33.4	27.7	38.7	31.9	40.4	27.8	27.9	17.8	25.3	46.0	22.4	22.6	25.2	38.0	37.4	41.6	40.6	24.8	24.8	55.1	26.3
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	58	"lymphoid tissue: 826.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 42.1;Extravillous trophoblasts: 25.4;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.4;RPMI-8226: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.2	0.4	0.0	0.3	0.0	0.0	6.0	0.1	0.3	3.6	0.0	5.7	4.4	0.7	13.5	2.9	5.6	4.0	0.0	0.1	0.0	1.8	0.0	3.8	0.1	0.0	0.0	2.5	14.1	7.8	1.4	4.1	0.1	3.2	6.7	0.1	7.5	4.2	0.0	5.1	3.3	0.2	0.0	0.3	4.8	1.0	0.0	826.7	13.1	0.0	1.4	2.5	1.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	3.8	4.7	0.0	0.7	0.0	0.0	1.5	2.7	3.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.1	0.5	0.0	20.4	0.0	4.1	0.5	0.0	1.7	2.5	1.9	0.0	1.2	0.5	0.0	0.7	2.1	0.5	0.0	0.0	11.5	2.4	3.6	0.0	0.0	1.4	3.2	0.0	4.5	2.0	0.9	0.0	0.0	0.7	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.7	2.1	0.9	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.6	7.7	0.0	2.6	6.4	10.8	4.6	8.6	0.0	16.6	9.5	0.4	15.7	4.6	14.7	0.0	42.1	0.2	22.9	1.9	10.0	0.6	2.5	0.8	0.4	4.2	0.0	0.7	17.6	25.4	0.7	12.8	8.0	5.7	0.1	0.0	0.0	4.0	0.0	0.2	20.0	14.2	0.3	0.4	0.5	0.6	0.3	5.4	0.0	0.2	1.2	0.0	0.0	0.1	9.4	18.7	0.0	13.7	6.9	16.5	0.7	3.4	0.0	0.0	0.0	1.2	2.0	6.1	8.6	6.5	31.7	1.1	0.0	14.9	8.5
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;skin 1: 31.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2714.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	1.6	1.6	66.0	1.2	64.2	0.0	4.0	57.2	88.4	1.8	21.5	4.4	0.6	0.1	0.8	7.9	0.3	0.7	1.3	64.0	64.1	0.1	0.1	1.2	0.0	60.9	62.9	0.7	2.7	0.0	2.3	0.2	62.4	1.0	1.1	19.0	3.4	0.7	0.1	31.9	1.0	1.3	63.7	1.0	13.8	0.3	58.6	0.2	0.1	0.3	2.6	0.9	2.3	72.4	0.1	0.0	425.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	27.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	126.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	5.4	15.2	0.1	0.0	0.0	0.1	0.0	0.0	0.7	10.9	5.6	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.0	64.2	57.2	88.4	64.0	64.1	60.9	62.9	62.4	63.7	58.6	72.4	0.1	0.0	1.5	625.2	0.2	25.2	8.6	82.2	44.9	18.3	5.6	12.2	1.3	0.0	39.7	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	37.7	0.7	0.1	1.3	9.2	0.0	0.0	10.1	0.0	0.0	0.1	65.6	72.0	0.0	0.0	0.0	1.6	0.7	0.3	0.1	19.6	22.5	0.0	90.4	0.0	2714.3	3.6	0.9	0.3	0.0	1.2	1.8	0.0	0.1	16.9	6.6	0.0	1.2	1.7	0.1	1.6	14.8	21.5	0.3	0.2	0.5	0.0	7.8
PUF60	"FIR, RoBPI, SIAHBP1"	ENSG00000179950	"Poly(U) binding splicing factor 60"	Q9UHX1	8	143816344-143829352	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 332.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045733, HPA052096, HPA059714"	Enhanced		Enhanced	Nucleoplasm		NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110"	"unprognostic (3.49e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.42e-2)"	71.6	73.5	7.9	11.0	7.6	39.6	75.5	8.1	22.9	71.4	5.3	84.8	22.3	84.9	5.9	84.9	76.3	7.3	88.5	7.8	15.4	82.8	124.3	64.0	17.7	12.2	11.6	57.2	62.9	11.7	71.0	19.2	14.1	67.2	5.8	1.3	63.3	17.8	125.5	108.7	69.5	10.5	7.3	72.3	73.2	70.8	14.5	15.9	59.8	9.0	9.7	74.5	68.6	12.4	95.7	211.5	36.7	31.3	16.6	15.6	62.7	74.4	27.4	70.3	75.1	95.4	103.9	89.4	71.2	58.9	52.8	83.0	86.5	91.4	3.6	91.4	147.7	110.2	117.0	106.3	60.4	38.5	70.0	45.4	61.8	89.8	26.9	21.1	69.0	92.1	88.7	37.4	20.5	332.5	156.1	26.4	77.8	63.3	191.6	84.2	42.9	91.8	19.5	91.8	71.5	80.3	101.6	40.4	77.7	9.1	116.7	21.4	79.0	72.9	176.2	85.7	98.6	66.7	103.9	109.7	70.7	73.3	71.9	90.8	112.6	99.8	129.0	133.7	139.3	116.8	103.1	128.6	127.1	135.9	98.6	113.1	58.8	132.6	137.6	76.8	139.0	193.9	7.9	7.6	8.1	22.9	7.8	15.4	12.2	11.6	14.1	7.3	14.5	12.4	70.2	38.5	46.4	21.5	64.7	107.7	102.1	197.4	65.4	62.8	51.3	67.9	63.7	51.5	103.0	29.5	29.2	146.6	56.4	98.0	92.0	110.7	20.5	65.6	55.3	67.3	66.9	65.0	8.2	89.8	134.3	68.4	74.9	60.3	55.8	75.0	41.7	76.8	101.1	43.7	8.3	75.9	118.0	44.0	62.3	47.8	64.0	52.3	90.7	6.5	105.2	182.6	81.4	9.5	23.7	98.2	91.4	59.0	52.7	83.0	91.9	118.1	85.4	64.8	65.7	57.1	122.9	104.2	128.5	63.1	107.1	173.3	74.2	99.3	97.7	81.2
PYGO2		ENSG00000163348	"Pygopus family PHD finger 2"	Q9BRQ0	1	154957026-154963853	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023689, HPA074813"	Supported		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA023689: AB_1855974, HPA074813: "	"unprognostic (1.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.76e-4)"	14.6	30.6	30.0	16.7	30.3	6.5	15.3	29.3	29.8	21.4	21.1	23.5	19.0	19.1	23.5	24.2	20.3	12.7	15.5	29.9	34.0	24.7	20.1	15.7	26.5	30.5	30.8	27.2	18.1	27.5	32.4	16.3	29.1	23.5	15.3	12.7	23.2	23.3	18.9	22.4	24.4	15.7	29.8	28.2	21.6	16.1	35.3	22.5	26.2	15.9	27.8	21.2	20.0	32.3	28.1	19.4	40.4	36.0	39.8	19.5	37.0	17.1	23.0	26.5	22.7	26.1	34.2	34.9	26.4	19.9	28.7	37.2	35.6	23.7	17.4	34.7	25.1	27.9	32.7	23.6	18.5	25.8	23.9	16.2	33.8	23.9	20.0	30.0	16.5	52.5	37.1	57.6	25.2	42.8	36.0	30.0	43.3	55.7	34.2	40.2	25.7	55.6	27.1	26.1	48.4	71.8	27.0	48.5	34.9	39.1	59.7	45.9	14.1	23.5	35.1	25.6	25.1	56.8	54.3	37.1	19.6	32.4	31.8	2.3	3.9	10.9	8.0	6.5	10.0	6.9	10.3	10.7	4.1	7.5	11.0	8.7	3.8	6.3	8.4	3.9	5.8	6.2	30.0	30.3	29.3	29.8	29.9	34.0	30.5	30.8	29.1	29.8	35.3	32.3	7.0	9.6	4.9	5.5	12.6	5.5	3.8	5.8	7.4	11.8	14.3	10.0	5.3	5.7	7.4	12.9	2.1	15.5	14.1	10.3	19.6	6.2	3.4	5.7	7.5	6.8	5.4	12.4	6.3	5.9	12.6	5.8	9.7	7.4	0.0	9.3	7.1	9.4	6.5	21.9	4.3	10.6	6.1	6.6	3.5	2.2	9.0	5.6	5.4	6.5	6.4	10.6	8.2	5.5	4.7	9.7	9.1	9.1	11.5	4.9	12.0	9.8	4.0	6.0	6.6	5.4	6.9	5.9	12.2	9.8	5.3	11.6	11.7	9.3	8.4	3.7
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No		27000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	24.5	30.8	19.8	24.0	20.2	22.5	27.9	21.5	24.8	26.1	22.9	31.1	31.6	22.1	41.5	72.3	22.7	19.8	21.8	19.5	20.7	26.3	43.0	20.8	35.4	20.5	20.6	17.1	28.0	26.3	22.3	22.8	20.5	31.2	30.0	17.4	34.0	15.9	29.8	41.9	29.5	19.8	20.1	31.1	24.1	25.9	20.1	33.2	27.0	29.0	42.1	24.8	31.4	20.2	50.3	39.1	56.1	31.4	33.4	43.2	92.6	36.1	43.1	33.3	28.0	57.7	57.9	62.9	53.6	35.1	15.4	38.6	43.6	77.1	26.7	48.6	32.7	51.0	35.1	71.8	40.7	59.7	44.7	39.2	48.8	37.7	56.0	42.2	35.9	27.3	44.5	67.4	39.7	75.3	38.6	105.7	98.3	56.7	20.2	34.3	22.3	72.5	69.5	69.8	37.7	43.4	46.2	61.1	33.1	51.8	74.5	124.0	28.2	20.0	28.3	31.5	26.6	35.5	58.2	97.2	34.2	40.9	31.9	17.5	79.8	75.8	58.5	92.2	72.3	98.1	105.4	82.2	120.2	88.2	68.7	69.5	19.1	53.1	66.5	65.6	186.0	87.2	19.8	20.2	21.5	24.8	19.5	20.7	20.5	20.6	20.5	20.1	20.1	20.2	16.2	19.2	17.3	0.0	28.6	0.0	29.4	0.0	21.1	12.7	41.7	38.4	0.0	25.8	14.2	23.9	8.4	84.3	21.1	29.8	78.2	40.6	15.2	21.1	17.0	16.3	7.3	32.2	0.0	50.6	76.3	17.6	22.4	21.1	18.9	14.5	22.9	44.3	55.2	6.7	0.0	32.1	0.0	47.7	0.0	11.7	23.3	42.8	0.0	0.0	110.4	55.7	48.4	0.0	0.0	54.1	33.7	23.7	21.9	34.7	66.8	61.3	16.8	13.6	13.1	18.0	15.7	23.8	25.6	63.1	0.0	62.0	29.6	16.5	29.3	34.3
RAB11A	YL8	ENSG00000103769	"RAB11A, member RAS oncogene family"	P62491	15	65726054-65891989	"Predicted intracellular proteins"	"Cell cycle, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 969.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013097, HPA051697, HPA060686"	Approved		Enhanced	"Vesicles,Centriolar satellite"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Vesicles, Centriolar satellite"		"CAB013097: AB_2533987, HPA051697: AB_2732569, HPA060686: AB_2684342"	"unprognostic (4.15e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.85e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.46e-5)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.21e-1)"	140.0	231.6	79.7	123.9	86.4	126.0	150.1	83.4	105.0	159.3	78.5	223.8	139.8	117.4	130.9	480.0	146.1	185.1	156.3	86.1	97.4	162.9	124.1	148.1	141.2	87.0	83.0	104.9	107.6	192.5	106.8	214.4	101.3	150.3	224.2	99.0	195.1	126.2	119.6	288.5	158.9	149.2	87.2	183.9	216.2	201.8	86.0	143.6	155.3	109.6	246.0	269.8	232.2	86.7	285.2	330.3	330.1	240.8	294.7	275.0	431.1	297.0	300.4	264.4	313.0	305.8	497.4	370.7	295.8	342.6	262.3	429.0	525.0	393.2	248.2	243.7	314.9	445.3	219.9	274.1	224.7	211.5	254.0	282.8	438.1	260.2	214.7	281.7	595.2	197.8	364.5	214.3	378.1	283.7	209.9	167.3	275.9	1057.4	185.9	176.3	250.5	346.3	716.1	734.7	237.4	251.9	214.0	335.6	286.5	387.8	445.0	243.0	453.7	208.4	296.4	203.1	267.8	112.2	289.5	288.8	193.7	353.5	228.8	183.5	154.8	235.2	56.7	133.9	58.8	78.8	85.3	68.6	137.1	64.1	78.9	63.6	232.8	71.3	154.6	87.6	109.5	340.2	79.7	86.4	83.4	105.0	86.1	97.4	87.0	83.0	101.3	87.2	86.0	86.7	155.7	57.7	57.8	15.3	90.2	192.2	180.2	375.2	134.3	42.3	107.5	69.6	89.5	105.8	245.4	187.6	33.3	326.4	76.0	313.4	346.3	360.6	413.1	119.3	72.7	260.7	206.2	91.1	31.3	337.0	340.4	96.9	149.9	194.5	74.9	75.9	235.2	88.4	239.2	57.2	27.7	227.4	244.1	114.8	214.2	80.9	97.3	148.1	186.7	42.2	217.8	137.9	65.9	25.6	21.9	391.1	277.0	86.5	72.1	187.6	205.8	271.5	240.0	36.1	46.0	45.2	161.5	407.5	95.3	225.5	284.4	969.3	96.6	97.6	209.2	360.8
RAB14	"FBP, RAB-14"	ENSG00000119396	"RAB14, member RAS oncogene family"	P61106	9	121178133-121223014	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026419, CAB037066"	Approved		Supported	Vesicles		NA	NA		2700000	"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB037066: AB_1841128, HPA026419: AB_1855996"	"unprognostic (1.30e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-3)"	"prognostic favorable (1.79e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	39.0	38.7	37.5	35.6	39.7	66.5	42.1	40.3	47.7	37.8	32.6	42.8	39.9	35.6	34.2	63.2	34.0	30.7	32.4	38.4	40.9	50.0	82.8	49.2	41.1	39.6	39.9	35.9	27.6	45.8	28.9	43.1	40.5	38.8	42.4	45.5	34.6	38.1	39.4	56.4	38.9	33.4	40.8	38.3	44.3	33.8	40.2	35.2	43.8	38.9	49.5	43.9	40.8	46.8	53.8	53.7	66.9	56.3	76.2	82.5	52.6	74.8	59.6	56.6	44.7	42.6	57.0	51.2	42.5	72.0	49.2	100.1	48.1	55.8	63.6	44.4	31.7	55.7	69.0	43.9	52.6	60.1	63.8	53.0	98.5	58.2	63.4	62.5	81.2	47.1	42.8	45.6	85.6	50.8	58.5	48.1	39.7	104.8	59.9	45.8	72.3	60.4	62.3	76.0	58.9	34.4	89.0	78.0	53.8	47.1	82.1	46.8	76.0	60.1	43.9	75.3	53.0	40.8	82.6	52.3	56.6	51.9	80.7	34.4	29.4	33.5	22.4	41.5	22.4	24.6	20.9	24.7	31.4	23.4	24.6	25.0	31.8	26.5	43.7	19.0	29.3	24.0	37.5	39.7	40.3	47.7	38.4	40.9	39.6	39.9	40.5	40.8	40.2	46.8	102.6	160.3	103.9	23.5	64.4	157.9	78.2	84.8	97.3	93.8	70.7	58.8	39.2	62.9	96.2	62.5	37.5	85.2	79.6	95.1	86.1	81.3	41.9	80.7	89.8	84.5	60.3	44.4	42.5	64.4	83.0	68.7	64.7	94.4	77.2	58.1	61.1	113.6	91.0	94.2	38.0	59.8	95.6	89.9	105.4	36.2	51.9	80.7	110.3	44.0	84.8	100.5	49.4	38.2	59.0	80.7	52.9	56.4	50.2	81.0	63.2	103.3	86.8	62.0	59.2	64.0	105.6	112.9	113.6	120.0	202.4	116.2	74.3	82.5	64.0	106.0
RAB38	NY-MEL-1	ENSG00000123892	"RAB38, member RAS oncogene family"	P57729	11	88113251-88175443	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.6;skin 1: 44.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.4;Basal respiratory cells: 74.8;Cytotrophoblasts: 94.5;Melanocytes: 131.6;Suprabasal keratinocytes: 98.5;Syncytiotrophoblasts: 54.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 73.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"NK-cell: 18.0"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 18.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 87.7;hTCEpi: 308.0;hTERT-HME1: 271.4;SK-MEL-30: 175.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	HPA071701			Uncertain	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies, Mitochondria"		"HPA071701: "	"unprognostic (2.85e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	2.6	27.8	0.4	1.4	0.4	1.6	8.6	0.3	0.8	11.8	6.3	1.9	2.4	4.7	6.7	48.6	5.6	6.0	1.1	0.7	0.6	4.5	1.8	5.8	1.7	0.5	0.7	3.3	1.6	1.8	2.8	14.7	0.5	2.4	1.3	2.9	7.7	6.4	0.6	44.3	2.3	3.6	0.4	1.6	1.6	2.5	0.8	3.5	7.9	0.4	17.9	8.7	23.5	0.6	10.7	1.4	0.3	0.5	0.4	2.4	0.6	6.5	26.1	10.4	19.0	4.7	4.8	0.5	6.3	6.9	1.2	71.2	5.7	87.7	14.1	1.3	5.1	54.0	6.2	0.0	1.0	0.6	0.6	2.2	308.0	1.4	271.4	13.0	12.3	1.0	0.3	0.9	0.0	0.0	0.7	18.4	8.2	0.7	0.1	0.5	0.1	0.8	20.0	40.6	1.9	1.2	0.3	0.1	175.6	6.2	15.7	4.6	6.7	0.0	4.6	0.0	1.1	1.5	6.5	0.2	1.7	2.2	1.2	0.0	0.8	0.1	1.5	0.6	0.8	0.0	0.4	1.8	1.6	0.0	0.1	0.8	0.6	18.0	1.3	4.4	1.0	0.7	0.4	0.4	0.3	0.8	0.7	0.6	0.5	0.7	0.5	0.4	0.8	0.6	1.0	0.0	6.7	0.7	0.1	46.4	15.9	74.8	21.1	0.1	6.9	9.7	0.2	8.6	25.0	0.0	0.0	94.5	2.7	0.5	3.9	1.7	0.0	2.1	0.9	2.7	0.0	5.5	0.6	1.1	10.5	9.1	3.1	2.3	16.5	5.3	1.1	0.0	17.5	0.0	0.4	0.3	14.2	1.6	21.2	0.1	3.4	3.9	131.6	3.7	6.3	0.6	1.0	2.0	0.1	2.6	2.6	1.2	0.1	9.5	2.1	5.3	7.4	6.4	0.0	0.6	5.3	0.1	5.9	38.1	98.5	54.7	2.7	5.9	2.5	23.3
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332192	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 420.5;Late spermatids: 1201.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		5900000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	73.8	47.8	26.6	44.4	27.0	82.8	48.5	40.4	37.4	42.8	22.0	47.7	41.9	41.9	68.8	63.6	40.9	34.1	48.7	29.0	29.2	44.4	140.8	39.3	39.4	26.9	27.0	37.8	64.5	50.4	30.5	77.7	26.3	48.2	47.7	42.1	38.4	43.5	153.0	64.7	40.6	55.0	22.5	36.2	41.5	59.4	27.7	58.4	42.6	123.5	49.9	67.5	42.8	30.7	132.9	114.9	158.6	102.9	107.5	166.6	179.9	200.6	162.3	172.8	116.9	190.1	140.5	184.8	79.3	218.6	156.4	181.2	221.0	175.9	172.9	126.4	73.0	96.2	112.0	147.6	140.3	174.2	79.3	141.1	161.3	165.3	248.0	136.0	124.3	79.6	158.3	133.6	159.5	215.0	169.6	88.3	170.5	231.2	133.0	125.3	209.6	87.8	149.8	122.1	144.9	98.2	138.8	193.1	125.8	237.5	197.7	70.5	114.3	129.0	127.0	161.6	152.5	91.9	181.2	98.5	138.0	101.7	138.0	0.9	1.1	1.1	1.9	1.2	2.1	1.8	1.1	1.6	1.0	2.1	1.7	1.5	2.9	2.3	0.8	1.1	2.2	0.6	26.6	27.0	40.4	37.4	29.0	29.2	26.9	27.0	26.3	22.5	27.7	30.7	49.7	44.8	40.4	32.3	54.7	195.5	148.1	40.5	79.1	40.5	65.3	36.6	117.4	68.6	42.2	35.0	27.1	269.7	37.1	82.9	50.9	89.2	420.5	69.8	80.8	68.7	101.0	76.1	54.9	77.4	259.7	79.3	60.6	90.8	36.2	83.0	55.6	209.9	99.5	50.5	47.2	83.8	38.7	65.6	131.1	1201.4	75.5	70.7	74.7	38.4	83.7	40.4	39.1	50.3	54.1	81.0	50.5	87.3	89.3	146.0	51.2	95.9	47.6	43.9	78.9	71.6	88.5	45.3	74.7	126.9	240.9	291.8	50.5	91.1	74.9	141.2
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 199.1;skin 1: 237.7;vagina: 113.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Microtubules"	"Cytokinetic bridge"	"HPA022895: AB_1856071"	"prognostic favorable (8.43e-4)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	6.3	4.4	38.4	6.8	36.1	4.4	9.1	12.1	58.3	48.7	1.8	53.8	48.3	4.6	9.9	199.1	6.6	8.8	6.8	55.1	12.9	3.8	10.5	8.0	2.2	12.0	11.4	3.7	7.9	1.1	14.2	2.3	10.9	17.7	44.5	6.1	27.4	6.9	12.6	237.7	40.6	4.0	8.3	7.3	31.8	10.2	15.2	3.3	4.5	2.8	20.7	21.9	113.2	30.6	5.3	2.6	13.7	10.2	1.5	3.3	6.6	1.9	1.4	2.7	3.2	6.0	7.6	4.2	1.9	2.7	2.4	92.4	2.7	3.3	3.8	7.7	6.9	2.5	3.6	6.0	1.7	5.2	8.5	3.9	45.8	2.8	1.3	4.0	4.1	13.9	1.9	2.8	2.1	14.6	4.9	6.3	4.3	26.1	2.6	8.8	1.6	2.6	1.7	27.6	26.2	5.3	3.3	31.2	1.3	11.5	80.7	3.9	7.9	3.3	6.8	3.5	3.2	4.6	4.7	3.4	7.8	3.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	38.4	36.1	12.1	58.3	55.1	12.9	12.0	11.4	10.9	8.3	15.2	30.6	1.9	0.0	1.1	7.5	1.0	45.5	9.7	14.0	13.1	5.7	2.6	3.7	2.4	11.5	10.9	1.8	6.2	0.2	0.7	87.7	0.0	0.9	2.7	5.9	2.1	2.2	4.9	2.7	47.8	0.8	0.3	1.4	32.6	9.4	5.7	1.7	3.9	4.4	0.5	1.7	32.1	31.9	6.1	1.2	5.2	2.2	3.4	1.9	5.4	1.0	2.4	2.9	1.0	8.0	5.0	1.6	44.6	3.8	0.1	10.9	55.3	0.1	6.5	4.4	0.0	2.1	1.9	12.0	15.0	95.4	97.0	0.7	1.1	1.8	44.1	39.2
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 141.6;skin 1: 121.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 6.7;T-cells: 18.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 101.0;MCF7: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	17.4	16.2	10.2	5.7	9.7	3.7	19.4	13.0	10.9	55.0	10.8	22.7	2.5	23.3	6.0	141.6	27.2	15.7	17.3	9.7	9.5	12.5	3.2	15.2	5.9	10.3	10.0	20.5	8.5	7.2	8.7	9.5	9.3	26.9	7.8	3.9	30.6	16.2	6.9	121.4	10.4	13.0	10.0	10.2	14.5	4.8	9.5	5.1	22.6	10.6	22.5	26.2	69.3	10.0	22.8	24.7	5.5	50.9	55.0	46.8	1.7	23.2	50.0	29.7	23.3	8.3	101.0	0.5	12.5	93.6	16.2	74.3	18.4	44.6	7.4	5.7	9.4	3.3	18.6	7.4	23.2	0.0	9.1	34.8	63.9	28.5	6.4	74.7	12.7	4.6	0.8	9.8	11.9	110.3	1.3	1.1	16.3	30.4	42.7	7.3	1.9	18.1	8.9	37.1	4.4	22.9	47.0	50.6	32.1	6.8	43.9	1.4	13.8	35.4	16.5	23.6	1.5	4.2	2.6	1.8	43.4	3.8	51.3	1.8	3.1	0.9	7.4	0.9	18.8	2.0	6.5	5.4	6.7	0.6	5.2	4.7	0.0	2.3	0.0	0.6	1.8	4.0	10.2	9.7	13.0	10.9	9.7	9.5	10.3	10.0	9.3	10.0	9.5	10.0	10.7	3.2	7.0	21.2	2.5	34.2	24.1	21.6	42.7	0.5	18.0	15.6	3.7	11.5	11.1	3.7	2.1	7.5	6.2	3.2	0.0	10.5	0.1	3.6	14.4	11.0	1.8	0.8	2.5	5.1	1.2	19.6	13.7	3.4	1.3	0.3	20.3	0.1	2.7	0.0	3.0	2.1	12.2	4.1	13.3	0.5	5.3	4.9	8.8	6.5	1.8	3.6	5.2	7.1	0.7	14.3	4.4	5.3	3.0	19.2	0.2	0.5	3.9	5.2	6.6	9.5	22.0	0.8	5.6	69.9	55.8	1.8	7.2	0.4	5.5	45.7
RCC2	TD-60	ENSG00000179051	"Regulator of chromosome condensation 2"	Q9P258	1	17406760-17439677	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072281	Approved					NA	NA		110000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA072281: AB_2686505"	"unprognostic (2.50e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (9.91e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.42e-8)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.03e-8)"	"unprognostic (6.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.44e-2)"	"unprognostic (4.41e-2)"	19.4	18.4	12.3	18.9	12.2	33.3	22.2	12.8	13.2	24.8	11.0	24.0	11.4	18.7	9.9	65.2	16.3	11.8	13.4	12.1	12.5	22.8	15.9	24.2	27.7	14.2	13.6	22.1	21.3	9.4	11.4	16.1	13.1	22.3	17.6	3.1	36.0	7.8	8.4	56.3	27.6	10.2	13.9	39.2	18.3	20.6	15.8	34.2	19.0	4.1	35.2	19.7	31.3	15.3	62.2	34.3	68.4	57.9	25.3	25.4	56.6	24.3	20.9	49.2	40.4	37.0	83.4	133.8	80.4	25.3	14.5	67.4	121.0	70.0	34.1	64.3	61.1	117.6	50.5	36.0	31.8	142.7	79.7	40.5	51.8	55.1	48.7	30.7	53.3	88.7	82.4	188.4	22.0	62.9	117.4	115.9	94.7	76.0	26.0	155.7	68.6	86.5	37.3	29.0	102.9	72.6	61.4	59.5	93.6	56.7	53.2	91.3	41.9	44.8	56.0	18.1	51.1	81.7	72.9	165.8	19.3	158.6	90.9	0.9	1.9	0.7	1.4	2.6	1.2	1.6	1.1	1.4	3.1	1.7	0.8	1.4	0.1	1.7	2.1	2.5	1.0	1.1	12.3	12.2	12.8	13.2	12.1	12.5	14.2	13.6	13.1	13.9	15.8	15.3	22.6	25.6	15.3	16.6	26.4	46.5	14.7	25.3	27.9	6.6	36.5	34.3	0.9	18.6	26.6	22.0	10.4	25.0	32.2	27.5	3.9	24.4	6.8	28.0	38.3	24.9	24.1	28.8	11.0	22.7	48.9	17.4	14.8	37.5	17.7	55.9	17.5	7.3	32.6	6.7	4.9	25.9	24.4	31.4	70.0	21.0	9.3	43.0	16.0	20.6	27.9	15.3	22.6	20.6	15.3	28.8	20.6	6.0	25.9	32.2	7.5	7.0	17.9	5.4	0.0	20.7	16.7	17.6	21.2	42.9	64.5	16.3	19.7	25.6	36.4	19.4
RELCH	"FLJ33841, HsT3308, HsT885, KIAA1468"	ENSG00000134444	"RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing"	Q9P260	18	62187255-62310249	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Cardiomyocytes: 9.4;Cytotrophoblasts: 6.5;dendritic cells: 8.2;Extravillous trophoblasts: 4.4;Hofbauer cells: 7.2;Plasma cells: 5.2;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039708, HPA040038"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA039708: AB_10794753, HPA040038: AB_10793860"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.71e-2)"	8.3	8.8	8.7	9.6	10.8	14.2	11.9	11.1	10.0	11.8	7.2	11.5	9.5	8.5	11.8	25.4	7.7	7.9	7.5	9.7	9.3	9.6	7.9	8.0	11.8	7.9	7.6	8.2	8.3	10.3	11.0	8.1	8.2	12.1	14.4	16.3	12.5	8.8	6.8	20.6	10.8	6.2	7.6	11.2	12.7	5.3	8.8	10.8	9.5	5.9	13.2	10.0	16.2	9.4	9.7	8.7	10.4	10.0	10.8	12.7	11.1	17.0	14.1	15.0	16.5	4.5	8.8	6.6	8.6	15.1	9.8	19.7	14.9	10.2	18.3	6.0	9.3	5.6	9.7	10.4	9.6	10.8	7.4	9.4	12.3	12.8	7.8	12.3	10.3	6.2	4.2	6.5	15.9	5.7	6.7	9.3	6.0	6.5	7.3	8.2	13.0	7.9	17.1	19.1	14.7	7.8	10.2	14.9	8.9	13.4	7.7	11.6	12.9	15.9	5.0	6.9	8.6	19.0	3.7	6.4	11.2	11.4	13.0	1.4	1.0	1.2	1.1	0.8	0.8	0.8	1.0	1.0	1.0	0.9	1.1	1.3	1.7	1.1	0.7	0.7	1.3	0.6	8.7	10.8	11.1	10.0	9.7	9.3	7.9	7.6	8.2	7.6	8.8	9.4	7.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.6	1.1	0.0	0.0	0.0
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 207.3;Excitatory neurons: 114.3;Inhibitory neurons: 138.1;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: AB_2673269"	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	13.5	11.9	24.7	14.9	25.4	23.2	23.6	27.7	36.8	19.2	14.8	17.4	15.4	21.9	40.2	28.0	18.4	14.0	23.9	27.4	24.0	17.4	31.3	15.2	19.4	25.2	23.9	21.1	18.8	41.0	31.7	17.2	21.3	15.9	17.3	38.8	26.1	16.2	17.5	30.0	16.4	19.5	21.5	22.1	18.1	35.6	25.9	36.0	17.8	12.6	22.2	19.5	20.1	25.3	29.3	22.6	42.3	53.1	23.4	41.6	46.2	27.8	30.7	31.9	38.2	54.1	24.8	35.2	22.9	38.9	38.0	33.6	48.7	42.0	42.1	37.6	41.9	29.6	12.9	32.9	35.3	94.6	45.9	34.1	33.7	58.6	70.3	30.2	33.5	51.2	40.2	35.1	41.4	49.4	53.9	51.3	40.4	37.4	21.3	62.4	26.0	20.0	26.5	43.6	37.7	37.2	25.7	38.7	38.0	62.0	18.6	64.4	32.9	17.8	29.6	48.5	38.8	34.4	33.7	49.2	21.1	38.3	26.4	5.9	1.3	1.9	2.2	4.0	3.8	3.0	2.9	3.2	1.9	1.6	2.9	3.6	0.7	2.9	4.5	3.5	3.3	1.2	24.7	25.4	27.7	36.8	27.4	24.0	25.2	23.9	21.3	21.5	25.9	25.3	11.8	19.2	7.4	207.3	18.0	13.4	11.7	7.9	22.2	12.6	13.7	9.5	28.4	10.0	12.2	5.5	16.7	25.6	18.9	11.9	7.9	7.8	13.7	17.5	9.7	10.3	6.0	5.0	114.3	7.1	28.3	11.5	16.3	23.3	15.9	14.4	15.7	43.8	13.3	13.5	138.1	12.8	6.1	24.0	10.3	7.7	7.2	17.2	5.4	47.8	10.5	36.8	15.5	99.5	71.2	8.9	14.7	8.6	23.9	11.2	13.5	8.6	16.5	14.4	19.7	16.8	10.9	41.7	33.8	26.4	14.9	28.6	18.7	7.6	15.2	18.1
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	12.2	9.5	10.6	13.4	10.9	27.4	15.5	11.4	11.5	12.6	11.1	13.4	9.0	9.6	8.4	18.6	10.1	8.6	10.1	10.5	10.9	14.7	21.2	11.3	23.5	11.7	11.3	11.3	13.3	11.8	7.9	18.4	11.4	11.5	15.0	8.8	12.2	7.6	18.8	20.3	11.2	12.6	11.5	14.2	13.6	10.0	10.7	20.2	9.2	12.2	30.8	11.5	12.6	11.8	74.3	55.6	65.2	64.6	13.1	15.2	29.4	42.5	46.7	85.2	101.4	62.6	67.3	69.2	11.5	30.7	78.7	49.7	53.3	69.2	87.5	49.6	91.5	42.9	76.4	46.7	10.1	64.6	25.3	15.4	15.9	79.8	55.0	18.5	46.0	63.9	89.4	41.9	66.4	87.2	65.1	124.7	74.1	116.3	47.4	95.0	72.0	85.8	45.7	58.1	52.4	65.5	50.7	94.8	34.7	79.2	68.7	58.0	17.4	83.4	54.9	64.6	96.3	25.1	35.1	120.6	42.4	98.4	89.3	33.4	36.7	27.3	18.0	42.3	18.1	31.6	15.5	16.5	31.9	36.8	19.5	14.3	46.4	42.9	40.1	17.1	23.9	29.1	10.6	10.9	11.4	11.5	10.5	10.9	11.7	11.3	11.4	11.5	10.7	11.8	15.4	12.8	11.1	2.6	19.0	23.8	24.3	24.3	19.9	13.2	12.6	17.4	6.1	5.7	16.5	5.5	2.1	68.6	17.5	12.4	5.9	21.0	2.8	8.1	13.3	13.5	4.8	38.3	3.0	19.0	65.0	17.4	10.7	11.5	23.4	25.1	13.6	14.0	37.7	3.3	2.6	13.1	20.3	14.4	28.2	2.5	8.7	18.2	21.4	1.9	26.3	16.1	23.7	1.5	2.2	13.8	6.9	10.9	17.5	11.0	13.2	13.8	8.8	9.5	6.6	14.6	17.5	33.8	44.6	20.1	17.0	46.1	16.9	12.9	19.1	15.3
RFESD		ENSG00000175449	"Rieske Fe-S domain containing"	Q8TAC1	5	95646754-95684773	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 26.9"	"Cell type enriched"	"Detected in many"	7	"Erythroid cells: 278.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 41.3;K-562: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016546	Uncertain		Approved	Nucleoplasm		NA	NA		48000	"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB016546: AB_630417"	"unprognostic (1.15e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.09e-1)"	1.7	2.3	1.3	1.1	1.7	26.9	2.8	2.1	3.4	2.2	1.8	1.8	1.2	2.0	4.4	2.4	2.0	1.2	3.5	1.4	1.6	2.5	2.5	1.5	3.1	1.8	1.6	2.9	3.6	3.9	2.8	1.6	1.7	3.1	1.4	3.6	4.7	1.4	5.8	7.6	1.4	1.4	1.6	2.4	2.5	12.2	1.7	4.9	3.3	3.5	3.2	2.3	1.9	2.2	3.6	5.5	1.0	3.5	3.4	6.2	0.0	1.9	2.9	3.1	3.1	4.4	3.8	5.8	3.8	1.6	7.3	5.2	3.8	3.0	3.3	8.7	3.3	41.3	5.2	1.6	4.3	3.8	4.2	2.8	5.5	4.0	3.6	2.8	3.1	17.1	78.3	4.5	4.9	2.4	12.4	16.4	4.4	1.6	5.2	6.0	0.7	2.6	1.1	2.1	5.3	3.8	5.4	2.4	0.0	0.3	2.8	2.0	1.6	3.9	3.1	2.9	3.4	3.9	10.1	4.7	3.4	4.5	2.1	0.0	0.7	0.4	3.6	0.9	9.6	3.9	8.7	6.2	1.6	3.3	12.7	7.5	0.0	6.1	0.9	1.9	5.4	2.7	1.3	1.7	2.1	3.4	1.4	1.6	1.8	1.6	1.7	1.6	1.7	2.2	2.0	12.8	3.3	1.6	2.8	3.2	4.5	6.0	3.4	2.1	2.3	3.4	7.8	0.0	5.5	1.8	0.0	3.5	4.2	0.5	1.9	2.4	18.2	2.3	2.4	1.4	0.0	278.7	1.6	1.8	12.1	3.2	2.0	1.8	3.8	2.0	2.9	2.1	3.8	1.7	1.9	1.1	14.2	1.6	0.8	8.5	1.8	1.2	0.0	2.8	2.3	3.8	3.1	0.0	1.7	1.7	0.3	1.2	1.0	2.5	0.9	2.9	5.3	1.9	6.6	2.8	2.7	37.2	14.3	4.5	6.8	2.1	4.6	2.5	1.2	2.5
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357924-177372596	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 72.8;Proximal tubular cells: 113.7;Squamous epithelial cells: 95.8;Suprabasal keratinocytes: 115.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 110.4;cerebral cortex: 67.9;hippocampal formation: 56.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 112.5;HMC-1: 95.4;NB-4: 44.8;RPMI-8226: 57.9"	"Group enriched"	"Detected in many"	10	"amygdala: 66.0;basal ganglia: 57.9;cerebral cortex: 46.8;hippocampal formation: 93.6;white matter: 23.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 102.1"	"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: AB_2679836, HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	3.5	2.8	16.0	13.9	110.4	22.4	2.9	0.0	67.9	3.1	1.8	3.7	6.3	2.3	0.4	10.0	7.7	4.3	1.3	56.4	4.5	8.5	28.7	5.5	18.1	0.0	0.4	1.1	3.7	1.5	2.4	1.4	0.1	3.5	0.9	0.0	6.2	2.1	2.6	6.1	11.0	1.8	0.1	27.7	4.9	1.9	15.2	16.3	6.1	0.9	6.6	4.1	5.0	3.2	5.4	1.1	2.3	1.4	0.1	0.0	3.7	0.2	0.0	0.5	0.6	3.7	10.4	13.3	7.3	0.4	1.3	10.6	0.2	3.8	0.0	112.5	0.5	20.7	1.0	4.7	0.9	16.3	95.4	1.8	1.1	0.6	0.7	1.4	0.6	14.9	3.5	26.5	0.2	0.4	21.7	44.8	1.7	5.4	2.8	10.2	0.3	57.9	1.5	1.6	0.4	1.9	0.4	0.4	8.8	0.0	3.5	25.2	1.1	0.2	1.9	0.0	9.7	13.9	7.1	5.8	1.6	30.3	2.4	70.6	39.9	148.8	62.4	37.9	63.0	27.7	57.9	57.8	39.8	26.6	47.4	43.1	140.0	23.6	41.2	17.6	60.9	43.9	16.0	110.4	0.0	67.9	56.4	4.5	0.0	0.4	0.1	0.1	15.2	3.2	5.3	6.4	4.4	2.6	27.3	68.8	23.9	15.4	72.8	0.7	8.9	11.8	2.3	37.1	5.6	11.0	2.1	3.9	41.4	4.2	31.3	11.4	0.6	19.5	2.0	6.5	4.8	7.4	4.6	16.7	10.4	5.4	12.2	8.1	24.7	2.8	8.2	64.0	26.1	0.0	1.5	10.0	10.2	17.0	23.3	1.5	2.8	18.2	21.4	6.5	18.1	9.9	48.4	0.5	0.3	12.8	17.2	2.2	18.0	14.1	16.8	113.7	11.7	2.0	0.0	1.6	4.6	0.1	20.3	95.8	115.1	3.3	51.2	1.1	4.4	20.0
RHEBL1	"FLJ25797, MGC34869, RHEB2"	ENSG00000167550	"RHEB like 1"	Q8TAI7	12	49064676-49070025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 10.6;Granulosa cells: 12.2;NK-cells: 14.4;Plasma cells: 8.2;Respiratory ciliated cells: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 16.1;T-cells: 10.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;U-266/84: 61.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA053111, HPA061001"	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Centrosome"		"HPA053111: AB_2682047, HPA061001: AB_2684409"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (9.81e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.03e-5)"	"unprognostic (9.13e-2)"	"unprognostic (9.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-10)"	"unprognostic (4.67e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.07e-1)"	0.8	0.2	2.2	1.5	2.3	2.1	0.8	2.1	4.1	0.3	1.7	0.5	0.5	1.4	1.0	0.4	2.6	0.5	0.5	2.2	2.2	0.3	0.3	1.2	3.6	2.3	2.1	0.3	0.2	0.2	0.3	0.6	2.1	0.2	0.8	0.8	0.4	0.2	0.2	2.6	0.9	0.5	1.9	2.5	0.6	1.5	2.1	1.6	0.3	1.1	1.9	0.4	0.4	2.4	1.7	3.4	2.2	4.8	1.2	0.2	2.1	1.4	4.8	9.1	9.9	3.2	2.9	4.7	1.5	0.4	4.7	1.8	1.5	1.8	3.9	30.8	0.4	4.9	2.9	1.9	1.0	2.4	10.1	0.5	0.8	4.5	1.4	0.6	3.5	8.3	6.1	14.8	3.3	1.7	2.3	13.3	3.0	6.0	3.9	4.7	3.2	7.9	0.7	0.2	1.0	2.9	1.4	1.3	8.4	2.6	0.5	3.5	1.3	2.7	4.4	5.3	1.7	17.8	61.0	3.0	2.3	7.2	1.2	16.1	0.3	0.7	7.6	1.8	10.4	2.0	3.2	4.1	0.8	2.9	1.0	3.8	0.7	1.4	1.7	1.0	6.7	1.4	2.2	2.3	2.1	4.1	2.2	2.2	2.3	2.1	2.1	1.9	2.1	2.4	2.8	0.0	0.0	0.3	6.8	1.3	0.5	1.9	4.0	1.8	1.2	1.7	1.5	1.5	1.8	0.0	0.0	0.1	10.6	0.1	0.0	0.5	0.5	2.8	0.3	2.6	0.0	8.0	6.9	0.2	0.5	1.4	0.5	0.4	0.0	12.2	1.8	0.1	1.8	3.3	2.3	0.2	0.0	0.3	2.0	0.6	0.0	3.7	0.0	0.0	4.5	0.6	14.4	0.5	0.3	0.2	0.0	0.0	8.2	0.4	0.1	0.1	12.0	0.4	0.0	1.3	1.8	0.9	5.4	4.8	2.0	0.1	5.7	0.2	0.4	0.2
RHNO1	"C12orf32, HKMT1188, MGC13204, RHINO"	ENSG00000171792	"RAD9-HUS1-RAD1 interacting nuclear orphan 1"	Q9BSD3	12	2876258-2889524	"Predicted intracellular proteins"	"Cell cycle, DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 16: Immune cells - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"				"unprognostic (3.90e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (5.74e-13)"	"unprognostic (1.97e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.53e-2)"	5.5	8.8	12.5	13.1	10.9	17.1	12.1	11.3	13.5	13.1	12.2	14.1	11.0	11.5	22.7	17.5	12.2	10.7	7.2	12.5	13.5	9.1	5.2	9.2	19.6	9.7	10.0	15.6	8.7	13.6	12.0	11.6	12.4	13.4	14.5	13.0	12.1	12.7	6.5	14.1	10.1	11.5	8.3	12.8	10.6	11.3	12.2	25.7	16.6	3.9	20.9	12.4	10.6	16.7	42.3	54.2	64.5	32.9	14.8	18.6	67.7	40.7	43.3	51.0	50.1	66.3	91.4	34.5	22.8	42.4	64.2	32.4	43.0	50.9	62.4	138.6	28.2	45.0	25.3	39.6	20.0	50.8	33.4	18.4	32.4	50.3	104.8	36.7	52.5	71.8	41.1	81.2	61.3	60.9	92.8	28.5	149.7	52.8	32.4	61.6	77.7	26.8	41.2	52.3	21.6	32.0	56.1	35.6	30.0	117.7	69.3	47.2	37.1	55.1	83.6	62.6	85.3	18.5	37.9	90.6	25.3	41.8	51.7	23.7	23.3	34.9	23.8	22.0	31.2	27.7	36.4	31.9	26.5	41.9	36.8	24.7	4.8	26.5	23.9	15.8	54.7	25.9	12.5	10.9	11.3	13.5	12.5	13.5	9.7	10.0	12.4	8.3	12.2	16.7	3.8	0.0	5.9	3.3	14.0	7.8	10.0	27.7	6.2	6.8	11.9	13.3	7.6	7.2	10.4	11.0	8.4	40.1	6.5	7.2	23.5	13.9	6.5	8.1	7.0	8.7	10.3	33.2	6.6	8.4	34.0	8.2	7.1	9.0	14.0	17.4	12.5	3.9	31.7	10.1	6.4	16.3	14.2	15.5	8.0	14.6	12.2	10.2	3.6	2.8	32.3	20.4	10.3	3.0	6.5	6.9	9.6	8.6	11.4	18.1	13.2	15.4	6.4	9.8	0.0	3.1	7.5	67.1	46.0	18.8	7.1	21.8	17.3	8.4	17.3	12.5
RHOD	"ARHD, Rho, RhoHP1"	ENSG00000173156	"Ras homolog family member D"	O00212	11	67056847-67072017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 182.2;liver: 122.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 124.7;Ductal cells: 102.8;Exocrine glandular cells: 141.6;Pancreatic endocrine cells: 271.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 156.0;CAPAN-2: 109.2;HaCaT: 135.9;HBEC3-KT: 179.8;hTCEpi: 208.6;MCF7: 101.0;T-47d: 148.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 14.9;pons and medulla: 5.1"	"Low region specificity"	"Detected in some"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (2.12e-2)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.89e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.38e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	13.0	2.5	3.3	2.5	3.0	0.0	13.9	4.0	4.7	36.7	18.1	9.1	9.1	12.5	1.1	182.2	11.4	6.6	53.4	3.5	2.7	24.0	122.9	8.9	1.1	3.5	2.9	11.8	36.2	24.8	15.6	7.3	3.1	18.0	1.2	0.8	34.9	7.1	28.2	58.6	7.3	3.3	2.8	2.6	15.6	4.9	2.7	1.4	23.0	5.0	6.0	7.8	60.1	2.5	156.0	12.2	0.8	15.8	2.3	1.7	23.1	13.7	22.5	8.2	8.1	11.4	109.2	0.0	24.6	16.1	0.0	135.9	1.6	179.8	1.5	0.0	0.5	0.0	62.6	1.3	21.7	0.1	0.2	21.4	208.6	2.5	54.2	10.1	8.3	0.0	0.0	10.6	2.5	101.0	0.2	0.1	17.8	16.6	62.6	0.0	0.0	0.3	76.3	11.2	1.0	0.0	70.9	4.0	6.1	2.9	148.7	0.5	5.1	0.1	0.4	2.2	0.8	0.0	3.5	0.2	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.0	4.0	4.7	3.5	2.7	3.5	2.9	3.1	2.8	2.7	2.5	6.6	16.0	4.4	0.7	1.3	32.9	34.6	124.7	56.9	0.2	38.8	57.7	28.2	28.6	29.0	16.5	0.0	29.9	0.6	67.7	45.0	102.8	16.7	6.5	8.1	7.2	4.2	3.6	0.4	141.6	34.1	14.8	24.5	9.7	0.0	8.0	5.7	46.3	3.6	0.0	0.3	4.5	10.2	1.0	4.0	9.4	11.8	1.0	8.8	1.0	0.6	13.6	0.0	0.5	0.2	271.3	66.1	22.2	1.7	61.0	90.8	24.7	19.3	0.6	0.0	2.1	9.1	0.9	4.7	55.4	57.7	36.0	2.8	1.5	6.6	71.8
RHOT1	"ARHT1, FLJ11040, MIRO-1, MIRO1"	ENSG00000126858	"Ras homolog family member T1"	Q8IXI2	17	32142454-32253374	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 128.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010687, CAB068223, CAB068224"	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"			"CAB068223: AB_2665691, CAB068224: AB_2665692, HPA010687: AB_1079813"	"unprognostic (3.28e-2)"	"unprognostic (4.02e-3)"	"unprognostic (6.85e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.59e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.08e-2)"	19.1	26.9	19.9	9.6	20.8	19.7	19.5	20.5	29.4	16.6	12.5	19.8	11.4	16.3	15.0	14.9	14.4	11.4	24.8	22.0	18.5	17.6	16.8	17.3	10.9	18.1	17.5	17.7	15.5	38.1	14.2	18.6	19.8	17.1	11.3	50.9	17.3	19.1	28.4	28.5	12.2	16.0	18.7	12.2	17.3	12.3	19.9	19.4	25.0	34.5	11.2	16.6	15.5	24.8	14.1	26.2	21.9	22.8	25.8	28.9	13.2	22.7	18.2	24.2	26.0	13.8	9.0	18.2	22.3	18.7	26.5	24.9	34.3	13.8	29.1	14.4	25.9	21.4	15.8	21.0	35.4	28.1	15.3	15.3	40.7	20.7	23.8	40.5	21.1	36.7	48.1	14.9	21.5	10.6	52.1	23.0	18.0	16.7	12.6	28.6	32.4	32.2	17.5	8.4	20.0	18.1	22.8	14.1	38.4	26.1	31.9	38.1	16.3	17.0	17.5	19.6	16.2	22.0	22.9	19.9	20.5	26.7	28.9	3.0	5.8	5.4	2.1	4.9	2.3	2.1	2.3	2.1	5.3	4.0	1.8	2.3	3.6	3.4	5.2	1.8	1.3	2.8	19.9	20.8	20.5	29.4	22.0	18.5	18.1	17.5	19.8	18.7	19.9	24.8	16.5	28.9	38.8	88.8	17.8	25.9	13.5	14.4	27.9	61.5	21.4	18.0	38.1	14.3	18.7	16.5	70.9	28.4	14.1	12.3	33.2	17.0	19.6	14.5	15.5	17.9	16.9	31.5	97.3	13.1	20.3	19.3	15.3	13.9	27.3	24.8	18.9	18.3	33.7	57.2	89.9	9.3	22.4	46.4	29.1	20.6	30.1	33.2	16.0	76.8	45.1	128.9	29.9	68.3	65.9	13.5	14.4	24.0	11.6	13.7	22.8	21.3	15.1	58.7	26.3	24.8	21.9	63.0	40.3	24.3	53.0	22.7	18.9	24.5	13.9	11.4
RNF135	MGC13061	ENSG00000181481	"Ring finger protein 135"	Q8IUD6	17	30970984-30999911	"Enzymes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 63.3"					"Low region specificity"	"Detected in all"			"HPA021576, HPA052404"	Approved		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA021576: AB_1856331, HPA052404: AB_2681817"	"unprognostic (1.13e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (6.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.47e-1)"	20.9	12.9	11.1	13.5	12.5	11.6	18.6	11.2	14.2	16.0	15.1	17.5	13.6	13.3	16.5	22.4	15.7	9.6	8.5	10.4	11.3	21.6	8.6	15.5	13.9	13.9	13.2	12.6	13.5	16.8	5.6	18.1	12.4	14.0	18.0	2.3	15.2	15.2	7.4	26.2	13.9	13.7	12.8	25.8	11.9	5.1	16.4	7.9	15.8	10.1	12.6	14.8	17.3	13.8	12.7	25.6	1.5	25.4	34.0	28.5	22.7	9.7	14.9	9.4	8.4	0.0	9.4	11.5	14.8	19.0	17.0	17.0	13.2	12.1	7.8	10.0	5.6	4.8	8.1	0.0	24.3	12.8	10.7	27.7	63.3	10.1	33.5	16.1	15.8	0.0	0.0	34.9	15.6	17.0	0.1	13.5	10.5	25.7	14.4	27.9	0.0	39.2	13.6	18.2	9.8	0.5	14.9	5.9	14.9	16.6	39.4	20.2	13.3	0.0	3.5	15.6	11.5	0.4	1.3	7.3	16.5	22.1	13.3	25.3	61.6	31.3	12.8	57.3	7.2	28.4	6.8	6.8	46.4	28.4	3.7	6.2	54.0	13.9	70.2	17.1	10.1	29.2	11.1	12.5	11.2	14.2	10.4	11.3	13.9	13.2	12.4	12.8	16.4	13.8	14.1	3.2	5.9	7.8	14.1	9.3	13.4	16.8	22.2	0.1	13.1	15.0	4.0	7.2	7.8	11.0	0.0	47.5	10.5	23.4	29.4	9.9	0.4	14.5	12.8	13.2	4.9	11.2	0.8	18.6	37.1	13.2	5.6	12.4	1.3	14.1	25.4	2.7	51.1	0.0	1.0	12.0	8.2	73.9	8.4	1.6	16.8	35.5	16.0	26.2	45.3	3.9	19.6	9.0	0.7	11.9	13.1	15.4	9.0	22.2	27.5	49.3	10.4	0.6	26.3	8.2	14.2	0.7	4.0	24.1	14.6	43.6	7.5	10.6	14.6	11.2
RNF185	FLJ38628	ENSG00000138942	"Ring finger protein 185"	Q96GF1	22	31160182-31207019	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.76e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"prognostic favorable (4.82e-5)"	"unprognostic (3.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.10e-1)"	19.8	18.7	21.5	14.4	22.5	10.1	22.8	21.7	25.1	22.3	22.5	23.4	20.5	22.5	25.1	25.9	23.0	16.4	21.1	22.5	22.1	36.2	48.4	19.0	16.2	21.7	22.0	26.1	19.2	48.8	15.8	21.0	22.0	38.2	22.2	16.5	30.2	28.7	23.4	29.9	21.9	25.6	21.9	16.6	21.7	10.8	23.2	21.0	52.0	25.5	21.3	24.2	23.0	23.6	23.7	13.8	26.1	29.9	51.8	34.5	24.9	27.7	53.3	37.2	50.2	15.6	11.1	22.5	15.2	49.3	32.8	14.6	25.3	28.6	38.1	22.6	27.5	9.8	13.2	19.1	72.5	24.1	14.6	37.1	100.8	26.2	60.2	34.0	31.7	23.5	11.7	26.2	45.2	16.8	20.8	13.5	11.7	48.8	15.2	21.1	26.1	26.5	27.0	20.4	11.6	23.4	20.2	26.5	41.0	26.7	18.4	15.8	22.2	26.1	18.7	30.9	13.6	36.2	31.6	28.4	34.5	15.1	21.4	16.9	15.7	9.0	12.2	15.8	13.6	10.0	12.4	13.8	13.3	8.2	12.5	11.5	22.3	16.9	13.7	4.9	14.6	14.8	21.5	22.5	21.7	25.1	22.5	22.1	21.7	22.0	22.0	21.9	23.2	23.6	9.3	22.4	12.6	10.7	8.8	9.1	10.3	10.0	9.6	11.0	14.2	10.8	5.5	20.0	11.5	18.4	8.4	13.0	11.3	16.4	21.5	15.1	19.0	8.9	8.2	8.5	16.8	5.0	14.0	14.9	23.2	10.9	8.2	10.3	5.7	8.4	23.2	28.9	14.2	8.4	17.3	15.8	14.2	8.8	7.5	18.3	7.5	10.5	8.8	10.3	10.7	11.9	7.2	13.6	22.5	15.5	12.7	15.8	6.8	14.5	17.7	22.9	12.4	7.8	6.6	9.5	9.3	7.4	9.8	10.6	10.7	37.2	7.2	6.0	7.8	9.8
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487382-228496188	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 189.0"					"Low region specificity"	"Detected in all"			HPA030098	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	26.8	66.6	16.2	7.5	16.2	11.3	25.8	14.8	24.3	40.5	3.4	28.1	8.6	31.8	4.3	59.1	28.7	5.6	35.4	15.9	16.9	40.7	52.0	23.6	7.3	19.4	15.2	39.3	34.5	22.5	47.7	5.5	18.4	33.5	3.7	9.0	39.7	8.2	64.2	45.0	22.5	5.6	15.6	37.0	27.6	20.8	18.5	8.5	36.1	19.8	6.1	29.9	41.2	19.8	26.7	23.1	14.8	28.9	16.8	12.5	26.6	21.5	17.3	15.6	12.7	12.8	19.2	65.9	43.1	28.9	11.4	20.9	19.1	22.1	5.8	25.9	28.5	20.8	13.2	12.6	46.1	22.1	34.4	20.4	44.7	11.6	15.8	18.3	14.0	52.6	35.6	115.2	12.4	17.7	35.2	20.8	30.7	19.1	24.0	27.8	12.5	61.5	11.4	17.2	29.9	30.0	21.9	44.1	62.3	4.3	34.6	50.2	27.8	18.3	16.9	19.6	19.3	189.0	56.7	36.4	46.7	22.7	28.7	0.0	0.5	3.6	0.6	1.0	0.7	0.5	0.7	1.0	0.6	1.0	0.6	0.7	0.1	0.4	1.4	0.7	0.6	0.3	16.2	16.2	14.8	24.3	15.9	16.9	19.4	15.2	18.4	15.6	18.5	19.8	54.0	25.6	15.5	8.1	47.2	36.2	42.9	10.6	38.7	85.2	59.5	58.5	70.8	65.8	14.2	40.5	18.8	19.7	52.2	39.8	113.5	15.2	0.8	35.5	47.2	32.1	40.0	118.4	16.6	24.5	27.1	54.4	34.7	32.0	44.5	45.0	41.7	67.4	27.4	55.5	17.2	36.6	2.0	40.1	30.5	4.2	24.5	35.8	39.2	12.2	29.7	145.3	62.8	7.1	12.6	21.4	23.4	25.9	35.4	44.0	32.9	126.4	10.3	47.7	19.7	52.2	38.4	4.2	21.5	57.0	55.3	17.6	54.6	217.5	38.6	31.7
RNF43	"DKFZp781H0392, FLJ20315, URCC"	ENSG00000108375	"Ring finger protein 43"	Q68DV7	17	58353676-58417595	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 67.7;Intestinal goblet cells: 41.6;Undifferentiated cells: 63.6"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 41.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 17.0;CACO-2: 24.7;Hep G2: 49.4;OE19: 54.7"									HPA008079	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA008079: AB_1856371"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (6.04e-9)"	"unprognostic (3.61e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	0.2	10.9	1.7	2.0	3.1	0.7	5.5	9.6	2.7	2.6	1.5	13.4	22.7	1.7	4.4	10.4	4.8	2.7	2.7	2.0	1.3	6.1	9.1	3.6	0.4	1.8	3.4	0.9	8.2	5.2	4.3	4.8	1.9	9.4	19.3	1.2	9.3	4.8	0.3	11.3	16.9	0.6	1.4	0.5	5.8	3.4	2.3	3.7	1.9	0.0	1.5	2.1	5.2	1.4	1.1	17.0	2.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	24.7	8.2	0.0	8.5	0.0	1.9	4.6	0.6	6.8	0.0	8.6	11.3	1.9	0.8	49.4	0.0	0.2	0.1	0.0	13.4	0.0	2.1	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.1	0.2	0.4	54.7	1.0	0.3	0.0	2.2	5.9	9.0	1.6	0.1	1.6	0.7	0.5	5.4	2.0	0.1	0.0	0.0	1.8	0.0	0.0	0.6	1.4	0.1	0.3	0.0	3.8	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.2	0.0	1.7	3.1	9.6	2.7	2.0	1.3	1.8	3.4	1.9	1.4	2.3	1.4	0.3	3.2	8.9	29.0	2.5	9.6	17.5	14.1	67.7	2.5	17.3	13.6	4.0	17.2	5.8	18.4	2.1	26.0	2.2	33.0	15.6	5.3	1.2	14.6	1.1	1.8	15.5	0.8	1.8	2.7	3.1	0.7	9.7	12.7	0.0	7.2	0.7	11.9	2.6	5.0	1.3	41.6	12.2	0.8	0.9	1.5	0.3	1.3	14.2	4.7	2.8	12.0	10.3	0.0	0.7	6.2	21.1	0.4	1.0	9.9	28.7	2.9	5.6	2.8	0.0	0.5	1.1	1.0	0.8	28.4	6.1	5.9	3.1	0.4	63.6	6.3
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272075-33276511	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 26385.3;Suprabasal keratinocytes: 31942.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050159, HPA055007"	Approved		Supported	Cytosol		NA	NA		120000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA050159: AB_2681035, HPA055007: AB_2682668"	"prognostic favorable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	3268.2	2353.2	1862.8	2097.6	1883.3	6071.7	6110.7	1827.2	2345.5	3989.9	1782.7	3060.6	2024.5	2386.7	2877.9	4570.6	3069.7	1608.3	1778.5	1806.3	1863.3	2052.0	2248.2	2034.3	4842.9	1889.4	1840.1	6497.6	5554.4	1294.1	1412.1	1956.1	1895.2	2780.5	2977.4	697.1	3045.6	1415.3	2861.9	6539.3	2565.0	1891.5	1948.2	3087.2	2634.1	789.9	1920.2	3097.1	2084.7	2140.2	4485.9	3011.2	3685.5	1926.5	4603.2	2645.2	3377.1	8930.5	5769.4	11474.6	5486.7	4471.1	6678.3	5939.4	4461.0	6787.2	2617.5	15106.6	4694.9	4890.5	2759.3	3293.1	5472.9	7251.7	4665.1	4722.4	8590.2	5617.0	2868.6	9108.9	11226.3	9771.0	2849.3	12386.6	14318.8	4498.5	13349.4	5436.5	5770.2	4373.8	7686.7	4590.7	5362.0	7880.9	4994.9	10924.1	4652.3	5367.0	3798.3	5853.7	5446.7	10293.5	5524.1	6007.1	3902.3	5714.2	1754.6	8884.0	14781.0	2429.4	6105.7	16713.0	4642.3	2714.4	3129.5	2894.4	5978.6	5376.3	12310.7	11828.5	1512.3	10665.4	3350.2	578.7	1878.9	236.8	2362.1	1653.6	4023.7	5634.6	4545.5	3382.7	3273.4	4515.8	4968.4	4374.8	184.7	3177.0	1265.3	2962.7	3727.6	9405.4	1862.8	1883.3	1827.2	2345.5	1806.3	1863.3	1889.4	1840.1	1895.2	1948.2	1920.2	1926.5	4065.5	1480.8	2569.4	9.4	8276.1	20537.2	16151.5	18150.8	5757.2	343.9	19342.8	26385.3	596.5	4185.0	6755.1	1841.0	231.4	8761.7	5535.7	2348.6	5106.4	4750.1	1164.5	1985.2	7580.0	5826.2	3089.9	3782.1	7.5	12662.2	14558.3	4617.6	2073.4	3457.9	3051.1	5393.6	6329.9	4513.1	6281.1	159.9	8.1	7793.0	4418.8	6115.9	12428.1	3197.4	9895.8	4296.2	8448.8	13.1	6356.1	1521.4	4753.9	5.0	11.5	8283.0	5985.7	4056.9	3499.7	14221.0	5563.4	5974.5	1936.4	683.4	2005.0	7010.5	6802.2	773.3	1827.1	8678.7	31942.8	8778.2	6742.0	7987.5	9896.2	16152.8
RSPH14	RTDR1	ENSG00000100218	"Radial spoke head 14 homolog"	Q9UHP6	22	23059415-23145021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.0"	"Group enriched"	"Detected in many"	6	"Early spermatids: 139.7;Late spermatids: 252.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 7.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 7.7"	"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;RPTEC TERT1: 4.2;U-266/70: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA018420, HPA050425"	Approved		Uncertain	Nucleoli		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoli		"HPA018420: AB_1856496, HPA050425: "	"unprognostic (8.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.28e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (5.18e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.73e-2)"	0.3	2.0	7.7	0.2	9.4	0.2	0.4	5.9	11.8	1.0	9.4	0.6	0.2	0.8	3.5	0.4	12.4	1.3	0.4	8.3	9.9	7.3	0.4	1.5	0.2	8.6	10.9	3.9	0.9	2.4	3.7	0.1	7.7	0.8	0.2	11.4	0.6	1.7	0.7	1.1	0.3	0.3	7.6	0.5	0.7	25.0	7.2	0.1	1.9	0.1	0.2	0.2	0.4	9.5	0.2	2.5	1.9	2.0	0.0	0.9	0.1	0.0	0.5	0.4	0.4	0.4	0.7	0.5	0.7	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.1	0.1	1.0	0.0	0.2	0.4	0.0	1.2	0.0	0.8	0.0	1.0	0.0	0.3	0.3	0.4	0.0	0.6	0.0	0.1	0.0	2.0	4.2	0.0	2.7	0.9	0.0	0.0	0.1	0.1	0.3	0.5	0.0	1.5	0.5	0.1	0.0	4.9	1.9	1.6	1.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	7.7	0.1	1.8	0.0	0.0	0.6	7.7	9.4	5.9	11.8	8.3	9.9	8.6	10.9	7.7	7.6	7.2	9.5	1.9	0.0	0.0	2.0	0.0	0.0	0.9	0.0	0.0	1.1	0.2	0.5	0.1	1.5	3.7	0.0	4.2	0.0	0.2	0.0	7.9	1.0	139.7	17.8	0.5	0.4	0.0	0.0	3.5	0.2	0.0	0.5	0.0	0.5	0.0	1.2	0.7	0.0	0.1	11.8	2.8	0.1	0.0	0.0	0.0	252.0	2.1	0.3	0.0	0.0	0.0	4.6	0.0	1.0	1.1	0.4	0.0	1.9	0.1	0.2	0.0	17.7	29.2	5.1	0.0	0.8	0.9	29.4	8.3	0.0	0.0	0.0	0.4	2.8	0.1	0.3
RTN4RL2	"NgR2, NGRH1"	ENSG00000186907	"Reticulon 4 receptor like 2"	Q86UN3	11	57460528-57477534	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 39.1;liver: 40.7;thyroid gland: 30.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.9;Cholangiocytes: 12.8;Excitatory neurons: 16.7;Hepatocytes: 14.0;Oligodendrocyte precursor cells: 9.5;Spermatocytes: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.1;Karpas-707: 67.5;REH: 42.3;RPMI-8226: 134.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"amygdala: 13.5;cerebral cortex: 23.8;hippocampal formation: 21.0"						"Intracellular and membrane"	NA	NA		27000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (6.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.40e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (3.05e-7)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.18e-2)"	4.1	0.7	19.0	0.3	39.1	0.8	3.5	0.0	27.3	2.1	0.0	1.0	1.1	2.0	0.2	1.6	1.7	3.0	3.3	25.2	0.0	2.8	40.7	2.6	0.4	0.0	0.0	1.1	2.4	3.7	3.6	1.9	0.0	1.6	0.1	1.0	3.4	0.3	1.7	4.3	1.1	0.7	0.0	1.0	1.5	1.8	0.0	1.9	30.5	0.4	0.3	1.2	1.6	8.2	7.4	10.1	7.6	13.1	3.1	4.4	1.0	0.1	2.9	0.3	2.7	1.3	1.4	0.2	0.2	0.4	4.3	0.2	11.9	0.2	0.1	1.7	4.7	2.3	1.1	7.2	4.4	1.7	44.1	11.9	1.3	1.1	1.1	1.3	0.1	12.9	1.6	67.5	0.1	1.4	0.2	5.3	13.3	0.5	7.6	42.3	5.4	134.0	0.1	0.2	14.0	1.2	1.1	0.6	7.7	0.6	8.5	2.0	0.1	0.5	22.7	3.1	2.4	4.1	9.2	1.4	16.7	7.3	5.8	0.0	0.3	0.0	0.0	0.6	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.0	39.1	0.0	27.3	25.2	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.7	0.0	0.0	2.0	0.4	5.7	0.4	0.3	2.8	19.9	2.1	1.5	0.4	12.8	0.1	0.0	0.0	0.0	0.9	0.2	3.9	1.3	2.6	0.6	0.9	2.1	1.8	0.8	16.7	0.6	5.5	1.6	0.5	2.1	0.0	0.0	1.1	14.0	0.4	0.0	1.1	0.6	0.0	0.0	2.1	1.3	0.3	0.6	1.8	3.7	0.5	0.8	2.1	9.5	1.2	0.8	0.1	1.2	0.0	1.0	0.0	1.1	0.0	1.4	6.6	1.0	5.4	10.2	1.7	1.1	2.8	0.0	0.9	0.1	0.2	0.2
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550554-179610012	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Macrophages: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		25000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	28.2	33.1	9.6	13.4	10.5	13.3	26.1	9.8	10.2	27.2	11.3	29.1	9.4	27.5	8.1	33.9	24.5	8.8	20.4	9.5	10.1	24.1	21.3	26.6	14.2	10.2	10.0	23.9	24.4	13.5	22.7	9.0	10.1	22.4	8.2	7.4	25.8	8.6	33.8	33.1	25.9	7.8	9.9	35.2	24.2	10.9	10.0	13.6	24.7	10.1	11.5	26.3	27.2	10.6	13.9	22.5	11.8	15.7	22.3	18.2	13.4	24.2	17.2	14.1	16.3	22.0	31.6	22.4	13.4	29.6	16.2	12.6	21.9	31.6	16.4	71.2	16.6	39.2	17.1	16.0	22.8	22.0	20.7	18.5	17.1	9.5	27.0	24.6	15.5	12.5	16.2	20.8	12.7	42.0	23.5	15.2	12.6	15.0	10.5	20.9	8.4	20.9	23.5	22.4	11.7	16.7	35.4	22.5	13.2	14.8	18.0	26.6	18.8	18.3	6.2	10.0	19.3	12.8	21.2	39.8	16.9	39.0	17.2	14.9	4.8	11.9	2.2	5.1	1.3	3.8	2.7	2.3	4.2	5.7	1.9	2.4	7.9	1.8	7.1	4.8	4.5	29.8	9.6	10.5	9.8	10.2	9.5	10.1	10.2	10.0	10.1	9.9	10.0	10.6	19.8	35.3	30.8	30.0	23.6	10.3	11.5	11.7	16.5	9.3	17.8	17.5	22.8	28.6	23.1	14.7	20.9	21.7	15.7	20.0	9.8	19.7	8.0	28.2	21.9	20.9	10.8	27.7	31.8	14.4	15.8	19.7	19.9	20.0	29.8	20.4	12.5	14.1	31.1	11.8	28.4	17.5	8.2	30.7	21.0	3.4	23.0	137.2	10.6	21.5	43.7	11.9	15.5	23.1	33.9	22.1	18.5	27.1	18.3	14.2	14.1	34.0	32.8	12.0	6.6	20.8	17.8	11.1	8.4	21.9	11.4	21.2	19.5	25.0	15.3	10.2
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 3719.5;vagina: 1174.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 2340.8;Paneth cells: 1098.9;Proximal enterocytes: 1549.1;Squamous epithelial cells: 3205.8;Suprabasal keratinocytes: 3612.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 798.6;HaCaT: 1072.9;HBEC3-KT: 1527.6;hTCEpi: 2232.0;OE19: 1675.1;SK-BR-3: 1579.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		260000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	2.2	0.8	1.5	24.9	1.6	0.2	78.3	1.5	2.0	530.8	1.3	241.0	265.4	5.4	14.7	3719.5	20.4	18.5	4.2	1.5	1.5	70.1	16.3	82.7	0.6	1.5	1.5	1.4	17.7	125.2	5.1	1.1	1.5	19.6	240.0	0.0	550.3	39.0	2.2	608.0	209.0	13.1	1.4	1.3	119.2	0.7	1.7	149.0	98.6	0.0	449.7	32.9	1174.2	1.5	798.6	0.2	0.1	0.2	0.2	0.3	7.4	0.2	0.1	0.2	0.1	97.6	140.1	0.6	2.3	0.2	0.5	1072.9	0.0	1527.6	0.1	0.5	0.3	0.1	10.8	7.3	0.0	0.0	0.9	0.6	2232.0	0.5	20.7	0.3	0.3	0.1	0.6	1.1	0.2	140.0	0.7	1.1	0.4	1675.1	1.9	0.6	0.6	2.8	8.1	51.2	0.7	0.7	2.2	1579.1	2.1	36.5	3.9	1.7	0.0	0.7	0.8	1.1	2.0	0.4	0.8	0.9	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.5	2.0	1.5	1.5	1.5	1.5	1.5	1.4	1.7	1.5	2.7	60.9	162.6	2.3	4.2	2340.8	448.6	770.5	657.9	0.0	256.2	178.3	5.3	270.2	387.7	35.0	0.0	2.7	2.2	1058.2	49.0	197.5	0.0	37.3	6.4	21.5	153.4	0.0	0.0	65.8	1.5	22.8	85.6	80.3	28.0	0.2	1.1	9.5	0.3	0.0	0.0	660.1	126.1	0.3	213.7	0.0	0.0	3.0	241.9	0.0	2.0	0.0	0.0	0.0	0.1	343.0	1098.9	0.0	7.5	619.3	1549.1	4.9	56.2	0.0	0.0	1.3	27.1	0.0	0.0	3205.8	3612.0	0.3	8.7	13.6	580.9	824.9
SAP130	FLJ12761	ENSG00000136715	"Sin3A associated protein 130"	Q9H0E3	2	127941217-128028120	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.5;Late spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034664			Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA034664: AB_10603238"	"unprognostic (2.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	9.1	8.6	8.8	8.7	8.5	21.7	8.2	8.5	10.2	10.5	5.1	10.3	8.3	10.4	9.2	10.4	9.6	7.2	8.5	8.1	10.8	7.2	8.3	8.0	10.0	6.4	7.9	11.2	8.7	12.4	14.5	9.0	7.1	8.7	9.7	8.6	9.1	7.9	11.9	12.9	9.8	10.2	6.1	8.5	9.7	47.3	8.0	14.8	8.8	13.0	12.6	9.5	10.3	8.8	35.3	18.9	35.3	28.6	22.9	15.7	38.5	22.0	21.4	33.4	26.2	45.1	14.4	29.4	19.3	25.0	17.4	24.0	39.3	22.7	34.5	16.3	25.2	29.2	16.7	35.9	27.5	25.5	22.2	14.8	16.7	44.1	27.5	17.6	27.0	24.4	35.9	21.1	28.2	39.3	35.6	20.0	36.6	20.7	21.1	24.3	29.0	19.6	17.9	30.7	18.5	22.3	23.2	21.7	13.6	22.1	16.4	17.3	23.2	32.1	34.5	30.1	23.6	29.3	31.2	34.3	26.4	17.0	21.0	2.3	4.2	4.6	5.3	2.7	4.0	2.0	3.8	3.5	3.4	5.0	2.7	3.1	14.0	3.6	8.6	6.2	2.7	3.8	8.8	8.5	8.5	10.2	8.1	10.8	6.4	7.9	7.1	6.1	8.0	8.8	5.4	0.0	10.9	29.0	7.9	7.9	2.3	3.2	5.7	5.2	6.5	5.3	15.2	2.8	3.1	1.8	8.4	11.9	9.4	13.1	0.0	4.9	71.5	4.6	8.6	6.2	6.7	11.6	25.4	4.7	12.8	5.2	8.6	8.7	1.3	5.3	5.3	5.8	7.8	8.4	28.9	7.0	4.1	8.4	6.3	44.2	8.4	7.0	5.4	16.9	4.9	5.0	6.2	26.2	31.0	6.1	7.8	8.2	13.2	4.9	6.5	3.4	4.0	5.8	6.6	4.4	5.5	31.0	17.9	9.2	10.4	19.3	7.6	3.7	7.8	4.3
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724409-246768137	"Metabolic proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 159.5"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1380.7;Spermatocytes: 822.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	20	"basophil: 872.9"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 872.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	26.6	53.7	35.1	14.4	45.5	35.7	23.6	51.5	43.2	22.6	40.8	27.2	34.4	26.2	17.6	9.3	31.6	21.6	32.8	35.3	45.4	49.8	158.2	21.0	13.5	64.0	45.2	22.4	18.8	36.5	24.3	23.8	64.3	39.4	26.8	31.7	15.3	26.0	60.7	24.1	34.6	24.0	57.0	11.5	28.0	159.5	47.3	20.1	33.5	54.7	10.6	81.5	12.0	86.8	55.3	53.2	37.7	22.8	44.5	55.7	0.5	42.3	58.8	70.1	58.3	32.7	150.6	29.3	53.8	49.0	38.9	17.7	32.4	12.6	71.6	40.8	11.9	49.6	46.9	65.9	41.6	97.1	40.7	37.6	5.9	47.4	4.8	65.7	76.4	60.0	62.9	0.1	70.9	13.5	101.6	122.6	56.5	29.6	41.7	83.8	48.5	0.3	216.6	128.2	42.7	48.0	57.3	2.5	39.0	20.2	42.1	99.6	49.8	32.1	28.5	78.7	110.5	138.0	51.1	17.4	54.7	130.2	43.3	872.9	24.3	44.1	18.1	22.2	22.4	11.2	5.4	15.7	10.7	9.4	7.1	22.0	6.4	34.1	15.4	18.2	4.0	17.1	35.1	45.5	51.5	43.2	35.3	45.4	64.0	45.2	64.3	57.0	47.3	86.8	25.0	6.4	11.5	25.8	8.0	30.1	40.6	54.6	1.8	31.2	42.4	17.5	38.0	55.8	40.5	152.6	18.8	41.4	14.6	42.4	31.3	67.2	1380.7	72.7	39.4	23.6	44.9	54.7	23.7	69.0	17.4	35.7	32.6	111.9	57.2	49.2	22.5	187.8	89.4	6.7	20.5	27.4	52.9	45.7	13.7	245.6	47.5	29.7	48.0	10.3	20.3	67.4	18.6	27.2	37.3	75.2	27.8	47.4	8.3	49.2	138.4	69.7	79.4	39.2	19.7	36.7	39.4	822.3	76.2	5.6	68.5	84.6	17.0	42.8	55.0	201.9
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"bone marrow: 74.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.4;Club cells: 2.7;Erythroid cells: 1.3;Kupffer cells: 1.2;monocytes: 4.7;Respiratory ciliated cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.3;eosinophil: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"U-937: 104.1"					"Not detected"	"Not detected"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: AB_2684072"	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	0.3	0.1	0.1	0.1	0.2	74.7	0.0	0.5	0.4	0.3	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.1	0.1	0.1	0.7	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.7	0.1	1.5	0.1	0.0	0.0	0.1	0.1	104.1	0.1	0.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.3	0.1	0.2	0.5	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476958-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 216.6;skin 1: 239.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 964.1;Basal prostatic cells: 358.7;Basal respiratory cells: 272.9;Squamous epithelial cells: 535.4;Suprabasal keratinocytes: 1215.3;Urothelial cells: 564.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1279.3;HBEC3-KT: 425.6;hTCEpi: 875.0;hTERT-HME1: 217.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		770000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavorable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavorable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.6	0.0	0.0	4.3	0.0	0.2	37.1	0.1	0.1	38.5	0.1	4.8	16.7	0.1	0.1	216.6	1.4	2.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	9.9	4.5	0.0	37.6	1.7	1.4	239.7	22.1	0.2	0.0	0.0	9.7	2.8	0.0	13.9	0.1	0.0	39.9	90.9	78.7	0.1	80.8	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	73.4	0.1	3.8	0.0	0.1	1279.3	0.0	425.6	0.0	0.0	0.0	0.0	95.8	0.2	0.0	0.0	0.6	0.1	875.0	0.0	217.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	179.9	93.4	0.1	0.0	0.2	0.0	95.1	1.4	0.0	60.2	0.3	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.2	0.9	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	964.1	358.7	272.9	224.3	0.0	5.1	27.3	0.2	0.0	90.0	3.7	0.0	0.3	0.1	14.2	0.0	0.1	9.0	6.2	0.1	5.4	3.5	0.0	0.3	0.0	0.2	5.8	12.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.3	34.6	0.0	57.6	18.6	0.6	1.8	62.2	0.0	0.0	0.0	0.0	0.0	0.1	16.3	51.7	0.0	2.5	85.4	13.5	0.1	85.4	0.0	0.0	0.0	7.1	6.6	2.2	535.4	1215.3	0.1	4.0	0.1	30.6	564.9
SFTPD	"COLEC7, SFTP4, SP-D"	ENSG00000133661	"Surfactant protein D"	P35247	10	79937467-79982614	"Predicted secreted proteins"	"Gaseous exchange, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"lung: 507.9"	"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 2: 1863.1"	"Cancer enriched"	"Detected in many"	16	"lung cancer: 106.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 10.0;non-classical monocyte: 36.3"	"Lineage enriched"	"Detected in many"	18	"monocytes: 36.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;HaCaT: 1.0;hTCEpi: 3.2;MCF7: 1.3;U-2197: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB004578, HPA044582, HPA056768"	Enhanced				"Secreted in other tissues"	NA	NA		8200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"			"CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232"	"unprognostic (3.81e-5)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.86e-2)"	1.1	1.8	2.2	0.4	2.4	19.7	0.9	1.7	2.5	1.3	2.3	1.0	0.1	0.5	1.3	1.8	1.8	0.9	1.1	2.2	2.4	1.6	1.0	507.9	0.0	1.7	2.0	1.1	4.2	2.0	3.4	0.7	1.8	1.4	0.1	0.3	1.0	1.2	0.2	5.0	0.4	0.4	1.4	0.6	1.1	1.3	2.6	0.5	5.8	0.2	0.2	0.3	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	10.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.9	2.2	2.4	1.7	2.5	2.2	2.4	1.7	2.0	1.8	1.4	2.6	1.7	0.3	439.1	1863.1	1.0	0.2	0.9	1.3	7.8	1.2	1.7	1.4	1.8	0.7	0.0	38.0	5.5	0.0	0.1	0.0	0.0	1.9	1.4	7.4	0.6	0.1	1.5	0.0	0.0	4.9	5.8	3.0	4.4	0.0	0.9	20.2	1.6	0.4	0.7	0.1	0.0	3.5	0.0	0.0	0.0	2.7	12.2	1.2	2.9	0.0	1.9	0.6	2.8	0.0	0.0	0.6	2.0	0.1	0.4	0.0	0.8	0.0	0.2	9.6	0.5	0.0	1.8	0.4	0.4	0.3	0.6	1.8	0.1	4.3	0.1	0.1	0.6
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"	Q86VZ5	10	50305586-50625163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	15.8	19.3	19.8	10.7	27.4	24.0	14.5	21.5	20.3	16.9	33.9	10.1	13.5	11.9	19.9	15.3	16.6	15.4	13.2	17.2	23.0	20.2	27.9	21.9	14.9	29.5	24.1	18.6	13.3	52.9	6.4	24.6	28.5	19.5	11.7	20.2	18.0	16.8	9.9	25.3	16.0	15.8	23.6	11.7	14.3	11.3	23.4	12.0	24.7	10.5	14.5	20.9	13.1	41.3	30.2	14.0	4.0	9.0	14.2	18.6	18.8	19.6	19.7	13.5	12.6	11.7	30.3	22.1	11.3	25.9	12.2	18.7	9.5	20.6	14.0	19.4	10.2	32.7	17.9	9.0	16.5	7.5	7.6	12.1	23.6	18.0	21.7	8.7	19.3	7.9	62.6	32.2	14.6	12.7	3.3	4.2	9.2	13.7	13.7	5.5	18.4	8.8	19.7	31.2	6.2	4.9	14.4	14.2	7.5	11.3	21.4	2.7	27.1	14.6	17.8	14.1	14.6	11.0	9.5	6.3	18.2	12.0	12.1	3.4	9.3	28.4	4.6	4.9	10.3	7.0	6.2	6.8	5.2	6.5	8.2	5.4	16.7	10.1	4.0	3.2	15.6	6.3	19.8	27.4	21.5	20.3	17.2	23.0	29.5	24.1	28.5	23.6	23.4	41.3	17.1	44.8	40.0	106.7	19.9	54.4	28.9	15.6	23.9	20.1	15.8	8.9	26.3	10.0	30.0	29.5	4.2	10.9	15.6	6.2	15.6	17.6	17.0	20.9	10.5	19.6	14.9	32.0	153.1	21.6	7.7	19.8	30.5	32.4	20.8	12.1	17.9	16.0	29.0	5.0	117.2	11.1	4.1	46.5	17.6	30.6	16.1	34.5	12.4	229.5	12.4	17.4	10.3	313.1	422.0	10.7	6.4	10.5	13.7	32.3	18.4	9.3	25.1	36.4	0.0	20.5	27.1	12.8	2.3	18.7	83.4	4.9	20.0	11.8	12.4	25.4
SIMC1	"C5orf25, FLJ44216, OOMA1, PLEIAD"	ENSG00000170085	"SUMO interacting motifs containing 1"	Q8NDZ2	5	176238367-176345991	"Predicted intracellular proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 47.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.2;Inhibitory neurons: 57.4;Spermatocytes: 83.1;Theca cells: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037889, HPA037890"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA037889: AB_2675720, HPA037890: AB_2675721"	"unprognostic (1.15e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (2.32e-6)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.20e-2)"	5.3	28.0	6.8	4.0	6.2	3.8	4.3	7.0	6.8	12.0	7.5	7.1	5.8	12.2	9.9	4.3	13.4	4.0	4.1	6.0	7.3	3.9	8.7	5.0	5.3	4.7	5.0	47.0	6.5	6.0	14.1	5.1	5.3	9.6	6.9	4.6	3.7	6.5	12.1	5.4	7.5	8.5	3.9	10.2	10.2	33.5	8.2	6.8	4.0	4.4	5.5	8.4	6.4	5.9	2.8	6.9	21.6	17.2	11.1	11.3	11.2	9.6	8.7	9.8	11.2	25.7	7.3	0.1	11.5	10.7	20.0	2.5	24.2	18.1	11.9	4.8	17.9	12.7	4.7	3.3	24.5	13.7	9.3	7.4	7.1	6.4	12.1	6.9	9.3	4.6	32.6	11.5	11.5	12.5	13.2	12.3	8.2	3.3	7.5	19.2	15.2	16.6	6.8	5.1	14.3	15.0	11.0	1.7	10.6	8.3	6.1	26.4	6.6	11.6	6.2	10.6	8.4	3.1	3.5	18.9	4.3	9.2	6.9	7.2	3.7	7.0	3.3	3.5	4.0	4.4	4.0	2.6	5.2	4.1	3.3	2.7	0.4	7.3	2.8	2.6	2.9	2.7	6.8	6.2	7.0	6.8	6.0	7.3	4.7	5.0	5.3	3.9	8.2	5.9	4.9	9.6	5.6	24.2	12.6	2.9	5.9	3.2	8.6	18.1	2.1	3.0	4.0	2.8	3.4	1.8	4.2	0.4	15.0	8.9	1.9	3.8	46.5	2.9	15.6	3.6	13.2	2.5	49.1	3.6	2.9	9.2	19.9	4.9	0.0	58.2	5.3	7.2	2.2	18.5	57.4	9.9	0.0	5.7	2.0	14.4	29.8	4.2	5.4	30.9	5.7	6.1	11.3	30.7	7.7	4.7	7.8	34.6	5.7	7.1	12.0	1.9	3.0	5.3	32.9	5.6	6.3	83.1	33.8	5.9	2.6	0.8	7.7	102.8	8.9	3.1
SIPA1L3	"KIAA0545, SPAR3"	ENSG00000105738	"Signal induced proliferation associated 1 like 3"	O60292	19	37907208-38208369	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 93.7;Inhibitory neurons: 87.3;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 59.6"	"Low region specificity"	"Detected in all"							"HPA042072, HPA045480, HPA074988"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: "	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.96e-2)"	2.2	3.0	6.0	6.6	3.0	2.9	5.1	10.4	16.2	4.8	2.6	10.6	18.4	3.3	1.3	4.9	4.8	3.9	6.2	28.9	2.0	6.4	3.4	5.7	6.8	4.2	4.1	2.9	9.7	3.3	3.2	1.4	3.5	5.3	7.0	5.0	8.4	3.5	6.5	11.1	18.1	1.8	1.6	7.3	9.1	4.3	5.6	3.8	10.0	7.3	5.5	4.3	3.6	5.5	34.4	59.6	7.3	9.3	4.3	4.3	4.9	14.5	12.2	9.4	8.8	20.6	19.5	19.5	12.2	12.4	7.9	7.6	6.7	27.1	10.4	6.7	3.3	5.3	5.5	6.5	8.3	3.7	5.5	3.3	14.1	17.5	37.3	13.9	10.8	5.6	3.9	4.1	16.6	10.6	5.0	5.1	6.0	27.2	15.8	10.8	5.9	2.9	20.7	29.1	17.3	9.3	16.0	27.1	2.2	3.9	18.0	3.5	23.2	15.6	5.5	48.4	22.6	5.4	10.0	6.6	20.1	4.9	20.6	0.1	0.1	0.4	0.1	0.2	0.0	1.1	0.1	0.2	0.1	1.5	0.1	0.5	0.1	0.3	1.5	0.3	0.1	0.1	6.0	3.0	10.4	16.2	28.9	2.0	4.2	4.1	3.5	1.6	5.6	5.5	4.8	6.4	10.1	41.4	24.5	12.0	5.2	10.4	6.2	21.9	22.6	12.1	5.2	22.8	10.8	23.9	14.6	2.1	9.3	93.7	3.9	7.2	4.5	19.8	4.8	5.4	25.2	10.8	61.1	15.3	1.4	3.7	40.2	16.5	2.5	4.8	6.4	23.5	3.5	33.7	87.3	46.3	20.3	5.1	13.9	9.2	2.1	8.3	5.4	50.6	7.1	3.0	5.2	99.5	58.7	13.4	38.7	1.9	12.8	6.6	50.0	21.1	19.1	5.7	6.6	4.5	3.6	1.7	5.1	8.9	16.1	0.8	5.1	1.7	30.4	5.6
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 302.1;tongue: 218.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Cytosol"	Nucleoplasm	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	43.2	44.0	101.6	11.5	137.5	17.4	39.7	141.1	123.0	41.5	79.4	49.2	12.6	37.2	10.4	42.5	37.2	15.0	76.9	100.7	111.2	35.9	51.5	38.2	13.7	151.0	129.6	49.0	33.4	18.2	31.2	10.5	144.7	32.7	10.2	11.9	41.5	14.9	302.1	48.8	32.4	18.3	121.3	40.1	41.4	43.5	127.6	13.1	34.5	218.2	13.0	41.3	37.8	173.5	16.1	9.8	8.4	20.6	46.7	31.8	5.8	11.3	20.2	17.8	22.7	17.1	10.2	5.4	23.7	21.3	13.2	8.3	14.6	25.1	10.9	25.2	15.6	10.1	10.9	10.9	33.0	7.0	22.4	33.5	29.7	14.4	16.9	21.4	31.9	17.7	10.1	42.0	28.2	8.9	15.4	6.2	1.2	27.6	13.6	19.9	22.8	15.3	14.8	14.9	20.7	9.0	12.9	17.8	13.0	7.0	8.0	19.2	28.9	24.0	5.1	37.2	17.0	16.9	8.8	12.6	18.1	19.0	22.0	48.9	54.7	59.8	44.9	69.1	28.5	24.9	21.9	31.0	42.9	28.9	14.3	23.6	42.7	36.5	56.7	44.0	33.1	51.9	101.6	137.5	141.1	123.0	100.7	111.2	151.0	129.6	144.7	121.3	127.6	173.5	39.5	16.0	19.4	26.1	21.0	51.6	30.3	35.1	35.3	29.7	28.8	29.7	42.1	14.3	27.2	12.9	35.5	36.5	90.8	28.4	37.2	29.0	173.0	24.7	15.4	31.1	17.5	27.1	31.2	17.6	15.2	30.3	44.9	26.5	25.4	29.5	28.5	19.7	66.3	30.3	27.2	24.1	97.6	38.3	51.7	74.8	31.1	37.1	46.2	11.2	20.0	22.6	85.5	76.4	110.8	26.5	23.9	41.0	39.7	14.9	54.0	38.8	30.1	28.2	19.7	113.5	27.9	15.3	7.2	30.1	60.1	42.3	45.8	31.3	18.2	21.5
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341529-48426201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 319.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol		NA	NA		210000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: AB_2685056"	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	24.9	12.6	7.0	14.6	6.6	15.5	17.0	10.5	9.0	21.4	9.0	27.3	13.4	23.6	18.6	38.7	25.7	18.5	40.6	6.1	7.2	18.6	26.7	21.0	16.5	6.9	7.1	22.2	15.1	29.6	7.8	22.2	6.8	25.8	24.0	15.8	19.1	30.2	71.8	32.5	16.3	35.4	6.0	16.3	18.2	40.3	8.1	24.4	20.0	98.8	21.0	26.3	21.9	8.5	32.8	12.7	22.2	22.0	33.9	41.6	15.6	49.3	62.3	43.0	44.5	12.6	26.8	19.4	29.7	56.7	76.7	21.2	91.5	46.1	75.6	16.1	9.5	34.1	17.5	14.4	36.5	31.5	33.4	35.4	67.1	50.0	58.0	32.2	25.8	17.1	22.3	21.1	43.7	16.5	36.4	25.9	9.4	25.7	18.2	20.6	43.1	12.4	38.0	35.4	14.7	18.7	20.0	14.8	21.2	20.4	18.6	22.2	33.0	46.8	44.2	29.9	50.5	28.6	32.1	16.3	36.8	35.2	34.5	9.5	6.5	7.7	6.6	4.7	7.2	5.1	8.1	9.9	6.6	7.5	6.6	7.1	5.8	8.8	7.3	2.3	5.7	3.6	7.0	6.6	10.5	9.0	6.1	7.2	6.9	7.1	6.8	6.0	8.1	8.5	37.2	54.5	38.7	43.8	27.9	84.2	50.6	32.6	38.7	15.8	26.5	19.4	79.6	18.6	32.3	27.6	14.6	29.3	31.7	35.0	21.5	29.9	162.4	145.1	64.7	28.8	25.2	16.6	47.0	34.9	29.1	31.9	28.5	57.4	21.6	20.3	21.8	33.0	21.6	35.3	47.3	34.5	22.4	20.5	31.0	319.2	27.4	29.2	19.6	38.4	37.5	20.7	28.8	54.3	43.1	32.2	27.9	36.9	26.2	53.9	23.4	26.4	85.1	41.0	32.9	54.1	43.1	98.7	48.8	55.0	91.5	75.5	35.0	32.8	25.6	58.3
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692731-1712344	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 263.6;Spermatogonia: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	29.9	26.4	38.6	37.6	40.2	114.2	26.7	38.0	65.7	28.4	34.4	30.6	23.9	27.3	32.9	35.9	27.6	21.9	18.4	40.9	43.6	35.1	33.9	27.2	71.7	36.4	39.1	28.0	24.4	24.0	26.7	42.0	39.3	22.8	30.6	17.1	25.6	25.3	22.6	37.7	25.6	28.8	37.7	28.3	26.9	63.1	41.8	53.5	27.3	19.2	69.5	35.0	28.0	41.1	132.7	53.9	76.6	80.7	65.3	70.0	81.9	120.1	92.5	131.4	133.8	120.3	144.7	180.6	67.4	96.0	150.9	77.8	147.0	103.0	154.1	75.4	98.5	215.9	63.3	123.6	82.6	208.3	102.8	55.0	84.7	98.1	67.3	74.4	76.5	108.8	172.7	170.3	163.2	52.8	314.6	200.6	97.4	136.7	108.6	241.1	126.3	105.3	131.0	99.5	86.1	69.3	95.4	59.6	69.5	96.8	99.0	127.7	66.3	108.0	63.8	116.1	180.4	107.4	192.2	428.3	99.6	176.0	106.0	25.7	65.4	47.5	47.1	49.7	43.3	51.6	59.7	64.8	50.6	37.8	50.6	49.6	95.8	46.3	44.8	42.2	77.9	75.4	38.6	40.2	38.0	65.7	40.9	43.6	36.4	39.1	39.3	37.7	41.8	41.1	35.2	16.0	18.8	7.2	96.3	105.2	96.3	38.8	61.5	19.4	35.9	34.0	8.2	27.1	23.6	36.8	25.0	166.3	80.5	28.8	107.6	50.6	75.9	38.8	34.9	36.1	35.9	146.0	14.6	31.3	51.8	49.1	53.5	55.5	23.5	45.9	30.0	27.0	81.3	25.2	15.1	33.6	44.7	36.8	58.6	41.6	44.1	60.3	65.8	6.5	64.4	27.4	43.3	9.0	14.4	38.7	25.3	44.0	94.2	88.6	22.5	55.4	16.3	13.6	13.1	46.3	43.8	263.6	294.0	84.1	105.8	44.7	96.6	33.2	44.1	76.5
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849384	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.1;skin 1: 13.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 59.5;Late spermatids: 191.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.2;HaCaT: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016662	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	5.2	0.3	0.1	0.7	0.3	0.0	2.8	0.1	0.2	3.1	0.0	0.4	0.1	0.5	0.3	9.1	0.6	1.0	0.7	0.1	0.4	0.1	0.1	0.3	0.1	0.2	0.3	0.1	0.7	0.6	0.2	0.1	0.3	0.4	0.3	0.0	1.5	0.2	0.7	13.4	0.2	1.0	0.1	0.2	0.3	4.3	0.9	0.3	1.0	1.1	1.2	0.9	4.7	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.1	0.9	0.7	9.3	0.0	0.0	6.2	0.0	13.8	0.0	0.8	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	1.7	1.0	2.6	0.0	0.0	2.5	0.0	0.1	0.6	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.2	191.7	1.5	0.1	0.0	2.8	0.0	0.0	0.0	3.5	4.8	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	1.2	1.2	0.6	6.0	24.9	0.0	0.0	0.0	0.0	0.2
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034982-230068993	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.0;Excitatory neurons: 18.5;Inhibitory neurons: 21.1;Microglial cells: 45.0;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"eosinophil: 11.3"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 24.2;Karpas-707: 15.2;REH: 19.5;RPMI-8226: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	4.6	3.9	7.9	1.7	7.2	5.6	3.2	8.9	7.7	5.0	2.4	3.7	1.0	3.9	2.3	4.0	3.1	2.8	2.4	7.1	7.2	2.3	2.0	1.9	1.3	5.2	6.1	7.3	0.8	7.0	1.4	1.2	4.7	4.5	4.0	2.5	18.6	3.6	1.0	11.0	1.3	3.8	3.8	5.9	1.4	1.2	9.4	2.2	1.5	2.0	1.5	2.0	2.7	4.7	2.9	1.6	1.3	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.4	0.0	0.5	0.0	0.3	0.1	0.0	0.5	5.1	1.4	0.1	0.0	9.7	0.2	3.1	0.0	0.3	24.2	0.0	0.5	3.6	0.0	0.0	3.9	0.2	4.7	0.0	15.2	0.3	0.0	2.4	2.7	1.0	0.3	2.7	19.5	0.0	17.3	5.6	2.6	6.3	2.3	4.9	0.0	0.1	0.1	7.7	1.9	0.0	0.0	1.3	3.3	2.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	11.3	0.4	0.0	0.3	0.3	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	7.2	8.9	7.7	7.1	7.2	5.2	6.1	4.7	3.8	9.4	4.7	17.0	0.0	0.0	2.3	1.5	2.5	0.5	1.9	3.4	3.3	1.2	0.8	3.9	0.0	3.5	0.0	2.1	0.0	0.1	1.8	0.0	0.8	0.0	0.5	2.6	10.8	3.6	0.0	18.5	0.6	0.0	2.3	0.0	0.3	0.0	0.2	4.2	2.1	0.1	3.3	21.1	0.3	4.1	0.3	0.6	0.0	1.2	0.1	1.8	45.0	0.0	1.9	0.0	13.6	1.8	0.8	1.0	3.0	8.4	0.9	0.0	0.3	1.6	1.6	0.0	0.5	1.4	0.2	0.2	6.8	4.7	0.3	1.4	8.4	1.3	0.3
SLC22A15	FLIPT1	ENSG00000163393	"Solute carrier family 22 member 15"	Q8IZD6	1	115976513-116070054	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.6;brain: 31.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.3;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 1.3;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 36.0;hTERT-HME1: 47.4;NB-4: 27.4;THP-1: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019785	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019785: AB_1857011"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.85e-5)"	"unprognostic (8.91e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.29e-3)"	"unprognostic (8.78e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.97e-4)"	"unprognostic (1.30e-1)"	3.2	3.1	7.8	2.3	16.5	30.6	1.7	12.3	12.0	3.1	0.9	1.3	1.0	1.1	1.3	5.2	1.5	1.9	4.7	8.6	11.6	3.4	1.1	4.9	0.9	13.3	11.6	1.1	3.1	4.2	2.7	2.0	14.3	1.9	1.7	6.7	4.5	1.6	0.6	9.4	1.9	1.0	11.6	3.4	3.5	1.1	13.1	0.5	2.8	1.0	1.1	1.7	5.0	31.8	3.0	0.2	2.1	0.0	3.7	4.4	1.5	4.7	6.9	2.8	5.0	0.0	0.5	3.3	5.0	2.3	2.4	4.5	3.6	9.7	2.7	0.0	2.3	3.2	3.7	0.5	12.3	4.9	4.3	4.5	36.0	0.1	47.4	0.2	0.0	0.0	0.1	0.0	4.7	2.7	0.0	27.4	3.0	2.8	2.3	0.0	0.0	0.1	3.9	1.6	2.2	1.9	8.1	1.7	13.8	3.1	0.4	29.4	0.0	5.0	2.7	1.0	1.2	4.8	4.8	0.4	5.3	8.0	8.1	0.3	0.8	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	0.1	7.8	16.5	12.3	12.0	8.6	11.6	13.3	11.6	14.3	11.6	13.1	31.8	0.2	0.0	13.7	46.7	2.3	2.8	3.1	3.6	5.2	3.0	0.3	0.4	7.8	0.0	3.2	5.5	10.4	0.6	0.8	0.5	1.9	1.1	1.3	2.5	0.7	0.2	8.4	0.4	44.2	0.4	0.4	4.6	4.6	1.4	1.3	0.6	1.1	0.0	2.8	8.4	33.9	0.3	0.0	9.4	0.5	0.1	0.9	6.9	1.8	9.4	8.7	1.0	1.0	53.3	250.2	1.6	1.2	0.4	0.7	1.1	0.1	0.3	5.2	2.1	0.0	0.4	1.4	0.3	0.7	5.7	3.0	0.0	1.0	1.2	0.5	1.3
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212642-19722926	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.7"	"Group enriched"	"Detected in many"	9	"Astrocytes: 134.5;Inhibitory neurons: 327.0;Oligodendrocyte precursor cells: 375.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"basophil: 5.8;eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	10.4	3.1	16.2	4.0	11.7	1.4	4.9	13.3	56.1	17.8	2.7	10.8	3.8	28.3	24.3	20.6	20.0	13.0	1.1	81.7	18.6	1.1	0.7	5.5	1.0	13.6	19.2	14.6	0.7	7.5	1.2	3.0	9.1	10.9	5.4	7.3	4.7	17.5	40.9	7.0	5.0	29.1	10.3	2.4	3.8	1.5	34.8	1.9	3.0	16.9	2.7	8.6	8.9	5.4	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.8	13.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	18.2	0.0	0.0	0.7	0.0	75.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	9.0	0.0	0.6	17.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.2	11.7	13.3	56.1	81.7	18.6	13.6	19.2	9.1	10.3	34.8	5.4	0.2	3.2	1.1	134.5	0.1	1.1	1.1	0.4	0.0	19.1	5.0	2.3	0.4	0.0	1.3	1.8	0.0	8.5	0.1	0.3	0.0	0.1	17.0	1.2	29.8	0.4	7.7	3.4	11.8	0.0	0.3	1.9	0.0	1.6	26.6	0.1	0.4	0.0	0.6	1.7	327.0	4.1	0.0	0.0	0.7	18.3	3.7	1.1	0.0	12.2	0.0	3.1	0.0	375.5	2.4	0.2	2.8	4.1	0.4	0.8	0.4	0.0	0.0	2.2	0.0	2.7	3.0	0.5	0.8	2.9	4.1	3.4	0.4	0.1	0.7	3.8
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399336-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.7;Oligodendrocyte precursor cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035188, HPA078530"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA035188: AB_10602400, HPA078530: "	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	10.6	2.6	3.1	7.3	3.4	1.8	9.3	3.3	4.1	8.2	5.4	14.0	14.2	5.0	3.4	21.4	5.3	4.3	5.0	3.2	3.6	7.7	10.6	10.2	5.5	4.3	3.5	6.0	5.9	6.9	1.9	8.3	3.9	4.6	15.5	0.5	10.8	4.6	1.6	16.3	12.8	8.8	3.5	4.9	8.9	2.1	3.6	3.6	4.2	4.5	11.3	7.9	11.3	3.8	32.4	23.3	1.9	9.2	30.0	44.5	12.2	17.9	21.7	13.8	13.2	12.4	16.0	4.0	10.2	47.4	41.1	23.2	18.2	16.0	12.4	28.5	5.4	11.3	7.4	16.4	19.3	10.6	11.7	18.8	28.3	22.5	19.8	18.9	16.6	6.1	2.3	17.1	15.7	58.9	0.1	15.9	10.3	16.6	35.1	3.2	0.0	4.6	22.3	10.9	1.5	0.0	23.0	47.8	29.1	7.3	8.5	11.0	24.2	22.2	7.1	25.0	28.0	0.4	14.2	8.3	22.3	17.8	19.7	0.0	3.5	0.2	0.9	4.9	1.7	4.4	1.8	2.9	6.0	3.7	0.9	1.8	0.1	6.4	11.2	1.6	1.5	1.6	3.1	3.4	3.3	4.1	3.2	3.6	4.3	3.5	3.9	3.5	3.6	3.8	8.3	6.4	9.7	30.7	8.0	7.8	7.3	8.9	9.6	0.2	6.1	6.6	1.6	2.8	5.6	3.7	0.0	11.9	9.1	21.8	9.8	4.5	0.0	0.9	7.6	6.9	7.3	3.4	10.3	8.9	7.1	11.8	9.7	1.8	8.2	2.1	6.4	5.8	10.3	0.0	6.2	9.6	4.1	7.1	13.6	0.4	8.1	7.5	10.6	1.0	11.9	0.2	9.2	36.7	1.4	13.9	11.4	5.7	2.8	5.4	19.8	9.6	2.0	0.4	0.0	7.8	9.2	0.5	2.3	19.8	13.9	6.8	6.8	1.0	12.2	5.8
SLC9A9	"FLJ35613, NHE9"	ENSG00000181804	"Solute carrier family 9 member A9"	Q8IVB4	3	143265222-143848485	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 149.8;Inhibitory neurons: 159.5;Microglial cells: 396.3;Oligodendrocyte precursor cells: 272.9;Oligodendrocytes: 431.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.3;ASC TERT1: 24.9;HSkMC: 17.6;Karpas-707: 62.8;RPMI-8226: 30.4;U-266/70: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058234	Approved					NA	NA		280000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA058234: AB_2683648"	"unprognostic (8.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.35e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (5.57e-7)"	"unprognostic (5.01e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-2)"	12.8	5.1	9.7	8.8	14.4	2.0	5.3	12.5	11.3	6.9	6.9	7.3	3.0	4.2	3.7	12.8	6.8	9.6	5.4	9.9	16.3	2.3	7.1	5.9	14.7	20.4	13.5	7.9	1.0	3.0	3.4	15.9	19.5	8.8	5.8	1.3	4.5	8.5	2.1	7.7	7.0	8.0	14.4	13.1	5.0	1.8	13.8	15.5	3.5	5.0	13.5	11.4	7.7	18.2	0.5	0.5	0.8	1.0	19.3	24.9	0.3	1.0	6.6	0.5	3.1	0.0	0.2	3.0	0.2	2.9	1.5	0.7	0.9	1.9	0.8	12.8	0.2	1.6	0.4	0.0	2.2	0.8	1.3	17.6	5.2	0.7	0.9	1.1	0.3	2.3	0.0	62.8	4.2	0.0	1.5	0.0	0.2	0.0	0.5	2.6	0.1	30.4	0.0	0.5	0.4	0.0	1.5	0.0	0.0	0.4	0.2	0.6	0.0	2.4	0.6	2.8	1.4	29.1	0.1	0.1	4.3	0.4	1.2	0.2	6.2	0.7	4.7	10.6	4.0	3.3	4.9	7.5	8.4	3.7	2.7	4.0	0.5	4.2	9.0	0.6	9.3	4.8	9.7	14.4	12.5	11.3	9.9	16.3	20.4	13.5	19.5	14.4	13.8	18.2	4.5	0.0	1.1	149.8	13.2	3.7	10.4	8.7	22.8	0.2	0.6	1.3	1.5	0.0	3.4	3.7	2.1	0.5	10.4	0.0	0.0	1.0	4.8	0.8	10.1	4.4	0.0	9.9	25.6	0.2	0.5	26.5	7.1	0.8	0.0	0.7	21.8	0.0	55.4	0.0	159.5	0.0	6.1	30.5	9.9	4.4	9.3	31.0	7.2	396.3	24.3	2.8	13.4	272.9	431.8	0.8	0.1	7.2	10.9	11.1	0.0	0.4	1.6	0.1	0.0	18.0	7.0	0.3	0.4	23.9	5.1	1.1	19.7	3.7	0.1	3.9
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 156.3;Distal enterocytes: 291.5;Paneth cells: 157.5;Proximal enterocytes: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"basophil: 80.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.2;hTCEpi: 36.9;OE19: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		26000000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	15.0	23.3	4.6	18.7	5.1	22.9	23.7	8.2	9.4	72.8	8.9	60.7	45.5	13.3	6.5	13.6	7.9	17.2	5.6	5.3	5.7	47.4	80.0	14.1	21.4	5.9	5.4	9.1	20.8	32.4	7.5	44.0	5.9	21.8	65.7	6.0	13.7	16.6	39.8	64.5	77.3	8.5	5.7	27.0	30.5	2.9	5.4	5.1	9.1	55.8	16.2	35.5	30.9	7.7	0.3	2.6	6.1	2.8	44.2	19.9	19.5	10.4	27.8	3.1	6.6	3.3	2.7	0.0	1.4	6.6	8.2	4.9	1.7	5.3	2.6	0.0	5.4	2.5	9.8	9.0	28.3	0.0	0.1	24.4	36.9	3.0	5.3	12.0	5.5	0.0	3.8	0.0	12.7	9.3	0.0	0.2	1.1	58.8	8.0	0.0	10.8	0.4	15.1	4.2	4.4	0.1	1.5	18.5	27.9	3.9	3.1	1.4	11.0	5.9	3.5	0.6	6.8	0.0	0.0	0.0	8.7	4.9	13.7	80.9	4.0	1.1	0.0	4.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	7.5	0.0	0.0	1.4	4.6	5.1	8.2	9.4	5.3	5.7	5.9	5.4	5.9	5.7	5.4	7.7	11.8	3.2	17.8	5.2	2.4	53.7	24.5	13.7	15.9	3.0	12.2	6.6	4.0	25.8	9.7	5.5	4.2	156.3	0.4	291.5	56.7	24.6	0.2	4.2	12.6	7.1	48.7	5.7	7.4	25.7	40.4	46.3	34.7	5.2	10.1	0.8	18.9	77.8	62.7	3.3	10.5	61.7	59.0	126.3	10.0	1.2	15.5	33.4	35.6	11.2	9.9	11.5	2.1	11.1	11.0	19.5	157.5	14.3	0.9	16.7	383.1	129.3	7.5	6.2	13.1	12.8	9.9	1.1	3.7	15.5	76.0	115.1	2.0	11.4	38.9	16.6
SMU1	"BWD, FLJ10805, fSAP57, SMU-1"	ENSG00000122692	"SMU1 DNA replication regulator and spliceosomal factor"	Q2TAY7	9	33041765-33076674	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019708	Supported		Approved	Vesicles		NA	NA		25000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA019708: AB_1857300"	"unprognostic (2.20e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (4.98e-3)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.67e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.96e-2)"	11.5	11.3	11.2	10.6	13.0	16.0	11.9	13.9	12.1	11.4	8.6	10.9	8.6	13.1	11.8	10.6	11.4	8.6	10.3	10.7	11.5	11.2	12.9	10.0	12.8	12.4	11.9	14.7	8.2	15.8	8.1	8.4	12.4	11.9	10.9	12.6	9.3	11.5	14.4	12.8	9.4	13.2	12.6	12.1	9.1	8.5	11.7	14.1	11.2	13.0	15.2	11.5	9.9	16.6	26.3	20.4	24.0	20.9	25.4	19.3	18.7	20.1	18.1	26.9	26.5	20.8	10.7	33.0	14.4	25.1	14.6	15.7	31.1	24.1	29.7	38.1	14.9	24.8	33.4	24.5	22.1	43.5	22.4	20.4	27.0	24.9	17.6	20.1	22.9	22.7	23.4	20.5	22.7	12.1	34.2	46.3	33.1	19.6	21.4	28.8	19.9	17.9	20.5	19.4	20.3	17.7	27.2	19.4	13.1	18.6	18.7	15.7	24.6	17.2	19.1	25.2	23.8	9.1	18.1	38.0	19.2	20.2	12.5	23.4	13.9	11.5	12.4	15.4	13.3	12.9	14.0	11.6	15.8	11.7	13.9	14.3	8.1	12.4	17.9	20.0	12.6	10.8	11.2	13.0	13.9	12.1	10.7	11.5	12.4	11.9	12.4	12.6	11.7	16.6	45.5	25.6	31.4	17.9	48.0	53.7	45.7	41.0	43.3	29.5	23.8	22.4	30.6	30.0	39.9	20.2	37.5	34.9	72.7	19.1	21.5	32.3	29.6	41.6	42.8	38.2	28.1	24.4	23.4	24.3	36.3	37.7	17.9	47.3	39.2	32.1	21.4	29.4	30.8	23.5	25.3	19.5	44.7	29.2	40.8	8.7	32.3	40.2	23.2	14.0	39.7	34.8	32.0	21.6	28.3	27.9	20.1	25.9	28.3	33.3	18.1	31.7	44.1	39.3	19.7	53.9	44.7	41.4	30.5	36.3	57.5	57.7	43.7	37.0	23.5	35.5
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	47.1	33.3	27.6	33.6	29.5	91.2	42.7	30.6	35.9	39.2	29.1	38.4	32.6	39.0	28.4	38.4	38.3	26.7	39.5	27.0	29.0	38.7	33.6	37.1	46.2	29.5	28.6	41.4	38.6	31.3	30.3	33.0	29.8	32.2	32.1	43.3	34.0	21.9	64.8	50.7	38.5	30.9	28.6	44.6	36.6	48.5	28.4	49.0	33.9	35.9	41.9	38.8	38.0	32.9	91.0	66.6	67.0	70.8	54.5	60.6	76.5	61.3	54.6	66.8	61.2	66.0	81.0	88.3	54.5	46.1	50.8	88.2	81.8	58.9	90.3	71.1	63.5	71.8	59.1	66.7	77.7	50.5	81.0	46.8	76.1	60.0	82.8	71.5	65.8	83.7	103.9	64.7	51.9	93.1	90.7	85.4	74.2	103.1	87.8	97.3	85.5	61.7	61.4	82.6	71.2	76.5	84.7	73.6	87.3	68.1	106.6	95.5	69.9	71.6	81.7	64.9	73.9	62.9	95.5	98.7	65.5	79.8	80.9	94.5	71.0	95.6	57.5	76.9	65.5	59.2	64.5	65.9	72.6	67.0	67.6	63.9	67.8	94.5	92.1	43.2	94.5	76.1	27.6	29.5	30.6	35.9	27.0	29.0	29.5	28.6	29.8	28.6	28.4	32.9	86.5	93.0	49.3	13.1	64.2	56.5	80.4	89.1	33.6	56.0	40.1	50.0	49.9	47.1	77.9	53.3	35.5	79.4	75.4	38.0	76.3	79.0	43.5	97.2	81.3	69.9	43.6	85.0	17.9	70.1	100.1	64.9	26.5	80.5	92.3	61.5	55.6	33.7	76.4	38.7	18.6	50.8	54.9	53.6	52.0	24.0	77.9	70.7	39.2	30.0	95.6	66.7	65.9	15.6	31.9	71.3	43.8	74.1	46.3	48.9	48.8	57.3	88.1	72.2	65.7	60.9	89.5	300.5	140.7	39.7	54.3	109.0	76.8	54.4	47.9	70.9
SPAG16	"DKFZp666P1710, FLJ22724, PF20, WDR29"	ENSG00000144451	"Sperm associated antigen 16"	Q8N0X2	2	213284379-214410501	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.1;Inhibitory neurons: 273.7;Respiratory ciliated cells: 330.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 70.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037542	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA037542: AB_10672353"	"unprognostic (4.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.17e-1)"	16.3	16.8	36.6	6.4	37.4	2.4	20.8	35.1	45.9	21.0	39.0	16.5	18.8	18.2	31.6	26.1	46.5	22.0	22.2	34.2	37.8	30.4	18.8	10.8	11.5	38.8	39.6	25.8	15.5	24.4	29.7	9.8	37.8	22.1	17.2	21.5	15.7	20.5	10.3	24.9	10.9	12.1	40.9	8.0	26.1	46.3	38.4	13.0	26.4	10.8	13.8	18.9	19.4	40.6	26.8	9.9	29.4	0.0	19.3	35.0	0.2	14.3	17.1	18.3	19.3	20.8	28.8	11.1	16.7	16.0	29.3	18.5	13.4	17.4	38.6	0.0	10.5	5.8	28.0	24.6	21.9	6.3	0.1	30.1	23.5	16.3	9.5	25.0	7.6	11.6	18.8	12.3	18.4	0.0	21.4	0.1	16.3	0.0	8.7	22.6	30.9	0.5	29.4	25.8	21.4	25.1	16.3	15.1	21.3	24.2	70.3	2.7	7.8	17.2	9.2	9.3	15.1	20.0	9.7	0.4	28.6	0.0	8.0	2.0	0.3	0.9	8.1	1.3	11.7	9.3	9.1	10.4	3.1	8.5	12.0	10.4	0.5	15.4	0.9	5.1	9.4	3.4	36.6	37.4	35.1	45.9	34.2	37.8	38.8	39.6	37.8	40.9	38.4	40.6	17.7	16.0	19.5	89.5	10.7	42.3	46.6	82.8	22.8	47.6	38.0	45.6	67.5	74.4	73.6	40.5	95.9	50.6	7.5	17.1	76.3	44.0	243.1	207.0	31.3	18.5	38.2	9.0	205.9	24.9	20.8	30.8	32.1	30.3	10.1	34.0	12.8	16.9	11.7	40.4	273.7	37.8	101.7	4.6	9.6	86.2	41.3	5.9	23.2	42.2	29.2	82.7	8.2	92.0	74.9	27.3	18.8	44.8	9.4	25.4	9.4	94.9	330.0	69.0	13.1	30.8	36.1	167.9	31.0	64.6	56.4	23.5	12.9	55.3	39.8	53.8
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051304-52097299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 68.3;testis: 28.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2341.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.5;BEWO: 24.4;BJ hTERT+: 15.9;HSkMC: 29.3;hTCEpi: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	5.0	2.4	0.7	2.2	0.0	6.3	1.3	1.0	10.7	15.6	4.1	2.1	4.2	2.0	4.6	68.3	6.7	1.8	2.5	2.7	5.3	5.4	8.0	0.3	6.8	8.3	1.8	2.0	4.5	4.9	1.9	5.5	4.2	5.6	0.1	10.1	5.6	0.8	6.6	2.2	3.1	6.0	0.6	4.9	28.8	2.6	3.2	1.2	1.3	0.9	2.8	3.4	3.8	0.0	3.8	1.8	0.0	12.7	31.5	24.4	9.3	15.9	0.6	0.7	0.0	1.5	0.0	0.0	12.3	0.2	0.3	0.1	7.1	0.3	0.0	1.1	0.0	0.0	8.0	11.2	0.0	0.0	29.3	28.7	1.0	4.5	5.1	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	2.0	1.0	0.0	0.0	9.7	0.0	0.2	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	1.3	1.0	2.5	2.7	6.8	8.3	5.5	6.0	2.6	3.8	0.3	9.6	3.0	0.3	0.0	5.2	8.5	9.4	8.6	0.0	6.0	6.7	2.2	8.6	15.1	0.0	0.0	1.7	0.3	1.8	1.9	1.2	561.1	124.6	1.8	1.2	1.8	0.0	1.7	2.6	1.8	4.3	11.2	4.7	2.5	1.9	1.4	3.4	0.3	0.0	0.5	1.6	6.1	0.6	1.6	2341.5	10.8	1.1	0.0	2.8	0.1	0.0	0.0	0.5	0.1	2.0	2.7	10.9	0.0	5.1	1.9	7.4	141.4	0.0	0.0	1.8	3.9	13.9	7.1	7.1	7.5	0.8	0.2	2.5	4.3	6.8
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66682497-66729226	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.6;skin 1: 85.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Vesicles	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	1.3	14.4	26.8	1.0	32.6	2.3	7.7	29.7	73.6	14.3	0.0	0.9	0.9	1.7	1.2	39.8	3.7	1.7	1.4	38.8	0.3	37.5	23.3	1.1	0.2	4.8	0.9	0.9	16.7	13.1	16.4	0.4	3.2	12.4	0.7	14.7	29.6	4.7	0.5	85.5	1.0	1.1	0.0	0.9	2.9	52.8	4.6	1.0	0.3	0.1	6.7	1.6	16.5	24.2	20.5	7.4	3.4	0.3	0.1	0.0	0.6	0.3	0.1	0.1	0.0	4.8	28.2	0.2	3.7	0.0	0.7	16.9	25.2	2.4	0.0	0.1	10.4	0.1	45.6	3.0	0.8	7.3	0.6	0.2	11.5	0.0	7.4	4.2	6.3	5.2	7.3	0.1	0.1	35.2	6.3	3.5	49.1	28.7	21.1	23.8	2.8	14.7	9.6	4.8	49.9	29.4	14.0	52.3	3.2	2.7	67.2	2.4	1.4	0.1	8.6	1.3	11.5	0.7	3.0	14.7	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	26.8	32.6	29.7	73.6	38.8	0.3	4.8	0.9	3.2	0.0	4.6	24.2	0.7	3.2	1.1	4.9	0.3	3.7	2.7	3.2	2.8	11.0	4.7	4.6	1.8	1.5	4.6	86.5	104.3	0.9	0.0	0.6	0.0	2.6	30.9	3.6	1.8	1.1	3.0	7.2	29.3	10.0	0.3	0.8	1.5	3.6	0.0	1.4	1.4	24.7	0.1	0.0	20.7	1.6	0.0	0.3	0.7	77.6	1.8	0.1	0.0	2.8	0.6	1.6	0.0	7.5	4.6	7.5	0.2	1.5	0.8	3.2	0.2	1.3	3.5	21.3	0.0	0.2	0.5	8.5	9.4	14.6	12.5	0.3	0.2	0.1	0.8	1.7
SRGAP2B	SRGAP2P2	ENSG00000196369	"SLIT-ROBO Rho GTPase activating protein 2B"	P0DMP2	1	144887265-145095528	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.7"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 239.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;granulocytes: 3.9;monocytes: 7.9"	"Low cell line specificity"	"Detected in all"											HPA078079			Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA078079: "	"unprognostic (1.13e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.48e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-5)"	"unprognostic (3.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-1)"	9.3	10.5	9.9	6.8	9.2	7.7	6.1	48.7	10.3	6.3	3.7	4.7	2.8	6.2	4.2	5.7	6.7	5.7	5.1	10.3	10.5	8.0	4.2	8.6	5.6	15.4	14.4	8.6	3.6	13.1	3.0	10.8	19.4	3.7	2.8	3.7	3.3	4.6	8.9	18.9	3.5	7.1	14.9	12.4	2.9	3.5	12.4	6.4	4.3	5.8	3.7	5.0	6.4	17.1	13.4	28.5	60.3	12.5	28.3	24.3	19.0	14.6	12.8	12.2	14.0	8.7	24.1	6.7	19.1	8.7	21.7	22.8	15.6	8.5	15.0	6.3	15.8	9.8	20.6	12.1	19.8	8.8	12.5	17.3	12.6	30.1	26.4	18.4	24.8	5.7	5.3	23.1	6.7	15.1	3.8	10.3	11.2	6.7	10.2	10.3	12.9	11.6	10.5	5.8	7.5	9.5	19.3	6.9	31.6	14.9	14.4	22.1	45.3	26.1	26.7	23.3	17.1	9.6	12.7	4.1	9.5	11.6	37.7	1.2	3.8	0.5	0.6	5.4	0.5	0.9	1.0	1.2	2.7	0.9	0.6	0.7	3.9	0.4	7.9	3.6	1.1	0.9	9.9	9.2	48.7	10.3	10.3	10.5	15.4	14.4	19.4	14.9	12.4	17.1	37.3	25.6	7.7	5.5	14.0	0.0	3.5	0.0	6.8	17.6	3.1	3.4	3.3	5.7	2.5	9.2	2.1	4.7	20.3	0.5	0.0	6.8	1.1	13.8	14.0	35.1	2.4	29.3	37.5	3.0	21.5	15.3	3.1	6.0	1.3	3.3	54.3	4.3	12.9	0.0	55.6	2.0	0.0	58.7	0.0	2.7	15.2	40.1	0.0	239.8	38.4	8.1	16.5	24.6	9.5	6.0	0.2	9.8	8.4	4.8	0.8	1.2	8.0	2.9	6.6	16.9	12.3	4.5	6.9	19.9	0.0	2.9	6.9	8.6	1.8	4.2
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072517	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 314.6"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 162.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"medulla oblongata: 314.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA023303: AB_1857477, HPA055617: AB_2682863"	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.02e-3)"	37.5	34.6	23.7	24.8	25.2	21.9	36.3	25.5	76.6	39.4	24.6	47.2	21.3	39.7	35.1	49.8	37.4	17.3	42.8	34.8	27.7	31.6	37.0	34.0	29.0	314.6	25.1	39.8	65.7	37.7	37.7	33.1	49.6	30.6	27.4	28.0	38.5	26.1	103.1	43.7	32.2	34.5	30.5	31.5	41.5	22.2	25.9	30.8	32.8	47.0	36.7	41.9	37.9	26.4	98.0	89.8	51.0	54.9	71.5	57.2	94.3	72.4	50.7	80.7	62.9	75.5	45.5	81.6	36.8	70.5	69.2	66.2	98.2	74.2	119.2	34.3	118.1	72.6	63.4	102.8	86.3	83.9	54.7	48.5	81.3	70.7	61.1	60.0	95.1	47.4	109.0	70.9	67.2	60.1	84.6	43.5	50.3	81.2	91.0	70.1	137.1	79.9	59.2	80.6	63.2	64.9	61.9	103.8	81.8	85.2	91.5	76.4	62.3	89.2	70.7	42.7	99.4	70.5	34.7	87.1	64.0	62.2	66.4	7.6	28.6	37.3	24.5	26.3	26.4	30.5	34.8	37.9	34.3	25.3	39.2	29.4	4.3	45.4	27.1	27.1	34.6	19.4	23.7	25.2	25.5	76.6	34.8	27.7	314.6	25.1	49.6	30.5	25.9	26.4	20.9	28.9	22.9	12.1	27.9	31.4	49.3	30.2	22.2	24.2	18.2	19.2	27.2	28.6	25.9	12.9	37.5	86.9	21.2	18.3	37.2	43.6	15.0	24.3	26.1	28.1	14.4	41.3	11.1	41.4	63.2	26.8	16.8	28.5	17.1	25.6	21.8	23.2	37.9	37.0	10.8	22.8	20.3	18.5	17.4	20.0	24.2	17.8	24.9	11.2	31.8	36.8	29.9	7.1	11.5	39.0	15.8	28.2	37.9	46.5	20.7	30.4	23.7	26.7	0.0	28.5	31.7	47.2	24.4	26.6	31.7	162.3	25.2	30.2	24.1	48.9
ST7L	"FAM4B, FLJ20284, ST7R, STLR"	ENSG00000007341	"Suppression of tumorigenicity 7 like"	Q8TDW4	1	112523514-112620825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 36.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 189.7;Late spermatids: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042324, HPA075418"	Uncertain		Approved	Centrosome		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome		"HPA042324: AB_10794273, HPA075418: AB_2686749"	"unprognostic (2.99e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (8.34e-5)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-6)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.16e-4)"	"prognostic favorable (3.04e-5)"	"unprognostic (2.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.27e-2)"	4.6	5.2	2.4	2.2	3.1	5.5	4.8	3.7	3.2	4.6	2.5	3.1	2.9	5.2	4.9	3.5	3.7	3.4	5.4	2.2	2.4	3.6	4.2	2.8	2.9	1.9	2.5	5.6	3.9	4.7	2.2	3.9	2.1	4.3	4.7	6.8	2.9	4.2	4.8	6.1	2.6	4.1	2.3	2.1	2.3	36.0	2.3	3.4	7.6	4.6	3.3	3.7	3.1	3.6	5.2	1.5	8.8	6.1	11.7	11.6	2.0	5.9	4.8	2.6	3.9	2.8	4.8	2.0	2.4	2.6	7.9	3.3	10.2	8.3	4.0	3.2	6.0	6.2	8.0	2.1	6.7	4.9	6.3	2.3	2.0	3.0	6.3	6.2	8.9	7.4	3.4	6.5	11.1	1.4	2.7	1.9	4.0	2.3	5.3	4.4	4.0	0.8	5.7	6.2	6.2	3.7	3.4	4.8	4.4	1.5	3.6	3.0	8.8	6.0	5.9	7.9	6.0	1.7	1.3	2.1	5.5	8.2	13.5	0.1	0.9	0.1	1.2	1.1	1.9	2.4	1.8	0.9	0.9	1.3	2.5	1.4	0.2	3.7	0.9	1.8	1.4	1.0	2.4	3.1	3.7	3.2	2.2	2.4	1.9	2.5	2.1	2.3	2.3	3.6	14.4	22.4	9.6	46.0	8.0	17.0	16.7	14.9	23.9	19.7	13.7	15.9	6.7	12.8	12.8	9.2	6.2	13.0	10.8	4.9	9.8	8.5	189.7	8.5	13.8	12.1	5.4	9.9	48.1	8.6	6.7	12.2	8.6	9.5	8.2	15.1	5.0	8.0	8.5	25.2	55.0	9.8	18.3	10.9	8.6	301.2	18.0	12.5	21.4	37.5	6.0	21.8	3.1	68.3	67.9	7.4	5.1	16.1	13.9	12.4	6.8	6.9	10.4	25.2	19.7	15.7	13.3	65.4	14.5	17.6	18.3	6.2	11.3	17.2	9.7	10.6
STAP2	"BKS, STAP-2"	ENSG00000178078	"Signal transducing adaptor family member 2"	Q9UGK3	19	4324043-4342786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 294.5;Paneth cells: 343.4;Proximal enterocytes: 415.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.2;NK-cells: 7.9;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 87.3;HaCaT: 70.3;MCF7: 104.3;RT4: 138.1"	"Region enriched"	"Detected in many"	13	"cerebellum: 20.5"	"Low region specificity"	"Detected in some"			"HPA002375, HPA027761"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA002375: AB_1078285, HPA027761: AB_1845364"	"unprognostic (1.42e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.52e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (4.35e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.52e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (4.13e-4)"	5.6	18.1	2.6	7.5	2.7	0.4	16.6	3.6	4.2	18.1	3.5	72.8	77.5	5.7	10.6	91.0	15.1	7.1	4.9	2.7	2.4	28.5	55.3	8.2	3.2	2.4	2.2	11.5	30.6	21.3	4.4	3.4	2.7	37.9	59.7	0.5	45.4	9.8	1.2	73.9	72.0	4.0	2.0	1.5	24.2	2.0	2.5	7.9	15.3	0.7	13.0	16.5	41.0	2.6	87.3	0.4	6.2	5.8	0.4	4.7	35.7	1.6	8.8	2.8	2.2	52.0	34.8	0.1	13.3	2.8	17.9	70.3	1.1	50.3	1.6	14.9	0.7	0.3	0.4	35.1	10.9	0.1	0.7	3.5	41.7	4.8	12.2	7.0	8.9	2.1	3.4	18.6	1.3	104.3	1.3	0.7	4.8	55.3	20.4	3.6	0.8	2.2	29.4	138.1	2.1	3.5	0.1	25.9	14.6	2.2	60.7	0.3	12.5	0.2	1.2	0.7	1.8	0.1	1.4	1.3	0.3	0.4	5.7	0.4	0.1	0.0	0.6	0.0	2.3	0.6	0.8	0.1	0.7	0.1	2.3	1.4	0.1	7.9	0.0	2.2	2.5	0.8	2.6	2.7	3.6	4.2	2.7	2.4	2.4	2.2	2.7	2.0	2.5	2.6	6.7	9.6	14.4	0.3	2.4	40.5	59.8	171.4	42.7	0.6	33.8	30.1	6.9	38.6	87.2	29.5	0.0	16.9	2.3	294.5	25.4	137.5	1.2	9.0	3.6	10.1	85.8	4.4	1.5	101.0	3.0	4.5	55.5	13.4	8.9	5.2	7.5	29.6	1.8	0.0	1.2	147.5	91.6	4.1	9.4	0.9	4.7	1.8	19.6	0.0	12.5	1.0	1.0	0.5	1.8	139.4	343.4	1.9	1.4	92.6	415.7	125.0	44.9	0.8	0.0	1.7	7.9	0.6	2.6	86.0	61.8	12.4	3.3	5.7	173.2	117.0
SYT8	DKFZp434K0322	ENSG00000149043	"Synaptotagmin 8"	Q8NBV8	11	1828307-1837521	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.2;skin 1: 65.5;urinary bladder: 40.5"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 184.7;Basal squamous epithelial cells: 520.2;Breast myoepithelial cells: 192.9;Cholangiocytes: 183.0;Extravillous trophoblasts: 201.8;Respiratory ciliated cells: 163.8;Squamous epithelial cells: 132.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 10.5;pancreatic cancer: 21.7;urothelial cancer: 33.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 32.2;hTCEpi: 50.2;T-47d: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047239, HPA052700"	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA047239: , HPA052700: AB_2681920"	"unprognostic (1.66e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-6)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.77e-2)"	0.1	0.2	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.3	0.1	0.4	0.5	0.0	0.5	29.2	1.0	8.6	0.0	0.0	0.0	0.3	0.6	4.7	0.0	0.0	0.0	0.0	14.9	0.0	0.2	1.6	0.0	2.5	0.0	0.0	20.9	2.9	0.0	65.5	2.5	0.0	0.0	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.1	40.5	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	32.2	0.0	0.0	0.0	0.6	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	50.2	0.0	5.8	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.7	0.0	0.0	0.3	0.0	0.1	1.0	0.0	0.3	0.0	2.7	0.0	0.0	13.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	16.0	3.9	0.0	0.3	184.7	5.6	24.9	520.2	0.0	3.2	192.9	0.6	183.0	39.1	5.5	0.0	28.7	0.7	3.4	0.0	31.1	0.0	15.6	0.1	1.7	0.0	0.0	0.0	9.7	201.8	1.6	12.2	0.6	1.3	0.0	0.0	0.1	7.1	0.0	0.0	1.3	16.2	0.0	14.7	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.0	0.0	0.0	28.3	3.5	0.0	6.2	1.3	18.3	0.0	163.8	0.0	0.0	0.0	7.0	0.0	0.0	132.5	47.2	36.8	0.6	0.1	1.7	31.5
SYT9		ENSG00000170743	"Synaptotagmin 9"	Q86SS6	11	7238778-7469043	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9;retina: 7.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 48.6;Late spermatids: 23.5;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 139.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEK 293: 10.3;RT4: 17.9;SH-SY5Y: 13.2;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.47e-1)"	"unprognostic (9.41e-2)"		"unprognostic (1.39e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.31e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.22e-4)"	0.0	2.0	9.1	0.0	9.2	0.0	0.8	11.7	5.9	0.4	1.4	0.1	0.0	1.2	0.0	0.0	0.1	0.1	0.3	4.7	7.6	2.0	3.6	0.0	0.0	9.9	11.8	0.1	1.3	0.9	1.5	0.0	9.6	1.0	0.0	7.6	0.0	3.6	0.0	0.1	0.1	0.1	8.1	0.0	0.1	0.9	15.9	0.0	1.1	0.0	0.0	0.2	0.3	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.5	0.0	0.0	0.0	0.0	17.9	3.2	13.2	0.0	0.0	0.0	0.4	0.0	0.0	20.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	9.2	11.7	5.9	4.7	7.6	9.9	11.8	9.6	8.1	15.9	11.7	0.0	0.0	0.0	48.6	0.5	0.0	0.1	0.0	0.0	13.6	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.9	0.0	0.2	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	3.3	9.8	0.0	0.0	0.3	0.0	23.5	0.0	0.0	0.0	5.6	0.0	2.0	0.0	55.3	139.2	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	3.5	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;pancreas: 106.3;skin 1: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 158.8;NK-cells: 208.1;Squamous epithelial cells: 179.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 4.3;cerebellum: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.8;CAPAN-2: 55.8;NB-4: 81.8;U-266/70: 44.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"	2.0	0.6	4.3	19.1	0.7	46.7	7.7	8.8	1.4	22.6	6.1	6.7	7.8	1.3	1.2	103.9	15.5	8.6	0.9	1.0	1.0	2.8	2.1	13.1	32.9	0.7	0.8	0.6	106.3	4.2	15.6	2.9	0.8	63.6	3.3	0.0	47.6	12.7	0.5	87.2	17.6	0.4	0.5	42.0	41.8	0.9	1.2	21.4	9.8	0.5	20.0	21.6	50.9	0.6	11.3	0.2	0.0	0.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	1.2	55.8	8.5	10.9	0.0	0.3	34.7	0.0	21.0	0.0	0.0	2.1	1.0	0.9	15.3	0.8	21.9	0.0	0.0	37.8	0.0	7.8	0.2	0.0	28.2	0.7	9.5	0.0	15.5	12.9	81.8	0.5	19.1	5.7	14.9	0.1	40.2	8.6	9.6	15.9	0.9	0.0	15.9	0.6	0.5	40.4	23.3	0.2	0.1	5.1	0.0	0.0	44.3	11.7	8.0	1.6	27.7	0.0	47.0	18.9	176.5	65.0	49.1	58.4	42.8	51.5	53.2	51.0	32.3	30.6	37.3	34.1	49.0	100.8	3.0	63.4	40.0	4.3	0.7	8.8	1.4	1.0	1.0	0.7	0.8	0.8	0.5	1.2	0.6	1.9	22.4	13.6	0.0	68.6	41.2	78.2	84.4	158.8	0.6	33.6	49.8	3.9	8.6	69.2	0.0	0.0	37.4	92.3	4.8	7.9	3.7	0.8	67.8	2.4	2.3	11.4	15.8	0.3	25.5	10.1	3.1	100.9	18.3	1.3	0.2	2.2	1.1	3.2	0.0	0.3	47.6	32.6	6.7	12.7	0.7	0.3	15.7	10.6	0.0	18.8	2.0	208.1	0.0	0.1	12.1	3.7	0.7	52.3	46.8	3.1	6.4	62.8	0.8	0.0	1.3	5.6	30.3	23.1	179.1	55.3	14.1	74.9	0.2	9.4	95.3
TACC2	"AZU-1, ECTACC"	ENSG00000138162	"Transforming acidic coiled-coil containing protein 2"	O95359	10	121989163-122254545	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 251.7;skeletal muscle: 387.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 210.1;Syncytiotrophoblasts: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031020, HPA031021, HPA061394"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		32000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500"	"unprognostic (3.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.50e-10)"	"unprognostic (7.02e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (1.61e-1)"	22.1	15.3	18.2	5.3	18.6	0.2	20.9	23.6	22.7	32.3	28.6	91.5	15.3	26.1	9.2	64.2	32.9	12.9	251.7	19.1	18.8	33.9	18.8	68.7	1.0	16.0	16.9	8.8	25.3	36.4	58.7	21.6	14.8	67.7	20.7	7.2	60.7	13.5	387.1	103.3	35.7	22.0	11.8	4.2	49.1	5.8	16.9	5.7	50.7	159.0	5.7	62.4	49.1	17.7	17.8	55.1	26.5	15.2	7.4	7.4	31.7	7.7	20.7	10.5	7.3	22.7	28.9	0.0	7.0	12.3	12.1	58.1	8.5	20.9	10.9	3.0	4.4	0.0	7.7	43.8	11.5	0.0	0.3	3.4	86.0	5.6	36.6	8.6	22.2	0.1	4.5	0.6	10.4	23.5	0.2	9.9	15.7	27.6	24.8	0.3	15.2	8.5	28.9	26.9	17.6	14.2	12.7	52.0	29.5	7.6	10.2	0.4	20.6	4.7	3.5	11.8	14.5	2.4	11.7	0.3	8.7	0.1	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	18.6	23.6	22.7	19.1	18.8	16.0	16.9	14.8	11.8	16.9	17.7	15.5	83.3	94.1	16.3	0.7	33.6	49.7	54.3	33.0	21.6	23.4	14.1	210.1	8.6	70.7	36.8	0.0	53.3	0.4	75.2	1.9	8.2	2.4	88.4	11.0	21.3	30.0	0.0	32.8	14.2	4.4	21.2	38.7	62.8	7.0	0.1	6.1	18.9	6.5	43.7	48.2	38.8	57.0	0.3	4.3	2.6	6.8	1.9	7.2	7.5	0.1	1.1	0.0	80.9	7.6	19.4	47.1	7.5	0.2	49.6	36.5	13.5	84.9	2.7	13.1	27.2	23.7	0.5	8.2	79.5	54.0	228.5	2.6	2.8	41.9	80.5
TCF20	"AR1, SPBP"	ENSG00000100207	"Transcription factor 20"	Q9UGU0	22	42160013-42343616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.0;Inhibitory neurons: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017849, HPA036786"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"CAB017849: , HPA036786: AB_2675313"	"unprognostic (2.17e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.07e-3)"	"unprognostic (4.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	7.1	6.5	4.2	1.7	3.1	1.6	7.5	0.0	2.9	10.2	0.0	9.1	1.6	9.0	0.2	16.3	6.9	1.0	4.9	3.7	2.4	7.6	7.4	7.1	1.6	0.9	1.0	7.6	8.2	1.2	7.4	1.2	1.1	6.9	1.3	0.9	9.9	1.0	5.7	14.3	10.0	1.4	0.0	7.3	8.0	15.3	1.8	2.3	9.6	1.3	1.6	7.8	11.0	2.1	6.6	2.3	3.2	2.1	1.0	2.1	5.5	4.2	2.8	2.1	3.5	5.0	2.5	10.9	3.6	1.1	3.1	5.4	3.9	3.3	1.2	8.5	3.9	3.4	2.2	1.6	1.5	6.0	4.7	1.2	2.9	3.0	3.0	0.9	1.0	3.1	4.1	3.9	1.6	3.0	9.4	1.8	3.4	2.2	3.1	4.7	2.0	5.7	0.5	5.2	6.2	2.0	2.7	2.0	2.7	2.0	1.2	4.8	3.9	3.8	8.9	3.9	1.9	7.0	6.2	4.5	2.3	4.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.1	0.0	2.9	3.7	2.4	0.9	1.0	1.1	0.0	1.8	2.1	10.0	0.0	9.6	23.5	9.1	22.6	11.3	19.4	12.0	25.1	11.5	6.9	7.3	17.2	10.1	9.2	18.8	6.3	11.0	16.6	0.0	10.8	127.0	14.2	9.9	9.3	16.8	9.9	54.0	7.5	5.5	8.1	10.7	22.2	1.3	10.0	8.9	12.6	6.2	10.1	63.5	13.8	12.2	12.4	13.3	36.2	12.5	9.4	7.2	22.5	12.0	5.6	6.2	29.7	55.0	13.3	13.5	6.4	8.7	20.9	13.0	6.0	13.4	12.6	6.6	5.8	8.5	19.1	13.4	19.5	22.9	4.5	13.0	4.3	17.9	14.6
THAP8	FLJ32891	ENSG00000161277	"THAP domain containing 8"	Q8NA92	19	36034984-36054739	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.8;Spermatogonia: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064056, HPA070139"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA064056: AB_2685184, HPA070139: AB_2686230"	"unprognostic (1.33e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (9.01e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.48e-1)"	3.3	3.2	9.1	2.5	9.8	0.9	2.7	9.4	9.6	5.0	6.3	9.5	3.7	4.7	3.4	3.7	3.8	3.5	3.5	8.3	9.7	4.1	4.6	2.8	3.1	10.1	9.8	3.5	2.8	3.7	3.4	2.8	10.2	3.6	2.4	4.6	3.0	4.3	10.2	5.2	3.5	4.4	8.9	3.4	3.6	9.7	9.7	4.0	3.1	3.3	2.2	6.6	4.0	11.2	3.3	8.2	4.4	3.7	11.6	8.0	2.8	2.7	4.8	5.5	7.8	3.6	2.3	4.5	9.7	4.5	5.7	1.5	2.5	3.3	2.1	3.2	1.6	2.8	3.0	4.3	12.7	1.6	2.7	6.2	5.0	3.8	2.6	6.2	2.6	8.2	2.4	5.3	5.8	5.5	4.1	3.4	3.9	5.6	3.1	3.9	1.4	4.2	4.5	2.9	8.1	6.1	4.6	3.9	3.3	5.7	4.1	2.2	2.3	7.3	4.5	4.5	2.2	5.2	4.5	3.3	8.0	2.6	4.7	7.1	6.5	7.9	5.2	7.6	5.9	4.1	5.5	5.4	4.7	3.0	4.1	6.1	2.7	6.2	6.6	4.5	5.8	4.1	9.1	9.8	9.4	9.6	8.3	9.7	10.1	9.8	10.2	8.9	9.7	11.2	1.4	3.2	3.7	3.6	3.4	1.1	1.2	3.2	2.8	2.2	3.0	2.4	3.7	5.7	2.9	7.3	2.1	10.2	3.5	2.1	1.9	5.7	3.0	1.5	3.9	2.5	6.6	1.3	2.7	0.5	5.5	3.8	4.1	2.7	5.7	8.8	3.9	3.5	15.8	3.3	3.3	1.3	12.2	4.4	0.8	6.1	1.8	3.2	1.8	1.9	4.4	5.2	8.2	4.5	5.5	2.6	2.7	4.1	2.5	1.2	5.3	11.7	1.2	3.0	0.0	1.7	2.9	18.8	21.5	2.3	2.3	10.5	2.5	5.8	2.2	1.0
TIMM29	"C19orf52, TIM29"	ENSG00000142444	"Translocase of inner mitochondrial membrane 29"	Q9BSF4	19	10928811-10933535	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.0;Ductal cells: 21.6;Extravillous trophoblasts: 31.4;Hofbauer cells: 22.4;Proximal tubular cells: 22.1;Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041858	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA041858: AB_10963429"	"unprognostic (8.45e-2)"	"prognostic favorable (9.93e-5)"	"unprognostic (8.99e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.79e-3)"	"prognostic favorable (7.03e-7)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.26e-3)"	8.4	11.7	4.6	5.4	4.5	10.1	8.4	3.7	6.1	10.4	3.5	11.0	8.0	11.0	1.1	14.9	9.0	3.1	13.5	4.9	3.8	11.5	12.2	8.1	6.0	5.8	4.3	7.9	9.9	3.3	10.7	4.6	4.2	10.1	2.0	1.1	10.1	3.8	23.5	13.9	9.7	2.1	3.8	10.7	11.0	13.0	4.2	5.3	7.5	5.9	2.8	10.5	11.4	4.7	21.3	8.0	6.2	10.4	5.3	5.1	16.7	14.3	7.6	10.7	9.9	14.7	7.0	18.0	24.7	7.0	5.8	20.1	3.3	8.9	1.8	21.3	25.0	20.7	8.4	10.0	8.4	15.8	15.5	4.5	8.6	7.5	3.2	4.3	6.5	15.7	23.1	15.4	4.1	19.0	17.4	29.1	21.8	6.6	34.0	23.4	8.7	22.3	4.7	8.6	15.6	15.8	16.9	9.1	18.3	2.3	13.1	16.7	10.7	17.1	10.0	21.6	23.1	49.7	52.8	19.8	10.6	19.3	14.8	3.7	8.7	9.8	5.3	9.3	8.9	17.9	10.6	11.7	5.8	15.0	10.1	8.3	1.7	11.3	7.4	11.0	12.8	3.8	4.6	4.5	3.7	6.1	4.9	3.8	5.8	4.3	4.2	3.8	4.2	4.7	6.9	3.2	5.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	9.6	8.4	0.0	0.0	1.3	16.5	0.0	36.0	13.8	0.0	19.6	21.6	0.0	9.6	10.9	4.9	0.0	0.0	0.0	10.5	31.4	5.2	0.0	9.2	1.3	10.5	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	2.4	0.0	0.0	22.1	0.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	35.7	5.5	14.7	0.0	0.0
TINCR	"FLJ90734, LINC00036, NCRNA00036, onco-lncRNA-16, PLAC2"	ENSG00000223573	"TINCR ubiquitin domain containing"		19	5558167-5578349	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	6	"skin 1: 119.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.4;Cytotrophoblasts: 61.0;Extravillous trophoblasts: 116.9;Squamous epithelial cells: 53.3;Suprabasal keratinocytes: 92.2;Syncytiotrophoblasts: 204.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 53.3;HaCaT: 35.9;MCF7: 14.9;SK-BR-3: 56.1"															NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (4.75e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.32e-2)"	0.9	1.9	6.6	0.7	6.6	2.9	3.6	4.7	8.0	5.7	1.0	2.0	0.5	0.6	1.5	21.2	0.7	0.5	0.5	4.9	4.8	1.1	0.1	2.9	0.9	4.1	7.3	0.6	0.3	0.3	2.9	17.8	7.2	4.7	2.5	2.8	4.3	0.8	0.9	119.1	0.8	0.4	0.6	0.9	0.3	1.7	11.7	0.2	0.5	0.0	4.9	1.4	13.7	4.4	2.0	1.6	0.2	0.6	0.5	1.0	53.3	0.2	0.1	0.1	0.2	0.9	6.3	0.3	0.5	0.2	0.5	35.9	0.6	0.1	0.4	0.6	1.2	0.4	1.9	0.5	0.1	0.7	0.5	0.0	11.5	0.3	0.3	0.3	0.0	2.9	0.3	0.8	0.1	14.9	0.2	0.8	1.0	1.4	2.5	1.2	0.4	1.3	0.0	3.8	0.7	0.1	3.9	56.1	5.6	5.0	6.7	0.5	0.0	0.6	0.5	1.0	0.1	1.4	0.4	1.0	0.3	0.7	1.1	3.2	0.4	0.5	0.4	0.3	0.3	0.9	0.3	0.3	0.1	0.9	0.3	0.4	2.3	0.6	0.4	1.3	0.4	0.2	6.6	6.6	4.7	8.0	4.9	4.8	4.1	7.3	7.2	0.6	11.7	4.4	2.1	12.8	1.7	0.3	0.6	46.4	5.2	2.9	21.1	4.2	6.1	3.2	1.3	4.3	2.6	1.8	0.0	61.0	1.4	3.3	11.7	0.0	0.4	1.2	1.8	2.4	1.8	0.0	0.8	0.5	116.9	1.7	0.0	2.6	0.0	0.5	2.9	0.3	6.6	0.0	1.2	3.0	4.1	1.4	4.6	0.2	0.6	1.2	7.2	0.0	0.5	3.5	1.0	0.0	0.2	0.1	7.5	0.7	0.1	5.9	0.1	0.4	1.9	2.1	0.0	3.6	1.3	1.0	3.1	53.3	92.2	204.5	1.1	0.2	0.9	10.1
TMEM134	FLJ21749	ENSG00000172663	"Transmembrane protein 134"	Q9H6X4	11	67461710-67469272	"Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043744	Approved		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA043744: AB_10794773"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.43e-3)"	12.6	24.3	22.5	8.6	23.2	4.7	14.8	21.2	29.9	15.6	19.9	14.0	8.3	9.6	11.0	55.5	10.2	6.5	46.8	21.6	22.2	25.2	33.9	11.2	11.9	22.8	22.6	8.6	42.9	7.9	8.7	5.3	22.4	25.7	4.5	2.8	20.6	7.3	57.4	57.5	14.5	4.4	22.7	16.2	22.4	26.5	22.9	6.6	13.5	26.0	8.8	15.9	25.4	22.5	12.3	4.6	6.5	14.0	4.3	7.3	7.2	2.5	4.6	2.9	1.2	5.8	14.3	11.7	27.2	6.2	9.2	10.0	2.9	10.7	1.8	11.3	4.9	2.2	4.5	5.9	6.6	2.3	3.2	7.3	13.4	2.3	7.7	12.7	3.0	7.9	3.0	6.6	6.3	29.0	13.3	8.6	11.0	20.4	16.3	6.5	3.8	38.5	11.3	12.5	6.0	13.3	9.1	14.2	28.6	4.4	34.5	2.3	5.8	10.4	9.0	12.5	3.3	27.8	19.4	8.2	15.6	3.0	8.5	58.2	54.3	98.5	71.4	132.7	78.8	203.7	84.2	80.6	66.6	195.7	85.6	80.6	25.7	90.2	176.0	87.3	123.9	73.3	22.5	23.2	21.2	29.9	21.6	22.2	22.8	22.6	22.4	22.7	22.9	22.5	43.3	16.0	41.5	11.8	83.0	90.0	87.7	177.7	99.0	29.3	139.9	173.4	53.4	60.1	93.5	68.0	10.4	69.5	46.5	64.7	133.1	95.0	50.2	53.0	35.3	36.6	71.4	22.3	9.4	126.0	147.9	31.3	120.3	73.4	23.4	52.5	29.3	69.6	84.0	11.8	8.2	100.3	97.6	43.6	49.3	46.2	20.8	49.0	110.3	2.8	61.2	39.5	63.8	9.5	14.1	189.9	81.7	24.8	47.2	142.6	150.8	148.9	75.0	29.5	6.6	24.4	45.9	105.8	80.1	185.1	180.1	72.8	53.3	37.6	73.5	152.2
TMEM203	"HBEBP1, MGC14327"	ENSG00000187713	"Transmembrane protein 203"	Q969S6	9	137204082-137205648	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.31e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.16e-2)"	"prognostic favorable (4.78e-6)"	"unprognostic (2.94e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.19e-1)"	25.7	32.6	32.8	17.2	33.6	10.9	25.5	33.8	36.8	28.1	33.1	30.2	22.2	29.9	26.4	31.4	24.2	16.4	45.9	32.9	33.4	33.2	49.2	20.5	27.0	33.6	33.6	27.7	26.2	30.7	25.6	15.9	33.4	27.1	18.2	16.4	26.8	21.8	49.7	43.6	28.5	16.9	32.8	30.4	30.1	19.1	34.9	20.3	25.1	45.9	22.7	27.8	27.6	33.0	38.0	39.3	36.5	60.7	53.1	41.1	43.6	48.4	46.6	55.1	41.1	32.6	33.3	39.0	45.7	42.2	53.0	72.6	45.3	48.1	32.1	71.0	43.5	27.0	45.5	37.4	44.3	63.1	26.8	39.6	75.4	36.0	47.4	36.8	35.8	50.5	64.2	44.4	43.2	65.2	50.5	54.6	60.8	72.4	63.2	54.2	51.1	78.2	46.5	27.2	48.3	47.3	38.6	48.8	39.2	25.0	68.8	50.6	32.0	56.3	30.1	63.6	55.1	23.8	80.0	49.5	43.5	46.3	47.3	4.7	3.8	4.1	5.2	4.3	6.4	8.3	5.8	6.5	4.6	4.5	8.7	6.0	1.9	7.5	3.9	4.8	4.0	2.6	32.8	33.6	33.8	36.8	32.9	33.4	33.6	33.6	33.4	32.8	34.9	33.0	23.2	9.6	6.8	4.6	21.4	17.6	22.7	7.0	23.9	33.6	29.6	33.8	13.5	40.0	7.9	31.3	4.2	30.5	23.7	15.9	52.8	49.4	3.5	15.3	24.2	20.7	16.3	29.8	5.7	42.0	26.3	22.3	14.8	13.3	5.7	31.7	21.4	41.1	29.3	32.0	6.2	13.4	10.2	27.1	13.2	9.4	22.1	20.8	24.9	5.6	54.2	58.8	24.7	2.5	6.1	41.7	10.8	20.7	13.3	37.2	18.5	59.2	4.9	25.7	13.1	19.5	32.5	18.6	15.9	28.5	27.3	19.4	24.4	36.2	18.6	17.9
TMEM254	"bA369J21.6, C10orf57, FLJ13263"	ENSG00000133678	"Transmembrane protein 254"	Q8TBM7	10	80078646-80092557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029105, HPA072613"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Nucleoplasm	"HPA029105: AB_2672909, HPA072613: AB_2732205"	"unprognostic (9.40e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.39e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.96e-2)"	15.2	11.9	7.9	11.1	8.3	9.4	26.5	7.3	8.3	16.0	7.0	22.6	16.3	10.7	62.1	39.5	28.0	14.0	5.7	8.0	7.0	14.8	52.8	9.4	10.4	8.0	8.7	13.0	19.0	16.5	4.4	15.6	8.5	43.1	22.3	11.2	16.6	14.2	4.4	72.3	15.4	10.4	8.3	7.8	15.0	15.5	7.5	15.4	14.8	2.9	14.6	12.4	22.7	9.3	14.4	13.8	20.0	17.2	27.1	29.7	33.4	13.5	9.3	9.0	9.7	10.6	43.5	11.0	22.1	16.9	9.3	15.2	8.9	11.5	10.0	17.5	16.5	3.0	3.8	14.3	11.2	12.8	13.0	20.3	48.6	8.9	7.3	20.6	7.7	9.1	7.9	22.9	9.4	29.8	10.7	9.9	11.0	12.6	43.2	13.2	2.8	9.7	13.5	11.9	8.0	12.1	12.6	31.4	13.3	14.8	45.1	9.1	12.1	7.8	12.8	12.0	8.0	15.8	24.7	0.8	17.8	13.6	6.6	57.3	25.0	13.0	18.1	28.6	22.3	21.3	20.2	18.8	20.7	14.3	33.8	22.6	2.8	17.5	31.5	23.1	27.2	20.5	7.9	8.3	7.3	8.3	8.0	7.0	8.0	8.7	8.5	8.3	7.5	9.3	4.6	9.6	9.6	17.6	7.3	8.2	5.9	9.7	5.2	7.9	22.6	17.5	4.4	12.8	13.7	9.2	16.7	40.9	3.8	9.0	21.5	15.7	10.5	37.6	10.0	5.4	8.4	5.9	17.2	8.7	37.2	7.6	11.2	10.5	5.7	12.9	5.7	33.4	19.4	16.8	16.4	23.7	8.2	10.3	5.8	7.5	9.3	8.5	3.6	4.7	15.2	15.7	12.3	8.5	14.8	10.3	15.3	11.7	5.2	15.6	19.6	23.1	40.2	13.3	13.1	2.6	7.1	36.8	8.7	20.9	24.0	22.7	6.9	11.2	18.1	8.4
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733528-12769457	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 219.8;skin 1: 64.7;vagina: 80.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 104.7;Cytotrophoblasts: 128.3;Macrophages: 121.3;Squamous epithelial cells: 116.5;Suprabasal keratinocytes: 201.9;Syncytiotrophoblasts: 656.6;Urothelial cells: 157.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3;urothelial cancer: 12.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 244.9;hTCEpi: 56.1;hTERT-HME1: 68.0;RT4: 36.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044165, HPA073122"	Enhanced		Approved	Cytosol		NA	NA		2500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA044165: AB_10961279, HPA073122: "	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.1	0.1	0.4	0.0	0.4	3.3	3.2	0.5	0.6	42.1	0.3	0.0	0.1	0.1	1.3	219.8	3.1	0.1	4.2	0.5	0.3	0.2	0.3	2.1	0.1	0.4	0.3	0.1	0.1	3.2	0.2	15.9	0.3	3.7	0.0	0.1	27.3	2.5	1.3	64.7	0.0	0.1	0.1	1.8	0.2	0.8	0.4	1.5	0.1	0.6	25.9	15.2	80.1	0.3	26.6	0.1	0.0	0.1	0.0	0.0	22.4	0.2	1.1	1.3	1.4	1.0	4.1	0.1	0.2	0.0	0.6	7.6	0.0	244.9	5.1	0.2	0.0	1.9	0.2	0.8	0.0	0.0	0.0	0.0	56.1	0.0	68.0	0.4	0.0	0.0	0.1	0.0	0.0	7.7	0.0	0.0	0.0	0.2	4.3	0.0	1.6	0.0	1.6	36.0	0.2	0.2	0.1	31.3	0.0	4.6	2.8	0.7	0.0	0.0	1.6	0.0	2.1	0.3	0.1	0.4	0.1	0.0	0.0	1.6	0.9	1.1	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	6.0	0.0	0.0	0.8	0.0	32.9	0.4	0.4	0.5	0.6	0.5	0.3	0.4	0.3	0.3	0.1	0.4	0.3	0.1	0.0	0.0	0.3	0.3	64.2	104.7	71.7	17.6	0.0	1.5	5.6	4.7	0.0	39.4	1.8	0.0	128.3	0.0	0.1	0.0	0.5	0.8	2.9	0.0	1.8	0.0	0.0	0.3	0.0	14.7	1.8	0.0	0.1	0.0	0.0	2.2	0.7	10.8	0.0	0.3	0.0	12.2	4.8	7.3	2.0	0.3	121.3	10.6	0.0	2.6	0.0	2.1	0.0	0.2	2.2	0.0	0.0	0.0	53.5	0.0	0.0	55.0	0.0	0.0	0.1	3.6	0.7	6.8	116.5	201.9	656.6	1.0	0.2	0.0	157.9
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059101: AB_2683905, HPA059790: AB_2684125"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	9.0	27.2	9.6	5.4	9.3	11.0	10.2	9.7	11.0	10.0	8.9	7.9	26.4	8.7	11.2	23.6	9.2	7.6	9.9	9.0	9.4	14.7	20.5	10.6	7.4	9.4	11.6	14.1	9.7	8.7	5.7	8.4	9.2	10.2	8.9	7.5	12.0	8.3	9.8	19.9	24.1	7.4	9.8	12.5	10.3	9.3	12.1	7.8	7.0	16.4	12.6	10.8	14.6	10.9	43.6	15.4	10.1	12.5	15.6	16.8	29.6	16.3	14.3	20.2	14.6	40.5	16.7	13.4	30.5	15.3	28.5	29.4	28.1	17.5	20.4	22.6	25.8	23.3	8.6	41.2	17.5	25.3	12.5	15.7	25.6	18.3	20.9	12.7	15.6	16.8	42.1	32.4	13.0	16.8	15.6	14.5	16.8	34.1	24.1	15.5	15.6	24.6	17.4	31.4	10.1	13.1	14.1	35.8	25.7	14.4	42.8	19.6	11.4	11.9	15.0	25.2	34.5	47.2	78.0	26.5	18.2	15.1	14.6	14.0	8.2	7.2	16.3	9.4	21.0	17.5	16.7	18.1	9.3	15.6	18.2	19.8	2.8	12.2	12.2	21.7	15.3	9.2	9.6	9.3	9.7	11.0	9.0	9.4	9.4	11.6	9.2	9.8	12.1	10.9	12.1	9.6	30.5	7.2	16.7	53.0	42.8	29.5	50.7	22.4	38.2	20.6	12.6	24.3	24.9	20.2	18.8	27.5	18.3	23.3	7.9	33.4	0.7	17.7	14.5	19.8	18.6	16.4	8.1	56.0	23.5	18.0	36.2	38.0	8.8	50.2	17.2	40.9	19.6	16.8	9.8	28.3	16.2	14.2	17.3	2.8	14.3	12.5	8.8	2.8	65.9	11.4	11.3	20.1	7.6	50.3	17.0	13.5	20.9	64.2	200.8	23.2	9.6	28.6	19.7	16.8	16.5	22.1	14.3	113.0	84.7	46.0	18.5	82.6	45.6	93.4
TMEM45A	"DERP7, FLJ10134"	ENSG00000181458	"Transmembrane protein 45A"	Q9NWC5	3	100492619-100577444	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skin 1: 475.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 425.3;Club cells: 841.5;Early spermatids: 207.3;Suprabasal keratinocytes: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 406.9;ASC TERT1: 118.3;HSkMC: 125.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA062101	Uncertain		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	Vesicles	"HPA062101: AB_2684682"	"unprognostic (5.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.43e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.18e-11)"	"unprognostic (1.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-5)"	"unprognostic (2.68e-2)"	19.4	18.1	1.4	11.7	3.3	2.0	42.8	1.7	2.5	38.4	2.3	10.3	3.6	18.3	3.2	16.5	20.9	18.9	21.9	1.5	1.8	3.7	99.0	13.1	2.6	1.9	1.9	11.9	23.3	2.7	22.9	40.9	1.8	9.1	6.6	1.7	26.9	6.3	3.2	475.1	6.4	25.4	1.7	5.0	7.0	13.3	1.9	1.6	9.1	2.5	50.7	19.5	79.5	2.1	28.6	2.0	2.7	9.6	406.9	118.3	0.3	66.9	62.0	9.4	84.8	2.5	0.6	0.0	32.6	44.1	24.6	31.9	2.4	13.0	23.4	7.2	8.4	23.9	9.3	8.0	25.7	0.4	1.5	125.4	7.4	17.1	25.4	39.0	3.5	0.0	0.6	3.2	22.6	0.3	0.1	0.7	3.2	0.0	16.8	0.0	23.3	0.4	0.6	1.0	2.9	19.4	16.4	8.5	7.3	18.2	0.8	13.6	9.3	62.9	44.3	0.5	15.2	53.8	32.9	0.1	49.7	1.9	42.6	0.0	0.9	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.6	1.4	3.3	1.7	2.5	1.5	1.8	1.9	1.9	1.8	1.7	1.9	2.1	1.6	60.9	61.4	0.7	3.0	94.6	5.4	425.3	9.6	3.2	19.1	8.9	2.5	1.5	841.5	0.0	0.0	2.6	0.4	0.2	0.0	7.5	207.3	3.0	79.1	8.9	1.2	1.3	0.8	14.9	46.3	56.3	2.0	2.0	65.0	10.7	15.0	137.1	5.8	8.4	2.4	2.0	63.1	6.5	25.4	25.4	16.1	6.6	23.2	13.1	1.1	3.5	0.0	16.1	11.8	6.5	2.6	27.8	26.8	3.1	0.3	0.2	121.0	0.9	6.6	22.8	56.6	1.5	3.3	5.4	254.9	7.5	6.4	26.7	0.1	4.4
TMEM54	CAC-1	ENSG00000121900	"Transmembrane protein 54"	Q969K7	1	32894594-32901438	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 268.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1231.3;Intestinal goblet cells: 357.2;Paneth cells: 800.1;Proximal enterocytes: 418.6;Undifferentiated cells: 355.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 198.9;OE19: 242.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060864, HPA061992"	Approved		Approved	Vesicles		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA060864: , HPA061992: AB_2684652"	"unprognostic (2.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.40e-2)"	19.2	15.6	68.2	39.9	64.2	0.0	24.6	61.3	98.4	59.0	52.8	268.0	116.0	40.4	26.6	145.3	25.5	62.0	18.7	64.1	70.0	44.3	14.9	26.8	4.6	70.5	68.8	20.3	31.8	49.5	22.6	18.4	64.8	58.2	113.2	4.2	54.0	22.9	6.9	116.0	123.1	21.3	67.8	13.2	108.0	11.9	65.5	2.4	47.8	4.9	13.0	51.1	78.6	66.4	133.3	33.9	0.0	32.0	59.1	35.4	119.9	20.0	29.2	43.1	55.2	84.7	198.9	0.0	57.1	24.8	55.2	80.0	28.6	107.4	12.8	158.3	6.4	0.2	11.3	4.5	42.9	0.4	2.0	30.5	96.2	66.1	18.1	29.1	19.3	13.0	18.7	0.1	22.7	135.6	0.1	2.6	10.3	242.7	60.8	17.7	52.2	0.6	16.2	159.8	1.8	17.1	14.4	82.1	44.0	19.3	89.3	24.2	39.9	42.3	47.5	95.9	40.8	5.2	12.4	15.8	30.1	3.3	61.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.2	64.2	61.3	98.4	64.1	70.0	70.5	68.8	64.8	67.8	65.5	66.4	6.4	19.2	27.6	3.9	6.6	20.4	92.3	36.9	20.5	8.2	82.0	61.0	4.7	97.2	36.9	47.8	4.2	42.8	1.3	1231.3	27.4	150.2	43.4	7.5	16.1	12.3	60.7	0.0	3.3	202.4	149.1	22.9	160.0	14.3	5.7	11.8	18.9	3.7	8.4	0.0	2.9	357.2	12.2	1.0	6.5	32.3	19.9	3.7	14.2	0.0	3.1	33.7	0.0	3.5	2.6	166.3	800.1	24.5	1.6	160.9	418.6	84.9	14.0	10.3	6.6	8.5	20.6	10.9	8.8	65.0	63.6	64.3	3.3	2.4	355.8	193.3
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 163.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Actin filaments"		"HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967"	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	12.4	19.6	18.1	9.5	18.9	17.9	12.6	18.9	24.7	17.8	15.1	24.6	17.1	11.4	12.1	34.6	10.7	12.8	26.5	25.1	21.0	17.1	39.2	38.3	5.8	19.9	17.5	12.1	12.6	20.2	15.6	13.6	20.4	17.4	19.4	31.6	20.9	8.6	51.6	41.4	18.5	9.9	15.7	9.8	25.4	31.0	19.8	8.6	16.2	21.2	8.6	18.8	23.2	18.3	41.7	23.1	21.1	34.6	32.3	18.6	34.6	17.0	22.8	18.7	17.7	16.1	15.7	7.2	25.5	25.3	30.1	37.8	25.6	62.6	12.3	20.6	19.5	20.8	17.2	49.1	22.2	4.6	19.2	24.8	55.5	26.2	16.7	37.8	18.9	15.3	67.7	11.2	22.0	42.7	4.6	10.3	11.4	163.7	11.2	5.8	14.0	13.2	52.2	44.5	24.3	18.8	15.2	35.5	35.8	26.0	40.1	11.6	21.8	23.8	27.0	17.9	20.7	14.0	11.1	8.8	35.9	6.6	30.7	0.2	0.4	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.2	0.4	0.2	18.1	18.9	18.9	24.7	25.1	21.0	19.9	17.5	20.4	15.7	19.8	18.3	7.2	16.0	19.7	17.6	3.3	13.6	14.9	41.3	21.1	18.4	11.2	9.3	3.8	10.0	25.1	11.0	16.7	14.1	4.2	75.1	1.9	17.0	72.9	10.6	8.9	6.9	18.6	28.4	26.3	15.2	16.6	11.0	45.9	25.1	0.0	11.0	11.7	43.4	26.4	16.8	28.4	32.4	30.5	11.7	11.4	87.6	11.8	9.1	7.2	15.0	8.5	9.4	5.2	21.6	12.1	32.5	45.7	9.1	6.4	21.9	32.7	10.8	15.7	27.6	6.6	10.4	12.0	2.1	14.7	19.4	18.3	20.0	5.5	7.1	24.3	29.4
TMEM79	"FLJ16057, FLJ32254, MATT, MGC13102"	ENSG00000163472	"Transmembrane protein 79"	Q9BSE2	1	156282935-156293185	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 132.4;skin 1: 89.9;vagina: 59.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 24.1;Squamous epithelial cells: 59.9;Suprabasal keratinocytes: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.2;SK-BR-3: 26.7;T-47d: 28.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA055214	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoli fibrillar center"		"HPA055214: AB_2682741"	"unprognostic (3.12e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (6.37e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.37e-1)"	2.1	2.8	5.5	1.5	6.3	2.9	4.5	6.2	7.5	34.5	5.1	2.4	2.6	2.4	2.6	132.4	2.5	1.8	1.8	5.2	5.7	2.4	3.6	1.9	2.9	6.2	6.2	2.4	2.1	6.0	3.7	1.6	6.0	28.4	1.3	1.7	23.5	2.6	2.9	89.9	2.7	1.2	5.8	3.8	2.9	2.0	6.1	3.6	2.2	0.7	10.9	6.9	59.4	7.8	12.5	7.2	2.4	4.7	1.8	1.8	5.9	3.5	1.4	6.2	2.4	8.5	3.4	2.2	7.6	0.9	2.2	10.8	2.8	5.1	2.7	8.3	3.9	2.3	3.3	2.5	3.3	2.6	3.3	1.7	30.2	4.6	4.7	4.4	1.4	8.2	10.5	14.8	2.9	14.1	7.3	4.0	3.6	9.0	5.7	8.5	2.3	5.0	1.3	3.0	4.3	4.7	4.3	26.7	7.0	2.9	28.3	7.4	3.4	11.5	3.8	4.2	9.5	11.3	13.0	5.2	8.0	6.0	8.8	0.0	2.0	3.0	1.7	0.7	1.8	1.7	1.5	1.8	1.6	2.2	2.0	2.4	3.7	1.7	1.3	2.0	2.1	1.7	5.5	6.3	6.2	7.5	5.2	5.7	6.2	6.2	6.0	5.8	6.1	7.8	1.8	3.2	1.5	8.8	3.9	13.3	1.4	24.1	9.1	3.0	10.0	6.5	1.2	2.8	14.3	1.8	2.1	7.7	3.6	2.4	1.9	2.5	0.1	3.7	2.4	2.0	3.0	0.8	1.8	3.3	1.8	2.1	1.5	6.7	0.0	3.1	2.2	2.4	3.4	8.4	2.2	2.9	10.2	2.5	1.8	0.3	1.5	1.4	5.4	3.7	4.4	1.5	1.0	2.5	5.8	4.5	2.1	0.7	1.6	10.7	4.3	1.6	4.2	2.2	0.0	1.0	1.9	1.3	2.1	59.9	33.1	7.4	3.2	2.9	3.1	6.4
TMTC3	"FLJ90492, SMILE"	ENSG00000139324	"Transmembrane O-mannosyltransferase targeting cadherins 3"	Q6ZXV5	12	88142296-88199887	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Transferase	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038550	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA038550: AB_10672715"	"unprognostic (1.05e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	5.9	4.4	3.6	3.8	3.8	1.7	6.7	5.8	4.7	5.6	2.1	4.5	5.4	6.4	5.2	9.1	3.9	5.7	3.8	3.9	4.6	8.1	9.0	5.2	2.9	3.4	3.9	5.3	3.2	6.2	2.8	10.2	4.1	7.4	4.7	7.9	3.8	6.3	1.7	12.5	4.4	9.2	3.2	3.9	3.8	4.1	3.6	4.0	6.3	4.3	4.5	6.8	4.7	4.1	13.2	14.0	12.6	11.9	28.8	25.4	22.5	28.1	26.6	15.8	16.9	20.3	9.2	4.1	5.0	25.8	9.6	28.9	13.5	22.4	26.5	2.4	10.2	4.0	9.5	9.3	15.0	4.3	2.5	21.7	12.0	30.5	12.0	16.2	24.9	3.4	8.9	1.4	17.8	7.9	3.0	5.5	9.7	5.0	7.3	2.6	27.4	4.1	13.7	21.3	10.7	10.6	22.8	16.1	7.3	13.3	25.9	4.3	26.4	21.8	12.0	19.4	13.7	4.5	6.3	4.7	6.8	5.0	16.5	7.4	1.3	2.3	1.8	1.1	2.2	2.3	2.0	1.4	0.9	1.8	2.4	2.0	1.3	1.2	1.6	0.9	1.7	0.7	3.6	3.8	5.8	4.7	3.9	4.6	3.4	3.9	4.1	3.2	3.6	4.1	15.9	12.8	8.2	19.6	6.9	34.2	24.4	29.1	24.5	12.5	11.4	8.1	11.1	5.7	20.0	7.3	27.1	29.6	3.5	6.7	3.9	14.5	26.8	23.7	22.2	16.9	3.6	9.5	51.6	10.8	18.2	23.8	8.6	21.9	9.5	12.4	15.7	19.2	8.2	13.5	46.8	5.9	75.3	5.9	6.0	18.2	20.2	3.7	8.8	20.6	2.8	8.3	2.1	28.1	42.4	12.4	4.9	19.5	4.6	18.0	7.3	13.9	34.9	23.4	19.7	17.1	22.3	12.0	8.7	32.6	40.5	17.8	5.2	14.1	7.1	14.4
TNFRSF18	"AITR, CD357, GITR"	ENSG00000186891	"TNF receptor superfamily member 18"	Q9Y5U5	1	1203508-1206592	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 189.0;dendritic cells: 72.2;Langerhans cells: 86.4;Melanocytes: 49.8;Plasma cells: 55.3;Suprabasal keratinocytes: 150.6;T-cells: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cell: 184.5;T-reg: 71.8"	"Group enriched"	"Detected in many"	11	"NK-cells: 184.5;T-cells: 71.8"	"Group enriched"	"Detected in some"	12	"RPMI-8226: 225.6;SCLC-21H: 152.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA008025	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA008025: AB_1849696"	"unprognostic (1.20e-3)"	"unprognostic (4.61e-2)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (2.73e-4)"	"prognostic favorable (4.12e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.40e-11)"	"unprognostic (1.02e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.08e-1)"	1.9	0.6	1.1	7.3	1.3	2.9	2.4	2.5	3.1	11.1	0.7	6.0	7.2	1.4	0.0	6.3	1.4	0.9	0.5	1.0	0.6	2.8	0.9	4.6	5.5	1.3	0.6	0.3	0.3	9.4	4.9	0.3	1.3	2.8	1.5	0.0	5.6	0.6	0.8	38.5	7.1	0.3	0.6	9.0	5.2	0.9	0.9	1.9	1.4	0.0	3.8	2.0	3.3	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	1.7	0.1	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	1.2	0.1	0.5	16.1	0.1	0.1	225.6	0.3	0.0	152.8	0.2	0.0	0.6	0.0	0.0	8.2	0.1	0.0	0.0	0.3	0.2	0.0	0.9	0.3	0.2	0.6	0.1	0.0	0.2	0.2	0.0	6.8	0.1	12.6	4.6	28.9	4.4	0.1	11.5	0.9	1.5	0.8	184.5	0.1	0.3	71.8	6.7	1.1	1.3	2.5	3.1	1.0	0.6	1.3	0.6	1.3	0.6	0.9	1.2	11.2	0.0	1.3	0.3	23.5	189.0	12.5	15.5	16.5	0.0	5.0	3.0	2.9	0.0	3.2	0.0	0.0	0.0	72.2	0.3	0.0	0.8	0.0	1.2	1.2	4.1	3.5	0.0	2.0	0.6	1.3	4.7	1.1	2.9	45.7	0.0	0.7	0.0	0.8	0.0	0.3	0.2	20.3	0.3	86.4	0.0	0.0	5.4	49.8	0.0	12.7	0.0	21.6	0.5	0.3	0.4	0.0	0.0	55.3	10.1	0.1	0.1	0.8	0.0	0.0	6.2	2.2	0.0	0.0	0.3	150.6	0.0	75.7	0.0	0.8	7.0
TNKS1BP1	"FLJ45975, KIAA1741, TAB182"	ENSG00000149115	"Tankyrase 1 binding protein 1"	Q9C0C2	11	57299638-57324952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037929, HPA037930"	Enhanced		Uncertain	"Plasma membrane"		NA	NA		180000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"HPA037929: AB_10672613, HPA037930: AB_2675745"	"unprognostic (7.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-1)"	"unprognostic (9.17e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (2.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.07e-1)"	62.7	27.3	11.8	17.3	10.2	3.3	41.9	4.6	9.4	43.3	18.0	23.6	28.8	40.3	30.3	55.4	35.3	28.1	23.3	11.3	9.2	14.7	31.6	40.3	6.6	9.6	8.8	32.2	30.9	18.9	17.1	29.5	7.2	33.6	16.2	3.3	44.2	40.2	67.2	83.0	26.6	29.4	4.9	18.1	52.8	10.1	11.0	22.3	25.0	29.9	14.3	38.5	45.6	6.7	89.5	58.7	41.2	33.6	127.8	97.1	31.0	61.5	113.8	46.3	42.5	26.1	59.5	2.0	38.5	101.2	49.6	151.7	31.4	105.3	30.1	34.2	10.4	11.5	38.2	12.2	86.6	14.4	4.3	96.8	123.5	70.9	54.6	57.5	60.0	12.4	13.2	9.3	65.3	45.4	11.0	14.7	45.8	46.5	45.9	16.9	57.2	25.9	53.5	116.6	14.6	22.6	81.5	121.5	44.3	29.0	182.2	11.9	115.1	47.3	45.8	56.6	35.2	15.0	4.1	11.3	107.0	4.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.8	10.2	4.6	9.4	11.3	9.2	9.6	8.8	7.2	4.9	11.0	6.7	38.1	12.8	35.4	12.7	1.9	83.6	28.0	61.9	40.9	4.8	24.8	23.9	7.9	38.6	39.0	44.1	2.1	16.8	1.3	27.3	0.0	31.8	1.8	18.5	25.4	25.9	18.0	7.4	7.2	22.3	3.2	31.2	49.5	38.4	2.5	3.7	19.6	46.0	3.9	8.4	4.8	25.8	18.3	1.5	25.4	2.9	48.1	3.8	17.8	1.9	0.7	4.0	0.0	4.5	2.4	38.8	14.3	49.2	0.6	41.2	18.2	2.4	15.4	1.3	32.9	41.2	26.9	1.5	3.0	68.9	88.2	24.5	2.3	23.4	14.5	36.8
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132698-55149206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	29	"skeletal muscle: 21567.3;tongue: 13372.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 61.2;Basal squamous epithelial cells: 47.8;Cardiomyocytes: 51.5;Skeletal myocytes: 192.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 211.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 211.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 829.4;RH-30: 638.8"	"Region enriched"	"Detected in many"	5	"thalamus: 125.0"	"Region enhanced"	"Detected in all"		"thalamus: 23.1"	"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		79000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavorable (4.66e-4)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	5.7	1.2	42.1	0.4	45.7	3.3	5.0	44.3	55.4	1.9	36.4	2.7	1.0	1.1	1.0	593.5	8.4	1.0	256.7	43.9	38.9	1.3	2.5	8.3	0.4	36.7	41.4	1.5	2.5	2.3	8.5	6.0	38.5	200.4	0.6	0.6	171.2	0.4	21567.3	48.5	2.0	0.4	35.6	1.9	1.9	10.6	40.8	3.4	3.8	13372.6	2.0	1.7	5.8	40.8	178.4	102.3	1.0	22.4	0.0	1.7	33.3	8.0	30.1	11.1	32.7	37.9	115.8	2.6	66.5	3.2	88.8	88.5	24.0	76.0	9.4	11.8	192.2	33.6	11.8	6.7	3.7	2.7	829.4	36.6	121.3	3.4	127.0	125.7	0.5	35.1	171.7	158.6	10.3	168.0	3.4	0.3	21.4	45.0	202.1	113.9	638.8	21.2	26.5	5.8	6.6	49.3	10.7	1.3	57.9	8.5	106.3	102.7	2.9	163.6	238.9	6.5	12.4	1.2	7.0	8.8	171.8	26.4	50.9	2.4	39.4	211.5	0.3	21.7	0.3	0.2	0.3	0.3	37.4	0.4	0.3	0.4	1.9	0.6	10.2	0.9	0.1	12.2	42.1	45.7	44.3	55.4	43.9	38.9	36.7	41.4	38.5	35.6	40.8	40.8	0.0	0.0	0.0	0.7	0.3	61.2	0.6	25.1	47.8	4.5	0.5	5.3	51.5	0.0	2.8	0.0	0.0	2.2	0.0	0.5	0.0	2.1	2.1	9.7	0.3	2.6	2.4	2.7	0.4	0.0	18.0	18.8	0.0	3.4	0.0	22.1	1.4	0.0	12.9	0.0	0.7	0.3	0.0	13.2	3.8	10.7	0.3	8.9	3.6	0.0	25.8	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.7	0.0	192.0	3.5	4.3	34.1	2.5	30.4	3.6	1.6	1.2	0.8	0.2
TPD52	"D52, hD52, N8L"	ENSG00000076554	"Tumor protein D52"	P55327	8	80034745-80231232	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 187.6"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 50.5"	"Group enriched"	"Detected in many"	5	"B-cells: 50.5;NK-cells: 15.1;T-cells: 22.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 252.6;SK-BR-3: 572.5"									"HPA028427, HPA062167"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		310000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	"Golgi apparatus"	"HPA028427: AB_10610561, HPA062167: AB_2684704"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.77e-3)"	"unprognostic (8.24e-2)"	"unprognostic (3.75e-1)"	"unprognostic (7.99e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-2)"	5.4	9.2	34.9	28.4	40.2	8.9	75.9	34.2	69.4	19.6	36.6	117.7	98.9	9.9	56.2	34.9	15.3	31.1	11.7	42.9	35.4	46.5	30.7	19.8	44.0	33.2	37.1	2.4	41.8	27.4	34.3	22.9	36.3	104.8	129.7	187.6	80.7	18.3	8.6	46.9	100.3	10.4	32.8	16.0	84.1	5.2	53.3	15.5	64.5	9.8	56.2	20.9	20.2	48.1	131.8	34.9	1.6	23.0	0.0	0.0	51.7	8.6	12.9	34.7	17.1	18.0	37.4	189.9	45.2	0.8	25.5	52.5	52.7	36.3	24.6	23.8	44.2	26.8	46.9	29.4	0.2	8.6	0.7	0.0	25.2	0.1	12.2	21.6	2.0	128.9	0.4	252.6	0.1	43.6	42.6	39.4	11.7	148.8	86.0	0.3	0.7	122.0	60.7	31.6	64.9	44.1	40.1	572.5	110.7	51.0	55.9	34.2	2.1	0.0	35.2	0.6	30.8	94.1	87.1	155.2	22.5	0.2	2.6	0.6	0.1	5.5	12.7	0.1	22.0	50.5	12.4	11.1	2.5	44.7	8.1	9.3	0.5	15.1	0.1	5.2	9.1	8.3	34.9	40.2	34.2	69.4	42.9	35.4	33.2	37.1	36.3	32.8	53.3	48.1	17.3	44.8	67.8	10.4	133.6	80.7	89.6	83.4	51.2	171.1	105.6	54.2	22.2	82.9	78.1	66.2	118.9	98.9	28.6	230.9	170.2	112.8	20.6	25.2	8.4	26.2	169.9	11.6	85.4	79.6	116.9	6.7	97.3	72.8	1.3	15.3	25.7	40.6	13.1	32.0	53.9	331.9	476.0	14.6	24.2	13.0	1.2	10.8	104.9	37.5	91.2	50.3	60.8	69.9	181.0	79.7	317.5	1.5	270.5	214.4	132.3	135.3	21.4	232.2	0.0	49.6	8.3	1.6	18.2	91.4	124.6	231.2	51.3	0.3	247.1	135.4
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225890	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 168.9;skeletal muscle: 262.4;tongue: 202.6"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.0;Cardiomyocytes: 262.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"	Nucleoplasm	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favorable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	26.0	13.1	23.0	17.1	26.2	18.2	18.0	28.5	27.7	13.7	27.8	27.1	34.5	12.2	10.4	29.3	19.8	26.9	168.9	24.2	19.5	20.1	15.3	24.1	22.8	24.4	30.3	8.5	13.1	32.2	17.7	15.3	21.6	15.4	25.4	96.7	44.1	13.1	262.4	45.1	42.0	16.8	19.1	22.2	61.0	12.1	26.0	17.9	31.4	202.6	22.6	33.8	18.4	21.4	22.2	19.2	37.9	16.4	25.6	24.9	48.9	29.5	33.5	19.0	20.6	12.8	30.7	43.9	15.1	75.2	20.4	10.7	26.5	68.8	20.6	39.6	18.8	30.4	19.9	35.6	12.8	34.6	22.9	21.4	28.9	41.9	38.0	28.1	38.6	11.6	15.7	34.4	24.4	9.2	3.7	18.1	16.4	60.4	14.8	16.1	14.1	36.8	26.3	165.3	23.8	27.9	11.3	16.3	16.2	31.4	14.6	29.3	39.6	16.6	19.2	99.0	17.4	25.7	23.0	38.9	18.2	30.2	16.4	0.9	1.3	0.5	0.6	2.4	0.5	2.4	0.9	0.7	1.5	3.6	0.3	0.9	0.6	1.0	1.4	2.5	0.4	0.7	23.0	26.2	28.5	27.7	24.2	19.5	24.4	30.3	21.6	19.1	26.0	21.4	27.4	32.1	32.4	173.0	23.9	38.0	16.3	32.1	30.1	22.7	18.5	17.7	262.0	24.3	38.1	14.7	100.1	23.0	13.9	61.4	1.9	10.8	1.1	53.3	21.8	23.9	22.8	6.5	62.0	12.3	18.3	14.0	81.1	70.0	10.8	11.5	6.8	10.3	15.7	33.7	81.3	39.5	26.4	15.7	33.4	3.0	1.8	23.3	24.9	97.4	17.9	27.8	4.1	105.1	64.8	24.2	37.1	2.6	5.4	18.5	97.9	10.2	80.6	139.9	32.9	15.9	29.9	1.0	3.9	27.5	43.2	15.7	7.5	4.6	35.6	27.0
TRAPPC9	"IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120"	ENSG00000167632	"Trafficking protein particle complex 9"	Q96Q05	8	139727725-140458579	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 89.5;Excitatory neurons: 121.8;Inhibitory neurons: 136.3;Late spermatids: 119.0;Microglial cells: 105.9;Oligodendrocyte precursor cells: 93.5;Oligodendrocytes: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026579			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA026579: AB_1854459"	"unprognostic (1.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.11e-6)"	"unprognostic (2.09e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.62e-1)"	8.6	13.4	10.3	6.9	11.0	11.1	8.9	10.7	12.7	10.3	12.5	11.1	8.0	11.3	5.1	12.3	12.2	5.8	15.0	10.8	10.3	13.8	11.6	9.5	8.0	13.1	14.1	10.5	11.9	27.4	20.7	7.2	13.9	11.7	6.0	14.2	11.6	8.3	33.5	11.4	10.9	7.2	10.2	11.3	12.5	9.0	11.9	11.3	12.9	17.6	6.8	11.1	10.8	13.0	9.6	16.6	7.4	20.8	15.5	9.0	4.9	6.0	9.9	3.1	5.0	6.2	11.2	11.6	14.0	11.9	4.7	12.2	10.0	9.4	3.4	16.8	6.1	18.6	9.8	6.2	11.2	4.7	14.5	8.9	9.3	2.5	7.9	11.1	12.9	13.1	6.7	10.1	5.1	27.0	29.2	6.2	2.3	31.3	14.0	12.2	2.7	19.4	11.6	11.6	19.1	10.6	9.8	4.7	10.6	7.6	15.3	6.8	7.7	4.6	7.9	10.8	4.9	14.1	10.9	7.8	9.6	10.1	7.4	15.4	3.5	2.9	4.2	3.3	4.6	2.7	2.9	3.3	3.5	4.4	2.8	3.6	5.0	4.9	3.4	4.2	2.1	3.5	10.3	11.0	10.7	12.7	10.8	10.3	13.1	14.1	13.9	10.2	11.9	13.0	5.1	3.2	8.3	89.5	9.6	2.3	4.7	3.1	5.7	14.2	5.5	4.1	13.9	5.7	5.3	11.0	20.9	10.9	5.4	15.2	9.8	6.5	47.9	8.4	3.7	6.5	30.5	3.4	121.8	6.2	4.4	5.3	29.6	10.2	8.8	7.9	4.6	9.2	7.5	28.6	136.3	14.4	10.2	10.5	3.7	119.0	5.9	10.3	10.6	105.9	5.3	13.6	11.3	93.5	170.6	5.1	6.6	7.9	11.0	3.7	13.4	19.9	15.7	13.7	6.6	9.0	5.3	3.6	6.6	8.7	3.0	14.6	10.5	8.6	12.0	5.4
TRIM69	"RNF36, Trif, TRIMLESS"	ENSG00000185880	"Tripartite motif containing 69"	Q86WT6	15	44728988-44767829	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 213.2;Late spermatids: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 4.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4;U-266/70: 8.2;U-266/84: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028894	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA028894: AB_10603136"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.72e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.49e-2)"	0.8	0.8	5.2	0.4	5.2	0.2	0.8	4.7	7.1	0.9	4.5	1.2	0.4	0.6	0.4	0.7	0.8	0.5	2.8	5.0	5.1	1.6	1.5	1.3	0.9	5.2	5.0	0.8	0.4	0.3	1.5	0.2	5.1	0.8	0.5	0.6	0.8	0.2	5.9	1.0	1.3	0.6	5.0	2.4	0.7	35.0	5.0	0.5	0.6	6.0	1.2	0.7	0.8	5.4	0.1	0.1	0.2	0.6	0.2	0.7	0.0	0.1	0.3	0.8	1.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.7	0.0	0.2	0.1	0.0	0.7	0.0	0.1	0.9	0.6	0.1	0.1	1.1	0.2	0.7	0.0	2.4	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.2	8.2	2.3	1.4	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.6	0.8	0.9	0.0	0.0	0.2	0.6	0.1	0.0	0.2	0.0	4.2	0.1	5.2	5.2	4.7	7.1	5.0	5.1	5.2	5.0	5.1	5.0	5.0	5.4	41.8	6.4	5.1	9.4	22.1	21.3	21.3	8.0	12.0	10.8	9.3	9.1	60.2	8.6	11.0	9.2	4.2	6.1	20.4	16.5	41.1	42.1	213.2	9.0	12.2	22.2	4.2	5.7	16.0	16.0	4.2	17.8	13.7	10.6	14.0	10.5	11.4	5.1	36.3	23.5	9.8	7.5	8.2	25.4	39.7	93.9	9.3	22.6	12.4	1.0	52.7	21.2	20.6	9.5	1.7	14.8	13.4	11.7	21.9	11.4	18.6	27.0	8.8	4.2	6.6	27.0	19.7	78.8	1.7	25.0	41.2	1.5	25.6	5.1	7.0	52.5
TSEN34	"LENG5, SEN34, SEN34L"	ENSG00000170892	"TRNA splicing endonuclease subunit 34"	Q9BSV6	19	54189938-54194536	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Disease variant, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.0;eosinophil: 1.9;neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041111, HPA048208"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA041111: AB_10794263, HPA048208: AB_2680313"	"unprognostic (3.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (2.38e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.12e-1)"	28.5	68.2	2.2	1.3	1.8	1.3	29.5	2.4	2.4	38.8	1.8	34.7	1.1	37.1	1.9	41.0	37.8	1.5	26.3	2.1	1.7	39.1	41.3	31.5	1.3	2.2	1.7	47.9	43.0	1.8	36.0	1.3	2.0	36.2	1.3	2.0	34.0	1.9	26.7	40.5	27.7	1.2	1.3	44.1	34.3	45.0	1.7	0.5	30.9	1.8	0.7	38.9	34.2	2.2	3.3	1.7	2.5	3.1	1.3	2.0	3.9	0.6	1.0	0.9	1.7	2.1	1.1	1.1	0.0	0.9	2.5	2.5	2.6	2.3	1.4	1.1	6.2	1.0	1.1	2.0	0.5	1.1	1.1	1.9	1.1	2.0	1.3	0.9	1.3	0.0	1.7	0.9	2.4	1.4	0.4	0.2	1.5	2.9	1.1	1.4	2.6	0.7	3.4	2.4	0.1	1.7	0.0	3.5	3.0	2.5	2.6	3.1	1.1	0.2	2.8	2.7	3.4	1.4	1.9	0.9	2.6	1.3	1.2	5.0	0.6	1.9	0.2	0.5	0.4	0.1	0.3	0.1	0.3	0.4	0.4	0.2	4.8	0.0	0.3	0.4	0.0	0.2	2.2	1.8	2.4	2.4	2.1	1.7	2.2	1.7	2.0	1.3	1.7	2.2	33.1	12.8	27.7	6.8	28.2	73.5	92.0	137.7	67.2	35.4	62.9	60.8	11.8	52.9	60.9	44.1	29.2	102.5	45.4	58.8	95.9	68.7	24.0	39.4	37.0	32.5	76.8	13.7	3.8	59.7	98.2	47.5	19.9	35.3	26.6	47.7	35.7	40.6	57.8	16.8	4.9	103.7	122.1	37.0	53.6	17.2	67.7	45.0	46.2	1.0	51.8	81.9	18.6	6.0	5.9	50.4	55.9	66.5	27.6	79.8	57.8	110.5	70.0	48.9	59.2	38.7	60.8	40.1	77.2	56.7	70.2	111.0	32.8	100.3	66.5	62.3
TSPAN5	"NET-4, TM4SF9, Tspan-5"	ENSG00000168785	"Tetraspanin 5"	P62079	4	98470367-98658611	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 175.4;Excitatory neurons: 362.2;Inhibitory neurons: 248.3;Microglial cells: 195.8;Oligodendrocytes: 587.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	37	"B-cells: 3.0;NK-cells: 3.8;T-cells: 6.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 120.8;BJ hTERT+: 121.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.83e-5)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.23e-1)"	2.7	1.2	32.5	3.8	37.2	10.4	15.4	62.0	42.7	13.5	21.6	6.4	1.5	19.9	29.2	12.9	7.2	5.0	3.2	41.4	33.5	5.1	0.6	4.3	6.7	32.8	30.8	46.4	0.9	4.0	5.1	7.9	34.5	5.3	3.8	28.1	10.8	8.7	3.8	20.0	3.0	16.4	32.4	9.9	8.9	12.6	33.7	8.5	18.5	3.2	9.2	8.8	9.7	47.4	27.8	10.8	11.0	0.7	41.2	120.8	3.7	111.9	121.4	39.4	48.3	9.6	14.6	0.0	1.1	40.2	21.6	7.0	9.6	52.6	87.7	34.3	5.2	16.9	1.5	0.4	42.5	9.5	0.9	70.1	1.6	72.5	89.1	60.5	64.5	11.3	6.6	29.1	95.3	0.7	29.1	0.1	7.2	23.8	49.2	8.8	10.5	4.2	3.5	8.1	77.5	14.8	2.0	35.4	0.2	3.7	1.2	1.4	66.4	82.7	37.4	29.8	39.9	20.0	31.8	0.0	32.4	22.5	28.8	0.0	0.0	0.0	3.3	0.0	3.6	1.3	4.7	4.7	0.1	3.0	2.4	1.6	0.1	3.8	0.0	0.0	6.0	1.1	32.5	37.2	62.0	42.7	41.4	33.5	32.8	30.8	34.5	32.4	33.7	47.4	4.6	22.4	9.1	129.3	5.6	22.0	24.8	9.1	10.8	63.9	30.9	26.0	2.3	0.0	9.3	29.5	27.1	1.0	17.2	1.4	5.9	2.3	69.6	8.5	45.9	19.7	80.9	175.4	362.2	7.1	0.9	26.0	10.2	15.1	2.5	11.6	8.2	0.9	2.3	111.0	248.3	4.6	20.3	3.4	15.4	91.4	46.0	7.1	28.4	195.8	0.3	21.5	39.1	94.5	587.2	25.3	0.5	17.0	9.3	45.9	0.4	0.6	3.7	41.9	6.6	9.7	13.1	10.1	4.1	33.0	57.7	2.9	31.4	79.7	3.8	44.8
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2 ribosome maturation factor"	Q969E8	X	54440404-54448032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	35.2	45.1	50.9	11.2	49.9	11.9	35.6	43.4	59.4	36.8	39.3	42.2	10.2	34.9	23.0	34.6	32.2	7.7	45.5	46.2	52.9	43.8	36.7	30.4	12.6	48.9	48.0	34.6	30.2	25.0	47.1	14.6	47.3	33.3	13.3	27.4	32.6	16.9	51.7	40.7	31.3	13.2	50.3	32.4	38.8	16.5	50.6	14.9	41.1	18.6	15.8	36.3	35.0	47.8	24.1	26.6	23.9	20.6	19.9	13.0	18.7	22.4	17.5	19.6	17.3	26.2	24.1	23.5	15.8	18.2	35.7	24.9	47.9	28.3	24.8	29.8	26.8	19.3	20.8	19.6	12.5	32.7	19.4	12.9	18.0	26.4	27.1	19.7	13.8	22.9	20.5	16.9	19.3	37.9	27.4	29.9	34.6	23.6	33.0	26.5	38.2	19.6	20.6	18.3	25.9	20.5	42.1	19.9	28.0	38.0	45.4	14.7	21.0	16.2	27.1	38.0	19.9	19.8	32.3	29.7	24.4	27.5	23.2	29.7	16.6	32.0	36.3	23.1	30.0	44.8	34.0	33.6	15.1	46.3	42.6	32.3	10.4	29.7	26.0	16.7	40.8	24.9	50.9	49.9	43.4	59.4	46.2	52.9	48.9	48.0	47.3	50.3	50.6	47.8	39.1	25.6	30.2	1.6	39.8	32.8	43.0	42.7	26.7	61.6	27.4	28.6	49.0	28.6	38.6	35.0	27.1	98.5	36.0	26.3	125.2	43.9	1.2	17.7	23.7	35.6	18.1	18.1	5.7	32.9	71.5	33.8	16.8	22.9	45.0	20.3	31.8	25.2	46.6	57.2	5.6	35.5	61.1	18.2	31.4	2.8	34.8	24.6	40.9	6.5	48.6	85.6	44.3	2.5	6.5	38.1	29.5	45.1	22.3	36.7	32.6	64.6	33.8	67.0	46.0	29.8	38.0	20.5	43.3	25.4	31.7	75.9	37.8	36.2	30.9	33.9
TSSK6	"CT72, FLJ24002, SSTK"	ENSG00000178093	"Testis specific serine kinase 6"	Q9BXA6	19	19512418-19515548	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"testis: 167.6"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 8709.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.4;CACO-2: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.39e-1)"	"unprognostic (7.20e-5)"	"unprognostic (3.38e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-4)"	"unprognostic (2.28e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.89e-2)"	0.6	0.7	0.4	0.0	0.6	0.1	0.7	0.5	0.5	0.4	0.1	0.7	0.5	0.8	0.0	0.7	0.6	0.0	0.3	0.3	0.2	0.9	1.2	0.4	0.3	0.7	0.6	0.5	1.0	0.0	0.7	0.0	0.7	0.9	0.0	0.0	0.6	0.0	0.3	1.6	1.0	0.0	0.6	1.2	0.9	167.6	0.5	0.1	0.9	0.0	0.1	0.6	0.6	1.0	0.0	0.6	0.0	0.0	0.0	0.1	3.4	0.1	0.2	0.0	0.1	1.7	0.0	0.7	0.1	0.0	0.0	0.4	0.1	0.6	0.0	0.5	0.0	0.4	0.4	0.0	0.4	0.4	0.7	0.3	0.1	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.3	0.7	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.5	0.2	0.9	0.2	0.8	0.6	0.0	0.7	0.4	0.9	0.0	0.1	0.3	0.1	0.0	0.1	0.7	0.0	0.2	0.0	0.1	0.8	0.4	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.6	0.5	0.5	0.3	0.2	0.7	0.6	0.7	0.6	0.5	1.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.3	0.1	1.7	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1462.5	0.5	0.4	2.7	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.8	0.0	0.1	0.7	0.5	0.1	0.0	0.0	0.0	2.0	0.8	0.5	8709.8	47.8	2.2	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	57.2	0.1	0.1	0.5	0.2	0.3	0.0	19.7	1.1	0.3	57.7	25.7	0.0	0.1	0.1	0.2	0.0	0.1	0.1
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715861-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	8.9	8.8	21.2	5.3	21.8	2.0	10.4	22.0	24.7	10.4	20.4	9.7	5.6	8.5	8.1	10.6	9.1	3.9	16.5	21.7	22.2	11.0	10.2	5.6	7.2	22.2	22.2	12.5	11.7	11.7	12.8	7.7	22.3	8.8	6.3	9.0	9.1	8.3	33.7	10.3	8.0	7.6	22.5	6.6	10.8	8.6	22.0	12.8	8.0	22.2	8.9	11.0	10.1	23.9	24.3	18.2	20.1	10.9	29.2	16.6	17.9	32.6	16.0	39.8	26.6	20.5	6.9	40.1	17.4	22.4	42.2	13.1	43.7	31.1	41.6	38.2	31.7	38.4	7.7	11.9	27.4	32.4	10.6	16.1	30.4	58.2	34.9	17.8	17.3	31.3	45.5	6.3	22.7	11.3	30.0	18.3	41.0	29.1	30.9	27.1	43.0	22.5	19.9	6.5	13.5	9.7	28.4	13.8	27.2	33.0	13.2	16.5	17.4	19.5	21.2	20.5	44.9	16.1	29.9	34.0	25.9	36.5	20.8	7.3	12.3	10.3	13.9	14.0	14.8	12.6	11.1	13.3	13.5	12.6	15.9	14.3	0.2	18.9	15.1	11.2	11.8	13.0	21.2	21.8	22.0	24.7	21.7	22.2	22.2	22.2	22.3	22.5	22.0	23.9	3.7	9.6	2.6	0.0	6.2	1.1	3.4	2.1	7.4	4.5	3.1	3.3	3.2	1.5	5.2	0.0	0.0	3.9	2.4	1.5	0.0	3.5	0.5	4.7	8.8	3.4	1.2	3.0	0.0	4.2	2.4	5.4	3.6	4.5	7.0	3.0	3.9	2.4	1.4	5.0	0.0	1.3	0.0	0.6	1.5	0.7	4.1	2.7	1.8	0.0	5.9	2.3	6.2	0.0	0.0	3.9	1.7	2.6	6.1	3.0	2.0	6.4	2.6	3.8	0.0	3.8	3.5	9.2	8.2	5.7	1.6	1.4	4.6	1.9	2.5	1.8
TULP4	"KIAA1397, TUSP"	ENSG00000130338	"TUB like protein 4"	Q9NRJ4	6	158232236-158511828	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 32.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Oligodendrocytes: 544.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005445	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA005445: AB_1080421"	"unprognostic (6.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.65e-2)"	2.4	2.5	27.1	2.1	32.7	1.1	3.1	15.0	16.1	2.8	0.0	2.5	4.0	3.0	2.8	3.5	2.1	2.2	2.6	15.2	13.1	3.1	2.3	2.7	3.1	16.1	23.9	2.5	2.7	5.0	4.6	2.6	10.8	2.4	2.0	7.0	3.1	2.4	6.3	6.0	4.3	2.4	14.8	2.9	3.0	4.0	19.3	3.2	4.6	3.6	3.0	2.4	3.0	27.1	2.7	5.7	4.1	9.1	7.2	4.5	8.6	2.6	3.7	2.4	2.9	8.4	1.7	7.4	2.5	5.3	7.0	4.7	4.9	6.4	4.4	4.8	2.7	3.7	4.2	8.7	5.2	3.4	3.9	3.5	7.3	4.0	8.3	8.7	6.2	7.0	5.8	11.3	6.8	4.1	3.5	3.9	2.8	3.2	2.6	7.4	9.8	4.7	4.0	4.3	7.9	9.8	7.5	11.1	8.0	3.9	6.5	4.5	10.0	6.2	7.4	9.2	10.1	7.7	10.1	6.2	5.9	2.6	7.8	0.3	1.4	0.0	1.8	1.5	2.4	1.8	2.1	2.4	0.9	1.9	1.5	1.7	0.1	1.3	2.1	3.2	2.9	1.6	27.1	32.7	15.0	16.1	15.2	13.1	16.1	23.9	10.8	14.8	19.3	27.1	27.0	3.2	25.4	62.7	25.8	21.4	16.4	12.3	16.5	51.2	31.3	22.5	52.8	12.8	20.6	25.8	171.0	29.4	25.9	16.5	15.6	18.0	5.3	46.5	51.2	25.7	20.4	7.8	157.3	15.7	8.9	20.0	13.7	51.6	5.1	17.7	16.8	15.2	12.9	158.2	153.4	13.3	8.2	17.9	10.7	8.4	28.3	15.4	16.0	76.8	13.0	16.1	14.4	137.2	544.9	22.5	15.3	41.8	24.7	20.8	53.2	26.0	18.8	79.8	13.1	33.9	26.8	21.8	33.5	19.6	39.2	18.9	21.1	52.4	17.3	23.6
UBAP2	"bA176F3.5, FLJ22435, KIAA1491"	ENSG00000137073	"Ubiquitin associated protein 2"	Q5T6F2	9	33921693-34048949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021684	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA021684: AB_2211887"	"unprognostic (2.71e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-3)"	"prognostic favorable (1.95e-4)"	"unprognostic (8.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.77e-2)"	12.2	25.7	12.5	8.2	12.9	17.2	12.8	17.3	13.4	15.5	5.3	13.8	8.7	13.0	8.8	19.1	11.4	6.6	15.3	9.5	13.7	14.9	11.1	13.2	10.4	9.4	9.5	15.2	15.4	9.3	11.0	11.8	9.7	14.3	12.1	9.9	13.1	6.7	37.8	22.2	10.8	10.3	6.8	10.9	14.0	32.5	13.6	13.9	15.8	20.5	12.1	12.5	15.2	12.9	40.5	36.5	25.9	32.9	25.2	22.0	31.2	31.8	19.6	32.1	31.0	49.9	21.0	46.8	9.8	26.7	24.7	23.1	43.9	34.9	35.5	34.8	21.5	26.2	47.2	55.0	20.5	59.6	40.3	20.4	28.8	40.8	28.2	16.7	26.3	28.3	36.5	37.6	29.4	26.9	44.6	100.4	27.7	22.6	28.5	34.1	16.0	29.9	31.2	30.1	26.5	18.4	37.6	30.3	9.4	25.8	26.9	26.3	30.9	19.0	25.5	22.8	35.7	14.5	32.3	49.3	20.9	22.5	48.3	1.6	2.7	3.0	2.2	3.1	4.7	2.7	2.7	3.2	3.1	1.4	2.4	3.3	1.6	4.5	7.2	4.1	3.3	2.3	12.5	12.9	17.3	13.4	9.5	13.7	9.4	9.5	9.7	6.8	13.6	12.9	23.8	54.5	23.1	56.8	15.0	28.2	23.8	21.0	27.3	28.7	25.3	26.2	59.9	8.6	32.4	12.9	60.5	44.4	24.7	28.1	3.9	20.0	102.8	52.5	30.3	28.6	25.1	20.8	46.8	19.8	36.3	23.7	32.6	68.8	14.5	36.2	11.7	14.0	16.6	16.8	48.3	30.4	14.2	17.0	21.4	85.0	30.4	17.1	26.6	33.7	19.0	12.5	16.5	50.8	46.3	27.0	26.8	24.5	28.4	24.9	12.3	15.9	24.1	27.0	26.3	27.4	22.6	81.0	70.4	25.9	31.1	72.9	22.3	68.4	29.6	23.7
UBTF	"NOR-90, UBF, UBF1, UBF2"	ENSG00000108312	"Upstream binding transcription factor"	P17480	17	44205033-44221626	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004611, HPA006385"	Supported	Supported	Enhanced	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"		"CAB004611: AB_671403, HPA006385: AB_1080447"	"unprognostic (1.37e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.96e-3)"	"unprognostic (5.44e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	34.8	36.5	36.2	44.8	33.7	54.9	35.4	38.2	37.1	50.6	30.1	49.4	33.6	50.8	27.5	41.8	41.9	32.5	38.8	35.5	32.7	38.1	36.1	32.3	67.6	34.0	34.5	41.6	41.4	38.2	33.8	29.2	32.2	41.6	28.2	23.1	37.7	40.8	63.7	47.4	42.5	36.3	31.6	49.8	34.7	20.8	34.9	73.6	46.4	36.6	51.7	45.1	41.8	35.0	69.1	104.3	77.3	93.2	49.6	56.5	72.3	70.6	46.7	70.1	52.0	50.7	54.8	250.0	69.3	65.3	51.9	63.6	99.1	59.2	57.9	145.3	109.5	100.5	73.8	83.7	32.5	192.1	85.7	56.9	52.2	44.6	65.6	67.2	58.9	108.8	117.4	75.9	58.9	113.7	188.3	75.0	73.7	46.6	81.6	184.0	104.3	112.0	40.4	54.5	119.5	90.3	70.4	62.2	54.2	47.9	89.9	120.8	75.5	109.9	133.1	65.1	95.0	66.6	61.7	151.1	64.8	86.0	100.1	9.6	5.7	6.1	15.5	6.3	16.7	11.7	10.8	16.2	6.7	14.1	12.2	13.1	9.7	15.7	11.6	12.7	10.0	11.3	36.2	33.7	38.2	37.1	35.5	32.7	34.0	34.5	32.2	31.6	34.9	35.0	41.4	41.7	42.1	14.7	57.5	20.5	19.6	17.9	57.5	88.8	31.0	29.6	44.5	35.8	32.2	38.6	79.2	30.9	60.3	41.7	35.2	27.2	2.3	39.3	57.7	42.7	47.3	61.2	8.5	40.8	40.7	38.9	23.9	48.1	31.7	43.1	32.5	26.5	25.9	26.9	8.2	32.5	12.2	18.4	13.3	3.6	36.7	27.4	23.2	8.4	38.1	33.9	54.6	3.5	10.6	28.1	30.7	50.8	42.2	17.4	26.7	25.4	26.5	57.6	52.6	48.5	45.9	5.3	44.0	52.1	24.3	32.7	53.1	40.2	32.8	11.8
URI1	"C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI"	ENSG00000105176	"URI1 prefoldin like chaperone"	O94763	19	29923644-30016612	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Protein phosphatase inhibitor, Repressor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 499.7;Late spermatids: 514.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071709	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA071709: AB_2686434"	"unprognostic (4.22e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	25.0	30.6	29.7	24.8	39.6	36.4	36.7	57.8	40.7	27.9	21.0	26.1	23.5	34.2	32.3	28.5	30.2	25.1	28.1	25.0	36.8	25.6	30.5	22.9	39.9	35.9	32.3	44.1	21.9	31.4	11.0	24.1	34.5	37.7	32.1	32.4	27.2	30.4	52.8	44.9	23.4	22.8	28.4	30.0	25.0	51.6	30.9	31.7	55.4	36.2	37.3	24.8	10.7	45.6	64.8	85.9	39.5	61.7	27.5	39.8	66.5	41.3	34.4	29.5	33.7	45.4	41.5	99.7	79.4	48.2	23.4	44.6	84.8	52.7	66.5	69.7	48.5	90.8	44.3	59.7	39.7	88.5	37.3	35.1	70.6	25.7	95.7	31.7	22.1	58.2	109.7	27.2	37.4	55.3	58.0	37.1	37.1	83.4	26.2	56.7	73.2	40.5	19.4	75.3	63.4	49.7	47.1	56.3	62.2	41.7	23.5	54.8	29.1	72.1	63.9	35.6	63.3	74.4	86.2	67.7	35.5	76.5	44.4	3.4	1.3	1.8	2.9	1.4	2.5	1.9	2.6	3.0	1.1	4.5	3.1	3.1	0.1	2.2	1.4	1.6	2.2	0.8	29.7	39.6	57.8	40.7	25.0	36.8	35.9	32.3	34.5	28.4	30.9	45.6	51.6	44.8	38.8	59.1	48.6	57.0	95.3	19.4	40.5	60.6	67.6	68.1	52.8	48.6	28.2	40.5	25.0	19.2	84.4	21.7	105.7	16.9	499.7	48.5	82.8	32.5	28.9	38.5	79.9	27.8	28.7	45.6	41.3	41.8	30.9	54.5	31.8	50.9	15.4	52.2	122.3	36.5	18.3	33.6	24.0	514.0	43.8	32.9	32.0	74.9	25.0	58.5	70.0	137.7	178.4	19.4	23.7	41.3	53.3	123.9	19.4	85.2	38.8	59.8	13.1	82.3	48.5	72.2	52.2	44.8	73.6	13.1	74.2	91.6	37.0	94.3
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852148-6866632	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	27.1	37.9	23.7	26.7	26.1	22.8	19.5	15.5	38.0	24.1	2.4	31.3	25.3	31.5	17.4	38.2	25.9	18.5	33.0	25.3	33.6	20.1	23.1	20.5	29.2	31.0	31.3	19.4	17.8	41.4	27.8	25.4	38.8	26.5	22.2	15.7	20.0	29.6	66.7	48.1	26.1	35.5	15.0	21.2	22.9	40.9	28.9	36.5	26.7	42.5	29.4	29.8	24.2	29.0	88.1	135.7	88.4	100.4	59.0	53.9	113.4	93.0	70.9	109.2	78.8	129.4	84.9	105.7	47.6	98.5	86.5	75.2	98.6	92.7	69.5	198.6	84.0	97.1	105.5	71.0	45.8	88.5	97.2	55.6	52.9	94.8	64.9	72.9	94.8	41.7	85.4	40.9	91.1	97.4	132.9	44.4	172.8	89.3	56.5	103.4	115.5	73.5	62.9	84.5	48.5	97.4	63.5	96.3	41.1	110.6	38.3	72.4	92.4	91.5	109.1	70.4	117.6	49.0	124.5	163.8	102.1	55.3	91.3	5.4	19.3	8.3	24.3	25.1	23.1	15.0	21.7	20.8	28.4	13.9	20.1	20.9	1.3	17.6	24.4	20.5	19.9	27.7	23.7	26.1	15.5	38.0	25.3	33.6	31.0	31.3	38.8	15.0	28.9	29.0	11.3	9.6	13.1	7.5	14.0	11.6	11.4	18.0	8.6	18.7	13.1	10.8	9.5	17.2	11.5	22.0	60.5	45.9	14.8	21.5	11.7	28.1	14.7	10.6	14.7	15.3	16.7	19.4	11.5	20.5	30.7	16.6	10.2	13.7	14.7	29.6	11.4	22.2	28.4	40.4	11.9	19.3	14.2	13.0	7.4	19.2	23.0	10.9	16.0	9.4	32.4	16.0	13.4	6.0	11.9	20.2	17.4	33.8	14.1	10.3	22.5	18.5	7.9	16.2	32.9	13.3	17.2	51.7	25.6	17.6	15.5	52.8	15.4	27.6	27.5	7.9
VAV3		ENSG00000134215	"Vav guanine nucleotide exchange factor 3"	Q9UKW4	1	107571161-107965180	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 83.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 263.5;Basal squamous epithelial cells: 163.9;Syncytiotrophoblasts: 246.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 28.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 52.8;RH-30: 61.7;RPTEC TERT1: 86.2;T-47d: 107.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002012	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB002012: "	"unprognostic (4.80e-3)"	"unprognostic (7.99e-3)"	"unprognostic (5.31e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.67e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.60e-8)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.23e-2)"	3.1	1.7	4.1	10.8	4.4	19.3	34.1	5.9	7.1	6.9	15.4	41.2	9.3	4.5	4.0	34.9	3.7	2.6	1.5	2.2	3.5	83.9	2.4	4.1	10.4	4.2	7.1	0.5	17.4	1.5	1.4	34.3	4.3	4.3	50.9	7.4	7.3	11.5	0.9	49.0	15.2	3.6	1.5	11.2	7.2	5.1	9.2	8.8	9.9	1.2	16.6	12.7	16.1	3.0	0.0	12.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3.5	16.9	0.6	0.2	0.0	0.0	4.5	17.4	5.8	10.2	0.0	16.3	6.5	0.0	36.6	0.0	1.1	0.0	0.0	8.5	0.0	13.3	0.2	5.7	34.2	4.2	5.0	0.2	1.2	52.8	61.7	0.4	86.2	29.5	2.8	2.6	16.4	7.2	0.3	1.5	107.2	29.7	1.2	0.6	0.0	0.1	0.6	8.0	3.3	0.5	13.0	26.1	1.2	4.7	0.6	0.7	2.1	0.5	1.1	1.7	0.6	1.0	2.6	2.0	0.1	1.4	1.7	2.1	0.2	1.6	2.6	0.7	4.1	4.4	5.9	7.1	2.2	3.5	4.2	7.1	4.3	1.5	9.2	3.0	7.3	0.0	1.7	263.5	37.0	11.7	10.3	13.3	163.9	15.0	48.5	21.5	2.4	5.7	17.8	51.5	2.1	108.8	91.0	87.3	117.4	7.9	55.7	11.2	1.1	9.6	21.1	11.3	38.2	0.0	25.6	3.1	2.6	5.8	7.6	0.0	10.0	0.2	23.6	0.0	77.7	29.1	4.1	15.7	10.6	40.1	0.3	22.1	3.6	23.4	13.3	3.8	69.0	36.2	2.4	0.1	47.2	0.4	32.7	2.1	25.2	79.6	12.3	28.4	6.6	51.1	1.6	1.3	3.0	108.7	21.0	246.0	30.3	8.8	45.9	4.7
WAPL	"FOE, KIAA0261, WAPAL"	ENSG00000062650	"WAPL cohesin release factor"	Q7Z5K2	10	86435256-86521792	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037874, HPA037875, HPA066141"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: "	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.78e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	15.4	13.2	8.4	19.6	9.9	27.1	16.6	11.9	9.2	12.8	7.8	15.4	15.2	14.8	8.7	15.9	11.7	13.1	10.3	7.5	8.3	16.8	22.6	16.5	25.0	8.2	8.5	13.7	14.4	16.9	4.9	18.4	8.3	13.0	15.2	36.0	11.2	11.7	20.9	17.9	16.0	14.8	8.9	19.0	16.5	35.1	9.0	33.7	17.9	22.5	27.7	17.9	9.2	10.4	42.6	19.6	33.5	44.4	26.1	27.6	29.6	36.4	44.2	30.3	32.4	42.9	36.6	64.3	24.1	32.5	26.7	39.1	38.3	31.3	46.3	42.1	25.3	38.9	30.9	47.4	29.7	79.8	43.1	21.9	35.7	38.9	64.9	34.5	34.6	36.8	41.7	37.6	35.2	36.3	49.9	29.6	29.9	26.4	19.5	35.2	27.1	25.6	26.3	37.2	13.1	25.2	32.3	21.4	40.9	33.2	47.1	41.9	33.5	29.1	34.4	25.8	48.6	36.8	54.9	66.9	26.7	55.8	20.9	15.0	3.5	7.7	3.4	4.1	4.9	3.9	4.5	4.7	4.8	4.0	5.1	4.0	5.5	3.2	7.4	3.6	6.1	2.4	8.4	9.9	11.9	9.2	7.5	8.3	8.2	8.5	8.3	8.9	9.0	10.4	38.3	83.3	54.8	0.0	48.3	0.0	57.4	0.0	35.3	49.1	41.3	27.9	0.0	20.0	21.1	16.5	20.9	42.8	62.4	17.4	21.5	60.8	86.8	36.7	44.4	33.9	18.2	94.1	0.0	52.5	28.3	30.0	37.8	52.2	25.2	40.3	32.5	47.6	40.4	55.5	0.0	21.5	0.0	56.5	0.0	42.0	32.0	58.3	0.0	0.0	81.0	48.7	55.6	0.0	0.0	52.1	27.5	32.4	50.5	56.6	25.0	35.5	13.8	113.4	65.7	70.3	33.6	153.4	90.2	48.4	0.0	76.1	51.4	35.2	24.8	74.1
WDR20	"DMR, FLJ33659, MGC33177"	ENSG00000140153	"WD repeat domain 20"	Q8TBZ3	14	102139503-102224847	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 241.9;Late spermatids: 250.6;Oligodendrocytes: 201.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (5.59e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.70e-2)"	"unprognostic (5.48e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (3.26e-9)"	"unprognostic (6.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.41e-2)"	12.2	17.0	11.2	9.4	16.3	10.7	11.7	18.7	15.6	11.5	13.3	10.8	16.0	10.3	12.0	13.5	10.7	8.9	10.0	12.3	15.0	12.5	10.9	8.8	11.5	16.5	14.0	12.3	12.3	11.9	10.5	9.9	16.1	10.2	10.5	29.9	11.4	7.4	11.8	16.0	13.1	9.1	11.6	10.4	10.6	23.9	14.3	12.3	14.1	13.0	10.8	10.4	12.1	28.7	16.2	20.6	14.6	13.0	16.4	14.3	19.2	19.8	16.4	21.9	17.7	17.6	15.2	17.7	12.9	18.6	11.9	19.3	21.6	17.8	27.7	25.0	9.8	9.3	14.8	19.4	12.6	14.4	16.1	11.2	16.7	15.8	15.5	22.0	15.4	14.2	12.3	18.6	23.9	37.2	13.3	21.8	13.0	22.3	22.7	13.3	14.5	11.9	31.8	25.4	18.4	20.8	17.3	22.2	13.9	16.2	24.1	13.8	17.0	20.3	9.3	32.2	18.7	14.6	21.9	18.8	18.5	11.7	22.2	28.5	20.7	37.7	25.8	21.2	27.0	27.6	28.4	24.2	21.0	19.9	28.9	27.4	40.2	30.4	21.4	12.4	33.6	21.0	11.2	16.3	18.7	15.6	12.3	15.0	16.5	14.0	16.1	11.6	14.3	28.7	17.5	9.6	14.5	48.6	21.0	25.1	15.4	19.6	16.5	20.5	16.3	12.7	10.4	10.0	16.7	11.0	16.7	25.6	22.8	19.6	21.5	17.9	241.9	20.1	14.5	12.9	11.4	25.0	43.3	17.3	19.4	15.6	14.3	21.1	22.9	15.0	15.0	12.7	13.4	33.7	42.9	12.8	18.3	10.4	13.8	250.6	13.1	12.9	21.4	48.7	15.6	23.8	22.6	68.9	201.5	18.9	17.6	15.1	17.4	19.0	27.5	25.1	15.6	54.6	13.1	18.6	17.4	43.0	25.3	16.4	27.4	34.9	22.3	8.7	12.1	21.7
WNT3A		ENSG00000154342	"Wnt family member 3A"	P56704	1	228006998-228061271	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 15.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Basal keratinocytes: 3.4;Basal prostatic cells: 3.1;Basal squamous epithelial cells: 8.6;Syncytiotrophoblasts: 2.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HEK 293: 1.1;U-2 OS: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049893			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA049893: "	"unprognostic (9.84e-3)"	"prognostic favorable (6.11e-5)"	"unprognostic (2.40e-1)"	"unprognostic (3.37e-1)"		"unprognostic (7.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.54e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.7	0.0	1.3	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	3.4	3.1	1.2	8.6	0.0	0.0	0.1	1.9	0.0	0.9	1.8	0.0	2.0	0.0	0.4	0.0	0.1	0.3	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.5	1.0	2.9	0.0	0.0	0.1	0.5
WNT7A	Wnt-7a	ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880071	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;gallbladder: 2.3;placenta: 2.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 68.7;Extravillous trophoblasts: 147.5;Pancreatic endocrine cells: 98.8;Syncytiotrophoblasts: 185.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2;ovarian cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 59.8;EFO-21: 56.0;PC-3: 19.9;RPTEC TERT1: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.0	0.0	3.6	0.1	3.1	0.1	0.0	1.0	3.7	0.2	0.3	0.0	0.0	1.1	0.2	0.4	0.1	2.3	0.0	2.4	2.1	0.2	0.0	2.0	0.2	5.1	1.9	0.0	0.1	0.0	0.0	2.7	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	3.4	1.3	0.0	1.3	2.5	0.0	0.0	0.0	0.1	0.3	0.1	2.8	8.6	0.0	0.8	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	7.6	0.0	56.0	0.0	0.1	11.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	1.7	100.3	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.6	3.1	1.0	3.7	2.4	2.1	5.1	1.9	2.5	3.4	2.5	2.8	0.0	12.8	0.0	8.5	0.0	5.9	2.8	2.6	0.0	0.0	0.0	0.0	0.7	8.6	1.4	0.0	0.0	68.7	0.0	0.0	0.0	13.8	17.3	14.5	0.4	0.6	0.0	0.0	4.0	9.1	147.5	0.4	0.0	17.9	0.0	0.0	0.0	0.0	7.4	0.0	2.4	0.0	0.0	0.0	0.0	5.6	0.0	0.1	0.0	1.0	0.0	0.0	0.0	4.5	0.3	98.8	0.0	0.0	0.0	3.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	6.0	2.3	0.0	1.3	185.7	1.5	0.0	0.0	6.0
YBX3	"CSDA, CSDA1, dbpA, ZONAB"	ENSG00000060138	"Y-box binding protein 3"	P16989	12	10699089-10723323	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 4915.7;tongue: 1635.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1418.1;Prostatic glandular cells: 1553.4;Skeletal myocytes: 1316.7;Urothelial cells: 1339.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034838	Approved		Supported	Cytosol		NA	NA		230000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA034838: AB_10670980"	"unprognostic (1.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.17e-13)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.44e-1)"	250.4	96.7	17.6	77.5	17.6	151.1	200.2	18.8	25.5	152.1	28.4	249.1	37.5	136.8	47.3	271.0	166.7	65.0	469.9	16.5	22.3	194.1	53.8	209.5	32.9	25.4	22.4	134.6	291.0	18.6	84.1	72.5	23.9	177.1	58.8	82.8	218.1	67.5	4915.7	358.1	99.0	100.9	20.9	79.5	149.7	265.7	22.2	36.7	136.1	1635.6	54.6	225.4	204.8	19.7	117.2	90.3	41.4	136.1	165.7	310.7	307.4	173.4	142.7	138.7	132.0	160.4	259.5	109.3	57.7	130.3	96.5	215.5	173.3	338.1	124.6	1.2	325.2	91.3	123.6	108.4	198.3	171.7	10.4	343.3	452.3	124.2	414.6	148.9	313.6	152.3	123.1	0.4	154.7	112.6	137.8	141.9	435.5	103.7	76.9	76.9	192.6	127.4	192.6	150.0	52.2	0.3	129.1	130.9	174.1	288.0	37.1	133.9	221.3	94.5	282.6	108.4	201.5	0.5	38.1	13.4	133.1	0.2	104.8	0.0	4.2	0.0	0.6	4.2	0.0	1.6	0.0	1.5	3.2	6.5	0.0	1.6	0.8	0.8	2.4	0.1	0.1	1.0	17.6	17.6	18.8	25.5	16.5	22.3	25.4	22.4	23.9	20.9	22.2	19.7	680.9	150.6	164.4	14.0	192.8	764.9	1226.9	212.9	552.7	36.1	288.8	292.7	497.7	105.8	177.8	145.3	89.6	145.7	39.2	94.3	133.1	125.3	1418.1	563.0	402.1	563.1	67.6	1081.5	2.4	143.3	84.3	484.8	119.8	551.3	63.3	291.0	235.6	23.1	97.7	16.8	1.0	139.5	120.1	223.2	494.7	470.2	264.7	292.2	259.7	21.5	83.9	67.2	2.1	4.5	0.1	122.0	76.3	223.8	80.6	1553.4	43.9	240.4	240.4	365.4	124.9	1316.7	643.1	594.6	158.4	638.6	1050.5	125.7	72.5	70.8	157.4	1339.7
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916523-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005065	Approved					NA	NA		320000000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB005065: AB_2218378"	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.28e-5)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	379.0	262.9	246.2	374.2	324.1	527.2	251.7	147.4	343.0	269.6	88.3	475.2	327.3	275.6	220.9	892.8	243.9	333.0	187.3	366.2	269.6	224.9	190.9	275.8	429.3	163.3	195.7	227.7	191.5	233.3	109.0	339.2	222.5	265.8	445.9	285.3	244.8	291.2	95.0	399.4	375.4	356.5	170.1	272.8	365.4	226.8	276.9	434.8	289.7	168.9	566.1	501.0	343.2	205.0	1902.4	879.2	1605.4	457.7	396.6	490.9	808.0	877.6	1099.2	1124.6	1098.2	602.4	1149.5	816.5	857.1	1349.3	937.2	785.0	1025.5	1213.5	1630.1	765.1	454.2	779.5	579.0	378.1	524.8	311.5	840.3	475.4	1524.0	936.7	1430.1	923.8	1008.7	584.9	887.8	758.9	920.2	660.6	1357.1	535.4	548.0	2269.0	1026.7	569.7	468.6	544.8	1023.1	963.5	889.7	642.7	669.5	609.8	1365.4	1094.7	896.0	374.6	879.0	554.6	834.3	693.7	798.3	503.6	625.3	994.6	925.8	595.2	2303.2	1340.5	427.5	705.8	559.0	589.1	559.3	484.8	463.3	537.3	497.3	395.9	348.3	441.8	616.5	503.7	726.9	313.4	663.9	1087.2	246.2	324.1	147.4	343.0	366.2	269.6	163.3	195.7	222.5	170.1	276.9	205.0	199.4	250.0	228.9	43.1	637.6	1007.0	438.4	309.3	507.6	120.4	285.9	209.9	87.0	188.8	321.3	263.0	89.6	243.4	491.2	552.7	121.3	405.2	1092.9	359.6	245.6	216.0	265.3	137.3	150.2	421.3	551.6	277.4	448.5	578.8	452.9	122.1	183.1	104.5	276.3	134.6	92.5	525.2	244.1	303.5	641.2	2118.0	125.6	456.9	391.3	56.2	334.9	110.9	407.8	51.3	91.5	771.0	452.7	147.1	457.2	427.2	310.6	160.4	292.0	96.3	131.5	229.4	290.4	170.2	92.6	908.0	1184.7	408.9	596.5	116.5	371.7	794.9
ZAN		ENSG00000146839	Zonadhesin	Q9Y493	7	100733595-100797797	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Early spermatids: 15.0;Late spermatids: 16.2"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"		"unprognostic (3.69e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.83e-6)"	"unprognostic (9.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.10e-9)"	"unprognostic (5.70e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.06e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ZBTB22	"BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A"	ENSG00000236104	"Zinc finger and BTB domain containing 22"	O15209	6	33314406-33317942	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043848			Approved	Nucleoplasm		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA043848: AB_10961146"	"unprognostic (1.32e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.54e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.32e-3)"	10.2	15.1	1.2	2.6	1.2	2.1	11.3	1.1	3.5	15.6	0.7	10.4	4.7	15.6	8.5	13.3	12.6	1.7	10.6	1.2	0.9	11.9	10.1	12.0	1.1	2.1	1.3	14.9	12.2	11.6	10.5	2.3	1.4	12.1	4.2	5.7	12.0	3.8	8.6	19.2	11.6	3.0	1.5	13.7	11.8	6.1	1.0	5.3	15.1	3.9	3.9	12.0	13.2	1.4	0.3	0.3	8.5	4.4	8.3	3.3	3.5	7.5	7.3	7.1	4.6	0.1	1.9	1.9	5.6	12.5	9.1	0.6	0.3	4.6	5.2	11.7	2.8	7.5	4.4	4.1	0.0	0.0	2.8	10.8	10.0	0.3	2.6	9.8	0.7	6.3	2.9	7.8	2.6	4.7	4.6	6.7	0.0	0.4	2.2	0.5	0.1	4.2	6.3	0.4	9.7	0.6	0.7	0.4	4.3	5.0	0.7	0.4	10.7	3.9	4.5	0.2	0.2	4.3	4.5	1.9	5.6	1.1	4.3	0.8	0.2	0.8	0.3	0.3	0.1	0.5	0.4	0.2	0.2	0.3	0.7	0.1	0.3	0.1	0.2	0.4	0.1	0.2	1.2	1.2	1.1	3.5	1.2	0.9	2.1	1.3	1.4	1.5	1.0	1.4	9.4	0.0	5.0	2.6	7.3	6.4	16.3	6.0	8.6	20.1	9.9	7.6	4.3	4.3	4.9	7.3	8.4	6.3	3.3	9.8	23.5	11.0	1.6	8.3	5.2	7.7	7.7	4.0	2.8	7.1	4.6	6.7	5.6	6.9	3.8	6.5	7.9	2.0	5.3	20.2	2.8	8.7	12.2	4.4	4.0	1.8	9.3	5.3	1.8	3.7	12.1	18.2	8.2	3.5	2.6	6.5	8.6	6.4	4.0	10.9	7.6	8.3	6.0	21.2	13.1	10.0	7.6	2.2	2.0	8.1	7.4	10.1	4.9	8.0	5.8	11.8
ZBTB33	"kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348"	ENSG00000177485	"Zinc finger and BTB domain containing 33"	Q86T24	X	120250752-120258398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000755, CAB001980, HPA005732"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166"	"unprognostic (9.14e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.59e-2)"	6.4	7.0	6.4	8.5	7.0	19.5	15.4	7.1	9.0	6.8	4.7	6.8	7.7	6.2	9.4	9.9	8.2	7.3	4.9	6.4	9.2	6.4	19.0	8.7	13.2	7.3	8.7	9.7	8.4	13.7	4.8	8.8	8.5	7.4	6.5	5.7	10.4	6.0	5.4	18.8	6.4	4.8	8.4	11.5	8.6	5.7	9.3	16.2	10.2	7.7	12.8	8.0	4.8	9.7	13.6	12.9	19.6	18.1	15.9	17.8	23.4	10.3	13.5	11.7	14.5	9.0	11.7	19.5	18.8	10.4	15.7	20.7	31.9	15.7	15.3	22.0	21.6	20.3	20.3	12.7	11.6	21.2	22.7	12.7	19.9	11.2	17.6	17.1	20.9	18.7	13.5	23.2	14.6	15.6	19.2	14.1	24.3	20.9	15.3	21.9	14.9	32.0	12.5	22.2	35.6	15.2	20.9	21.3	25.3	14.9	11.5	29.6	19.6	9.5	6.9	14.3	18.5	12.7	13.1	24.7	12.6	29.4	11.9	11.5	4.2	5.6	2.9	6.4	5.0	2.4	3.8	3.9	6.2	2.2	4.6	3.4	0.9	4.0	4.2	6.7	3.5	3.6	6.4	7.0	7.1	9.0	6.4	9.2	7.3	8.7	8.5	8.4	9.3	9.7	15.7	16.0	7.0	3.9	7.9	12.7	7.8	5.1	12.5	4.5	11.5	13.1	5.2	8.6	11.9	1.8	0.0	7.7	21.7	5.3	1.9	5.5	0.1	12.9	8.7	8.5	8.4	10.3	3.4	6.7	8.7	7.9	7.1	10.3	0.0	16.0	7.9	16.6	7.6	3.3	4.6	7.0	6.1	12.8	10.3	0.4	4.4	8.2	3.6	3.7	14.6	7.0	14.4	5.0	4.6	6.9	5.7	2.6	5.4	9.5	6.8	4.0	15.3	1.6	6.6	6.9	4.1	5.0	10.0	12.7	13.1	9.3	8.7	11.2	6.0	11.9
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type palmitoyltransferase 12"	Q96GR4	9	128720870-128724127	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 224.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	18.8	23.9	7.8	15.5	7.7	41.3	19.3	7.5	9.9	16.8	8.4	40.5	26.3	12.9	7.1	67.8	12.0	14.1	13.7	7.4	8.8	30.6	52.3	23.3	20.0	9.6	7.8	7.4	67.1	9.8	11.3	16.3	8.4	26.6	13.7	0.5	43.2	12.5	15.6	42.4	36.8	6.3	8.4	31.7	49.2	24.7	10.5	12.4	16.2	4.1	13.7	18.7	30.5	9.7	53.5	127.6	6.0	31.3	17.6	12.1	59.4	32.8	28.8	34.5	22.9	109.6	61.5	37.3	29.6	25.5	62.9	139.8	13.0	65.0	3.8	65.0	31.7	20.1	92.7	49.1	34.7	33.1	87.1	19.9	44.7	29.6	11.0	17.7	25.6	65.6	18.8	93.6	7.1	187.3	45.9	66.2	26.8	118.8	107.6	21.0	21.0	108.4	28.7	43.4	42.1	30.4	46.2	64.1	18.3	9.6	98.9	35.6	27.5	0.1	36.9	25.9	45.8	58.1	106.8	17.3	61.3	38.4	41.4	231.1	122.3	385.6	105.1	123.9	91.2	94.6	95.9	101.5	100.1	111.0	99.2	91.4	269.5	90.5	150.0	244.7	130.9	101.0	7.8	7.7	7.5	9.9	7.4	8.8	9.6	7.8	8.4	8.4	10.5	9.7	10.0	16.0	12.0	1.3	31.8	16.2	43.3	94.0	10.8	1.2	55.5	30.4	14.8	77.2	59.0	46.0	0.0	183.9	39.1	171.0	13.7	106.8	73.2	20.7	11.5	21.1	51.2	51.1	0.6	200.0	224.0	14.2	38.7	52.5	18.4	13.7	35.7	55.3	137.0	0.0	0.5	108.5	67.1	62.2	20.9	30.0	9.6	46.5	42.7	6.5	115.3	18.4	81.4	0.5	2.0	133.8	167.7	7.2	43.3	56.5	186.0	48.5	20.1	2.0	6.6	5.4	16.3	36.0	18.6	55.2	28.1	134.1	34.1	22.0	110.0	77.5
ZFP64	"dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338"	ENSG00000020256	"ZFP64 zinc finger protein"	Q9NTW7	20	52051663-52204308	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035112, HPA058387"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA035112: AB_10672859, HPA058387: AB_2683702"	"unprognostic (3.86e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (4.68e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	4.2	4.8	5.8	5.7	5.5	5.3	4.6	5.2	5.5	5.7	3.0	6.3	6.6	5.7	4.2	7.0	6.7	5.3	4.8	5.1	3.4	4.7	5.2	4.5	6.6	4.7	3.4	7.8	5.6	7.2	4.7	4.3	4.6	6.3	5.7	5.0	5.8	5.7	5.4	11.2	5.9	5.5	2.6	5.7	5.9	6.6	4.5	7.3	6.8	4.5	5.3	5.6	6.1	5.6	35.1	19.6	14.7	35.1	7.2	13.0	21.0	11.9	17.3	25.5	21.1	18.8	14.3	15.5	23.2	21.5	21.1	46.2	12.0	26.6	15.6	6.6	37.5	9.3	35.0	20.1	19.9	10.4	6.6	11.3	39.4	13.0	14.8	13.0	17.6	16.4	11.2	19.5	6.4	14.6	14.5	8.9	14.8	19.0	15.1	15.9	7.6	15.6	12.1	13.9	15.2	18.0	23.1	28.6	22.5	12.0	19.2	12.3	11.6	18.0	26.1	19.7	7.7	21.1	20.6	12.6	17.2	10.3	12.2	5.1	3.3	8.1	4.5	1.8	3.3	5.1	3.4	3.6	4.2	3.2	3.8	3.7	1.8	5.3	4.8	4.1	3.3	2.8	5.8	5.5	5.2	5.5	5.1	3.4	4.7	3.4	4.6	2.6	4.5	5.6	4.7	3.2	3.3	7.2	5.4	8.7	4.3	5.4	19.9	5.1	5.1	3.9	4.0	4.3	2.5	0.0	2.1	4.3	6.2	7.5	7.9	8.2	7.4	3.9	4.4	4.2	6.7	5.5	18.0	5.8	8.5	5.9	9.7	3.9	7.0	5.2	9.3	6.1	4.0	1.7	15.5	9.5	8.2	4.1	4.2	9.1	6.5	2.9	3.6	14.0	4.0	2.7	7.2	15.6	18.6	5.4	6.0	7.2	11.6	3.5	5.3	4.9	4.0	4.7	6.6	3.8	5.5	19.7	2.9	11.3	13.4	1.2	5.8	3.9	9.0	2.6
ZFPM1	"FOG, FOG1, ZC2HC11A, ZNF89A"	ENSG00000179588	"Zinc finger protein, FOG family member 1"	Q8IX07	16	88453280-88537031	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 35.3;Muller glia cells: 58.0;Theca cells: 37.4"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 12.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 19.3;K-562: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046603	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA046603: AB_2679718"	"unprognostic (1.29e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (4.24e-4)"	2.1	2.5	4.8	1.9	2.4	9.2	1.9	5.7	5.8	2.3	4.2	1.7	12.4	2.2	1.0	1.8	4.0	1.5	4.8	5.8	2.1	3.7	8.6	2.1	2.7	3.5	3.2	2.2	10.4	1.4	5.6	0.8	2.6	3.2	0.8	0.7	2.8	1.3	1.6	3.7	6.8	0.2	1.6	4.9	13.7	5.7	3.3	1.5	4.0	0.3	1.2	2.3	2.0	1.6	1.4	3.8	2.8	5.9	0.5	0.1	11.9	4.0	0.5	1.3	0.4	12.1	1.5	5.9	3.0	0.6	1.4	9.5	0.1	3.3	0.3	4.6	2.5	19.3	8.1	10.7	2.1	1.1	6.2	1.3	2.1	1.4	0.5	1.4	1.3	1.6	29.2	0.4	1.0	7.3	6.9	7.0	1.9	9.3	3.2	2.0	1.3	2.9	1.3	4.8	7.7	12.8	4.9	0.3	3.9	1.4	3.1	3.1	4.8	4.9	3.1	2.2	0.8	1.4	1.0	0.5	1.4	2.3	4.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	2.4	5.7	5.8	5.8	2.1	3.5	3.2	2.6	1.6	3.3	1.6	16.7	3.2	2.2	12.4	4.8	0.9	6.1	0.7	0.0	20.7	13.5	25.8	17.2	5.7	0.4	1.8	29.2	0.4	27.5	10.8	1.9	1.3	0.7	24.1	23.7	6.3	6.0	4.8	6.8	5.1	0.2	10.9	14.3	20.1	0.0	16.0	5.0	8.8	0.9	35.3	8.0	6.7	0.0	5.3	1.2	1.1	0.9	7.5	1.8	8.4	1.6	58.0	2.1	5.5	13.4	2.9	6.2	1.5	9.5	1.4	1.3	1.3	0.4	23.9	0.0	16.1	12.4	0.7	1.0	1.9	1.4	0.3	9.6	37.4	5.2	2.1
ZNF134	pHZ-15	ENSG00000213762	"Zinc finger protein 134"	P52741	19	57614233-57624724	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA009064	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA009064: AB_1080668"	"unprognostic (3.60e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.88e-1)"	"unprognostic (4.29e-2)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	4.6	5.4	4.9	4.7	5.2	12.5	7.5	8.7	5.3	5.7	4.0	6.5	3.5	5.5	6.0	5.3	6.5	4.5	6.0	4.9	5.5	5.6	4.9	5.8	7.5	3.9	4.0	7.6	3.8	12.0	5.7	7.9	3.7	7.3	4.5	10.6	5.4	8.3	6.3	7.1	4.9	6.0	3.6	7.1	6.0	6.6	5.5	11.1	8.3	7.2	8.5	6.1	4.1	4.7	2.5	6.6	15.5	8.4	6.8	9.1	7.7	6.8	11.1	9.8	4.9	2.2	2.9	5.0	4.7	8.5	7.5	2.1	7.2	12.6	16.8	0.1	33.2	15.8	7.0	6.2	9.9	10.6	11.2	12.3	12.1	7.4	16.7	12.9	6.6	8.2	2.1	5.7	14.8	3.7	21.0	4.4	21.8	1.6	13.6	12.2	22.5	7.9	7.3	21.5	12.4	14.5	11.3	4.9	7.2	17.0	6.9	8.4	8.7	14.7	6.3	3.5	9.0	15.3	21.8	6.9	7.7	1.8	9.9	2.3	4.2	7.4	6.3	3.0	8.3	9.5	6.5	6.7	4.6	8.3	7.5	7.5	3.4	11.9	3.4	3.5	4.4	5.5	4.9	5.2	8.7	5.3	4.9	5.5	3.9	4.0	3.7	3.6	5.5	4.7	6.0	9.6	4.1	1.0	14.4	5.4	12.7	4.4	8.6	8.4	9.8	8.0	11.2	11.5	5.6	3.7	12.5	8.2	11.1	1.2	7.9	7.8	1.7	6.0	7.8	8.3	1.2	13.0	1.0	3.7	4.3	6.2	1.1	7.3	6.3	10.6	9.7	4.1	5.3	8.4	0.9	4.0	6.1	5.1	3.2	1.5	7.2	4.4	3.6	0.0	7.0	11.3	9.2	1.0	1.6	3.8	2.6	14.7	5.0	9.3	2.8	4.6	5.1	11.9	6.6	6.6	8.5	2.2	15.2	6.7	7.7	16.3	8.8	8.0	3.6	13.8
ZNF250	"MGC9718, ZFP647, ZNF647"	ENSG00000196150	"Zinc finger protein 250"	P15622	8	144876497-144902168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020853	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA020853: AB_1859152"	"unprognostic (1.16e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.43e-7)"	"unprognostic (2.23e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-2)"	"prognostic favorable (8.26e-4)"	4.7	3.9	3.2	3.3	3.2	2.9	5.6	10.5	4.7	9.7	2.3	6.9	4.8	7.4	2.8	6.4	7.6	3.3	4.9	2.4	4.5	7.6	4.0	5.1	3.0	3.0	3.2	9.7	4.9	6.0	7.3	5.5	3.3	7.5	3.6	7.9	6.0	5.2	4.8	10.9	5.2	4.2	1.5	5.5	4.9	4.5	3.3	4.5	10.0	5.8	3.3	6.3	8.6	3.4	5.1	2.9	13.4	11.1	6.8	5.9	4.3	5.6	6.4	9.4	7.7	2.4	3.9	12.0	9.8	6.5	3.8	6.6	5.3	4.8	6.0	3.8	7.8	10.8	14.9	3.5	2.0	1.8	3.6	3.9	6.5	5.6	4.5	7.2	3.9	7.1	8.6	11.5	7.9	6.8	12.6	4.1	4.0	6.0	12.5	14.4	5.9	5.0	7.8	3.7	13.2	10.1	11.8	4.4	5.3	5.3	6.3	6.1	5.1	9.2	8.8	7.3	5.3	5.6	5.1	8.0	4.7	6.2	4.1	3.2	5.1	5.8	10.5	2.7	8.1	10.3	7.7	5.8	6.6	9.7	8.9	7.3	2.9	6.0	3.7	2.6	11.7	4.5	3.2	3.2	10.5	4.7	2.4	4.5	3.0	3.2	3.3	1.5	3.3	3.4	5.8	12.8	3.0	10.7	10.7	5.5	3.2	7.5	10.2	8.4	4.3	6.6	4.3	1.5	3.9	5.5	0.0	2.3	18.6	2.4	3.9	7.5	7.4	5.1	6.0	5.5	4.2	1.7	11.9	1.9	1.3	5.2	2.6	4.9	2.5	6.3	5.0	2.1	1.7	8.4	17.5	1.9	12.2	2.2	8.0	3.0	4.1	3.0	5.4	4.7	2.0	3.3	5.2	11.1	7.8	2.6	1.0	5.3	8.2	3.3	3.7	3.4	5.0	9.9	13.1	4.1	6.1	14.3	8.7	4.4	5.5	1.9	10.9	4.9	3.4	2.3
ZNF410	"APA-1, APA1"	ENSG00000119725	"Zinc finger protein 410"	Q86VK4	14	73886617-73932521	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002871			Approved	"Nuclear bodies"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nuclear bodies"		"HPA002871: AB_1080712"	"unprognostic (5.84e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (5.86e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.19e-1)"	29.0	33.0	26.8	18.7	30.4	57.7	29.4	30.9	33.9	30.0	28.9	30.6	19.0	27.5	43.7	33.4	28.1	22.6	21.0	26.3	28.0	33.0	28.8	27.6	25.6	29.1	27.5	38.7	20.6	27.1	27.0	32.2	29.6	29.5	24.4	22.8	24.4	27.3	21.1	37.6	25.2	28.4	26.7	26.1	25.7	44.7	28.3	29.9	24.6	18.3	30.7	29.1	28.7	37.0	46.7	35.8	42.4	45.2	44.8	39.8	52.4	51.4	56.9	88.2	82.0	37.6	40.1	38.4	21.7	65.7	28.2	42.1	42.9	52.8	83.2	56.2	26.9	36.2	31.6	29.9	67.4	30.6	45.6	37.0	72.4	44.5	83.1	39.5	47.5	43.9	38.2	33.0	43.3	88.6	45.8	51.2	15.5	56.3	41.7	40.7	48.5	24.7	57.0	43.7	39.0	50.3	57.2	52.5	54.6	35.5	48.3	52.2	30.7	62.7	59.0	37.1	47.2	45.2	83.4	48.0	40.1	34.1	53.7	65.9	45.3	74.8	47.5	43.1	51.9	37.7	49.0	49.0	45.6	43.0	42.3	43.5	34.4	60.5	50.1	30.8	46.7	55.9	26.8	30.4	30.9	33.9	26.3	28.0	29.1	27.5	29.6	26.7	28.3	37.0	4.3	0.0	3.1	27.7	10.8	0.6	1.5	1.0	10.8	1.5	2.2	1.7	1.1	0.0	2.9	0.0	4.2	1.8	5.0	1.7	0.0	1.0	3.8	4.7	5.6	2.6	0.0	5.9	22.7	0.9	1.5	5.3	10.7	6.7	10.8	2.9	1.8	0.4	1.2	1.7	23.8	1.1	0.0	2.2	3.1	1.1	1.2	5.4	1.8	18.7	1.1	2.4	2.1	18.1	31.0	1.3	1.4	0.4	13.4	1.0	2.4	0.7	0.2	4.7	0.0	4.0	5.1	3.3	1.9	10.1	1.1	2.6	10.5	4.1	0.8	1.4
ZNF416	FLJ20557	ENSG00000083817	"Zinc finger protein 416"	Q9BWM5	19	57571566-57578911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA063318			Approved	"Nuclear bodies,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear bodies"	"HPA063318: AB_2684983"	"unprognostic (1.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.57e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.20e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-1)"	2.2	2.2	2.6	1.6	3.0	2.6	3.7	4.3	3.7	2.7	2.2	2.3	1.4	2.3	3.9	3.2	3.4	1.8	2.7	2.7	2.5	2.6	2.0	2.5	2.8	2.0	2.2	4.4	1.4	4.4	2.0	2.9	2.0	2.7	2.1	3.7	2.2	3.1	2.6	5.1	1.7	2.8	2.2	2.8	2.1	4.2	2.6	4.0	3.6	3.0	4.1	2.4	2.4	2.9	3.2	3.1	6.5	5.2	3.9	5.6	4.3	3.2	5.8	6.2	4.0	2.2	1.7	2.2	2.3	4.1	4.5	1.2	3.8	5.5	7.6	3.5	15.5	5.3	3.5	1.8	7.0	4.7	3.3	5.6	5.6	3.9	8.2	4.9	4.3	5.3	0.7	1.7	8.4	1.3	9.9	2.2	7.7	3.8	5.7	4.9	9.7	4.8	4.3	6.8	4.7	5.3	5.8	3.0	2.9	7.3	2.7	5.6	3.2	6.7	3.2	2.2	4.8	5.4	9.5	5.9	1.5	3.1	4.1	1.1	2.6	1.9	4.3	1.9	7.7	6.6	5.9	6.3	4.1	10.4	8.0	5.8	0.8	9.0	1.7	3.7	2.9	3.7	2.6	3.0	4.3	3.7	2.7	2.5	2.0	2.2	2.0	2.2	2.6	2.9	1.1	0.0	0.5	1.3	2.9	1.7	1.6	1.6	1.2	3.5	1.6	1.8	1.8	1.5	1.6	0.0	0.0	2.1	1.0	0.6	3.9	2.8	5.0	0.9	0.9	1.8	0.0	3.6	1.5	0.9	0.8	1.1	1.5	1.1	2.5	2.6	0.7	1.2	1.7	8.4	1.4	1.1	0.0	1.0	0.6	2.0	0.9	0.6	0.0	1.0	0.5	3.2	3.1	3.0	0.2	1.4	1.2	0.7	0.8	1.3	1.1	1.3	0.6	2.8	6.6	1.5	1.2	3.1	4.1	1.3	2.4	1.9	1.3	2.4	0.9	2.2
ZNF526	"KIAA1951, MGC4267"	ENSG00000167625	"Zinc finger protein 526"	Q8TF50	19	42220312-42228201	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 33.3;granulocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023070, HPA056609"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA023070: AB_2671057, HPA056609: AB_2683189"	"unprognostic (2.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.84e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.30e-1)"	3.4	2.5	2.1	2.8	2.3	3.8	3.1	4.3	2.6	3.9	2.0	3.3	3.3	3.6	2.3	3.1	3.5	1.9	2.8	2.0	2.1	2.3	2.8	2.6	4.0	2.4	2.2	4.5	3.5	3.9	3.0	3.0	2.3	3.3	2.1	2.0	4.6	3.3	5.1	5.2	3.1	2.4	1.6	3.6	3.1	3.5	2.4	4.2	2.8	4.0	3.6	3.5	3.4	3.4	7.8	24.8	7.1	6.4	8.0	7.7	6.2	8.9	8.2	9.2	10.1	13.0	5.5	12.6	6.3	9.5	4.2	5.7	7.7	9.7	5.7	7.5	9.2	12.6	12.0	12.5	7.5	8.1	7.8	7.6	7.7	9.2	9.6	5.7	5.8	6.7	12.3	7.8	5.9	10.8	8.2	5.2	4.7	6.8	8.7	9.4	8.7	5.7	4.2	14.0	7.3	6.4	10.2	10.1	7.2	5.4	4.1	14.4	7.8	11.3	7.7	4.8	11.2	9.3	5.9	8.5	7.5	7.8	9.5	1.8	3.6	1.4	4.5	3.6	6.9	4.7	3.5	4.1	2.8	4.4	4.2	5.3	0.7	3.4	5.3	4.2	3.9	3.3	2.1	2.3	4.3	2.6	2.0	2.1	2.4	2.2	2.3	1.6	2.4	3.4	3.0	22.4	33.3	2.0	6.9	5.5	4.4	2.8	4.0	7.4	3.1	2.4	3.2	0.0	17.1	3.7	14.6	8.0	3.2	5.7	3.9	4.1	5.8	1.7	4.0	7.1	13.8	9.5	1.4	3.0	8.3	7.4	4.6	2.3	25.2	4.9	3.6	2.6	4.6	6.7	1.5	4.2	2.0	6.8	1.8	6.3	7.2	7.0	0.0	1.9	5.8	4.1	11.3	1.0	1.4	2.9	2.8	3.0	6.1	4.6	7.8	2.8	9.2	9.6	0.0	5.7	3.6	9.9	10.1	1.9	5.1	10.3	6.7	3.7	5.7	2.6
ZNF703	"FLJ14299, NLZ1, ZEPPO1, ZNF503L, Zpo1"	ENSG00000183779	"Zinc finger protein 703"	Q9H7S9	8	37695782-37700019	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 108.4"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 3.3;non-classical monocyte: 4.3"	"Lineage enriched"	"Detected in single"	12	"monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 156.8;OE19: 61.2;SK-MEL-30: 60.0;T-47d: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023930, CAB068249"	Supported					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB068249: AB_2665667, HPA023930: AB_1859425"	"unprognostic (4.64e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (2.70e-7)"	"unprognostic (5.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.23e-1)"	24.6	14.4	16.6	7.6	15.0	1.9	27.4	10.7	16.9	39.9	9.8	46.9	15.1	27.8	12.7	18.2	33.2	6.2	18.8	14.2	10.3	8.1	4.2	10.7	4.1	21.8	17.9	19.6	8.7	1.9	5.9	12.1	16.4	21.7	12.6	0.4	18.3	8.7	108.4	57.4	25.9	11.6	15.0	18.9	22.8	2.9	14.7	2.8	10.6	33.3	2.9	36.8	28.7	10.7	3.2	6.6	0.8	5.2	15.1	7.9	5.2	29.1	13.6	8.8	7.4	27.2	36.0	0.0	7.2	18.4	4.0	17.2	3.0	4.4	6.8	0.8	156.8	0.0	9.5	17.5	14.9	0.0	3.0	26.6	8.2	9.1	3.7	19.0	7.8	0.3	0.4	0.0	14.1	27.4	0.1	0.8	2.6	61.2	11.6	2.7	4.7	3.7	2.7	14.2	2.9	0.2	5.4	4.6	60.0	6.2	52.6	3.1	23.1	10.3	23.7	16.1	12.3	1.9	0.1	0.2	9.1	3.2	6.7	0.0	0.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	16.6	15.0	10.7	16.9	14.2	10.3	21.8	17.9	16.4	15.0	14.7	10.7	11.9	6.4	0.0	14.7	15.3	48.2	13.2	28.9	103.0	3.7	39.3	27.8	9.1	2.8	14.5	5.5	0.0	41.4	7.7	52.0	3.9	7.1	0.4	30.8	37.0	9.5	79.6	0.0	1.5	2.5	37.2	36.0	14.8	20.3	0.0	5.8	2.5	2.2	36.2	0.0	2.8	95.4	10.2	23.6	31.9	0.7	31.4	31.2	33.8	11.2	7.9	9.3	0.0	0.0	0.6	3.7	56.9	15.8	1.9	9.7	35.4	2.8	7.7	0.9	52.6	54.9	66.4	0.0	0.6	99.7	74.6	434.1	6.0	6.1	92.6	10.7
ZNF843	MGC46336	ENSG00000176723	"Zinc finger protein 843"	Q8N446	16	31432593-31443160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 4.6;Cardiomyocytes: 5.3;Prostatic glandular cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;EFO-21: 1.8;HMC-1: 1.6"									"HPA030911, HPA030912, HPA077945"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nuclear speckles"	"HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: "	"unprognostic (9.27e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.43e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.86e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-5)"	"unprognostic (1.17e-1)"	0.6	0.5	1.5	0.3	1.2	0.3	0.6	2.5	1.3	1.0	0.0	0.4	0.2	1.0	0.7	0.4	1.1	0.7	1.7	1.6	1.9	0.6	0.4	0.3	0.3	1.1	1.4	3.0	2.1	0.9	1.5	0.4	0.9	0.6	0.1	1.1	1.5	0.8	2.2	0.9	0.3	0.5	1.1	0.4	0.4	0.5	1.8	0.2	1.0	0.8	0.2	0.5	0.6	0.9	0.1	0.3	0.2	1.2	2.3	0.6	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.0	1.8	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.2	1.6	1.2	0.3	0.0	0.1	0.8	0.0	0.2	0.2	0.2	0.6	0.8	0.1	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.8	0.0	0.2	0.1	0.1	0.0	0.1	0.4	1.0	0.2	0.2	0.7	0.1	0.4	0.2	0.2	0.7	0.1	0.2	0.1	0.4	0.7	1.7	0.1	0.2	0.1	1.0	1.5	1.2	2.5	1.3	1.6	1.9	1.1	1.4	0.9	1.1	1.8	0.9	0.5	0.0	0.5	2.9	0.3	0.8	4.6	0.1	0.0	2.2	0.9	1.3	5.3	0.0	0.7	0.0	2.1	0.3	0.1	0.3	0.0	0.3	0.2	0.4	2.0	1.0	1.2	0.0	1.4	0.2	0.1	1.4	0.0	0.4	1.3	1.4	1.8	0.3	0.6	0.0	1.7	0.0	0.0	0.3	2.1	0.0	1.5	0.9	0.0	0.0	0.1	1.4	2.1	1.0	1.3	0.1	0.1	1.5	0.1	3.6	0.0	0.4	0.0	1.9	0.0	2.8	1.3	0.4	0.7	0.1	1.4	0.3	1.2	0.8	0.1	1.9
ZNRF1	"DKFZp434E229, FLJ14846, nin283"	ENSG00000186187	"Zinc and ring finger 1"	Q8ND25	16	74999024-75110994	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.4;T-reg: 2.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.4;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"HMC-1: 176.9;MOLT-4: 134.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027470	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA027470: AB_10603108"	"unprognostic (2.78e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-2)"	18.7	16.5	21.1	9.6	22.3	6.7	17.8	9.1	22.8	25.3	19.0	30.6	9.6	22.5	9.5	65.9	18.0	7.5	21.0	23.4	24.5	14.7	17.6	24.1	7.7	19.6	22.5	17.4	11.5	11.8	13.4	11.2	18.6	13.7	12.1	7.4	16.9	7.0	81.2	25.0	15.3	11.4	13.4	4.5	21.0	37.4	30.7	53.2	29.3	30.6	13.3	22.5	26.4	17.5	10.9	15.7	26.7	27.5	27.7	21.4	91.2	13.0	18.3	17.5	17.1	25.4	33.2	2.9	9.9	28.3	16.8	25.5	13.0	17.8	13.9	26.7	7.5	56.7	4.8	47.0	22.0	27.5	176.9	19.5	14.7	18.4	14.9	30.8	29.0	68.3	27.8	8.8	13.7	104.5	134.6	100.6	37.1	31.4	16.7	59.0	10.0	17.4	25.1	30.5	35.4	37.7	20.7	27.0	8.3	21.7	71.6	25.8	19.9	12.0	21.0	21.5	7.9	50.5	55.1	31.6	15.8	30.2	12.6	2.4	0.5	0.4	0.0	0.5	0.5	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.5	0.0	2.4	0.1	21.1	22.3	9.1	22.8	23.4	24.5	19.6	22.5	18.6	13.4	30.7	17.5	34.8	9.6	14.4	16.6	1.8	15.9	16.0	11.2	4.6	12.6	24.3	22.4	16.4	18.6	14.0	3.7	52.1	6.4	2.3	25.5	0.0	8.9	25.9	30.7	15.1	30.2	19.8	30.5	45.2	12.7	10.1	15.1	18.3	28.0	36.8	23.7	12.8	14.4	10.4	3.3	42.4	14.0	14.2	7.3	10.9	16.3	6.8	7.3	14.2	33.7	7.6	15.0	0.0	33.7	29.5	20.0	12.1	4.1	1.8	17.2	9.6	6.2	15.1	6.5	0.0	12.4	14.7	13.6	18.7	21.0	19.6	4.5	13.3	16.7	12.7	29.6
ZW10	KNTC1AP	ENSG00000086827	"Zw10 kinetochore protein"	O43264	11	113733187-113773735	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011565, HPA051253, HPA055410"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809"	"unprognostic (4.33e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (3.12e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (7.44e-2)"	"unprognostic (8.01e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.57e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-3)"	6.9	6.0	3.5	8.1	4.1	9.2	10.9	5.0	4.8	8.1	3.7	8.3	7.2	7.6	7.3	9.6	6.1	5.9	5.6	3.8	3.8	8.8	13.0	6.4	9.4	4.2	4.7	6.9	9.1	7.2	5.1	7.7	4.6	7.9	10.0	6.8	8.3	7.3	13.4	13.7	7.1	8.7	3.8	7.0	7.3	13.5	4.2	12.1	6.7	12.0	12.0	8.5	7.5	5.7	25.0	14.4	30.2	22.1	18.4	20.0	17.4	26.1	21.4	32.2	32.5	38.1	46.1	29.0	34.5	25.8	28.1	34.2	36.7	31.6	46.0	19.1	15.1	30.9	12.0	23.5	20.6	31.7	18.8	16.5	20.8	34.1	27.4	14.2	33.5	31.7	36.3	11.8	33.8	12.2	29.3	20.9	21.7	29.8	29.0	27.0	34.4	32.7	21.2	22.2	13.3	15.7	29.1	24.2	11.8	24.2	44.9	17.4	21.1	28.8	44.2	14.4	28.8	6.1	10.6	30.6	9.9	38.1	33.0	8.5	7.4	7.4	6.3	10.4	8.5	5.9	5.9	5.6	9.5	5.1	5.4	6.8	1.9	6.2	9.2	3.0	5.6	5.6	3.5	4.1	5.0	4.8	3.8	3.8	4.2	4.7	4.6	3.8	4.2	5.7	5.6	0.0	4.8	11.1	5.8	12.1	7.6	7.5	8.0	2.9	5.9	5.0	6.8	7.2	7.3	0.0	0.0	9.2	3.9	3.9	9.8	10.1	10.7	7.7	7.1	6.9	3.6	10.7	12.5	11.8	10.0	6.5	8.2	12.7	3.8	7.8	3.9	8.1	9.2	3.3	11.1	4.6	4.1	6.0	5.4	7.3	5.0	6.1	3.6	10.3	8.0	7.6	3.1	12.1	18.7	8.4	3.8	5.7	10.4	5.6	5.3	7.2	4.8	4.9	19.7	7.0	7.0	44.4	17.5	9.4	12.5	10.5	5.9	6.9	6.4	5.8
